data_2kc5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kc5 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.8 mm -119.37 126.01 74.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 169.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.67 145.28 38.87 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.029 0.442 . . . . 0.0 109.816 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.02 146.2 50.34 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.795 1.188 . . . . 0.0 111.456 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -89.57 139.84 30.14 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.323 1.049 . . . . 0.0 108.912 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -71.42 -38.86 71.36 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.7 p -155.1 166.2 34.32 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 128.162 2.585 . . . . 0.0 107.847 170.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.5 m -54.08 141.02 51.21 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.419 1.088 . . . . 0.0 112.203 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -75.89 49.38 2.48 Favored 'Trans proline' 0 CA--C 1.541 0.844 1 C-N-CA 125.429 4.086 . . . . 0.0 110.872 170.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -54.21 -46.15 72.4 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.879 1.672 . . . . 0.0 112.032 -169.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.95 98.53 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 122.506 0.323 . . . . 0.0 111.259 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -40.19 69.44 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 119.074 -0.488 . . . . 0.0 109.804 -174.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 84.2 t -58.22 -45.67 88.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 171.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -61.17 -53.86 51.61 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.861 0.755 . . . . 0.0 110.95 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.0 -39.25 93.17 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.713 0.688 . . . . 0.0 111.128 -174.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.26 -47.54 81.96 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -70.69 -24.42 62.66 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-O 118.289 -0.862 . . . . 0.0 112.592 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -62.11 -37.35 84.78 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.342 0.974 . . . . 0.0 108.979 172.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -80.46 -45.24 17.9 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.8 mt -61.92 -31.9 52.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 O-C-N 120.896 -1.128 . . . . 0.0 110.219 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.99 -24.7 63.35 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.282 -0.886 . . . . 0.0 112.201 174.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.9 ttm105 -83.71 -41.64 17.47 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.936 0.894 . . . . 0.0 109.632 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo . . . . . 0 N--CA 1.457 -0.66 0 CA-C-O 120.638 0.182 . . . . 0.0 111.746 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 m -65.59 148.31 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 171.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -143.11 157.75 44.23 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 124.06 0.944 . . . . 0.0 109.076 -175.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.2 t -138.99 126.62 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -177.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.6 p -89.01 150.67 22.69 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 169.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -132.61 132.79 42.87 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.561 1.544 . . . . 0.0 108.24 173.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.462 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 43.1 p90 -169.9 145.76 3.02 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.354 0.662 . . . . 0.0 112.704 -171.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.8 m 58.52 165.14 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 128.014 2.525 . . . . 0.0 115.409 167.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.2 tp -115.84 58.3 0.74 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.07 1.348 . . . . 0.0 109.157 175.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.91 137.21 47.25 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.025 0.93 . . . . 0.0 110.042 -173.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 55.15 22.85 4.88 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.367 1.067 . . . . 0.0 111.874 -171.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.07 20.61 77.37 Favored Glycine 0 CA--C 1.531 1.053 0 O-C-N 121.223 -0.923 . . . . 0.0 112.874 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -135.79 143.11 45.04 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.223 1.511 . . . . 0.0 108.118 -172.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -65.7 135.39 54.9 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.303 -0.873 . . . . 0.0 108.961 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.462 ' HB ' ' CE2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -103.09 160.07 14.97 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.857 0.837 . . . . 0.0 109.514 -177.299 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -169.35 168.81 41.54 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 56.4 m -135.96 146.82 47.68 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 168.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.1 p -111.81 143.55 21.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 171.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.85 141.64 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 169.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.3 p -136.8 173.83 5.1 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 171.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.9 -25.7 74.31 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 CA-C-N 121.386 1.531 . . . . 0.0 111.238 169.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.4 p-90 -93.41 -26.57 17.17 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 118.155 -0.926 . . . . 0.0 113.215 -172.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.97 170.21 23.05 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 120.256 1.389 . . . . 0.0 113.057 -174.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 tt -137.57 127.96 26.45 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 168.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.6 m -140.68 137.52 33.6 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 123.04 0.536 . . . . 0.0 110.017 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.6 146.82 48.14 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 168.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.3 m -138.48 144.18 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.23 1.412 . . . . 0.0 108.178 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 31.7 mt -142.69 141.91 27.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 125.37 1.468 . . . . 0.0 107.283 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -130.33 133.79 25.32 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-O 117.646 -1.168 . . . . 0.0 108.203 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.85 137.78 21.4 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.282 2.655 . . . . 0.0 111.899 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.56 179.07 34.26 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.302 0.953 . . . . 0.0 112.756 -173.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.67 145.05 56.47 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.982 2.455 . . . . 0.0 111.019 -172.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.1 t0 50.63 57.69 6.34 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.381 1.472 . . . . 0.0 112.188 177.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -128.76 148.93 50.89 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.385 1.474 . . . . 0.0 108.223 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -124.34 83.03 2.1 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 175.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.71 150.91 97.51 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 172.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.34 155.23 70.98 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.901 1.734 . . . . 0.0 109.972 170.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 68.9 tp -63.85 129.25 39.33 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 170.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -104.61 163.38 12.51 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.474 0.579 . . . . 0.0 109.559 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -89.52 157.18 18.19 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 169.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.1 t -86.5 153.41 3.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -169.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . 0.254 42.7 m 65.84 11.84 7.92 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.229 1.411 . . . . 0.0 113.58 -174.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -74.85 158.16 33.88 Favored 'General case' 0 C--N 1.346 0.42 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 168.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -112.27 141.03 46.47 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.624 -0.673 . . . . 0.0 109.976 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.5 mm -120.38 123.92 71.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.09 121.99 6.4 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.8 mt -113.26 143.12 44.96 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.24 1.016 . . . . 0.0 108.299 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -95.05 127.41 41.09 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mp -135.59 153.96 77.92 Favored Pre-proline 0 C--O 1.234 0.288 0 C-N-CA 125.595 1.558 . . . . 0.0 107.282 174.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -64.58 -21.82 65.35 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.236 1.291 . . . . 0.0 112.497 172.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -58.7 -23.51 59.69 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.67 1.588 . . . . 0.0 111.524 169.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 129.65 148.35 6.49 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.979 2.228 . . . . 0.0 108.066 -173.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.0 m -63.11 130.92 46.74 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 170.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 43.7 ttp -144.61 138.76 27.63 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -169.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.54 130.95 35.45 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -104.4 131.68 51.49 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 169.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.8 m -85.25 139.26 31.77 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 97.7 t -70.82 110.86 4.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 172.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -94.24 155.91 22.02 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 106.91 -2.476 . . . . 0.0 106.91 169.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -134.55 122.32 22.21 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 169.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.6 tp -142.3 145.65 34.21 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.885 0.474 . . . . 0.0 110.411 -169.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -58.71 132.07 52.76 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.917 0.887 . . . . 0.0 111.062 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.93 0.3 50.19 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.046 0.831 . . . . 0.0 113.688 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 87.2 t -122.23 -27.11 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.267 1.427 . . . . 0.0 109.852 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.2 m 60.16 -150.52 0.42 Allowed 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.236 1.415 . . . . 0.0 108.691 -174.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -78.06 137.28 38.16 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.368 0.531 . . . . 0.0 110.152 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -152.44 166.81 30.79 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.974 1.71 . . . . 0.0 107.988 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.0 mp -117.81 122.32 43.1 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.1 m -143.79 158.36 43.73 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.008 0.822 . . . . 0.0 111.305 -169.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 15.6 p -149.4 140.38 22.89 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.844 -0.535 . . . . 0.0 109.816 169.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.0 m -67.09 138.25 56.98 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 174.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.0 mt -107.83 -48.45 3.4 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.174 0.99 . . . . 0.0 110.145 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 13.3 ptp -164.09 172.5 13.68 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.858 0.863 . . . . 0.0 110.329 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.1 m . . . . . 0 CA--C 1.541 0.611 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.627 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 CA--C 1.535 0.391 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.436 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -59.7 -31.17 46.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 123.618 0.767 . . . . 0.0 110.708 179.162 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.93 -46.72 73.92 Favored 'General case' 0 C--O 1.226 -0.166 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -63.24 -33.42 75.47 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.103 173.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.46 -62.13 6.63 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 171.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -65.07 -43.27 92.75 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 117.742 0.771 . . . . 0.0 111.282 -175.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -58.67 -40.98 85.09 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.37 0.668 . . . . 0.0 109.722 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.8 tp -81.28 -21.98 38.96 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 117.783 -1.104 . . . . 0.0 111.684 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.14 -42.71 79.74 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.837 1.653 . . . . 0.0 108.75 169.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -70.07 -41.2 74.44 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.262 0.625 . . . . 0.0 111.699 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -66.9 -31.04 71.36 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.064 -1.022 . . . . 0.0 110.653 174.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 21.1 m -69.31 -41.27 76.96 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.793 0.724 . . . . 0.0 110.257 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -55.89 -54.11 48.67 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.657 0.783 . . . . 0.0 109.549 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -52.27 -54.09 35.71 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.066 0.947 . . . . 0.0 109.974 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 57.0 ttp -49.42 -55.24 13.75 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.65 1.58 . . . . 0.0 111.271 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.7 pt -78.68 -25.34 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 118.955 0.798 . . . . 0.0 112.233 -171.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.1 mt . . . . . 0 CA--C 1.53 0.201 0 CA-C-N 118.671 0.669 . . . . 0.0 110.452 169.814 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.8 mm -118.4 131.62 70.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 126.627 1.971 . . . . 0.0 106.03 175.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.57 142.0 44.71 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 120.701 0.286 . . . . 0.0 110.373 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.8 151.57 51.04 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.209 0.909 . . . . 0.0 111.945 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -93.03 151.2 20.03 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.304 1.041 . . . . 0.0 109.669 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -94.19 -19.25 20.93 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.779 -0.629 . . . . 0.0 112.105 176.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.2 p -156.94 164.42 38.05 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 127.344 2.258 . . . . 0.0 107.734 169.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.1 m -56.9 133.49 79.57 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-O 118.236 -0.888 . . . . 0.0 109.614 169.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -70.83 50.14 1.05 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.433 3.422 . . . . 0.0 112.648 170.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.6 tttm -51.69 -48.68 63.39 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.831 1.652 . . . . 0.0 112.061 -169.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.2 94.93 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 122.705 0.402 . . . . 0.0 111.128 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -73.17 -40.13 65.07 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.384 0.674 . . . . 0.0 109.834 -175.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 80.9 t -61.11 -47.12 95.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -59.41 -50.49 73.76 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 118.923 -0.56 . . . . 0.0 110.872 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.74 -43.27 98.14 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.771 0.714 . . . . 0.0 110.423 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.18 -49.77 76.6 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.058 0.39 . . . . 0.0 110.234 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -66.05 -26.15 67.37 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.943 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -67.64 -29.18 68.42 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 120.098 1.317 . . . . 0.0 111.539 174.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -77.39 -54.82 5.99 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.172 0.896 . . . . 0.0 109.095 171.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.3 mt -60.52 -44.78 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 123.944 0.897 . . . . 0.0 109.851 -169.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.11 -28.71 70.25 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.953 -0.467 . . . . 0.0 111.346 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -81.79 -43.15 18.72 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 118.751 0.705 . . . . 0.0 109.828 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? . . . . . 0 N--CA 1.465 0.286 0 C-N-CA 123.112 0.565 . . . . 0.0 110.316 172.871 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo . . . . . 0 CA--C 1.536 0.601 0 N-CA-C 114.924 1.086 . . . . 0.0 114.924 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.3 m -109.04 56.58 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 104.629 -2.359 . . . . 0.0 104.629 167.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -83.93 156.86 22.15 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.548 1.139 . . . . 0.0 111.63 -168.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.0 t -140.07 127.14 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 123.695 0.798 . . . . 0.0 109.431 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.0 m -91.41 145.36 24.69 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.084 0.954 . . . . 0.0 108.952 168.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -125.6 138.22 53.92 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.873 1.669 . . . . 0.0 108.277 170.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.415 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 29.9 p90 -162.03 130.65 4.25 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -175.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 t 47.97 -179.78 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 129.992 3.317 . . . . 0.0 117.071 168.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.9 tp -117.58 86.4 2.51 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 171.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -74.6 -38.8 62.52 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -168.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.07 56.75 1.13 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 122.323 1.059 . . . . 0.0 108.495 -176.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 62.98 20.94 63.03 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.627 -175.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -144.15 139.94 29.09 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 126.616 1.966 . . . . 0.0 105.834 -174.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -74.75 143.58 44.02 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.415 ' HB ' ' CE2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -111.41 153.42 26.09 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.581 0.705 . . . . 0.0 109.299 -173.082 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -163.5 167.81 37.86 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 35.4 m -140.94 152.76 45.26 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 169.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.2 t -128.09 143.98 39.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.8 tt -127.14 148.19 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 169.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 49.3 p -137.78 177.83 1.96 Allowed Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 175.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -61.38 -6.31 6.64 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.63 2.22 . . . . 0.0 113.387 169.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.1 p-90 -131.14 -23.51 2.43 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -169.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.9 169.63 21.81 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.256 1.389 . . . . 0.0 112.13 -176.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 tt -139.27 123.13 17.66 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 168.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.7 m -139.56 134.16 31.77 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.236 0.541 . . . . 0.0 110.141 -175.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.99 146.25 54.92 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 168.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.4 m -137.17 141.76 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.7 mt -143.81 144.45 23.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -169.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -132.59 136.81 28.51 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 118.196 -0.907 . . . . 0.0 109.387 -173.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -46.75 138.49 14.91 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 124.007 3.138 . . . . 0.0 112.166 169.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.89 -179.92 46.32 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 123.734 0.683 . . . . 0.0 113.043 -174.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.71 145.76 52.51 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 123.518 2.812 . . . . 0.0 110.917 -173.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.2 t0 50.76 54.56 10.99 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.284 1.434 . . . . 0.0 111.986 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -124.32 154.32 40.47 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.941 1.297 . . . . 0.0 107.769 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 92.2 mt -129.16 85.3 2.3 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 8.8 m0 -65.67 153.09 91.53 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -62.86 155.04 62.44 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.658 2.239 . . . . 0.0 111.131 171.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.43 129.76 43.24 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 169.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -144.45 160.03 41.76 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -124.17 172.93 8.66 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 122.985 1.374 . . . . 0.0 110.529 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 70.1 t -70.03 150.93 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 112.461 -2.154 . . . . 0.0 109.645 -169.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.0 m 68.89 1.09 2.98 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.244 1.818 . . . . 0.0 114.096 -177.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -73.47 155.77 38.9 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 169.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -119.75 143.77 47.62 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 118.615 0.643 . . . . 0.0 110.122 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 48.3 mm -117.56 123.92 72.37 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.81 118.02 7.34 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 108.006 -2.038 . . . . 0.0 108.006 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.4 tp -123.75 130.46 52.66 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.907 0.883 . . . . 0.0 108.759 -172.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.34 128.53 34.58 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 174.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 mp -133.98 159.46 72.3 Favored Pre-proline 0 C--O 1.234 0.253 0 C-N-CA 124.721 1.209 . . . . 0.0 108.875 172.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -58.41 -26.45 77.78 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.13 1.887 . . . . 0.0 113.464 170.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -65.28 -9.43 24.07 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.389 1.075 . . . . 0.0 113.198 173.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.43 157.1 18.84 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 108.025 -2.03 . . . . 0.0 108.025 -169.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.8 m -67.48 130.94 44.64 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 49.5 mtm -142.54 145.05 33.23 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -177.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.53 123.52 25.62 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 170.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -95.64 135.97 36.63 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 169.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.0 m -89.05 144.03 26.44 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 70.5 t -76.57 119.26 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 169.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -106.7 169.85 15.6 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 169.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -138.2 141.55 40.02 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 169.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 19.0 mt -132.35 152.95 51.2 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 169.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.07 135.14 57.07 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.52 3.72 72.75 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 118.816 -0.991 . . . . 0.0 113.467 -175.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.91 -33.47 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 119.18 1.49 . . . . 0.0 109.933 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.1 m 59.66 -156.01 0.35 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -169.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -58.71 136.29 57.66 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.37 0.532 . . . . 0.0 110.327 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -148.76 166.59 27.97 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.838 1.655 . . . . 0.0 107.448 170.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.4 mp -102.76 143.67 32.1 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.3 p -146.31 160.2 42.34 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.778 0.831 . . . . 0.0 110.645 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 30.8 t -147.78 128.84 14.55 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 171.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.5 m -66.9 134.78 52.73 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.3 mt -105.94 -59.68 1.74 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.986 0.914 . . . . 0.0 108.701 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -142.03 166.84 23.61 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.751 1.22 . . . . 0.0 108.878 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 28.6 m . . . . . 0 CA--C 1.541 0.608 0 C-N-CA 124.346 1.058 . . . . 0.0 109.906 176.51 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 90.4 p . . . . . 0 N--CA 1.457 -0.122 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -57.78 -22.5 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.157 0.983 . . . . 0.0 111.793 168.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -85.26 -45.6 11.81 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.328 1.051 . . . . 0.0 109.507 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -63.13 -32.05 73.33 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.277 0.49 . . . . 0.0 110.039 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.51 -54.76 34.46 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -65.28 -47.78 75.48 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 117.298 0.549 . . . . 0.0 110.08 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 83.9 mtm-85 -65.33 -46.7 79.23 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 118.852 -0.594 . . . . 0.0 111.398 -175.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.1 tp -76.82 -28.87 55.72 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 118.058 -0.973 . . . . 0.0 111.697 -171.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.8 m -71.64 -36.98 70.88 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.977 1.262 . . . . 0.0 109.546 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -70.37 -41.25 73.34 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.359 0.663 . . . . 0.0 111.529 174.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -65.24 -31.07 72.04 Favored 'General case' 0 CA--C 1.53 0.212 0 O-C-N 121.114 -0.991 . . . . 0.0 110.52 173.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 34.1 m -69.94 -40.06 75.7 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 121.922 -0.486 . . . . 0.0 110.227 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.17 -50.87 72.01 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.718 0.407 . . . . 0.0 110.074 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -55.26 -55.78 27.51 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 123.902 0.881 . . . . 0.0 110.057 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 16.3 ptt? -59.42 -39.4 83.38 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 117.992 -1.004 . . . . 0.0 111.038 -172.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . 0.274 6.6 pt -79.83 -21.69 12.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 119.761 1.164 . . . . 0.0 112.248 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 30.8 mt . . . . . 0 N--CA 1.468 0.437 0 CA-C-N 118.914 0.779 . . . . 0.0 108.951 168.19 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.2 mt -132.61 143.84 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.594 1.957 . . . . 0.0 105.786 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.76 147.06 41.64 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.801 0.728 . . . . 0.0 110.501 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.79 163.73 51.8 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.476 1.036 . . . . 0.0 111.439 170.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -126.52 142.01 51.68 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.042 1.337 . . . . 0.0 109.852 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -73.63 -19.77 60.77 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 122.951 0.501 . . . . 0.0 111.817 -173.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 p -146.82 154.08 40.93 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.85 1.66 . . . . 0.0 108.303 171.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -67.02 148.92 98.78 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 171.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.61 54.91 5.27 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 124.943 3.762 . . . . 0.0 111.002 175.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.3 tttm -53.83 -43.92 69.83 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.184 1.394 . . . . 0.0 111.993 -169.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.0 -40.77 97.12 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 118.43 0.559 . . . . 0.0 111.224 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -74.98 -35.44 62.05 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.101 -177.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.45 -45.77 96.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 170.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -60.29 -50.12 74.9 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.104 0.562 . . . . 0.0 110.144 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.76 -39.53 93.77 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.593 0.633 . . . . 0.0 111.352 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.46 -49.51 76.52 Favored 'General case' 0 C--N 1.337 0.065 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -71.49 -28.56 64.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 118.032 -0.985 . . . . 0.0 112.183 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -60.29 -40.59 90.99 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.85 1.204 . . . . 0.0 109.32 170.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -71.93 -46.41 57.67 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -175.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.2 mt -57.89 -45.8 87.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.0 -34.94 79.14 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.68 -0.638 . . . . 0.0 111.516 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -72.41 -36.02 68.53 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.96 0.904 . . . . 0.0 109.244 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? . . . . . 0 CA--C 1.536 0.405 0 C-N-CA 124.297 1.039 . . . . 0.0 110.659 169.856 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.452 -0.937 0 N-CA-C 110.332 -0.68 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.8 t -71.02 130.03 34.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 169.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -138.8 150.16 45.76 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.166 0.986 . . . . 0.0 108.801 -169.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.2 t -141.55 124.08 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -172.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.8 m -91.55 134.75 34.4 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 168.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -121.7 135.61 54.95 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.854 1.262 . . . . 0.0 107.885 169.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.457 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 25.8 p90 -167.66 142.21 3.69 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -169.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m 58.46 158.33 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.935 2.494 . . . . 0.0 115.735 167.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.1 tp -111.19 66.04 0.62 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 169.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -57.11 -33.67 67.57 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 -165.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -136.42 26.65 3.14 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.226 0.61 . . . . 0.0 111.255 175.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.13 15.91 60.09 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 119.378 -0.679 . . . . 0.0 112.302 -169.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -136.94 143.92 43.14 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 174.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -69.22 143.56 53.94 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.457 ' HB ' ' CE2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -107.48 155.1 20.43 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -177.11 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.9 163.41 36.37 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 67.2 m -140.73 146.96 38.43 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 p -124.95 144.19 35.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 175.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.7 tt -126.76 150.18 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 169.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.5 p -140.87 178.03 1.73 Allowed Pre-proline 0 N--CA 1.442 -0.87 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 173.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -61.82 -28.6 81.79 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 CA-C-N 119.286 0.781 . . . . 0.0 110.941 168.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.5 p-90 -95.4 -25.36 16.3 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -170.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.19 170.77 21.73 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.623 1.556 . . . . 0.0 113.416 -175.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 tt -136.04 125.46 24.99 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 103.07 -2.937 . . . . 0.0 103.07 167.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.2 m -137.05 133.94 36.0 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 122.991 0.517 . . . . 0.0 109.992 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.37 145.15 41.89 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 168.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.2 m -138.09 146.83 26.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.7 mt -137.94 135.45 45.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -174.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -122.99 150.43 59.21 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.435 1.094 . . . . 0.0 110.872 -169.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -44.38 152.51 0.43 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 124.736 3.624 . . . . 0.0 114.962 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.41 175.21 15.89 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 123.898 0.761 . . . . 0.0 113.697 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.82 -49.03 10.9 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.578 2.852 . . . . 0.0 114.305 -169.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -161.42 89.57 0.77 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.314 1.445 . . . . 0.0 107.231 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -155.79 -178.01 6.98 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.727 1.611 . . . . 0.0 106.688 178.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -95.7 136.71 35.76 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 168.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -107.97 144.04 28.56 Favored Pre-proline 0 C--N 1.324 -0.513 0 C-N-CA 126.656 1.983 . . . . 0.0 107.207 173.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.2 136.61 44.7 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.015 1.81 . . . . 0.0 110.606 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 64.1 tp -77.54 130.31 36.78 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 169.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.37 158.37 44.42 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 119.175 0.898 . . . . 0.0 109.956 -174.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -73.45 150.93 41.31 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.6 t -91.05 155.92 3.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -170.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.0 m 61.44 33.2 18.75 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.83 0.852 . . . . 0.0 111.658 -175.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -111.76 151.19 29.26 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 126.804 2.041 . . . . 0.0 106.983 169.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -105.26 142.37 35.15 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.092 0.86 . . . . 0.0 111.031 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.2 mm -118.86 130.04 74.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 174.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.21 123.2 6.77 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.9 mt -112.94 140.79 47.45 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.25 127.7 35.79 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 171.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mp -134.95 158.43 74.94 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 124.812 1.245 . . . . 0.0 107.774 174.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -60.81 -23.58 76.96 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.141 1.894 . . . . 0.0 113.98 172.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -64.2 -17.02 63.14 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.996 1.318 . . . . 0.0 111.949 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.94 152.12 9.12 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 107.881 -2.088 . . . . 0.0 107.881 -169.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.5 m -64.63 131.96 48.42 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 38.8 ttp -149.01 138.01 21.4 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -170.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.94 134.66 37.83 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -111.09 137.99 48.07 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 169.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.1 m -85.89 138.21 32.19 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 72.2 t -70.14 117.07 12.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 169.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -104.98 157.94 16.33 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 108.044 -2.022 . . . . 0.0 108.044 171.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -127.49 81.66 2.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 171.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.6 tp -66.1 128.89 37.88 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -169.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.66 131.38 50.52 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 122.832 0.453 . . . . 0.0 110.724 -172.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.36 4.92 75.71 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-O 118.607 -1.107 . . . . 0.0 113.576 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.2 t -122.39 -121.87 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.5 m -151.12 175.97 11.62 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.277 1.431 . . . . 0.0 109.544 -169.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -69.56 141.78 53.73 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 169.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -157.08 -179.15 7.93 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.308 1.443 . . . . 0.0 108.532 178.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 13.6 mt -113.78 136.66 52.61 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.2 p -139.75 153.59 47.22 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.793 0.837 . . . . 0.0 110.672 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 43.8 t -141.26 116.11 9.76 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 173.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.3 m -75.92 135.75 40.09 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 175.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 69.6 mt -116.7 -42.64 2.96 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.92 0.488 . . . . 0.0 112.276 -169.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 20.0 ptp -159.03 164.91 35.05 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.639 0.775 . . . . 0.0 109.746 -176.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.3 m . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 170.193 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.6 p . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.434 ' H ' HD11 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -56.25 -41.01 68.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 123.679 0.791 . . . . 0.0 109.293 169.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -71.31 -44.27 65.47 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.097 0.559 . . . . 0.0 109.629 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -68.24 -22.33 64.78 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.645 -0.66 . . . . 0.0 110.998 175.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.29 -48.77 81.56 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 169.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -68.97 -54.05 17.39 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.71 -0.877 . . . . 0.0 110.584 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -65.5 -42.18 92.39 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 118.588 -0.72 . . . . 0.0 112.028 -169.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.9 tp -76.6 -27.15 55.66 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 119.896 1.225 . . . . 0.0 111.246 -171.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.2 m -71.45 -38.05 71.34 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.008 1.276 . . . . 0.0 109.232 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.85 -41.12 78.91 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.897 -0.502 . . . . 0.0 111.637 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -65.21 -34.97 79.63 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 121.022 -1.049 . . . . 0.0 110.325 173.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 18.0 t -67.71 -34.0 76.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.3 -51.73 54.46 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.363 0.665 . . . . 0.0 109.678 170.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 35.6 tpt85 -52.9 -50.08 64.63 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.55 0.74 . . . . 0.0 110.542 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 13.7 ptt? -59.53 -26.55 65.43 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 118.989 0.813 . . . . 0.0 112.306 -172.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 24.3 pt -96.16 5.49 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-N 119.166 0.894 . . . . 0.0 111.898 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.1 mt . . . . . 0 CA--C 1.542 0.647 0 C-N-CA 125.951 1.7 . . . . 0.0 112.078 -174.692 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 CA--C 1.534 0.36 0 CA-C-O 120.833 0.349 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.0 mm -128.56 125.9 64.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 172.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -72.7 128.59 35.99 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 173.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.46 153.51 52.91 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -84.08 136.07 34.16 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.136 0.974 . . . . 0.0 109.74 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -72.26 -33.03 67.18 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.806 -0.616 . . . . 0.0 110.075 173.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.8 p -150.72 155.32 39.06 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.427 1.891 . . . . 0.0 108.543 169.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.6 m -53.26 138.59 47.77 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 125.573 1.549 . . . . 0.0 113.703 -170.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -81.89 44.65 1.76 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 124.909 3.739 . . . . 0.0 110.88 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -61.63 -35.04 76.77 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.212 -1.555 . . . . 0.0 112.688 -168.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.58 -42.38 95.65 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 123.155 0.582 . . . . 0.0 110.983 176.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -68.45 -41.65 79.96 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.336 0.654 . . . . 0.0 109.343 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.6 t -59.44 -46.48 92.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 173.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -60.69 -53.4 57.93 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.284 0.634 . . . . 0.0 110.452 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.73 -44.75 95.39 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.941 0.496 . . . . 0.0 110.832 -172.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.58 -47.27 86.92 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -67.87 -26.26 65.93 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 118.37 -0.824 . . . . 0.0 112.31 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -63.76 -34.5 78.04 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.851 1.205 . . . . 0.0 110.051 176.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -70.91 -50.12 38.32 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.808 0.731 . . . . 0.0 109.34 174.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.8 mt -65.69 -39.67 85.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 123.988 0.915 . . . . 0.0 110.594 -169.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.3 -26.37 65.61 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.082 0.553 . . . . 0.0 111.51 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -85.25 -100.3 0.06 Allowed 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 172.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.546 0.817 0 C-N-CA 125.569 1.548 . . . . 0.0 114.273 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 N--CA 1.456 -0.734 0 N-CA-C 114.204 0.809 . . . . 0.0 114.204 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.9 t -108.3 112.02 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 167.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -148.86 151.77 35.3 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.645 0.778 . . . . 0.0 109.65 -169.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.2 t -137.67 116.24 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 123.669 0.788 . . . . 0.0 109.187 -173.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.0 m -80.62 157.3 26.03 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.913 0.885 . . . . 0.0 110.318 169.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.88 140.5 52.92 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.76 2.024 . . . . 0.0 109.498 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.478 ' CE2' ' CB ' ' A' ' 131' ' ' ALA . 60.1 m-85 -147.06 169.7 18.7 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -169.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.8 t -52.03 167.45 0.12 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 129.132 2.973 . . . . 0.0 114.505 -169.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.9 tp -77.99 125.5 29.44 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 174.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.89 135.7 33.15 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.18 1.792 . . . . 0.0 107.299 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 55.38 24.16 6.37 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.864 0.866 . . . . 0.0 111.992 -170.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.23 5.88 78.12 Favored Glycine 0 CA--C 1.534 1.233 0 O-C-N 121.026 -1.046 . . . . 0.0 113.817 -174.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -119.14 157.22 28.34 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.191 1.796 . . . . 0.0 108.952 -175.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -79.3 147.76 32.36 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.311 -1.493 . . . . 0.0 110.091 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.58 162.82 12.94 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 122.506 1.146 . . . . 0.0 109.885 169.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.14 172.13 39.88 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 107.49 -2.244 . . . . 0.0 107.49 169.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 11.6 m -138.93 152.4 47.69 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 105.591 -2.004 . . . . 0.0 105.591 169.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.71 138.86 52.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 175.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.6 tt -116.1 146.22 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 167.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.4 t -154.8 157.11 31.97 Favored Pre-proline 0 N--CA 1.442 -0.863 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 175.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -50.23 -29.7 23.69 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.934 2.422 . . . . 0.0 113.646 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -93.14 -19.88 21.04 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -174.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -166.69 159.45 13.99 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.911 1.687 . . . . 0.0 112.66 -175.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.4 tt -124.57 124.88 43.19 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 103.848 -2.649 . . . . 0.0 103.848 167.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.8 m -137.65 134.46 35.49 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.35 0.595 . . . . 0.0 109.724 -172.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.84 144.2 52.65 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 167.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.7 m -136.11 150.44 28.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 32.1 mt -135.92 143.4 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -123.89 139.43 32.41 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -53.98 132.16 48.41 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.868 1.712 . . . . 0.0 108.928 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.4 -175.91 31.27 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.292 0.948 . . . . 0.0 114.68 -169.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -71.17 153.79 62.17 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.203 2.602 . . . . 0.0 110.204 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.0 t0 46.67 44.59 13.88 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.067 1.747 . . . . 0.0 113.068 172.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -133.62 143.52 48.67 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.103 1.361 . . . . 0.0 107.842 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -112.19 95.94 5.75 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 172.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -65.63 155.64 85.2 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.443 171.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -68.35 164.46 32.44 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.629 2.22 . . . . 0.0 109.909 169.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.25 87.68 1.12 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 169.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -70.82 148.98 47.29 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -89.9 159.04 17.15 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 169.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.8 t -91.37 154.22 3.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 114.048 -1.433 . . . . 0.0 107.647 -169.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.8 m 66.26 6.19 4.1 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.433 1.493 . . . . 0.0 113.673 -175.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -80.06 158.63 26.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.988 1.315 . . . . 0.0 108.268 169.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -113.97 144.22 43.44 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.966 0.803 . . . . 0.0 110.847 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.4 mm -118.21 121.09 66.36 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 176.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.11 125.33 7.74 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 173.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.3 mt -123.27 141.17 52.27 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.317 1.047 . . . . 0.0 109.084 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -90.53 133.65 34.92 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 172.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -153.49 157.51 32.76 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 124.958 1.303 . . . . 0.0 107.895 172.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -61.04 -20.26 66.84 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.059 2.506 . . . . 0.0 114.705 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -62.51 -20.65 64.83 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.944 0.898 . . . . 0.0 112.067 172.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.54 145.71 7.04 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 -170.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.9 m -60.64 131.07 49.56 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 174.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 47.6 ttp -149.67 146.21 27.14 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -169.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.55 134.02 34.42 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 121.883 -0.511 . . . . 0.0 110.493 176.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -104.98 132.25 51.46 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 168.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.2 m -82.01 144.11 31.1 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.0 t -75.96 114.39 16.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -98.1 162.75 21.02 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 171.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -129.9 133.86 47.13 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 169.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.6 tp -143.84 145.97 32.71 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -176.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -59.5 134.88 57.42 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.789 0.435 . . . . 0.0 110.572 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.17 4.45 59.71 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 118.945 -0.919 . . . . 0.0 113.701 -177.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.4 t -124.7 -33.15 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 118.928 1.364 . . . . 0.0 109.746 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.7 m 57.39 -150.09 0.45 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.331 1.053 . . . . 0.0 108.445 -169.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -58.61 132.15 52.94 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.884 0.874 . . . . 0.0 110.579 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -154.5 179.41 9.05 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.365 1.866 . . . . 0.0 107.011 169.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.6 mp -113.47 144.36 42.95 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 121.131 -0.981 . . . . 0.0 109.217 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.8 p -142.86 154.58 44.28 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.571 1.148 . . . . 0.0 110.278 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 12.2 t -144.75 111.87 5.96 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 170.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.9 m -67.98 130.17 42.14 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.7 mt -96.38 -59.34 1.85 Allowed 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -176.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.87 170.28 12.4 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.342 1.457 . . . . 0.0 108.377 177.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 170.844 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 78.7 p . . . . . 0 C--O 1.236 0.373 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.52 HD13 ' H ' ' A' ' 120' ' ' ILE . 1.9 mp -58.34 -36.87 60.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 169.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -72.59 -44.99 61.29 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.572 0.749 . . . . 0.0 109.959 -174.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -64.23 -31.92 73.31 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.646 172.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.07 -58.39 14.42 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-N 119.455 1.025 . . . . 0.0 111.533 169.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -63.82 -48.55 76.4 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.043 0.922 . . . . 0.0 110.478 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -57.41 -45.44 84.59 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.935 1.294 . . . . 0.0 110.699 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.6 tp -78.35 -27.87 47.07 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.201 -174.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.9 m -65.83 -44.84 84.35 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.724 1.147 . . . . 0.0 109.173 173.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -65.68 -46.42 79.11 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.45 0.7 . . . . 0.0 111.299 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.04 -33.29 75.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.813 0.445 . . . . 0.0 110.548 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 19.0 m -68.22 -39.64 82.29 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.23 0.468 . . . . 0.0 110.797 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.478 ' CB ' ' CE2' ' A' ' 45' ' ' PHE . . . -65.23 -50.69 64.88 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 171.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -52.9 -51.36 61.52 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.065 0.848 . . . . 0.0 110.737 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 58.2 ttp -43.13 -48.23 6.27 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.152 2.181 . . . . 0.0 112.476 173.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 11.0 pt -92.78 -15.37 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 118.767 0.712 . . . . 0.0 112.513 -174.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 18.6 mt . . . . . 0 N--CA 1.456 -0.156 0 C-N-CA 124.384 1.074 . . . . 0.0 110.548 -175.677 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.64 133.08 70.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 169.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -153.14 164.0 38.84 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.232 1.013 . . . . 0.0 110.207 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 134.78 -150.54 20.14 Favored Glycine 0 C--N 1.341 0.828 0 C-N-CA 125.035 1.302 . . . . 0.0 110.368 176.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -84.54 -27.26 27.46 Favored 'General case' 0 C--O 1.221 -0.447 0 C-N-CA 125.061 1.344 . . . . 0.0 107.463 169.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 58.9 16.32 4.49 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 167.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.3 p -52.28 145.38 11.04 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.336 1.054 . . . . 0.0 112.069 -177.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -48.12 126.22 11.68 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 126.04 1.736 . . . . 0.0 111.146 -175.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -73.45 53.21 2.58 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.906 3.071 . . . . 0.0 112.036 174.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.7 tttm -47.66 -48.76 28.78 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.44 1.896 . . . . 0.0 112.998 -169.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.64 -41.19 88.66 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.275 0.489 . . . . 0.0 111.69 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -71.87 -38.75 70.0 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.926 0.49 . . . . 0.0 109.795 -176.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 71.7 t -61.63 -44.16 98.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 172.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -60.31 -53.74 54.08 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.58 0.627 . . . . 0.0 110.078 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.93 -40.09 96.59 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.613 0.642 . . . . 0.0 111.194 -176.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.61 -46.9 86.15 Favored 'General case' 0 C--N 1.339 0.126 0 O-C-N 122.064 -0.398 . . . . 0.0 110.019 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -68.79 -25.15 64.56 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 118.419 -0.8 . . . . 0.0 112.379 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -67.08 -33.19 74.96 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 119.504 1.047 . . . . 0.0 109.803 173.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -77.58 -45.99 23.56 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.746 -0.596 . . . . 0.0 109.888 176.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.0 mt -60.43 -39.73 81.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.09 -34.46 77.65 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.362 -0.836 . . . . 0.0 111.549 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -71.73 -43.19 66.28 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.052 0.842 . . . . 0.0 109.059 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? . . . . . 0 CA--C 1.533 0.303 0 C-N-CA 123.957 0.903 . . . . 0.0 111.152 175.235 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo . . . . . 0 N--CA 1.453 -0.883 0 N-CA-C 112.827 0.28 . . . . 0.0 112.827 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.2 m -67.06 152.92 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 168.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -140.53 155.56 46.59 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.453 1.024 . . . . 0.0 110.073 -175.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.4 t -139.54 114.28 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.2 m -78.86 142.0 37.2 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 168.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -125.37 134.74 52.07 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.401 1.48 . . . . 0.0 107.865 169.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -165.11 142.8 6.09 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -172.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.4 m 54.58 166.27 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.104 2.562 . . . . 0.0 116.312 167.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.0 tp -113.54 110.34 20.09 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 168.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -131.22 135.74 47.65 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.678 1.591 . . . . 0.0 107.089 -169.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 55.51 25.05 7.43 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 121.644 0.735 . . . . 0.0 110.51 -168.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.16 3.64 65.75 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 118.146 -1.363 . . . . 0.0 113.901 -174.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -115.34 154.86 28.39 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.599 1.699 . . . . 0.0 109.403 -173.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -74.59 137.66 42.47 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.683 -1.26 . . . . 0.0 108.997 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.79 155.97 18.19 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.667 1.122 . . . . 0.0 110.255 -173.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.15 171.58 41.25 Favored Glycine 0 CA--C 1.526 0.721 0 O-C-N 121.081 -1.012 . . . . 0.0 111.732 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 15.0 m -145.76 152.44 39.57 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 170.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.87 144.6 35.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 124.986 1.314 . . . . 0.0 107.466 173.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.9 tt -127.83 150.28 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 169.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.2 p -138.56 175.87 3.05 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 169.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -59.54 -30.42 92.4 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 CA-C-N 119.701 0.929 . . . . 0.0 110.835 168.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 48.4 p-90 -92.45 -25.59 18.38 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -171.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.51 170.45 21.93 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.42 1.464 . . . . 0.0 113.491 -175.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.6 tt -138.29 128.45 25.78 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 104.147 -2.538 . . . . 0.0 104.147 168.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.2 m -140.65 138.74 34.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.655 0.741 . . . . 0.0 109.622 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.63 146.58 51.57 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 168.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.0 m -138.84 144.85 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 C-N-CA 123.807 0.843 . . . . 0.0 108.786 175.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 52.2 mt -138.35 144.07 31.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -128.3 146.18 58.6 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-O 117.974 -1.012 . . . . 0.0 108.621 -175.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.64 134.65 21.83 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.469 2.779 . . . . 0.0 111.023 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.78 173.61 53.36 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 123.01 0.338 . . . . 0.0 112.878 -175.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -69.71 149.9 67.81 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 122.532 2.155 . . . . 0.0 110.296 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.0 t70 50.71 40.46 24.27 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.409 1.884 . . . . 0.0 112.696 169.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -128.27 131.12 48.74 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.3 mp -96.74 83.23 3.41 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 -175.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 3.7 m0 -66.33 140.4 96.73 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.645 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -66.86 161.68 41.12 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.842 1.695 . . . . 0.0 108.454 168.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.0 tp -67.38 106.44 2.09 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 169.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -73.77 155.13 39.19 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.335 0.588 . . . . 0.0 109.642 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -89.87 148.14 23.34 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 169.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.6 t -89.84 154.72 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -169.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.1 m 65.01 12.86 8.25 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.149 1.38 . . . . 0.0 113.713 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -85.96 158.97 19.76 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.114 1.365 . . . . 0.0 108.212 169.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -111.23 143.24 42.3 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 118.796 0.726 . . . . 0.0 110.504 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.9 mp -114.09 127.82 71.34 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 N-CA-C 104.775 -2.305 . . . . 0.0 104.775 170.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.51 121.09 5.54 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 170.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.8 mt -109.32 132.57 54.0 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 174.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -85.97 125.96 33.77 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 173.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 37.1 mt -133.6 148.52 68.97 Favored Pre-proline 0 C--O 1.233 0.224 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -59.12 -24.6 74.48 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.383 2.055 . . . . 0.0 112.802 169.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -58.05 -29.61 65.51 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.995 1.318 . . . . 0.0 112.158 169.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.32 142.15 4.84 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 -169.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.7 m -61.5 130.47 46.17 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 174.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 44.2 ttp -147.75 136.97 22.31 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -170.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.12 139.79 35.42 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.753 -0.592 . . . . 0.0 110.145 175.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -112.81 136.72 52.12 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 169.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.5 m -91.8 140.97 29.17 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.3 t -72.61 129.21 35.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -114.39 159.64 13.61 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 107.54 -2.224 . . . . 0.0 107.54 169.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -127.5 100.32 5.96 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 171.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.8 tp -79.11 121.79 25.43 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -171.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.09 129.98 44.07 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.042 0.537 . . . . 0.0 110.604 -172.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.88 5.81 70.98 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.669 -1.073 . . . . 0.0 113.632 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.9 t -124.75 -113.23 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 118.847 1.324 . . . . 0.0 107.611 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 11.8 m -152.98 174.45 14.13 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.793 1.237 . . . . 0.0 110.142 -169.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -75.49 145.78 41.13 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 169.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.16 167.52 30.16 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.501 1.52 . . . . 0.0 108.277 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.4 mp -110.51 137.85 47.67 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.9 m -136.84 152.13 49.91 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.586 0.754 . . . . 0.0 110.47 -174.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 43.0 t -144.81 124.11 13.02 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 169.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.0 m -65.09 143.49 57.87 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 176.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.6 mt -117.69 -47.9 2.6 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 118.576 -0.726 . . . . 0.0 111.131 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 19.0 ptp -160.07 165.19 32.29 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.036 0.835 . . . . 0.0 110.541 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.3 m . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 169.896 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 CA--C 1.528 0.121 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.68 -24.84 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 O-C-N 120.923 -1.111 . . . . 0.0 111.114 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -67.04 -37.44 84.1 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.569 -0.707 . . . . 0.0 110.05 173.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -69.74 -31.72 69.86 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 118.888 0.767 . . . . 0.0 109.728 170.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.33 -36.94 46.98 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 169.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -84.6 -52.38 6.15 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.23 -1.159 . . . . 0.0 110.821 173.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 60.1 ttp85 -65.58 -38.5 89.68 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -169.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.62 -31.24 46.93 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 119.677 1.126 . . . . 0.0 109.2 -173.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 m -67.43 -42.52 83.04 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 123.677 0.791 . . . . 0.0 109.061 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -66.75 -41.26 88.11 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.349 1.06 . . . . 0.0 111.828 173.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.97 -30.54 65.37 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 121.176 -0.952 . . . . 0.0 110.636 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 44.0 m -69.32 -43.02 74.6 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.974 0.51 . . . . 0.0 110.172 173.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -54.34 -49.76 68.98 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.217 1.007 . . . . 0.0 110.276 173.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.0 ttp-105 -68.49 -42.69 78.29 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.43 -0.794 . . . . 0.0 111.851 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 51.4 ttp -48.31 -56.4 8.17 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.312 1.045 . . . . 0.0 110.601 171.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.6 pt -78.36 -6.07 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 118.865 0.757 . . . . 0.0 112.961 -176.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 19.0 tp . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 170.007 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 . . . . . 0 CA--C 1.536 0.411 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 71.2 mt -131.82 129.93 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 174.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.59 145.66 36.69 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.149 0.499 . . . . 0.0 110.49 -178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.17 151.18 51.66 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.911 1.243 . . . . 0.0 112.422 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -86.45 131.14 34.27 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 170.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -74.02 -32.7 63.48 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 171.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 p -149.73 148.22 28.97 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.489 1.916 . . . . 0.0 107.488 169.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.6 m -59.84 150.67 67.38 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 126.816 2.046 . . . . 0.0 114.13 -169.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -80.6 42.28 1.3 Allowed 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 124.306 3.337 . . . . 0.0 111.737 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 tttm -52.83 -46.91 67.97 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.853 1.261 . . . . 0.0 112.04 -169.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.57 -41.05 98.41 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 122.57 0.348 . . . . 0.0 111.407 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -72.28 -38.63 68.74 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -175.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 99.3 t -61.35 -44.08 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 172.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -62.17 -50.44 71.83 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 118.849 -0.596 . . . . 0.0 110.579 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.62 -39.13 93.17 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.765 0.711 . . . . 0.0 111.032 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.43 -50.33 74.02 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -68.36 -28.19 66.91 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 118.172 -0.918 . . . . 0.0 112.594 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.8 -33.88 76.66 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 120.028 1.285 . . . . 0.0 109.582 175.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -80.05 -43.27 22.16 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.289 0.495 . . . . 0.0 110.352 176.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.1 mt -65.22 -37.96 81.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.263 -0.898 . . . . 0.0 109.117 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.31 -32.69 74.25 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.467 0.707 . . . . 0.0 110.707 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -72.53 -41.8 65.46 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.841 0.856 . . . . 0.0 109.459 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.274 0 C-N-CA 124.332 1.053 . . . . 0.0 110.266 173.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 N--CA 1.454 -0.818 0 N-CA-C 115.769 1.411 . . . . 0.0 115.769 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.6 t -111.63 107.9 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 101.128 -3.656 . . . . 0.0 101.128 167.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -140.85 159.17 42.78 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.946 0.898 . . . . 0.0 110.197 -169.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.3 t -138.16 112.21 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.7 m -76.17 147.82 38.2 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.487 1.04 . . . . 0.0 108.982 169.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -144.26 130.18 19.4 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.679 1.192 . . . . 0.0 111.622 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 176.59 159.35 0.33 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.017 1.327 . . . . 0.0 113.398 -172.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 m 61.64 152.86 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 128.473 2.709 . . . . 0.0 114.688 168.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.5 mt -103.62 125.55 50.21 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 169.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -135.34 138.45 43.4 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 173.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 54.18 26.31 6.57 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.971 0.908 . . . . 0.0 111.017 -169.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.54 7.14 82.68 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.927 1.251 . . . . 0.0 114.263 -176.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -119.17 148.68 42.82 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.236 1.518 . . . . 0.0 109.322 -173.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -66.72 145.3 55.68 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.235 0.925 . . . . 0.0 110.134 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.87 160.19 19.03 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.911 0.862 . . . . 0.0 110.173 -172.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -176.31 178.59 47.66 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 13.6 m -142.04 150.25 41.02 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 169.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.1 p -114.87 147.12 18.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 169.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.6 tt -130.08 151.34 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 169.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.5 p -142.41 172.06 6.35 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 169.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -73.89 21.06 0.38 Allowed 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 121.344 1.363 . . . . 0.0 112.063 169.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -138.13 -23.27 1.02 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.288 0.949 . . . . 0.0 113.403 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.18 164.71 37.57 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 120.363 1.438 . . . . 0.0 111.733 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 tt -137.61 125.87 23.18 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 168.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.3 m -138.18 134.18 34.21 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 123.332 0.395 . . . . 0.0 110.084 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.1 141.41 56.12 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 168.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 m -138.76 144.83 28.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 51.5 mt -141.33 134.35 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 -170.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -119.95 145.05 38.81 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.33 -172.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -44.68 125.8 6.62 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.738 2.959 . . . . 0.0 112.18 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.65 176.45 28.47 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 123.364 0.507 . . . . 0.0 113.193 -175.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -67.19 135.14 36.1 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.125 2.55 . . . . 0.0 110.411 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.7 t70 49.1 32.57 4.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.925 1.69 . . . . 0.0 113.259 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 -91.37 151.85 20.67 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 172.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -118.42 88.72 2.98 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 172.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 22.9 m0 -65.28 150.66 95.37 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 169.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.58 168.21 23.27 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.706 1.604 . . . . 0.0 108.375 169.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.8 tp -71.09 91.36 0.9 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 170.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -75.55 151.79 37.85 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.418 0.628 . . . . 0.0 109.679 -176.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -89.83 149.88 22.48 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 173.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.8 t -91.88 154.86 3.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 124.311 1.044 . . . . 0.0 108.281 -169.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.9 m 62.45 23.52 13.96 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.637 1.175 . . . . 0.0 112.667 -176.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -99.43 151.71 20.8 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.206 1.802 . . . . 0.0 107.648 169.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -106.2 143.63 34.06 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.503 0.592 . . . . 0.0 110.345 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 9.8 mt -123.92 128.41 74.18 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.85 123.14 6.89 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.8 mt -109.57 131.56 54.95 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 172.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.64 127.75 34.0 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 172.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.9 mt -135.2 153.62 78.33 Favored Pre-proline 0 C--O 1.234 0.275 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.79 -26.06 82.32 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.71 2.274 . . . . 0.0 112.759 174.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -65.37 -23.3 66.94 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.123 1.369 . . . . 0.0 111.911 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 129.69 147.15 6.2 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 126.176 1.846 . . . . 0.0 108.835 -169.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.7 m -62.78 133.86 55.39 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 55.7 ttm -144.47 136.09 25.72 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -169.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.42 130.11 35.11 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.521 -0.737 . . . . 0.0 109.169 173.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -106.06 136.48 45.65 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 169.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.8 m -87.58 137.88 31.96 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.1 t -71.02 114.81 9.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -101.47 163.31 17.74 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 169.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -130.58 97.8 4.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 170.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.5 tp -78.06 128.05 33.25 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -169.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -58.92 130.9 49.2 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.172 0.589 . . . . 0.0 110.52 -176.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.5 3.65 72.43 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.646 -1.086 . . . . 0.0 113.818 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.3 t -126.19 -121.0 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 119.143 1.471 . . . . 0.0 107.188 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.4 m -151.65 -176.79 5.76 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.776 1.63 . . . . 0.0 109.019 -169.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -72.91 148.62 44.17 Favored 'General case' 0 C--N 1.34 0.188 0 O-C-N 121.748 -0.595 . . . . 0.0 110.155 169.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -154.49 163.29 40.42 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.123 1.769 . . . . 0.0 108.03 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.4 mt -104.44 130.55 52.34 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.6 m -137.61 151.89 48.8 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.018 0.527 . . . . 0.0 110.884 -171.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 25.8 t -142.44 123.77 14.74 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 170.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.2 m -70.97 135.27 47.78 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 176.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.5 mt -110.48 -50.68 2.94 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.359 0.664 . . . . 0.0 111.165 -173.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 9.4 ptp -159.75 172.31 17.93 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.708 0.803 . . . . 0.0 109.982 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 CA--C 1.539 0.539 0 C-N-CA 124.044 0.938 . . . . 0.0 109.648 -177.051 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.7 t . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.504 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.6 OUTLIER -57.08 -36.59 51.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 119.09 0.859 . . . . 0.0 109.905 177.45 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -71.67 -32.41 67.84 Favored 'General case' 0 C--O 1.223 -0.308 0 O-C-N 121.652 -0.655 . . . . 0.0 110.462 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -73.73 -42.25 61.42 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.992 0.814 . . . . 0.0 109.372 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -49.01 -30.86 9.94 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 123.756 0.693 . . . . 0.0 113.882 169.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -90.33 -57.62 2.78 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.602 1.201 . . . . 0.0 111.481 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 71.8 ttt-85 -68.79 -32.58 72.41 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -168.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.6 mp -76.74 -38.34 54.37 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.757 1.162 . . . . 0.0 108.464 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.0 m -63.14 -43.58 97.93 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.3 1.04 . . . . 0.0 109.301 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.71 -55.0 39.81 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 118.657 -0.687 . . . . 0.0 110.801 171.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.27 -34.86 75.86 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.138 0.881 . . . . 0.0 111.408 -174.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 99.5 m -73.39 -27.14 61.3 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 122.11 -0.369 . . . . 0.0 111.854 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.52 -41.19 40.1 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.484 -0.76 . . . . 0.0 109.101 169.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -57.81 -55.34 36.11 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.262 1.425 . . . . 0.0 110.277 -173.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 17.3 ptt? -48.95 -34.09 12.21 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.655 1.582 . . . . 0.0 112.56 177.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 34.3 pt -93.53 2.5 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 119.863 1.21 . . . . 0.0 112.435 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 26.5 mt . . . . . 0 N--CA 1.465 0.316 0 C-N-CA 125.304 1.442 . . . . 0.0 112.844 -169.69 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 . . . . . 0 CA--C 1.544 0.74 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.0 mt -134.08 139.09 49.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 126.831 2.052 . . . . 0.0 106.19 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.28 150.61 45.02 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.931 -0.481 . . . . 0.0 111.307 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.24 163.1 42.63 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.301 0.953 . . . . 0.0 112.508 172.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -115.94 155.58 27.76 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.271 1.428 . . . . 0.0 109.736 175.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -88.63 -22.76 23.29 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.302 0.641 . . . . 0.0 111.659 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.3 p -159.2 -178.01 6.89 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 129.393 3.077 . . . . 0.0 106.323 172.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 m -57.19 134.99 80.92 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 121.247 -0.908 . . . . 0.0 109.534 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -74.19 63.48 5.23 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 124.537 3.491 . . . . 0.0 110.295 172.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -53.01 -50.74 63.6 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 124.266 1.026 . . . . 0.0 111.559 -169.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.32 -41.23 89.98 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 123.317 0.385 . . . . 0.0 110.708 -171.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -65.51 -45.91 81.7 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.595 0.758 . . . . 0.0 109.919 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 71.3 t -62.81 -41.12 91.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -62.98 -52.85 61.39 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.873 0.869 . . . . 0.0 109.996 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.77 -40.54 97.62 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.719 0.69 . . . . 0.0 110.648 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.04 71.56 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -68.06 -26.95 66.11 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 118.068 -0.968 . . . . 0.0 112.639 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -66.27 -31.1 71.71 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.826 1.194 . . . . 0.0 110.15 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -83.67 -41.63 17.53 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.243 0.617 . . . . 0.0 110.525 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.5 mt -65.52 -36.7 78.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 120.912 -1.117 . . . . 0.0 108.064 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.1 -27.78 68.61 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.228 -0.92 . . . . 0.0 112.244 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 62.9 ttp85 -76.41 -32.99 58.82 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.151 0.887 . . . . 0.0 109.665 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 . . . . . 0 CA--C 1.533 0.31 0 CA-C-O 118.904 -0.569 . . . . 0.0 110.857 171.293 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo . . . . . 0 N--CA 1.452 -0.92 0 N-CA-C 113.696 0.614 . . . . 0.0 113.696 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.3 t -99.49 106.98 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 1 N-CA-C 99.943 -4.095 . . . . 0.0 99.943 167.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -150.59 161.68 42.11 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.959 0.904 . . . . 0.0 109.944 -169.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 t -138.91 127.32 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.064 0.946 . . . . 0.0 108.748 -176.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.3 m -93.18 148.74 21.76 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.934 0.894 . . . . 0.0 109.039 168.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -121.9 141.28 51.45 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.361 1.865 . . . . 0.0 110.1 -176.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.419 ' CE2' ' CB ' ' A' ' 131' ' ' ALA . 91.1 m-85 -148.89 174.73 11.93 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.927 1.291 . . . . 0.0 113.053 -169.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.0 t -45.99 167.22 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 129.765 3.226 . . . . 0.0 115.121 -171.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.2 tp -84.76 107.1 16.77 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 105.69 -1.966 . . . . 0.0 105.69 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -76.64 -55.68 5.3 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 117.905 0.321 . . . . 0.0 111.578 -169.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.35 55.52 1.03 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.434 1.494 . . . . 0.0 109.347 177.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.83 10.25 79.34 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.075 -177.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -138.37 143.43 39.83 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.565 1.946 . . . . 0.0 107.362 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -74.79 152.08 39.04 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.679 0.672 . . . . 0.0 109.719 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.89 156.23 18.92 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.5 171.65 41.52 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.3 m -138.37 145.8 41.51 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 169.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 p -115.89 148.04 18.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 170.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.8 tt -129.73 152.11 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.885 1.274 . . . . 0.0 107.598 169.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.0 p -143.46 178.21 1.55 Allowed Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 125.337 1.455 . . . . 0.0 107.181 170.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.3 -24.57 77.84 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 121.331 1.354 . . . . 0.0 111.896 168.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.5 p-90 -104.3 -22.44 13.36 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -169.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.74 169.73 24.06 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 120.278 1.399 . . . . 0.0 112.608 -175.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.1 tt -138.29 126.4 22.82 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 103.946 -2.612 . . . . 0.0 103.946 168.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.6 m -138.89 134.69 33.6 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.16 147.48 46.57 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 168.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.4 m -139.04 148.41 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 124.574 1.15 . . . . 0.0 108.58 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 50.7 mt -138.57 137.85 42.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -126.31 148.33 63.36 Favored Pre-proline 0 N--CA 1.466 0.335 0 C-N-CA 124.042 0.937 . . . . 0.0 109.841 -173.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.4 133.86 31.32 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.709 2.273 . . . . 0.0 111.265 172.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.18 -171.35 16.47 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 123.756 0.693 . . . . 0.0 111.918 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.31 157.45 33.25 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.611 2.207 . . . . 0.0 111.297 -177.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.2 t0 43.76 56.33 4.62 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.747 2.019 . . . . 0.0 113.388 169.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -149.35 160.48 43.38 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.266 1.027 . . . . 0.0 109.315 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -111.7 105.69 14.27 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 169.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -70.67 143.45 89.8 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 172.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.16 150.25 85.12 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.049 1.833 . . . . 0.0 110.379 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.3 tp -76.12 92.9 3.26 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 170.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -79.36 171.49 15.1 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.032 0.933 . . . . 0.0 110.271 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -99.01 162.13 13.24 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 123.546 1.641 . . . . 0.0 107.481 168.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 87.9 t -89.84 154.27 3.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 113.044 -1.889 . . . . 0.0 107.112 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.9 m 67.11 5.82 4.38 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.058 1.343 . . . . 0.0 113.732 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -71.69 150.09 44.86 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 169.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -116.17 138.18 51.49 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.598 0.636 . . . . 0.0 110.032 177.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.6 mp -111.03 122.27 65.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 103.696 -2.705 . . . . 0.0 103.696 175.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.61 116.87 4.61 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 173.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.6 tp -106.72 132.36 52.79 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -87.53 127.58 35.25 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 172.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 mp -134.76 155.0 79.76 Favored Pre-proline 0 C--O 1.234 0.283 0 C-N-CA 125.426 1.49 . . . . 0.0 107.304 172.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -64.52 -23.93 63.95 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 CA-C-N 120.757 1.306 . . . . 0.0 112.402 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -55.25 -30.33 59.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.826 1.651 . . . . 0.0 111.763 169.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.06 148.32 5.54 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 108.116 -1.993 . . . . 0.0 108.116 -171.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.1 m -65.1 131.46 46.62 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 171.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 45.4 ttp -146.21 135.59 22.94 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -171.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.26 134.47 35.28 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 118.54 0.609 . . . . 0.0 110.021 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -103.48 134.13 47.35 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 168.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.6 m -94.9 141.49 28.58 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 92.5 t -74.16 123.83 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 171.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -113.0 156.74 15.41 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 169.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -115.08 98.53 6.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 169.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.1 tp -75.14 124.29 26.76 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -169.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -61.12 128.78 38.09 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.416 0.686 . . . . 0.0 110.219 -173.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.42 4.74 84.88 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.645 -1.086 . . . . 0.0 113.857 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.7 t -127.72 -118.99 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 119.069 1.435 . . . . 0.0 107.282 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.2 m -151.39 -179.57 7.49 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.174 1.79 . . . . 0.0 108.31 -169.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -70.66 146.14 50.16 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 121.671 -0.643 . . . . 0.0 109.691 169.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.82 167.64 26.87 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.671 1.588 . . . . 0.0 108.511 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.6 mt -103.43 138.63 39.89 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 174.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.5 p -154.93 160.59 41.26 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 119.298 0.954 . . . . 0.0 111.821 -177.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 9.5 p -149.17 135.63 19.36 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 168.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.2 p -74.17 145.63 44.07 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.457 0.703 . . . . 0.0 109.463 176.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.6 mt -116.36 -70.29 0.8 Allowed 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.768 0.827 . . . . 0.0 109.387 -173.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -148.53 161.16 42.21 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.077 0.951 . . . . 0.0 109.892 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 CA--C 1.544 0.728 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 168.761 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 96.6 p . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.491 ' H ' HD11 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -61.85 -32.07 52.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 O-C-N 121.186 -0.946 . . . . 0.0 110.222 170.041 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -75.35 -43.95 47.79 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.472 0.578 . . . . 0.0 109.664 -177.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -62.66 -31.58 72.48 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.32 170.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.88 -50.64 61.99 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 119.97 1.259 . . . . 0.0 111.158 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -62.43 -50.88 69.74 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.988 -0.713 . . . . 0.0 109.87 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 66.0 ttp85 -61.61 -38.63 88.34 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 123.465 0.706 . . . . 0.0 110.927 -175.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.5 tp -80.51 -24.33 39.45 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 117.817 -1.087 . . . . 0.0 111.248 -174.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.9 m -65.42 -44.18 88.2 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 120.463 1.483 . . . . 0.0 108.724 170.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.96 -53.84 47.83 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 118.761 -0.638 . . . . 0.0 109.939 174.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -61.49 -32.22 72.23 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.615 0.643 . . . . 0.0 111.129 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 57.3 m -73.26 -30.47 63.47 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.994 -0.441 . . . . 0.0 111.621 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.419 ' CB ' ' CE2' ' A' ' 45' ' ' PHE . . . -73.8 -49.13 26.78 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 119.231 0.923 . . . . 0.0 109.57 170.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -46.82 -58.22 4.12 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 127.465 2.306 . . . . 0.0 110.469 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 15.8 ptt? -51.84 -42.68 62.77 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.601 1.161 . . . . 0.0 112.25 178.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 22.8 pt -84.24 -25.93 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 119.693 1.133 . . . . 0.0 111.789 -175.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 72.7 mt . . . . . 0 CA--C 1.538 0.49 0 C-N-CA 123.472 0.709 . . . . 0.0 109.306 169.281 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.543 0.71 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.7 mt -132.35 130.46 60.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.33 123.7 32.58 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.8 159.65 47.97 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 123.361 0.505 . . . . 0.0 111.902 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -111.09 164.75 12.51 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.427 1.491 . . . . 0.0 110.648 -169.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -76.03 -13.93 60.22 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.206 1.002 . . . . 0.0 112.336 -177.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 p -152.88 168.86 24.36 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 127.652 2.381 . . . . 0.0 106.959 171.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.9 m -64.76 145.53 98.78 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 169.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.92 65.94 7.67 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 124.554 3.503 . . . . 0.0 110.628 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -52.83 -48.61 66.85 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 123.912 0.885 . . . . 0.0 112.255 -169.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.8 -36.59 84.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.095 0.474 . . . . 0.0 110.95 -173.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -74.43 -41.75 60.31 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.034 0.934 . . . . 0.0 109.848 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.7 t -60.23 -45.32 96.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 172.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -62.19 -50.25 72.55 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.348 1.059 . . . . 0.0 110.402 -177.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.34 -39.2 93.88 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.778 0.717 . . . . 0.0 110.957 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.27 -47.02 84.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.176 -0.327 . . . . 0.0 110.32 175.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -68.05 -24.97 65.14 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 118.354 -0.831 . . . . 0.0 112.362 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -69.78 -32.42 70.9 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.857 1.208 . . . . 0.0 109.544 175.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -72.94 -46.89 49.95 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 173.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mt -64.6 -40.88 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 121.632 -0.668 . . . . 0.0 109.731 -176.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.1 -27.03 67.75 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.528 0.731 . . . . 0.0 111.302 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 51.9 ttm-85 -78.17 -45.26 23.64 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.72 0.808 . . . . 0.0 109.325 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 . . . . . 0 CA--C 1.534 0.344 0 C-N-CA 125.02 1.328 . . . . 0.0 111.092 177.918 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo . . . . . 0 N--CA 1.449 -1.117 0 CA-C-O 120.576 0.157 . . . . 0.0 112.356 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.6 t -94.86 101.52 12.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 100.505 -3.887 . . . . 0.0 100.505 167.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -147.12 159.12 43.98 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.51 1.124 . . . . 0.0 109.855 -169.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.3 t -137.48 139.03 44.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.428 1.091 . . . . 0.0 108.161 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.0 m -106.79 152.01 24.41 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.949 1.299 . . . . 0.0 108.666 169.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -149.37 129.54 13.63 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.38 1.472 . . . . 0.0 109.838 -175.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -179.99 155.25 0.59 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.695 1.198 . . . . 0.0 112.468 -169.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.6 m 64.16 151.0 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.818 2.447 . . . . 0.0 112.613 170.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.6 tp -111.36 59.65 0.62 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.996 0.918 . . . . 0.0 109.409 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.31 134.26 50.04 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 123.566 0.746 . . . . 0.0 109.921 -175.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 54.96 23.46 5.09 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.827 0.851 . . . . 0.0 111.632 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.82 14.29 81.14 Favored Glycine 0 CA--C 1.537 1.427 0 CA-C-O 118.489 -1.173 . . . . 0.0 113.68 -176.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -132.75 149.23 52.3 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.621 1.71 . . . . 0.0 108.708 -171.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -70.4 135.74 49.01 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.034 -1.041 . . . . 0.0 109.665 -175.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.1 156.09 16.75 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -168.7 176.21 43.03 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 175.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 43.9 m -144.91 151.75 39.17 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 169.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.5 p -118.68 144.26 27.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 169.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.3 145.63 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 170.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.8 p -142.71 175.35 2.96 Favored Pre-proline 0 C--N 1.321 -0.655 0 C-N-CA 125.451 1.5 . . . . 0.0 107.034 169.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.57 -30.1 91.53 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 120.895 1.063 . . . . 0.0 111.44 168.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 48.1 p-90 -95.51 -25.23 16.29 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 118.128 -0.939 . . . . 0.0 113.292 -169.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.89 168.12 28.41 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-N 120.282 1.401 . . . . 0.0 113.206 -175.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.9 tt -137.32 121.9 18.48 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 168.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.1 m -134.13 130.75 37.81 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.198 0.523 . . . . 0.0 109.82 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.38 143.27 53.74 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 168.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.22 150.83 29.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.7 mm -134.06 134.51 55.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -125.8 143.03 43.87 Favored Pre-proline 0 CA--C 1.537 0.442 0 CA-C-O 118.318 -0.849 . . . . 0.0 111.044 -171.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -48.22 129.72 19.43 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.931 3.087 . . . . 0.0 113.829 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.48 177.02 34.1 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.247 1.403 . . . . 0.0 114.489 -171.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -61.86 118.53 5.42 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.854 3.036 . . . . 0.0 112.253 -169.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.5 t70 52.17 29.87 7.05 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.119 1.768 . . . . 0.0 113.602 175.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -82.68 146.94 28.78 Favored 'General case' 0 C--N 1.34 0.195 0 O-C-N 121.435 -0.79 . . . . 0.0 109.021 175.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.7 mp -101.26 82.58 2.36 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -67.3 145.84 98.67 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.531 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -64.6 157.71 53.95 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.274 1.982 . . . . 0.0 109.872 171.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.1 tp -77.07 77.3 3.62 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -64.63 148.18 51.44 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.07 0.548 . . . . 0.0 110.393 -174.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -92.08 151.04 20.63 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.1 t -88.43 153.03 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 125.452 1.501 . . . . 0.0 111.131 -168.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.8 m 68.27 7.49 5.96 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.068 1.747 . . . . 0.0 114.116 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -83.28 163.47 20.67 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 168.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -115.41 150.71 35.98 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.202 0.91 . . . . 0.0 111.574 175.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.2 mm -122.61 123.96 69.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.21 124.1 6.58 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 108.656 -1.777 . . . . 0.0 108.656 173.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.4 mt -116.79 138.22 51.65 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.481 1.112 . . . . 0.0 108.031 173.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -91.21 124.1 35.17 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mp -132.98 156.65 79.85 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 125.027 1.331 . . . . 0.0 108.162 170.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -67.01 -21.82 48.93 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 CA-C-N 120.625 1.259 . . . . 0.0 112.865 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -55.99 -31.45 63.05 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.816 1.247 . . . . 0.0 111.233 169.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.49 150.92 5.52 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.86 2.171 . . . . 0.0 107.776 -172.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.1 m -64.47 132.58 50.39 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 171.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 54.6 ttm -133.95 130.58 37.9 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -169.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.04 114.13 20.39 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 171.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -89.08 142.93 27.22 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 169.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.6 m -92.3 141.96 27.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.27 119.6 23.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 171.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -109.35 167.35 12.86 Favored Glycine 0 CA--C 1.52 0.361 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 169.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -117.57 117.09 28.47 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 169.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.0 119.19 21.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 176.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.34 131.62 51.53 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 122.721 0.408 . . . . 0.0 111.379 -171.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.55 3.56 72.4 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-O 118.968 -0.907 . . . . 0.0 113.526 -178.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.1 t -122.33 -110.58 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.0 m -154.71 173.54 16.27 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 119.776 1.171 . . . . 0.0 109.765 -169.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -66.96 142.24 57.33 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 169.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.02 173.19 16.33 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.084 1.754 . . . . 0.0 107.429 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.9 mp -109.07 140.0 43.21 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -176.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.0 t -142.08 152.94 43.78 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.489 1.115 . . . . 0.0 109.588 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 35.5 t -149.19 118.43 6.82 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 172.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.7 m -71.75 136.16 47.04 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -85.75 -62.96 1.4 Allowed 'General case' 0 C--O 1.231 0.112 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 172.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.92 175.72 5.75 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.529 1.532 . . . . 0.0 108.634 -175.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 CA--C 1.542 0.636 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 169.815 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 84.3 p . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 23.4 pt -66.19 -25.49 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 121.507 -0.746 . . . . 0.0 111.731 170.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -76.67 -45.59 29.1 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -63.05 -31.75 72.96 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.503 170.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.16 -60.79 8.32 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 120.16 1.346 . . . . 0.0 110.679 172.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -62.16 -48.71 78.89 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 117.412 0.606 . . . . 0.0 110.779 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 61.1 ttt-85 -61.2 -35.1 76.27 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 123.622 0.769 . . . . 0.0 110.817 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.5 tp -78.35 -23.91 46.71 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 117.607 -1.187 . . . . 0.0 111.407 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -46.6 85.43 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.88 1.673 . . . . 0.0 109.037 169.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -66.02 -46.77 76.71 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 122.609 0.364 . . . . 0.0 111.251 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -66.2 -33.21 75.25 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 119.248 -0.406 . . . . 0.0 110.778 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 28.4 m -67.07 -36.93 83.08 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.608 0.64 . . . . 0.0 110.435 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.05 -52.23 50.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 173.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 41.1 tpt85 -52.47 -46.03 66.35 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.961 0.905 . . . . 0.0 111.138 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 56.7 ttp -49.39 -52.53 27.89 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.959 1.704 . . . . 0.0 111.145 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 11.0 pt -88.93 -24.79 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 118.743 0.701 . . . . 0.0 112.612 -172.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 76.3 mt . . . . . 0 CA--C 1.532 0.285 0 C-N-CA 124.003 0.921 . . . . 0.0 109.074 171.729 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 C--O 1.239 0.531 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.3 mp -104.81 118.89 52.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 -174.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.51 119.61 20.59 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 169.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.87 177.6 54.21 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 121.423 0.457 . . . . 0.0 113.694 -175.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -115.67 169.51 9.14 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.985 1.714 . . . . 0.0 110.267 -169.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -72.88 -13.76 61.34 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -174.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.2 p -151.31 174.05 13.77 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 127.867 2.467 . . . . 0.0 106.404 169.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.4 m -61.93 147.69 89.39 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 169.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.53 67.43 6.36 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 124.752 3.635 . . . . 0.0 110.293 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.421 ' HE3' ' O ' ' A' ' 42' ' ' VAL . 45.5 mtpt -52.74 -52.43 56.41 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.513 1.125 . . . . 0.0 112.201 -169.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.01 -38.89 92.74 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 118.762 0.71 . . . . 0.0 110.968 -172.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -69.06 -42.71 75.92 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.746 1.219 . . . . 0.0 109.848 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.6 t -63.04 -42.21 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 174.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -61.36 -52.38 64.89 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.71 -49.47 75.06 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.762 0.825 . . . . 0.0 110.203 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.5 -49.83 75.04 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -70.01 -24.52 63.3 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 117.901 -1.047 . . . . 0.0 112.642 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -66.93 -33.17 74.99 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 120.05 1.296 . . . . 0.0 109.199 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -74.68 -49.09 22.57 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.391 -0.818 . . . . 0.0 109.544 173.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.1 mt -61.85 -30.68 49.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.42 -31.96 64.14 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 124.182 0.993 . . . . 0.0 112.014 173.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 53.6 ttp85 -72.05 -41.23 67.67 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.92 1.236 . . . . 0.0 109.594 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 124.289 1.035 . . . . 0.0 109.983 168.751 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo . . . . . 0 N--CA 1.451 -1.008 0 N-CA-C 110.376 -0.663 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 m -61.06 147.92 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 169.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -143.78 152.67 41.53 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 120.966 -1.084 . . . . 0.0 109.811 -177.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.421 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 7.1 p -135.89 127.05 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 124.488 1.115 . . . . 0.0 110.79 -175.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.9 m -92.54 146.81 23.39 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.649 1.18 . . . . 0.0 109.421 169.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -119.97 137.96 53.76 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.532 1.533 . . . . 0.0 107.786 169.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -164.87 146.29 7.84 Favored 'General case' 0 C--O 1.218 -0.569 0 C-N-CA 123.351 0.66 . . . . 0.0 111.715 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.8 m 58.37 154.13 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.826 2.45 . . . . 0.0 115.52 168.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.4 tp -105.75 109.32 21.23 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 169.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -103.04 95.9 6.44 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.258 2.223 . . . . 0.0 108.107 -173.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 55.06 45.73 25.61 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.455 1.102 . . . . 0.0 111.658 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.59 22.44 62.13 Favored Glycine 0 CA--C 1.531 1.085 0 O-C-N 121.853 -0.529 . . . . 0.0 113.315 176.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -136.59 144.56 44.18 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 125.68 1.592 . . . . 0.0 107.121 -177.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -74.33 141.05 45.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 120.514 1.506 . . . . 0.0 109.399 172.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.02 154.68 19.25 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 172.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.84 168.73 35.66 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 175.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 36.1 m -142.42 148.43 37.79 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 p -129.32 135.0 62.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.0 tt -111.23 151.11 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.751 1.22 . . . . 0.0 108.032 171.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.1 p -136.86 175.11 3.74 Favored Pre-proline 0 N--CA 1.444 -0.739 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 172.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.42 -10.6 28.26 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 CA-C-N 121.132 1.44 . . . . 0.0 112.009 169.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -110.16 -25.6 10.1 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -173.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.37 171.48 20.31 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 120.306 1.412 . . . . 0.0 112.368 -175.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.3 tt -136.98 123.03 20.3 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 167.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.2 m -130.91 134.79 47.08 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.398 0.679 . . . . 0.0 109.925 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.05 149.4 35.8 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 168.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.9 m -138.74 146.55 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.61 1.164 . . . . 0.0 108.172 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.6 mm -130.76 114.85 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -115.0 146.66 36.65 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.314 1.046 . . . . 0.0 112.229 -168.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -39.08 128.56 1.39 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 125.178 3.918 . . . . 0.0 115.256 173.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.45 -178.51 49.92 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.219 0.914 . . . . 0.0 114.415 -173.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.02 106.42 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 124.084 3.189 . . . . 0.0 111.7 -169.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.6 t70 50.07 28.39 2.96 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.621 1.568 . . . . 0.0 112.658 -175.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -89.22 142.46 27.63 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -91.69 91.34 7.95 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 31.1 t90 -70.16 131.97 88.46 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.59 153.36 77.75 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.387 2.058 . . . . 0.0 111.811 -169.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 50.5 tp -61.77 130.23 44.78 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 169.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 69.8 mtt85 -125.55 156.67 38.7 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.881 0.873 . . . . 0.0 109.097 172.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -89.26 147.92 23.86 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 169.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.3 t -90.14 153.22 3.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 124.572 1.149 . . . . 0.0 110.809 -168.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.9 m 63.81 29.07 14.8 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.856 1.262 . . . . 0.0 112.461 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -104.47 155.3 18.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.518 1.927 . . . . 0.0 107.311 169.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -107.43 142.34 37.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.844 0.747 . . . . 0.0 110.191 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 35.4 mm -123.1 128.81 75.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.15 120.86 6.01 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 173.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.3 mt -105.0 139.35 39.81 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 170.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -90.48 129.14 36.68 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 173.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mp -135.79 155.76 77.79 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 125.151 1.381 . . . . 0.0 107.593 175.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.84 -23.94 68.45 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 121.541 1.494 . . . . 0.0 112.395 173.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -56.71 -30.7 63.75 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.062 1.345 . . . . 0.0 111.733 169.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 133.12 149.7 6.2 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 108.099 -2.0 . . . . 0.0 108.099 -170.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.0 m -64.37 133.34 52.42 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 41.4 ttp -147.2 139.42 24.54 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -171.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.33 134.05 36.61 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 118.747 0.703 . . . . 0.0 109.777 176.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -109.2 130.88 55.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 169.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.6 m -83.02 139.52 33.22 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.3 t -70.48 119.01 15.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 170.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -110.21 158.36 14.5 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 171.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -127.83 84.62 2.27 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.2 tp -65.23 125.29 24.56 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -172.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.3 136.33 58.01 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.466 0.706 . . . . 0.0 110.418 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.39 2.85 64.3 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.283 -0.731 . . . . 0.0 113.27 -176.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.0 t -128.81 -119.68 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.6 p -163.45 -175.09 4.04 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.166 1.387 . . . . 0.0 108.935 -171.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -70.05 144.81 52.07 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.633 -0.667 . . . . 0.0 110.725 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.38 165.11 36.04 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.717 1.607 . . . . 0.0 109.011 174.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.9 mp -102.7 126.11 49.68 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 174.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.9 m -144.65 156.45 44.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 119.594 1.088 . . . . 0.0 110.858 -170.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 18.8 p -145.37 139.88 27.29 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.453 -0.779 . . . . 0.0 110.008 170.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.3 m -75.14 137.48 41.38 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 171.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 85.2 mt -124.07 -30.16 3.52 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -171.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 14.9 ptp -159.44 167.21 29.27 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.057 0.943 . . . . 0.0 109.28 175.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.5 m . . . . . 0 CA--C 1.536 0.432 0 C-N-CA 124.349 1.059 . . . . 0.0 108.985 179.218 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 81.9 p . . . . . 0 C--O 1.235 0.331 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.434 ' H ' HD11 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -60.68 -34.38 58.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 121.213 -0.93 . . . . 0.0 109.171 172.215 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -64.54 -45.49 86.91 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 123.601 0.76 . . . . 0.0 110.148 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -67.39 -29.67 69.24 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.369 0.986 . . . . 0.0 110.621 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.27 -37.29 64.5 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.788 -0.57 . . . . 0.0 111.773 169.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -82.69 -54.62 5.0 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.928 -1.337 . . . . 0.0 110.208 174.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 61.0 mtm-85 -67.56 -29.82 69.29 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 118.116 -0.945 . . . . 0.0 113.31 -169.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.8 tp -82.89 -27.17 30.89 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 120.525 1.511 . . . . 0.0 109.886 -176.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.2 m -71.19 -40.4 71.24 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.69 -44.19 82.38 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.224 1.01 . . . . 0.0 111.752 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.36 -39.28 92.62 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 121.175 -0.953 . . . . 0.0 109.752 175.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 37.9 t -63.13 -44.95 94.14 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -52.34 -50.76 61.69 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.953 1.301 . . . . 0.0 110.897 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.0 ptt85 -82.6 -24.47 33.88 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 15.5 tmm? -55.98 -44.31 78.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 118.648 -0.691 . . . . 0.0 109.812 171.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 6.8 pt -81.94 0.3 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.3 mt . . . . . 0 C--N 1.342 0.269 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 169.56 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 CA--C 1.534 0.351 0 N-CA-C 110.733 -0.099 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.8 mt -141.06 134.28 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.25 128.25 35.07 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 169.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.97 163.34 47.8 Favored Glycine 0 CA--C 1.537 1.454 0 N-CA-C 112.061 -0.415 . . . . 0.0 112.061 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -73.15 126.77 30.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.463 0.705 . . . . 0.0 109.516 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -67.62 -32.05 72.5 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 119.121 -0.466 . . . . 0.0 110.516 175.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.8 p -150.72 153.9 36.4 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 126.308 1.843 . . . . 0.0 107.857 169.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -56.8 137.95 78.3 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 125.388 1.475 . . . . 0.0 113.108 -169.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -80.34 43.89 1.62 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 124.626 3.551 . . . . 0.0 111.412 174.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -53.52 -45.21 69.67 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.086 1.354 . . . . 0.0 112.257 -169.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.09 -41.86 99.48 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 122.963 0.505 . . . . 0.0 111.606 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -72.48 -40.32 67.03 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -175.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.7 t -60.07 -46.12 94.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 172.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -59.74 -54.93 40.61 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.132 0.573 . . . . 0.0 110.347 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.02 -41.76 97.34 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.467 0.707 . . . . 0.0 110.853 -173.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.54 -39.25 77.59 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 118.511 0.596 . . . . 0.0 110.718 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -67.57 -31.17 71.05 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 121.317 -0.864 . . . . 0.0 111.738 173.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -68.95 -29.39 67.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.321 0.964 . . . . 0.0 111.107 173.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -70.41 -48.64 55.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mt -59.36 -41.89 85.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.566 0.746 . . . . 0.0 109.453 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.99 -23.79 67.32 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.769 0.828 . . . . 0.0 112.862 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -80.72 -45.22 17.44 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 171.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 . . . . . 0 C--N 1.33 -0.275 0 C-N-CA 124.794 1.238 . . . . 0.0 112.611 -174.468 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo . . . . . 0 N--CA 1.453 -0.895 0 CA-C-O 121.122 0.384 . . . . 0.0 113.039 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.1 t -75.4 139.23 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 168.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -139.61 154.03 47.48 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.641 0.777 . . . . 0.0 109.88 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.1 t -137.71 119.11 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 123.995 0.918 . . . . 0.0 109.265 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.1 m -82.22 143.88 31.06 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 168.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -126.63 134.29 50.79 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.552 1.541 . . . . 0.0 109.258 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.408 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 29.8 p90 -170.6 149.74 3.26 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 123.373 0.669 . . . . 0.0 112.737 -170.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.5 m 55.66 165.53 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 128.739 2.816 . . . . 0.0 116.257 167.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 30.3 mt -116.53 66.46 0.72 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.792 1.237 . . . . 0.0 108.705 171.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.12 136.14 42.94 Favored 'General case' 0 N--CA 1.457 -0.083 0 O-C-N 121.726 -0.609 . . . . 0.0 109.599 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 56.74 22.78 7.23 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.792 0.837 . . . . 0.0 111.247 -172.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.29 12.53 83.5 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.658 1.123 . . . . 0.0 113.474 -175.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -121.33 143.86 48.96 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.815 1.646 . . . . 0.0 108.202 -173.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -61.38 133.13 55.47 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 118.318 -0.849 . . . . 0.0 109.154 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.408 ' HB ' ' CE2' ' A' ' 45' ' ' PHE . 0.3 OUTLIER -98.84 157.53 16.24 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 122.207 1.004 . . . . 0.0 108.56 179.279 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.75 167.83 39.3 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 56.4 m -141.43 150.56 42.47 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 169.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.91 139.77 50.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 175.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.6 tt -116.46 147.03 20.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 169.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.7 p -138.37 172.2 7.05 Favored Pre-proline 0 N--CA 1.439 -0.979 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 171.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -63.24 -22.63 72.5 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 CA-C-N 119.928 1.01 . . . . 0.0 111.074 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 44.4 p-90 -94.45 -26.27 16.55 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -174.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.94 173.51 12.57 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 120.527 1.512 . . . . 0.0 112.71 -173.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.5 tt -135.43 128.48 31.62 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 167.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 77.7 p -138.03 142.61 40.35 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 122.029 0.919 . . . . 0.0 110.728 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.02 144.41 47.18 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 167.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.9 m -135.39 151.32 30.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 39.9 mt -136.59 139.77 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -116.61 139.66 25.77 Favored Pre-proline 0 C--O 1.234 0.266 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -54.86 131.17 44.56 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 121.629 1.552 . . . . 0.0 109.018 177.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.57 -179.46 27.72 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.509 1.052 . . . . 0.0 114.596 -169.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.16 158.25 41.67 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.365 2.71 . . . . 0.0 111.096 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.4 t0 46.04 45.58 12.36 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.795 2.038 . . . . 0.0 113.604 169.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -150.12 147.68 28.05 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.6 mp -104.3 107.26 18.09 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -72.22 157.82 88.62 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.186 -0.916 . . . . 0.0 108.776 169.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.31 166.93 28.63 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.1 1.867 . . . . 0.0 108.972 169.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 61.3 tp -69.2 82.53 0.35 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 169.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -75.46 139.78 42.47 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -173.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -90.86 141.89 28.35 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 122.812 1.291 . . . . 0.0 108.175 176.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 79' ' ' VAL . 0.7 OUTLIER -68.93 156.08 7.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 127.992 2.517 . . . . 0.0 109.152 174.382 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.0 m 69.93 0.74 3.18 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 128.336 2.655 . . . . 0.0 114.437 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -81.52 158.02 24.61 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 169.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -110.08 143.09 40.62 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.0 0.52 . . . . 0.0 110.0 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.5 mt -121.08 118.8 57.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -74.61 123.66 7.7 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 174.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 72.8 mt -125.2 151.76 45.42 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.667 1.187 . . . . 0.0 108.654 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -108.65 128.11 54.56 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.377 1.071 . . . . 0.0 108.753 -175.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.0 mp -137.06 168.95 14.61 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 125.331 1.452 . . . . 0.0 108.641 175.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -58.83 -23.26 66.23 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.366 2.044 . . . . 0.0 113.979 173.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -56.43 -38.32 71.42 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.603 0.761 . . . . 0.0 111.805 170.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.85 -167.55 24.27 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 -169.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 m -80.05 135.14 36.28 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 172.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 20.6 ptp -144.16 148.79 35.5 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 169.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.92 128.62 35.68 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 173.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -96.33 128.05 42.89 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 168.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.4 m -77.79 138.95 39.27 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 171.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.9 t -72.2 121.92 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 170.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -103.64 165.76 15.67 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -121.81 127.61 50.77 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.099 -2.185 . . . . 0.0 105.099 169.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.5 tp -141.19 142.61 33.99 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.063 0.847 . . . . 0.0 109.849 -176.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -59.04 135.02 57.49 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.312 0.645 . . . . 0.0 111.023 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.83 -2.12 50.85 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.044 0.831 . . . . 0.0 113.668 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.5 t -125.59 -31.49 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 118.638 1.219 . . . . 0.0 109.91 -173.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.0 m 54.58 -122.71 1.99 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.348 1.059 . . . . 0.0 109.001 -169.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -82.73 130.35 35.11 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.512 1.051 . . . . 0.0 109.861 -169.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -156.25 179.54 9.14 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 126.294 1.838 . . . . 0.0 106.993 176.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp -119.23 143.15 47.45 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.981 0.913 . . . . 0.0 109.217 -175.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.9 m -139.73 148.52 42.41 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.925 1.29 . . . . 0.0 110.123 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 20.2 t -140.34 110.1 6.4 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 171.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.7 m -73.1 135.91 44.83 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 71.5 mt -121.31 -47.85 2.23 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 119.374 -0.346 . . . . 0.0 111.26 -169.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.24 167.27 29.43 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.63 1.172 . . . . 0.0 108.286 175.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.0 m . . . . . 0 CA--C 1.54 0.588 0 C-N-CA 123.777 0.831 . . . . 0.0 110.194 -178.376 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 65.1 p . . . . . 0 C--O 1.234 0.289 0 CA-C-O 120.818 0.342 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.436 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -63.76 -26.01 39.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 121.863 -0.523 . . . . 0.0 109.708 169.584 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -68.18 -43.05 79.03 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.315 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -64.89 -30.08 71.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.308 0.958 . . . . 0.0 110.604 169.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.19 -61.07 7.79 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -61.59 -51.25 69.32 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.809 -0.818 . . . . 0.0 110.534 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 65.6 ttt-85 -63.4 -30.18 71.35 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.226 1.01 . . . . 0.0 111.867 -174.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.7 tp -89.38 -24.81 21.85 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 120.477 1.489 . . . . 0.0 110.294 -177.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.6 m -70.32 -40.77 73.97 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 170.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -70.03 -41.95 73.58 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.788 0.835 . . . . 0.0 111.582 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.98 -30.33 71.31 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 121.127 -0.983 . . . . 0.0 110.217 172.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 37.0 t -66.3 -45.89 78.81 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.931 0.787 . . . . 0.0 109.053 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -54.39 -51.1 65.9 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.473 1.109 . . . . 0.0 109.79 174.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -58.21 -54.77 43.25 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 123.115 0.566 . . . . 0.0 110.19 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 50.9 ttp -47.17 -41.4 17.78 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.867 1.667 . . . . 0.0 112.012 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.9 pt -86.12 -14.55 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.278 0.944 . . . . 0.0 113.433 -176.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.6 pp . . . . . 0 N--CA 1.449 -0.506 0 C-N-CA 125.461 1.504 . . . . 0.0 108.457 174.368 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 . . . . . 0 CA--C 1.534 0.362 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.7 mt -119.66 136.57 56.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 171.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.7 146.82 54.2 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.87 135.53 17.03 Favored Glycine 0 C--N 1.336 0.557 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 170.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -96.4 138.64 33.69 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.863 0.865 . . . . 0.0 109.056 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -71.78 -37.38 70.45 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.0 p -157.48 168.54 27.01 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 129.732 3.213 . . . . 0.0 106.31 169.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.9 m -51.91 130.57 38.84 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.736 0.814 . . . . 0.0 111.498 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -77.01 63.66 7.67 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 125.179 3.919 . . . . 0.0 111.525 -176.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -52.97 -51.62 60.9 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.739 0.815 . . . . 0.0 111.497 -171.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.78 -39.76 91.32 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 123.315 0.384 . . . . 0.0 110.79 -170.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -67.17 -47.01 72.28 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.646 0.778 . . . . 0.0 109.903 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.0 t -63.06 -40.37 88.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.46 -53.17 58.76 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.743 0.817 . . . . 0.0 109.831 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.03 -40.51 97.96 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.47 0.577 . . . . 0.0 110.759 -176.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.71 -50.5 73.24 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -71.7 -24.09 61.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 118.033 -0.984 . . . . 0.0 112.597 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -66.58 -33.8 76.48 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.267 1.394 . . . . 0.0 110.273 172.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -74.38 -47.19 35.62 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.0 mt -61.05 -40.73 86.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.22 -28.38 69.33 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.587 0.755 . . . . 0.0 112.189 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -70.81 -44.19 67.07 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 172.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 . . . . . 0 CA--C 1.536 0.43 0 C-N-CA 124.628 1.171 . . . . 0.0 112.51 -175.785 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo . . . . . 0 N--CA 1.453 -0.911 0 N-CA-C 114.435 0.898 . . . . 0.0 114.435 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.7 t -61.75 137.49 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 169.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -149.71 159.27 44.48 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.926 0.89 . . . . 0.0 109.487 -175.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.7 t -136.87 141.05 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.1 m -110.79 152.25 26.86 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.227 1.411 . . . . 0.0 108.788 169.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -120.52 143.29 48.65 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 127.248 2.219 . . . . 0.0 110.813 -176.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -145.98 173.35 12.24 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.608 1.163 . . . . 0.0 111.651 -172.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.5 t -52.17 160.31 0.79 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.92 2.088 . . . . 0.0 115.323 -168.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -75.66 106.01 6.99 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 169.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -75.98 -53.98 7.56 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -168.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.91 -42.86 0.74 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.344 1.858 . . . . 0.0 110.226 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.55 -0.21 0.09 OUTLIER Glycine 0 CA--C 1.534 1.256 0 C-N-CA 127.82 2.629 . . . . 0.0 110.684 175.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -137.39 134.94 36.49 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 119.247 1.523 . . . . 0.0 109.112 -170.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -60.64 152.27 26.86 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.861 0.864 . . . . 0.0 110.337 170.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.23 163.2 12.58 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.301 1.04 . . . . 0.0 109.732 172.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.47 170.92 41.28 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 171.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 7.0 m -140.5 131.04 25.44 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.4 p -103.5 149.2 7.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 173.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.7 tt -131.19 149.65 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 169.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.8 p -139.74 175.75 3.01 Favored Pre-proline 0 N--CA 1.444 -0.764 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 172.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.13 -19.67 69.34 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 CA-C-N 120.528 1.224 . . . . 0.0 111.145 168.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.0 p-90 -102.73 -24.43 13.74 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -172.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.68 170.35 22.58 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.547 1.521 . . . . 0.0 112.806 -175.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 tt -137.41 125.84 23.44 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 168.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.8 m -138.26 133.2 32.83 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.359 0.599 . . . . 0.0 110.256 -176.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.93 144.78 52.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 168.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 m -139.46 149.17 22.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 124.14 0.976 . . . . 0.0 108.565 -176.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.2 mt -143.38 141.54 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -170.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -134.79 138.23 29.23 Favored Pre-proline 0 N--CA 1.468 0.468 0 CA-C-O 117.839 -1.077 . . . . 0.0 110.517 -170.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -48.4 139.44 22.53 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.718 2.945 . . . . 0.0 112.548 173.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.38 175.79 28.56 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 123.974 0.797 . . . . 0.0 113.856 -174.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.4 140.65 44.58 Favored 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 122.818 2.345 . . . . 0.0 110.095 -174.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.6 t70 50.94 34.92 11.36 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.518 1.527 . . . . 0.0 113.31 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -132.55 131.81 41.94 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.124 1.37 . . . . 0.0 107.522 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.37 99.64 9.34 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -175.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.79 145.15 97.8 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 169.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.36 148.52 61.37 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 121.606 1.537 . . . . 0.0 109.898 171.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.4 tp -63.21 140.06 58.83 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.72 158.69 25.97 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.826 0.739 . . . . 0.0 109.355 174.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.43 140.52 44.72 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.1 t -79.48 159.24 4.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 124.422 1.089 . . . . 0.0 109.038 -169.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.0 m 63.7 23.32 13.46 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.941 1.296 . . . . 0.0 112.92 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -100.57 154.56 18.47 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.226 1.811 . . . . 0.0 107.516 169.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -111.19 141.22 44.99 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.434 0.561 . . . . 0.0 110.666 -177.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 23.7 mm -112.87 128.62 69.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 176.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.42 118.97 5.42 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 173.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.4 tp -108.04 143.61 36.52 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 172.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -105.05 125.49 51.04 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.6 mp -135.77 157.54 75.91 Favored Pre-proline 0 C--O 1.234 0.265 0 C-N-CA 125.25 1.42 . . . . 0.0 107.288 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -66.59 -22.82 50.48 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 CA-C-N 120.609 1.253 . . . . 0.0 112.853 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -54.87 -35.98 64.63 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.592 1.157 . . . . 0.0 111.156 169.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 145.85 157.27 7.21 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 108.026 -2.03 . . . . 0.0 108.026 -173.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.1 m -67.45 133.41 49.49 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 171.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 58.6 ttm -140.72 128.36 21.54 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -170.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.69 132.97 38.43 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 173.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -108.14 130.39 55.12 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 169.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.5 m -80.72 142.37 33.92 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.102 0.961 . . . . 0.0 108.554 177.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 75.7 t -76.45 118.92 23.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 169.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -105.33 161.45 14.71 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 170.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -128.93 93.81 3.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 170.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.9 tp -79.33 127.8 32.53 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -169.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.0 133.78 56.42 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.149 0.58 . . . . 0.0 110.397 -176.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.14 3.47 69.58 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-O 118.635 -1.092 . . . . 0.0 113.473 -177.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.6 t -124.81 -118.68 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.8 t -159.6 -169.27 2.52 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.024 1.33 . . . . 0.0 108.025 -176.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -70.36 143.86 51.8 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.275 0.559 . . . . 0.0 109.688 169.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.78 173.79 16.28 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.176 1.79 . . . . 0.0 107.508 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.7 mp -108.42 142.69 38.41 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 176.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.9 p -142.48 155.42 45.06 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.942 0.897 . . . . 0.0 110.579 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 41.9 t -144.85 116.43 8.12 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 172.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.3 m -69.49 133.03 47.21 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.0 mt -102.08 -66.58 0.91 Allowed 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -175.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.93 164.08 25.97 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.963 0.905 . . . . 0.0 109.753 176.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.9 m . . . . . 0 CA--C 1.541 0.611 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 169.59 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 CA--C 1.529 0.169 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 41.8 pt -67.43 -24.32 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 121.582 -0.698 . . . . 0.0 111.518 169.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -75.4 -44.58 43.93 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -62.76 -34.51 77.37 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.869 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.35 -52.27 54.2 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 120.196 1.362 . . . . 0.0 111.636 176.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -72.38 -36.97 68.83 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 117.574 0.687 . . . . 0.0 111.268 -177.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 22.9 tpp85 -66.46 -34.42 77.89 Favored 'General case' 0 C--N 1.339 0.11 0 O-C-N 121.053 -1.03 . . . . 0.0 109.823 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 21.4 tp -84.38 -24.94 29.45 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 116.948 -1.501 . . . . 0.0 111.684 -175.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.7 p -66.26 -44.41 83.71 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 121.794 2.088 . . . . 0.0 108.283 169.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -62.42 -50.45 71.47 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 122.773 0.429 . . . . 0.0 111.547 176.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -64.21 -34.5 78.24 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 118.758 -0.639 . . . . 0.0 110.534 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 32.9 m -69.25 -39.5 78.43 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.524 0.602 . . . . 0.0 111.109 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.3 -50.74 62.63 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 175.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -59.51 -46.58 88.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 118.738 -0.649 . . . . 0.0 111.582 -176.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 50.6 ttp -39.55 -48.81 2.1 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.204 1.801 . . . . 0.0 111.23 169.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 23.6 pt -92.09 -20.74 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 118.776 0.716 . . . . 0.0 112.719 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.2 mt . . . . . 0 C--N 1.345 0.372 0 CA-C-N 119.26 0.936 . . . . 0.0 109.039 171.062 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.3 mm -127.92 128.59 69.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 126.773 2.029 . . . . 0.0 105.636 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.37 133.9 35.97 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 172.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.83 -179.14 35.46 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.159 0.885 . . . . 0.0 112.795 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -119.04 156.88 28.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.934 1.294 . . . . 0.0 112.23 -169.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -72.0 -30.4 65.19 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.137 0.975 . . . . 0.0 111.547 -178.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.4 p -158.57 -175.17 5.16 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 130.477 3.511 . . . . 0.0 105.537 172.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.1 m -56.95 146.44 59.46 Favored Pre-proline 0 CA--C 1.545 0.75 0 O-C-N 120.959 -1.088 . . . . 0.0 109.295 169.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -71.14 56.64 2.03 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 124.439 3.426 . . . . 0.0 109.945 169.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.453 ' HE2' ' O ' ' A' ' 42' ' ' VAL . 27.8 tttm -47.22 -50.93 20.0 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 126.667 1.987 . . . . 0.0 113.623 -168.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.6 -41.06 96.48 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.187 0.903 . . . . 0.0 111.567 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -70.96 -40.18 72.13 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.193 0.597 . . . . 0.0 109.768 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 94.0 t -60.11 -44.9 96.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 172.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -60.78 -55.81 28.65 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 118.744 0.702 . . . . 0.0 110.368 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.65 -41.07 98.27 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.418 0.553 . . . . 0.0 110.826 -173.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.73 -51.81 60.43 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -67.41 -28.74 68.16 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 118.161 -0.923 . . . . 0.0 111.648 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -66.72 -37.58 84.98 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 119.76 1.164 . . . . 0.0 110.108 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -72.79 -42.47 63.87 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.858 0.753 . . . . 0.0 109.23 178.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.7 mt -62.84 -45.59 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.84 -38.48 85.62 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 123.512 0.725 . . . . 0.0 111.054 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.4 ttt-85 -68.25 -48.73 64.29 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -175.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.373 0 C-N-CA 124.26 1.024 . . . . 0.0 110.674 175.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo . . . . . 0 N--CA 1.455 -0.786 0 CA-C-O 120.353 0.064 . . . . 0.0 111.939 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 36.1 t -61.47 127.59 21.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 169.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -139.02 149.3 44.49 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 124.066 0.947 . . . . 0.0 109.078 -174.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.453 ' O ' ' HE2' ' A' ' 13' ' ' LYS . 2.5 p -139.71 131.13 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 125.71 1.604 . . . . 0.0 109.5 -176.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 p -108.61 151.46 26.09 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.276 0.63 . . . . 0.0 109.81 169.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -116.24 142.63 46.58 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.596 1.959 . . . . 0.0 109.337 -172.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -147.58 167.42 24.57 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -168.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.5 m -4.4 132.09 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.446 1 C-N-CA 133.537 4.735 . . . . 0.0 118.319 169.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.0 tp -81.13 99.22 8.41 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 168.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -86.41 -55.46 3.89 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.337 0.517 . . . . 0.0 111.525 -169.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -140.96 71.55 1.37 Allowed 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.495 1.518 . . . . 0.0 108.316 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 64.14 16.32 59.81 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.677 0.656 . . . . 0.0 112.946 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -146.27 142.51 28.41 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.438 1.895 . . . . 0.0 107.077 -170.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -81.73 155.38 25.53 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.298 1.039 . . . . 0.0 109.785 174.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.4 162.28 13.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.229 1.014 . . . . 0.0 109.343 169.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.52 161.53 34.99 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 107.207 -2.357 . . . . 0.0 107.207 171.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 60.9 m -133.52 149.22 51.7 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 169.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.7 p -131.63 149.14 32.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 173.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.2 tt -130.56 150.78 34.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 124.899 1.279 . . . . 0.0 107.798 173.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.8 p -143.54 174.78 3.29 Favored Pre-proline 0 N--CA 1.443 -0.776 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -62.05 -21.42 72.37 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 CA-C-N 120.067 1.06 . . . . 0.0 111.619 168.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 42.5 p-90 -100.25 -26.46 13.91 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -172.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.61 172.15 17.66 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 120.285 1.402 . . . . 0.0 112.379 -174.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 tt -132.63 128.51 37.26 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 168.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.1 p -140.57 143.19 35.17 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 122.273 1.035 . . . . 0.0 110.839 177.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.16 143.78 35.11 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 167.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.4 m -132.87 144.44 36.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 125.061 1.345 . . . . 0.0 108.055 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 30.2 mt -141.45 143.92 26.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 C-N-CA 124.837 1.255 . . . . 0.0 107.901 -169.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -141.54 144.04 31.98 Favored Pre-proline 0 N--CA 1.467 0.382 0 CA-C-O 117.552 -1.213 . . . . 0.0 108.92 -172.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -63.13 150.26 89.11 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.178 1.919 . . . . 0.0 111.815 174.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.97 -179.38 39.75 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.472 1.034 . . . . 0.0 114.31 -172.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -62.14 126.53 18.88 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.001 2.467 . . . . 0.0 111.783 -170.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.3 t70 50.5 31.08 5.19 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.47 1.508 . . . . 0.0 113.249 175.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -87.0 141.97 28.28 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 171.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -103.48 90.99 3.85 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -71.94 159.58 85.06 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.363 169.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -68.77 166.45 26.17 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.448 2.099 . . . . 0.0 110.644 172.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 63.2 tp -69.26 95.54 0.78 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 170.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -74.98 146.52 41.6 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -102.48 159.64 15.26 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 122.404 1.097 . . . . 0.0 108.646 169.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 90.6 t -83.48 153.14 3.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 113.674 -1.603 . . . . 0.0 108.09 -169.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.9 m 65.84 6.46 3.99 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.905 1.682 . . . . 0.0 114.078 -176.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -80.68 161.56 24.58 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.468 1.107 . . . . 0.0 108.738 169.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -118.97 143.22 47.17 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.602 -0.686 . . . . 0.0 110.586 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.0 mp -113.84 127.16 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 170.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.29 120.18 5.52 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.5 mt -111.05 129.05 56.03 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.49 131.01 35.93 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 169.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.7 mt -140.99 155.04 68.94 Favored Pre-proline 0 C--N 1.332 -0.182 0 C-N-CA 125.69 1.596 . . . . 0.0 107.181 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -64.32 -22.81 66.13 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.058 1.839 . . . . 0.0 112.51 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -62.02 -26.48 68.26 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.149 1.38 . . . . 0.0 112.221 170.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 123.75 148.71 7.58 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -169.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.3 m -63.47 131.31 47.74 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 41.9 ttp -149.68 143.32 25.4 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -172.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.03 138.98 34.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 121.702 -0.623 . . . . 0.0 110.48 176.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -110.35 136.15 49.97 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 168.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.4 m -91.85 142.39 27.63 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -177.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.9 t -75.31 121.72 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 172.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -109.54 171.86 15.51 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 107.518 -2.233 . . . . 0.0 107.518 168.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -118.28 118.29 31.41 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 168.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.9 tp -74.45 131.27 40.91 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -58.9 123.36 16.25 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 122.607 0.363 . . . . 0.0 110.89 -170.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.99 8.1 84.65 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-O 118.672 -1.071 . . . . 0.0 113.994 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.1 t -126.03 -120.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 119.204 1.502 . . . . 0.0 107.914 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.4 m -148.05 -175.7 4.99 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.725 1.61 . . . . 0.0 109.912 -169.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -58.65 145.19 40.73 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.797 0.839 . . . . 0.0 110.542 172.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.12 165.37 35.85 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.572 1.949 . . . . 0.0 107.721 172.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.7 mp -105.33 139.45 39.95 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.7 m -140.28 153.43 46.49 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.891 0.877 . . . . 0.0 110.379 -176.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 41.2 t -143.43 118.04 9.79 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 169.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.8 m -69.72 133.42 47.48 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 174.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.6 mt -106.36 -65.35 1.08 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.432 0.693 . . . . 0.0 109.513 -172.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -145.1 161.3 39.79 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.64 1.176 . . . . 0.0 108.982 -177.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.4 m . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 169.121 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 38.8 m . . . . . 0 CA--C 1.533 0.326 0 CA-C-O 122.631 1.205 . . . . 0.0 113.916 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.87 -22.55 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.552 1.141 . . . . 0.0 112.262 -172.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -69.13 -46.97 66.3 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 119.393 0.997 . . . . 0.0 108.892 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.98 -39.95 83.33 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.63 1.104 . . . . 0.0 109.0 169.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.68 -35.18 37.54 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 123.821 0.724 . . . . 0.0 112.973 175.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -95.61 -54.05 3.51 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.876 1.338 . . . . 0.0 110.77 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -67.07 -33.04 74.64 Favored 'General case' 0 C--O 1.227 -0.094 0 C-N-CA 124.594 1.158 . . . . 0.0 112.301 -169.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.2 mt -77.9 -39.41 43.13 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 119.351 0.978 . . . . 0.0 109.073 -177.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.8 m -60.77 -47.18 87.49 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.535 1.134 . . . . 0.0 109.376 176.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.64 -48.53 80.43 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.58 1.152 . . . . 0.0 111.393 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -60.41 -40.17 90.01 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 122.614 0.365 . . . . 0.0 110.291 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 73.0 m -66.81 -24.0 66.12 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -73.18 -53.97 9.63 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.381 170.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -59.41 -37.91 79.24 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 121.306 1.866 . . . . 0.0 110.268 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 61.0 ttp -44.66 -35.9 2.85 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.987 172.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 9.0 pt -112.73 1.68 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 124.508 1.123 . . . . 0.0 113.04 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 C--O 1.233 0.199 0 C-N-CA 128.397 2.679 . . . . 0.0 105.278 175.593 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 122.673 1.225 . . . . 0.0 112.218 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.7 mt -71.12 129.27 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 126.085 1.754 . . . . 0.0 108.943 -169.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.02 129.79 40.98 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.33 143.44 16.91 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 169.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -116.2 173.16 6.74 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.801 1.24 . . . . 0.0 111.897 -169.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -72.39 -11.28 60.62 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.743 1.617 . . . . 0.0 112.173 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 p -148.19 157.55 43.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.991 1.717 . . . . 0.0 107.991 170.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 m -62.68 158.29 52.17 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 169.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.31 55.32 4.07 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.679 3.586 . . . . 0.0 111.328 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -50.08 -49.46 51.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.95 2.1 . . . . 0.0 112.073 -169.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.55 -42.12 83.15 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 122.513 0.325 . . . . 0.0 111.24 -176.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -70.53 -39.31 74.11 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -176.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.4 t -58.91 -46.99 91.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 171.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -62.31 -50.97 69.55 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-O 118.969 -0.538 . . . . 0.0 110.885 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.34 -38.5 90.32 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.772 0.714 . . . . 0.0 111.073 -175.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.93 -49.38 75.01 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 175.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -66.91 -28.11 68.04 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 118.398 -0.811 . . . . 0.0 112.402 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -66.58 -37.88 85.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.554 1.07 . . . . 0.0 110.074 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -73.41 -41.61 63.09 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.626 -0.671 . . . . 0.0 109.35 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.8 mt -60.68 -45.83 96.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.21 -31.84 72.42 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.673 0.789 . . . . 0.0 112.045 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -65.73 -38.46 89.21 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 . . . . . 0 CA--C 1.533 0.299 0 C-N-CA 125.169 1.387 . . . . 0.0 112.646 -175.928 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo . . . . . 0 N--CA 1.454 -0.851 0 N-CA-C 118.625 2.51 . . . . 0.0 118.625 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.7 t -106.99 102.2 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 100.257 -3.979 . . . . 0.0 100.257 166.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -132.6 155.74 48.16 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.746 0.818 . . . . 0.0 110.885 -169.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.0 t -134.42 120.07 32.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.081 0.953 . . . . 0.0 108.676 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.9 m -91.65 143.87 26.11 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.429 1.092 . . . . 0.0 108.568 169.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -123.69 146.82 47.96 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.347 1.859 . . . . 0.0 110.128 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.485 ' CE1' ' CB ' ' A' ' 131' ' ' ALA . 81.6 m-85 -149.15 172.77 14.28 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -168.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.4 m -14.99 144.7 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.479 1 C-N-CA 133.851 4.861 . . . . 0.0 116.834 169.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.9 tp -78.85 71.08 5.29 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.159 0.984 . . . . 0.0 109.514 172.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -70.04 119.92 14.98 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.518 1.527 . . . . 0.0 108.686 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 50.72 36.2 13.67 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.944 0.898 . . . . 0.0 111.914 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.87 10.84 80.37 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-O 118.379 -1.234 . . . . 0.0 114.418 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -142.24 141.95 32.56 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 120.11 1.955 . . . . 0.0 109.849 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -67.1 140.14 57.56 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 121.164 -0.96 . . . . 0.0 109.788 -173.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.66 162.21 15.72 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 171.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -171.01 167.34 40.51 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 176.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 3.5 m -141.72 147.26 37.13 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 169.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.7 p -120.41 141.88 38.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 169.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.7 tt -123.04 148.52 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 169.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.6 p -141.61 175.61 2.91 Favored Pre-proline 0 N--CA 1.441 -0.876 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 169.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -65.71 -21.65 58.39 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.184 1.256 . . . . 0.0 111.817 169.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 42.6 p-90 -97.94 -21.87 16.62 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.46 177.78 9.75 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.878 1.672 . . . . 0.0 112.906 -176.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 tt -143.75 127.28 16.95 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 103.102 -2.925 . . . . 0.0 103.102 168.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.5 m -137.25 130.62 31.18 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 124.167 0.917 . . . . 0.0 109.215 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.51 147.79 43.69 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 168.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.89 151.85 29.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 72.4 mt -135.83 134.01 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 105.553 -2.018 . . . . 0.0 105.553 177.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -129.62 141.42 41.78 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 118.117 -0.944 . . . . 0.0 110.872 -169.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -54.43 142.17 70.7 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.906 2.404 . . . . 0.0 113.76 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.18 173.92 53.64 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.342 0.972 . . . . 0.0 112.825 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -65.83 148.41 86.35 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.266 2.644 . . . . 0.0 112.035 -175.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.5 t70 53.15 44.26 30.52 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.249 1.419 . . . . 0.0 111.857 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -118.67 148.14 43.05 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.838 1.255 . . . . 0.0 108.249 173.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.43 84.31 2.11 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 172.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 8.8 t90 -71.45 121.65 84.92 Favored Pre-proline 0 C--O 1.235 0.316 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -170.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -56.17 147.88 63.04 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.171 1.914 . . . . 0.0 112.274 -175.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 40.7 tp -58.5 128.06 35.26 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 169.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -109.95 159.47 17.23 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.145 0.978 . . . . 0.0 109.698 -178.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -86.3 142.69 28.34 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 168.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.8 t -88.96 154.91 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -169.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.2 m 65.87 10.32 6.79 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.242 1.417 . . . . 0.0 113.706 -177.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -80.93 153.74 27.37 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.833 1.253 . . . . 0.0 108.131 169.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -107.76 142.73 37.32 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.383 0.538 . . . . 0.0 110.214 176.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.6 mm -118.46 124.21 72.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 173.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.94 120.95 5.6 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 176.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 72.3 mt -106.58 124.75 50.07 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.86 79.46 9.24 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 55.9 mt -74.92 145.93 81.97 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 172.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -60.32 -25.61 80.67 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 121.662 1.575 . . . . 0.0 112.763 170.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -55.4 -30.38 60.31 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.527 1.531 . . . . 0.0 111.952 170.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.72 143.21 4.57 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 107.974 -2.05 . . . . 0.0 107.974 -171.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.8 m -61.45 131.25 49.58 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 60.1 ttm -140.22 129.97 24.47 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.28 132.66 35.87 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 118.721 0.691 . . . . 0.0 109.22 173.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -106.24 135.1 48.31 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 169.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.3 m -87.93 137.88 31.94 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 70.1 t -68.96 122.1 19.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 170.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -107.25 157.05 15.7 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 171.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -122.42 95.42 4.63 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 170.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.9 tt -72.77 115.84 12.55 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -175.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.46 131.68 51.51 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 122.633 0.373 . . . . 0.0 111.378 -173.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.66 2.96 71.27 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 118.888 -0.951 . . . . 0.0 113.402 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.3 t -123.72 -103.33 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.5 p -164.01 171.69 14.88 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.719 1.6 . . . . 0.0 111.089 -173.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -73.49 144.7 46.1 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 169.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.54 179.68 8.39 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.826 1.65 . . . . 0.0 108.594 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.2 mt -109.22 137.87 46.44 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.5 m -140.62 158.24 44.28 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.092 0.957 . . . . 0.0 111.275 -173.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 38.7 t -143.44 108.95 5.08 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 169.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.2 m -85.75 143.82 28.12 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.991 0.916 . . . . 0.0 109.942 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.43 -10.7 0.73 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -172.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 10.0 tpp -125.0 147.14 49.08 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 120.592 1.542 . . . . 0.0 111.778 -170.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 CA--C 1.544 0.719 0 C-N-CA 124.584 1.154 . . . . 0.0 111.158 177.806 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.6 p . . . . . 0 CA--C 1.53 0.188 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.424 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -62.32 -28.57 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 O-C-N 121.472 -0.768 . . . . 0.0 110.624 169.675 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -68.03 -49.0 64.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -65.91 -39.37 90.51 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.668 0.667 . . . . 0.0 110.017 177.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.12 -25.31 59.69 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.569 1.08 . . . . 0.0 112.696 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -96.33 -52.37 4.01 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.321 1.06 . . . . 0.0 110.672 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 44.1 mtm-85 -65.2 -41.71 94.23 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.648 -0.658 . . . . 0.0 112.199 -170.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.72 -35.74 60.18 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 119.406 1.003 . . . . 0.0 110.596 -170.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.64 -45.56 93.62 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.851 0.75 . . . . 0.0 109.067 175.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -66.63 -48.44 69.46 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.012 1.325 . . . . 0.0 111.46 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.61 -38.93 92.71 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.43 -0.794 . . . . 0.0 111.793 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 88.8 m -71.21 -24.16 62.16 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 119.499 -0.286 . . . . 0.0 111.276 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.485 ' CB ' ' CE1' ' A' ' 45' ' ' PHE . . . -78.96 -47.17 16.84 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 118.845 0.748 . . . . 0.0 109.037 169.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.1 ttp-105 -55.74 -41.95 74.68 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.731 0.812 . . . . 0.0 112.025 -177.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 16.9 ptt? -55.1 -50.09 70.09 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 118.613 0.642 . . . . 0.0 110.658 175.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 42.8 pt -75.81 -19.8 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 O-C-N 120.957 -1.089 . . . . 0.0 111.376 -177.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.6 tp . . . . . 0 CA--C 1.538 0.517 0 C-N-CA 126.857 2.063 . . . . 0.0 110.337 169.31 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 CA--C 1.535 0.374 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.2 mm -123.64 128.61 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 173.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.69 142.44 42.51 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.6 151.74 50.56 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.487 1.041 . . . . 0.0 112.052 176.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -102.91 154.72 18.93 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.733 1.213 . . . . 0.0 109.996 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -84.73 -21.12 30.2 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.694 -0.629 . . . . 0.0 112.265 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.9 p -158.39 -176.67 6.03 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 129.476 3.11 . . . . 0.0 105.987 170.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.0 m -58.44 145.17 76.68 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 168.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -73.59 59.23 4.03 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.817 3.011 . . . . 0.0 108.943 169.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.5 tttm -50.54 -51.62 46.22 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.638 1.975 . . . . 0.0 112.481 -168.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.93 -40.89 91.83 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.6 0.36 . . . . 0.0 111.707 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -69.3 -45.32 69.86 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.887 0.875 . . . . 0.0 109.773 -174.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 73.7 t -62.13 -42.97 97.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.372 1.069 . . . . 0.0 108.471 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -59.64 -54.01 51.39 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.469 0.577 . . . . 0.0 110.041 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.0 -39.68 93.81 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.194 0.598 . . . . 0.0 111.112 -175.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.03 -46.32 78.3 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -70.86 -27.17 63.64 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-O 117.918 -1.039 . . . . 0.0 112.071 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -61.69 -38.27 87.22 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 120.055 1.298 . . . . 0.0 110.211 171.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -73.8 -41.71 61.97 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 121.702 -0.624 . . . . 0.0 109.389 -177.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.6 mt -61.27 -43.88 97.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.3 -27.28 68.92 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.077 0.853 . . . . 0.0 112.146 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -79.81 -42.32 24.61 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.019 0.928 . . . . 0.0 109.17 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 . . . . . 0 C--N 1.328 -0.331 0 C-N-CA 123.788 0.835 . . . . 0.0 111.702 178.879 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo . . . . . 0 N--CA 1.452 -0.933 0 CA-C-O 121.0 0.333 . . . . 0.0 112.342 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.8 t -73.58 139.4 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 169.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -142.65 154.39 44.31 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.968 0.907 . . . . 0.0 108.923 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.2 t -141.09 125.21 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.748 0.819 . . . . 0.0 108.895 -173.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.4 m -89.15 144.02 26.42 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.203 1.001 . . . . 0.0 108.745 168.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -119.96 135.82 54.76 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.792 1.637 . . . . 0.0 108.035 169.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -167.57 143.33 4.03 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -176.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.7 m 57.17 166.4 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.525 2.33 . . . . 0.0 115.341 167.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.1 tp -120.99 66.63 0.86 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.806 1.242 . . . . 0.0 108.521 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.2 131.27 42.53 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.646 -0.658 . . . . 0.0 110.117 -175.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 52.38 31.5 9.67 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.477 1.111 . . . . 0.0 111.87 -175.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.65 11.06 85.82 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 118.153 -1.359 . . . . 0.0 113.613 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -125.36 143.76 50.82 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.893 1.847 . . . . 0.0 108.062 -174.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -67.97 138.39 55.88 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.416 1.007 . . . . 0.0 109.549 -176.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.65 155.39 17.34 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.95 171.43 37.87 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 173.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 45.0 m -140.32 150.62 44.23 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 169.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.4 p -127.66 141.76 45.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 124.853 1.261 . . . . 0.0 107.602 175.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.0 tt -118.52 149.04 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 169.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.6 p -142.83 172.61 5.51 Favored Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 171.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.36 -19.09 65.18 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 CA-C-N 120.149 1.089 . . . . 0.0 111.646 168.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 37.8 p-90 -102.16 -23.36 14.05 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.518 1.054 . . . . 0.0 113.836 -172.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.74 166.06 24.77 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.819 1.247 . . . . 0.0 111.882 -175.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 tt -132.94 124.74 28.37 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 104.2 -2.518 . . . . 0.0 104.2 168.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.2 m -137.63 133.15 34.01 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.367 0.604 . . . . 0.0 110.891 -176.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.35 148.28 49.9 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 168.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.4 m -139.97 151.88 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 123.946 0.898 . . . . 0.0 109.038 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.6 mt -138.32 145.63 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -133.15 142.49 44.67 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.191 -176.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -44.8 129.42 9.46 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 124.012 3.142 . . . . 0.0 112.447 174.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.97 178.62 15.56 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.085 0.85 . . . . 0.0 114.525 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -67.33 131.16 24.16 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.381 2.721 . . . . 0.0 111.141 -172.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.8 t70 51.15 31.34 6.56 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.538 1.535 . . . . 0.0 113.219 175.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -88.96 155.63 19.39 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -116.8 88.12 2.83 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 170.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -67.24 151.18 97.4 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.164 174.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.38 159.42 49.37 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.256 1.97 . . . . 0.0 109.284 169.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 51.9 tp -64.53 118.75 9.26 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 169.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -88.95 158.98 17.86 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.41 138.26 31.9 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 168.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.7 t -83.13 154.98 3.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 123.834 0.853 . . . . 0.0 108.704 -169.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.1 m 66.23 9.97 6.77 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.295 1.438 . . . . 0.0 113.828 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -83.8 163.0 20.42 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.807 1.243 . . . . 0.0 107.891 168.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -110.93 142.16 43.39 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 118.923 0.783 . . . . 0.0 111.02 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 30.4 mm -113.45 130.96 66.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.08 123.09 6.01 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -109.97 155.31 21.94 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.897 1.279 . . . . 0.0 108.328 170.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.0 tp60 -126.7 131.74 51.31 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 169.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -155.57 166.14 16.89 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 126.067 1.747 . . . . 0.0 107.199 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -57.72 -22.54 53.29 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.697 2.265 . . . . 0.0 115.0 -174.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -58.29 -33.51 69.53 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.681 0.792 . . . . 0.0 111.715 172.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.24 177.89 15.67 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.677 1.608 . . . . 0.0 110.03 -176.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.2 m -67.01 128.13 35.2 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 169.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 41.0 ttp -147.35 130.74 16.64 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.25 141.71 33.85 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 172.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -113.17 135.92 53.29 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 169.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.2 m -80.26 143.81 33.39 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 176.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 62.6 t -76.14 125.72 36.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 170.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -108.97 156.02 15.82 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -133.95 123.32 24.44 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 170.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.6 tp -141.23 144.08 34.52 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.36 0.527 . . . . 0.0 110.171 -172.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -54.27 131.55 41.88 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.32 1.048 . . . . 0.0 110.788 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.8 -1.36 58.77 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 118.717 -1.046 . . . . 0.0 113.591 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 44.8 t -121.57 -28.64 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 119.441 1.62 . . . . 0.0 109.947 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.1 m 60.11 -144.86 0.51 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.804 1.241 . . . . 0.0 108.279 -170.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -83.44 136.6 34.25 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.847 0.749 . . . . 0.0 110.654 -175.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -156.91 175.72 13.7 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.257 1.823 . . . . 0.0 107.869 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.2 mp -116.53 147.09 42.13 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.323 1.049 . . . . 0.0 108.501 -177.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.6 p -143.65 153.04 42.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.754 1.222 . . . . 0.0 110.615 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.8 t -147.28 121.93 9.83 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 170.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.9 m -72.97 137.57 45.56 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.334 0.515 . . . . 0.0 109.99 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -89.17 -66.78 0.89 Allowed 'General case' 0 C--N 1.338 0.102 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 171.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.78 174.64 7.44 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.031 1.332 . . . . 0.0 108.859 -175.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 CA--C 1.542 0.663 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 169.676 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 CA--C 1.53 0.206 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.1 -27.17 26.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.674 -0.641 . . . . 0.0 111.619 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.39 -42.26 96.23 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.977 0.511 . . . . 0.0 110.148 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -67.88 -29.28 68.36 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.043 0.937 . . . . 0.0 110.482 171.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.85 -60.87 8.02 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 169.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -65.06 -49.61 69.39 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.864 -0.786 . . . . 0.0 110.279 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -58.08 -45.34 87.3 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 124.439 1.096 . . . . 0.0 110.688 -175.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.5 tp -79.66 -25.76 41.22 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 119.858 1.208 . . . . 0.0 111.668 -173.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.4 m -69.61 -42.88 73.8 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.829 1.195 . . . . 0.0 109.197 173.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.51 -41.55 79.83 Favored 'General case' 0 N--CA 1.461 0.095 0 C-N-CA 123.165 0.586 . . . . 0.0 111.358 177.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -66.22 -29.64 69.94 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.351 -0.843 . . . . 0.0 110.267 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 20.0 m -69.53 -43.34 73.21 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.991 0.814 . . . . 0.0 110.239 175.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -56.41 -52.92 62.85 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.59 0.756 . . . . 0.0 109.698 171.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -52.61 -53.86 40.99 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.91 1.284 . . . . 0.0 110.559 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 54.0 ttp -49.24 -50.16 39.86 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.607 1.563 . . . . 0.0 110.922 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 6.4 pt -82.12 -19.93 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 119.027 0.83 . . . . 0.0 112.513 -174.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 74.4 mt . . . . . 0 CA--C 1.533 0.322 0 CA-C-N 118.387 0.54 . . . . 0.0 109.729 169.028 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 . . . . . 0 CA--C 1.537 0.464 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.4 mm -120.94 128.93 76.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 171.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.47 131.97 42.39 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.86 151.48 51.2 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.109 0.861 . . . . 0.0 111.096 174.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -93.84 138.45 31.99 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.282 1.033 . . . . 0.0 109.736 -175.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -71.1 -34.03 70.73 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.909 -0.567 . . . . 0.0 109.902 176.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.3 p -156.64 161.78 39.88 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 128.618 2.767 . . . . 0.0 106.812 169.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.0 m -51.82 137.44 34.75 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.226 1.011 . . . . 0.0 112.346 -174.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -76.55 46.71 1.92 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 124.907 3.738 . . . . 0.0 110.555 172.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -62.64 -31.77 72.69 Favored 'General case' 0 C--O 1.221 -0.438 0 O-C-N 120.498 -1.376 . . . . 0.0 113.232 -168.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.76 -42.64 94.97 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 118.762 0.71 . . . . 0.0 111.006 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -72.84 -39.3 66.67 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -177.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.2 t -58.46 -46.42 89.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 171.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -60.77 -53.18 60.52 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 123.526 0.73 . . . . 0.0 110.371 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.55 -40.36 95.44 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.694 0.679 . . . . 0.0 110.931 -174.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.21 -41.82 80.73 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.013 -0.43 . . . . 0.0 110.506 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -69.52 -27.33 65.08 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-O 118.331 -0.843 . . . . 0.0 112.415 175.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -63.22 -36.74 84.64 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.569 1.077 . . . . 0.0 109.104 172.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -71.48 -46.25 60.33 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.2 mt -61.01 -36.87 75.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 123.491 0.717 . . . . 0.0 109.845 177.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.74 -36.39 78.32 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.196 -0.94 . . . . 0.0 110.614 176.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.7 ttm105 -70.57 -34.8 72.62 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.448 1.099 . . . . 0.0 110.061 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? . . . . . 0 CA--C 1.545 0.757 0 C-N-CA 125.092 1.357 . . . . 0.0 111.645 169.142 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo . . . . . 0 N--CA 1.45 -1.046 0 N-CA-C 108.562 -1.361 . . . . 0.0 108.562 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.1 t -65.62 108.66 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 169.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -149.53 155.73 40.8 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.36 1.464 . . . . 0.0 109.256 -168.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.7 t -140.12 120.1 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.9 m -85.39 148.4 26.03 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.851 0.86 . . . . 0.0 109.792 169.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -125.28 141.86 51.84 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.828 2.051 . . . . 0.0 110.567 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.454 ' CE2' ' CB ' ' A' ' 131' ' ' ALA . 98.4 m-85 -149.61 171.16 17.1 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -169.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.8 m -6.64 135.99 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.357 1 C-N-CA 133.43 4.692 . . . . 0.0 117.285 169.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.0 tt -78.53 103.61 8.59 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 168.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -84.92 -138.65 0.07 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.026 1.73 . . . . 0.0 107.872 -174.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -73.46 74.21 1.41 Allowed 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.823 -1.173 . . . . 0.0 110.129 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.79 16.33 78.05 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.542 1.068 . . . . 0.0 113.665 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -153.69 140.43 19.02 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.687 1.243 . . . . 0.0 109.862 -172.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -77.32 148.02 35.88 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.996 1.318 . . . . 0.0 110.063 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.58 158.29 15.86 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.61 0.719 . . . . 0.0 110.374 175.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -167.05 168.88 40.62 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 175.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 15.4 m -143.43 142.82 31.35 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 169.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.6 p -114.27 149.96 16.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 124.958 1.303 . . . . 0.0 107.678 172.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.4 tt -136.59 156.67 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 169.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.6 p -146.47 177.35 1.8 Allowed Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 126.353 1.861 . . . . 0.0 106.816 175.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -59.49 -28.88 88.6 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 CA-C-N 120.154 1.091 . . . . 0.0 111.015 168.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 50.0 p-90 -97.19 -19.41 18.64 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -171.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.67 172.81 15.64 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.804 1.638 . . . . 0.0 113.717 -176.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 tt -135.68 126.15 26.81 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 103.523 -2.769 . . . . 0.0 103.523 167.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.8 m -135.33 134.25 39.64 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.21 146.5 47.29 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 169.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.1 m -139.35 147.12 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 123.639 0.775 . . . . 0.0 109.335 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.9 mm -140.64 142.94 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -171.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -132.81 140.11 36.69 Favored Pre-proline 0 N--CA 1.468 0.43 0 CA-C-O 117.482 -1.247 . . . . 0.0 109.445 -175.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -57.14 142.35 94.39 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.151 1.901 . . . . 0.0 111.29 175.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.99 -179.3 29.16 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.731 1.158 . . . . 0.0 114.24 -171.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.87 145.34 56.21 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.35 2.7 . . . . 0.0 111.779 -171.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.6 t0 43.16 57.08 3.89 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.395 1.878 . . . . 0.0 112.395 174.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -142.84 146.59 34.29 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -172.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -117.12 101.0 8.1 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -76.12 154.72 84.56 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 169.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -69.97 158.9 55.18 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.187 1.924 . . . . 0.0 110.798 172.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 66.0 tp -64.09 136.74 57.53 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 169.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -118.79 160.49 21.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.109 0.868 . . . . 0.0 109.052 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -86.11 149.56 25.04 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 169.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 36.0 t -90.6 154.73 3.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -169.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.0 m 61.67 28.25 17.44 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.798 0.839 . . . . 0.0 112.344 -175.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -107.46 154.38 21.44 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.819 2.047 . . . . 0.0 107.264 169.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -104.76 147.88 27.22 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.333 0.969 . . . . 0.0 111.463 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.6 mm -122.97 132.12 72.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 176.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -81.75 123.33 6.02 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.5 mp -106.26 134.0 50.08 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 169.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -89.93 116.6 28.12 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 169.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.1 mt -106.12 155.53 38.34 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 169.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.31 -28.03 55.39 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 CA-C-N 120.187 1.102 . . . . 0.0 111.136 169.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -52.46 -38.66 59.82 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.688 1.595 . . . . 0.0 111.517 169.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 153.53 169.88 19.03 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -174.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.3 m -71.74 130.39 41.01 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 173.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 60.4 ttm -138.23 123.43 19.26 Favored 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.35 136.36 37.68 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.483 -0.761 . . . . 0.0 109.135 170.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -111.49 140.76 45.82 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 169.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.5 m -90.12 141.45 28.68 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.2 t -70.49 119.1 16.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 169.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -102.53 158.39 18.0 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 108.052 -2.019 . . . . 0.0 108.052 169.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -132.81 122.28 24.23 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 169.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.6 tp -138.26 147.81 44.07 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.794 0.838 . . . . 0.0 109.127 -169.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -58.1 128.91 39.47 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.227 0.611 . . . . 0.0 111.503 -172.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.53 -30.64 1.94 Allowed Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.731 1.634 . . . . 0.0 112.812 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.4 t -79.58 -29.15 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.847 1.659 . . . . 0.0 110.003 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.0 m 56.75 -139.36 0.92 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 -169.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -84.18 138.36 33.03 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.155 0.889 . . . . 0.0 110.956 -175.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -155.98 169.1 25.23 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.936 2.094 . . . . 0.0 107.115 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.8 mp -112.06 140.68 46.54 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.2 m -138.3 151.14 47.31 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.29 1.036 . . . . 0.0 110.211 -173.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 44.3 t -138.92 115.67 10.72 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 169.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.5 m -67.44 123.93 21.78 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.28 -47.32 4.98 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.237 0.615 . . . . 0.0 110.47 -170.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 16.2 ptp -159.62 163.9 34.58 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.103 0.961 . . . . 0.0 109.413 175.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.9 m . . . . . 0 CA--C 1.542 0.662 0 CA-C-O 117.643 -1.17 . . . . 0.0 112.217 -179.477 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 43.1 m . . . . . 0 CA--C 1.539 0.541 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.3 pt -60.52 -25.49 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -174.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -75.72 -47.28 26.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 30.0 mp0 -61.47 -35.36 77.41 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.365 1.066 . . . . 0.0 109.623 169.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.84 -54.06 41.13 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 120.197 1.362 . . . . 0.0 110.842 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -64.81 -48.2 75.28 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.528 -0.983 . . . . 0.0 110.275 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 75.5 mtp85 -64.11 -30.85 71.89 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 122.785 0.434 . . . . 0.0 111.387 -177.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.2 tp -82.57 -22.68 34.78 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-O 118.003 -0.999 . . . . 0.0 111.311 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.2 m -64.28 -46.24 84.55 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.304 1.411 . . . . 0.0 107.762 169.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -64.53 -51.29 63.66 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.006 0.922 . . . . 0.0 111.659 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -61.44 -36.03 79.23 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.628 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 21.8 m -64.01 -39.59 94.44 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.252 0.478 . . . . 0.0 110.211 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.454 ' CB ' ' CE2' ' A' ' 45' ' ' PHE . . . -65.81 -48.81 70.46 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 121.635 -0.666 . . . . 0.0 110.59 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.5 ptt85 -67.32 -27.26 67.0 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.444 1.474 . . . . 0.0 112.641 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -56.61 -45.5 81.43 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.324 169.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 12.7 pt -81.84 -25.38 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 119.731 1.151 . . . . 0.0 113.118 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 70.8 mt . . . . . 0 N--CA 1.469 0.514 0 CA-C-N 119.845 1.202 . . . . 0.0 109.154 169.681 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.9 mt -119.29 138.77 48.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 171.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.35 160.81 31.6 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.159 0.583 . . . . 0.0 110.865 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.03 160.73 52.89 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.631 -0.587 . . . . 0.0 111.631 171.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -120.53 144.39 48.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.81 1.244 . . . . 0.0 111.918 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -104.96 81.25 1.72 Allowed 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.203 -1.776 . . . . 0.0 106.203 169.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.9 p 63.58 176.16 0.16 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 127.249 2.22 . . . . 0.0 111.28 -169.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.1 m -59.9 150.32 69.41 Favored Pre-proline 0 CA--C 1.541 0.625 0 O-C-N 121.713 -0.617 . . . . 0.0 111.17 -171.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.18 54.66 3.29 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 124.639 3.56 . . . . 0.0 109.972 169.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.4 tttm -52.12 -50.0 62.54 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 127.357 2.263 . . . . 0.0 111.962 -169.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.79 -41.49 95.78 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 122.644 0.377 . . . . 0.0 111.463 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -73.49 -38.9 65.23 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -174.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.7 t -61.91 -42.64 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 172.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -62.02 -51.2 68.97 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 118.305 0.502 . . . . 0.0 110.271 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.67 -40.19 96.2 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.502 0.721 . . . . 0.0 110.907 -176.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.08 -51.27 68.61 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.011 176.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -66.6 -31.69 72.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 118.287 -0.863 . . . . 0.0 111.881 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.86 -31.62 72.68 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.586 1.084 . . . . 0.0 110.086 176.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -82.7 -44.49 15.61 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.41 0.684 . . . . 0.0 110.617 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.0 mt -65.95 -40.16 86.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 O-C-N 121.027 -1.046 . . . . 0.0 109.016 -175.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.9 -30.14 69.99 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.734 -0.604 . . . . 0.0 111.102 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.9 ttp-105 -81.25 -41.78 21.7 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.386 1.074 . . . . 0.0 109.917 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 . . . . . 0 CA--C 1.535 0.392 0 C-N-CA 123.366 0.666 . . . . 0.0 110.586 173.726 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 N--CA 1.453 -0.869 0 N-CA-C 114.687 0.995 . . . . 0.0 114.687 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.8 t -110.84 101.88 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 1 N-CA-C 98.888 -4.486 . . . . 0.0 98.888 166.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -141.99 157.25 45.16 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.64 1.176 . . . . 0.0 110.066 -168.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.0 t -140.39 120.16 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.472 0.709 . . . . 0.0 109.192 -172.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.1 m -84.02 142.9 30.13 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 168.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -120.91 137.03 54.79 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 125.682 1.593 . . . . 0.0 108.865 170.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.439 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 44.1 p90 -169.01 146.17 3.64 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -173.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.8 m 57.34 161.35 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.1 2.56 . . . . 0.0 115.86 167.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.2 tp -112.68 84.33 1.96 Allowed 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 170.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -76.17 118.63 19.1 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.57 1.148 . . . . 0.0 108.806 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 51.83 35.4 15.39 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.356 1.062 . . . . 0.0 112.336 176.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.37 17.66 73.24 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 118.859 -0.967 . . . . 0.0 113.992 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -133.57 138.64 46.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.809 1.644 . . . . 0.0 107.853 -176.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -71.62 142.49 49.96 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.645 -1.284 . . . . 0.0 108.973 -177.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.439 ' HB ' ' CE2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -103.66 157.9 16.74 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.497 1.044 . . . . 0.0 109.56 -179.686 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.89 169.62 38.15 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 171.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 36.1 m -137.04 146.9 45.78 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 169.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 p -123.62 140.86 45.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 175.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.6 tt -119.83 152.06 22.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 168.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 48.6 p -140.53 176.79 2.29 Favored Pre-proline 0 C--N 1.32 -0.701 0 C-N-CA 125.595 1.558 . . . . 0.0 107.237 169.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -59.78 -6.05 4.2 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.501 2.134 . . . . 0.0 114.297 169.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.0 p-90 -130.09 -21.75 2.93 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -169.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.12 166.1 32.69 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 120.089 1.313 . . . . 0.0 112.721 -177.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.81 122.39 18.53 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 168.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.2 m -136.51 135.38 38.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.326 0.584 . . . . 0.0 109.973 -175.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.65 145.11 52.68 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 168.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.5 m -137.61 146.08 28.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.9 mt -141.19 146.44 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -174.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -134.21 157.09 78.36 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-O 117.438 -1.267 . . . . 0.0 110.376 -172.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -57.2 9.21 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 0.989 1 C-N-CA 126.053 4.502 . . . . 0.0 120.001 -169.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.27 -155.85 44.46 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 117.86 -1.522 . . . . 0.0 111.43 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -65.42 -146.91 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.815 1 C-N-CA 125.324 4.016 . . . . 0.0 113.383 -174.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -74.43 58.1 0.74 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.457 1.503 . . . . 0.0 111.059 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -102.87 135.76 43.95 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 127.178 2.191 . . . . 0.0 106.855 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -108.11 88.19 2.67 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -177.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -69.23 149.79 97.42 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-O 118.847 -0.596 . . . . 0.0 109.407 172.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -67.76 157.21 62.79 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 N-CA-C 107.708 -1.689 . . . . 0.0 107.708 168.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 40.2 tp -62.94 122.99 17.39 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -88.27 159.23 18.2 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -174.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -86.03 152.65 22.73 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 168.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 83.9 t -99.74 155.08 4.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.342 -1.299 . . . . 0.0 107.862 -169.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.4 m 65.14 7.49 4.15 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.581 1.552 . . . . 0.0 113.489 -173.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -78.27 157.99 29.06 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.344 1.457 . . . . 0.0 107.967 169.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -122.86 141.29 52.03 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 123.054 0.542 . . . . 0.0 110.471 -177.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.2 mm -117.2 121.25 67.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -74.28 122.44 7.38 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.655 -1.778 . . . . 0.0 108.655 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.4 tp -120.36 132.35 55.24 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 124.443 1.097 . . . . 0.0 108.637 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.48 127.8 35.23 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 173.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mp -135.89 157.91 75.03 Favored Pre-proline 0 C--O 1.235 0.296 0 C-N-CA 125.295 1.438 . . . . 0.0 107.91 173.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -61.66 -20.24 68.15 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.367 2.044 . . . . 0.0 114.243 171.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -58.22 -32.26 68.13 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.504 0.722 . . . . 0.0 111.147 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 133.17 157.31 8.37 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 106.621 -2.592 . . . . 0.0 106.621 -169.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.1 m -66.53 130.02 41.79 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 58.5 mtm -137.46 141.16 41.57 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -176.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.77 129.88 34.77 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 170.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -99.21 124.75 44.51 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 169.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.6 m -81.07 140.43 35.11 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.3 t -75.38 120.11 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 169.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -109.48 163.54 12.5 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 172.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -125.3 95.04 4.33 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 170.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.7 tp -74.25 125.76 29.14 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -169.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -59.34 128.57 37.73 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.625 0.77 . . . . 0.0 110.108 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.77 3.91 84.53 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.689 -1.062 . . . . 0.0 113.869 -177.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.4 t -126.64 -119.92 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 119.263 1.531 . . . . 0.0 107.596 177.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.2 m -150.73 -179.31 7.15 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.622 1.569 . . . . 0.0 108.791 -169.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -69.85 143.44 52.85 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 169.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.26 172.57 16.79 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.437 1.495 . . . . 0.0 108.559 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.6 mp -106.52 142.6 35.91 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 172.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.3 p -142.11 152.65 43.46 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.693 0.797 . . . . 0.0 110.411 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 15.7 t -144.43 119.69 10.19 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 171.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.0 m -67.68 129.09 38.82 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 81.4 mt -92.3 -52.57 4.61 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.72 175.32 12.11 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.455 1.502 . . . . 0.0 108.102 171.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 CA--C 1.543 0.69 0 C-N-CA 124.633 1.173 . . . . 0.0 110.69 -175.647 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 93.5 p . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 121.767 0.794 . . . . 0.0 112.286 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.1 pp -64.64 -20.09 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 124.871 1.268 . . . . 0.0 112.215 169.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -79.63 -55.39 5.06 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -66.1 -30.85 71.43 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 123.591 0.757 . . . . 0.0 110.584 177.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -64.15 -52.18 46.57 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 119.804 1.184 . . . . 0.0 111.596 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -65.75 -46.82 77.4 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.164 0.982 . . . . 0.0 110.082 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -58.55 -43.82 89.47 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 118.423 -0.799 . . . . 0.0 110.566 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.0 tp -76.74 -28.34 55.72 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 119.365 0.984 . . . . 0.0 111.619 -173.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -69.08 -39.75 78.87 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 120.083 1.31 . . . . 0.0 109.498 174.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.21 -43.87 66.52 Favored 'General case' 0 N--CA 1.46 0.052 0 C-N-CA 122.985 0.514 . . . . 0.0 111.332 176.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -57.92 -39.14 77.25 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 121.176 -0.952 . . . . 0.0 109.612 173.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 20.0 m -64.33 -34.53 78.36 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 119.424 -0.322 . . . . 0.0 110.758 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.69 -56.79 15.93 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.397 0.679 . . . . 0.0 109.926 174.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -42.16 97.94 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 119.412 1.006 . . . . 0.0 109.556 -177.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 53.1 ttp -49.31 -55.39 12.93 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.956 1.302 . . . . 0.0 110.192 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 6.7 pt -80.3 -21.99 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 119.879 1.218 . . . . 0.0 112.604 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 24.5 mt . . . . . 0 C--O 1.231 0.11 0 CA-C-N 118.615 0.643 . . . . 0.0 110.947 177.866 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 mt -117.91 138.59 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 174.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.07 154.6 39.13 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.744 0.417 . . . . 0.0 110.55 176.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.22 156.65 34.14 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 169.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -125.07 151.48 45.61 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.474 1.11 . . . . 0.0 110.007 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -85.21 -21.16 29.25 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.941 0.896 . . . . 0.0 111.844 -176.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.4 p -159.06 -178.73 7.44 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 128.739 2.815 . . . . 0.0 105.897 173.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.7 m -59.49 139.91 88.87 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 168.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.16 54.45 4.19 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 124.553 3.502 . . . . 0.0 107.807 169.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.7 pttm -60.41 -34.89 74.59 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.634 1.174 . . . . 0.0 113.13 -168.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.58 -42.34 87.13 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.207 0.912 . . . . 0.0 110.614 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -70.9 -41.08 71.74 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 81.3 t -59.97 -42.55 89.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 172.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -60.74 -53.55 56.06 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 123.479 0.712 . . . . 0.0 109.71 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.57 -40.97 98.55 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.367 0.53 . . . . 0.0 110.857 -176.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.74 -46.81 83.66 Favored 'General case' 0 N--CA 1.456 -0.126 0 O-C-N 122.238 -0.289 . . . . 0.0 110.466 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -70.96 -28.25 64.33 Favored 'General case' 0 C--O 1.23 0.065 0 CA-C-O 118.65 -0.69 . . . . 0.0 112.446 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.8 -37.24 83.64 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.114 0.87 . . . . 0.0 109.615 174.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -65.73 -41.49 92.18 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.721 -0.657 . . . . 0.0 110.448 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.6 mm -64.76 -41.86 93.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 119.717 1.144 . . . . 0.0 109.559 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.6 -26.54 66.31 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.939 0.495 . . . . 0.0 111.459 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 55.5 ttp85 -71.93 -47.88 49.35 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 172.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.541 0.602 0 C-N-CA 125.487 1.515 . . . . 0.0 114.132 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo . . . . . 0 N--CA 1.453 -0.86 0 N-CA-C 111.671 -0.165 . . . . 0.0 111.671 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.46 128.68 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 169.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -148.55 150.82 34.02 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.583 1.153 . . . . 0.0 108.634 -170.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.6 t -141.73 121.15 10.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.2 p -96.82 154.93 17.0 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 118.849 0.749 . . . . 0.0 110.939 169.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -119.52 142.87 47.93 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.743 2.017 . . . . 0.0 109.614 -171.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -147.22 167.73 23.47 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -169.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.7 m -14.3 139.82 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 1 C-N-CA 133.208 4.603 . . . . 0.0 117.149 169.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.0 tp -78.4 127.95 32.93 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 169.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -147.6 146.07 29.24 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 125.47 1.508 . . . . 0.0 107.311 175.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 53.91 26.63 6.4 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 120.482 1.492 . . . . 0.0 112.876 -175.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.18 25.4 75.47 Favored Glycine 0 CA--C 1.535 1.303 0 O-C-N 121.228 -0.92 . . . . 0.0 113.446 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -148.36 149.06 31.12 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.222 1.409 . . . . 0.0 110.056 -173.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -79.75 140.35 36.96 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 121.212 -0.93 . . . . 0.0 109.122 -177.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.0 160.09 20.11 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.805 0.812 . . . . 0.0 108.857 170.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -167.19 162.74 36.53 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 107.581 -2.208 . . . . 0.0 107.581 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 13.0 m -138.92 147.03 41.78 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 169.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 p -122.23 147.65 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 125.108 1.363 . . . . 0.0 107.817 172.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.4 tt -128.31 151.24 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 169.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.0 p -141.98 177.7 1.8 Allowed Pre-proline 0 C--N 1.32 -0.706 0 C-N-CA 125.331 1.452 . . . . 0.0 107.282 171.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -60.23 -30.37 91.06 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 CA-C-N 119.99 1.032 . . . . 0.0 110.552 168.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -94.29 -25.24 17.1 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -169.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.57 170.36 22.59 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 120.506 1.503 . . . . 0.0 112.965 -174.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 tt -137.72 123.98 20.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 168.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.7 m -137.36 134.51 36.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.438 0.637 . . . . 0.0 110.451 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.32 139.62 44.3 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 168.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 m -139.21 140.16 38.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -172.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.6 mm -135.73 138.53 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -169.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -131.02 145.63 58.6 Favored Pre-proline 0 N--CA 1.474 0.729 0 CA-C-O 117.692 -1.147 . . . . 0.0 111.867 -169.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -51.02 137.6 44.26 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.15 2.567 . . . . 0.0 112.698 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.52 179.83 28.92 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 123.427 0.537 . . . . 0.0 113.306 -175.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.43 123.4 11.73 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.992 2.461 . . . . 0.0 110.191 -173.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.1 t70 49.69 35.7 9.37 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.218 1.407 . . . . 0.0 113.15 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -95.87 127.77 42.18 Favored 'General case' 0 C--N 1.344 0.341 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.49 75.74 0.94 Allowed 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -170.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 48.7 m0 -68.58 149.07 98.1 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.192 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.31 151.84 80.09 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.011 1.807 . . . . 0.0 109.053 169.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.8 tp -56.04 131.91 48.69 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.557 -0.715 . . . . 0.0 109.254 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.41 157.95 16.06 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -90.3 148.86 22.61 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 169.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.2 t -91.6 154.81 3.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -169.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.5 m 60.72 33.7 20.13 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.911 0.884 . . . . 0.0 111.98 -176.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -112.27 155.6 23.79 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 127.019 2.128 . . . . 0.0 106.989 169.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -105.77 142.22 35.87 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.289 0.949 . . . . 0.0 110.546 178.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.7 mm -121.19 131.58 72.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.11 126.36 8.26 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 174.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.8 mt -113.01 124.87 53.62 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 172.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.64 133.36 43.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 169.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.4 mt -141.19 158.22 64.79 Favored Pre-proline 0 C--O 1.234 0.254 0 C-N-CA 124.13 0.972 . . . . 0.0 108.465 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -57.77 -29.63 86.48 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.738 2.292 . . . . 0.0 112.81 170.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -64.38 -18.5 64.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.45 1.1 . . . . 0.0 113.023 173.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 110.47 154.54 14.13 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 107.821 -2.112 . . . . 0.0 107.821 -168.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.1 m -65.03 132.35 48.98 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -175.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 64.3 mtm -141.12 145.75 36.16 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.846 1.258 . . . . 0.0 108.345 -178.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.41 136.91 37.09 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 121.597 -0.689 . . . . 0.0 109.33 172.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -115.34 139.7 49.76 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 169.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.7 m -87.12 137.18 32.57 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 52.5 t -68.08 122.56 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 170.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -109.34 163.11 12.57 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 107.565 -2.214 . . . . 0.0 107.565 169.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -133.38 94.25 3.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 171.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.5 tp -80.28 126.44 31.14 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -170.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -59.81 132.4 53.83 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.219 0.608 . . . . 0.0 110.451 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.94 5.43 75.34 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.659 -1.078 . . . . 0.0 113.482 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.9 t -125.62 -115.27 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.8 p -159.23 178.67 9.74 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 119.742 1.155 . . . . 0.0 110.236 -169.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -73.64 138.05 44.56 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 169.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.87 165.15 36.99 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.777 1.631 . . . . 0.0 107.684 -175.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.4 mp -111.47 130.35 55.75 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.5 m -131.23 150.46 52.14 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.519 0.728 . . . . 0.0 110.913 -170.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 40.4 t -143.14 121.47 12.31 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 169.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.1 m -76.2 137.55 40.08 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -90.41 -67.49 0.84 Allowed 'General case' 0 C--N 1.339 0.119 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 175.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.14 173.2 8.1 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.908 1.283 . . . . 0.0 109.054 -175.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.2 m . . . . . 0 CA--C 1.54 0.56 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 169.354 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 62.6 m . . . . . 0 CA--C 1.53 0.202 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.36 -38.42 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.778 1.231 . . . . 0.0 111.394 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -75.74 -35.01 60.34 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.898 0.479 . . . . 0.0 109.751 -174.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -68.15 -28.87 67.67 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 124.6 1.16 . . . . 0.0 110.585 169.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.76 -55.54 30.27 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 120.235 1.379 . . . . 0.0 110.13 171.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -63.56 -51.35 65.75 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.557 -0.966 . . . . 0.0 110.189 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -68.41 -17.61 64.26 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 117.979 -1.01 . . . . 0.0 112.908 -175.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 32.8 tp -88.53 -25.86 22.32 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 120.257 1.389 . . . . 0.0 109.56 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.8 m -63.57 -48.74 76.21 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 169.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -61.06 -49.37 77.64 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 124.58 1.152 . . . . 0.0 111.933 175.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -62.47 -33.82 75.6 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.636 0.653 . . . . 0.0 110.469 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 34.8 m -69.99 -28.47 65.55 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.444 0.565 . . . . 0.0 111.216 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.03 -51.07 13.1 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.884 0.765 . . . . 0.0 109.564 170.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -51.84 -49.88 61.98 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.042 0.937 . . . . 0.0 110.147 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -56.79 -39.69 74.55 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.055 -178.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 22.4 pt -82.77 -22.62 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 119.722 1.147 . . . . 0.0 111.928 -178.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 52.2 mt . . . . . 0 CA--C 1.537 0.48 0 C-N-CA 123.414 0.686 . . . . 0.0 109.491 169.114 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 . . . . . 0 CA--C 1.54 0.59 0 CA-C-O 121.938 0.875 . . . . 0.0 112.711 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.1 mm -71.24 138.29 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.36 132.27 47.35 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.6 -0.687 . . . . 0.0 109.244 176.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.12 145.76 49.29 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 173.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -91.88 147.08 23.24 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.632 0.773 . . . . 0.0 109.65 -174.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -74.07 -29.48 61.9 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 118.969 -0.539 . . . . 0.0 110.756 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.1 p -154.88 164.03 39.43 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 127.337 2.255 . . . . 0.0 107.962 171.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.4 m -45.85 135.77 6.36 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 125.644 1.578 . . . . 0.0 111.801 173.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.11 52.41 3.82 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.201 3.267 . . . . 0.0 110.525 172.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -53.54 -49.69 67.07 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.202 1.801 . . . . 0.0 111.675 -169.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.58 -41.34 96.33 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.609 0.363 . . . . 0.0 111.284 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -71.51 -41.57 69.06 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.877 0.471 . . . . 0.0 109.764 -174.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 89.9 t -62.31 -45.95 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 172.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -58.85 -53.12 62.02 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.096 0.862 . . . . 0.0 110.872 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.52 -42.46 95.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.901 0.773 . . . . 0.0 111.034 -174.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.25 -46.26 87.73 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -71.21 -25.34 62.47 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 118.147 -0.93 . . . . 0.0 112.014 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -62.91 -34.29 77.11 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.98 1.264 . . . . 0.0 109.579 172.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -79.65 -46.91 16.29 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.718 0.407 . . . . 0.0 110.554 177.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.4 mt -59.93 -39.97 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.447 0.699 . . . . 0.0 109.185 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.79 -36.3 82.68 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.445 -0.784 . . . . 0.0 111.183 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -74.36 -40.42 62.14 Favored 'General case' 0 N--CA 1.46 0.06 0 C-N-CA 123.252 0.621 . . . . 0.0 109.955 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? . . . . . 0 CA--C 1.534 0.331 0 C-N-CA 123.677 0.791 . . . . 0.0 110.831 170.343 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo . . . . . 0 N--CA 1.451 -1.021 0 CA-C-O 121.037 0.349 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.7 t -104.51 105.89 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 102.058 -3.312 . . . . 0.0 102.058 167.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -142.43 156.33 45.18 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.574 1.15 . . . . 0.0 109.109 -169.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.0 t -137.38 117.24 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -176.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.6 p -78.27 150.06 33.44 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.394 0.997 . . . . 0.0 108.893 168.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.96 131.98 49.25 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.77 1.628 . . . . 0.0 108.64 173.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.401 ' CE1' ' CB ' ' A' ' 131' ' ' ALA . 5.3 p90 -168.78 150.6 4.79 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 123.645 0.778 . . . . 0.0 112.408 -176.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 95.1 m 55.65 157.36 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 128.571 2.748 . . . . 0.0 116.591 167.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.2 tt -111.87 116.15 30.17 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 169.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -139.44 141.82 37.44 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.219 1.408 . . . . 0.0 108.966 -172.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 53.94 26.41 6.27 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.538 1.135 . . . . 0.0 112.297 -172.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.64 5.43 83.2 Favored Glycine 0 CA--C 1.536 1.346 0 O-C-N 120.957 -1.089 . . . . 0.0 113.576 -175.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -118.16 165.92 13.2 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.603 2.361 . . . . 0.0 109.732 -173.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -85.52 148.76 25.8 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.692 1.133 . . . . 0.0 109.866 172.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.19 157.45 19.41 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.494 1.043 . . . . 0.0 110.23 -174.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -171.3 175.76 44.78 Favored Glycine 0 N--CA 1.449 -0.458 0 O-C-N 120.826 -1.171 . . . . 0.0 110.574 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 31.3 m -140.07 154.79 47.17 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 169.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 p -124.88 144.37 35.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.5 tt -124.65 150.79 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 168.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.5 p -142.52 177.16 1.97 Allowed Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 171.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.26 -14.31 44.38 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 CA-C-N 121.179 1.457 . . . . 0.0 111.593 168.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.4 p-90 -108.56 -21.91 12.51 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -172.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 21.9 ptt? -157.59 164.96 36.73 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 120.421 1.464 . . . . 0.0 112.669 -177.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 tt -134.68 123.99 24.59 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 103.185 -2.895 . . . . 0.0 103.185 167.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.7 m -142.17 134.46 27.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.029 0.377 . . . . 0.0 110.069 -172.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.76 143.32 57.58 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 168.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.3 m -140.12 145.79 25.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 37.8 mt -139.83 133.05 35.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 -172.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -122.1 154.04 61.39 Favored Pre-proline 0 N--CA 1.467 0.394 0 CA-C-O 117.785 -1.102 . . . . 0.0 111.023 -169.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -47.96 118.91 3.42 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.546 2.831 . . . . 0.0 112.466 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.43 179.09 26.19 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 123.246 0.342 . . . . 0.0 112.478 -177.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.6 160.18 31.68 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.021 2.481 . . . . 0.0 111.571 -174.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.8 t0 42.91 52.09 5.2 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.805 2.042 . . . . 0.0 113.776 169.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -152.31 160.68 43.29 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.525 1.13 . . . . 0.0 108.526 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -103.73 112.19 25.03 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 169.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.0 130.13 91.7 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.76 147.51 81.28 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.883 1.722 . . . . 0.0 109.825 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 34.0 tp -69.29 121.91 17.82 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 173.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.82 159.83 18.61 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.688 1.195 . . . . 0.0 108.924 176.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -80.27 151.23 29.69 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 169.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.4 t -99.34 151.31 4.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -169.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.9 m 59.92 24.66 13.75 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.116 0.967 . . . . 0.0 112.324 -175.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -109.82 157.63 18.99 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 128.652 2.781 . . . . 0.0 105.023 169.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -108.77 147.55 31.87 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.03 0.832 . . . . 0.0 111.606 -176.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.7 mm -122.16 131.98 71.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.35 124.65 7.73 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 173.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.1 mt -111.67 137.26 49.79 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 171.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -90.71 129.43 36.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 174.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -153.86 159.24 32.27 Favored Pre-proline 0 C--O 1.235 0.307 0 C-N-CA 125.06 1.344 . . . . 0.0 108.562 172.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -67.08 -15.7 47.28 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.224 1.949 . . . . 0.0 114.219 -170.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -58.39 -26.01 62.72 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.299 0.64 . . . . 0.0 111.042 169.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.57 148.02 7.59 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 106.41 -2.676 . . . . 0.0 106.41 -169.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.0 m -60.26 130.85 48.69 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 49.9 mtm -134.15 141.92 47.27 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 124.025 0.93 . . . . 0.0 108.649 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.96 113.29 19.77 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 172.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -91.9 136.71 32.95 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 171.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.1 m -83.48 137.92 33.67 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.5 t -73.39 125.81 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 173.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -106.74 154.83 16.65 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.197 -2.361 . . . . 0.0 107.197 169.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -129.12 103.03 6.75 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 170.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.8 tp -85.26 122.39 29.36 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -176.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -60.38 131.35 50.49 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.265 0.626 . . . . 0.0 110.687 -173.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.01 3.59 69.21 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 118.759 -1.023 . . . . 0.0 113.66 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.9 t -120.61 -103.87 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 119.074 1.437 . . . . 0.0 107.24 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.8 p -163.97 173.94 12.01 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 119.952 1.251 . . . . 0.0 110.737 -171.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -78.8 142.01 37.29 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 168.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -154.26 177.65 10.89 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.027 1.331 . . . . 0.0 108.029 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.3 mt -124.45 137.79 54.41 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.18 0.992 . . . . 0.0 108.922 -173.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.7 m -135.66 147.39 48.56 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.627 1.171 . . . . 0.0 110.028 -173.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 36.6 t -140.52 118.28 11.7 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 172.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.9 m -67.99 135.05 51.73 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.242 0.617 . . . . 0.0 109.438 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.8 mt -109.22 -47.77 3.36 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 123.646 0.778 . . . . 0.0 110.636 -176.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 17.7 ptp -160.42 169.46 23.01 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.918 0.887 . . . . 0.0 110.111 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.2 m . . . . . 0 CA--C 1.541 0.617 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 169.625 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 29.8 m . . . . . 0 C--O 1.23 0.074 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.33 -21.0 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 O-C-N 121.066 -1.021 . . . . 0.0 112.771 -176.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -70.63 -44.72 66.59 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 173.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -60.5 -39.55 88.13 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 118.278 -0.868 . . . . 0.0 109.313 172.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.68 -54.96 33.21 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 119.595 1.088 . . . . 0.0 111.521 177.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -62.36 -49.23 76.38 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.671 -0.9 . . . . 0.0 110.358 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 83.6 mtt-85 -69.97 -19.17 63.37 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.62 -0.675 . . . . 0.0 111.985 -175.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.1 tp -89.06 -18.94 26.28 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 124.138 0.975 . . . . 0.0 109.447 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.5 m -69.64 -44.99 69.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 169.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -66.94 -42.53 85.14 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.577 -0.702 . . . . 0.0 112.003 174.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -69.64 -29.76 67.31 Favored 'General case' 0 C--N 1.334 -0.067 0 O-C-N 121.176 -0.953 . . . . 0.0 110.731 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 22.8 m -70.27 -43.02 71.34 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.378 0.535 . . . . 0.0 110.281 174.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.401 ' CB ' ' CE1' ' A' ' 45' ' ' PHE . . . -53.67 -45.79 70.41 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.296 1.039 . . . . 0.0 109.922 173.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.5 ttp-105 -69.75 -50.09 46.77 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.354 -0.841 . . . . 0.0 111.578 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.88 -26.68 67.59 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.53 1.059 . . . . 0.0 112.764 -171.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 10.7 pt -77.31 -11.52 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 120.2 1.364 . . . . 0.0 113.376 174.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 75.4 mt . . . . . 0 N--CA 1.467 0.401 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 169.021 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.4 mt -132.15 131.89 61.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 175.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.75 128.22 35.03 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 170.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.67 146.07 48.75 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -93.03 138.79 31.18 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.701 0.8 . . . . 0.0 111.034 -169.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -69.14 -24.32 64.08 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.566 0.747 . . . . 0.0 111.151 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -162.12 172.42 15.87 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.86 1.264 . . . . 0.0 108.984 171.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.2 m -61.08 138.22 94.24 Favored Pre-proline 0 C--N 1.324 -0.502 0 C-N-CA 125.776 1.63 . . . . 0.0 110.432 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -69.77 48.14 0.61 Allowed 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 124.607 3.538 . . . . 0.0 112.706 169.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -50.97 -57.15 9.32 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.025 1.73 . . . . 0.0 112.771 -169.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.85 -38.18 79.59 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 117.821 0.282 . . . . 0.0 110.273 -177.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -61.01 -45.37 95.07 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.627 0.771 . . . . 0.0 110.842 178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.0 t -64.57 -42.6 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -61.15 -51.54 68.62 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.839 0.745 . . . . 0.0 110.427 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.85 -39.41 93.51 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.006 0.922 . . . . 0.0 110.837 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.84 -46.17 90.62 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 175.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -72.81 -26.09 61.38 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 118.208 -0.901 . . . . 0.0 112.703 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -65.55 -28.87 69.47 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 120.084 1.311 . . . . 0.0 109.636 172.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -81.78 -47.52 12.76 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.244 1.018 . . . . 0.0 109.713 176.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.8 mt -67.9 -38.5 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 O-C-N 121.277 -0.889 . . . . 0.0 109.674 -175.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.6 -30.33 71.35 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.413 -0.804 . . . . 0.0 110.676 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.9 ttm105 -76.62 -37.5 56.27 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 123.518 0.727 . . . . 0.0 109.713 174.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 . . . . . 0 CA--C 1.535 0.396 0 C-N-CA 123.915 0.886 . . . . 0.0 110.923 173.306 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo . . . . . 0 N--CA 1.454 -0.84 0 N-CA-C 114.351 0.866 . . . . 0.0 114.351 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.9 t -92.58 111.8 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 101.441 -3.541 . . . . 0.0 101.441 167.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -145.4 158.94 43.74 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.075 0.95 . . . . 0.0 110.152 -169.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.1 t -139.27 124.0 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.577 0.751 . . . . 0.0 109.61 -175.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.0 m -90.18 154.51 19.7 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.252 1.021 . . . . 0.0 110.57 168.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -118.83 147.08 44.31 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 127.78 2.432 . . . . 0.0 111.013 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.451 ' CE2' ' CB ' ' A' ' 131' ' ' ALA . 55.0 m-85 -155.65 170.37 22.18 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.919 1.452 . . . . 0.0 114.919 -170.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.1 m -17.17 153.72 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.566 1 C-N-CA 134.413 5.085 . . . . 0.0 118.486 169.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.9 mt -85.97 118.56 25.53 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 169.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -121.89 108.9 13.98 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.813 2.045 . . . . 0.0 106.688 -173.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 52.12 37.93 22.94 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.566 1.146 . . . . 0.0 111.06 -170.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.27 13.77 82.41 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 118.856 -0.969 . . . . 0.0 113.907 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -121.34 134.77 55.14 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.101 1.451 . . . . 0.0 108.608 -177.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -63.28 142.08 58.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 120.354 1.434 . . . . 0.0 109.654 173.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.42 162.93 13.45 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 122.236 1.017 . . . . 0.0 108.748 169.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.84 173.15 40.7 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 107.87 -2.092 . . . . 0.0 107.87 169.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 1.3 m -136.04 145.89 46.51 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 169.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 p -118.4 141.36 38.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 169.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.0 tt -122.75 151.93 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 169.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.1 p -141.19 179.05 1.32 Allowed Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 172.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -68.73 -13.19 36.5 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 CA-C-N 121.602 1.608 . . . . 0.0 111.585 169.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -111.76 -21.09 11.83 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -169.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -157.36 160.57 38.6 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 120.161 1.346 . . . . 0.0 112.172 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 tt -130.77 123.21 28.67 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 103.351 -2.833 . . . . 0.0 103.351 167.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.4 m -134.4 131.81 38.64 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 123.875 0.734 . . . . 0.0 109.765 -177.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.01 145.28 50.09 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 168.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.4 m -135.62 147.84 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -177.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 58.6 mt -139.7 138.87 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -173.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -130.97 139.05 34.39 Favored Pre-proline 0 N--CA 1.466 0.332 0 CA-C-O 117.595 -1.193 . . . . 0.0 108.98 -177.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.37 130.1 34.47 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.567 2.178 . . . . 0.0 110.827 172.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.64 -166.84 33.47 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 119.602 -0.554 . . . . 0.0 112.426 -174.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -71.6 164.44 35.7 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.892 2.395 . . . . 0.0 112.915 -175.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.4 t0 42.57 55.69 4.09 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.397 2.279 . . . . 0.0 113.755 169.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -152.55 148.61 27.57 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.173 0.989 . . . . 0.0 109.35 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.9 mp -110.74 95.0 5.28 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.28 150.7 85.34 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.267 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -66.9 145.78 75.57 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.01 1.807 . . . . 0.0 110.763 171.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.1 tp -66.68 127.03 30.85 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 169.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -98.46 161.79 13.5 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.577 0.626 . . . . 0.0 110.074 -176.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.1 tmtm? -96.05 139.18 32.61 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 169.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.0 t -82.62 154.34 3.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 123.662 0.785 . . . . 0.0 109.332 -169.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.4 m 66.09 8.97 5.87 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.91 1.684 . . . . 0.0 113.769 -177.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -79.86 160.69 25.97 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.466 1.106 . . . . 0.0 108.136 168.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -112.9 142.33 45.69 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.708 -0.62 . . . . 0.0 110.41 177.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.6 mm -118.23 121.13 66.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 177.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.44 125.31 8.01 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 108.619 -1.793 . . . . 0.0 108.619 175.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.4 mt -120.51 141.81 49.89 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 124.344 1.057 . . . . 0.0 108.642 174.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -91.18 128.38 36.98 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 174.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 mp -135.07 162.01 60.22 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 124.763 1.225 . . . . 0.0 108.809 177.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -60.23 -21.89 68.28 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.527 2.151 . . . . 0.0 114.004 172.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -72.67 -4.21 29.72 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.599 1.16 . . . . 0.0 112.366 174.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.81 161.88 26.82 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 107.957 -2.057 . . . . 0.0 107.957 -168.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.8 m -68.84 131.99 46.03 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 69.8 mtm -139.9 144.04 36.97 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -177.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.68 132.29 35.18 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 172.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -102.17 132.66 47.94 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 169.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.5 m -83.95 142.19 30.7 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 66.5 t -74.59 124.83 33.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 170.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -112.02 161.4 12.75 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 170.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -132.59 93.78 3.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 171.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.9 tp -77.58 135.21 38.14 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -169.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.17 123.17 15.06 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.312 0.645 . . . . 0.0 111.691 -169.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.5 -3.4 33.27 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 118.688 -1.062 . . . . 0.0 113.998 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.8 t -101.31 -119.75 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 119.68 1.74 . . . . 0.0 106.337 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.3 m -148.17 174.99 11.41 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.629 1.571 . . . . 0.0 108.921 -169.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -72.53 142.31 48.49 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 168.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -153.48 171.8 18.12 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.1 1.36 . . . . 0.0 108.055 -178.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.4 mp -111.41 142.0 44.23 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.1 p -141.82 153.87 44.8 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.627 0.771 . . . . 0.0 110.588 -178.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.3 t -144.0 115.28 7.99 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 173.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.1 m -73.79 135.18 43.5 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 175.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.7 mt -123.95 -35.03 2.9 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.914 -1.041 . . . . 0.0 113.47 -169.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 13.4 ptp -159.64 169.62 23.34 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 120.249 1.386 . . . . 0.0 110.913 176.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 CA--C 1.546 0.806 0 C-N-CA 124.808 1.243 . . . . 0.0 108.425 169.921 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.401 ' H ' ' HB2' ' A' ' 122' ' ' GLU . 80.4 p . . . . . 0 CA--C 1.533 0.302 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.544 HD13 ' H ' ' A' ' 120' ' ' ILE . 2.7 mp -53.82 -39.78 41.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.443 1.097 . . . . 0.0 109.59 171.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.69 -43.61 65.68 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.545 0.738 . . . . 0.0 109.456 -175.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.401 ' HB2' ' H ' ' A' ' 119' ' ' SER . 30.7 mm-40 -66.87 -28.48 68.36 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.079 173.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.61 -57.97 16.77 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 172.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -64.21 -52.73 57.42 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.647 -0.914 . . . . 0.0 110.778 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -66.83 -24.8 66.2 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 117.963 -1.017 . . . . 0.0 112.099 -173.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.7 tp -86.38 -29.9 22.57 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 120.748 1.613 . . . . 0.0 109.588 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.9 m -58.96 -48.19 82.42 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 169.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -64.0 -51.37 64.56 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.004 1.322 . . . . 0.0 112.083 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -65.5 -33.5 76.07 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.699 -0.626 . . . . 0.0 110.789 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 40.6 t -70.9 -34.03 71.16 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.451 ' CB ' ' CE2' ' A' ' 45' ' ' PHE . . . -68.13 -52.81 30.61 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 43.3 tpt85 -53.95 -46.84 71.71 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 123.539 0.736 . . . . 0.0 111.898 -175.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 15.2 ptt? -57.38 -27.25 62.14 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.58 1.082 . . . . 0.0 112.007 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 19.8 pt -102.2 9.9 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.421 1.089 . . . . 0.0 111.242 178.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 16.8 tp . . . . . 0 N--CA 1.455 -0.184 0 C-N-CA 125.863 1.665 . . . . 0.0 109.108 -168.071 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 . . . . . 0 CA--C 1.535 0.386 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.4 mm -126.26 125.74 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 170.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.48 150.23 33.0 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.962 0.41 . . . . 0.0 110.092 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.18 156.71 47.65 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.589 1.09 . . . . 0.0 112.848 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -112.81 150.5 31.57 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.874 1.27 . . . . 0.0 110.101 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -82.35 -29.15 31.14 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.671 0.788 . . . . 0.0 111.368 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.8 p -158.52 -177.86 6.84 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 129.966 3.306 . . . . 0.0 105.601 172.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.8 m -57.59 144.23 73.22 Favored Pre-proline 0 CA--C 1.541 0.616 0 O-C-N 120.95 -1.094 . . . . 0.0 110.137 169.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.45 58.48 3.77 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 124.811 3.674 . . . . 0.0 109.652 169.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HE2' ' O ' ' A' ' 42' ' ' VAL . 41.1 tttm -50.55 -52.76 35.87 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.77 2.428 . . . . 0.0 112.692 -169.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.88 95.59 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.656 0.383 . . . . 0.0 111.144 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -70.11 -39.81 75.26 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -176.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 81.3 t -62.97 -40.79 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -62.54 -52.43 63.46 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.496 0.589 . . . . 0.0 110.195 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.2 -39.29 94.22 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.762 0.825 . . . . 0.0 110.899 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.34 -50.39 73.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -72.43 -29.4 63.67 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 117.84 -1.076 . . . . 0.0 112.493 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -59.95 -35.22 74.49 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.293 1.406 . . . . 0.0 109.886 169.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -76.53 -52.59 9.48 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.594 0.634 . . . . 0.0 109.378 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.0 mt -61.28 -39.06 81.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.907 1.283 . . . . 0.0 110.425 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.12 -24.04 67.54 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.351 -0.843 . . . . 0.0 112.272 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.4 ttp85 -99.89 -30.34 12.08 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 125.465 1.506 . . . . 0.0 109.494 -175.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 . . . . . 0 C--N 1.339 0.134 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 169.101 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo . . . . . 0 N--CA 1.454 -0.804 0 N-CA-C 114.205 0.81 . . . . 0.0 114.205 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.1 t -63.91 136.94 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 168.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -142.49 156.08 45.12 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.028 0.831 . . . . 0.0 110.102 -171.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.41 ' O ' ' HE2' ' A' ' 13' ' ' LYS . 34.5 t -140.03 127.78 24.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -178.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.5 m -100.55 151.62 21.38 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.146 0.979 . . . . 0.0 109.772 169.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -123.95 143.24 50.51 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.136 1.774 . . . . 0.0 110.292 -176.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -145.3 170.2 16.77 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.239 1.415 . . . . 0.0 114.153 -169.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.8 t -54.19 169.29 0.18 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.226 2.611 . . . . 0.0 115.468 -169.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.6 tp -77.31 124.4 27.81 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.753 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -104.52 -125.12 0.22 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.969 2.108 . . . . 0.0 107.172 -175.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -77.29 70.75 3.72 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.701 1.137 . . . . 0.0 109.814 177.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.06 15.58 65.32 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.335 0.969 . . . . 0.0 113.315 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -143.32 143.34 31.64 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 125.637 1.575 . . . . 0.0 108.104 -169.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -72.18 153.88 41.37 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.083 0.856 . . . . 0.0 110.27 174.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.52 158.39 16.11 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 169.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.71 168.51 39.02 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 108.056 -2.017 . . . . 0.0 108.056 173.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 48.2 m -140.39 145.14 36.69 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 169.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.07 144.11 25.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 171.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.9 tt -131.17 152.82 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 172.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.4 p -144.5 178.75 1.34 Allowed Pre-proline 0 N--CA 1.446 -0.662 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -63.84 1.0 1.64 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.437 2.092 . . . . 0.0 113.601 168.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.4 p-90 -138.6 -19.54 1.06 Allowed 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 -169.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -153.78 164.44 38.34 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 120.589 1.54 . . . . 0.0 111.703 -176.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 tp -136.49 116.57 13.37 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 169.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.1 m -136.26 122.52 20.49 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -172.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.05 145.87 55.35 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 169.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.6 m -139.5 146.64 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.887 1.275 . . . . 0.0 108.585 -177.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 45.4 mt -142.2 140.94 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -170.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -137.0 144.37 46.1 Favored Pre-proline 0 N--CA 1.469 0.512 0 CA-C-O 117.638 -1.172 . . . . 0.0 110.065 -170.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -52.49 137.95 57.35 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.312 2.675 . . . . 0.0 112.919 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.41 -178.78 25.58 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 123.815 0.721 . . . . 0.0 112.943 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -64.16 140.7 72.74 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.017 2.478 . . . . 0.0 112.8 -171.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.7 t70 52.84 26.86 4.88 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.832 1.653 . . . . 0.0 114.035 170.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -87.02 152.98 21.9 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 171.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.7 83.65 2.03 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 170.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -66.87 152.9 95.16 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.896 172.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -71.56 159.1 52.18 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.901 1.734 . . . . 0.0 109.634 169.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.5 tp -66.78 117.24 8.64 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 169.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -85.78 154.78 21.35 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -177.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -84.19 142.33 30.39 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.4 t -89.23 154.55 3.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -168.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.3 m 66.12 8.62 5.63 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.702 1.601 . . . . 0.0 113.683 -176.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -78.74 161.55 26.78 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.687 1.195 . . . . 0.0 108.088 169.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -113.46 143.26 44.81 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 121.427 -0.795 . . . . 0.0 110.329 175.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.2 mm -118.33 126.13 74.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 176.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.24 123.8 7.42 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 174.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.8 mt -116.24 143.87 44.95 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.604 1.162 . . . . 0.0 108.167 174.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -96.14 128.01 42.67 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 175.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mp -138.54 155.17 73.78 Favored Pre-proline 0 C--O 1.236 0.376 0 C-N-CA 124.809 1.244 . . . . 0.0 107.702 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -63.43 -20.92 70.93 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 121.96 1.774 . . . . 0.0 113.619 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -58.86 -28.98 66.62 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.654 0.781 . . . . 0.0 111.535 169.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 129.03 155.78 8.68 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 106.679 -2.568 . . . . 0.0 106.679 -169.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.1 m -64.29 131.2 46.61 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 176.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 62.9 mtm -141.26 144.13 34.51 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.485 1.114 . . . . 0.0 108.349 -176.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.98 135.14 35.82 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 121.932 -0.48 . . . . 0.0 109.879 172.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -108.61 138.6 44.66 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 168.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.2 m -87.7 140.71 29.24 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.3 t -73.24 126.77 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 169.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -119.27 163.14 13.46 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 171.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -126.06 93.83 3.93 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 173.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.6 tp -75.36 124.89 27.9 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -169.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -59.97 132.79 55.04 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.101 0.56 . . . . 0.0 110.468 -176.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.24 3.7 70.99 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-O 118.752 -1.026 . . . . 0.0 113.581 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.3 t -127.49 -120.13 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.7 m -152.49 -178.6 6.94 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.744 1.618 . . . . 0.0 108.846 -169.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -68.79 143.3 54.66 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 169.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -150.51 169.45 21.46 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.548 1.539 . . . . 0.0 108.679 177.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.5 mp -104.4 141.8 35.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 170.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.8 p -141.13 155.4 46.11 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.705 0.802 . . . . 0.0 110.486 -177.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 48.0 t -144.99 110.83 5.42 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 171.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.7 m -71.22 127.73 33.55 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 24.0 mt -119.76 -40.2 2.78 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 118.677 -0.678 . . . . 0.0 112.33 -169.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 23.8 mtm -141.79 161.5 37.8 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.182 0.993 . . . . 0.0 108.724 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.2 p . . . . . 0 CA--C 1.545 0.752 0 C-N-CA 125.042 1.337 . . . . 0.0 110.117 -179.04 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.5 p . . . . . 0 CA--C 1.528 0.1 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.427 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -67.48 -26.55 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 120.986 -1.071 . . . . 0.0 110.33 170.163 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -67.05 -44.19 80.82 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 174.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -65.59 -30.13 70.82 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.204 0.911 . . . . 0.0 110.571 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.88 -27.63 50.9 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.674 1.13 . . . . 0.0 112.323 171.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -95.5 -55.04 3.16 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.332 1.066 . . . . 0.0 110.828 171.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -71.01 -29.68 65.69 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -169.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.5 tp -83.03 -29.72 28.64 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 120.152 1.342 . . . . 0.0 109.608 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -64.75 -43.23 94.01 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -64.0 -48.53 76.03 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.167 0.587 . . . . 0.0 111.972 172.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -69.8 -25.71 63.91 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.115 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 35.3 t -64.32 -42.41 96.33 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.68 -47.23 73.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 174.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 50.1 ttt-85 -57.0 -46.63 82.15 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.336 0.971 . . . . 0.0 111.315 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 52.6 ttp -47.4 -31.3 3.95 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.565 1.546 . . . . 0.0 112.229 174.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 25.7 pt -104.15 -18.98 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 120.066 1.303 . . . . 0.0 113.009 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . 0.299 3.5 pp . . . . . 0 N--CA 1.47 0.526 0 CA-C-N 120.087 1.312 . . . . 0.0 108.074 168.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.0 ttp . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.0 p -82.59 -21.85 35.06 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.712 0.805 . . . . 0.0 112.555 -174.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -88.66 133.48 34.19 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -170.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -148.78 164.39 34.55 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.837 1.255 . . . . 0.0 109.86 -169.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.8 mm -119.37 126.01 74.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 169.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.67 145.28 38.87 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.029 0.442 . . . . 0.0 109.816 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.02 146.2 50.34 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.795 1.188 . . . . 0.0 111.456 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -89.57 139.84 30.14 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.323 1.049 . . . . 0.0 108.912 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -71.42 -38.86 71.36 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.7 p -155.1 166.2 34.32 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 128.162 2.585 . . . . 0.0 107.847 170.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.5 m -54.08 141.02 51.21 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.419 1.088 . . . . 0.0 112.203 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -75.89 49.38 2.48 Favored 'Trans proline' 0 CA--C 1.541 0.844 1 C-N-CA 125.429 4.086 . . . . 0.0 110.872 170.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -54.21 -46.15 72.4 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.879 1.672 . . . . 0.0 112.032 -169.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.95 98.53 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 122.506 0.323 . . . . 0.0 111.259 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -40.19 69.44 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 119.074 -0.488 . . . . 0.0 109.804 -174.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 84.2 t -58.22 -45.67 88.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 171.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -61.17 -53.86 51.61 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.861 0.755 . . . . 0.0 110.95 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.0 -39.25 93.17 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.713 0.688 . . . . 0.0 111.128 -174.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.26 -47.54 81.96 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -70.69 -24.42 62.66 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-O 118.289 -0.862 . . . . 0.0 112.592 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -62.11 -37.35 84.78 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.342 0.974 . . . . 0.0 108.979 172.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -80.46 -45.24 17.9 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.8 mt -61.92 -31.9 52.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 O-C-N 120.896 -1.128 . . . . 0.0 110.219 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.99 -24.7 63.35 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.282 -0.886 . . . . 0.0 112.201 174.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.9 ttm105 -83.71 -41.64 17.47 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.936 0.894 . . . . 0.0 109.632 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.75 119.0 6.82 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -177.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.9 m -154.8 114.37 3.73 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 49.4 ttp -83.67 172.28 12.43 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.849 1.26 . . . . 0.0 110.048 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.582 ' CG ' ' H ' ' A' ' 30' ' ' ASP . 47.1 t60 63.02 -169.01 0.19 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.744 1.617 . . . . 0.0 111.415 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.582 ' H ' ' CG ' ' A' ' 29' ' ' HIS . 36.6 t70 -63.96 -8.49 11.56 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.109 1.764 . . . . 0.0 113.771 -169.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -61.07 -31.02 70.69 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.797 0.839 . . . . 0.0 110.564 170.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.4 m 61.68 157.56 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.075 2.15 . . . . 0.0 113.623 -173.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -81.88 56.33 3.05 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.689 1.195 . . . . 0.0 110.387 -177.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.7 mt -61.69 149.7 38.81 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.253 1.021 . . . . 0.0 109.81 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -66.53 157.77 81.39 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 123.498 0.719 . . . . 0.0 110.667 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -65.84 -29.11 50.55 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.65 1.566 . . . . 0.0 114.876 -169.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.0 m 60.1 10.59 2.33 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.718 1.607 . . . . 0.0 113.965 -176.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 4.5 tmm? -155.6 110.64 2.19 Favored Pre-proline 0 C--O 1.234 0.246 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -55.51 121.32 9.72 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.823 2.349 . . . . 0.0 111.746 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 m -65.59 148.31 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 171.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -143.11 157.75 44.23 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 124.06 0.944 . . . . 0.0 109.076 -175.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.2 t -138.99 126.62 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -177.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.6 p -89.01 150.67 22.69 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 169.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -132.61 132.79 42.87 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.561 1.544 . . . . 0.0 108.24 173.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.462 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 43.1 p90 -169.9 145.76 3.02 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.354 0.662 . . . . 0.0 112.704 -171.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.8 m 58.52 165.14 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 128.014 2.525 . . . . 0.0 115.409 167.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.2 tp -115.84 58.3 0.74 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.07 1.348 . . . . 0.0 109.157 175.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.91 137.21 47.25 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.025 0.93 . . . . 0.0 110.042 -173.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 55.15 22.85 4.88 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.367 1.067 . . . . 0.0 111.874 -171.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.07 20.61 77.37 Favored Glycine 0 CA--C 1.531 1.053 0 O-C-N 121.223 -0.923 . . . . 0.0 112.874 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -135.79 143.11 45.04 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.223 1.511 . . . . 0.0 108.118 -172.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -65.7 135.39 54.9 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.303 -0.873 . . . . 0.0 108.961 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.462 ' HB ' ' CE2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -103.09 160.07 14.97 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.857 0.837 . . . . 0.0 109.514 -177.299 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -169.35 168.81 41.54 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 56.4 m -135.96 146.82 47.68 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 168.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.1 p -111.81 143.55 21.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 171.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.85 141.64 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 169.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.3 p -136.8 173.83 5.1 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 171.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.9 -25.7 74.31 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 CA-C-N 121.386 1.531 . . . . 0.0 111.238 169.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.4 p-90 -93.41 -26.57 17.17 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 118.155 -0.926 . . . . 0.0 113.215 -172.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.97 170.21 23.05 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 120.256 1.389 . . . . 0.0 113.057 -174.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 tt -137.57 127.96 26.45 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 168.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.6 m -140.68 137.52 33.6 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 123.04 0.536 . . . . 0.0 110.017 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.6 146.82 48.14 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 168.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.3 m -138.48 144.18 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.23 1.412 . . . . 0.0 108.178 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 31.7 mt -142.69 141.91 27.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 125.37 1.468 . . . . 0.0 107.283 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -130.33 133.79 25.32 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-O 117.646 -1.168 . . . . 0.0 108.203 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.85 137.78 21.4 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.282 2.655 . . . . 0.0 111.899 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.56 179.07 34.26 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.302 0.953 . . . . 0.0 112.756 -173.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.67 145.05 56.47 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.982 2.455 . . . . 0.0 111.019 -172.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.1 t0 50.63 57.69 6.34 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.381 1.472 . . . . 0.0 112.188 177.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -128.76 148.93 50.89 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.385 1.474 . . . . 0.0 108.223 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -124.34 83.03 2.1 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 175.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.71 150.91 97.51 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 172.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.34 155.23 70.98 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.901 1.734 . . . . 0.0 109.972 170.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 68.9 tp -63.85 129.25 39.33 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 170.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -104.61 163.38 12.51 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.474 0.579 . . . . 0.0 109.559 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -89.52 157.18 18.19 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 169.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.1 t -86.5 153.41 3.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -169.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . 0.254 42.7 m 65.84 11.84 7.92 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.229 1.411 . . . . 0.0 113.58 -174.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -74.85 158.16 33.88 Favored 'General case' 0 C--N 1.346 0.42 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 168.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -112.27 141.03 46.47 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.624 -0.673 . . . . 0.0 109.976 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.5 mm -120.38 123.92 71.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.09 121.99 6.4 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.8 mt -113.26 143.12 44.96 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.24 1.016 . . . . 0.0 108.299 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -95.05 127.41 41.09 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mp -135.59 153.96 77.92 Favored Pre-proline 0 C--O 1.234 0.288 0 C-N-CA 125.595 1.558 . . . . 0.0 107.282 174.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -64.58 -21.82 65.35 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.236 1.291 . . . . 0.0 112.497 172.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -58.7 -23.51 59.69 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.67 1.588 . . . . 0.0 111.524 169.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 129.65 148.35 6.49 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.979 2.228 . . . . 0.0 108.066 -173.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.0 m -63.11 130.92 46.74 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 170.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 43.7 ttp -144.61 138.76 27.63 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -169.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.54 130.95 35.45 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -104.4 131.68 51.49 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 169.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.8 m -85.25 139.26 31.77 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 97.7 t -70.82 110.86 4.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 172.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -94.24 155.91 22.02 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 106.91 -2.476 . . . . 0.0 106.91 169.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -134.55 122.32 22.21 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 169.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.6 tp -142.3 145.65 34.21 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.885 0.474 . . . . 0.0 110.411 -169.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -58.71 132.07 52.76 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.917 0.887 . . . . 0.0 111.062 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.93 0.3 50.19 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.046 0.831 . . . . 0.0 113.688 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 87.2 t -122.23 -27.11 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.267 1.427 . . . . 0.0 109.852 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.2 m 60.16 -150.52 0.42 Allowed 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.236 1.415 . . . . 0.0 108.691 -174.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -78.06 137.28 38.16 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.368 0.531 . . . . 0.0 110.152 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -152.44 166.81 30.79 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.974 1.71 . . . . 0.0 107.988 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.0 mp -117.81 122.32 43.1 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.1 m -143.79 158.36 43.73 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.008 0.822 . . . . 0.0 111.305 -169.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 15.6 p -149.4 140.38 22.89 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.844 -0.535 . . . . 0.0 109.816 169.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.0 m -67.09 138.25 56.98 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 174.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.0 mt -107.83 -48.45 3.4 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.174 0.99 . . . . 0.0 110.145 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 13.3 ptp -164.09 172.5 13.68 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.858 0.863 . . . . 0.0 110.329 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.1 m -112.01 111.58 53.38 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -81.59 59.42 7.24 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.693 2.928 . . . . 0.0 111.151 -172.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 91.8 mt -93.17 28.47 2.16 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.907 1.283 . . . . 0.0 111.883 -172.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 7.0 m -73.45 146.74 44.78 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.451 1.101 . . . . 0.0 109.415 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -77.97 -19.41 54.59 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.21 -0.931 . . . . 0.0 111.527 176.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.9 p -76.21 -3.65 37.52 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.492 1.517 . . . . 0.0 112.353 172.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.2 tpt -61.65 143.31 56.32 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.743 1.217 . . . . 0.0 110.747 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.3 t -157.17 167.52 30.14 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.447 1.899 . . . . 0.0 106.826 177.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.436 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -59.7 -31.17 46.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 123.618 0.767 . . . . 0.0 110.708 179.162 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.93 -46.72 73.92 Favored 'General case' 0 C--O 1.226 -0.166 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -63.24 -33.42 75.47 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.103 173.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.46 -62.13 6.63 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 171.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -65.07 -43.27 92.75 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 117.742 0.771 . . . . 0.0 111.282 -175.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -58.67 -40.98 85.09 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.37 0.668 . . . . 0.0 109.722 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.8 tp -81.28 -21.98 38.96 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 117.783 -1.104 . . . . 0.0 111.684 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.14 -42.71 79.74 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.837 1.653 . . . . 0.0 108.75 169.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -70.07 -41.2 74.44 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.262 0.625 . . . . 0.0 111.699 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -66.9 -31.04 71.36 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.064 -1.022 . . . . 0.0 110.653 174.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 21.1 m -69.31 -41.27 76.96 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.793 0.724 . . . . 0.0 110.257 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -55.89 -54.11 48.67 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.657 0.783 . . . . 0.0 109.549 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -52.27 -54.09 35.71 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.066 0.947 . . . . 0.0 109.974 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 57.0 ttp -49.42 -55.24 13.75 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.65 1.58 . . . . 0.0 111.271 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.7 pt -78.68 -25.34 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 118.955 0.798 . . . . 0.0 112.233 -171.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.1 mt -71.6 -33.95 69.46 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.671 0.669 . . . . 0.0 110.452 169.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.9 m 56.74 26.09 10.97 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.113 1.765 . . . . 0.0 112.133 -169.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 92.5 mt -142.2 150.57 55.88 Favored Pre-proline 0 C--O 1.236 0.351 0 C-N-CA 127.608 2.363 . . . . 0.0 107.773 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -58.7 150.84 67.68 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.345 2.696 . . . . 0.0 111.212 175.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.02 152.49 11.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 125.061 1.345 . . . . 0.0 107.889 -176.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 65.5 m -61.34 119.0 7.64 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.308 0.643 . . . . 0.0 109.347 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -72.59 126.4 90.83 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 169.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -82.45 58.56 6.58 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.829 2.353 . . . . 0.0 112.889 -169.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -142.89 42.0 1.56 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.76 1.624 . . . . 0.0 109.739 172.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.4 m -78.52 171.37 12.68 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 124.215 1.006 . . . . 0.0 109.888 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -49.21 159.73 1.04 Allowed 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 124.008 3.139 . . . . 0.0 114.681 170.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -63.77 120.1 11.22 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 171.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -94.79 -13.98 25.11 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.556 0.742 . . . . 0.0 112.469 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.26 146.09 45.43 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 91.5 mmt-85 -143.0 160.77 39.73 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.827 1.651 . . . . 0.0 108.011 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -66.48 145.52 55.56 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 172.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.72 140.65 30.33 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 169.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.0 168.09 28.53 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.879 1.671 . . . . 0.0 109.023 177.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.8 tt 51.72 59.71 4.37 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.498 1.519 . . . . 0.0 109.727 -175.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -66.35 148.95 51.12 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.001 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 173.99 -175.53 46.5 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.9 ttp180 -147.7 148.38 30.95 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 175.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -69.9 128.27 35.8 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 169.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 61.0 m -138.39 150.17 46.27 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.92 1.288 . . . . 0.0 108.715 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 136.48 -96.58 0.25 Allowed Glycine 0 C--N 1.336 0.567 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -66.03 -35.65 81.13 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 170.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -76.53 123.17 25.65 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 169.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 C-N-CA 123.516 0.726 . . . . 0.0 109.236 -178.503 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 tpt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.4 p -74.21 155.1 38.68 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.211 1.005 . . . . 0.0 110.199 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -86.49 18.97 3.0 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.79 0.805 . . . . 0.0 111.126 174.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -146.88 155.49 42.35 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.589 2.356 . . . . 0.0 108.063 -173.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.8 mm -118.4 131.62 70.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 126.627 1.971 . . . . 0.0 106.03 175.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.57 142.0 44.71 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 120.701 0.286 . . . . 0.0 110.373 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.8 151.57 51.04 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.209 0.909 . . . . 0.0 111.945 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -93.03 151.2 20.03 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.304 1.041 . . . . 0.0 109.669 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -94.19 -19.25 20.93 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.779 -0.629 . . . . 0.0 112.105 176.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.2 p -156.94 164.42 38.05 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 127.344 2.258 . . . . 0.0 107.734 169.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.1 m -56.9 133.49 79.57 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-O 118.236 -0.888 . . . . 0.0 109.614 169.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -70.83 50.14 1.05 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.433 3.422 . . . . 0.0 112.648 170.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.6 tttm -51.69 -48.68 63.39 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.831 1.652 . . . . 0.0 112.061 -169.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.2 94.93 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 122.705 0.402 . . . . 0.0 111.128 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -73.17 -40.13 65.07 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.384 0.674 . . . . 0.0 109.834 -175.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 80.9 t -61.11 -47.12 95.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -59.41 -50.49 73.76 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 118.923 -0.56 . . . . 0.0 110.872 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.74 -43.27 98.14 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.771 0.714 . . . . 0.0 110.423 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.18 -49.77 76.6 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.058 0.39 . . . . 0.0 110.234 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -66.05 -26.15 67.37 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.943 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -67.64 -29.18 68.42 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 120.098 1.317 . . . . 0.0 111.539 174.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -77.39 -54.82 5.99 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.172 0.896 . . . . 0.0 109.095 171.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.3 mt -60.52 -44.78 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 123.944 0.897 . . . . 0.0 109.851 -169.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.11 -28.71 70.25 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.953 -0.467 . . . . 0.0 111.346 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -81.79 -43.15 18.72 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 118.751 0.705 . . . . 0.0 109.828 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -54.77 -46.15 74.36 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.112 0.565 . . . . 0.0 110.316 172.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.6 m -70.15 -57.18 5.23 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 119.216 -0.421 . . . . 0.0 110.933 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . 0.25 22.3 ptt? 42.56 -150.51 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.054 1.742 . . . . 0.0 111.281 -169.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -138.26 166.91 23.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.787 1.635 . . . . 0.0 107.636 177.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -62.64 -32.09 73.07 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -170.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.62 4.1 17.03 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.41 1.084 . . . . 0.0 113.317 176.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.0 m 65.0 -42.78 0.32 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 129.102 2.961 . . . . 0.0 116.823 174.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -74.14 -19.9 60.41 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 120.183 1.356 . . . . 0.0 113.829 -169.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.3 mt -80.83 94.54 6.46 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 172.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -142.85 -161.73 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 127.603 2.361 . . . . 0.0 106.1 -177.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -58.79 13.5 0.04 OUTLIER 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 122.998 2.465 . . . . 0.0 117.824 176.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 p -60.08 -45.85 91.54 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 167.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 52.8 mtt -79.69 148.38 69.1 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 168.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -68.34 146.0 67.48 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 121.952 1.768 . . . . 0.0 114.924 -169.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.3 m -109.04 56.58 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 104.629 -2.359 . . . . 0.0 104.629 167.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -83.93 156.86 22.15 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.548 1.139 . . . . 0.0 111.63 -168.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.0 t -140.07 127.14 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 123.695 0.798 . . . . 0.0 109.431 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.0 m -91.41 145.36 24.69 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.084 0.954 . . . . 0.0 108.952 168.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -125.6 138.22 53.92 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.873 1.669 . . . . 0.0 108.277 170.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.415 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 29.9 p90 -162.03 130.65 4.25 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -175.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 t 47.97 -179.78 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 129.992 3.317 . . . . 0.0 117.071 168.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.9 tp -117.58 86.4 2.51 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 171.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -74.6 -38.8 62.52 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -168.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.07 56.75 1.13 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 122.323 1.059 . . . . 0.0 108.495 -176.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 62.98 20.94 63.03 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.627 -175.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -144.15 139.94 29.09 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 126.616 1.966 . . . . 0.0 105.834 -174.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -74.75 143.58 44.02 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.415 ' HB ' ' CE2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -111.41 153.42 26.09 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.581 0.705 . . . . 0.0 109.299 -173.082 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -163.5 167.81 37.86 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 35.4 m -140.94 152.76 45.26 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 169.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.2 t -128.09 143.98 39.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.8 tt -127.14 148.19 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 169.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 49.3 p -137.78 177.83 1.96 Allowed Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 175.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -61.38 -6.31 6.64 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.63 2.22 . . . . 0.0 113.387 169.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.1 p-90 -131.14 -23.51 2.43 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -169.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.9 169.63 21.81 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.256 1.389 . . . . 0.0 112.13 -176.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 tt -139.27 123.13 17.66 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 168.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.7 m -139.56 134.16 31.77 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.236 0.541 . . . . 0.0 110.141 -175.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.99 146.25 54.92 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 168.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.4 m -137.17 141.76 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.7 mt -143.81 144.45 23.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -169.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -132.59 136.81 28.51 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 118.196 -0.907 . . . . 0.0 109.387 -173.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -46.75 138.49 14.91 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 124.007 3.138 . . . . 0.0 112.166 169.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.89 -179.92 46.32 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 123.734 0.683 . . . . 0.0 113.043 -174.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.71 145.76 52.51 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 123.518 2.812 . . . . 0.0 110.917 -173.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.2 t0 50.76 54.56 10.99 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.284 1.434 . . . . 0.0 111.986 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -124.32 154.32 40.47 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.941 1.297 . . . . 0.0 107.769 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 92.2 mt -129.16 85.3 2.3 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 8.8 m0 -65.67 153.09 91.53 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -62.86 155.04 62.44 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.658 2.239 . . . . 0.0 111.131 171.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.43 129.76 43.24 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 169.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -144.45 160.03 41.76 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -124.17 172.93 8.66 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 122.985 1.374 . . . . 0.0 110.529 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 70.1 t -70.03 150.93 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 112.461 -2.154 . . . . 0.0 109.645 -169.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.0 m 68.89 1.09 2.98 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.244 1.818 . . . . 0.0 114.096 -177.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -73.47 155.77 38.9 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 169.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -119.75 143.77 47.62 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 118.615 0.643 . . . . 0.0 110.122 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 48.3 mm -117.56 123.92 72.37 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.81 118.02 7.34 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 108.006 -2.038 . . . . 0.0 108.006 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.4 tp -123.75 130.46 52.66 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.907 0.883 . . . . 0.0 108.759 -172.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.34 128.53 34.58 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 174.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 mp -133.98 159.46 72.3 Favored Pre-proline 0 C--O 1.234 0.253 0 C-N-CA 124.721 1.209 . . . . 0.0 108.875 172.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -58.41 -26.45 77.78 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.13 1.887 . . . . 0.0 113.464 170.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -65.28 -9.43 24.07 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.389 1.075 . . . . 0.0 113.198 173.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.43 157.1 18.84 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 108.025 -2.03 . . . . 0.0 108.025 -169.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.8 m -67.48 130.94 44.64 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 49.5 mtm -142.54 145.05 33.23 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -177.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.53 123.52 25.62 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 170.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -95.64 135.97 36.63 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 169.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.0 m -89.05 144.03 26.44 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 70.5 t -76.57 119.26 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 169.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -106.7 169.85 15.6 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 169.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -138.2 141.55 40.02 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 169.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 19.0 mt -132.35 152.95 51.2 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 169.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.07 135.14 57.07 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.52 3.72 72.75 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 118.816 -0.991 . . . . 0.0 113.467 -175.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.91 -33.47 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 119.18 1.49 . . . . 0.0 109.933 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.1 m 59.66 -156.01 0.35 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -169.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -58.71 136.29 57.66 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.37 0.532 . . . . 0.0 110.327 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -148.76 166.59 27.97 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.838 1.655 . . . . 0.0 107.448 170.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.4 mp -102.76 143.67 32.1 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.3 p -146.31 160.2 42.34 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.778 0.831 . . . . 0.0 110.645 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 30.8 t -147.78 128.84 14.55 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 171.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.5 m -66.9 134.78 52.73 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.3 mt -105.94 -59.68 1.74 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.986 0.914 . . . . 0.0 108.701 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -142.03 166.84 23.61 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.751 1.22 . . . . 0.0 108.878 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 28.6 m -121.68 65.28 17.85 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.346 1.058 . . . . 0.0 109.906 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -60.75 132.97 45.37 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.459 2.106 . . . . 0.0 110.442 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 40.0 tp -156.48 81.94 0.97 Allowed 'General case' 0 C--O 1.236 0.363 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 172.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.7 m -141.95 148.2 38.26 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 124.32 1.048 . . . . 0.0 108.218 -170.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -81.31 -15.94 53.93 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.135 -0.978 . . . . 0.0 112.427 -178.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.9 m -72.16 -11.11 60.59 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.664 0.786 . . . . 0.0 111.867 170.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.55 141.11 58.89 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.616 1.567 . . . . 0.0 108.688 176.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 90.4 p -156.74 174.57 15.28 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.529 0.732 . . . . 0.0 110.075 -173.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -57.78 -22.5 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.157 0.983 . . . . 0.0 111.793 168.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -85.26 -45.6 11.81 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.328 1.051 . . . . 0.0 109.507 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -63.13 -32.05 73.33 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.277 0.49 . . . . 0.0 110.039 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.51 -54.76 34.46 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -65.28 -47.78 75.48 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 117.298 0.549 . . . . 0.0 110.08 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 83.9 mtm-85 -65.33 -46.7 79.23 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 118.852 -0.594 . . . . 0.0 111.398 -175.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.1 tp -76.82 -28.87 55.72 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 118.058 -0.973 . . . . 0.0 111.697 -171.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.8 m -71.64 -36.98 70.88 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.977 1.262 . . . . 0.0 109.546 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -70.37 -41.25 73.34 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.359 0.663 . . . . 0.0 111.529 174.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -65.24 -31.07 72.04 Favored 'General case' 0 CA--C 1.53 0.212 0 O-C-N 121.114 -0.991 . . . . 0.0 110.52 173.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 34.1 m -69.94 -40.06 75.7 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 121.922 -0.486 . . . . 0.0 110.227 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.17 -50.87 72.01 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.718 0.407 . . . . 0.0 110.074 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -55.26 -55.78 27.51 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 123.902 0.881 . . . . 0.0 110.057 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 16.3 ptt? -59.42 -39.4 83.38 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 117.992 -1.004 . . . . 0.0 111.038 -172.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . 0.274 6.6 pt -79.83 -21.69 12.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 119.761 1.164 . . . . 0.0 112.248 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 30.8 mt -74.08 -27.2 60.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.914 0.779 . . . . 0.0 108.951 168.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.2 m 55.6 20.67 3.98 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.446 1.898 . . . . 0.0 113.334 -175.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 99.5 mt -150.74 149.77 26.52 Favored Pre-proline 0 C--O 1.236 0.389 0 C-N-CA 128.455 2.702 . . . . 0.0 107.525 -173.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -63.35 160.1 36.8 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.688 2.259 . . . . 0.0 110.452 169.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 23.3 m -76.12 173.7 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 123.258 0.623 . . . . 0.0 110.463 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 8.1 m -50.19 139.36 14.74 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.678 1.591 . . . . 0.0 111.355 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -126.67 119.26 22.8 Favored Pre-proline 0 C--O 1.237 0.407 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 170.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -73.19 163.58 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.499 2.133 . . . . 0.0 111.736 -176.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -139.75 131.5 27.43 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.532 1.533 . . . . 0.0 107.89 171.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.7 t -145.78 147.81 33.97 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -173.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.51 161.19 15.03 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.055 2.503 . . . . 0.0 111.757 169.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 66.6 t-80 -60.89 138.86 58.12 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.37 171.35 12.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.699 0.799 . . . . 0.0 110.87 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -69.29 -13.77 68.01 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-O 119.329 -0.706 . . . . 0.0 113.722 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -132.51 160.38 36.68 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.879 1.671 . . . . 0.0 108.845 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -65.28 153.25 41.62 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 172.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.05 131.44 46.56 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.4 pp -151.76 164.98 35.83 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.46 1.104 . . . . 0.0 110.101 -173.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 47.7 tp -91.01 -25.07 19.87 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.504 0.722 . . . . 0.0 112.503 -171.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -73.58 158.8 34.13 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.29 0.636 . . . . 0.0 111.567 -173.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 72.77 12.43 78.33 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 123.637 0.637 . . . . 0.0 114.046 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -85.94 149.43 25.2 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 118.504 1.152 . . . . 0.0 108.31 174.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -108.41 4.19 24.1 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -173.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 13.2 m 53.83 40.81 31.96 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.746 1.218 . . . . 0.0 112.39 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -66.85 -16.66 66.39 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 123.524 0.583 . . . . 0.0 113.591 -174.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -81.01 -10.41 59.71 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.165 0.982 . . . . 0.0 111.763 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -70.16 149.17 47.82 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.688 0.676 . . . . 0.0 110.148 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.263 0 C-N-CA 123.576 0.75 . . . . 0.0 109.649 175.656 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.4 mtm . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.6 t -140.16 138.43 35.19 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 169.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -98.73 4.25 47.74 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -172.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 53.85 167.24 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 130.251 3.42 . . . . 0.0 116.511 169.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.2 mt -132.61 143.84 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.594 1.957 . . . . 0.0 105.786 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.76 147.06 41.64 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.801 0.728 . . . . 0.0 110.501 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.79 163.73 51.8 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.476 1.036 . . . . 0.0 111.439 170.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -126.52 142.01 51.68 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.042 1.337 . . . . 0.0 109.852 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -73.63 -19.77 60.77 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 122.951 0.501 . . . . 0.0 111.817 -173.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 p -146.82 154.08 40.93 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.85 1.66 . . . . 0.0 108.303 171.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -67.02 148.92 98.78 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 171.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.61 54.91 5.27 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 124.943 3.762 . . . . 0.0 111.002 175.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.3 tttm -53.83 -43.92 69.83 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.184 1.394 . . . . 0.0 111.993 -169.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.0 -40.77 97.12 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 118.43 0.559 . . . . 0.0 111.224 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -74.98 -35.44 62.05 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.101 -177.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.45 -45.77 96.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 170.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -60.29 -50.12 74.9 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.104 0.562 . . . . 0.0 110.144 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.76 -39.53 93.77 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.593 0.633 . . . . 0.0 111.352 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.46 -49.51 76.52 Favored 'General case' 0 C--N 1.337 0.065 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -71.49 -28.56 64.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 118.032 -0.985 . . . . 0.0 112.183 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -60.29 -40.59 90.99 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.85 1.204 . . . . 0.0 109.32 170.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -71.93 -46.41 57.67 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -175.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.2 mt -57.89 -45.8 87.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.0 -34.94 79.14 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.68 -0.638 . . . . 0.0 111.516 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -72.41 -36.02 68.53 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.96 0.904 . . . . 0.0 109.244 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -63.35 -42.01 98.88 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.297 1.039 . . . . 0.0 110.659 169.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 53.3 m -68.03 -50.34 55.94 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.261 0.937 . . . . 0.0 111.956 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.95 154.5 39.33 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.251 0.62 . . . . 0.0 110.485 -178.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -148.54 153.48 38.46 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.163 0.985 . . . . 0.0 109.114 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.9 t70 63.55 -50.57 0.24 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 128.495 2.718 . . . . 0.0 115.378 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -81.39 -7.23 59.54 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.977 0.808 . . . . 0.0 112.917 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.5 m -69.24 142.96 54.06 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.123 0.969 . . . . 0.0 110.092 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -116.21 57.06 0.77 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.595 1.158 . . . . 0.0 107.97 175.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 98.0 mt 55.89 15.73 1.82 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.671 1.988 . . . . 0.0 112.472 -169.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -153.86 153.01 28.09 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 128.715 2.806 . . . . 0.0 105.365 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.93 166.25 12.65 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.403 2.069 . . . . 0.0 113.068 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 p -61.69 -32.78 72.99 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.135 1.374 . . . . 0.0 112.898 -174.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 62.0 mtt -136.17 147.72 61.64 Favored Pre-proline 0 C--O 1.235 0.336 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -67.16 135.22 36.45 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.082 1.855 . . . . 0.0 110.332 -170.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.8 t -71.02 130.03 34.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 169.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -138.8 150.16 45.76 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.166 0.986 . . . . 0.0 108.801 -169.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.2 t -141.55 124.08 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -172.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.8 m -91.55 134.75 34.4 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 168.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -121.7 135.61 54.95 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.854 1.262 . . . . 0.0 107.885 169.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.457 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 25.8 p90 -167.66 142.21 3.69 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -169.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m 58.46 158.33 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.935 2.494 . . . . 0.0 115.735 167.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.1 tp -111.19 66.04 0.62 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 169.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -57.11 -33.67 67.57 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 -165.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -136.42 26.65 3.14 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.226 0.61 . . . . 0.0 111.255 175.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.13 15.91 60.09 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 119.378 -0.679 . . . . 0.0 112.302 -169.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -136.94 143.92 43.14 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 174.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -69.22 143.56 53.94 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.457 ' HB ' ' CE2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -107.48 155.1 20.43 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -177.11 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.9 163.41 36.37 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 67.2 m -140.73 146.96 38.43 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 p -124.95 144.19 35.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 175.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.7 tt -126.76 150.18 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 169.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.5 p -140.87 178.03 1.73 Allowed Pre-proline 0 N--CA 1.442 -0.87 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 173.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -61.82 -28.6 81.79 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 CA-C-N 119.286 0.781 . . . . 0.0 110.941 168.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.5 p-90 -95.4 -25.36 16.3 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -170.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.19 170.77 21.73 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.623 1.556 . . . . 0.0 113.416 -175.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 tt -136.04 125.46 24.99 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 103.07 -2.937 . . . . 0.0 103.07 167.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.2 m -137.05 133.94 36.0 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 122.991 0.517 . . . . 0.0 109.992 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.37 145.15 41.89 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 168.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.2 m -138.09 146.83 26.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.7 mt -137.94 135.45 45.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -174.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -122.99 150.43 59.21 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.435 1.094 . . . . 0.0 110.872 -169.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -44.38 152.51 0.43 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 124.736 3.624 . . . . 0.0 114.962 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.41 175.21 15.89 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 123.898 0.761 . . . . 0.0 113.697 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.82 -49.03 10.9 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.578 2.852 . . . . 0.0 114.305 -169.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -161.42 89.57 0.77 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.314 1.445 . . . . 0.0 107.231 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -155.79 -178.01 6.98 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.727 1.611 . . . . 0.0 106.688 178.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -95.7 136.71 35.76 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 168.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -107.97 144.04 28.56 Favored Pre-proline 0 C--N 1.324 -0.513 0 C-N-CA 126.656 1.983 . . . . 0.0 107.207 173.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.2 136.61 44.7 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.015 1.81 . . . . 0.0 110.606 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 64.1 tp -77.54 130.31 36.78 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 169.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.37 158.37 44.42 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 119.175 0.898 . . . . 0.0 109.956 -174.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -73.45 150.93 41.31 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.6 t -91.05 155.92 3.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -170.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.0 m 61.44 33.2 18.75 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.83 0.852 . . . . 0.0 111.658 -175.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -111.76 151.19 29.26 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 126.804 2.041 . . . . 0.0 106.983 169.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -105.26 142.37 35.15 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.092 0.86 . . . . 0.0 111.031 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.2 mm -118.86 130.04 74.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 174.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.21 123.2 6.77 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.9 mt -112.94 140.79 47.45 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.25 127.7 35.79 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 171.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mp -134.95 158.43 74.94 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 124.812 1.245 . . . . 0.0 107.774 174.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -60.81 -23.58 76.96 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.141 1.894 . . . . 0.0 113.98 172.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -64.2 -17.02 63.14 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.996 1.318 . . . . 0.0 111.949 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.94 152.12 9.12 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 107.881 -2.088 . . . . 0.0 107.881 -169.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.5 m -64.63 131.96 48.42 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 38.8 ttp -149.01 138.01 21.4 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -170.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.94 134.66 37.83 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -111.09 137.99 48.07 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 169.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.1 m -85.89 138.21 32.19 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 72.2 t -70.14 117.07 12.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 169.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -104.98 157.94 16.33 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 108.044 -2.022 . . . . 0.0 108.044 171.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -127.49 81.66 2.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 171.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.6 tp -66.1 128.89 37.88 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -169.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.66 131.38 50.52 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 122.832 0.453 . . . . 0.0 110.724 -172.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.36 4.92 75.71 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-O 118.607 -1.107 . . . . 0.0 113.576 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.2 t -122.39 -121.87 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.5 m -151.12 175.97 11.62 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.277 1.431 . . . . 0.0 109.544 -169.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -69.56 141.78 53.73 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 169.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -157.08 -179.15 7.93 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.308 1.443 . . . . 0.0 108.532 178.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 13.6 mt -113.78 136.66 52.61 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.2 p -139.75 153.59 47.22 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.793 0.837 . . . . 0.0 110.672 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 43.8 t -141.26 116.11 9.76 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 173.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.3 m -75.92 135.75 40.09 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 175.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 69.6 mt -116.7 -42.64 2.96 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.92 0.488 . . . . 0.0 112.276 -169.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 20.0 ptp -159.03 164.91 35.05 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.639 0.775 . . . . 0.0 109.746 -176.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.3 m -113.32 93.78 28.16 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 170.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -82.77 37.03 0.64 Allowed 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 124.128 3.219 . . . . 0.0 112.553 -169.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 34.7 tp -80.46 71.06 7.27 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.917 -1.115 . . . . 0.0 108.18 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.5 m -138.57 162.48 34.46 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.34 1.456 . . . . 0.0 111.077 -169.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -76.02 -18.33 59.3 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.802 -0.561 . . . . 0.0 111.038 171.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 m -76.63 15.68 0.6 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.225 1.41 . . . . 0.0 112.159 170.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 10.1 tpt -130.34 148.52 52.17 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.272 2.229 . . . . 0.0 106.84 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.6 p -160.92 -179.97 7.99 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.368 1.467 . . . . 0.0 108.534 -172.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.434 ' H ' HD11 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -56.25 -41.01 68.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 123.679 0.791 . . . . 0.0 109.293 169.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -71.31 -44.27 65.47 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.097 0.559 . . . . 0.0 109.629 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -68.24 -22.33 64.78 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.645 -0.66 . . . . 0.0 110.998 175.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.29 -48.77 81.56 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 169.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -68.97 -54.05 17.39 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.71 -0.877 . . . . 0.0 110.584 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -65.5 -42.18 92.39 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 118.588 -0.72 . . . . 0.0 112.028 -169.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.9 tp -76.6 -27.15 55.66 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 119.896 1.225 . . . . 0.0 111.246 -171.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.2 m -71.45 -38.05 71.34 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.008 1.276 . . . . 0.0 109.232 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.85 -41.12 78.91 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.897 -0.502 . . . . 0.0 111.637 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -65.21 -34.97 79.63 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 121.022 -1.049 . . . . 0.0 110.325 173.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 18.0 t -67.71 -34.0 76.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.3 -51.73 54.46 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.363 0.665 . . . . 0.0 109.678 170.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 35.6 tpt85 -52.9 -50.08 64.63 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.55 0.74 . . . . 0.0 110.542 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 13.7 ptt? -59.53 -26.55 65.43 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 118.989 0.813 . . . . 0.0 112.306 -172.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 24.3 pt -96.16 5.49 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-N 119.166 0.894 . . . . 0.0 111.898 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.1 mt -115.73 31.39 6.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.951 1.7 . . . . 0.0 112.078 -174.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.6 m -78.29 64.11 3.34 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.734 -1.228 . . . . 0.0 110.809 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.6 mp 64.6 77.26 0.3 Allowed Pre-proline 0 N--CA 1.47 0.544 0 C-N-CA 127.933 2.493 . . . . 0.0 109.634 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -74.37 167.06 28.03 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.346 2.697 . . . . 0.0 111.968 -175.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.5 m -68.97 -29.75 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 122.961 0.504 . . . . 0.0 112.29 -169.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 11.2 m -114.59 56.64 0.72 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.969 1.308 . . . . 0.0 107.774 174.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -62.43 121.45 67.08 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 169.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -61.65 135.83 59.0 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.975 1.783 . . . . 0.0 112.974 -169.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -159.06 148.3 18.66 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.4 1.88 . . . . 0.0 107.731 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.44 149.31 26.12 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.825 0.85 . . . . 0.0 109.285 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -58.04 177.95 0.24 Allowed 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 124.301 3.334 . . . . 0.0 111.858 168.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -61.67 121.24 12.31 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 169.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.42 168.99 19.08 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.208 0.603 . . . . 0.0 110.5 -176.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -168.69 177.52 42.56 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.589 1.09 . . . . 0.0 110.398 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -68.68 151.91 46.05 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.216 0.606 . . . . 0.0 110.023 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -123.07 47.17 2.02 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.016 1.326 . . . . 0.0 108.666 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.07 126.05 26.84 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 174.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 86.0 mt -145.29 159.47 42.98 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.757 1.623 . . . . 0.0 108.309 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 64.3 tp -66.45 123.43 20.0 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -75.82 150.2 37.74 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.085 0.554 . . . . 0.0 110.083 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -175.78 154.15 16.67 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 173.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -145.66 97.53 2.99 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 72.6 ttp85 -65.76 -40.49 92.09 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 119.103 -0.475 . . . . 0.0 111.152 -169.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.5 m -85.93 147.16 26.38 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.223 0.609 . . . . 0.0 109.804 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 73.49 -83.21 0.67 Allowed Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.238 0.923 . . . . 0.0 111.421 174.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -68.39 -32.64 72.85 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.629 1.172 . . . . 0.0 110.818 -177.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 53.22 43.17 31.89 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.426 1.49 . . . . 0.0 111.996 -174.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.249 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 169.87 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.3 tpp . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.5 p -134.93 150.11 50.35 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.283 1.433 . . . . 0.0 108.63 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -87.88 42.82 1.07 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.352 1.061 . . . . 0.0 109.632 -177.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -142.25 157.82 44.42 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.385 1.474 . . . . 0.0 110.198 -170.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.0 mm -128.56 125.9 64.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 172.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -72.7 128.59 35.99 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 173.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.46 153.51 52.91 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -84.08 136.07 34.16 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.136 0.974 . . . . 0.0 109.74 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -72.26 -33.03 67.18 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.806 -0.616 . . . . 0.0 110.075 173.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.8 p -150.72 155.32 39.06 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.427 1.891 . . . . 0.0 108.543 169.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.6 m -53.26 138.59 47.77 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 125.573 1.549 . . . . 0.0 113.703 -170.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -81.89 44.65 1.76 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 124.909 3.739 . . . . 0.0 110.88 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -61.63 -35.04 76.77 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.212 -1.555 . . . . 0.0 112.688 -168.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.58 -42.38 95.65 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 123.155 0.582 . . . . 0.0 110.983 176.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -68.45 -41.65 79.96 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.336 0.654 . . . . 0.0 109.343 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.6 t -59.44 -46.48 92.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 173.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -60.69 -53.4 57.93 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.284 0.634 . . . . 0.0 110.452 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.73 -44.75 95.39 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.941 0.496 . . . . 0.0 110.832 -172.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.58 -47.27 86.92 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -67.87 -26.26 65.93 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 118.37 -0.824 . . . . 0.0 112.31 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -63.76 -34.5 78.04 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.851 1.205 . . . . 0.0 110.051 176.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -70.91 -50.12 38.32 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.808 0.731 . . . . 0.0 109.34 174.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.8 mt -65.69 -39.67 85.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 123.988 0.915 . . . . 0.0 110.594 -169.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.3 -26.37 65.61 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.082 0.553 . . . . 0.0 111.51 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -85.25 -100.3 0.06 Allowed 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 172.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 48.36 27.05 1.26 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.569 1.548 . . . . 0.0 114.273 -173.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.9 p -131.39 9.62 4.75 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.086 1.754 . . . . 0.0 111.466 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -83.93 144.76 28.97 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.534 0.734 . . . . 0.0 110.443 -173.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -113.28 -28.87 7.44 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.137 0.975 . . . . 0.0 111.566 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -126.15 136.6 53.07 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 169.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.6 mt -73.88 -0.83 17.2 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -169.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.3 m -65.83 -26.02 67.48 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.786 0.721 . . . . 0.0 110.5 169.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -95.34 32.16 1.81 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.545 1.138 . . . . 0.0 110.891 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.06 -30.66 69.35 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.236 1.014 . . . . 0.0 112.393 -177.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -68.81 134.3 90.17 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.466 1.106 . . . . 0.0 111.496 -173.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -62.46 155.12 59.79 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.006 2.471 . . . . 0.0 110.607 169.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.3 m -78.58 -12.3 60.01 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -172.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.6 mmt -141.28 159.21 61.99 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 127.291 2.236 . . . . 0.0 105.854 173.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -65.48 137.18 49.71 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.936 1.757 . . . . 0.0 114.204 -169.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.9 t -108.3 112.02 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 167.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -148.86 151.77 35.3 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.645 0.778 . . . . 0.0 109.65 -169.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.2 t -137.67 116.24 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 123.669 0.788 . . . . 0.0 109.187 -173.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.0 m -80.62 157.3 26.03 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.913 0.885 . . . . 0.0 110.318 169.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.88 140.5 52.92 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.76 2.024 . . . . 0.0 109.498 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.478 ' CE2' ' CB ' ' A' ' 131' ' ' ALA . 60.1 m-85 -147.06 169.7 18.7 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -169.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.8 t -52.03 167.45 0.12 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 129.132 2.973 . . . . 0.0 114.505 -169.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.9 tp -77.99 125.5 29.44 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 174.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.89 135.7 33.15 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.18 1.792 . . . . 0.0 107.299 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 55.38 24.16 6.37 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.864 0.866 . . . . 0.0 111.992 -170.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.23 5.88 78.12 Favored Glycine 0 CA--C 1.534 1.233 0 O-C-N 121.026 -1.046 . . . . 0.0 113.817 -174.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -119.14 157.22 28.34 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.191 1.796 . . . . 0.0 108.952 -175.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -79.3 147.76 32.36 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.311 -1.493 . . . . 0.0 110.091 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.58 162.82 12.94 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 122.506 1.146 . . . . 0.0 109.885 169.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.14 172.13 39.88 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 107.49 -2.244 . . . . 0.0 107.49 169.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 11.6 m -138.93 152.4 47.69 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 105.591 -2.004 . . . . 0.0 105.591 169.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.71 138.86 52.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 175.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.6 tt -116.1 146.22 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 167.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.4 t -154.8 157.11 31.97 Favored Pre-proline 0 N--CA 1.442 -0.863 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 175.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -50.23 -29.7 23.69 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.934 2.422 . . . . 0.0 113.646 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -93.14 -19.88 21.04 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -174.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -166.69 159.45 13.99 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.911 1.687 . . . . 0.0 112.66 -175.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.4 tt -124.57 124.88 43.19 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 103.848 -2.649 . . . . 0.0 103.848 167.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.8 m -137.65 134.46 35.49 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.35 0.595 . . . . 0.0 109.724 -172.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.84 144.2 52.65 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 167.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.7 m -136.11 150.44 28.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 32.1 mt -135.92 143.4 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -123.89 139.43 32.41 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -53.98 132.16 48.41 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.868 1.712 . . . . 0.0 108.928 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.4 -175.91 31.27 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.292 0.948 . . . . 0.0 114.68 -169.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -71.17 153.79 62.17 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.203 2.602 . . . . 0.0 110.204 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.0 t0 46.67 44.59 13.88 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.067 1.747 . . . . 0.0 113.068 172.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -133.62 143.52 48.67 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.103 1.361 . . . . 0.0 107.842 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -112.19 95.94 5.75 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 172.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -65.63 155.64 85.2 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.443 171.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -68.35 164.46 32.44 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.629 2.22 . . . . 0.0 109.909 169.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.25 87.68 1.12 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 169.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -70.82 148.98 47.29 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -89.9 159.04 17.15 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 169.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.8 t -91.37 154.22 3.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 114.048 -1.433 . . . . 0.0 107.647 -169.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.8 m 66.26 6.19 4.1 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.433 1.493 . . . . 0.0 113.673 -175.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -80.06 158.63 26.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.988 1.315 . . . . 0.0 108.268 169.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -113.97 144.22 43.44 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.966 0.803 . . . . 0.0 110.847 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.4 mm -118.21 121.09 66.36 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 176.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.11 125.33 7.74 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 173.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.3 mt -123.27 141.17 52.27 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.317 1.047 . . . . 0.0 109.084 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -90.53 133.65 34.92 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 172.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -153.49 157.51 32.76 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 124.958 1.303 . . . . 0.0 107.895 172.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -61.04 -20.26 66.84 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.059 2.506 . . . . 0.0 114.705 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -62.51 -20.65 64.83 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.944 0.898 . . . . 0.0 112.067 172.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.54 145.71 7.04 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 -170.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.9 m -60.64 131.07 49.56 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 174.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 47.6 ttp -149.67 146.21 27.14 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -169.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.55 134.02 34.42 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 121.883 -0.511 . . . . 0.0 110.493 176.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -104.98 132.25 51.46 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 168.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.2 m -82.01 144.11 31.1 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.0 t -75.96 114.39 16.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -98.1 162.75 21.02 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 171.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -129.9 133.86 47.13 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 169.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.6 tp -143.84 145.97 32.71 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -176.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -59.5 134.88 57.42 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.789 0.435 . . . . 0.0 110.572 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.17 4.45 59.71 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 118.945 -0.919 . . . . 0.0 113.701 -177.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.4 t -124.7 -33.15 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 118.928 1.364 . . . . 0.0 109.746 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.7 m 57.39 -150.09 0.45 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.331 1.053 . . . . 0.0 108.445 -169.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -58.61 132.15 52.94 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.884 0.874 . . . . 0.0 110.579 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -154.5 179.41 9.05 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.365 1.866 . . . . 0.0 107.011 169.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.6 mp -113.47 144.36 42.95 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 121.131 -0.981 . . . . 0.0 109.217 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.8 p -142.86 154.58 44.28 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.571 1.148 . . . . 0.0 110.278 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 12.2 t -144.75 111.87 5.96 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 170.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.9 m -67.98 130.17 42.14 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.7 mt -96.38 -59.34 1.85 Allowed 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -176.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.87 170.28 12.4 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.342 1.457 . . . . 0.0 108.377 177.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.9 m -86.71 132.08 43.47 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 170.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -68.67 164.65 32.34 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.11 1.873 . . . . 0.0 110.043 169.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 56.8 tp -133.64 141.61 47.7 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.251 1.02 . . . . 0.0 109.313 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.9 m -62.44 -17.7 60.0 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.924 1.29 . . . . 0.0 113.639 -172.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -60.17 115.12 3.26 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.785 0.834 . . . . 0.0 110.059 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.4 m 54.6 20.73 3.03 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.679 1.592 . . . . 0.0 114.04 -176.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.0 mmm -76.43 154.15 35.05 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.361 -0.837 . . . . 0.0 110.238 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 78.7 p -159.0 177.07 11.53 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.377 1.471 . . . . 0.0 108.021 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.52 HD13 ' H ' ' A' ' 120' ' ' ILE . 1.9 mp -58.34 -36.87 60.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 169.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -72.59 -44.99 61.29 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.572 0.749 . . . . 0.0 109.959 -174.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -64.23 -31.92 73.31 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.646 172.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.07 -58.39 14.42 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-N 119.455 1.025 . . . . 0.0 111.533 169.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -63.82 -48.55 76.4 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.043 0.922 . . . . 0.0 110.478 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -57.41 -45.44 84.59 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.935 1.294 . . . . 0.0 110.699 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.6 tp -78.35 -27.87 47.07 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.201 -174.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.9 m -65.83 -44.84 84.35 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.724 1.147 . . . . 0.0 109.173 173.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -65.68 -46.42 79.11 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.45 0.7 . . . . 0.0 111.299 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.04 -33.29 75.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.813 0.445 . . . . 0.0 110.548 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 19.0 m -68.22 -39.64 82.29 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.23 0.468 . . . . 0.0 110.797 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.478 ' CB ' ' CE2' ' A' ' 45' ' ' PHE . . . -65.23 -50.69 64.88 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 171.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -52.9 -51.36 61.52 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.065 0.848 . . . . 0.0 110.737 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 58.2 ttp -43.13 -48.23 6.27 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.152 2.181 . . . . 0.0 112.476 173.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 11.0 pt -92.78 -15.37 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 118.767 0.712 . . . . 0.0 112.513 -174.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 18.6 mt -81.94 -73.38 0.39 Allowed 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.384 1.074 . . . . 0.0 110.548 -175.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.6 m -147.57 30.26 0.91 Allowed 'General case' 0 C--O 1.234 0.255 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -168.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 12.6 tp -48.92 124.71 13.02 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 123.743 0.817 . . . . 0.0 111.088 176.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.91 167.22 22.42 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.848 2.365 . . . . 0.0 112.179 -172.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 44.5 t -127.31 145.25 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 169.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 9.4 m -60.67 133.77 56.43 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.261 0.624 . . . . 0.0 110.39 -174.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -146.27 115.74 4.65 Favored Pre-proline 0 C--O 1.236 0.38 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 169.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.13 132.55 18.23 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.836 1.691 . . . . 0.0 109.796 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -156.01 151.36 26.8 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 126.114 1.766 . . . . 0.0 108.652 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.3 p -145.56 142.73 18.45 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 124.35 1.06 . . . . 0.0 108.596 176.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -68.17 -175.68 0.88 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.87 3.047 . . . . 0.0 110.988 170.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -57.18 123.21 14.52 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 169.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -81.21 125.54 30.42 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 71.35 176.8 25.14 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 121.725 0.625 . . . . 0.0 112.029 -173.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -71.24 162.57 29.21 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.401 0.68 . . . . 0.0 110.171 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -57.17 143.95 36.96 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 171.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.83 108.45 2.54 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 170.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 59.4 tp -156.85 141.5 16.84 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.859 1.264 . . . . 0.0 108.053 -169.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 58.8 tp -149.56 147.5 28.23 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.268 1.027 . . . . 0.0 108.871 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -129.42 159.25 36.81 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.358 1.463 . . . . 0.0 108.687 173.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -175.63 -173.37 41.29 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -71.41 -21.54 61.98 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.313 0.645 . . . . 0.0 112.141 -175.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 53.11 52.11 14.37 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.562 1.145 . . . . 0.0 109.422 -174.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.3 m -57.53 140.76 49.94 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.218 1.007 . . . . 0.0 110.493 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 79.48 112.13 0.24 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.581 1.086 . . . . 0.0 110.619 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 50.43 52.41 14.86 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.284 1.433 . . . . 0.0 110.766 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -62.6 122.22 15.27 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.397 0 C-N-CA 126.541 1.937 . . . . 0.0 107.112 175.206 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 120.645 0.26 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.7 p -72.47 156.98 38.47 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.198 0.999 . . . . 0.0 110.249 174.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -87.68 54.03 2.98 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.131 0.973 . . . . 0.0 108.584 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -150.52 157.89 43.53 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.531 1.932 . . . . 0.0 109.042 -171.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.64 133.08 70.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 169.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -153.14 164.0 38.84 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.232 1.013 . . . . 0.0 110.207 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 134.78 -150.54 20.14 Favored Glycine 0 C--N 1.341 0.828 0 C-N-CA 125.035 1.302 . . . . 0.0 110.368 176.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -84.54 -27.26 27.46 Favored 'General case' 0 C--O 1.221 -0.447 0 C-N-CA 125.061 1.344 . . . . 0.0 107.463 169.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 58.9 16.32 4.49 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 167.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.3 p -52.28 145.38 11.04 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.336 1.054 . . . . 0.0 112.069 -177.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -48.12 126.22 11.68 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 126.04 1.736 . . . . 0.0 111.146 -175.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -73.45 53.21 2.58 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.906 3.071 . . . . 0.0 112.036 174.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.7 tttm -47.66 -48.76 28.78 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.44 1.896 . . . . 0.0 112.998 -169.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.64 -41.19 88.66 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.275 0.489 . . . . 0.0 111.69 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -71.87 -38.75 70.0 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.926 0.49 . . . . 0.0 109.795 -176.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 71.7 t -61.63 -44.16 98.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 172.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -60.31 -53.74 54.08 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.58 0.627 . . . . 0.0 110.078 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.93 -40.09 96.59 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.613 0.642 . . . . 0.0 111.194 -176.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.61 -46.9 86.15 Favored 'General case' 0 C--N 1.339 0.126 0 O-C-N 122.064 -0.398 . . . . 0.0 110.019 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -68.79 -25.15 64.56 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 118.419 -0.8 . . . . 0.0 112.379 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -67.08 -33.19 74.96 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 119.504 1.047 . . . . 0.0 109.803 173.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -77.58 -45.99 23.56 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.746 -0.596 . . . . 0.0 109.888 176.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.0 mt -60.43 -39.73 81.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.09 -34.46 77.65 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.362 -0.836 . . . . 0.0 111.549 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -71.73 -43.19 66.28 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.052 0.842 . . . . 0.0 109.059 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -58.81 -41.42 86.74 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.957 0.903 . . . . 0.0 111.152 175.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.2 m -67.55 -47.9 68.5 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.147 0.885 . . . . 0.0 110.553 176.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 56.6 mtm -92.18 44.35 1.16 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.643 1.177 . . . . 0.0 111.025 -175.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.0 p-80 -70.82 -3.31 18.3 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -172.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.36 -26.02 67.55 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.053 0.842 . . . . 0.0 110.43 169.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -81.96 9.23 8.65 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.038 1.335 . . . . 0.0 111.633 174.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.9 m 53.54 -133.11 1.84 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.934 1.294 . . . . 0.0 110.216 -176.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -81.02 -2.13 46.75 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.97 0.804 . . . . 0.0 113.099 -173.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.74 146.87 53.05 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.306 0.957 . . . . 0.0 110.161 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -70.06 160.79 79.19 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 123.733 0.813 . . . . 0.0 109.52 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -58.24 148.17 80.31 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.344 2.029 . . . . 0.0 112.7 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.9 m -65.17 -25.62 67.81 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.92 0.888 . . . . 0.0 112.49 -169.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 61.3 mtt -136.35 137.63 24.85 Favored Pre-proline 0 C--O 1.236 0.343 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 170.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -49.84 130.9 28.25 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.168 2.579 . . . . 0.0 112.827 175.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.2 m -67.06 152.92 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 168.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -140.53 155.56 46.59 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.453 1.024 . . . . 0.0 110.073 -175.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.4 t -139.54 114.28 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.2 m -78.86 142.0 37.2 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 168.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -125.37 134.74 52.07 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.401 1.48 . . . . 0.0 107.865 169.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -165.11 142.8 6.09 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -172.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.4 m 54.58 166.27 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.104 2.562 . . . . 0.0 116.312 167.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.0 tp -113.54 110.34 20.09 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 168.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -131.22 135.74 47.65 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.678 1.591 . . . . 0.0 107.089 -169.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 55.51 25.05 7.43 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 121.644 0.735 . . . . 0.0 110.51 -168.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.16 3.64 65.75 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 118.146 -1.363 . . . . 0.0 113.901 -174.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -115.34 154.86 28.39 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.599 1.699 . . . . 0.0 109.403 -173.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -74.59 137.66 42.47 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.683 -1.26 . . . . 0.0 108.997 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.79 155.97 18.19 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.667 1.122 . . . . 0.0 110.255 -173.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.15 171.58 41.25 Favored Glycine 0 CA--C 1.526 0.721 0 O-C-N 121.081 -1.012 . . . . 0.0 111.732 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 15.0 m -145.76 152.44 39.57 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 170.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.87 144.6 35.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 124.986 1.314 . . . . 0.0 107.466 173.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.9 tt -127.83 150.28 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 169.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.2 p -138.56 175.87 3.05 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 169.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -59.54 -30.42 92.4 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 CA-C-N 119.701 0.929 . . . . 0.0 110.835 168.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 48.4 p-90 -92.45 -25.59 18.38 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -171.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.51 170.45 21.93 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.42 1.464 . . . . 0.0 113.491 -175.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.6 tt -138.29 128.45 25.78 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 104.147 -2.538 . . . . 0.0 104.147 168.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.2 m -140.65 138.74 34.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.655 0.741 . . . . 0.0 109.622 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.63 146.58 51.57 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 168.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.0 m -138.84 144.85 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 C-N-CA 123.807 0.843 . . . . 0.0 108.786 175.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 52.2 mt -138.35 144.07 31.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -128.3 146.18 58.6 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-O 117.974 -1.012 . . . . 0.0 108.621 -175.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.64 134.65 21.83 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.469 2.779 . . . . 0.0 111.023 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.78 173.61 53.36 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 123.01 0.338 . . . . 0.0 112.878 -175.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -69.71 149.9 67.81 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 122.532 2.155 . . . . 0.0 110.296 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.0 t70 50.71 40.46 24.27 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.409 1.884 . . . . 0.0 112.696 169.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -128.27 131.12 48.74 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.3 mp -96.74 83.23 3.41 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 -175.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 3.7 m0 -66.33 140.4 96.73 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.645 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -66.86 161.68 41.12 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.842 1.695 . . . . 0.0 108.454 168.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.0 tp -67.38 106.44 2.09 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 169.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -73.77 155.13 39.19 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.335 0.588 . . . . 0.0 109.642 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -89.87 148.14 23.34 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 169.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.6 t -89.84 154.72 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -169.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.1 m 65.01 12.86 8.25 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.149 1.38 . . . . 0.0 113.713 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -85.96 158.97 19.76 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.114 1.365 . . . . 0.0 108.212 169.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -111.23 143.24 42.3 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 118.796 0.726 . . . . 0.0 110.504 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.9 mp -114.09 127.82 71.34 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 N-CA-C 104.775 -2.305 . . . . 0.0 104.775 170.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.51 121.09 5.54 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 170.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.8 mt -109.32 132.57 54.0 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 174.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -85.97 125.96 33.77 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 173.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 37.1 mt -133.6 148.52 68.97 Favored Pre-proline 0 C--O 1.233 0.224 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -59.12 -24.6 74.48 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.383 2.055 . . . . 0.0 112.802 169.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -58.05 -29.61 65.51 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.995 1.318 . . . . 0.0 112.158 169.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.32 142.15 4.84 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 -169.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.7 m -61.5 130.47 46.17 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 174.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 44.2 ttp -147.75 136.97 22.31 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -170.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.12 139.79 35.42 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.753 -0.592 . . . . 0.0 110.145 175.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -112.81 136.72 52.12 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 169.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.5 m -91.8 140.97 29.17 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.3 t -72.61 129.21 35.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -114.39 159.64 13.61 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 107.54 -2.224 . . . . 0.0 107.54 169.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -127.5 100.32 5.96 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 171.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.8 tp -79.11 121.79 25.43 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -171.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.09 129.98 44.07 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.042 0.537 . . . . 0.0 110.604 -172.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.88 5.81 70.98 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.669 -1.073 . . . . 0.0 113.632 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.9 t -124.75 -113.23 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 118.847 1.324 . . . . 0.0 107.611 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 11.8 m -152.98 174.45 14.13 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.793 1.237 . . . . 0.0 110.142 -169.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -75.49 145.78 41.13 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 169.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.16 167.52 30.16 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.501 1.52 . . . . 0.0 108.277 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.4 mp -110.51 137.85 47.67 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.9 m -136.84 152.13 49.91 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.586 0.754 . . . . 0.0 110.47 -174.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 43.0 t -144.81 124.11 13.02 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 169.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.0 m -65.09 143.49 57.87 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 176.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.6 mt -117.69 -47.9 2.6 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 118.576 -0.726 . . . . 0.0 111.131 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 19.0 ptp -160.07 165.19 32.29 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.036 0.835 . . . . 0.0 110.541 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.3 m -119.5 95.5 49.28 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 169.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -77.32 -71.29 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.266 1.977 . . . . 0.0 111.942 -169.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.8 tp 46.0 36.74 3.19 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.69 1.596 . . . . 0.0 112.111 -171.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.2 m -75.31 148.56 39.24 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.107 0.963 . . . . 0.0 109.965 -174.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -78.11 -23.15 47.98 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.529 -0.732 . . . . 0.0 111.311 174.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.3 m -77.69 -0.15 25.67 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.236 1.014 . . . . 0.0 112.221 173.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.7 tpt -60.75 142.05 56.31 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.398 1.079 . . . . 0.0 109.636 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.7 m -143.28 157.56 44.38 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 125.807 1.643 . . . . 0.0 107.15 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.68 -24.84 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 O-C-N 120.923 -1.111 . . . . 0.0 111.114 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -67.04 -37.44 84.1 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.569 -0.707 . . . . 0.0 110.05 173.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -69.74 -31.72 69.86 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 118.888 0.767 . . . . 0.0 109.728 170.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.33 -36.94 46.98 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 169.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -84.6 -52.38 6.15 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.23 -1.159 . . . . 0.0 110.821 173.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 60.1 ttp85 -65.58 -38.5 89.68 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -169.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.62 -31.24 46.93 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 119.677 1.126 . . . . 0.0 109.2 -173.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 m -67.43 -42.52 83.04 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 123.677 0.791 . . . . 0.0 109.061 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -66.75 -41.26 88.11 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.349 1.06 . . . . 0.0 111.828 173.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.97 -30.54 65.37 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 121.176 -0.952 . . . . 0.0 110.636 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 44.0 m -69.32 -43.02 74.6 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.974 0.51 . . . . 0.0 110.172 173.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -54.34 -49.76 68.98 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.217 1.007 . . . . 0.0 110.276 173.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.0 ttp-105 -68.49 -42.69 78.29 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.43 -0.794 . . . . 0.0 111.851 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 51.4 ttp -48.31 -56.4 8.17 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.312 1.045 . . . . 0.0 110.601 171.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.6 pt -78.36 -6.07 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 118.865 0.757 . . . . 0.0 112.961 -176.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 19.0 tp -74.9 -83.8 0.05 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 170.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.3 m -155.78 10.36 0.28 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.5 tp 41.97 52.01 6.44 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 124.728 1.211 . . . . 0.0 113.812 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -60.45 154.95 49.93 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.131 1.887 . . . . 0.0 111.349 172.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.9 t -133.79 140.19 47.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 172.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 7.0 m -64.77 132.57 49.94 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.346 0.658 . . . . 0.0 109.466 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -152.14 118.75 3.13 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 124.811 1.244 . . . . 0.0 108.042 174.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -60.03 140.09 90.91 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.429 2.086 . . . . 0.0 111.659 177.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -155.6 141.43 18.09 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.351 1.46 . . . . 0.0 108.694 175.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -149.8 137.79 11.89 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.568 1.147 . . . . 0.0 108.682 176.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -48.17 113.28 0.76 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 124.491 3.46 . . . . 0.0 112.905 174.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 23.6 t60 49.9 25.42 1.6 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.684 1.994 . . . . 0.0 113.556 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 48.01 32.74 3.02 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.202 1.401 . . . . 0.0 113.526 -170.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.54 136.14 33.85 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -138.61 150.87 46.73 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.803 1.641 . . . . 0.0 108.406 -176.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.21 -37.06 69.3 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 119.098 -0.477 . . . . 0.0 110.93 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . 48.87 39.17 13.69 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.283 1.433 . . . . 0.0 112.004 -175.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -76.76 167.55 21.64 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.738 0.815 . . . . 0.0 111.771 -177.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 66.3 tp -125.7 130.96 52.57 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -76.09 154.56 35.48 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 122.946 0.498 . . . . 0.0 110.577 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.51 177.74 43.16 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 123.887 0.756 . . . . 0.0 112.004 176.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -135.59 138.09 42.61 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.402 1.481 . . . . 0.0 108.358 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -79.4 -34.92 41.4 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 122.566 0.346 . . . . 0.0 110.207 177.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 11.6 m -73.69 127.72 33.56 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.154 0.582 . . . . 0.0 109.542 -172.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 173.36 146.3 5.44 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 107.538 -2.225 . . . . 0.0 107.538 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -87.66 154.87 20.25 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.354 0.661 . . . . 0.0 109.93 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -146.07 147.5 31.66 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.018 1.327 . . . . 0.0 108.789 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.348 0 C-N-CA 125.457 1.503 . . . . 0.0 107.992 177.424 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.4 tpt . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 p -78.05 -40.6 38.2 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.708 0.803 . . . . 0.0 110.976 -177.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 57.71 49.78 11.8 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.85 1.26 . . . . 0.0 110.125 -169.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -140.61 164.59 29.75 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.466 1.906 . . . . 0.0 109.088 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 71.2 mt -131.82 129.93 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 174.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.59 145.66 36.69 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.149 0.499 . . . . 0.0 110.49 -178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.17 151.18 51.66 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.911 1.243 . . . . 0.0 112.422 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -86.45 131.14 34.27 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 170.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -74.02 -32.7 63.48 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 171.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 p -149.73 148.22 28.97 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.489 1.916 . . . . 0.0 107.488 169.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.6 m -59.84 150.67 67.38 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 126.816 2.046 . . . . 0.0 114.13 -169.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -80.6 42.28 1.3 Allowed 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 124.306 3.337 . . . . 0.0 111.737 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 tttm -52.83 -46.91 67.97 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.853 1.261 . . . . 0.0 112.04 -169.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.57 -41.05 98.41 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 122.57 0.348 . . . . 0.0 111.407 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -72.28 -38.63 68.74 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -175.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 99.3 t -61.35 -44.08 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 172.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -62.17 -50.44 71.83 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 118.849 -0.596 . . . . 0.0 110.579 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.62 -39.13 93.17 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.765 0.711 . . . . 0.0 111.032 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.43 -50.33 74.02 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -68.36 -28.19 66.91 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 118.172 -0.918 . . . . 0.0 112.594 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.8 -33.88 76.66 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 120.028 1.285 . . . . 0.0 109.582 175.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -80.05 -43.27 22.16 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.289 0.495 . . . . 0.0 110.352 176.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.1 mt -65.22 -37.96 81.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.263 -0.898 . . . . 0.0 109.117 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.31 -32.69 74.25 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.467 0.707 . . . . 0.0 110.707 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -72.53 -41.8 65.46 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.841 0.856 . . . . 0.0 109.459 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -57.92 -39.03 77.0 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.332 1.053 . . . . 0.0 110.266 173.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.9 m -79.56 58.81 2.8 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.811 1.644 . . . . 0.0 110.522 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 55.5 mtt -61.66 108.8 1.05 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.774 0.83 . . . . 0.0 109.677 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -81.13 -20.1 42.12 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.034 0.533 . . . . 0.0 110.155 170.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -137.09 140.62 42.08 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 169.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -76.26 1.78 15.08 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.805 0.73 . . . . 0.0 112.805 -169.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.5 m -119.27 17.44 13.09 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.547 1.539 . . . . 0.0 110.769 169.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -61.16 -40.48 94.02 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.944 0.898 . . . . 0.0 110.933 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.2 mt 49.91 -135.4 1.32 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.499 1.519 . . . . 0.0 110.452 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -66.21 143.88 98.51 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 119.27 0.941 . . . . 0.0 109.862 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -56.43 129.64 35.84 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.452 2.101 . . . . 0.0 114.006 -169.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.0 m -82.14 -9.26 59.58 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.438 1.095 . . . . 0.0 112.407 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 7.9 mmt -135.23 156.49 78.05 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 126.426 1.89 . . . . 0.0 107.184 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -63.34 132.37 35.77 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.666 2.244 . . . . 0.0 115.769 -168.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.6 t -111.63 107.9 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 101.128 -3.656 . . . . 0.0 101.128 167.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -140.85 159.17 42.78 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.946 0.898 . . . . 0.0 110.197 -169.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.3 t -138.16 112.21 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.7 m -76.17 147.82 38.2 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.487 1.04 . . . . 0.0 108.982 169.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -144.26 130.18 19.4 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.679 1.192 . . . . 0.0 111.622 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 176.59 159.35 0.33 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.017 1.327 . . . . 0.0 113.398 -172.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 m 61.64 152.86 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 128.473 2.709 . . . . 0.0 114.688 168.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.5 mt -103.62 125.55 50.21 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 169.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -135.34 138.45 43.4 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 173.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 54.18 26.31 6.57 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.971 0.908 . . . . 0.0 111.017 -169.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.54 7.14 82.68 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.927 1.251 . . . . 0.0 114.263 -176.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -119.17 148.68 42.82 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.236 1.518 . . . . 0.0 109.322 -173.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -66.72 145.3 55.68 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.235 0.925 . . . . 0.0 110.134 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.87 160.19 19.03 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.911 0.862 . . . . 0.0 110.173 -172.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -176.31 178.59 47.66 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 13.6 m -142.04 150.25 41.02 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 169.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.1 p -114.87 147.12 18.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 169.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.6 tt -130.08 151.34 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 169.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.5 p -142.41 172.06 6.35 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 169.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -73.89 21.06 0.38 Allowed 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 121.344 1.363 . . . . 0.0 112.063 169.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -138.13 -23.27 1.02 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.288 0.949 . . . . 0.0 113.403 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.18 164.71 37.57 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 120.363 1.438 . . . . 0.0 111.733 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 tt -137.61 125.87 23.18 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 168.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.3 m -138.18 134.18 34.21 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 123.332 0.395 . . . . 0.0 110.084 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.1 141.41 56.12 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 168.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 m -138.76 144.83 28.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 51.5 mt -141.33 134.35 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 -170.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -119.95 145.05 38.81 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.33 -172.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -44.68 125.8 6.62 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.738 2.959 . . . . 0.0 112.18 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.65 176.45 28.47 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 123.364 0.507 . . . . 0.0 113.193 -175.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -67.19 135.14 36.1 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.125 2.55 . . . . 0.0 110.411 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.7 t70 49.1 32.57 4.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.925 1.69 . . . . 0.0 113.259 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 -91.37 151.85 20.67 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 172.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -118.42 88.72 2.98 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 172.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 22.9 m0 -65.28 150.66 95.37 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 169.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.58 168.21 23.27 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.706 1.604 . . . . 0.0 108.375 169.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.8 tp -71.09 91.36 0.9 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 170.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -75.55 151.79 37.85 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.418 0.628 . . . . 0.0 109.679 -176.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -89.83 149.88 22.48 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 173.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.8 t -91.88 154.86 3.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 124.311 1.044 . . . . 0.0 108.281 -169.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.9 m 62.45 23.52 13.96 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.637 1.175 . . . . 0.0 112.667 -176.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -99.43 151.71 20.8 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.206 1.802 . . . . 0.0 107.648 169.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -106.2 143.63 34.06 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.503 0.592 . . . . 0.0 110.345 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 9.8 mt -123.92 128.41 74.18 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.85 123.14 6.89 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.8 mt -109.57 131.56 54.95 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 172.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.64 127.75 34.0 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 172.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.9 mt -135.2 153.62 78.33 Favored Pre-proline 0 C--O 1.234 0.275 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.79 -26.06 82.32 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.71 2.274 . . . . 0.0 112.759 174.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -65.37 -23.3 66.94 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.123 1.369 . . . . 0.0 111.911 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 129.69 147.15 6.2 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 126.176 1.846 . . . . 0.0 108.835 -169.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.7 m -62.78 133.86 55.39 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 55.7 ttm -144.47 136.09 25.72 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -169.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.42 130.11 35.11 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.521 -0.737 . . . . 0.0 109.169 173.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -106.06 136.48 45.65 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 169.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.8 m -87.58 137.88 31.96 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.1 t -71.02 114.81 9.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -101.47 163.31 17.74 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 169.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -130.58 97.8 4.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 170.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.5 tp -78.06 128.05 33.25 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -169.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -58.92 130.9 49.2 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.172 0.589 . . . . 0.0 110.52 -176.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.5 3.65 72.43 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.646 -1.086 . . . . 0.0 113.818 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.3 t -126.19 -121.0 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 119.143 1.471 . . . . 0.0 107.188 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.4 m -151.65 -176.79 5.76 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.776 1.63 . . . . 0.0 109.019 -169.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -72.91 148.62 44.17 Favored 'General case' 0 C--N 1.34 0.188 0 O-C-N 121.748 -0.595 . . . . 0.0 110.155 169.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -154.49 163.29 40.42 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.123 1.769 . . . . 0.0 108.03 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.4 mt -104.44 130.55 52.34 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.6 m -137.61 151.89 48.8 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.018 0.527 . . . . 0.0 110.884 -171.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 25.8 t -142.44 123.77 14.74 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 170.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.2 m -70.97 135.27 47.78 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 176.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.5 mt -110.48 -50.68 2.94 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.359 0.664 . . . . 0.0 111.165 -173.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 9.4 ptp -159.75 172.31 17.93 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.708 0.803 . . . . 0.0 109.982 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.9 m -119.74 80.5 24.42 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.044 0.938 . . . . 0.0 109.648 -177.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -62.67 161.26 29.08 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.48 2.12 . . . . 0.0 110.407 169.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 47.9 tp -137.66 154.83 49.65 Favored 'General case' 0 CA--C 1.526 0.052 0 C-N-CA 125.004 1.322 . . . . 0.0 107.67 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.6 m -48.49 -30.73 5.47 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.13 1.772 . . . . 0.0 114.589 -175.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -70.44 -28.5 65.07 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.441 0.564 . . . . 0.0 112.175 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.8 m -106.35 36.7 2.51 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.2 1.4 . . . . 0.0 109.605 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 65.0 mmm -133.99 155.5 49.86 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.668 1.187 . . . . 0.0 110.291 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.7 t -159.67 166.61 30.24 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 127.968 2.507 . . . . 0.0 104.632 170.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.504 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.6 OUTLIER -57.08 -36.59 51.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 119.09 0.859 . . . . 0.0 109.905 177.45 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -71.67 -32.41 67.84 Favored 'General case' 0 C--O 1.223 -0.308 0 O-C-N 121.652 -0.655 . . . . 0.0 110.462 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -73.73 -42.25 61.42 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.992 0.814 . . . . 0.0 109.372 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -49.01 -30.86 9.94 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 123.756 0.693 . . . . 0.0 113.882 169.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -90.33 -57.62 2.78 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.602 1.201 . . . . 0.0 111.481 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 71.8 ttt-85 -68.79 -32.58 72.41 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -168.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.6 mp -76.74 -38.34 54.37 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.757 1.162 . . . . 0.0 108.464 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.0 m -63.14 -43.58 97.93 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.3 1.04 . . . . 0.0 109.301 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.71 -55.0 39.81 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 118.657 -0.687 . . . . 0.0 110.801 171.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.27 -34.86 75.86 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.138 0.881 . . . . 0.0 111.408 -174.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 99.5 m -73.39 -27.14 61.3 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 122.11 -0.369 . . . . 0.0 111.854 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.52 -41.19 40.1 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.484 -0.76 . . . . 0.0 109.101 169.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -57.81 -55.34 36.11 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.262 1.425 . . . . 0.0 110.277 -173.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 17.3 ptt? -48.95 -34.09 12.21 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.655 1.582 . . . . 0.0 112.56 177.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 34.3 pt -93.53 2.5 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 119.863 1.21 . . . . 0.0 112.435 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 26.5 mt -124.34 -71.11 0.73 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.304 1.442 . . . . 0.0 112.844 -169.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.6 m -82.94 0.97 41.96 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -168.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 67.3 tp -66.31 115.47 24.08 Favored Pre-proline 0 N--CA 1.441 -0.899 0 C-N-CA 126.353 1.861 . . . . 0.0 106.319 169.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -71.23 155.01 61.49 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.131 1.888 . . . . 0.0 113.754 -169.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.3 p -149.86 151.77 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 126.445 1.898 . . . . 0.0 106.626 170.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.8 m -68.03 127.22 32.07 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -154.73 119.72 2.62 Favored Pre-proline 0 C--O 1.236 0.391 0 C-N-CA 124.776 1.23 . . . . 0.0 107.894 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -58.6 135.39 67.12 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.682 2.255 . . . . 0.0 111.302 176.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -73.96 -29.67 62.12 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 122.945 0.498 . . . . 0.0 112.009 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.6 m -110.37 149.14 39.77 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 125.401 1.48 . . . . 0.0 110.645 -174.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -76.66 -24.82 9.95 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.545 2.164 . . . . 0.0 112.194 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -146.39 148.46 32.35 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.112 1.765 . . . . 0.0 107.618 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.83 -19.11 61.38 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -173.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 69.86 -153.24 52.08 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 53.82 41.34 32.08 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.627 1.171 . . . . 0.0 112.254 170.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -69.32 -28.28 66.11 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 119.075 -0.488 . . . . 0.0 111.123 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . 51.95 40.46 28.22 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.406 1.482 . . . . 0.0 112.327 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.84 162.57 28.99 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.109 0.564 . . . . 0.0 110.413 174.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -137.12 155.4 49.66 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.791 1.236 . . . . 0.0 109.492 171.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -95.89 158.32 15.5 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.01 0.924 . . . . 0.0 110.269 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -72.9 174.15 46.82 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 170.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.33 132.93 16.78 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 175.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -80.09 130.1 34.99 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.2 m 59.41 -172.65 0.11 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.033 1.333 . . . . 0.0 112.433 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -174.68 173.6 46.2 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -72.19 142.19 49.04 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -147.53 157.2 43.46 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 125.121 1.368 . . . . 0.0 108.591 176.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.282 0 C-N-CA 123.463 0.705 . . . . 0.0 109.666 175.325 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 tmt? . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.3 m -139.66 146.98 40.37 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.86 162.6 39.68 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.099 1.36 . . . . 0.0 107.58 176.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 57.13 154.05 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 130.529 3.532 . . . . 0.0 116.403 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.0 mt -134.08 139.09 49.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 126.831 2.052 . . . . 0.0 106.19 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.28 150.61 45.02 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.931 -0.481 . . . . 0.0 111.307 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.24 163.1 42.63 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.301 0.953 . . . . 0.0 112.508 172.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -115.94 155.58 27.76 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.271 1.428 . . . . 0.0 109.736 175.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -88.63 -22.76 23.29 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.302 0.641 . . . . 0.0 111.659 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.3 p -159.2 -178.01 6.89 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 129.393 3.077 . . . . 0.0 106.323 172.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 m -57.19 134.99 80.92 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 121.247 -0.908 . . . . 0.0 109.534 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -74.19 63.48 5.23 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 124.537 3.491 . . . . 0.0 110.295 172.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -53.01 -50.74 63.6 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 124.266 1.026 . . . . 0.0 111.559 -169.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.32 -41.23 89.98 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 123.317 0.385 . . . . 0.0 110.708 -171.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -65.51 -45.91 81.7 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.595 0.758 . . . . 0.0 109.919 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 71.3 t -62.81 -41.12 91.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -62.98 -52.85 61.39 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.873 0.869 . . . . 0.0 109.996 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.77 -40.54 97.62 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.719 0.69 . . . . 0.0 110.648 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.04 71.56 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -68.06 -26.95 66.11 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 118.068 -0.968 . . . . 0.0 112.639 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -66.27 -31.1 71.71 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.826 1.194 . . . . 0.0 110.15 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -83.67 -41.63 17.53 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.243 0.617 . . . . 0.0 110.525 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.5 mt -65.52 -36.7 78.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 120.912 -1.117 . . . . 0.0 108.064 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.1 -27.78 68.61 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.228 -0.92 . . . . 0.0 112.244 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 62.9 ttp85 -76.41 -32.99 58.82 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.151 0.887 . . . . 0.0 109.665 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -71.91 -39.7 69.35 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.904 -0.569 . . . . 0.0 110.857 171.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 63.4 m -69.3 -44.59 71.45 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.673 0.789 . . . . 0.0 112.426 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.6 mmm -133.62 153.88 51.33 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.58 1.552 . . . . 0.0 109.344 -169.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -128.2 164.12 23.22 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.148 0.979 . . . . 0.0 109.557 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.1 t70 55.55 40.2 31.08 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.125 1.37 . . . . 0.0 112.697 178.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -122.17 19.64 10.69 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.14 1.376 . . . . 0.0 113.031 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.9 m 52.42 59.07 4.76 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.835 1.254 . . . . 0.0 111.57 177.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -57.99 -21.09 42.96 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -169.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 93.9 mt -70.03 -27.36 64.6 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.859 0.754 . . . . 0.0 111.768 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 67.0 t60 -148.93 80.93 7.83 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 173.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -58.19 146.32 89.08 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.044 2.496 . . . . 0.0 113.966 -169.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.1 m -70.75 -17.7 62.8 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.988 0.915 . . . . 0.0 113.026 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 68.4 mtt -131.42 149.49 73.73 Favored Pre-proline 0 N--CA 1.464 0.26 0 N-CA-C 105.769 -1.938 . . . . 0.0 105.769 170.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.22 138.59 33.58 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.179 1.253 . . . . 0.0 113.696 -169.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.3 t -99.49 106.98 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 1 N-CA-C 99.943 -4.095 . . . . 0.0 99.943 167.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -150.59 161.68 42.11 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.959 0.904 . . . . 0.0 109.944 -169.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 t -138.91 127.32 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.064 0.946 . . . . 0.0 108.748 -176.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.3 m -93.18 148.74 21.76 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.934 0.894 . . . . 0.0 109.039 168.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -121.9 141.28 51.45 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.361 1.865 . . . . 0.0 110.1 -176.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.419 ' CE2' ' CB ' ' A' ' 131' ' ' ALA . 91.1 m-85 -148.89 174.73 11.93 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.927 1.291 . . . . 0.0 113.053 -169.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.0 t -45.99 167.22 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 129.765 3.226 . . . . 0.0 115.121 -171.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.2 tp -84.76 107.1 16.77 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 105.69 -1.966 . . . . 0.0 105.69 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -76.64 -55.68 5.3 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 117.905 0.321 . . . . 0.0 111.578 -169.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.35 55.52 1.03 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.434 1.494 . . . . 0.0 109.347 177.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.83 10.25 79.34 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.075 -177.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -138.37 143.43 39.83 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.565 1.946 . . . . 0.0 107.362 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -74.79 152.08 39.04 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.679 0.672 . . . . 0.0 109.719 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.89 156.23 18.92 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.5 171.65 41.52 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.3 m -138.37 145.8 41.51 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 169.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 p -115.89 148.04 18.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 170.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.8 tt -129.73 152.11 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.885 1.274 . . . . 0.0 107.598 169.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.0 p -143.46 178.21 1.55 Allowed Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 125.337 1.455 . . . . 0.0 107.181 170.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.3 -24.57 77.84 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 121.331 1.354 . . . . 0.0 111.896 168.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.5 p-90 -104.3 -22.44 13.36 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -169.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.74 169.73 24.06 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 120.278 1.399 . . . . 0.0 112.608 -175.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.1 tt -138.29 126.4 22.82 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 103.946 -2.612 . . . . 0.0 103.946 168.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.6 m -138.89 134.69 33.6 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.16 147.48 46.57 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 168.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.4 m -139.04 148.41 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 124.574 1.15 . . . . 0.0 108.58 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 50.7 mt -138.57 137.85 42.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -126.31 148.33 63.36 Favored Pre-proline 0 N--CA 1.466 0.335 0 C-N-CA 124.042 0.937 . . . . 0.0 109.841 -173.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.4 133.86 31.32 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.709 2.273 . . . . 0.0 111.265 172.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.18 -171.35 16.47 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 123.756 0.693 . . . . 0.0 111.918 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.31 157.45 33.25 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.611 2.207 . . . . 0.0 111.297 -177.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.2 t0 43.76 56.33 4.62 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.747 2.019 . . . . 0.0 113.388 169.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -149.35 160.48 43.38 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.266 1.027 . . . . 0.0 109.315 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -111.7 105.69 14.27 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 169.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -70.67 143.45 89.8 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 172.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.16 150.25 85.12 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.049 1.833 . . . . 0.0 110.379 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.3 tp -76.12 92.9 3.26 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 170.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -79.36 171.49 15.1 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.032 0.933 . . . . 0.0 110.271 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -99.01 162.13 13.24 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 123.546 1.641 . . . . 0.0 107.481 168.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 87.9 t -89.84 154.27 3.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 113.044 -1.889 . . . . 0.0 107.112 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.9 m 67.11 5.82 4.38 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.058 1.343 . . . . 0.0 113.732 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -71.69 150.09 44.86 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 169.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -116.17 138.18 51.49 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.598 0.636 . . . . 0.0 110.032 177.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.6 mp -111.03 122.27 65.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 103.696 -2.705 . . . . 0.0 103.696 175.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.61 116.87 4.61 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 173.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.6 tp -106.72 132.36 52.79 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -87.53 127.58 35.25 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 172.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 mp -134.76 155.0 79.76 Favored Pre-proline 0 C--O 1.234 0.283 0 C-N-CA 125.426 1.49 . . . . 0.0 107.304 172.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -64.52 -23.93 63.95 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 CA-C-N 120.757 1.306 . . . . 0.0 112.402 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -55.25 -30.33 59.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.826 1.651 . . . . 0.0 111.763 169.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.06 148.32 5.54 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 108.116 -1.993 . . . . 0.0 108.116 -171.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.1 m -65.1 131.46 46.62 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 171.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 45.4 ttp -146.21 135.59 22.94 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -171.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.26 134.47 35.28 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 118.54 0.609 . . . . 0.0 110.021 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -103.48 134.13 47.35 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 168.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.6 m -94.9 141.49 28.58 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 92.5 t -74.16 123.83 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 171.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -113.0 156.74 15.41 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 169.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -115.08 98.53 6.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 169.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.1 tp -75.14 124.29 26.76 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -169.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -61.12 128.78 38.09 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.416 0.686 . . . . 0.0 110.219 -173.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.42 4.74 84.88 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.645 -1.086 . . . . 0.0 113.857 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.7 t -127.72 -118.99 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 119.069 1.435 . . . . 0.0 107.282 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.2 m -151.39 -179.57 7.49 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.174 1.79 . . . . 0.0 108.31 -169.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -70.66 146.14 50.16 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 121.671 -0.643 . . . . 0.0 109.691 169.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.82 167.64 26.87 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.671 1.588 . . . . 0.0 108.511 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.6 mt -103.43 138.63 39.89 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 174.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.5 p -154.93 160.59 41.26 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 119.298 0.954 . . . . 0.0 111.821 -177.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 9.5 p -149.17 135.63 19.36 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 168.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.2 p -74.17 145.63 44.07 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.457 0.703 . . . . 0.0 109.463 176.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.6 mt -116.36 -70.29 0.8 Allowed 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.768 0.827 . . . . 0.0 109.387 -173.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -148.53 161.16 42.21 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.077 0.951 . . . . 0.0 109.892 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.9 m -87.8 118.99 70.4 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 168.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -83.18 -9.13 10.64 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.642 2.228 . . . . 0.0 115.19 -169.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.285 2.3 pt? -74.41 30.61 0.08 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 116.045 1.869 . . . . 0.0 116.045 -169.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.8 m -61.73 155.05 23.81 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.79 0.836 . . . . 0.0 109.685 169.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -66.82 -23.73 66.08 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.353 -1.467 . . . . 0.0 112.86 -170.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.9 m -71.65 -8.94 57.2 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.031 0.932 . . . . 0.0 112.891 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.8 tpt -63.63 150.71 43.58 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.767 1.627 . . . . 0.0 111.258 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 96.6 p -153.88 176.38 12.23 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.987 1.715 . . . . 0.0 107.815 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.491 ' H ' HD11 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -61.85 -32.07 52.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 O-C-N 121.186 -0.946 . . . . 0.0 110.222 170.041 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -75.35 -43.95 47.79 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.472 0.578 . . . . 0.0 109.664 -177.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -62.66 -31.58 72.48 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.32 170.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.88 -50.64 61.99 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 119.97 1.259 . . . . 0.0 111.158 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -62.43 -50.88 69.74 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.988 -0.713 . . . . 0.0 109.87 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 66.0 ttp85 -61.61 -38.63 88.34 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 123.465 0.706 . . . . 0.0 110.927 -175.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.5 tp -80.51 -24.33 39.45 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 117.817 -1.087 . . . . 0.0 111.248 -174.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.9 m -65.42 -44.18 88.2 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 120.463 1.483 . . . . 0.0 108.724 170.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.96 -53.84 47.83 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 118.761 -0.638 . . . . 0.0 109.939 174.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -61.49 -32.22 72.23 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.615 0.643 . . . . 0.0 111.129 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 57.3 m -73.26 -30.47 63.47 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.994 -0.441 . . . . 0.0 111.621 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.419 ' CB ' ' CE2' ' A' ' 45' ' ' PHE . . . -73.8 -49.13 26.78 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 119.231 0.923 . . . . 0.0 109.57 170.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -46.82 -58.22 4.12 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 127.465 2.306 . . . . 0.0 110.469 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 15.8 ptt? -51.84 -42.68 62.77 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.601 1.161 . . . . 0.0 112.25 178.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 22.8 pt -84.24 -25.93 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 119.693 1.133 . . . . 0.0 111.789 -175.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 72.7 mt -69.06 -24.02 64.11 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.472 0.709 . . . . 0.0 109.306 169.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.7 m 59.38 39.5 22.1 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.943 1.697 . . . . 0.0 112.629 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.6 mp 49.54 75.99 0.6 Allowed Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 126.786 2.034 . . . . 0.0 111.507 175.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.57 145.15 82.35 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.088 2.526 . . . . 0.0 112.143 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.5 m -74.03 -33.51 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 122.523 0.329 . . . . 0.0 111.132 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 42.9 m -79.39 121.13 24.77 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 174.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -86.22 121.51 72.6 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.042 -0.98 . . . . 0.0 108.5 172.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -69.73 131.6 21.61 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.359 2.039 . . . . 0.0 109.767 173.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -81.89 69.9 8.68 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.305 1.042 . . . . 0.0 110.112 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.0 m -64.74 154.14 86.06 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 124.923 1.289 . . . . 0.0 110.772 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.74 -17.74 61.16 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.504 2.136 . . . . 0.0 112.717 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -75.27 -7.63 54.43 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.356 1.062 . . . . 0.0 112.36 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.1 167.19 14.53 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.591 0.756 . . . . 0.0 111.047 178.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -75.3 3.93 44.2 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.281 0.943 . . . . 0.0 115.046 -174.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -60.86 133.84 56.5 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.417 1.608 . . . . 0.0 109.124 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.31 142.43 39.42 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -101.12 130.26 47.15 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 169.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -114.64 137.45 51.88 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.932 0.893 . . . . 0.0 108.641 -174.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 63.8 tp -75.69 -38.47 58.65 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.063 0.545 . . . . 0.0 110.802 177.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -90.22 160.11 16.37 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.909 0.884 . . . . 0.0 111.109 -169.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -175.38 -175.52 42.88 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.538 1.542 . . . . 0.0 109.836 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -135.82 113.94 11.38 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -62.51 125.98 25.77 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -170.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.5 m 51.84 26.64 3.68 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.867 1.267 . . . . 0.0 113.797 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 62.11 15.58 50.74 Favored Glycine 0 CA--C 1.535 1.3 0 O-C-N 121.486 -0.759 . . . . 0.0 113.256 -175.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 52.45 31.22 9.4 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.239 1.816 . . . . 0.0 112.362 -169.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -67.32 138.47 56.83 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.653 0.781 . . . . 0.0 109.699 174.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.08 0 C-N-CA 125.484 1.513 . . . . 0.0 107.871 177.006 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 p -70.68 114.81 9.13 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.924 0.889 . . . . 0.0 108.761 174.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -127.68 5.83 6.15 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.513 1.125 . . . . 0.0 113.173 -175.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 53.83 173.43 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 129.444 3.098 . . . . 0.0 115.428 171.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.7 mt -132.35 130.46 60.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.33 123.7 32.58 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.8 159.65 47.97 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 123.361 0.505 . . . . 0.0 111.902 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -111.09 164.75 12.51 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.427 1.491 . . . . 0.0 110.648 -169.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -76.03 -13.93 60.22 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.206 1.002 . . . . 0.0 112.336 -177.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 p -152.88 168.86 24.36 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 127.652 2.381 . . . . 0.0 106.959 171.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.9 m -64.76 145.53 98.78 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 169.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.92 65.94 7.67 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 124.554 3.503 . . . . 0.0 110.628 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -52.83 -48.61 66.85 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 123.912 0.885 . . . . 0.0 112.255 -169.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.8 -36.59 84.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.095 0.474 . . . . 0.0 110.95 -173.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -74.43 -41.75 60.31 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.034 0.934 . . . . 0.0 109.848 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.7 t -60.23 -45.32 96.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 172.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -62.19 -50.25 72.55 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.348 1.059 . . . . 0.0 110.402 -177.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.34 -39.2 93.88 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.778 0.717 . . . . 0.0 110.957 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.27 -47.02 84.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.176 -0.327 . . . . 0.0 110.32 175.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -68.05 -24.97 65.14 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 118.354 -0.831 . . . . 0.0 112.362 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -69.78 -32.42 70.9 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.857 1.208 . . . . 0.0 109.544 175.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -72.94 -46.89 49.95 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 173.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mt -64.6 -40.88 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 121.632 -0.668 . . . . 0.0 109.731 -176.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.1 -27.03 67.75 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.528 0.731 . . . . 0.0 111.302 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 51.9 ttm-85 -78.17 -45.26 23.64 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.72 0.808 . . . . 0.0 109.325 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -52.55 -41.24 63.37 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.02 1.328 . . . . 0.0 111.092 177.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.8 m -73.65 81.28 1.53 Allowed 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 169.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 12.8 tpt -56.18 128.66 36.67 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.5 1.12 . . . . 0.0 112.594 -169.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -150.57 117.03 5.73 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 102.808 -3.034 . . . . 0.0 102.808 169.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.94 -35.92 73.92 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.647 0.658 . . . . 0.0 112.376 -169.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -65.54 -43.32 90.29 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.4 m -74.35 -26.51 60.18 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.099 0.56 . . . . 0.0 111.673 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -66.36 -34.78 78.75 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.577 0.626 . . . . 0.0 109.704 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.5 mt -84.27 56.6 3.84 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.113 1.365 . . . . 0.0 109.764 172.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 30.5 t60 66.39 134.14 0.04 OUTLIER Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 128.415 2.686 . . . . 0.0 112.647 -169.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -52.96 134.09 54.11 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 123.14 2.56 . . . . 0.0 113.892 -175.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.7 m -74.09 -15.83 61.04 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.935 0.894 . . . . 0.0 112.566 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 67.2 mtt -138.58 154.16 73.06 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.05 138.22 25.22 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.622 1.548 . . . . 0.0 112.356 -168.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.6 t -94.86 101.52 12.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 100.505 -3.887 . . . . 0.0 100.505 167.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -147.12 159.12 43.98 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.51 1.124 . . . . 0.0 109.855 -169.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.3 t -137.48 139.03 44.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.428 1.091 . . . . 0.0 108.161 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.0 m -106.79 152.01 24.41 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.949 1.299 . . . . 0.0 108.666 169.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -149.37 129.54 13.63 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.38 1.472 . . . . 0.0 109.838 -175.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -179.99 155.25 0.59 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.695 1.198 . . . . 0.0 112.468 -169.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.6 m 64.16 151.0 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.818 2.447 . . . . 0.0 112.613 170.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.6 tp -111.36 59.65 0.62 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.996 0.918 . . . . 0.0 109.409 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.31 134.26 50.04 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 123.566 0.746 . . . . 0.0 109.921 -175.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 54.96 23.46 5.09 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.827 0.851 . . . . 0.0 111.632 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.82 14.29 81.14 Favored Glycine 0 CA--C 1.537 1.427 0 CA-C-O 118.489 -1.173 . . . . 0.0 113.68 -176.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -132.75 149.23 52.3 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.621 1.71 . . . . 0.0 108.708 -171.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -70.4 135.74 49.01 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.034 -1.041 . . . . 0.0 109.665 -175.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.1 156.09 16.75 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -168.7 176.21 43.03 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 175.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 43.9 m -144.91 151.75 39.17 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 169.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.5 p -118.68 144.26 27.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 169.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.3 145.63 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 170.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.8 p -142.71 175.35 2.96 Favored Pre-proline 0 C--N 1.321 -0.655 0 C-N-CA 125.451 1.5 . . . . 0.0 107.034 169.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.57 -30.1 91.53 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 120.895 1.063 . . . . 0.0 111.44 168.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 48.1 p-90 -95.51 -25.23 16.29 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 118.128 -0.939 . . . . 0.0 113.292 -169.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.89 168.12 28.41 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-N 120.282 1.401 . . . . 0.0 113.206 -175.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.9 tt -137.32 121.9 18.48 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 168.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.1 m -134.13 130.75 37.81 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.198 0.523 . . . . 0.0 109.82 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.38 143.27 53.74 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 168.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.22 150.83 29.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.7 mm -134.06 134.51 55.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -125.8 143.03 43.87 Favored Pre-proline 0 CA--C 1.537 0.442 0 CA-C-O 118.318 -0.849 . . . . 0.0 111.044 -171.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -48.22 129.72 19.43 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.931 3.087 . . . . 0.0 113.829 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.48 177.02 34.1 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.247 1.403 . . . . 0.0 114.489 -171.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -61.86 118.53 5.42 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.854 3.036 . . . . 0.0 112.253 -169.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.5 t70 52.17 29.87 7.05 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.119 1.768 . . . . 0.0 113.602 175.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -82.68 146.94 28.78 Favored 'General case' 0 C--N 1.34 0.195 0 O-C-N 121.435 -0.79 . . . . 0.0 109.021 175.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.7 mp -101.26 82.58 2.36 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -67.3 145.84 98.67 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.531 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -64.6 157.71 53.95 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.274 1.982 . . . . 0.0 109.872 171.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.1 tp -77.07 77.3 3.62 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -64.63 148.18 51.44 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.07 0.548 . . . . 0.0 110.393 -174.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -92.08 151.04 20.63 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.1 t -88.43 153.03 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 125.452 1.501 . . . . 0.0 111.131 -168.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.8 m 68.27 7.49 5.96 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.068 1.747 . . . . 0.0 114.116 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -83.28 163.47 20.67 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 168.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -115.41 150.71 35.98 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.202 0.91 . . . . 0.0 111.574 175.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.2 mm -122.61 123.96 69.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.21 124.1 6.58 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 108.656 -1.777 . . . . 0.0 108.656 173.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.4 mt -116.79 138.22 51.65 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.481 1.112 . . . . 0.0 108.031 173.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -91.21 124.1 35.17 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mp -132.98 156.65 79.85 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 125.027 1.331 . . . . 0.0 108.162 170.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -67.01 -21.82 48.93 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 CA-C-N 120.625 1.259 . . . . 0.0 112.865 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -55.99 -31.45 63.05 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.816 1.247 . . . . 0.0 111.233 169.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.49 150.92 5.52 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.86 2.171 . . . . 0.0 107.776 -172.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.1 m -64.47 132.58 50.39 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 171.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 54.6 ttm -133.95 130.58 37.9 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -169.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.04 114.13 20.39 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 171.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -89.08 142.93 27.22 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 169.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.6 m -92.3 141.96 27.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.27 119.6 23.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 171.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -109.35 167.35 12.86 Favored Glycine 0 CA--C 1.52 0.361 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 169.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -117.57 117.09 28.47 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 169.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.0 119.19 21.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 176.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.34 131.62 51.53 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 122.721 0.408 . . . . 0.0 111.379 -171.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.55 3.56 72.4 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-O 118.968 -0.907 . . . . 0.0 113.526 -178.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.1 t -122.33 -110.58 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.0 m -154.71 173.54 16.27 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 119.776 1.171 . . . . 0.0 109.765 -169.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -66.96 142.24 57.33 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 169.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.02 173.19 16.33 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.084 1.754 . . . . 0.0 107.429 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.9 mp -109.07 140.0 43.21 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -176.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.0 t -142.08 152.94 43.78 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.489 1.115 . . . . 0.0 109.588 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 35.5 t -149.19 118.43 6.82 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 172.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.7 m -71.75 136.16 47.04 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -85.75 -62.96 1.4 Allowed 'General case' 0 C--O 1.231 0.112 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 172.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.92 175.72 5.75 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.529 1.532 . . . . 0.0 108.634 -175.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.1 m -90.29 118.89 69.16 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 169.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -85.92 19.97 1.31 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.562 2.841 . . . . 0.0 112.759 -171.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 17.7 tp -82.18 43.97 0.83 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.922 1.289 . . . . 0.0 111.123 -171.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.1 m -73.02 163.18 28.55 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.92 1.288 . . . . 0.0 110.178 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -78.36 -37.01 45.32 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.837 -0.54 . . . . 0.0 110.605 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.5 m -83.83 69.7 10.27 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.591 1.156 . . . . 0.0 108.375 176.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.1 tpt -148.02 154.36 40.16 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.583 1.553 . . . . 0.0 108.735 -171.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 84.3 p -152.59 174.97 13.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.461 1.504 . . . . 0.0 108.202 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 23.4 pt -66.19 -25.49 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 121.507 -0.746 . . . . 0.0 111.731 170.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -76.67 -45.59 29.1 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -63.05 -31.75 72.96 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.503 170.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.16 -60.79 8.32 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 120.16 1.346 . . . . 0.0 110.679 172.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -62.16 -48.71 78.89 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 117.412 0.606 . . . . 0.0 110.779 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 61.1 ttt-85 -61.2 -35.1 76.27 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 123.622 0.769 . . . . 0.0 110.817 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.5 tp -78.35 -23.91 46.71 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 117.607 -1.187 . . . . 0.0 111.407 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -46.6 85.43 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.88 1.673 . . . . 0.0 109.037 169.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -66.02 -46.77 76.71 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 122.609 0.364 . . . . 0.0 111.251 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -66.2 -33.21 75.25 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 119.248 -0.406 . . . . 0.0 110.778 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 28.4 m -67.07 -36.93 83.08 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.608 0.64 . . . . 0.0 110.435 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.05 -52.23 50.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 173.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 41.1 tpt85 -52.47 -46.03 66.35 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.961 0.905 . . . . 0.0 111.138 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 56.7 ttp -49.39 -52.53 27.89 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.959 1.704 . . . . 0.0 111.145 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 11.0 pt -88.93 -24.79 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 118.743 0.701 . . . . 0.0 112.612 -172.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 76.3 mt -65.56 -38.74 90.44 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.003 0.921 . . . . 0.0 109.074 171.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.3 m 57.77 33.72 23.57 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.441 1.497 . . . . 0.0 114.536 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.4 tp 46.26 65.38 6.82 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.894 1.278 . . . . 0.0 113.705 169.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -65.36 144.1 78.96 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.713 2.275 . . . . 0.0 111.751 -171.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.2 m -140.74 178.46 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 126.117 1.767 . . . . 0.0 108.659 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.1 m -49.66 137.06 16.27 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.282 1.433 . . . . 0.0 110.603 173.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -133.35 117.77 14.64 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 124.622 1.169 . . . . 0.0 108.726 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -61.08 141.7 94.85 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.88 2.387 . . . . 0.0 111.331 171.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -139.2 131.86 28.93 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.714 1.606 . . . . 0.0 107.58 172.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 10.8 m -135.02 149.03 69.25 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.53 1.532 . . . . 0.0 109.124 -169.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.01 -22.27 42.0 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.355 2.037 . . . . 0.0 113.977 -169.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -82.22 -9.76 59.38 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.652 0.66 . . . . 0.0 112.653 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.88 125.61 25.39 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.299 0.954 . . . . 0.0 109.144 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 69.09 11.19 63.34 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-O 119.354 -0.692 . . . . 0.0 113.382 -176.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -127.95 46.71 2.51 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.96 1.704 . . . . 0.0 108.983 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -116.66 153.98 31.35 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.234 1.414 . . . . 0.0 108.052 173.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.32 142.78 55.41 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.68 164.64 36.5 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.749 1.619 . . . . 0.0 108.054 -175.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 26.1 tp 51.39 56.64 7.61 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.634 1.574 . . . . 0.0 110.758 176.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -64.13 146.2 54.63 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.926 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.91 150.91 49.74 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 175.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 26.1 ptt-85 -131.81 42.9 3.11 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.679 1.191 . . . . 0.0 110.354 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 56.01 37.48 28.89 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.004 0.922 . . . . 0.0 109.116 -168.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.3 m -58.55 131.2 50.08 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.639 1.176 . . . . 0.0 109.769 -170.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 98.06 -39.52 2.74 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.917 1.246 . . . . 0.0 111.181 -176.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -81.83 -32.39 31.25 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.424 1.112 . . . . 0.0 108.673 169.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -120.25 149.34 42.44 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 128.863 2.865 . . . . 0.0 107.86 175.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.205 0 C-N-CA 123.679 0.791 . . . . 0.0 110.525 -177.895 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 119.801 -0.142 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.6 p -75.91 159.83 30.52 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.154 0.982 . . . . 0.0 109.895 177.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -84.45 50.83 1.96 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.344 1.058 . . . . 0.0 111.403 -173.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -54.1 147.31 13.02 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 126.518 1.927 . . . . 0.0 108.843 169.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.3 mp -104.81 118.89 52.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 -174.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.51 119.61 20.59 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 169.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.87 177.6 54.21 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 121.423 0.457 . . . . 0.0 113.694 -175.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -115.67 169.51 9.14 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.985 1.714 . . . . 0.0 110.267 -169.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -72.88 -13.76 61.34 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -174.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.2 p -151.31 174.05 13.77 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 127.867 2.467 . . . . 0.0 106.404 169.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.4 m -61.93 147.69 89.39 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 169.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.53 67.43 6.36 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 124.752 3.635 . . . . 0.0 110.293 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.421 ' HE3' ' O ' ' A' ' 42' ' ' VAL . 45.5 mtpt -52.74 -52.43 56.41 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.513 1.125 . . . . 0.0 112.201 -169.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.01 -38.89 92.74 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 118.762 0.71 . . . . 0.0 110.968 -172.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -69.06 -42.71 75.92 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.746 1.219 . . . . 0.0 109.848 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.6 t -63.04 -42.21 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 174.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -61.36 -52.38 64.89 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.71 -49.47 75.06 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.762 0.825 . . . . 0.0 110.203 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.5 -49.83 75.04 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -70.01 -24.52 63.3 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 117.901 -1.047 . . . . 0.0 112.642 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -66.93 -33.17 74.99 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 120.05 1.296 . . . . 0.0 109.199 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -74.68 -49.09 22.57 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.391 -0.818 . . . . 0.0 109.544 173.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.1 mt -61.85 -30.68 49.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.42 -31.96 64.14 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 124.182 0.993 . . . . 0.0 112.014 173.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 53.6 ttp85 -72.05 -41.23 67.67 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.92 1.236 . . . . 0.0 109.594 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -65.53 -21.38 66.61 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.289 1.035 . . . . 0.0 109.983 168.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.0 m 47.54 52.83 11.94 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 127.455 2.302 . . . . 0.0 108.51 -174.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 46.0 ttm 65.89 -72.79 0.07 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.758 2.023 . . . . 0.0 108.497 -168.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -148.89 4.48 0.65 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.962 1.305 . . . . 0.0 110.973 169.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.15 -15.66 56.59 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.842 -1.161 . . . . 0.0 111.878 -174.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.7 tp 52.2 40.6 29.21 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.718 2.007 . . . . 0.0 112.371 170.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 p -104.07 -44.08 5.1 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.351 1.061 . . . . 0.0 112.031 -169.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -85.16 49.02 1.66 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.091 0.956 . . . . 0.0 110.139 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.1 mt -58.31 130.98 49.25 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 170.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 40.1 t60 52.33 73.85 0.88 Allowed Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.557 1.143 . . . . 0.0 108.147 -169.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -51.56 123.23 11.74 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.461 2.774 . . . . 0.0 112.214 -169.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 m -70.27 -19.31 63.12 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.051 0.941 . . . . 0.0 112.322 -169.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 20.3 mmt -125.69 121.6 24.57 Favored Pre-proline 0 N--CA 1.453 -0.294 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 172.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -50.7 128.69 24.78 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.333 2.022 . . . . 0.0 110.376 169.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 m -61.06 147.92 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 169.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -143.78 152.67 41.53 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 120.966 -1.084 . . . . 0.0 109.811 -177.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.421 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 7.1 p -135.89 127.05 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 124.488 1.115 . . . . 0.0 110.79 -175.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.9 m -92.54 146.81 23.39 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.649 1.18 . . . . 0.0 109.421 169.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -119.97 137.96 53.76 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.532 1.533 . . . . 0.0 107.786 169.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -164.87 146.29 7.84 Favored 'General case' 0 C--O 1.218 -0.569 0 C-N-CA 123.351 0.66 . . . . 0.0 111.715 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.8 m 58.37 154.13 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.826 2.45 . . . . 0.0 115.52 168.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.4 tp -105.75 109.32 21.23 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 169.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -103.04 95.9 6.44 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.258 2.223 . . . . 0.0 108.107 -173.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 55.06 45.73 25.61 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.455 1.102 . . . . 0.0 111.658 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.59 22.44 62.13 Favored Glycine 0 CA--C 1.531 1.085 0 O-C-N 121.853 -0.529 . . . . 0.0 113.315 176.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -136.59 144.56 44.18 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 125.68 1.592 . . . . 0.0 107.121 -177.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -74.33 141.05 45.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 120.514 1.506 . . . . 0.0 109.399 172.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.02 154.68 19.25 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 172.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.84 168.73 35.66 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 175.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 36.1 m -142.42 148.43 37.79 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 p -129.32 135.0 62.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.0 tt -111.23 151.11 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.751 1.22 . . . . 0.0 108.032 171.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.1 p -136.86 175.11 3.74 Favored Pre-proline 0 N--CA 1.444 -0.739 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 172.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.42 -10.6 28.26 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 CA-C-N 121.132 1.44 . . . . 0.0 112.009 169.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -110.16 -25.6 10.1 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -173.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.37 171.48 20.31 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 120.306 1.412 . . . . 0.0 112.368 -175.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.3 tt -136.98 123.03 20.3 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 167.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.2 m -130.91 134.79 47.08 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.398 0.679 . . . . 0.0 109.925 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.05 149.4 35.8 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 168.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.9 m -138.74 146.55 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.61 1.164 . . . . 0.0 108.172 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.6 mm -130.76 114.85 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -115.0 146.66 36.65 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.314 1.046 . . . . 0.0 112.229 -168.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -39.08 128.56 1.39 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 125.178 3.918 . . . . 0.0 115.256 173.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.45 -178.51 49.92 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.219 0.914 . . . . 0.0 114.415 -173.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.02 106.42 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 124.084 3.189 . . . . 0.0 111.7 -169.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.6 t70 50.07 28.39 2.96 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.621 1.568 . . . . 0.0 112.658 -175.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -89.22 142.46 27.63 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -91.69 91.34 7.95 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 31.1 t90 -70.16 131.97 88.46 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.59 153.36 77.75 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.387 2.058 . . . . 0.0 111.811 -169.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 50.5 tp -61.77 130.23 44.78 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 169.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 69.8 mtt85 -125.55 156.67 38.7 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.881 0.873 . . . . 0.0 109.097 172.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -89.26 147.92 23.86 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 169.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.3 t -90.14 153.22 3.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 124.572 1.149 . . . . 0.0 110.809 -168.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.9 m 63.81 29.07 14.8 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.856 1.262 . . . . 0.0 112.461 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -104.47 155.3 18.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.518 1.927 . . . . 0.0 107.311 169.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -107.43 142.34 37.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.844 0.747 . . . . 0.0 110.191 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 35.4 mm -123.1 128.81 75.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.15 120.86 6.01 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 173.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.3 mt -105.0 139.35 39.81 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 170.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -90.48 129.14 36.68 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 173.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mp -135.79 155.76 77.79 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 125.151 1.381 . . . . 0.0 107.593 175.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.84 -23.94 68.45 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 121.541 1.494 . . . . 0.0 112.395 173.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -56.71 -30.7 63.75 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.062 1.345 . . . . 0.0 111.733 169.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 133.12 149.7 6.2 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 108.099 -2.0 . . . . 0.0 108.099 -170.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.0 m -64.37 133.34 52.42 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 41.4 ttp -147.2 139.42 24.54 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -171.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.33 134.05 36.61 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 118.747 0.703 . . . . 0.0 109.777 176.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -109.2 130.88 55.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 169.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.6 m -83.02 139.52 33.22 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.3 t -70.48 119.01 15.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 170.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -110.21 158.36 14.5 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 171.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -127.83 84.62 2.27 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.2 tp -65.23 125.29 24.56 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -172.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.3 136.33 58.01 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.466 0.706 . . . . 0.0 110.418 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.39 2.85 64.3 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.283 -0.731 . . . . 0.0 113.27 -176.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.0 t -128.81 -119.68 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.6 p -163.45 -175.09 4.04 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.166 1.387 . . . . 0.0 108.935 -171.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -70.05 144.81 52.07 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.633 -0.667 . . . . 0.0 110.725 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.38 165.11 36.04 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.717 1.607 . . . . 0.0 109.011 174.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.9 mp -102.7 126.11 49.68 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 174.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.9 m -144.65 156.45 44.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 119.594 1.088 . . . . 0.0 110.858 -170.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 18.8 p -145.37 139.88 27.29 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.453 -0.779 . . . . 0.0 110.008 170.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.3 m -75.14 137.48 41.38 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 171.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 85.2 mt -124.07 -30.16 3.52 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -171.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 14.9 ptp -159.44 167.21 29.27 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.057 0.943 . . . . 0.0 109.28 175.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.5 m -122.69 92.79 48.9 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 124.349 1.059 . . . . 0.0 108.985 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.17 171.36 5.24 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.566 2.844 . . . . 0.0 112.048 172.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 64.0 tp -148.34 133.71 18.54 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 169.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 9.5 m -50.45 -27.41 6.44 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.947 1.699 . . . . 0.0 114.925 -170.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -59.6 -33.29 71.28 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.683 0.674 . . . . 0.0 112.19 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.5 m -106.16 30.22 6.1 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.841 1.256 . . . . 0.0 110.714 -177.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 93.8 mtp -133.94 168.38 18.88 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.628 1.171 . . . . 0.0 110.905 -174.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 81.9 p -151.96 169.15 23.02 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.103 2.161 . . . . 0.0 105.424 169.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.434 ' H ' HD11 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -60.68 -34.38 58.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 121.213 -0.93 . . . . 0.0 109.171 172.215 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -64.54 -45.49 86.91 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 123.601 0.76 . . . . 0.0 110.148 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -67.39 -29.67 69.24 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.369 0.986 . . . . 0.0 110.621 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.27 -37.29 64.5 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.788 -0.57 . . . . 0.0 111.773 169.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -82.69 -54.62 5.0 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.928 -1.337 . . . . 0.0 110.208 174.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 61.0 mtm-85 -67.56 -29.82 69.29 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 118.116 -0.945 . . . . 0.0 113.31 -169.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.8 tp -82.89 -27.17 30.89 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 120.525 1.511 . . . . 0.0 109.886 -176.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.2 m -71.19 -40.4 71.24 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.69 -44.19 82.38 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.224 1.01 . . . . 0.0 111.752 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.36 -39.28 92.62 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 121.175 -0.953 . . . . 0.0 109.752 175.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 37.9 t -63.13 -44.95 94.14 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -52.34 -50.76 61.69 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.953 1.301 . . . . 0.0 110.897 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.0 ptt85 -82.6 -24.47 33.88 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 15.5 tmm? -55.98 -44.31 78.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 118.648 -0.691 . . . . 0.0 109.812 171.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 6.8 pt -81.94 0.3 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.3 mt -89.75 -89.75 0.15 Allowed 'General case' 0 C--N 1.342 0.269 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 169.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.0 p -163.63 26.17 0.08 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.038 1.735 . . . . 0.0 110.942 -172.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.4 mt 49.27 45.78 3.16 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 126.956 2.102 . . . . 0.0 116.408 -169.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.71 178.1 3.6 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.02 1.813 . . . . 0.0 109.584 168.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.9 p -114.99 139.52 40.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.833 0.853 . . . . 0.0 109.404 173.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.2 m -83.21 154.42 24.23 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.636 1.174 . . . . 0.0 109.167 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -117.65 76.99 10.71 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 169.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -71.66 151.91 58.56 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.428 2.085 . . . . 0.0 111.248 -173.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -151.59 129.83 11.98 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.537 1.535 . . . . 0.0 107.769 169.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.4 p -155.88 150.54 20.35 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.842 1.257 . . . . 0.0 108.052 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -53.49 -42.77 63.09 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.717 2.944 . . . . 0.0 113.883 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -155.61 157.96 37.59 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.862 1.265 . . . . 0.0 109.152 172.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -108.6 170.96 7.7 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.938 1.295 . . . . 0.0 109.735 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 74.49 28.06 64.29 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.551 -0.583 . . . . 0.0 113.814 170.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 42.1 ttm105 -139.35 147.33 41.4 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.551 1.141 . . . . 0.0 108.084 172.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.2 mtm180 -67.87 164.67 19.24 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.622 0.369 . . . . 0.0 110.357 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.21 -26.71 65.85 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 122.536 0.334 . . . . 0.0 111.303 171.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -130.09 125.92 36.34 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.999 1.32 . . . . 0.0 109.135 174.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -154.7 124.12 6.46 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 45.8 t80 60.68 171.18 0.09 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.299 1.84 . . . . 0.0 113.156 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 172.33 161.79 23.41 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.255 1.407 . . . . 0.0 110.1 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -141.79 145.73 35.09 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 175.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -71.03 135.26 47.69 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 14.5 m -67.03 153.72 42.96 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.379 0.671 . . . . 0.0 109.887 171.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -174.74 -148.67 6.76 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -68.03 151.6 46.82 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 122.861 0.464 . . . . 0.0 109.817 171.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -70.64 139.46 51.33 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 172.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.222 0 C-N-CA 125.378 1.471 . . . . 0.0 107.966 176.847 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.8 p -75.51 154.45 36.9 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.179 0.992 . . . . 0.0 109.742 173.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -134.45 63.33 1.63 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -175.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -146.24 165.18 29.97 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.666 1.586 . . . . 0.0 110.733 -170.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.8 mt -141.06 134.28 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.25 128.25 35.07 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 169.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.97 163.34 47.8 Favored Glycine 0 CA--C 1.537 1.454 0 N-CA-C 112.061 -0.415 . . . . 0.0 112.061 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -73.15 126.77 30.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.463 0.705 . . . . 0.0 109.516 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -67.62 -32.05 72.5 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 119.121 -0.466 . . . . 0.0 110.516 175.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.8 p -150.72 153.9 36.4 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 126.308 1.843 . . . . 0.0 107.857 169.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -56.8 137.95 78.3 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 125.388 1.475 . . . . 0.0 113.108 -169.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -80.34 43.89 1.62 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 124.626 3.551 . . . . 0.0 111.412 174.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -53.52 -45.21 69.67 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.086 1.354 . . . . 0.0 112.257 -169.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.09 -41.86 99.48 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 122.963 0.505 . . . . 0.0 111.606 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -72.48 -40.32 67.03 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -175.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.7 t -60.07 -46.12 94.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 172.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -59.74 -54.93 40.61 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.132 0.573 . . . . 0.0 110.347 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.02 -41.76 97.34 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.467 0.707 . . . . 0.0 110.853 -173.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.54 -39.25 77.59 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 118.511 0.596 . . . . 0.0 110.718 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -67.57 -31.17 71.05 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 121.317 -0.864 . . . . 0.0 111.738 173.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -68.95 -29.39 67.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.321 0.964 . . . . 0.0 111.107 173.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -70.41 -48.64 55.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mt -59.36 -41.89 85.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.566 0.746 . . . . 0.0 109.453 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.99 -23.79 67.32 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.769 0.828 . . . . 0.0 112.862 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -80.72 -45.22 17.44 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 171.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -71.87 -1.46 14.33 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.794 1.238 . . . . 0.0 112.611 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.9 m -59.54 -29.89 68.22 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.688 1.131 . . . . 0.0 110.326 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -98.29 46.55 1.0 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.153 1.381 . . . . 0.0 109.865 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -64.8 -13.82 56.94 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -169.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -58.6 -26.63 63.86 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.437 0.695 . . . . 0.0 111.823 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.13 -24.71 0.44 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -178.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.5 m 56.25 7.03 0.29 Allowed 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 116.396 1.998 . . . . 0.0 116.396 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -78.21 -29.58 48.44 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.704 1.138 . . . . 0.0 110.791 173.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.78 153.07 44.46 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 172.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -137.74 166.64 24.87 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 125.354 1.462 . . . . 0.0 109.802 -169.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -56.66 -34.84 96.72 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.199 2.599 . . . . 0.0 114.546 -169.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.2 m 61.61 4.81 1.1 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.877 1.671 . . . . 0.0 114.353 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 35.8 tpp -153.97 119.97 2.8 Favored Pre-proline 0 N--CA 1.453 -0.281 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 170.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -55.05 138.86 79.6 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.172 1.915 . . . . 0.0 113.039 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.1 t -75.4 139.23 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 168.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -139.61 154.03 47.48 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.641 0.777 . . . . 0.0 109.88 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.1 t -137.71 119.11 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 123.995 0.918 . . . . 0.0 109.265 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.1 m -82.22 143.88 31.06 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 168.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -126.63 134.29 50.79 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.552 1.541 . . . . 0.0 109.258 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.408 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 29.8 p90 -170.6 149.74 3.26 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 123.373 0.669 . . . . 0.0 112.737 -170.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.5 m 55.66 165.53 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 128.739 2.816 . . . . 0.0 116.257 167.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 30.3 mt -116.53 66.46 0.72 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.792 1.237 . . . . 0.0 108.705 171.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.12 136.14 42.94 Favored 'General case' 0 N--CA 1.457 -0.083 0 O-C-N 121.726 -0.609 . . . . 0.0 109.599 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 56.74 22.78 7.23 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.792 0.837 . . . . 0.0 111.247 -172.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.29 12.53 83.5 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.658 1.123 . . . . 0.0 113.474 -175.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -121.33 143.86 48.96 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.815 1.646 . . . . 0.0 108.202 -173.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -61.38 133.13 55.47 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 118.318 -0.849 . . . . 0.0 109.154 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.408 ' HB ' ' CE2' ' A' ' 45' ' ' PHE . 0.3 OUTLIER -98.84 157.53 16.24 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 122.207 1.004 . . . . 0.0 108.56 179.279 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.75 167.83 39.3 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 56.4 m -141.43 150.56 42.47 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 169.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.91 139.77 50.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 175.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.6 tt -116.46 147.03 20.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 169.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.7 p -138.37 172.2 7.05 Favored Pre-proline 0 N--CA 1.439 -0.979 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 171.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -63.24 -22.63 72.5 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 CA-C-N 119.928 1.01 . . . . 0.0 111.074 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 44.4 p-90 -94.45 -26.27 16.55 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -174.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.94 173.51 12.57 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 120.527 1.512 . . . . 0.0 112.71 -173.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.5 tt -135.43 128.48 31.62 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 167.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 77.7 p -138.03 142.61 40.35 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 122.029 0.919 . . . . 0.0 110.728 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.02 144.41 47.18 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 167.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.9 m -135.39 151.32 30.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 39.9 mt -136.59 139.77 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -116.61 139.66 25.77 Favored Pre-proline 0 C--O 1.234 0.266 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -54.86 131.17 44.56 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 121.629 1.552 . . . . 0.0 109.018 177.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.57 -179.46 27.72 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.509 1.052 . . . . 0.0 114.596 -169.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.16 158.25 41.67 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.365 2.71 . . . . 0.0 111.096 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.4 t0 46.04 45.58 12.36 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.795 2.038 . . . . 0.0 113.604 169.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -150.12 147.68 28.05 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.6 mp -104.3 107.26 18.09 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -72.22 157.82 88.62 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.186 -0.916 . . . . 0.0 108.776 169.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.31 166.93 28.63 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.1 1.867 . . . . 0.0 108.972 169.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 61.3 tp -69.2 82.53 0.35 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 169.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -75.46 139.78 42.47 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -173.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -90.86 141.89 28.35 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 122.812 1.291 . . . . 0.0 108.175 176.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 79' ' ' VAL . 0.7 OUTLIER -68.93 156.08 7.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 127.992 2.517 . . . . 0.0 109.152 174.382 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.0 m 69.93 0.74 3.18 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 128.336 2.655 . . . . 0.0 114.437 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -81.52 158.02 24.61 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 169.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -110.08 143.09 40.62 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.0 0.52 . . . . 0.0 110.0 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.5 mt -121.08 118.8 57.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -74.61 123.66 7.7 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 174.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 72.8 mt -125.2 151.76 45.42 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.667 1.187 . . . . 0.0 108.654 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -108.65 128.11 54.56 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.377 1.071 . . . . 0.0 108.753 -175.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.0 mp -137.06 168.95 14.61 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 125.331 1.452 . . . . 0.0 108.641 175.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -58.83 -23.26 66.23 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.366 2.044 . . . . 0.0 113.979 173.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -56.43 -38.32 71.42 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.603 0.761 . . . . 0.0 111.805 170.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.85 -167.55 24.27 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 -169.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 m -80.05 135.14 36.28 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 172.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 20.6 ptp -144.16 148.79 35.5 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 169.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.92 128.62 35.68 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 173.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -96.33 128.05 42.89 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 168.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.4 m -77.79 138.95 39.27 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 171.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.9 t -72.2 121.92 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 170.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -103.64 165.76 15.67 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -121.81 127.61 50.77 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.099 -2.185 . . . . 0.0 105.099 169.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.5 tp -141.19 142.61 33.99 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.063 0.847 . . . . 0.0 109.849 -176.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -59.04 135.02 57.49 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.312 0.645 . . . . 0.0 111.023 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.83 -2.12 50.85 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.044 0.831 . . . . 0.0 113.668 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.5 t -125.59 -31.49 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 118.638 1.219 . . . . 0.0 109.91 -173.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.0 m 54.58 -122.71 1.99 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.348 1.059 . . . . 0.0 109.001 -169.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -82.73 130.35 35.11 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.512 1.051 . . . . 0.0 109.861 -169.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -156.25 179.54 9.14 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 126.294 1.838 . . . . 0.0 106.993 176.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp -119.23 143.15 47.45 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.981 0.913 . . . . 0.0 109.217 -175.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.9 m -139.73 148.52 42.41 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.925 1.29 . . . . 0.0 110.123 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 20.2 t -140.34 110.1 6.4 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 171.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.7 m -73.1 135.91 44.83 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 71.5 mt -121.31 -47.85 2.23 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 119.374 -0.346 . . . . 0.0 111.26 -169.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.24 167.27 29.43 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.63 1.172 . . . . 0.0 108.286 175.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.0 m -123.94 66.9 41.05 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 123.777 0.831 . . . . 0.0 110.194 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.53 136.64 40.17 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.001 2.467 . . . . 0.0 110.433 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 45.9 tp -150.92 63.85 0.92 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 169.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.8 m -65.02 149.1 50.46 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.244 0.618 . . . . 0.0 110.244 -172.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 11.8 p-80 -61.85 135.24 57.5 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.6 m 53.76 31.61 13.28 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.753 1.221 . . . . 0.0 113.472 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 25.2 ptm -66.31 159.0 27.64 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.522 -0.736 . . . . 0.0 110.133 173.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 65.1 p -120.47 169.47 10.29 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.114 1.366 . . . . 0.0 110.369 -174.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.436 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -63.76 -26.01 39.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 121.863 -0.523 . . . . 0.0 109.708 169.584 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -68.18 -43.05 79.03 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.315 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -64.89 -30.08 71.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.308 0.958 . . . . 0.0 110.604 169.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.19 -61.07 7.79 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -61.59 -51.25 69.32 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.809 -0.818 . . . . 0.0 110.534 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 65.6 ttt-85 -63.4 -30.18 71.35 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.226 1.01 . . . . 0.0 111.867 -174.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.7 tp -89.38 -24.81 21.85 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 120.477 1.489 . . . . 0.0 110.294 -177.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.6 m -70.32 -40.77 73.97 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 170.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -70.03 -41.95 73.58 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.788 0.835 . . . . 0.0 111.582 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.98 -30.33 71.31 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 121.127 -0.983 . . . . 0.0 110.217 172.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 37.0 t -66.3 -45.89 78.81 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.931 0.787 . . . . 0.0 109.053 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -54.39 -51.1 65.9 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.473 1.109 . . . . 0.0 109.79 174.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -58.21 -54.77 43.25 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 123.115 0.566 . . . . 0.0 110.19 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 50.9 ttp -47.17 -41.4 17.78 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.867 1.667 . . . . 0.0 112.012 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.9 pt -86.12 -14.55 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.278 0.944 . . . . 0.0 113.433 -176.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.6 pp -143.04 75.48 1.48 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.461 1.504 . . . . 0.0 108.457 174.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.8 m -66.21 56.35 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 129.739 3.216 . . . . 0.0 113.104 -177.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 95.4 mt -141.84 169.7 10.62 Favored Pre-proline 0 C--N 1.321 -0.649 0 C-N-CA 130.577 3.551 . . . . 0.0 106.756 -175.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.92 123.68 14.04 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.203 1.936 . . . . 0.0 109.214 169.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.0 p -76.14 148.29 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -177.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 97.1 m -102.57 117.31 34.4 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -177.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -142.92 97.61 5.8 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 170.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.61 179.59 6.35 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.578 2.185 . . . . 0.0 109.85 170.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -75.24 82.42 2.38 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 169.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.91 147.03 98.63 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 123.748 0.819 . . . . 0.0 110.6 -169.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -56.64 170.33 1.38 Allowed 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 124.532 3.488 . . . . 0.0 112.009 168.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 76.0 t60 -61.34 151.54 31.87 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.959 0.504 . . . . 0.0 110.396 177.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -92.05 -138.89 0.18 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.223 1.409 . . . . 0.0 109.521 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 74.42 25.89 69.33 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 121.705 -0.622 . . . . 0.0 112.654 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -85.35 162.97 18.84 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.271 1.028 . . . . 0.0 109.919 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 23.1 tpt85 -142.54 124.51 15.25 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -92.54 135.35 34.14 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 168.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.32 169.33 22.28 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.231 1.012 . . . . 0.0 110.27 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 57.3 tp -138.16 126.85 23.65 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 169.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -91.73 156.18 17.75 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.372 0.669 . . . . 0.0 109.927 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -173.02 161.14 32.2 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -137.07 145.35 43.86 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.326 1.45 . . . . 0.0 107.87 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 51.6 ttt85 -77.86 -36.02 50.36 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 122.326 0.25 . . . . 0.0 110.834 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 13.0 m -69.26 143.57 53.86 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.419 0.688 . . . . 0.0 110.747 -175.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -73.14 154.95 50.1 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 169.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -150.96 150.02 30.3 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.844 1.258 . . . . 0.0 107.94 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -68.09 138.18 55.56 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 122.637 0.375 . . . . 0.0 110.223 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.269 0 C-N-CA 125.555 1.542 . . . . 0.0 107.955 174.916 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 tpt . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.8 p -71.27 -25.77 62.6 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.166 -0.959 . . . . 0.0 112.145 -176.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -82.68 35.6 0.47 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.972 1.309 . . . . 0.0 111.28 -177.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -140.83 160.83 39.22 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.946 1.698 . . . . 0.0 109.207 -174.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.7 mt -119.66 136.57 56.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 171.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.7 146.82 54.2 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.87 135.53 17.03 Favored Glycine 0 C--N 1.336 0.557 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 170.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -96.4 138.64 33.69 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.863 0.865 . . . . 0.0 109.056 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -71.78 -37.38 70.45 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.0 p -157.48 168.54 27.01 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 129.732 3.213 . . . . 0.0 106.31 169.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.9 m -51.91 130.57 38.84 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.736 0.814 . . . . 0.0 111.498 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -77.01 63.66 7.67 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 125.179 3.919 . . . . 0.0 111.525 -176.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -52.97 -51.62 60.9 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.739 0.815 . . . . 0.0 111.497 -171.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.78 -39.76 91.32 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 123.315 0.384 . . . . 0.0 110.79 -170.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -67.17 -47.01 72.28 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.646 0.778 . . . . 0.0 109.903 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.0 t -63.06 -40.37 88.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.46 -53.17 58.76 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.743 0.817 . . . . 0.0 109.831 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.03 -40.51 97.96 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.47 0.577 . . . . 0.0 110.759 -176.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.71 -50.5 73.24 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -71.7 -24.09 61.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 118.033 -0.984 . . . . 0.0 112.597 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -66.58 -33.8 76.48 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.267 1.394 . . . . 0.0 110.273 172.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -74.38 -47.19 35.62 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.0 mt -61.05 -40.73 86.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.22 -28.38 69.33 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.587 0.755 . . . . 0.0 112.189 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -70.81 -44.19 67.07 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 172.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -72.16 -7.48 49.36 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.628 1.171 . . . . 0.0 112.51 -175.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.8 m -70.22 0.15 6.85 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.569 1.148 . . . . 0.0 112.09 168.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 6.2 tpt 64.44 23.92 13.05 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.956 1.702 . . . . 0.0 113.432 171.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -144.85 146.19 31.95 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.641 1.576 . . . . 0.0 106.842 169.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 39.7 t0 51.13 38.7 21.61 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 122.816 1.293 . . . . 0.0 111.103 -169.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -87.67 0.07 56.2 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.848 1.659 . . . . 0.0 112.768 -175.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 m -63.36 161.91 13.25 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.574 1.55 . . . . 0.0 112.677 -170.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -73.63 -19.92 60.72 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.46 0.704 . . . . 0.0 112.026 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.1 mt -68.15 167.7 13.63 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.047 0.939 . . . . 0.0 109.728 173.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -60.9 146.05 87.84 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -65.95 154.99 71.7 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.411 2.074 . . . . 0.0 111.247 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.7 m -65.71 -28.45 69.07 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.893 0.877 . . . . 0.0 111.998 -178.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 16.7 ptp -149.16 103.76 3.34 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 173.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -47.3 134.93 19.95 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 124.212 3.275 . . . . 0.0 114.435 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.7 t -61.75 137.49 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 169.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -149.71 159.27 44.48 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.926 0.89 . . . . 0.0 109.487 -175.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.7 t -136.87 141.05 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.1 m -110.79 152.25 26.86 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.227 1.411 . . . . 0.0 108.788 169.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -120.52 143.29 48.65 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 127.248 2.219 . . . . 0.0 110.813 -176.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -145.98 173.35 12.24 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.608 1.163 . . . . 0.0 111.651 -172.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.5 t -52.17 160.31 0.79 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.92 2.088 . . . . 0.0 115.323 -168.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -75.66 106.01 6.99 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 169.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -75.98 -53.98 7.56 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -168.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.91 -42.86 0.74 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.344 1.858 . . . . 0.0 110.226 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.55 -0.21 0.09 OUTLIER Glycine 0 CA--C 1.534 1.256 0 C-N-CA 127.82 2.629 . . . . 0.0 110.684 175.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -137.39 134.94 36.49 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 119.247 1.523 . . . . 0.0 109.112 -170.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -60.64 152.27 26.86 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.861 0.864 . . . . 0.0 110.337 170.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.23 163.2 12.58 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.301 1.04 . . . . 0.0 109.732 172.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.47 170.92 41.28 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 171.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 7.0 m -140.5 131.04 25.44 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.4 p -103.5 149.2 7.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 173.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.7 tt -131.19 149.65 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 169.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.8 p -139.74 175.75 3.01 Favored Pre-proline 0 N--CA 1.444 -0.764 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 172.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.13 -19.67 69.34 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 CA-C-N 120.528 1.224 . . . . 0.0 111.145 168.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.0 p-90 -102.73 -24.43 13.74 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -172.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.68 170.35 22.58 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.547 1.521 . . . . 0.0 112.806 -175.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 tt -137.41 125.84 23.44 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 168.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.8 m -138.26 133.2 32.83 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.359 0.599 . . . . 0.0 110.256 -176.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.93 144.78 52.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 168.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 m -139.46 149.17 22.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 124.14 0.976 . . . . 0.0 108.565 -176.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.2 mt -143.38 141.54 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -170.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -134.79 138.23 29.23 Favored Pre-proline 0 N--CA 1.468 0.468 0 CA-C-O 117.839 -1.077 . . . . 0.0 110.517 -170.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -48.4 139.44 22.53 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.718 2.945 . . . . 0.0 112.548 173.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.38 175.79 28.56 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 123.974 0.797 . . . . 0.0 113.856 -174.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.4 140.65 44.58 Favored 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 122.818 2.345 . . . . 0.0 110.095 -174.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.6 t70 50.94 34.92 11.36 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.518 1.527 . . . . 0.0 113.31 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -132.55 131.81 41.94 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.124 1.37 . . . . 0.0 107.522 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.37 99.64 9.34 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -175.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.79 145.15 97.8 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 169.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.36 148.52 61.37 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 121.606 1.537 . . . . 0.0 109.898 171.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.4 tp -63.21 140.06 58.83 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.72 158.69 25.97 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.826 0.739 . . . . 0.0 109.355 174.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.43 140.52 44.72 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.1 t -79.48 159.24 4.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 124.422 1.089 . . . . 0.0 109.038 -169.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.0 m 63.7 23.32 13.46 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.941 1.296 . . . . 0.0 112.92 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -100.57 154.56 18.47 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.226 1.811 . . . . 0.0 107.516 169.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -111.19 141.22 44.99 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.434 0.561 . . . . 0.0 110.666 -177.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 23.7 mm -112.87 128.62 69.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 176.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.42 118.97 5.42 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 173.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.4 tp -108.04 143.61 36.52 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 172.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -105.05 125.49 51.04 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.6 mp -135.77 157.54 75.91 Favored Pre-proline 0 C--O 1.234 0.265 0 C-N-CA 125.25 1.42 . . . . 0.0 107.288 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -66.59 -22.82 50.48 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 CA-C-N 120.609 1.253 . . . . 0.0 112.853 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -54.87 -35.98 64.63 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.592 1.157 . . . . 0.0 111.156 169.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 145.85 157.27 7.21 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 108.026 -2.03 . . . . 0.0 108.026 -173.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.1 m -67.45 133.41 49.49 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 171.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 58.6 ttm -140.72 128.36 21.54 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -170.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.69 132.97 38.43 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 173.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -108.14 130.39 55.12 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 169.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.5 m -80.72 142.37 33.92 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.102 0.961 . . . . 0.0 108.554 177.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 75.7 t -76.45 118.92 23.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 169.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -105.33 161.45 14.71 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 170.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -128.93 93.81 3.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 170.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.9 tp -79.33 127.8 32.53 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -169.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.0 133.78 56.42 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.149 0.58 . . . . 0.0 110.397 -176.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.14 3.47 69.58 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-O 118.635 -1.092 . . . . 0.0 113.473 -177.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.6 t -124.81 -118.68 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.8 t -159.6 -169.27 2.52 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.024 1.33 . . . . 0.0 108.025 -176.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -70.36 143.86 51.8 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.275 0.559 . . . . 0.0 109.688 169.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.78 173.79 16.28 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.176 1.79 . . . . 0.0 107.508 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.7 mp -108.42 142.69 38.41 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 176.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.9 p -142.48 155.42 45.06 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.942 0.897 . . . . 0.0 110.579 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 41.9 t -144.85 116.43 8.12 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 172.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.3 m -69.49 133.03 47.21 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.0 mt -102.08 -66.58 0.91 Allowed 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -175.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.93 164.08 25.97 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.963 0.905 . . . . 0.0 109.753 176.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.9 m -75.49 126.9 87.0 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 169.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -87.23 -11.35 5.27 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.117 2.544 . . . . 0.0 113.545 -174.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 56.8 tp -70.61 113.49 7.77 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.054 0.843 . . . . 0.0 110.048 -171.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 52.1 m -145.03 168.09 21.12 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.337 2.255 . . . . 0.0 106.877 173.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -71.94 -32.0 66.89 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.453 -0.779 . . . . 0.0 110.337 173.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.6 m -80.81 75.36 7.75 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 169.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.6 tpt -152.38 149.9 29.11 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.418 1.487 . . . . 0.0 108.207 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 92.3 p -155.37 174.71 14.84 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.288 1.435 . . . . 0.0 107.827 173.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 41.8 pt -67.43 -24.32 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 121.582 -0.698 . . . . 0.0 111.518 169.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -75.4 -44.58 43.93 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -62.76 -34.51 77.37 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.869 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.35 -52.27 54.2 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 120.196 1.362 . . . . 0.0 111.636 176.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -72.38 -36.97 68.83 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 117.574 0.687 . . . . 0.0 111.268 -177.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 22.9 tpp85 -66.46 -34.42 77.89 Favored 'General case' 0 C--N 1.339 0.11 0 O-C-N 121.053 -1.03 . . . . 0.0 109.823 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 21.4 tp -84.38 -24.94 29.45 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 116.948 -1.501 . . . . 0.0 111.684 -175.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.7 p -66.26 -44.41 83.71 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 121.794 2.088 . . . . 0.0 108.283 169.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -62.42 -50.45 71.47 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 122.773 0.429 . . . . 0.0 111.547 176.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -64.21 -34.5 78.24 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 118.758 -0.639 . . . . 0.0 110.534 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 32.9 m -69.25 -39.5 78.43 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.524 0.602 . . . . 0.0 111.109 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.3 -50.74 62.63 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 175.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -59.51 -46.58 88.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 118.738 -0.649 . . . . 0.0 111.582 -176.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 50.6 ttp -39.55 -48.81 2.1 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.204 1.801 . . . . 0.0 111.23 169.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 23.6 pt -92.09 -20.74 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 118.776 0.716 . . . . 0.0 112.719 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.2 mt -61.65 -44.94 96.03 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.26 0.936 . . . . 0.0 109.039 171.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.9 m 51.08 36.65 15.98 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.13 0.972 . . . . 0.0 111.743 -171.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.3 tp -55.9 134.39 73.25 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 125.329 1.452 . . . . 0.0 112.767 -169.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -60.59 163.2 16.01 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.169 2.579 . . . . 0.0 112.366 169.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.5 p -63.78 145.55 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 172.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 4.7 m -63.09 142.73 58.27 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.835 0.854 . . . . 0.0 110.187 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -132.6 112.76 13.97 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 172.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -80.47 37.56 0.69 Allowed 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.843 3.029 . . . . 0.0 112.668 -173.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -152.77 141.42 20.91 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.21 1.804 . . . . 0.0 108.317 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.5 p -153.2 149.1 20.92 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 124.998 1.319 . . . . 0.0 108.397 176.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -55.04 167.25 1.74 Allowed 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.979 3.119 . . . . 0.0 112.695 169.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -59.82 132.88 55.32 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 169.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -147.75 160.54 42.61 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.568 1.147 . . . . 0.0 109.805 -172.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 73.07 -179.08 39.56 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 123.788 0.709 . . . . 0.0 112.233 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -151.37 158.32 43.6 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.4 1.48 . . . . 0.0 109.06 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -73.66 -52.21 14.09 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . 46.87 39.79 8.02 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.587 1.555 . . . . 0.0 112.617 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 97.0 mt -82.61 149.53 27.37 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.194 0.597 . . . . 0.0 109.508 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 63.0 tp -140.07 115.82 10.2 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 171.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -89.24 -22.46 22.73 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.807 0.443 . . . . 0.0 112.08 -172.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.43 -155.96 49.02 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -175.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -133.58 141.67 47.79 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 172.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 26.2 mtp-105 -117.39 3.4 12.52 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.606 0.762 . . . . 0.0 113.018 -173.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 11.6 m 61.02 173.45 0.1 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.625 1.57 . . . . 0.0 112.934 -175.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 65.92 28.97 74.11 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 119.59 -0.561 . . . . 0.0 112.458 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 54.07 52.09 13.41 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.794 1.237 . . . . 0.0 109.468 -170.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 57.9 t30 51.26 62.04 2.92 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 126.392 1.877 . . . . 0.0 111.29 -173.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.252 0 C-N-CA 124.24 1.016 . . . . 0.0 111.167 -175.571 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.3 m -66.79 146.21 54.68 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.074 0.95 . . . . 0.0 108.923 176.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -82.85 27.56 0.53 Allowed 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.399 -0.813 . . . . 0.0 111.307 -178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -142.82 157.47 44.58 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.279 1.831 . . . . 0.0 109.32 -174.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.3 mm -127.92 128.59 69.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 126.773 2.029 . . . . 0.0 105.636 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.37 133.9 35.97 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 172.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.83 -179.14 35.46 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.159 0.885 . . . . 0.0 112.795 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -119.04 156.88 28.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.934 1.294 . . . . 0.0 112.23 -169.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -72.0 -30.4 65.19 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.137 0.975 . . . . 0.0 111.547 -178.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.4 p -158.57 -175.17 5.16 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 130.477 3.511 . . . . 0.0 105.537 172.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.1 m -56.95 146.44 59.46 Favored Pre-proline 0 CA--C 1.545 0.75 0 O-C-N 120.959 -1.088 . . . . 0.0 109.295 169.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -71.14 56.64 2.03 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 124.439 3.426 . . . . 0.0 109.945 169.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.453 ' HE2' ' O ' ' A' ' 42' ' ' VAL . 27.8 tttm -47.22 -50.93 20.0 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 126.667 1.987 . . . . 0.0 113.623 -168.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.6 -41.06 96.48 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.187 0.903 . . . . 0.0 111.567 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -70.96 -40.18 72.13 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.193 0.597 . . . . 0.0 109.768 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 94.0 t -60.11 -44.9 96.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 172.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -60.78 -55.81 28.65 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 118.744 0.702 . . . . 0.0 110.368 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.65 -41.07 98.27 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.418 0.553 . . . . 0.0 110.826 -173.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.73 -51.81 60.43 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -67.41 -28.74 68.16 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 118.161 -0.923 . . . . 0.0 111.648 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -66.72 -37.58 84.98 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 119.76 1.164 . . . . 0.0 110.108 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -72.79 -42.47 63.87 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.858 0.753 . . . . 0.0 109.23 178.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.7 mt -62.84 -45.59 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.84 -38.48 85.62 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 123.512 0.725 . . . . 0.0 111.054 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.4 ttt-85 -68.25 -48.73 64.29 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -175.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -41.77 71.58 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.26 1.024 . . . . 0.0 110.674 175.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.1 m -65.2 -42.36 93.62 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.538 1.063 . . . . 0.0 111.371 174.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -66.61 -20.4 65.99 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.483 0.713 . . . . 0.0 112.398 -175.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -60.28 -21.18 61.63 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.098 -1.001 . . . . 0.0 112.595 173.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -58.11 -24.76 59.93 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.144 0.884 . . . . 0.0 111.99 176.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.4 pp -120.58 27.27 8.65 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.486 1.514 . . . . 0.0 111.238 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.8 m 66.33 18.33 10.87 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.362 1.865 . . . . 0.0 114.009 171.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -82.7 97.57 8.62 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 169.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.6 mt -69.51 -18.04 63.64 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.161 0.984 . . . . 0.0 112.436 175.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 49.9 t60 -135.76 140.13 32.77 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 125.345 1.458 . . . . 0.0 107.743 174.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.15 120.21 6.45 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.656 2.237 . . . . 0.0 110.385 -176.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.4 m -75.78 -18.22 59.6 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.162 0.585 . . . . 0.0 112.435 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -103.88 115.88 62.63 Favored Pre-proline 0 C--O 1.235 0.302 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 173.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -62.82 117.66 4.56 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.326 2.017 . . . . 0.0 111.939 -177.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 36.1 t -61.47 127.59 21.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 169.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -139.02 149.3 44.49 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 124.066 0.947 . . . . 0.0 109.078 -174.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.453 ' O ' ' HE2' ' A' ' 13' ' ' LYS . 2.5 p -139.71 131.13 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 125.71 1.604 . . . . 0.0 109.5 -176.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 p -108.61 151.46 26.09 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.276 0.63 . . . . 0.0 109.81 169.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -116.24 142.63 46.58 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.596 1.959 . . . . 0.0 109.337 -172.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -147.58 167.42 24.57 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -168.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.5 m -4.4 132.09 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.446 1 C-N-CA 133.537 4.735 . . . . 0.0 118.319 169.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.0 tp -81.13 99.22 8.41 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 168.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -86.41 -55.46 3.89 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.337 0.517 . . . . 0.0 111.525 -169.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -140.96 71.55 1.37 Allowed 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.495 1.518 . . . . 0.0 108.316 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 64.14 16.32 59.81 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.677 0.656 . . . . 0.0 112.946 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -146.27 142.51 28.41 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.438 1.895 . . . . 0.0 107.077 -170.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -81.73 155.38 25.53 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.298 1.039 . . . . 0.0 109.785 174.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.4 162.28 13.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.229 1.014 . . . . 0.0 109.343 169.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.52 161.53 34.99 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 107.207 -2.357 . . . . 0.0 107.207 171.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 60.9 m -133.52 149.22 51.7 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 169.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.7 p -131.63 149.14 32.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 173.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.2 tt -130.56 150.78 34.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 124.899 1.279 . . . . 0.0 107.798 173.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.8 p -143.54 174.78 3.29 Favored Pre-proline 0 N--CA 1.443 -0.776 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -62.05 -21.42 72.37 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 CA-C-N 120.067 1.06 . . . . 0.0 111.619 168.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 42.5 p-90 -100.25 -26.46 13.91 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -172.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.61 172.15 17.66 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 120.285 1.402 . . . . 0.0 112.379 -174.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 tt -132.63 128.51 37.26 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 168.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.1 p -140.57 143.19 35.17 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 122.273 1.035 . . . . 0.0 110.839 177.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.16 143.78 35.11 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 167.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.4 m -132.87 144.44 36.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 125.061 1.345 . . . . 0.0 108.055 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 30.2 mt -141.45 143.92 26.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 C-N-CA 124.837 1.255 . . . . 0.0 107.901 -169.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -141.54 144.04 31.98 Favored Pre-proline 0 N--CA 1.467 0.382 0 CA-C-O 117.552 -1.213 . . . . 0.0 108.92 -172.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -63.13 150.26 89.11 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.178 1.919 . . . . 0.0 111.815 174.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.97 -179.38 39.75 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.472 1.034 . . . . 0.0 114.31 -172.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -62.14 126.53 18.88 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.001 2.467 . . . . 0.0 111.783 -170.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.3 t70 50.5 31.08 5.19 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.47 1.508 . . . . 0.0 113.249 175.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -87.0 141.97 28.28 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 171.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -103.48 90.99 3.85 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -71.94 159.58 85.06 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.363 169.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -68.77 166.45 26.17 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.448 2.099 . . . . 0.0 110.644 172.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 63.2 tp -69.26 95.54 0.78 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 170.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -74.98 146.52 41.6 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -102.48 159.64 15.26 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 122.404 1.097 . . . . 0.0 108.646 169.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 90.6 t -83.48 153.14 3.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 113.674 -1.603 . . . . 0.0 108.09 -169.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.9 m 65.84 6.46 3.99 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.905 1.682 . . . . 0.0 114.078 -176.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -80.68 161.56 24.58 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.468 1.107 . . . . 0.0 108.738 169.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -118.97 143.22 47.17 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.602 -0.686 . . . . 0.0 110.586 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.0 mp -113.84 127.16 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 170.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.29 120.18 5.52 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.5 mt -111.05 129.05 56.03 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.49 131.01 35.93 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 169.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.7 mt -140.99 155.04 68.94 Favored Pre-proline 0 C--N 1.332 -0.182 0 C-N-CA 125.69 1.596 . . . . 0.0 107.181 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -64.32 -22.81 66.13 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.058 1.839 . . . . 0.0 112.51 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -62.02 -26.48 68.26 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.149 1.38 . . . . 0.0 112.221 170.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 123.75 148.71 7.58 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -169.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.3 m -63.47 131.31 47.74 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 41.9 ttp -149.68 143.32 25.4 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -172.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.03 138.98 34.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 121.702 -0.623 . . . . 0.0 110.48 176.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -110.35 136.15 49.97 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 168.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.4 m -91.85 142.39 27.63 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -177.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.9 t -75.31 121.72 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 172.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -109.54 171.86 15.51 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 107.518 -2.233 . . . . 0.0 107.518 168.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -118.28 118.29 31.41 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 168.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.9 tp -74.45 131.27 40.91 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -58.9 123.36 16.25 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 122.607 0.363 . . . . 0.0 110.89 -170.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.99 8.1 84.65 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-O 118.672 -1.071 . . . . 0.0 113.994 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.1 t -126.03 -120.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 119.204 1.502 . . . . 0.0 107.914 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.4 m -148.05 -175.7 4.99 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.725 1.61 . . . . 0.0 109.912 -169.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -58.65 145.19 40.73 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.797 0.839 . . . . 0.0 110.542 172.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.12 165.37 35.85 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.572 1.949 . . . . 0.0 107.721 172.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.7 mp -105.33 139.45 39.95 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.7 m -140.28 153.43 46.49 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.891 0.877 . . . . 0.0 110.379 -176.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 41.2 t -143.43 118.04 9.79 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 169.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.8 m -69.72 133.42 47.48 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 174.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.6 mt -106.36 -65.35 1.08 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.432 0.693 . . . . 0.0 109.513 -172.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -145.1 161.3 39.79 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.64 1.176 . . . . 0.0 108.982 -177.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.4 m -97.47 109.38 50.01 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 169.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.14 174.28 13.07 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.144 2.562 . . . . 0.0 111.002 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 65.3 tp -59.57 133.83 56.45 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 169.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.8 p -95.79 -28.4 14.77 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -169.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -135.88 156.58 48.55 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 125.222 1.409 . . . . 0.0 109.663 -172.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.5 m 52.68 43.12 31.65 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.726 0.81 . . . . 0.0 110.558 -173.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -130.23 129.6 43.55 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 -171.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 38.8 m -113.32 171.36 7.61 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 122.631 1.205 . . . . 0.0 113.916 -168.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.87 -22.55 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.552 1.141 . . . . 0.0 112.262 -172.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -69.13 -46.97 66.3 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 119.393 0.997 . . . . 0.0 108.892 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.98 -39.95 83.33 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.63 1.104 . . . . 0.0 109.0 169.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.68 -35.18 37.54 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 123.821 0.724 . . . . 0.0 112.973 175.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -95.61 -54.05 3.51 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.876 1.338 . . . . 0.0 110.77 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -67.07 -33.04 74.64 Favored 'General case' 0 C--O 1.227 -0.094 0 C-N-CA 124.594 1.158 . . . . 0.0 112.301 -169.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.2 mt -77.9 -39.41 43.13 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 119.351 0.978 . . . . 0.0 109.073 -177.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.8 m -60.77 -47.18 87.49 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.535 1.134 . . . . 0.0 109.376 176.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.64 -48.53 80.43 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.58 1.152 . . . . 0.0 111.393 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -60.41 -40.17 90.01 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 122.614 0.365 . . . . 0.0 110.291 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 73.0 m -66.81 -24.0 66.12 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -73.18 -53.97 9.63 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.381 170.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -59.41 -37.91 79.24 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 121.306 1.866 . . . . 0.0 110.268 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 61.0 ttp -44.66 -35.9 2.85 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.987 172.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 9.0 pt -112.73 1.68 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 124.508 1.123 . . . . 0.0 113.04 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -126.19 66.86 1.21 Allowed 'General case' 0 C--O 1.233 0.199 0 C-N-CA 128.397 2.679 . . . . 0.0 105.278 175.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.5 m -71.29 32.94 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.348 1.459 . . . . 0.0 113.148 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -153.06 156.45 32.69 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 127.972 2.509 . . . . 0.0 109.171 -175.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -59.08 139.93 92.84 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.008 2.472 . . . . 0.0 112.5 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.2 p -74.63 -39.22 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.641 0.776 . . . . 0.0 109.901 173.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 8.4 m -73.52 137.06 44.18 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.586 0.754 . . . . 0.0 109.098 -175.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -146.54 118.64 4.89 Favored Pre-proline 0 C--O 1.236 0.378 0 CA-C-O 117.911 -1.042 . . . . 0.0 108.356 173.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -61.07 149.67 87.98 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.644 2.229 . . . . 0.0 112.11 176.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -77.55 118.21 19.75 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 172.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.8 t -145.17 149.68 42.56 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -51.23 -33.54 45.17 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 124.751 3.634 . . . . 0.0 115.152 173.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 64.0 t-80 -143.31 151.36 40.41 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.055 1.342 . . . . 0.0 107.592 175.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.89 139.87 57.86 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 122.779 0.431 . . . . 0.0 110.046 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -74.1 -26.96 67.3 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 119.642 -0.532 . . . . 0.0 112.542 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 78.9 mtp85 50.58 43.04 27.54 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.229 1.412 . . . . 0.0 111.582 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -69.66 153.42 43.43 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -79.46 -4.4 51.02 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.532 0.733 . . . . 0.0 112.62 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -145.42 160.23 41.87 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.892 1.677 . . . . 0.0 109.969 -176.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -88.0 122.38 31.53 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 169.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -106.37 145.84 31.19 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.427 1.091 . . . . 0.0 109.044 175.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.24 144.01 43.81 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -175.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 78.4 ttt-85 -63.64 137.95 58.3 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 48.72 38.49 11.75 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.697 1.199 . . . . 0.0 111.072 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.6 m 55.15 20.8 3.54 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.121 1.368 . . . . 0.0 114.296 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 68.77 17.8 71.62 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 121.477 -0.764 . . . . 0.0 112.961 -177.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -64.92 139.35 58.75 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 118.629 1.214 . . . . 0.0 109.435 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -69.97 139.24 52.8 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.066 0.546 . . . . 0.0 110.596 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 C-N-CA 125.618 1.567 . . . . 0.0 107.855 174.954 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.3 m -67.92 140.6 56.48 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.954 0.902 . . . . 0.0 109.364 178.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -151.13 156.92 42.01 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.21 1.404 . . . . 0.0 108.585 173.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 35.59 75.74 0.06 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 128.161 2.584 . . . . 0.0 112.218 169.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.7 mt -71.12 129.27 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 126.085 1.754 . . . . 0.0 108.943 -169.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.02 129.79 40.98 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.33 143.44 16.91 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 169.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -116.2 173.16 6.74 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.801 1.24 . . . . 0.0 111.897 -169.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -72.39 -11.28 60.62 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.743 1.617 . . . . 0.0 112.173 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 p -148.19 157.55 43.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.991 1.717 . . . . 0.0 107.991 170.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 m -62.68 158.29 52.17 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 169.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.31 55.32 4.07 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.679 3.586 . . . . 0.0 111.328 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -50.08 -49.46 51.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.95 2.1 . . . . 0.0 112.073 -169.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.55 -42.12 83.15 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 122.513 0.325 . . . . 0.0 111.24 -176.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -70.53 -39.31 74.11 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -176.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.4 t -58.91 -46.99 91.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 171.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -62.31 -50.97 69.55 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-O 118.969 -0.538 . . . . 0.0 110.885 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.34 -38.5 90.32 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.772 0.714 . . . . 0.0 111.073 -175.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.93 -49.38 75.01 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 175.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -66.91 -28.11 68.04 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 118.398 -0.811 . . . . 0.0 112.402 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -66.58 -37.88 85.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.554 1.07 . . . . 0.0 110.074 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -73.41 -41.61 63.09 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.626 -0.671 . . . . 0.0 109.35 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.8 mt -60.68 -45.83 96.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.21 -31.84 72.42 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.673 0.789 . . . . 0.0 112.045 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -65.73 -38.46 89.21 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -86.23 -13.46 46.79 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.169 1.387 . . . . 0.0 112.646 -175.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.1 m -59.73 -42.74 93.8 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.686 1.13 . . . . 0.0 111.629 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.5 mmt 45.06 52.7 8.23 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.896 1.278 . . . . 0.0 111.655 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -65.26 -22.99 66.93 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 122.001 -0.437 . . . . 0.0 111.017 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -120.12 138.27 53.67 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 168.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 45.3 mt -75.55 -0.03 18.94 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -169.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.0 m -123.76 22.31 9.01 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.781 1.632 . . . . 0.0 110.582 171.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -58.82 -43.25 90.59 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.726 0.811 . . . . 0.0 111.257 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.8 mt 51.25 -117.95 1.19 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.508 1.523 . . . . 0.0 111.271 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 31.3 t-80 -74.54 140.25 75.22 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 118.998 0.817 . . . . 0.0 110.145 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.83 69.17 2.26 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.341 2.694 . . . . 0.0 112.51 170.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.2 m -70.68 -21.53 62.58 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.578 1.151 . . . . 0.0 111.521 170.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 61.0 tpp -84.56 129.07 58.78 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 171.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -53.11 129.21 32.27 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 N-CA-C 118.625 2.51 . . . . 0.0 118.625 -168.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.7 t -106.99 102.2 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 100.257 -3.979 . . . . 0.0 100.257 166.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -132.6 155.74 48.16 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.746 0.818 . . . . 0.0 110.885 -169.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.0 t -134.42 120.07 32.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.081 0.953 . . . . 0.0 108.676 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.9 m -91.65 143.87 26.11 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.429 1.092 . . . . 0.0 108.568 169.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -123.69 146.82 47.96 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.347 1.859 . . . . 0.0 110.128 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.485 ' CE1' ' CB ' ' A' ' 131' ' ' ALA . 81.6 m-85 -149.15 172.77 14.28 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -168.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.4 m -14.99 144.7 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.479 1 C-N-CA 133.851 4.861 . . . . 0.0 116.834 169.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.9 tp -78.85 71.08 5.29 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.159 0.984 . . . . 0.0 109.514 172.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -70.04 119.92 14.98 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.518 1.527 . . . . 0.0 108.686 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 50.72 36.2 13.67 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.944 0.898 . . . . 0.0 111.914 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.87 10.84 80.37 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-O 118.379 -1.234 . . . . 0.0 114.418 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -142.24 141.95 32.56 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 120.11 1.955 . . . . 0.0 109.849 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -67.1 140.14 57.56 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 121.164 -0.96 . . . . 0.0 109.788 -173.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.66 162.21 15.72 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 171.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -171.01 167.34 40.51 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 176.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 3.5 m -141.72 147.26 37.13 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 169.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.7 p -120.41 141.88 38.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 169.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.7 tt -123.04 148.52 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 169.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.6 p -141.61 175.61 2.91 Favored Pre-proline 0 N--CA 1.441 -0.876 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 169.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -65.71 -21.65 58.39 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.184 1.256 . . . . 0.0 111.817 169.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 42.6 p-90 -97.94 -21.87 16.62 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.46 177.78 9.75 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.878 1.672 . . . . 0.0 112.906 -176.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 tt -143.75 127.28 16.95 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 103.102 -2.925 . . . . 0.0 103.102 168.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.5 m -137.25 130.62 31.18 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 124.167 0.917 . . . . 0.0 109.215 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.51 147.79 43.69 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 168.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.89 151.85 29.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 72.4 mt -135.83 134.01 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 105.553 -2.018 . . . . 0.0 105.553 177.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -129.62 141.42 41.78 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 118.117 -0.944 . . . . 0.0 110.872 -169.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -54.43 142.17 70.7 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.906 2.404 . . . . 0.0 113.76 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.18 173.92 53.64 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.342 0.972 . . . . 0.0 112.825 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -65.83 148.41 86.35 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.266 2.644 . . . . 0.0 112.035 -175.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.5 t70 53.15 44.26 30.52 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.249 1.419 . . . . 0.0 111.857 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -118.67 148.14 43.05 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.838 1.255 . . . . 0.0 108.249 173.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.43 84.31 2.11 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 172.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 8.8 t90 -71.45 121.65 84.92 Favored Pre-proline 0 C--O 1.235 0.316 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -170.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -56.17 147.88 63.04 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.171 1.914 . . . . 0.0 112.274 -175.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 40.7 tp -58.5 128.06 35.26 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 169.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -109.95 159.47 17.23 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.145 0.978 . . . . 0.0 109.698 -178.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -86.3 142.69 28.34 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 168.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.8 t -88.96 154.91 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -169.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.2 m 65.87 10.32 6.79 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.242 1.417 . . . . 0.0 113.706 -177.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -80.93 153.74 27.37 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.833 1.253 . . . . 0.0 108.131 169.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -107.76 142.73 37.32 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.383 0.538 . . . . 0.0 110.214 176.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.6 mm -118.46 124.21 72.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 173.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.94 120.95 5.6 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 176.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 72.3 mt -106.58 124.75 50.07 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.86 79.46 9.24 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 55.9 mt -74.92 145.93 81.97 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 172.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -60.32 -25.61 80.67 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 121.662 1.575 . . . . 0.0 112.763 170.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -55.4 -30.38 60.31 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.527 1.531 . . . . 0.0 111.952 170.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.72 143.21 4.57 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 107.974 -2.05 . . . . 0.0 107.974 -171.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.8 m -61.45 131.25 49.58 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 60.1 ttm -140.22 129.97 24.47 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.28 132.66 35.87 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 118.721 0.691 . . . . 0.0 109.22 173.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -106.24 135.1 48.31 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 169.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.3 m -87.93 137.88 31.94 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 70.1 t -68.96 122.1 19.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 170.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -107.25 157.05 15.7 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 171.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -122.42 95.42 4.63 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 170.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.9 tt -72.77 115.84 12.55 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -175.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.46 131.68 51.51 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 122.633 0.373 . . . . 0.0 111.378 -173.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.66 2.96 71.27 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 118.888 -0.951 . . . . 0.0 113.402 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.3 t -123.72 -103.33 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.5 p -164.01 171.69 14.88 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.719 1.6 . . . . 0.0 111.089 -173.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -73.49 144.7 46.1 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 169.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.54 179.68 8.39 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.826 1.65 . . . . 0.0 108.594 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.2 mt -109.22 137.87 46.44 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.5 m -140.62 158.24 44.28 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.092 0.957 . . . . 0.0 111.275 -173.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 38.7 t -143.44 108.95 5.08 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 169.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.2 m -85.75 143.82 28.12 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.991 0.916 . . . . 0.0 109.942 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.43 -10.7 0.73 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -172.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 10.0 tpp -125.0 147.14 49.08 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 120.592 1.542 . . . . 0.0 111.778 -170.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.1 m -92.05 166.83 16.51 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.584 1.154 . . . . 0.0 111.158 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -63.16 156.34 55.9 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.65 2.233 . . . . 0.0 113.77 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 24.4 tp 49.88 69.14 0.64 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 126.713 2.005 . . . . 0.0 111.52 172.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.9 m -58.12 150.49 21.11 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.26 172.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -78.95 146.7 33.3 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.8 m 55.63 27.24 10.23 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.684 1.194 . . . . 0.0 112.736 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.13 140.87 56.19 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -177.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.6 p -161.48 178.85 8.73 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.119 1.368 . . . . 0.0 108.594 -170.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.424 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -62.32 -28.57 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 O-C-N 121.472 -0.768 . . . . 0.0 110.624 169.675 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -68.03 -49.0 64.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -65.91 -39.37 90.51 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.668 0.667 . . . . 0.0 110.017 177.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.12 -25.31 59.69 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.569 1.08 . . . . 0.0 112.696 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -96.33 -52.37 4.01 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.321 1.06 . . . . 0.0 110.672 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 44.1 mtm-85 -65.2 -41.71 94.23 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.648 -0.658 . . . . 0.0 112.199 -170.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.72 -35.74 60.18 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 119.406 1.003 . . . . 0.0 110.596 -170.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.64 -45.56 93.62 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.851 0.75 . . . . 0.0 109.067 175.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -66.63 -48.44 69.46 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.012 1.325 . . . . 0.0 111.46 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.61 -38.93 92.71 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.43 -0.794 . . . . 0.0 111.793 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 88.8 m -71.21 -24.16 62.16 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 119.499 -0.286 . . . . 0.0 111.276 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.485 ' CB ' ' CE1' ' A' ' 45' ' ' PHE . . . -78.96 -47.17 16.84 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 118.845 0.748 . . . . 0.0 109.037 169.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.1 ttp-105 -55.74 -41.95 74.68 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.731 0.812 . . . . 0.0 112.025 -177.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 16.9 ptt? -55.1 -50.09 70.09 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 118.613 0.642 . . . . 0.0 110.658 175.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 42.8 pt -75.81 -19.8 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 O-C-N 120.957 -1.089 . . . . 0.0 111.376 -177.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.6 tp -65.08 -3.47 3.7 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.857 2.063 . . . . 0.0 110.337 169.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.0 m 63.2 26.97 15.45 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.918 2.087 . . . . 0.0 112.779 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.2 mp -96.82 157.31 35.37 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 124.994 1.318 . . . . 0.0 107.748 169.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.19 155.6 19.06 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 123.222 2.615 . . . . 0.0 111.5 169.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.6 m -69.28 165.1 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 121.637 0.732 . . . . 0.0 109.872 175.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 92.2 m -55.53 133.17 50.06 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.119 1.368 . . . . 0.0 111.923 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -90.58 122.64 66.88 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 105.339 -2.096 . . . . 0.0 105.339 168.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.64 156.88 62.5 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.168 1.912 . . . . 0.0 112.634 -169.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -69.24 130.53 42.88 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 170.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.3 m -138.52 157.35 72.39 Favored Pre-proline 0 C--O 1.239 0.51 0 C-N-CA 125.038 1.335 . . . . 0.0 110.165 -169.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -68.14 149.56 76.57 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.455 2.103 . . . . 0.0 111.955 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 19.1 t60 54.27 24.82 5.3 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.595 1.958 . . . . 0.0 113.914 173.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -159.57 -41.12 0.05 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.489 -0.757 . . . . 0.0 111.967 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -71.11 129.68 18.24 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -176.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -83.24 127.97 34.1 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 169.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -73.64 141.37 46.51 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -176.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -141.93 25.86 1.92 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.472 1.109 . . . . 0.0 110.773 177.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -81.46 150.88 28.11 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.278 0.631 . . . . 0.0 110.446 -175.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -150.54 148.59 28.87 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 126.188 1.795 . . . . 0.0 107.544 169.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -135.65 167.43 21.14 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.222 1.009 . . . . 0.0 110.711 -169.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 76.84 173.19 37.51 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.099 0.857 . . . . 0.0 113.371 172.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -144.59 162.81 35.68 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.49 2.316 . . . . 0.0 106.207 174.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -62.76 130.96 47.21 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.9 m -61.53 150.24 36.51 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.701 0.8 . . . . 0.0 111.496 -175.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -160.54 -120.25 0.55 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 107.926 -2.07 . . . . 0.0 107.926 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -63.35 -39.52 94.78 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 172.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -87.47 133.14 33.8 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 169.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.344 0 C-N-CA 125.153 1.381 . . . . 0.0 107.723 175.739 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.3 p -73.04 151.84 41.55 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.925 0.89 . . . . 0.0 109.819 176.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -84.33 16.44 3.05 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 122.007 0.908 . . . . 0.0 112.46 175.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -144.48 159.49 42.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.731 2.412 . . . . 0.0 108.226 -175.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.2 mm -123.64 128.61 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 173.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.69 142.44 42.51 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.6 151.74 50.56 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.487 1.041 . . . . 0.0 112.052 176.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -102.91 154.72 18.93 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.733 1.213 . . . . 0.0 109.996 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -84.73 -21.12 30.2 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.694 -0.629 . . . . 0.0 112.265 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.9 p -158.39 -176.67 6.03 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 129.476 3.11 . . . . 0.0 105.987 170.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.0 m -58.44 145.17 76.68 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 168.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -73.59 59.23 4.03 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.817 3.011 . . . . 0.0 108.943 169.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.5 tttm -50.54 -51.62 46.22 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.638 1.975 . . . . 0.0 112.481 -168.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.93 -40.89 91.83 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.6 0.36 . . . . 0.0 111.707 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -69.3 -45.32 69.86 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.887 0.875 . . . . 0.0 109.773 -174.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 73.7 t -62.13 -42.97 97.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.372 1.069 . . . . 0.0 108.471 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -59.64 -54.01 51.39 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.469 0.577 . . . . 0.0 110.041 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.0 -39.68 93.81 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.194 0.598 . . . . 0.0 111.112 -175.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.03 -46.32 78.3 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -70.86 -27.17 63.64 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-O 117.918 -1.039 . . . . 0.0 112.071 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -61.69 -38.27 87.22 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 120.055 1.298 . . . . 0.0 110.211 171.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -73.8 -41.71 61.97 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 121.702 -0.624 . . . . 0.0 109.389 -177.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.6 mt -61.27 -43.88 97.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.3 -27.28 68.92 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.077 0.853 . . . . 0.0 112.146 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -79.81 -42.32 24.61 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.019 0.928 . . . . 0.0 109.17 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -76.92 -25.48 52.98 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.788 0.835 . . . . 0.0 111.702 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.3 m -72.14 102.3 3.0 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.3 mpt? 64.91 -34.39 0.17 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 128.585 2.754 . . . . 0.0 116.594 169.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -68.25 -57.17 6.4 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 120.012 1.278 . . . . 0.0 109.87 -176.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.2 t0 48.56 38.23 10.76 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.237 1.415 . . . . 0.0 111.704 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.4 tp -151.99 -25.71 0.18 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.414 1.485 . . . . 0.0 111.415 -169.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.87 20.07 0.19 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.57 1.148 . . . . 0.0 113.806 -169.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -78.07 -24.06 47.82 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.912 -1.117 . . . . 0.0 109.322 169.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.4 mt -68.35 -51.98 38.34 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.549 0.739 . . . . 0.0 109.169 174.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -160.76 152.17 16.08 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 127.177 2.191 . . . . 0.0 107.092 175.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -63.68 146.36 92.23 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.05 1.833 . . . . 0.0 110.606 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.4 p -65.99 -46.55 77.6 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.876 0.871 . . . . 0.0 109.237 173.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.1 tpp -146.57 126.85 6.93 Favored Pre-proline 0 C--O 1.234 0.254 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 169.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.03 131.54 45.2 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.25 1.966 . . . . 0.0 112.342 178.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.8 t -73.58 139.4 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 169.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -142.65 154.39 44.31 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.968 0.907 . . . . 0.0 108.923 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.2 t -141.09 125.21 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.748 0.819 . . . . 0.0 108.895 -173.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.4 m -89.15 144.02 26.42 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.203 1.001 . . . . 0.0 108.745 168.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -119.96 135.82 54.76 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.792 1.637 . . . . 0.0 108.035 169.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -167.57 143.33 4.03 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -176.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.7 m 57.17 166.4 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.525 2.33 . . . . 0.0 115.341 167.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.1 tp -120.99 66.63 0.86 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.806 1.242 . . . . 0.0 108.521 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.2 131.27 42.53 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.646 -0.658 . . . . 0.0 110.117 -175.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 52.38 31.5 9.67 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.477 1.111 . . . . 0.0 111.87 -175.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.65 11.06 85.82 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 118.153 -1.359 . . . . 0.0 113.613 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -125.36 143.76 50.82 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.893 1.847 . . . . 0.0 108.062 -174.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -67.97 138.39 55.88 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.416 1.007 . . . . 0.0 109.549 -176.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.65 155.39 17.34 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.95 171.43 37.87 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 173.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 45.0 m -140.32 150.62 44.23 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 169.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.4 p -127.66 141.76 45.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 124.853 1.261 . . . . 0.0 107.602 175.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.0 tt -118.52 149.04 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 169.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.6 p -142.83 172.61 5.51 Favored Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 171.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.36 -19.09 65.18 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 CA-C-N 120.149 1.089 . . . . 0.0 111.646 168.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 37.8 p-90 -102.16 -23.36 14.05 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.518 1.054 . . . . 0.0 113.836 -172.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.74 166.06 24.77 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.819 1.247 . . . . 0.0 111.882 -175.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 tt -132.94 124.74 28.37 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 104.2 -2.518 . . . . 0.0 104.2 168.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.2 m -137.63 133.15 34.01 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.367 0.604 . . . . 0.0 110.891 -176.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.35 148.28 49.9 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 168.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.4 m -139.97 151.88 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 123.946 0.898 . . . . 0.0 109.038 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.6 mt -138.32 145.63 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -133.15 142.49 44.67 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.191 -176.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -44.8 129.42 9.46 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 124.012 3.142 . . . . 0.0 112.447 174.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.97 178.62 15.56 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.085 0.85 . . . . 0.0 114.525 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -67.33 131.16 24.16 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.381 2.721 . . . . 0.0 111.141 -172.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.8 t70 51.15 31.34 6.56 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.538 1.535 . . . . 0.0 113.219 175.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -88.96 155.63 19.39 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -116.8 88.12 2.83 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 170.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -67.24 151.18 97.4 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.164 174.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.38 159.42 49.37 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.256 1.97 . . . . 0.0 109.284 169.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 51.9 tp -64.53 118.75 9.26 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 169.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -88.95 158.98 17.86 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.41 138.26 31.9 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 168.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.7 t -83.13 154.98 3.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 123.834 0.853 . . . . 0.0 108.704 -169.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.1 m 66.23 9.97 6.77 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.295 1.438 . . . . 0.0 113.828 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -83.8 163.0 20.42 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.807 1.243 . . . . 0.0 107.891 168.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -110.93 142.16 43.39 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 118.923 0.783 . . . . 0.0 111.02 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 30.4 mm -113.45 130.96 66.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.08 123.09 6.01 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -109.97 155.31 21.94 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.897 1.279 . . . . 0.0 108.328 170.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.0 tp60 -126.7 131.74 51.31 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 169.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -155.57 166.14 16.89 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 126.067 1.747 . . . . 0.0 107.199 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -57.72 -22.54 53.29 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.697 2.265 . . . . 0.0 115.0 -174.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -58.29 -33.51 69.53 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.681 0.792 . . . . 0.0 111.715 172.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.24 177.89 15.67 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.677 1.608 . . . . 0.0 110.03 -176.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.2 m -67.01 128.13 35.2 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 169.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 41.0 ttp -147.35 130.74 16.64 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.25 141.71 33.85 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 172.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -113.17 135.92 53.29 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 169.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.2 m -80.26 143.81 33.39 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 176.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 62.6 t -76.14 125.72 36.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 170.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -108.97 156.02 15.82 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -133.95 123.32 24.44 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 170.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.6 tp -141.23 144.08 34.52 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.36 0.527 . . . . 0.0 110.171 -172.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -54.27 131.55 41.88 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.32 1.048 . . . . 0.0 110.788 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.8 -1.36 58.77 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 118.717 -1.046 . . . . 0.0 113.591 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 44.8 t -121.57 -28.64 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 119.441 1.62 . . . . 0.0 109.947 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.1 m 60.11 -144.86 0.51 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.804 1.241 . . . . 0.0 108.279 -170.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -83.44 136.6 34.25 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.847 0.749 . . . . 0.0 110.654 -175.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -156.91 175.72 13.7 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.257 1.823 . . . . 0.0 107.869 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.2 mp -116.53 147.09 42.13 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.323 1.049 . . . . 0.0 108.501 -177.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.6 p -143.65 153.04 42.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.754 1.222 . . . . 0.0 110.615 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.8 t -147.28 121.93 9.83 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 170.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.9 m -72.97 137.57 45.56 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.334 0.515 . . . . 0.0 109.99 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -89.17 -66.78 0.89 Allowed 'General case' 0 C--N 1.338 0.102 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 171.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.78 174.64 7.44 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.031 1.332 . . . . 0.0 108.859 -175.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.6 m -85.37 121.29 73.72 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 169.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -88.64 4.71 5.41 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.372 2.715 . . . . 0.0 113.091 -173.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 57.2 tp -67.15 117.72 9.57 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.727 0.694 . . . . 0.0 110.531 -170.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.8 m -144.24 159.52 42.53 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.849 2.06 . . . . 0.0 106.662 171.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -82.97 -29.94 28.63 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.126 0.421 . . . . 0.0 111.29 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.9 m -82.92 60.14 5.25 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.634 1.173 . . . . 0.0 109.032 174.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.22 138.67 35.28 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.276 1.43 . . . . 0.0 108.053 -170.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.3 m -145.16 167.96 21.5 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.726 1.61 . . . . 0.0 108.141 -175.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.1 -27.17 26.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.674 -0.641 . . . . 0.0 111.619 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.39 -42.26 96.23 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.977 0.511 . . . . 0.0 110.148 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -67.88 -29.28 68.36 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.043 0.937 . . . . 0.0 110.482 171.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.85 -60.87 8.02 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 169.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -65.06 -49.61 69.39 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.864 -0.786 . . . . 0.0 110.279 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -58.08 -45.34 87.3 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 124.439 1.096 . . . . 0.0 110.688 -175.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.5 tp -79.66 -25.76 41.22 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 119.858 1.208 . . . . 0.0 111.668 -173.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.4 m -69.61 -42.88 73.8 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.829 1.195 . . . . 0.0 109.197 173.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.51 -41.55 79.83 Favored 'General case' 0 N--CA 1.461 0.095 0 C-N-CA 123.165 0.586 . . . . 0.0 111.358 177.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -66.22 -29.64 69.94 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.351 -0.843 . . . . 0.0 110.267 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 20.0 m -69.53 -43.34 73.21 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.991 0.814 . . . . 0.0 110.239 175.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -56.41 -52.92 62.85 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.59 0.756 . . . . 0.0 109.698 171.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -52.61 -53.86 40.99 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.91 1.284 . . . . 0.0 110.559 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 54.0 ttp -49.24 -50.16 39.86 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.607 1.563 . . . . 0.0 110.922 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 6.4 pt -82.12 -19.93 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 119.027 0.83 . . . . 0.0 112.513 -174.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 74.4 mt -72.89 -33.21 65.89 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.387 0.54 . . . . 0.0 109.729 169.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.5 m 55.26 28.51 11.34 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.516 1.926 . . . . 0.0 113.685 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 84.9 mt -85.69 147.09 45.38 Favored Pre-proline 0 C--O 1.236 0.353 0 C-N-CA 124.411 1.084 . . . . 0.0 109.445 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -62.78 155.57 58.8 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 123.637 2.892 . . . . 0.0 111.286 174.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.0 p -60.82 139.13 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 123.529 0.731 . . . . 0.0 110.284 -173.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 2.7 m -73.87 147.17 43.5 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.749 0.819 . . . . 0.0 109.261 -177.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -108.23 105.94 57.59 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 169.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -82.14 35.53 0.58 Allowed 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.726 2.95 . . . . 0.0 112.505 -170.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -153.26 140.67 19.69 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.02 1.728 . . . . 0.0 108.665 177.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.6 t -143.85 147.74 39.69 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 175.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -52.59 156.13 9.18 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.758 2.972 . . . . 0.0 111.667 168.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -62.74 138.87 58.62 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 175.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.18 147.71 38.25 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.02 0.528 . . . . 0.0 110.27 -176.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -74.24 160.17 53.05 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 173.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -147.63 141.18 25.46 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.254 1.421 . . . . 0.0 107.33 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.55 142.21 48.46 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -130.38 21.66 5.19 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.137 1.375 . . . . 0.0 110.646 173.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.5 pp -80.8 160.3 24.88 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.212 1.005 . . . . 0.0 110.853 -176.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -144.29 157.26 44.37 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.372 1.469 . . . . 0.0 108.515 170.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -72.16 129.74 39.21 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.09 138.65 29.84 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.2 mpt_? -86.34 149.75 24.82 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 171.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -128.86 19.03 6.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.262 1.025 . . . . 0.0 112.545 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.6 m 59.35 179.6 0.08 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.322 1.449 . . . . 0.0 112.177 -173.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -174.14 -127.02 0.96 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.68 -30.52 71.54 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.056 0.428 . . . . 0.0 110.214 171.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -93.47 133.48 36.71 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 169.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.28 0 C-N-CA 125.63 1.572 . . . . 0.0 107.753 176.783 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 120.765 0.317 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.1 p -72.69 157.65 37.13 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.192 0.997 . . . . 0.0 110.032 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -138.32 41.35 2.24 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.485 1.114 . . . . 0.0 108.518 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -142.25 158.84 43.27 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.192 1.397 . . . . 0.0 109.317 -172.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.4 mm -120.94 128.93 76.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 171.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.47 131.97 42.39 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.86 151.48 51.2 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.109 0.861 . . . . 0.0 111.096 174.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -93.84 138.45 31.99 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.282 1.033 . . . . 0.0 109.736 -175.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -71.1 -34.03 70.73 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.909 -0.567 . . . . 0.0 109.902 176.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.3 p -156.64 161.78 39.88 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 128.618 2.767 . . . . 0.0 106.812 169.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.0 m -51.82 137.44 34.75 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.226 1.011 . . . . 0.0 112.346 -174.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -76.55 46.71 1.92 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 124.907 3.738 . . . . 0.0 110.555 172.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -62.64 -31.77 72.69 Favored 'General case' 0 C--O 1.221 -0.438 0 O-C-N 120.498 -1.376 . . . . 0.0 113.232 -168.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.76 -42.64 94.97 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 118.762 0.71 . . . . 0.0 111.006 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -72.84 -39.3 66.67 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -177.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.2 t -58.46 -46.42 89.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 171.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -60.77 -53.18 60.52 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 123.526 0.73 . . . . 0.0 110.371 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.55 -40.36 95.44 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.694 0.679 . . . . 0.0 110.931 -174.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.21 -41.82 80.73 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.013 -0.43 . . . . 0.0 110.506 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -69.52 -27.33 65.08 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-O 118.331 -0.843 . . . . 0.0 112.415 175.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -63.22 -36.74 84.64 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.569 1.077 . . . . 0.0 109.104 172.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -71.48 -46.25 60.33 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.2 mt -61.01 -36.87 75.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 123.491 0.717 . . . . 0.0 109.845 177.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.74 -36.39 78.32 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.196 -0.94 . . . . 0.0 110.614 176.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.7 ttm105 -70.57 -34.8 72.62 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.448 1.099 . . . . 0.0 110.061 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -65.31 -2.44 3.1 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.092 1.357 . . . . 0.0 111.645 169.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.6 m 54.3 72.71 0.44 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.496 1.918 . . . . 0.0 113.234 169.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 4.5 tmm? -62.93 -52.81 61.62 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 169.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -81.01 164.08 22.78 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 168.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -86.96 106.18 17.63 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.1 mt -79.19 85.0 5.1 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -174.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.1 m -46.25 160.71 0.06 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.416 1.487 . . . . 0.0 111.974 169.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -63.45 -9.87 14.71 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -169.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.0 mt -65.13 166.02 10.3 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.591 0.756 . . . . 0.0 110.888 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -65.64 160.54 59.91 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 170.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -55.31 123.45 13.83 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.304 2.003 . . . . 0.0 111.017 -176.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.6 p -72.95 -28.18 62.27 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 123.572 0.749 . . . . 0.0 112.29 -170.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 76.4 mtm -142.62 134.19 13.04 Favored Pre-proline 0 N--CA 1.45 -0.442 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 170.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -72.64 144.03 38.98 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 N-CA-C 108.562 -1.361 . . . . 0.0 108.562 -172.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.1 t -65.62 108.66 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 169.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -149.53 155.73 40.8 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.36 1.464 . . . . 0.0 109.256 -168.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.7 t -140.12 120.1 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.9 m -85.39 148.4 26.03 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.851 0.86 . . . . 0.0 109.792 169.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -125.28 141.86 51.84 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.828 2.051 . . . . 0.0 110.567 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.454 ' CE2' ' CB ' ' A' ' 131' ' ' ALA . 98.4 m-85 -149.61 171.16 17.1 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -169.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.8 m -6.64 135.99 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.357 1 C-N-CA 133.43 4.692 . . . . 0.0 117.285 169.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.0 tt -78.53 103.61 8.59 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 168.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -84.92 -138.65 0.07 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.026 1.73 . . . . 0.0 107.872 -174.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -73.46 74.21 1.41 Allowed 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.823 -1.173 . . . . 0.0 110.129 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.79 16.33 78.05 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.542 1.068 . . . . 0.0 113.665 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -153.69 140.43 19.02 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.687 1.243 . . . . 0.0 109.862 -172.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -77.32 148.02 35.88 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.996 1.318 . . . . 0.0 110.063 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.58 158.29 15.86 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.61 0.719 . . . . 0.0 110.374 175.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -167.05 168.88 40.62 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 175.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 15.4 m -143.43 142.82 31.35 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 169.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.6 p -114.27 149.96 16.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 124.958 1.303 . . . . 0.0 107.678 172.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.4 tt -136.59 156.67 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 169.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.6 p -146.47 177.35 1.8 Allowed Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 126.353 1.861 . . . . 0.0 106.816 175.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -59.49 -28.88 88.6 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 CA-C-N 120.154 1.091 . . . . 0.0 111.015 168.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 50.0 p-90 -97.19 -19.41 18.64 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -171.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.67 172.81 15.64 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.804 1.638 . . . . 0.0 113.717 -176.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 tt -135.68 126.15 26.81 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 103.523 -2.769 . . . . 0.0 103.523 167.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.8 m -135.33 134.25 39.64 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.21 146.5 47.29 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 169.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.1 m -139.35 147.12 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 123.639 0.775 . . . . 0.0 109.335 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.9 mm -140.64 142.94 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -171.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -132.81 140.11 36.69 Favored Pre-proline 0 N--CA 1.468 0.43 0 CA-C-O 117.482 -1.247 . . . . 0.0 109.445 -175.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -57.14 142.35 94.39 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.151 1.901 . . . . 0.0 111.29 175.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.99 -179.3 29.16 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.731 1.158 . . . . 0.0 114.24 -171.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.87 145.34 56.21 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.35 2.7 . . . . 0.0 111.779 -171.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.6 t0 43.16 57.08 3.89 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.395 1.878 . . . . 0.0 112.395 174.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -142.84 146.59 34.29 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -172.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -117.12 101.0 8.1 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -76.12 154.72 84.56 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 169.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -69.97 158.9 55.18 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.187 1.924 . . . . 0.0 110.798 172.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 66.0 tp -64.09 136.74 57.53 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 169.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -118.79 160.49 21.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.109 0.868 . . . . 0.0 109.052 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -86.11 149.56 25.04 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 169.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 36.0 t -90.6 154.73 3.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -169.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.0 m 61.67 28.25 17.44 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.798 0.839 . . . . 0.0 112.344 -175.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -107.46 154.38 21.44 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.819 2.047 . . . . 0.0 107.264 169.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -104.76 147.88 27.22 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.333 0.969 . . . . 0.0 111.463 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.6 mm -122.97 132.12 72.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 176.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -81.75 123.33 6.02 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.5 mp -106.26 134.0 50.08 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 169.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -89.93 116.6 28.12 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 169.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.1 mt -106.12 155.53 38.34 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 169.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.31 -28.03 55.39 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 CA-C-N 120.187 1.102 . . . . 0.0 111.136 169.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -52.46 -38.66 59.82 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.688 1.595 . . . . 0.0 111.517 169.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 153.53 169.88 19.03 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -174.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.3 m -71.74 130.39 41.01 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 173.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 60.4 ttm -138.23 123.43 19.26 Favored 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.35 136.36 37.68 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.483 -0.761 . . . . 0.0 109.135 170.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -111.49 140.76 45.82 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 169.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.5 m -90.12 141.45 28.68 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.2 t -70.49 119.1 16.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 169.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -102.53 158.39 18.0 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 108.052 -2.019 . . . . 0.0 108.052 169.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -132.81 122.28 24.23 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 169.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.6 tp -138.26 147.81 44.07 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.794 0.838 . . . . 0.0 109.127 -169.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -58.1 128.91 39.47 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.227 0.611 . . . . 0.0 111.503 -172.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.53 -30.64 1.94 Allowed Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.731 1.634 . . . . 0.0 112.812 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.4 t -79.58 -29.15 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.847 1.659 . . . . 0.0 110.003 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.0 m 56.75 -139.36 0.92 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 -169.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -84.18 138.36 33.03 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.155 0.889 . . . . 0.0 110.956 -175.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -155.98 169.1 25.23 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.936 2.094 . . . . 0.0 107.115 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.8 mp -112.06 140.68 46.54 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.2 m -138.3 151.14 47.31 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.29 1.036 . . . . 0.0 110.211 -173.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 44.3 t -138.92 115.67 10.72 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 169.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.5 m -67.44 123.93 21.78 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.28 -47.32 4.98 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.237 0.615 . . . . 0.0 110.47 -170.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 16.2 ptp -159.62 163.9 34.58 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.103 0.961 . . . . 0.0 109.413 175.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.428 ' H ' ' HD2' ' A' ' 113' ' ' PRO . 13.9 m -123.01 -57.63 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 117.643 -1.17 . . . . 0.0 112.217 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.428 ' HD2' ' H ' ' A' ' 112' ' ' SER . 61.3 Cg_endo -68.32 150.76 76.46 Favored 'Trans proline' 0 C--N 1.353 0.804 0 CA-C-N 121.616 1.613 . . . . 0.0 112.074 -174.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 19.5 tp -74.21 129.88 38.66 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 172.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 38.0 m -69.89 138.98 52.93 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 172.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -43.38 -52.25 6.01 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.391 1.476 . . . . 0.0 113.655 -169.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.2 m -99.59 10.78 40.74 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.25 0.62 . . . . 0.0 112.513 -171.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 5.2 ptm -93.56 146.73 23.58 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.495 0.718 . . . . 0.0 110.19 -175.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 43.1 m -136.67 -166.7 1.94 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.982 1.713 . . . . 0.0 108.527 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.3 pt -60.52 -25.49 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -174.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -75.72 -47.28 26.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 30.0 mp0 -61.47 -35.36 77.41 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.365 1.066 . . . . 0.0 109.623 169.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.84 -54.06 41.13 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 120.197 1.362 . . . . 0.0 110.842 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -64.81 -48.2 75.28 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.528 -0.983 . . . . 0.0 110.275 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 75.5 mtp85 -64.11 -30.85 71.89 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 122.785 0.434 . . . . 0.0 111.387 -177.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.2 tp -82.57 -22.68 34.78 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-O 118.003 -0.999 . . . . 0.0 111.311 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.2 m -64.28 -46.24 84.55 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.304 1.411 . . . . 0.0 107.762 169.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -64.53 -51.29 63.66 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.006 0.922 . . . . 0.0 111.659 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -61.44 -36.03 79.23 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.628 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 21.8 m -64.01 -39.59 94.44 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.252 0.478 . . . . 0.0 110.211 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.454 ' CB ' ' CE2' ' A' ' 45' ' ' PHE . . . -65.81 -48.81 70.46 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 121.635 -0.666 . . . . 0.0 110.59 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.5 ptt85 -67.32 -27.26 67.0 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.444 1.474 . . . . 0.0 112.641 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -56.61 -45.5 81.43 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.324 169.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 12.7 pt -81.84 -25.38 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 119.731 1.151 . . . . 0.0 113.118 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 70.8 mt -62.7 -38.08 89.03 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.845 1.202 . . . . 0.0 109.154 169.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.6 m 56.74 20.27 4.99 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.534 1.934 . . . . 0.0 112.837 -169.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 98.3 mt -153.35 156.1 32.22 Favored Pre-proline 0 C--O 1.236 0.389 0 C-N-CA 128.844 2.858 . . . . 0.0 107.65 -170.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.11 164.21 23.19 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.771 2.314 . . . . 0.0 109.75 168.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.5 t -65.53 143.71 15.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 20.2 m -127.59 127.05 43.21 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.173 0.989 . . . . 0.0 109.593 -169.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -77.78 127.15 82.95 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 168.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -59.76 131.31 39.23 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 121.994 1.796 . . . . 0.0 112.606 -171.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -159.04 147.5 18.14 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.088 1.755 . . . . 0.0 107.91 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.2 p -149.84 148.34 25.08 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 124.145 0.978 . . . . 0.0 108.829 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -55.48 168.13 1.67 Allowed 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.975 3.117 . . . . 0.0 112.583 169.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -64.08 113.88 3.8 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -89.35 -12.9 39.16 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.623 0.769 . . . . 0.0 112.556 -172.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 68.09 -163.64 47.83 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -171.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -148.16 143.99 27.46 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.04 1.336 . . . . 0.0 108.004 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 27.4 mmt85 -71.17 153.63 42.34 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.41 119.2 19.17 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 169.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -153.88 165.6 35.57 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.105 1.362 . . . . 0.0 109.662 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 62.5 tp -145.32 140.12 27.52 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 173.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -79.01 119.4 22.11 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 172.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 62.61 -157.81 37.25 Favored Glycine 0 CA--C 1.532 1.145 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -172.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -150.86 146.41 26.31 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.22 -1.771 . . . . 0.0 106.22 172.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -65.63 136.6 56.54 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.9 m -74.75 -1.02 20.11 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.446 1.099 . . . . 0.0 113.857 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 82.21 -57.62 4.98 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.484 1.516 . . . . 0.0 111.24 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -78.55 -19.82 52.0 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.548 0.739 . . . . 0.0 111.633 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -75.66 137.79 40.93 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.212 0.605 . . . . 0.0 109.455 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 C-N-CA 125.52 1.528 . . . . 0.0 107.794 177.108 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.7 m 65.87 158.92 0.12 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.691 1.596 . . . . 0.0 111.877 -176.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -121.25 133.82 55.16 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 174.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -146.87 169.87 18.23 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.587 1.155 . . . . 0.0 109.905 -169.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.9 mt -119.29 138.77 48.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 171.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.35 160.81 31.6 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.159 0.583 . . . . 0.0 110.865 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.03 160.73 52.89 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.631 -0.587 . . . . 0.0 111.631 171.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -120.53 144.39 48.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.81 1.244 . . . . 0.0 111.918 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -104.96 81.25 1.72 Allowed 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.203 -1.776 . . . . 0.0 106.203 169.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.9 p 63.58 176.16 0.16 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 127.249 2.22 . . . . 0.0 111.28 -169.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.1 m -59.9 150.32 69.41 Favored Pre-proline 0 CA--C 1.541 0.625 0 O-C-N 121.713 -0.617 . . . . 0.0 111.17 -171.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.18 54.66 3.29 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 124.639 3.56 . . . . 0.0 109.972 169.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.4 tttm -52.12 -50.0 62.54 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 127.357 2.263 . . . . 0.0 111.962 -169.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.79 -41.49 95.78 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 122.644 0.377 . . . . 0.0 111.463 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -73.49 -38.9 65.23 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -174.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.7 t -61.91 -42.64 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 172.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -62.02 -51.2 68.97 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 118.305 0.502 . . . . 0.0 110.271 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.67 -40.19 96.2 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.502 0.721 . . . . 0.0 110.907 -176.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.08 -51.27 68.61 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.011 176.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -66.6 -31.69 72.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 118.287 -0.863 . . . . 0.0 111.881 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.86 -31.62 72.68 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.586 1.084 . . . . 0.0 110.086 176.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -82.7 -44.49 15.61 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.41 0.684 . . . . 0.0 110.617 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.0 mt -65.95 -40.16 86.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 O-C-N 121.027 -1.046 . . . . 0.0 109.016 -175.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.9 -30.14 69.99 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.734 -0.604 . . . . 0.0 111.102 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.9 ttp-105 -81.25 -41.78 21.7 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.386 1.074 . . . . 0.0 109.917 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 -58.58 -37.37 75.64 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.366 0.666 . . . . 0.0 110.586 173.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.1 m -82.35 -0.77 47.35 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.109 0.964 . . . . 0.0 113.433 174.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 85.7 mtp 54.79 38.46 30.23 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.542 1.937 . . . . 0.0 113.361 176.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.2 m-70 -82.6 56.33 3.3 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.849 0.86 . . . . 0.0 110.531 177.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -88.01 -28.38 21.44 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.412 0.685 . . . . 0.0 112.25 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . 0.276 1.0 OUTLIER 40.7 44.3 1.82 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.298 1.839 . . . . 0.0 113.525 -176.078 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.3 m 60.44 18.74 8.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.179 1.791 . . . . 0.0 114.36 177.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -67.42 -33.42 75.14 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.689 1.131 . . . . 0.0 110.578 169.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.0 mt 52.26 19.91 1.22 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.953 2.101 . . . . 0.0 113.062 -173.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -163.38 158.01 17.37 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 127.353 2.261 . . . . 0.0 107.25 -175.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -69.99 40.12 0.3 Allowed 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 124.09 3.193 . . . . 0.0 114.825 174.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.4 m -60.76 -27.84 68.26 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.642 1.177 . . . . 0.0 112.448 -175.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 28.4 ttt -111.24 122.7 37.02 Favored Pre-proline 0 N--CA 1.454 -0.227 0 N-CA-C 103.039 -2.949 . . . . 0.0 103.039 169.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.79 160.43 30.97 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 121.517 1.478 . . . . 0.0 114.687 -168.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.8 t -110.84 101.88 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 1 N-CA-C 98.888 -4.486 . . . . 0.0 98.888 166.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -141.99 157.25 45.16 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.64 1.176 . . . . 0.0 110.066 -168.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.0 t -140.39 120.16 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.472 0.709 . . . . 0.0 109.192 -172.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.1 m -84.02 142.9 30.13 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 168.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -120.91 137.03 54.79 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 125.682 1.593 . . . . 0.0 108.865 170.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.439 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 44.1 p90 -169.01 146.17 3.64 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -173.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.8 m 57.34 161.35 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.1 2.56 . . . . 0.0 115.86 167.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.2 tp -112.68 84.33 1.96 Allowed 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 170.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -76.17 118.63 19.1 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.57 1.148 . . . . 0.0 108.806 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 51.83 35.4 15.39 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.356 1.062 . . . . 0.0 112.336 176.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.37 17.66 73.24 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 118.859 -0.967 . . . . 0.0 113.992 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -133.57 138.64 46.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.809 1.644 . . . . 0.0 107.853 -176.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -71.62 142.49 49.96 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.645 -1.284 . . . . 0.0 108.973 -177.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.439 ' HB ' ' CE2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -103.66 157.9 16.74 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.497 1.044 . . . . 0.0 109.56 -179.686 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.89 169.62 38.15 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 171.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 36.1 m -137.04 146.9 45.78 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 169.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 p -123.62 140.86 45.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 175.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.6 tt -119.83 152.06 22.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 168.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 48.6 p -140.53 176.79 2.29 Favored Pre-proline 0 C--N 1.32 -0.701 0 C-N-CA 125.595 1.558 . . . . 0.0 107.237 169.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -59.78 -6.05 4.2 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.501 2.134 . . . . 0.0 114.297 169.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.0 p-90 -130.09 -21.75 2.93 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -169.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.12 166.1 32.69 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 120.089 1.313 . . . . 0.0 112.721 -177.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.81 122.39 18.53 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 168.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.2 m -136.51 135.38 38.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.326 0.584 . . . . 0.0 109.973 -175.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.65 145.11 52.68 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 168.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.5 m -137.61 146.08 28.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.9 mt -141.19 146.44 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -174.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -134.21 157.09 78.36 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-O 117.438 -1.267 . . . . 0.0 110.376 -172.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -57.2 9.21 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 0.989 1 C-N-CA 126.053 4.502 . . . . 0.0 120.001 -169.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.27 -155.85 44.46 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 117.86 -1.522 . . . . 0.0 111.43 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -65.42 -146.91 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.815 1 C-N-CA 125.324 4.016 . . . . 0.0 113.383 -174.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -74.43 58.1 0.74 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.457 1.503 . . . . 0.0 111.059 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -102.87 135.76 43.95 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 127.178 2.191 . . . . 0.0 106.855 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -108.11 88.19 2.67 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -177.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -69.23 149.79 97.42 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-O 118.847 -0.596 . . . . 0.0 109.407 172.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -67.76 157.21 62.79 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 N-CA-C 107.708 -1.689 . . . . 0.0 107.708 168.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 40.2 tp -62.94 122.99 17.39 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -88.27 159.23 18.2 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -174.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -86.03 152.65 22.73 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 168.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 83.9 t -99.74 155.08 4.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.342 -1.299 . . . . 0.0 107.862 -169.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.4 m 65.14 7.49 4.15 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.581 1.552 . . . . 0.0 113.489 -173.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -78.27 157.99 29.06 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.344 1.457 . . . . 0.0 107.967 169.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -122.86 141.29 52.03 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 123.054 0.542 . . . . 0.0 110.471 -177.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.2 mm -117.2 121.25 67.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -74.28 122.44 7.38 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.655 -1.778 . . . . 0.0 108.655 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.4 tp -120.36 132.35 55.24 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 124.443 1.097 . . . . 0.0 108.637 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.48 127.8 35.23 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 173.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mp -135.89 157.91 75.03 Favored Pre-proline 0 C--O 1.235 0.296 0 C-N-CA 125.295 1.438 . . . . 0.0 107.91 173.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -61.66 -20.24 68.15 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.367 2.044 . . . . 0.0 114.243 171.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -58.22 -32.26 68.13 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.504 0.722 . . . . 0.0 111.147 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 133.17 157.31 8.37 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 106.621 -2.592 . . . . 0.0 106.621 -169.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.1 m -66.53 130.02 41.79 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 58.5 mtm -137.46 141.16 41.57 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -176.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.77 129.88 34.77 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 170.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -99.21 124.75 44.51 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 169.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.6 m -81.07 140.43 35.11 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.3 t -75.38 120.11 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 169.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -109.48 163.54 12.5 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 172.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -125.3 95.04 4.33 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 170.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.7 tp -74.25 125.76 29.14 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -169.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -59.34 128.57 37.73 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.625 0.77 . . . . 0.0 110.108 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.77 3.91 84.53 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.689 -1.062 . . . . 0.0 113.869 -177.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.4 t -126.64 -119.92 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 119.263 1.531 . . . . 0.0 107.596 177.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.2 m -150.73 -179.31 7.15 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.622 1.569 . . . . 0.0 108.791 -169.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -69.85 143.44 52.85 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 169.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.26 172.57 16.79 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.437 1.495 . . . . 0.0 108.559 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.6 mp -106.52 142.6 35.91 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 172.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.3 p -142.11 152.65 43.46 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.693 0.797 . . . . 0.0 110.411 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 15.7 t -144.43 119.69 10.19 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 171.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.0 m -67.68 129.09 38.82 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 81.4 mt -92.3 -52.57 4.61 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.72 175.32 12.11 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.455 1.502 . . . . 0.0 108.102 171.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.3 m -116.64 62.79 2.71 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.633 1.173 . . . . 0.0 110.69 -175.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -64.33 129.7 24.81 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.297 1.998 . . . . 0.0 109.771 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.2 tt -151.84 110.33 3.78 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 171.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.7 m -148.37 144.1 27.28 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -176.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -82.13 -25.59 34.26 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.332 0.514 . . . . 0.0 109.935 173.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.5 m -80.29 63.95 4.94 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.773 1.229 . . . . 0.0 109.046 170.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.87 161.2 41.78 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.946 1.699 . . . . 0.0 107.745 -175.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 93.5 p -152.37 172.23 16.8 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.767 0.794 . . . . 0.0 112.286 -169.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.1 pp -64.64 -20.09 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 124.871 1.268 . . . . 0.0 112.215 169.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -79.63 -55.39 5.06 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -66.1 -30.85 71.43 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 123.591 0.757 . . . . 0.0 110.584 177.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -64.15 -52.18 46.57 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 119.804 1.184 . . . . 0.0 111.596 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -65.75 -46.82 77.4 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.164 0.982 . . . . 0.0 110.082 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -58.55 -43.82 89.47 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 118.423 -0.799 . . . . 0.0 110.566 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.0 tp -76.74 -28.34 55.72 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 119.365 0.984 . . . . 0.0 111.619 -173.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -69.08 -39.75 78.87 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 120.083 1.31 . . . . 0.0 109.498 174.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.21 -43.87 66.52 Favored 'General case' 0 N--CA 1.46 0.052 0 C-N-CA 122.985 0.514 . . . . 0.0 111.332 176.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -57.92 -39.14 77.25 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 121.176 -0.952 . . . . 0.0 109.612 173.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 20.0 m -64.33 -34.53 78.36 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 119.424 -0.322 . . . . 0.0 110.758 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.69 -56.79 15.93 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.397 0.679 . . . . 0.0 109.926 174.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -42.16 97.94 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 119.412 1.006 . . . . 0.0 109.556 -177.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 53.1 ttp -49.31 -55.39 12.93 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.956 1.302 . . . . 0.0 110.192 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 6.7 pt -80.3 -21.99 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 119.879 1.218 . . . . 0.0 112.604 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 24.5 mt -67.16 -56.53 9.56 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.615 0.643 . . . . 0.0 110.947 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.8 m -143.93 6.7 1.39 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -169.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.9 tp 44.86 54.18 12.5 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.137 1.375 . . . . 0.0 114.255 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -66.33 162.24 37.12 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.777 2.318 . . . . 0.0 111.355 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 43.1 t -123.59 148.46 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.306 1.442 . . . . 0.0 107.256 174.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 7.8 m -57.29 133.1 54.81 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.013 0.925 . . . . 0.0 110.217 -176.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -147.85 121.5 4.84 Favored Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 124.925 1.29 . . . . 0.0 107.684 175.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -59.54 150.74 74.05 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.745 2.297 . . . . 0.0 111.915 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -141.0 145.69 36.27 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.315 1.446 . . . . 0.0 109.93 -176.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.27 146.62 20.27 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.591 1.557 . . . . 0.0 107.44 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -59.67 -39.79 70.72 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.746 2.298 . . . . 0.0 112.489 178.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -153.07 125.15 7.97 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.877 1.271 . . . . 0.0 108.044 173.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.32 -31.6 48.83 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.403 0.281 . . . . 0.0 111.293 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 71.5 -178.01 35.93 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.106 0.86 . . . . 0.0 111.995 -176.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 89.0 mmt-85 -145.91 157.55 43.89 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 126.034 1.733 . . . . 0.0 107.693 172.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -83.22 64.99 8.02 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 171.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -60.89 -31.43 70.92 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.097 0.559 . . . . 0.0 112.316 -169.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -81.35 -2.71 50.23 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -178.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 37.6 tp -84.08 66.75 9.4 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -70.63 -32.0 69.16 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.474 0.709 . . . . 0.0 111.58 -175.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 66.7 -162.12 45.5 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -172.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 68.76 139.53 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.273 2.229 . . . . 0.0 110.351 -170.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 53.3 29.77 9.1 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.074 0.95 . . . . 0.0 111.549 -169.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.8 m -58.71 139.24 56.43 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.744 0.818 . . . . 0.0 111.077 -169.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 100.13 -48.91 1.18 Allowed Glycine 0 CA--C 1.528 0.89 0 C-N-CA 125.08 1.324 . . . . 0.0 110.032 -175.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -77.7 -45.13 25.75 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 169.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -87.39 127.84 35.2 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.737 1.615 . . . . 0.0 107.006 169.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 C-N-CA 125.583 1.553 . . . . 0.0 107.772 178.04 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 tpt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 120.662 0.267 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.4 p -70.19 -25.52 63.46 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.034 -1.041 . . . . 0.0 112.276 -176.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -84.54 39.35 0.73 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.659 1.184 . . . . 0.0 111.004 -177.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -138.94 162.24 35.36 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.88 1.672 . . . . 0.0 109.374 -177.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 mt -117.91 138.59 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 174.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.07 154.6 39.13 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.744 0.417 . . . . 0.0 110.55 176.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.22 156.65 34.14 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 169.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -125.07 151.48 45.61 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.474 1.11 . . . . 0.0 110.007 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -85.21 -21.16 29.25 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.941 0.896 . . . . 0.0 111.844 -176.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.4 p -159.06 -178.73 7.44 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 128.739 2.815 . . . . 0.0 105.897 173.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.7 m -59.49 139.91 88.87 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 168.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.16 54.45 4.19 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 124.553 3.502 . . . . 0.0 107.807 169.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.7 pttm -60.41 -34.89 74.59 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.634 1.174 . . . . 0.0 113.13 -168.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.58 -42.34 87.13 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.207 0.912 . . . . 0.0 110.614 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -70.9 -41.08 71.74 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 81.3 t -59.97 -42.55 89.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 172.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -60.74 -53.55 56.06 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 123.479 0.712 . . . . 0.0 109.71 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.57 -40.97 98.55 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.367 0.53 . . . . 0.0 110.857 -176.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.74 -46.81 83.66 Favored 'General case' 0 N--CA 1.456 -0.126 0 O-C-N 122.238 -0.289 . . . . 0.0 110.466 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -70.96 -28.25 64.33 Favored 'General case' 0 C--O 1.23 0.065 0 CA-C-O 118.65 -0.69 . . . . 0.0 112.446 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.8 -37.24 83.64 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.114 0.87 . . . . 0.0 109.615 174.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -65.73 -41.49 92.18 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.721 -0.657 . . . . 0.0 110.448 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.6 mm -64.76 -41.86 93.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 119.717 1.144 . . . . 0.0 109.559 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.6 -26.54 66.31 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.939 0.495 . . . . 0.0 111.459 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 55.5 ttp85 -71.93 -47.88 49.35 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 172.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.08 -16.34 1.93 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.487 1.515 . . . . 0.0 114.132 175.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.5 m -62.95 -22.73 67.0 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 119.799 1.181 . . . . 0.0 112.084 172.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 21.2 ptt? -110.97 169.59 8.67 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.48 1.512 . . . . 0.0 108.962 169.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -62.44 153.66 30.74 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.021 0.439 . . . . 0.0 110.106 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -63.29 -29.96 71.19 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -169.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -83.49 -8.9 59.27 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.1 m -79.85 147.72 31.64 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 119.028 0.831 . . . . 0.0 109.377 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -136.7 30.84 2.82 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.811 0.844 . . . . 0.0 110.94 -175.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -64.04 147.12 52.89 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.659 -0.65 . . . . 0.0 109.445 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 86.7 t60 -69.64 140.88 89.76 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-O 118.447 -0.787 . . . . 0.0 109.513 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -66.35 -32.39 41.23 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.21 1.94 . . . . 0.0 113.851 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.3 m 65.64 -4.87 0.54 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.3 2.24 . . . . 0.0 114.464 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 22.4 mmt -141.61 90.49 8.77 Favored Pre-proline 0 N--CA 1.458 -0.069 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 170.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -51.58 134.72 47.12 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.976 2.451 . . . . 0.0 111.671 -176.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.46 128.68 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 169.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -148.55 150.82 34.02 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.583 1.153 . . . . 0.0 108.634 -170.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.6 t -141.73 121.15 10.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.2 p -96.82 154.93 17.0 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 118.849 0.749 . . . . 0.0 110.939 169.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -119.52 142.87 47.93 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.743 2.017 . . . . 0.0 109.614 -171.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -147.22 167.73 23.47 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -169.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.7 m -14.3 139.82 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 1 C-N-CA 133.208 4.603 . . . . 0.0 117.149 169.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.0 tp -78.4 127.95 32.93 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 169.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -147.6 146.07 29.24 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 125.47 1.508 . . . . 0.0 107.311 175.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 53.91 26.63 6.4 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 120.482 1.492 . . . . 0.0 112.876 -175.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.18 25.4 75.47 Favored Glycine 0 CA--C 1.535 1.303 0 O-C-N 121.228 -0.92 . . . . 0.0 113.446 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -148.36 149.06 31.12 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.222 1.409 . . . . 0.0 110.056 -173.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -79.75 140.35 36.96 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 121.212 -0.93 . . . . 0.0 109.122 -177.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.0 160.09 20.11 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.805 0.812 . . . . 0.0 108.857 170.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -167.19 162.74 36.53 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 107.581 -2.208 . . . . 0.0 107.581 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 13.0 m -138.92 147.03 41.78 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 169.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 p -122.23 147.65 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 125.108 1.363 . . . . 0.0 107.817 172.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.4 tt -128.31 151.24 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 169.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.0 p -141.98 177.7 1.8 Allowed Pre-proline 0 C--N 1.32 -0.706 0 C-N-CA 125.331 1.452 . . . . 0.0 107.282 171.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -60.23 -30.37 91.06 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 CA-C-N 119.99 1.032 . . . . 0.0 110.552 168.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -94.29 -25.24 17.1 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -169.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.57 170.36 22.59 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 120.506 1.503 . . . . 0.0 112.965 -174.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 tt -137.72 123.98 20.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 168.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.7 m -137.36 134.51 36.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.438 0.637 . . . . 0.0 110.451 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.32 139.62 44.3 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 168.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 m -139.21 140.16 38.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -172.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.6 mm -135.73 138.53 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -169.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -131.02 145.63 58.6 Favored Pre-proline 0 N--CA 1.474 0.729 0 CA-C-O 117.692 -1.147 . . . . 0.0 111.867 -169.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -51.02 137.6 44.26 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.15 2.567 . . . . 0.0 112.698 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.52 179.83 28.92 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 123.427 0.537 . . . . 0.0 113.306 -175.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.43 123.4 11.73 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.992 2.461 . . . . 0.0 110.191 -173.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.1 t70 49.69 35.7 9.37 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.218 1.407 . . . . 0.0 113.15 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -95.87 127.77 42.18 Favored 'General case' 0 C--N 1.344 0.341 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.49 75.74 0.94 Allowed 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -170.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 48.7 m0 -68.58 149.07 98.1 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.192 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.31 151.84 80.09 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.011 1.807 . . . . 0.0 109.053 169.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.8 tp -56.04 131.91 48.69 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.557 -0.715 . . . . 0.0 109.254 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.41 157.95 16.06 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -90.3 148.86 22.61 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 169.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.2 t -91.6 154.81 3.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -169.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.5 m 60.72 33.7 20.13 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.911 0.884 . . . . 0.0 111.98 -176.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -112.27 155.6 23.79 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 127.019 2.128 . . . . 0.0 106.989 169.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -105.77 142.22 35.87 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.289 0.949 . . . . 0.0 110.546 178.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.7 mm -121.19 131.58 72.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.11 126.36 8.26 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 174.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.8 mt -113.01 124.87 53.62 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 172.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.64 133.36 43.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 169.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.4 mt -141.19 158.22 64.79 Favored Pre-proline 0 C--O 1.234 0.254 0 C-N-CA 124.13 0.972 . . . . 0.0 108.465 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -57.77 -29.63 86.48 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.738 2.292 . . . . 0.0 112.81 170.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -64.38 -18.5 64.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.45 1.1 . . . . 0.0 113.023 173.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 110.47 154.54 14.13 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 107.821 -2.112 . . . . 0.0 107.821 -168.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.1 m -65.03 132.35 48.98 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -175.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 64.3 mtm -141.12 145.75 36.16 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.846 1.258 . . . . 0.0 108.345 -178.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.41 136.91 37.09 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 121.597 -0.689 . . . . 0.0 109.33 172.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -115.34 139.7 49.76 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 169.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.7 m -87.12 137.18 32.57 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 52.5 t -68.08 122.56 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 170.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -109.34 163.11 12.57 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 107.565 -2.214 . . . . 0.0 107.565 169.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -133.38 94.25 3.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 171.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.5 tp -80.28 126.44 31.14 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -170.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -59.81 132.4 53.83 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.219 0.608 . . . . 0.0 110.451 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.94 5.43 75.34 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.659 -1.078 . . . . 0.0 113.482 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.9 t -125.62 -115.27 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.8 p -159.23 178.67 9.74 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 119.742 1.155 . . . . 0.0 110.236 -169.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -73.64 138.05 44.56 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 169.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.87 165.15 36.99 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.777 1.631 . . . . 0.0 107.684 -175.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.4 mp -111.47 130.35 55.75 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.5 m -131.23 150.46 52.14 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.519 0.728 . . . . 0.0 110.913 -170.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 40.4 t -143.14 121.47 12.31 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 169.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.1 m -76.2 137.55 40.08 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -90.41 -67.49 0.84 Allowed 'General case' 0 C--N 1.339 0.119 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 175.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.14 173.2 8.1 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.908 1.283 . . . . 0.0 109.054 -175.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.2 m -83.63 124.89 74.8 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 169.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -82.1 41.23 1.09 Allowed 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.61 2.873 . . . . 0.0 112.0 -171.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.2 mt -87.17 42.6 1.04 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.36 1.464 . . . . 0.0 110.242 -173.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.0 m -66.45 155.36 37.75 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.128 0.971 . . . . 0.0 110.418 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -72.17 -56.79 4.97 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 175.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.1 m -84.95 99.44 10.97 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.36 139.58 15.61 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -169.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 62.6 m -148.68 163.9 35.95 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.142 1.777 . . . . 0.0 107.993 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.36 -38.42 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.778 1.231 . . . . 0.0 111.394 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -75.74 -35.01 60.34 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.898 0.479 . . . . 0.0 109.751 -174.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -68.15 -28.87 67.67 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 124.6 1.16 . . . . 0.0 110.585 169.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.76 -55.54 30.27 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 120.235 1.379 . . . . 0.0 110.13 171.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -63.56 -51.35 65.75 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.557 -0.966 . . . . 0.0 110.189 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -68.41 -17.61 64.26 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 117.979 -1.01 . . . . 0.0 112.908 -175.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 32.8 tp -88.53 -25.86 22.32 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 120.257 1.389 . . . . 0.0 109.56 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.8 m -63.57 -48.74 76.21 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 169.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -61.06 -49.37 77.64 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 124.58 1.152 . . . . 0.0 111.933 175.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -62.47 -33.82 75.6 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.636 0.653 . . . . 0.0 110.469 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 34.8 m -69.99 -28.47 65.55 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.444 0.565 . . . . 0.0 111.216 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.03 -51.07 13.1 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.884 0.765 . . . . 0.0 109.564 170.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -51.84 -49.88 61.98 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.042 0.937 . . . . 0.0 110.147 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -56.79 -39.69 74.55 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.055 -178.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 22.4 pt -82.77 -22.62 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 119.722 1.147 . . . . 0.0 111.928 -178.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 52.2 mt -74.45 -24.93 59.13 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.414 0.686 . . . . 0.0 109.491 169.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.4 m 55.25 18.2 2.37 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.15 2.58 . . . . 0.0 114.993 176.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 96.6 mt -151.08 140.66 13.94 Favored Pre-proline 0 C--O 1.234 0.249 0 C-N-CA 127.04 2.136 . . . . 0.0 108.058 -174.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -71.67 124.89 10.62 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.277 1.985 . . . . 0.0 107.985 169.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.2 p -153.46 144.57 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 7.3 m -86.5 144.89 27.03 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.276 1.03 . . . . 0.0 109.185 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -141.13 104.84 6.1 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 169.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -60.32 136.09 65.9 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.561 2.174 . . . . 0.0 111.429 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.51 140.33 38.58 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 170.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.5 t -141.79 146.51 41.37 Favored Pre-proline 0 C--O 1.238 0.467 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.53 147.13 49.61 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.668 2.912 . . . . 0.0 109.928 168.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -69.03 125.09 25.56 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.53 156.94 28.98 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.334 0.654 . . . . 0.0 110.14 -174.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 70.54 18.35 75.45 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.384 -0.676 . . . . 0.0 114.108 170.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 62.5 mtm180 -64.6 147.46 52.88 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.9 1.35 . . . . 0.0 109.455 174.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 -68.96 153.84 43.1 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.45 -8.02 59.38 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.451 0.701 . . . . 0.0 112.31 175.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -143.35 159.93 41.46 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.336 1.454 . . . . 0.0 110.183 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 94.1 mt -107.11 162.72 13.62 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.457 1.103 . . . . 0.0 109.154 172.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -122.33 148.68 44.75 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.955 1.302 . . . . 0.0 109.428 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -97.74 -177.07 33.87 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 173.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -66.08 -32.96 74.74 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.852 -0.793 . . . . 0.0 111.014 176.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -74.73 -19.64 60.16 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.5 m -67.68 153.74 43.03 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.462 0.705 . . . . 0.0 110.772 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -178.23 166.49 36.55 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -138.6 158.73 43.7 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.637 1.575 . . . . 0.0 108.492 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -74.88 143.71 43.71 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 122.862 0.465 . . . . 0.0 109.975 174.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.2 0 C-N-CA 126.084 1.754 . . . . 0.0 110.599 -178.593 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.495 1.811 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.4 p -80.09 -29.95 39.13 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.943 0.897 . . . . 0.0 111.253 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -66.46 137.95 57.19 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 46.81 80.76 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.738 2.015 . . . . 0.0 112.711 174.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.1 mm -71.24 138.29 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.36 132.27 47.35 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.6 -0.687 . . . . 0.0 109.244 176.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.12 145.76 49.29 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 173.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -91.88 147.08 23.24 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.632 0.773 . . . . 0.0 109.65 -174.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -74.07 -29.48 61.9 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 118.969 -0.539 . . . . 0.0 110.756 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.1 p -154.88 164.03 39.43 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 127.337 2.255 . . . . 0.0 107.962 171.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.4 m -45.85 135.77 6.36 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 125.644 1.578 . . . . 0.0 111.801 173.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.11 52.41 3.82 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.201 3.267 . . . . 0.0 110.525 172.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -53.54 -49.69 67.07 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.202 1.801 . . . . 0.0 111.675 -169.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.58 -41.34 96.33 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.609 0.363 . . . . 0.0 111.284 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -71.51 -41.57 69.06 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.877 0.471 . . . . 0.0 109.764 -174.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 89.9 t -62.31 -45.95 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 172.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -58.85 -53.12 62.02 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.096 0.862 . . . . 0.0 110.872 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.52 -42.46 95.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.901 0.773 . . . . 0.0 111.034 -174.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.25 -46.26 87.73 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -71.21 -25.34 62.47 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 118.147 -0.93 . . . . 0.0 112.014 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -62.91 -34.29 77.11 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.98 1.264 . . . . 0.0 109.579 172.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -79.65 -46.91 16.29 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.718 0.407 . . . . 0.0 110.554 177.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.4 mt -59.93 -39.97 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.447 0.699 . . . . 0.0 109.185 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.79 -36.3 82.68 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.445 -0.784 . . . . 0.0 111.183 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -74.36 -40.42 62.14 Favored 'General case' 0 N--CA 1.46 0.06 0 C-N-CA 123.252 0.621 . . . . 0.0 109.955 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -59.57 -40.65 88.02 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.677 0.791 . . . . 0.0 110.831 170.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 64.6 m -77.49 -44.24 29.48 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.259 0.624 . . . . 0.0 112.441 -172.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 47.5 tpp -79.85 146.21 32.34 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 122.975 0.51 . . . . 0.0 110.221 -172.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -116.77 167.0 11.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.893 1.277 . . . . 0.0 110.03 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.3 t70 57.28 35.05 25.63 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 122.924 1.345 . . . . 0.0 109.978 -169.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.9 tp -111.06 41.1 1.89 Allowed 'General case' 0 C--N 1.342 0.263 0 C-N-CA 126.333 1.853 . . . . 0.0 108.878 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.5 m -59.06 -15.5 14.04 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.688 1.195 . . . . 0.0 113.641 -177.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -69.16 -14.58 63.07 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.682 1.193 . . . . 0.0 112.323 170.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 98.7 mt 55.29 27.61 10.09 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.855 2.462 . . . . 0.0 113.943 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 67.7 t60 -142.78 145.91 35.73 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -52.88 142.88 50.92 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.121 2.548 . . . . 0.0 114.349 -178.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 p -79.7 -19.77 48.12 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.784 1.633 . . . . 0.0 112.619 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 68.6 mtm -138.24 159.73 66.91 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 128.147 2.579 . . . . 0.0 104.22 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -69.62 142.99 50.09 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.221 1.281 . . . . 0.0 112.509 -168.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 97.7 t -104.51 105.89 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 102.058 -3.312 . . . . 0.0 102.058 167.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -142.43 156.33 45.18 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.574 1.15 . . . . 0.0 109.109 -169.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.0 t -137.38 117.24 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -176.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.6 p -78.27 150.06 33.44 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.394 0.997 . . . . 0.0 108.893 168.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.96 131.98 49.25 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.77 1.628 . . . . 0.0 108.64 173.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.401 ' CE1' ' CB ' ' A' ' 131' ' ' ALA . 5.3 p90 -168.78 150.6 4.79 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 123.645 0.778 . . . . 0.0 112.408 -176.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 95.1 m 55.65 157.36 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 128.571 2.748 . . . . 0.0 116.591 167.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.2 tt -111.87 116.15 30.17 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 169.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -139.44 141.82 37.44 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.219 1.408 . . . . 0.0 108.966 -172.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 53.94 26.41 6.27 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.538 1.135 . . . . 0.0 112.297 -172.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.64 5.43 83.2 Favored Glycine 0 CA--C 1.536 1.346 0 O-C-N 120.957 -1.089 . . . . 0.0 113.576 -175.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -118.16 165.92 13.2 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.603 2.361 . . . . 0.0 109.732 -173.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -85.52 148.76 25.8 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.692 1.133 . . . . 0.0 109.866 172.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.19 157.45 19.41 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.494 1.043 . . . . 0.0 110.23 -174.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -171.3 175.76 44.78 Favored Glycine 0 N--CA 1.449 -0.458 0 O-C-N 120.826 -1.171 . . . . 0.0 110.574 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 31.3 m -140.07 154.79 47.17 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 169.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 p -124.88 144.37 35.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.5 tt -124.65 150.79 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 168.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.5 p -142.52 177.16 1.97 Allowed Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 171.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.26 -14.31 44.38 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 CA-C-N 121.179 1.457 . . . . 0.0 111.593 168.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.4 p-90 -108.56 -21.91 12.51 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -172.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 21.9 ptt? -157.59 164.96 36.73 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 120.421 1.464 . . . . 0.0 112.669 -177.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 tt -134.68 123.99 24.59 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 103.185 -2.895 . . . . 0.0 103.185 167.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.7 m -142.17 134.46 27.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.029 0.377 . . . . 0.0 110.069 -172.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.76 143.32 57.58 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 168.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.3 m -140.12 145.79 25.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 37.8 mt -139.83 133.05 35.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 -172.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -122.1 154.04 61.39 Favored Pre-proline 0 N--CA 1.467 0.394 0 CA-C-O 117.785 -1.102 . . . . 0.0 111.023 -169.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -47.96 118.91 3.42 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.546 2.831 . . . . 0.0 112.466 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.43 179.09 26.19 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 123.246 0.342 . . . . 0.0 112.478 -177.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.6 160.18 31.68 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.021 2.481 . . . . 0.0 111.571 -174.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.8 t0 42.91 52.09 5.2 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.805 2.042 . . . . 0.0 113.776 169.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -152.31 160.68 43.29 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.525 1.13 . . . . 0.0 108.526 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -103.73 112.19 25.03 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 169.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.0 130.13 91.7 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.76 147.51 81.28 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.883 1.722 . . . . 0.0 109.825 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 34.0 tp -69.29 121.91 17.82 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 173.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.82 159.83 18.61 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.688 1.195 . . . . 0.0 108.924 176.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -80.27 151.23 29.69 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 169.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.4 t -99.34 151.31 4.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -169.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.9 m 59.92 24.66 13.75 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.116 0.967 . . . . 0.0 112.324 -175.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -109.82 157.63 18.99 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 128.652 2.781 . . . . 0.0 105.023 169.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -108.77 147.55 31.87 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.03 0.832 . . . . 0.0 111.606 -176.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.7 mm -122.16 131.98 71.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.35 124.65 7.73 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 173.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.1 mt -111.67 137.26 49.79 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 171.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -90.71 129.43 36.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 174.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -153.86 159.24 32.27 Favored Pre-proline 0 C--O 1.235 0.307 0 C-N-CA 125.06 1.344 . . . . 0.0 108.562 172.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -67.08 -15.7 47.28 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.224 1.949 . . . . 0.0 114.219 -170.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -58.39 -26.01 62.72 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.299 0.64 . . . . 0.0 111.042 169.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.57 148.02 7.59 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 106.41 -2.676 . . . . 0.0 106.41 -169.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.0 m -60.26 130.85 48.69 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 49.9 mtm -134.15 141.92 47.27 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 124.025 0.93 . . . . 0.0 108.649 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.96 113.29 19.77 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 172.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -91.9 136.71 32.95 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 171.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.1 m -83.48 137.92 33.67 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.5 t -73.39 125.81 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 173.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -106.74 154.83 16.65 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.197 -2.361 . . . . 0.0 107.197 169.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -129.12 103.03 6.75 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 170.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.8 tp -85.26 122.39 29.36 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -176.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -60.38 131.35 50.49 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.265 0.626 . . . . 0.0 110.687 -173.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.01 3.59 69.21 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 118.759 -1.023 . . . . 0.0 113.66 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.9 t -120.61 -103.87 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 119.074 1.437 . . . . 0.0 107.24 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.8 p -163.97 173.94 12.01 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 119.952 1.251 . . . . 0.0 110.737 -171.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -78.8 142.01 37.29 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 168.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -154.26 177.65 10.89 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.027 1.331 . . . . 0.0 108.029 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.3 mt -124.45 137.79 54.41 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.18 0.992 . . . . 0.0 108.922 -173.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.7 m -135.66 147.39 48.56 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.627 1.171 . . . . 0.0 110.028 -173.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 36.6 t -140.52 118.28 11.7 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 172.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.9 m -67.99 135.05 51.73 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.242 0.617 . . . . 0.0 109.438 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.8 mt -109.22 -47.77 3.36 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 123.646 0.778 . . . . 0.0 110.636 -176.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 17.7 ptp -160.42 169.46 23.01 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.918 0.887 . . . . 0.0 110.111 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.2 m -111.68 108.5 56.07 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 169.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -69.12 161.25 46.62 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.569 2.18 . . . . 0.0 111.084 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -143.61 158.23 43.82 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 124.822 1.249 . . . . 0.0 109.563 175.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.5 m -69.01 -17.53 63.93 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -169.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -82.57 140.84 33.03 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 118.775 0.716 . . . . 0.0 109.999 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.9 m 54.19 38.21 28.74 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.323 1.049 . . . . 0.0 111.111 -176.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 8.3 tpt -148.64 144.36 27.13 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.272 1.429 . . . . 0.0 109.12 -169.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 29.8 m -145.02 164.76 30.18 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 125.977 1.711 . . . . 0.0 107.178 173.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.33 -21.0 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 O-C-N 121.066 -1.021 . . . . 0.0 112.771 -176.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -70.63 -44.72 66.59 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 173.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -60.5 -39.55 88.13 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 118.278 -0.868 . . . . 0.0 109.313 172.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.68 -54.96 33.21 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 119.595 1.088 . . . . 0.0 111.521 177.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -62.36 -49.23 76.38 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.671 -0.9 . . . . 0.0 110.358 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 83.6 mtt-85 -69.97 -19.17 63.37 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.62 -0.675 . . . . 0.0 111.985 -175.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.1 tp -89.06 -18.94 26.28 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 124.138 0.975 . . . . 0.0 109.447 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.5 m -69.64 -44.99 69.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 169.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -66.94 -42.53 85.14 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.577 -0.702 . . . . 0.0 112.003 174.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -69.64 -29.76 67.31 Favored 'General case' 0 C--N 1.334 -0.067 0 O-C-N 121.176 -0.953 . . . . 0.0 110.731 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 22.8 m -70.27 -43.02 71.34 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.378 0.535 . . . . 0.0 110.281 174.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.401 ' CB ' ' CE1' ' A' ' 45' ' ' PHE . . . -53.67 -45.79 70.41 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.296 1.039 . . . . 0.0 109.922 173.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.5 ttp-105 -69.75 -50.09 46.77 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.354 -0.841 . . . . 0.0 111.578 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.88 -26.68 67.59 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.53 1.059 . . . . 0.0 112.764 -171.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 10.7 pt -77.31 -11.52 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 120.2 1.364 . . . . 0.0 113.376 174.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 75.4 mt -73.78 -32.59 63.85 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 169.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.9 m 54.1 24.85 5.1 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.387 1.875 . . . . 0.0 114.89 173.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 92.4 mt -144.45 150.59 48.26 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.197 1.799 . . . . 0.0 108.969 -174.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -70.02 168.9 20.55 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.182 2.588 . . . . 0.0 110.697 170.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 44.6 t -67.23 137.81 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 173.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 3.8 m -65.08 144.62 57.13 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.12 0.968 . . . . 0.0 110.228 -176.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -125.65 84.88 59.78 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 171.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.25 160.57 48.5 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.983 2.455 . . . . 0.0 111.356 -175.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -148.2 132.87 17.84 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.944 1.697 . . . . 0.0 107.823 170.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.5 m -139.94 157.11 70.12 Favored Pre-proline 0 C--O 1.24 0.585 0 C-N-CA 124.898 1.279 . . . . 0.0 110.542 -169.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -67.61 174.22 7.78 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.773 2.315 . . . . 0.0 110.631 169.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -55.79 131.58 47.17 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.13 0.572 . . . . 0.0 109.708 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.53 -39.47 45.98 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.6 0.36 . . . . 0.0 110.311 176.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -90.35 -149.47 22.38 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.658 1.123 . . . . 0.0 110.715 173.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -61.63 161.86 9.24 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.176 0.59 . . . . 0.0 111.194 173.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -64.33 145.84 55.37 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 169.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -79.77 -9.21 59.62 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 175.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 11.3 mp -63.73 148.88 48.01 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.461 1.104 . . . . 0.0 109.577 177.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -73.56 122.05 21.62 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 169.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -151.56 161.39 42.76 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.332 1.053 . . . . 0.0 109.143 -173.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 73.9 25.3 72.0 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 119.467 -0.63 . . . . 0.0 113.252 174.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -127.91 140.79 51.79 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.339 1.056 . . . . 0.0 108.625 174.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -80.15 -31.83 38.92 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 122.986 0.514 . . . . 0.0 110.633 177.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.3 m -65.33 144.03 57.38 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.882 0.873 . . . . 0.0 111.083 -173.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -81.01 -171.51 44.88 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 169.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -142.79 145.99 33.79 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.986 1.314 . . . . 0.0 107.804 175.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -68.84 137.1 53.65 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 122.922 0.489 . . . . 0.0 110.096 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.303 0 C-N-CA 125.527 1.531 . . . . 0.0 107.89 176.389 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tpt . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 119.604 -0.236 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.2 p -75.19 160.03 30.88 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.045 0.938 . . . . 0.0 110.281 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -85.82 55.94 3.75 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.051 0.94 . . . . 0.0 109.201 177.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -143.34 161.68 37.7 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.98 1.712 . . . . 0.0 109.383 -172.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.4 mt -132.15 131.89 61.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 175.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.75 128.22 35.03 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 170.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.67 146.07 48.75 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -93.03 138.79 31.18 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.701 0.8 . . . . 0.0 111.034 -169.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -69.14 -24.32 64.08 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.566 0.747 . . . . 0.0 111.151 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -162.12 172.42 15.87 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.86 1.264 . . . . 0.0 108.984 171.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.2 m -61.08 138.22 94.24 Favored Pre-proline 0 C--N 1.324 -0.502 0 C-N-CA 125.776 1.63 . . . . 0.0 110.432 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -69.77 48.14 0.61 Allowed 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 124.607 3.538 . . . . 0.0 112.706 169.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -50.97 -57.15 9.32 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.025 1.73 . . . . 0.0 112.771 -169.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.409 ' HB1' ' CD2' ' A' ' 146' ' ' HIS . . . -68.85 -38.18 79.59 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 117.821 0.282 . . . . 0.0 110.273 -177.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -61.01 -45.37 95.07 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.627 0.771 . . . . 0.0 110.842 178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.0 t -64.57 -42.6 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -61.15 -51.54 68.62 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.839 0.745 . . . . 0.0 110.427 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.85 -39.41 93.51 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.006 0.922 . . . . 0.0 110.837 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.84 -46.17 90.62 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 175.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -72.81 -26.09 61.38 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 118.208 -0.901 . . . . 0.0 112.703 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -65.55 -28.87 69.47 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 120.084 1.311 . . . . 0.0 109.636 172.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -81.78 -47.52 12.76 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.244 1.018 . . . . 0.0 109.713 176.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.8 mt -67.9 -38.5 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 O-C-N 121.277 -0.889 . . . . 0.0 109.674 -175.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.6 -30.33 71.35 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.413 -0.804 . . . . 0.0 110.676 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.9 ttm105 -76.62 -37.5 56.27 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 123.518 0.727 . . . . 0.0 109.713 174.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -54.93 -38.89 68.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.915 0.886 . . . . 0.0 110.923 173.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.2 m -67.88 -8.79 39.46 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 174.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 60.9 mtt -122.21 33.97 5.31 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.132 2.173 . . . . 0.0 109.088 176.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.26 151.99 11.75 Favored 'General case' 0 C--N 1.34 0.189 0 O-C-N 121.478 -0.764 . . . . 0.0 111.478 -178.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.4 t70 68.41 -33.08 0.23 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 127.726 2.41 . . . . 0.0 112.685 -169.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 mp -89.25 23.92 2.34 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.453 1.501 . . . . 0.0 109.076 169.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.4 m -60.38 -17.22 42.28 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.832 1.653 . . . . 0.0 114.0 -169.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -66.58 -18.1 65.18 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.853 1.261 . . . . 0.0 112.501 174.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.0 mt -66.38 160.21 25.24 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.477 0.711 . . . . 0.0 110.662 177.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -119.26 157.07 52.09 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 125.683 1.593 . . . . 0.0 108.54 169.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -57.44 134.61 64.65 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.538 2.159 . . . . 0.0 112.309 -177.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.2 m -71.42 -15.38 62.35 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.049 0.94 . . . . 0.0 112.638 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 35.2 tpp -144.8 144.41 24.27 Favored Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 174.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -52.77 139.71 58.37 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.014 1.809 . . . . 0.0 114.351 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.9 t -92.58 111.8 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 101.441 -3.541 . . . . 0.0 101.441 167.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -145.4 158.94 43.74 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.075 0.95 . . . . 0.0 110.152 -169.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.1 t -139.27 124.0 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.577 0.751 . . . . 0.0 109.61 -175.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.0 m -90.18 154.51 19.7 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.252 1.021 . . . . 0.0 110.57 168.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -118.83 147.08 44.31 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 127.78 2.432 . . . . 0.0 111.013 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.451 ' CE2' ' CB ' ' A' ' 131' ' ' ALA . 55.0 m-85 -155.65 170.37 22.18 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.919 1.452 . . . . 0.0 114.919 -170.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.1 m -17.17 153.72 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.566 1 C-N-CA 134.413 5.085 . . . . 0.0 118.486 169.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.9 mt -85.97 118.56 25.53 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 169.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -121.89 108.9 13.98 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.813 2.045 . . . . 0.0 106.688 -173.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 52.12 37.93 22.94 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.566 1.146 . . . . 0.0 111.06 -170.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.27 13.77 82.41 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 118.856 -0.969 . . . . 0.0 113.907 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -121.34 134.77 55.14 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.101 1.451 . . . . 0.0 108.608 -177.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -63.28 142.08 58.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 120.354 1.434 . . . . 0.0 109.654 173.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.42 162.93 13.45 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 122.236 1.017 . . . . 0.0 108.748 169.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.84 173.15 40.7 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 107.87 -2.092 . . . . 0.0 107.87 169.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 1.3 m -136.04 145.89 46.51 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 169.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 p -118.4 141.36 38.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 169.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.0 tt -122.75 151.93 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 169.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.1 p -141.19 179.05 1.32 Allowed Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 172.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -68.73 -13.19 36.5 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 CA-C-N 121.602 1.608 . . . . 0.0 111.585 169.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -111.76 -21.09 11.83 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -169.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -157.36 160.57 38.6 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 120.161 1.346 . . . . 0.0 112.172 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 tt -130.77 123.21 28.67 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 103.351 -2.833 . . . . 0.0 103.351 167.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.4 m -134.4 131.81 38.64 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 123.875 0.734 . . . . 0.0 109.765 -177.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.01 145.28 50.09 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 168.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.4 m -135.62 147.84 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -177.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 58.6 mt -139.7 138.87 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -173.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -130.97 139.05 34.39 Favored Pre-proline 0 N--CA 1.466 0.332 0 CA-C-O 117.595 -1.193 . . . . 0.0 108.98 -177.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.37 130.1 34.47 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.567 2.178 . . . . 0.0 110.827 172.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.64 -166.84 33.47 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 119.602 -0.554 . . . . 0.0 112.426 -174.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -71.6 164.44 35.7 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.892 2.395 . . . . 0.0 112.915 -175.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.4 t0 42.57 55.69 4.09 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.397 2.279 . . . . 0.0 113.755 169.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -152.55 148.61 27.57 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.173 0.989 . . . . 0.0 109.35 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.9 mp -110.74 95.0 5.28 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.28 150.7 85.34 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.267 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -66.9 145.78 75.57 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.01 1.807 . . . . 0.0 110.763 171.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.1 tp -66.68 127.03 30.85 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 169.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -98.46 161.79 13.5 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.577 0.626 . . . . 0.0 110.074 -176.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.1 tmtm? -96.05 139.18 32.61 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 169.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.0 t -82.62 154.34 3.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 123.662 0.785 . . . . 0.0 109.332 -169.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.4 m 66.09 8.97 5.87 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.91 1.684 . . . . 0.0 113.769 -177.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -79.86 160.69 25.97 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.466 1.106 . . . . 0.0 108.136 168.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -112.9 142.33 45.69 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.708 -0.62 . . . . 0.0 110.41 177.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.6 mm -118.23 121.13 66.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 177.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.44 125.31 8.01 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 108.619 -1.793 . . . . 0.0 108.619 175.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.4 mt -120.51 141.81 49.89 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 124.344 1.057 . . . . 0.0 108.642 174.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -91.18 128.38 36.98 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 174.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 mp -135.07 162.01 60.22 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 124.763 1.225 . . . . 0.0 108.809 177.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -60.23 -21.89 68.28 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.527 2.151 . . . . 0.0 114.004 172.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -72.67 -4.21 29.72 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.599 1.16 . . . . 0.0 112.366 174.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.81 161.88 26.82 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 107.957 -2.057 . . . . 0.0 107.957 -168.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.8 m -68.84 131.99 46.03 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 69.8 mtm -139.9 144.04 36.97 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -177.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.68 132.29 35.18 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 172.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -102.17 132.66 47.94 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 169.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.5 m -83.95 142.19 30.7 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 66.5 t -74.59 124.83 33.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 170.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -112.02 161.4 12.75 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 170.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -132.59 93.78 3.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 171.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.9 tp -77.58 135.21 38.14 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -169.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.17 123.17 15.06 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.312 0.645 . . . . 0.0 111.691 -169.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.5 -3.4 33.27 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 118.688 -1.062 . . . . 0.0 113.998 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.8 t -101.31 -119.75 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 119.68 1.74 . . . . 0.0 106.337 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.3 m -148.17 174.99 11.41 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.629 1.571 . . . . 0.0 108.921 -169.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -72.53 142.31 48.49 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 168.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -153.48 171.8 18.12 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.1 1.36 . . . . 0.0 108.055 -178.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.4 mp -111.41 142.0 44.23 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.1 p -141.82 153.87 44.8 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.627 0.771 . . . . 0.0 110.588 -178.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.3 t -144.0 115.28 7.99 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 173.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.1 m -73.79 135.18 43.5 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 175.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.7 mt -123.95 -35.03 2.9 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.914 -1.041 . . . . 0.0 113.47 -169.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 13.4 ptp -159.64 169.62 23.34 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 120.249 1.386 . . . . 0.0 110.913 176.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.5 m -100.24 120.15 57.29 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.808 1.243 . . . . 0.0 108.425 169.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -70.8 -156.52 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 124.808 3.672 . . . . 0.0 113.313 174.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 62.91 41.09 8.9 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.275 1.43 . . . . 0.0 110.771 -174.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 m -73.18 157.65 36.76 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.926 -0.484 . . . . 0.0 109.854 172.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -63.89 -29.07 70.29 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.535 -0.728 . . . . 0.0 112.346 -170.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.2 m -89.22 -0.03 57.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.014 0.926 . . . . 0.0 112.836 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 42.4 mtp -73.58 156.47 38.04 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.275 0.943 . . . . 0.0 111.96 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.401 ' H ' ' HB2' ' A' ' 122' ' ' GLU . 80.4 p -156.93 176.71 12.4 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.384 2.274 . . . . 0.0 107.426 -175.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.544 HD13 ' H ' ' A' ' 120' ' ' ILE . 2.7 mp -53.82 -39.78 41.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.443 1.097 . . . . 0.0 109.59 171.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.69 -43.61 65.68 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.545 0.738 . . . . 0.0 109.456 -175.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.401 ' HB2' ' H ' ' A' ' 119' ' ' SER . 30.7 mm-40 -66.87 -28.48 68.36 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.079 173.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.61 -57.97 16.77 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 172.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -64.21 -52.73 57.42 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.647 -0.914 . . . . 0.0 110.778 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -66.83 -24.8 66.2 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 117.963 -1.017 . . . . 0.0 112.099 -173.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.7 tp -86.38 -29.9 22.57 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 120.748 1.613 . . . . 0.0 109.588 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.9 m -58.96 -48.19 82.42 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 169.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -64.0 -51.37 64.56 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.004 1.322 . . . . 0.0 112.083 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -65.5 -33.5 76.07 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.699 -0.626 . . . . 0.0 110.789 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 40.6 t -70.9 -34.03 71.16 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.451 ' CB ' ' CE2' ' A' ' 45' ' ' PHE . . . -68.13 -52.81 30.61 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 43.3 tpt85 -53.95 -46.84 71.71 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 123.539 0.736 . . . . 0.0 111.898 -175.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 15.2 ptt? -57.38 -27.25 62.14 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.58 1.082 . . . . 0.0 112.007 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 19.8 pt -102.2 9.9 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.421 1.089 . . . . 0.0 111.242 178.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 16.8 tp -151.06 69.97 0.97 Allowed 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.863 1.665 . . . . 0.0 109.108 -168.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.1 m -73.12 32.08 0.07 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.27 126.36 4.75 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 124.12 0.968 . . . . 0.0 109.647 169.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -101.15 146.11 0.3 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.05 2.5 . . . . 0.0 111.249 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.7 p -152.65 157.66 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.154 0.981 . . . . 0.0 108.376 169.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 7.4 m -56.25 146.63 23.05 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.527 1.531 . . . . 0.0 111.361 -177.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -131.13 126.15 21.4 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.18 1.392 . . . . 0.0 107.948 170.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -62.43 160.43 31.63 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.274 2.649 . . . . 0.0 113.304 177.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -135.06 143.25 46.6 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.22 1.808 . . . . 0.0 108.953 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 27.9 m -134.05 160.85 66.93 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 126.33 1.852 . . . . 0.0 109.051 -173.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.36 117.06 3.83 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 N-CA-C 104.116 -3.071 . . . . 0.0 104.116 167.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . 0.409 ' CD2' ' HB1' ' A' ' 14' ' ' ALA . 3.8 t60 -62.59 137.96 58.38 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -167.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.64 145.52 38.78 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.453 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.79 149.61 46.66 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 175.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -66.36 152.3 45.32 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 117.363 0.582 . . . . 0.0 110.543 175.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -68.71 141.71 55.22 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.5 134.47 34.84 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 169.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -158.27 167.29 30.17 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.942 1.297 . . . . 0.0 110.02 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -142.5 124.45 15.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 169.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -150.69 157.4 42.92 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.463 1.105 . . . . 0.0 108.985 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -169.56 148.79 12.33 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 171.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -87.76 58.03 4.67 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.97 0.908 . . . . 0.0 109.5 -176.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 44.2 mmm-85 -74.31 -25.69 59.72 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.08 -0.387 . . . . 0.0 110.995 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 14.9 m -67.07 132.53 48.05 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 70.43 16.44 73.63 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 119.65 -0.528 . . . . 0.0 113.394 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -67.87 134.07 50.24 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.278 1.039 . . . . 0.0 108.926 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -78.43 138.95 38.74 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.049 0.54 . . . . 0.0 110.013 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.493 0 C-N-CA 125.452 1.501 . . . . 0.0 108.114 175.355 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 119.159 -0.448 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 m 57.93 43.32 21.54 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.285 1.034 . . . . 0.0 111.293 171.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -86.21 45.5 1.23 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.398 1.079 . . . . 0.0 109.343 -178.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -142.98 159.45 42.21 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.535 1.534 . . . . 0.0 110.022 -169.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.4 mm -126.26 125.74 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 170.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.48 150.23 33.0 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.962 0.41 . . . . 0.0 110.092 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.18 156.71 47.65 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.589 1.09 . . . . 0.0 112.848 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -112.81 150.5 31.57 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.874 1.27 . . . . 0.0 110.101 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -82.35 -29.15 31.14 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.671 0.788 . . . . 0.0 111.368 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.8 p -158.52 -177.86 6.84 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 129.966 3.306 . . . . 0.0 105.601 172.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.8 m -57.59 144.23 73.22 Favored Pre-proline 0 CA--C 1.541 0.616 0 O-C-N 120.95 -1.094 . . . . 0.0 110.137 169.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.45 58.48 3.77 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 124.811 3.674 . . . . 0.0 109.652 169.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HE2' ' O ' ' A' ' 42' ' ' VAL . 41.1 tttm -50.55 -52.76 35.87 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.77 2.428 . . . . 0.0 112.692 -169.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.88 95.59 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.656 0.383 . . . . 0.0 111.144 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -70.11 -39.81 75.26 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -176.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 81.3 t -62.97 -40.79 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -62.54 -52.43 63.46 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.496 0.589 . . . . 0.0 110.195 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.2 -39.29 94.22 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.762 0.825 . . . . 0.0 110.899 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.34 -50.39 73.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -72.43 -29.4 63.67 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 117.84 -1.076 . . . . 0.0 112.493 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -59.95 -35.22 74.49 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.293 1.406 . . . . 0.0 109.886 169.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -76.53 -52.59 9.48 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.594 0.634 . . . . 0.0 109.378 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.0 mt -61.28 -39.06 81.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.907 1.283 . . . . 0.0 110.425 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.12 -24.04 67.54 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.351 -0.843 . . . . 0.0 112.272 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.4 ttp85 -99.89 -30.34 12.08 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 125.465 1.506 . . . . 0.0 109.494 -175.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -61.21 -43.17 99.31 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 169.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.3 m -63.0 119.72 9.99 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 173.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 11.6 tmm? -65.86 117.47 8.29 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -177.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -140.34 164.23 30.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 127.119 2.168 . . . . 0.0 106.669 175.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.24 -35.7 76.08 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.41 -0.806 . . . . 0.0 110.869 173.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.8 pp -65.95 -18.35 65.28 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.533 0.733 . . . . 0.0 112.944 175.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.6 m -70.86 -21.94 62.36 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 120.388 1.449 . . . . 0.0 111.566 -176.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -91.94 -9.98 41.09 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.357 1.063 . . . . 0.0 111.991 177.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.6 mt -129.46 7.57 5.35 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.234 1.414 . . . . 0.0 112.305 -169.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . 0.266 0.1 OUTLIER 64.67 157.76 0.12 Allowed Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 128.37 2.668 . . . . 0.0 112.29 -169.018 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -49.62 135.1 34.05 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.484 2.789 . . . . 0.0 113.551 -174.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 p -65.28 -37.89 88.55 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.553 1.141 . . . . 0.0 111.07 -176.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 67.6 mtt -137.43 133.44 18.13 Favored Pre-proline 0 N--CA 1.455 -0.204 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 174.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -47.22 129.4 15.61 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.394 2.729 . . . . 0.0 114.205 178.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.1 t -63.91 136.94 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 168.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -142.49 156.08 45.12 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.028 0.831 . . . . 0.0 110.102 -171.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.41 ' O ' ' HE2' ' A' ' 13' ' ' LYS . 34.5 t -140.03 127.78 24.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -178.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.5 m -100.55 151.62 21.38 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.146 0.979 . . . . 0.0 109.772 169.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -123.95 143.24 50.51 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.136 1.774 . . . . 0.0 110.292 -176.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -145.3 170.2 16.77 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.239 1.415 . . . . 0.0 114.153 -169.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.8 t -54.19 169.29 0.18 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.226 2.611 . . . . 0.0 115.468 -169.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.6 tp -77.31 124.4 27.81 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.753 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -104.52 -125.12 0.22 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.969 2.108 . . . . 0.0 107.172 -175.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -77.29 70.75 3.72 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.701 1.137 . . . . 0.0 109.814 177.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.06 15.58 65.32 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.335 0.969 . . . . 0.0 113.315 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -143.32 143.34 31.64 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 125.637 1.575 . . . . 0.0 108.104 -169.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -72.18 153.88 41.37 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.083 0.856 . . . . 0.0 110.27 174.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.52 158.39 16.11 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 169.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.71 168.51 39.02 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 108.056 -2.017 . . . . 0.0 108.056 173.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 48.2 m -140.39 145.14 36.69 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 169.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.07 144.11 25.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 171.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.9 tt -131.17 152.82 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 172.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.4 p -144.5 178.75 1.34 Allowed Pre-proline 0 N--CA 1.446 -0.662 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -63.84 1.0 1.64 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.437 2.092 . . . . 0.0 113.601 168.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.4 p-90 -138.6 -19.54 1.06 Allowed 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 -169.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -153.78 164.44 38.34 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 120.589 1.54 . . . . 0.0 111.703 -176.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 tp -136.49 116.57 13.37 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 169.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.1 m -136.26 122.52 20.49 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -172.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.05 145.87 55.35 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 169.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.6 m -139.5 146.64 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.887 1.275 . . . . 0.0 108.585 -177.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 45.4 mt -142.2 140.94 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -170.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -137.0 144.37 46.1 Favored Pre-proline 0 N--CA 1.469 0.512 0 CA-C-O 117.638 -1.172 . . . . 0.0 110.065 -170.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -52.49 137.95 57.35 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.312 2.675 . . . . 0.0 112.919 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.41 -178.78 25.58 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 123.815 0.721 . . . . 0.0 112.943 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -64.16 140.7 72.74 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.017 2.478 . . . . 0.0 112.8 -171.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.7 t70 52.84 26.86 4.88 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.832 1.653 . . . . 0.0 114.035 170.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -87.02 152.98 21.9 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 171.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.7 83.65 2.03 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 170.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -66.87 152.9 95.16 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.896 172.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -71.56 159.1 52.18 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.901 1.734 . . . . 0.0 109.634 169.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.5 tp -66.78 117.24 8.64 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 169.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -85.78 154.78 21.35 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -177.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -84.19 142.33 30.39 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.4 t -89.23 154.55 3.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -168.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.3 m 66.12 8.62 5.63 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.702 1.601 . . . . 0.0 113.683 -176.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -78.74 161.55 26.78 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.687 1.195 . . . . 0.0 108.088 169.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -113.46 143.26 44.81 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 121.427 -0.795 . . . . 0.0 110.329 175.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.2 mm -118.33 126.13 74.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 176.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.24 123.8 7.42 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 174.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.8 mt -116.24 143.87 44.95 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.604 1.162 . . . . 0.0 108.167 174.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -96.14 128.01 42.67 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 175.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mp -138.54 155.17 73.78 Favored Pre-proline 0 C--O 1.236 0.376 0 C-N-CA 124.809 1.244 . . . . 0.0 107.702 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -63.43 -20.92 70.93 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 121.96 1.774 . . . . 0.0 113.619 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -58.86 -28.98 66.62 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.654 0.781 . . . . 0.0 111.535 169.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 129.03 155.78 8.68 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 106.679 -2.568 . . . . 0.0 106.679 -169.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.1 m -64.29 131.2 46.61 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 176.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 62.9 mtm -141.26 144.13 34.51 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.485 1.114 . . . . 0.0 108.349 -176.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.98 135.14 35.82 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 121.932 -0.48 . . . . 0.0 109.879 172.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -108.61 138.6 44.66 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 168.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.2 m -87.7 140.71 29.24 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.3 t -73.24 126.77 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 169.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -119.27 163.14 13.46 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 171.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -126.06 93.83 3.93 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 173.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.6 tp -75.36 124.89 27.9 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -169.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -59.97 132.79 55.04 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.101 0.56 . . . . 0.0 110.468 -176.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.24 3.7 70.99 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-O 118.752 -1.026 . . . . 0.0 113.581 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.3 t -127.49 -120.13 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.7 m -152.49 -178.6 6.94 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.744 1.618 . . . . 0.0 108.846 -169.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -68.79 143.3 54.66 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 169.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -150.51 169.45 21.46 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.548 1.539 . . . . 0.0 108.679 177.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.5 mp -104.4 141.8 35.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 170.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.8 p -141.13 155.4 46.11 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.705 0.802 . . . . 0.0 110.486 -177.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 48.0 t -144.99 110.83 5.42 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 171.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.7 m -71.22 127.73 33.55 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 24.0 mt -119.76 -40.2 2.78 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 118.677 -0.678 . . . . 0.0 112.33 -169.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 23.8 mtm -141.79 161.5 37.8 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.182 0.993 . . . . 0.0 108.724 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.2 p -123.16 66.19 30.94 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.042 1.337 . . . . 0.0 110.117 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -60.87 153.25 64.56 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.591 2.194 . . . . 0.0 110.699 174.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 95.9 mt -130.57 152.81 49.54 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.633 1.573 . . . . 0.0 106.767 172.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.1 m -73.68 58.45 0.61 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.352 1.461 . . . . 0.0 112.977 -174.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -136.39 -67.28 0.52 Allowed 'General case' 0 C--O 1.231 0.115 0 C-N-CA 124.872 1.269 . . . . 0.0 109.405 172.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.6 m -87.84 51.52 2.23 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.6 tpt -159.3 162.46 36.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 128.047 2.539 . . . . 0.0 106.976 -168.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.5 p -151.2 171.59 17.17 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 174.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.427 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -67.48 -26.55 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 120.986 -1.071 . . . . 0.0 110.33 170.163 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -67.05 -44.19 80.82 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 174.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -65.59 -30.13 70.82 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.204 0.911 . . . . 0.0 110.571 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.88 -27.63 50.9 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.674 1.13 . . . . 0.0 112.323 171.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -95.5 -55.04 3.16 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.332 1.066 . . . . 0.0 110.828 171.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -71.01 -29.68 65.69 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -169.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.5 tp -83.03 -29.72 28.64 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 120.152 1.342 . . . . 0.0 109.608 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -64.75 -43.23 94.01 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -64.0 -48.53 76.03 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.167 0.587 . . . . 0.0 111.972 172.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -69.8 -25.71 63.91 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.115 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 35.3 t -64.32 -42.41 96.33 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.68 -47.23 73.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 174.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 50.1 ttt-85 -57.0 -46.63 82.15 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.336 0.971 . . . . 0.0 111.315 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 52.6 ttp -47.4 -31.3 3.95 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.565 1.546 . . . . 0.0 112.229 174.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 25.7 pt -104.15 -18.98 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 120.066 1.303 . . . . 0.0 113.009 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . 0.299 3.5 pp -99.99 43.79 1.04 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 120.087 1.312 . . . . 0.0 108.074 168.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.3 p -76.59 52.71 0.82 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.746 2.418 . . . . 0.0 112.325 -169.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -66.76 144.03 98.38 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.067 173.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -81.76 56.55 5.95 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 124.455 3.437 . . . . 0.0 111.841 -174.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.7 t 66.12 153.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 126.708 2.003 . . . . 0.0 111.568 -173.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 6.8 m -62.07 140.9 58.36 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.105 0.962 . . . . 0.0 109.516 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -140.68 116.48 7.59 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.937 1.295 . . . . 0.0 107.835 174.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -80.21 65.19 8.92 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.553 2.835 . . . . 0.0 110.041 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 30.8 t70 63.23 -46.11 0.22 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 129.158 2.983 . . . . 0.0 114.487 -170.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.4 p -149.09 148.03 25.68 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 125.043 1.337 . . . . 0.0 108.843 174.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -54.58 166.02 2.1 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.843 3.028 . . . . 0.0 112.654 169.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -62.91 122.72 16.68 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 169.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -115.04 3.18 14.39 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.364 1.066 . . . . 0.0 112.215 -173.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.35 142.77 41.53 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -71.16 140.37 50.52 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -86.24 162.56 18.23 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 175.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -60.25 -31.01 69.81 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.949 0.5 . . . . 0.0 112.179 -177.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.44 13.07 14.62 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -178.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 37.8 tp -107.69 103.82 13.19 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 171.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -153.6 157.02 39.06 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.539 1.136 . . . . 0.0 109.473 173.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.7 -161.67 35.45 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 123.848 0.737 . . . . 0.0 111.509 -175.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -74.34 -54.48 7.56 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 173.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -145.33 30.77 1.12 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.511 1.124 . . . . 0.0 109.675 172.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 9.6 m -71.94 -40.5 68.66 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -85.09 144.32 20.87 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 107.542 -2.223 . . . . 0.0 107.542 169.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.66 23.07 3.21 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -169.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -54.99 -36.62 65.6 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.704 0.802 . . . . 0.0 111.417 172.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 C-N-CA 124.66 1.184 . . . . 0.0 107.897 172.378 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.8 mm -119.37 126.01 74.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 169.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.67 145.28 38.87 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.029 0.442 . . . . 0.0 109.816 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.02 146.2 50.34 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.795 1.188 . . . . 0.0 111.456 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -89.57 139.84 30.14 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.323 1.049 . . . . 0.0 108.912 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -71.42 -38.86 71.36 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.7 p -155.1 166.2 34.32 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 128.162 2.585 . . . . 0.0 107.847 170.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.5 m -54.08 141.02 51.21 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.419 1.088 . . . . 0.0 112.203 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -75.89 49.38 2.48 Favored 'Trans proline' 0 CA--C 1.541 0.844 1 C-N-CA 125.429 4.086 . . . . 0.0 110.872 170.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -54.21 -46.15 72.4 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.879 1.672 . . . . 0.0 112.032 -169.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.95 98.53 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 122.506 0.323 . . . . 0.0 111.259 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -40.19 69.44 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 119.074 -0.488 . . . . 0.0 109.804 -174.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 84.2 t -58.22 -45.67 88.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 171.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -61.17 -53.86 51.61 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.861 0.755 . . . . 0.0 110.95 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.0 -39.25 93.17 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.713 0.688 . . . . 0.0 111.128 -174.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.26 -47.54 81.96 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -70.69 -24.42 62.66 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-O 118.289 -0.862 . . . . 0.0 112.592 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -62.11 -37.35 84.78 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.342 0.974 . . . . 0.0 108.979 172.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -80.46 -45.24 17.9 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.8 mt -61.92 -31.9 52.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 O-C-N 120.896 -1.128 . . . . 0.0 110.219 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.99 -24.7 63.35 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.282 -0.886 . . . . 0.0 112.201 174.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.9 ttm105 -83.71 -41.64 17.47 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.936 0.894 . . . . 0.0 109.632 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo . . . . . 0 N--CA 1.457 -0.66 0 CA-C-O 120.638 0.182 . . . . 0.0 111.746 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 m -65.59 148.31 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 171.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -143.11 157.75 44.23 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 124.06 0.944 . . . . 0.0 109.076 -175.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.2 t -138.99 126.62 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -177.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.6 p -89.01 150.67 22.69 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 169.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -132.61 132.79 42.87 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.561 1.544 . . . . 0.0 108.24 173.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.43 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 43.1 p90 -169.9 145.76 3.02 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.354 0.662 . . . . 0.0 112.704 -171.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.8 m 58.52 165.14 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 128.014 2.525 . . . . 0.0 115.409 167.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.2 tp -115.84 58.3 0.74 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.07 1.348 . . . . 0.0 109.157 175.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.91 137.21 47.25 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.025 0.93 . . . . 0.0 110.042 -173.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 55.15 22.85 4.88 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.367 1.067 . . . . 0.0 111.874 -171.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.07 20.61 77.37 Favored Glycine 0 CA--C 1.531 1.053 0 O-C-N 121.223 -0.923 . . . . 0.0 112.874 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -135.79 143.11 45.04 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.223 1.511 . . . . 0.0 108.118 -172.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -65.7 135.39 54.9 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.303 -0.873 . . . . 0.0 108.961 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.43 ' HB ' ' CE2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -103.09 160.07 14.97 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.857 0.837 . . . . 0.0 109.514 -177.299 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -169.35 168.81 41.54 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 56.4 m -135.96 146.82 47.68 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 168.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.1 p -111.81 143.55 21.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 171.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.85 141.64 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 169.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.3 p -136.8 173.83 5.1 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 171.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.9 -25.7 74.31 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 CA-C-N 121.386 1.531 . . . . 0.0 111.238 169.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.4 p-90 -93.41 -26.57 17.17 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 118.155 -0.926 . . . . 0.0 113.215 -172.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.97 170.21 23.05 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 120.256 1.389 . . . . 0.0 113.057 -174.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 tt -137.57 127.96 26.45 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 168.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.6 m -140.68 137.52 33.6 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 123.04 0.536 . . . . 0.0 110.017 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.6 146.82 48.14 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 168.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.3 m -138.48 144.18 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.23 1.412 . . . . 0.0 108.178 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 31.7 mt -142.69 141.91 27.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 125.37 1.468 . . . . 0.0 107.283 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -130.33 133.79 25.32 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-O 117.646 -1.168 . . . . 0.0 108.203 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.85 137.78 21.4 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.282 2.655 . . . . 0.0 111.899 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.56 179.07 34.26 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.302 0.953 . . . . 0.0 112.756 -173.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.67 145.05 56.47 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.982 2.455 . . . . 0.0 111.019 -172.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.1 t0 50.63 57.69 6.34 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.381 1.472 . . . . 0.0 112.188 177.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -128.76 148.93 50.89 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.385 1.474 . . . . 0.0 108.223 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -124.34 83.03 2.1 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 175.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.71 150.91 97.51 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 172.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.34 155.23 70.98 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.901 1.734 . . . . 0.0 109.972 170.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 68.9 tp -63.85 129.25 39.33 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 170.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -104.61 163.38 12.51 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.474 0.579 . . . . 0.0 109.559 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -89.52 157.18 18.19 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 169.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.1 t -86.5 153.41 3.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -169.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . 0.254 42.7 m 65.84 11.84 7.92 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.229 1.411 . . . . 0.0 113.58 -174.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -74.85 158.16 33.88 Favored 'General case' 0 C--N 1.346 0.42 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 168.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -112.27 141.03 46.47 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.624 -0.673 . . . . 0.0 109.976 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.5 mm -120.38 123.92 71.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.09 121.99 6.4 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.8 mt -113.26 143.12 44.96 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.24 1.016 . . . . 0.0 108.299 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -95.05 127.41 41.09 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mp -135.59 153.96 77.92 Favored Pre-proline 0 C--O 1.234 0.288 0 C-N-CA 125.595 1.558 . . . . 0.0 107.282 174.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -64.58 -21.82 65.35 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.236 1.291 . . . . 0.0 112.497 172.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -58.7 -23.51 59.69 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.67 1.588 . . . . 0.0 111.524 169.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 129.65 148.35 6.49 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.979 2.228 . . . . 0.0 108.066 -173.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.0 m -63.11 130.92 46.74 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 170.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 43.7 ttp -144.61 138.76 27.63 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -169.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.54 130.95 35.45 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -104.4 131.68 51.49 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 169.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.8 m -85.25 139.26 31.77 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 97.7 t -70.82 110.86 4.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 172.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -94.24 155.91 22.02 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 106.91 -2.476 . . . . 0.0 106.91 169.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -134.55 122.32 22.21 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 169.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.6 tp -142.3 145.65 34.21 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.885 0.474 . . . . 0.0 110.411 -169.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -58.71 132.07 52.76 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.917 0.887 . . . . 0.0 111.062 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.93 0.3 50.19 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.046 0.831 . . . . 0.0 113.688 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 87.2 t -122.23 -27.11 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.267 1.427 . . . . 0.0 109.852 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.2 m 60.16 -150.52 0.42 Allowed 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.236 1.415 . . . . 0.0 108.691 -174.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -78.06 137.28 38.16 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.368 0.531 . . . . 0.0 110.152 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -152.44 166.81 30.79 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.974 1.71 . . . . 0.0 107.988 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.0 mp -117.81 122.32 43.1 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.1 m -143.79 158.36 43.73 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.008 0.822 . . . . 0.0 111.305 -169.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 15.6 p -149.4 140.38 22.89 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.844 -0.535 . . . . 0.0 109.816 169.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.0 m -67.09 138.25 56.98 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 174.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.0 mt -107.83 -48.45 3.4 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.174 0.99 . . . . 0.0 110.145 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 13.3 ptp -164.09 172.5 13.68 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.858 0.863 . . . . 0.0 110.329 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.1 m . . . . . 0 CA--C 1.541 0.611 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.627 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 CA--C 1.535 0.391 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -59.7 -31.17 46.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 123.618 0.767 . . . . 0.0 110.708 179.162 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.93 -46.72 73.92 Favored 'General case' 0 C--O 1.226 -0.166 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -63.24 -33.42 75.47 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.103 173.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.46 -62.13 6.63 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 171.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -65.07 -43.27 92.75 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 117.742 0.771 . . . . 0.0 111.282 -175.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -58.67 -40.98 85.09 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.37 0.668 . . . . 0.0 109.722 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.8 tp -81.28 -21.98 38.96 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 117.783 -1.104 . . . . 0.0 111.684 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.14 -42.71 79.74 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.837 1.653 . . . . 0.0 108.75 169.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -70.07 -41.2 74.44 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.262 0.625 . . . . 0.0 111.699 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -66.9 -31.04 71.36 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.064 -1.022 . . . . 0.0 110.653 174.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 21.1 m -69.31 -41.27 76.96 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.793 0.724 . . . . 0.0 110.257 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.417 ' HB2' ' CE1' ' A' ' 45' ' ' PHE . . . -55.89 -54.11 48.67 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.657 0.783 . . . . 0.0 109.549 172.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -52.27 -54.09 35.71 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.066 0.947 . . . . 0.0 109.974 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 57.0 ttp -49.42 -55.24 13.75 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.65 1.58 . . . . 0.0 111.271 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.7 pt -78.68 -25.34 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 118.955 0.798 . . . . 0.0 112.233 -171.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.1 mt . . . . . 0 CA--C 1.53 0.201 0 CA-C-N 118.671 0.669 . . . . 0.0 110.452 169.814 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.8 mm -118.4 131.62 70.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 126.627 1.971 . . . . 0.0 106.03 175.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.57 142.0 44.71 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 120.701 0.286 . . . . 0.0 110.373 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.8 151.57 51.04 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.209 0.909 . . . . 0.0 111.945 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -93.03 151.2 20.03 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.304 1.041 . . . . 0.0 109.669 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -94.19 -19.25 20.93 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.779 -0.629 . . . . 0.0 112.105 176.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.2 p -156.94 164.42 38.05 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 127.344 2.258 . . . . 0.0 107.734 169.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.1 m -56.9 133.49 79.57 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-O 118.236 -0.888 . . . . 0.0 109.614 169.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.401 ' HD2' ' CE1' ' A' ' 67' ' ' PHE . 33.3 Cg_exo -70.83 50.14 1.05 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.433 3.422 . . . . 0.0 112.648 170.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.6 tttm -51.69 -48.68 63.39 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.831 1.652 . . . . 0.0 112.061 -169.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.2 94.93 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 122.705 0.402 . . . . 0.0 111.128 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -73.17 -40.13 65.07 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.384 0.674 . . . . 0.0 109.834 -175.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 80.9 t -61.11 -47.12 95.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -59.41 -50.49 73.76 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 118.923 -0.56 . . . . 0.0 110.872 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.74 -43.27 98.14 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.771 0.714 . . . . 0.0 110.423 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.18 -49.77 76.6 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.058 0.39 . . . . 0.0 110.234 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -66.05 -26.15 67.37 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.943 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -67.64 -29.18 68.42 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 120.098 1.317 . . . . 0.0 111.539 174.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -77.39 -54.82 5.99 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.172 0.896 . . . . 0.0 109.095 171.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.3 mt -60.52 -44.78 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 123.944 0.897 . . . . 0.0 109.851 -169.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.11 -28.71 70.25 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.953 -0.467 . . . . 0.0 111.346 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -81.79 -43.15 18.72 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 118.751 0.705 . . . . 0.0 109.828 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? . . . . . 0 N--CA 1.465 0.286 0 C-N-CA 123.112 0.565 . . . . 0.0 110.316 172.871 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo . . . . . 0 CA--C 1.536 0.601 0 N-CA-C 114.924 1.086 . . . . 0.0 114.924 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.3 m -109.04 56.58 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 104.629 -2.359 . . . . 0.0 104.629 167.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -83.93 156.86 22.15 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.548 1.139 . . . . 0.0 111.63 -168.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.0 t -140.07 127.14 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 123.695 0.798 . . . . 0.0 109.431 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.0 m -91.41 145.36 24.69 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.084 0.954 . . . . 0.0 108.952 168.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -125.6 138.22 53.92 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.873 1.669 . . . . 0.0 108.277 170.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -162.03 130.65 4.25 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -175.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 t 47.97 -179.78 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 129.992 3.317 . . . . 0.0 117.071 168.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.9 tp -117.58 86.4 2.51 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 171.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -74.6 -38.8 62.52 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -168.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.07 56.75 1.13 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 122.323 1.059 . . . . 0.0 108.495 -176.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 62.98 20.94 63.03 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.627 -175.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -144.15 139.94 29.09 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 126.616 1.966 . . . . 0.0 105.834 -174.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -74.75 143.58 44.02 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.41 153.42 26.09 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.581 0.705 . . . . 0.0 109.299 -173.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -163.5 167.81 37.86 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 35.4 m -140.94 152.76 45.26 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 169.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.2 t -128.09 143.98 39.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.403 HG21 ' HA2' ' A' ' 123' ' ' GLY . 15.8 tt -127.14 148.19 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 169.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 49.3 p -137.78 177.83 1.96 Allowed Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 175.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -61.38 -6.31 6.64 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.63 2.22 . . . . 0.0 113.387 169.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.1 p-90 -131.14 -23.51 2.43 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -169.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.9 169.63 21.81 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.256 1.389 . . . . 0.0 112.13 -176.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 tt -139.27 123.13 17.66 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 168.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.7 m -139.56 134.16 31.77 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.236 0.541 . . . . 0.0 110.141 -175.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.99 146.25 54.92 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 168.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.4 m -137.17 141.76 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.7 mt -143.81 144.45 23.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -169.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.401 ' CE1' ' HD2' ' A' ' 12' ' ' PRO . 25.5 m-85 -132.59 136.81 28.51 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 118.196 -0.907 . . . . 0.0 109.387 -173.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -46.75 138.49 14.91 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 124.007 3.138 . . . . 0.0 112.166 169.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.89 -179.92 46.32 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 123.734 0.683 . . . . 0.0 113.043 -174.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.71 145.76 52.51 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 123.518 2.812 . . . . 0.0 110.917 -173.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.2 t0 50.76 54.56 10.99 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.284 1.434 . . . . 0.0 111.986 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -124.32 154.32 40.47 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.941 1.297 . . . . 0.0 107.769 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 92.2 mt -129.16 85.3 2.3 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 8.8 m0 -65.67 153.09 91.53 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -62.86 155.04 62.44 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.658 2.239 . . . . 0.0 111.131 171.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.43 129.76 43.24 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 169.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -144.45 160.03 41.76 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -124.17 172.93 8.66 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 122.985 1.374 . . . . 0.0 110.529 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 70.1 t -70.03 150.93 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 112.461 -2.154 . . . . 0.0 109.645 -169.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.0 m 68.89 1.09 2.98 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.244 1.818 . . . . 0.0 114.096 -177.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -73.47 155.77 38.9 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 169.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -119.75 143.77 47.62 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 118.615 0.643 . . . . 0.0 110.122 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 48.3 mm -117.56 123.92 72.37 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.81 118.02 7.34 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 108.006 -2.038 . . . . 0.0 108.006 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.4 tp -123.75 130.46 52.66 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.907 0.883 . . . . 0.0 108.759 -172.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.34 128.53 34.58 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 174.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 mp -133.98 159.46 72.3 Favored Pre-proline 0 C--O 1.234 0.253 0 C-N-CA 124.721 1.209 . . . . 0.0 108.875 172.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -58.41 -26.45 77.78 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.13 1.887 . . . . 0.0 113.464 170.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -65.28 -9.43 24.07 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.389 1.075 . . . . 0.0 113.198 173.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.43 157.1 18.84 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 108.025 -2.03 . . . . 0.0 108.025 -169.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.8 m -67.48 130.94 44.64 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 49.5 mtm -142.54 145.05 33.23 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -177.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.53 123.52 25.62 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 170.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -95.64 135.97 36.63 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 169.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.0 m -89.05 144.03 26.44 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 70.5 t -76.57 119.26 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 169.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -106.7 169.85 15.6 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 169.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -138.2 141.55 40.02 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 169.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 19.0 mt -132.35 152.95 51.2 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 169.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.07 135.14 57.07 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.52 3.72 72.75 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 118.816 -0.991 . . . . 0.0 113.467 -175.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.91 -33.47 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 119.18 1.49 . . . . 0.0 109.933 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.1 m 59.66 -156.01 0.35 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -169.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -58.71 136.29 57.66 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.37 0.532 . . . . 0.0 110.327 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -148.76 166.59 27.97 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.838 1.655 . . . . 0.0 107.448 170.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.4 mp -102.76 143.67 32.1 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.3 p -146.31 160.2 42.34 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.778 0.831 . . . . 0.0 110.645 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 30.8 t -147.78 128.84 14.55 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 171.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.5 m -66.9 134.78 52.73 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.3 mt -105.94 -59.68 1.74 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.986 0.914 . . . . 0.0 108.701 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -142.03 166.84 23.61 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.751 1.22 . . . . 0.0 108.878 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 28.6 m . . . . . 0 CA--C 1.541 0.608 0 C-N-CA 124.346 1.058 . . . . 0.0 109.906 176.51 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 90.4 p . . . . . 0 N--CA 1.457 -0.122 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -57.78 -22.5 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.157 0.983 . . . . 0.0 111.793 168.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -85.26 -45.6 11.81 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.328 1.051 . . . . 0.0 109.507 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -63.13 -32.05 73.33 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.277 0.49 . . . . 0.0 110.039 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.403 ' HA2' HG21 ' A' ' 57' ' ' ILE . . . -60.51 -54.76 34.46 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 175.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -65.28 -47.78 75.48 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 117.298 0.549 . . . . 0.0 110.08 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 83.9 mtm-85 -65.33 -46.7 79.23 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 118.852 -0.594 . . . . 0.0 111.398 -175.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.1 tp -76.82 -28.87 55.72 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 118.058 -0.973 . . . . 0.0 111.697 -171.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.8 m -71.64 -36.98 70.88 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.977 1.262 . . . . 0.0 109.546 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -70.37 -41.25 73.34 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.359 0.663 . . . . 0.0 111.529 174.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -65.24 -31.07 72.04 Favored 'General case' 0 CA--C 1.53 0.212 0 O-C-N 121.114 -0.991 . . . . 0.0 110.52 173.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 34.1 m -69.94 -40.06 75.7 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 121.922 -0.486 . . . . 0.0 110.227 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.17 -50.87 72.01 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.718 0.407 . . . . 0.0 110.074 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -55.26 -55.78 27.51 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 123.902 0.881 . . . . 0.0 110.057 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 16.3 ptt? -59.42 -39.4 83.38 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 117.992 -1.004 . . . . 0.0 111.038 -172.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . 0.274 6.6 pt -79.83 -21.69 12.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 119.761 1.164 . . . . 0.0 112.248 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 30.8 mt . . . . . 0 N--CA 1.468 0.437 0 CA-C-N 118.914 0.779 . . . . 0.0 108.951 168.19 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.2 mt -132.61 143.84 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.594 1.957 . . . . 0.0 105.786 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.76 147.06 41.64 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.801 0.728 . . . . 0.0 110.501 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.79 163.73 51.8 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.476 1.036 . . . . 0.0 111.439 170.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -126.52 142.01 51.68 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.042 1.337 . . . . 0.0 109.852 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -73.63 -19.77 60.77 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 122.951 0.501 . . . . 0.0 111.817 -173.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 p -146.82 154.08 40.93 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.85 1.66 . . . . 0.0 108.303 171.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -67.02 148.92 98.78 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 171.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.61 54.91 5.27 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 124.943 3.762 . . . . 0.0 111.002 175.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.3 tttm -53.83 -43.92 69.83 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.184 1.394 . . . . 0.0 111.993 -169.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.0 -40.77 97.12 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 118.43 0.559 . . . . 0.0 111.224 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -74.98 -35.44 62.05 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.101 -177.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.45 -45.77 96.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 170.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -60.29 -50.12 74.9 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.104 0.562 . . . . 0.0 110.144 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.76 -39.53 93.77 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.593 0.633 . . . . 0.0 111.352 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.46 -49.51 76.52 Favored 'General case' 0 C--N 1.337 0.065 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -71.49 -28.56 64.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 118.032 -0.985 . . . . 0.0 112.183 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -60.29 -40.59 90.99 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.85 1.204 . . . . 0.0 109.32 170.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -71.93 -46.41 57.67 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -175.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.2 mt -57.89 -45.8 87.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.0 -34.94 79.14 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.68 -0.638 . . . . 0.0 111.516 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -72.41 -36.02 68.53 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.96 0.904 . . . . 0.0 109.244 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? . . . . . 0 CA--C 1.536 0.405 0 C-N-CA 124.297 1.039 . . . . 0.0 110.659 169.856 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.443 ' CD ' HG23 ' A' ' 120' ' ' ILE . 73.5 Cg_endo . . . . . 0 N--CA 1.452 -0.937 0 N-CA-C 110.332 -0.68 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.406 HG13 HG22 ' A' ' 58' ' ' THR . 34.8 t -71.02 130.03 34.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 169.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -138.8 150.16 45.76 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.166 0.986 . . . . 0.0 108.801 -169.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.2 t -141.55 124.08 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -172.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.8 m -91.55 134.75 34.4 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 168.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -121.7 135.61 54.95 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.854 1.262 . . . . 0.0 107.885 169.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.448 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 25.8 p90 -167.66 142.21 3.69 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -169.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m 58.46 158.33 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.935 2.494 . . . . 0.0 115.735 167.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.1 tp -111.19 66.04 0.62 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 169.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -57.11 -33.67 67.57 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 -165.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -136.42 26.65 3.14 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.226 0.61 . . . . 0.0 111.255 175.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.13 15.91 60.09 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 119.378 -0.679 . . . . 0.0 112.302 -169.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -136.94 143.92 43.14 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 174.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -69.22 143.56 53.94 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.448 ' HB ' ' CE2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -107.48 155.1 20.43 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -177.11 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.9 163.41 36.37 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 67.2 m -140.73 146.96 38.43 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 p -124.95 144.19 35.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 175.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.7 tt -126.76 150.18 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 169.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.406 HG22 HG13 ' A' ' 40' ' ' VAL . 30.5 p -140.87 178.03 1.73 Allowed Pre-proline 0 N--CA 1.442 -0.87 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 173.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -61.82 -28.6 81.79 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 CA-C-N 119.286 0.781 . . . . 0.0 110.941 168.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.5 p-90 -95.4 -25.36 16.3 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -170.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.19 170.77 21.73 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.623 1.556 . . . . 0.0 113.416 -175.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 tt -136.04 125.46 24.99 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 103.07 -2.937 . . . . 0.0 103.07 167.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.2 m -137.05 133.94 36.0 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 122.991 0.517 . . . . 0.0 109.992 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.37 145.15 41.89 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 168.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.2 m -138.09 146.83 26.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.7 mt -137.94 135.45 45.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -174.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -122.99 150.43 59.21 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.435 1.094 . . . . 0.0 110.872 -169.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -44.38 152.51 0.43 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 124.736 3.624 . . . . 0.0 114.962 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.41 175.21 15.89 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 123.898 0.761 . . . . 0.0 113.697 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.82 -49.03 10.9 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.578 2.852 . . . . 0.0 114.305 -169.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -161.42 89.57 0.77 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.314 1.445 . . . . 0.0 107.231 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -155.79 -178.01 6.98 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.727 1.611 . . . . 0.0 106.688 178.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -95.7 136.71 35.76 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 168.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -107.97 144.04 28.56 Favored Pre-proline 0 C--N 1.324 -0.513 0 C-N-CA 126.656 1.983 . . . . 0.0 107.207 173.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.2 136.61 44.7 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.015 1.81 . . . . 0.0 110.606 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 64.1 tp -77.54 130.31 36.78 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 169.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.37 158.37 44.42 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 119.175 0.898 . . . . 0.0 109.956 -174.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -73.45 150.93 41.31 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.6 t -91.05 155.92 3.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -170.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.0 m 61.44 33.2 18.75 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.83 0.852 . . . . 0.0 111.658 -175.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -111.76 151.19 29.26 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 126.804 2.041 . . . . 0.0 106.983 169.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -105.26 142.37 35.15 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.092 0.86 . . . . 0.0 111.031 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.2 mm -118.86 130.04 74.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 174.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.21 123.2 6.77 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.9 mt -112.94 140.79 47.45 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.25 127.7 35.79 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 171.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mp -134.95 158.43 74.94 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 124.812 1.245 . . . . 0.0 107.774 174.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -60.81 -23.58 76.96 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.141 1.894 . . . . 0.0 113.98 172.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -64.2 -17.02 63.14 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.996 1.318 . . . . 0.0 111.949 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.94 152.12 9.12 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 107.881 -2.088 . . . . 0.0 107.881 -169.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.5 m -64.63 131.96 48.42 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 38.8 ttp -149.01 138.01 21.4 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -170.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.94 134.66 37.83 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -111.09 137.99 48.07 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 169.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.1 m -85.89 138.21 32.19 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 72.2 t -70.14 117.07 12.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 169.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -104.98 157.94 16.33 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 108.044 -2.022 . . . . 0.0 108.044 171.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -127.49 81.66 2.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 171.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.6 tp -66.1 128.89 37.88 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -169.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.66 131.38 50.52 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 122.832 0.453 . . . . 0.0 110.724 -172.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.36 4.92 75.71 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-O 118.607 -1.107 . . . . 0.0 113.576 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.2 t -122.39 -121.87 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.5 m -151.12 175.97 11.62 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.277 1.431 . . . . 0.0 109.544 -169.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -69.56 141.78 53.73 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 169.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -157.08 -179.15 7.93 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.308 1.443 . . . . 0.0 108.532 178.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 13.6 mt -113.78 136.66 52.61 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.2 p -139.75 153.59 47.22 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.793 0.837 . . . . 0.0 110.672 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 43.8 t -141.26 116.11 9.76 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 173.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.3 m -75.92 135.75 40.09 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 175.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 69.6 mt -116.7 -42.64 2.96 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.92 0.488 . . . . 0.0 112.276 -169.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 20.0 ptp -159.03 164.91 35.05 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.639 0.775 . . . . 0.0 109.746 -176.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.3 m . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 170.193 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.6 p . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.479 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -56.25 -41.01 68.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 123.679 0.791 . . . . 0.0 109.293 169.717 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -71.31 -44.27 65.47 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.097 0.559 . . . . 0.0 109.629 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -68.24 -22.33 64.78 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.645 -0.66 . . . . 0.0 110.998 175.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.29 -48.77 81.56 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 169.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -68.97 -54.05 17.39 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.71 -0.877 . . . . 0.0 110.584 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -65.5 -42.18 92.39 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 118.588 -0.72 . . . . 0.0 112.028 -169.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.9 tp -76.6 -27.15 55.66 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 119.896 1.225 . . . . 0.0 111.246 -171.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.2 m -71.45 -38.05 71.34 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.008 1.276 . . . . 0.0 109.232 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.85 -41.12 78.91 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.897 -0.502 . . . . 0.0 111.637 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -65.21 -34.97 79.63 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 121.022 -1.049 . . . . 0.0 110.325 173.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 18.0 t -67.71 -34.0 76.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.424 ' HB2' ' CE1' ' A' ' 45' ' ' PHE . . . -66.3 -51.73 54.46 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.363 0.665 . . . . 0.0 109.678 170.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 35.6 tpt85 -52.9 -50.08 64.63 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.55 0.74 . . . . 0.0 110.542 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 13.7 ptt? -59.53 -26.55 65.43 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 118.989 0.813 . . . . 0.0 112.306 -172.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 24.3 pt -96.16 5.49 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-N 119.166 0.894 . . . . 0.0 111.898 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.1 mt . . . . . 0 CA--C 1.542 0.647 0 C-N-CA 125.951 1.7 . . . . 0.0 112.078 -174.692 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 CA--C 1.534 0.36 0 CA-C-O 120.833 0.349 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.0 mm -128.56 125.9 64.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 172.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -72.7 128.59 35.99 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 173.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.46 153.51 52.91 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -84.08 136.07 34.16 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.136 0.974 . . . . 0.0 109.74 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -72.26 -33.03 67.18 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.806 -0.616 . . . . 0.0 110.075 173.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.8 p -150.72 155.32 39.06 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.427 1.891 . . . . 0.0 108.543 169.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.6 m -53.26 138.59 47.77 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 125.573 1.549 . . . . 0.0 113.703 -170.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -81.89 44.65 1.76 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 124.909 3.739 . . . . 0.0 110.88 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -61.63 -35.04 76.77 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.212 -1.555 . . . . 0.0 112.688 -168.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.58 -42.38 95.65 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 123.155 0.582 . . . . 0.0 110.983 176.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -68.45 -41.65 79.96 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.336 0.654 . . . . 0.0 109.343 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.6 t -59.44 -46.48 92.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 173.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -60.69 -53.4 57.93 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.284 0.634 . . . . 0.0 110.452 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.73 -44.75 95.39 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.941 0.496 . . . . 0.0 110.832 -172.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.58 -47.27 86.92 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -67.87 -26.26 65.93 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 118.37 -0.824 . . . . 0.0 112.31 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -63.76 -34.5 78.04 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.851 1.205 . . . . 0.0 110.051 176.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -70.91 -50.12 38.32 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.808 0.731 . . . . 0.0 109.34 174.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.8 mt -65.69 -39.67 85.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 123.988 0.915 . . . . 0.0 110.594 -169.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.3 -26.37 65.61 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.082 0.553 . . . . 0.0 111.51 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -85.25 -100.3 0.06 Allowed 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 172.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.546 0.817 0 C-N-CA 125.569 1.548 . . . . 0.0 114.273 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 N--CA 1.456 -0.734 0 N-CA-C 114.204 0.809 . . . . 0.0 114.204 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.9 t -108.3 112.02 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 167.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -148.86 151.77 35.3 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.645 0.778 . . . . 0.0 109.65 -169.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.2 t -137.67 116.24 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 123.669 0.788 . . . . 0.0 109.187 -173.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.0 m -80.62 157.3 26.03 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.913 0.885 . . . . 0.0 110.318 169.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.88 140.5 52.92 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.76 2.024 . . . . 0.0 109.498 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.478 ' CE2' ' CB ' ' A' ' 131' ' ' ALA . 60.1 m-85 -147.06 169.7 18.7 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -169.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.8 t -52.03 167.45 0.12 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 129.132 2.973 . . . . 0.0 114.505 -169.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.9 tp -77.99 125.5 29.44 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 174.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.89 135.7 33.15 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.18 1.792 . . . . 0.0 107.299 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 55.38 24.16 6.37 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.864 0.866 . . . . 0.0 111.992 -170.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.23 5.88 78.12 Favored Glycine 0 CA--C 1.534 1.233 0 O-C-N 121.026 -1.046 . . . . 0.0 113.817 -174.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -119.14 157.22 28.34 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.191 1.796 . . . . 0.0 108.952 -175.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -79.3 147.76 32.36 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.311 -1.493 . . . . 0.0 110.091 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.58 162.82 12.94 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 122.506 1.146 . . . . 0.0 109.885 169.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.14 172.13 39.88 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 107.49 -2.244 . . . . 0.0 107.49 169.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 11.6 m -138.93 152.4 47.69 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 105.591 -2.004 . . . . 0.0 105.591 169.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.71 138.86 52.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 175.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.441 HD13 ' HA2' ' A' ' 123' ' ' GLY . 13.6 tt -116.1 146.22 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 167.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.4 t -154.8 157.11 31.97 Favored Pre-proline 0 N--CA 1.442 -0.863 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 175.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -50.23 -29.7 23.69 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.934 2.422 . . . . 0.0 113.646 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -93.14 -19.88 21.04 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -174.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -166.69 159.45 13.99 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.911 1.687 . . . . 0.0 112.66 -175.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.4 tt -124.57 124.88 43.19 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 103.848 -2.649 . . . . 0.0 103.848 167.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.8 m -137.65 134.46 35.49 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.35 0.595 . . . . 0.0 109.724 -172.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.84 144.2 52.65 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 167.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.7 m -136.11 150.44 28.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 32.1 mt -135.92 143.4 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -123.89 139.43 32.41 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -53.98 132.16 48.41 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.868 1.712 . . . . 0.0 108.928 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.4 -175.91 31.27 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.292 0.948 . . . . 0.0 114.68 -169.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -71.17 153.79 62.17 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.203 2.602 . . . . 0.0 110.204 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.0 t0 46.67 44.59 13.88 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.067 1.747 . . . . 0.0 113.068 172.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -133.62 143.52 48.67 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.103 1.361 . . . . 0.0 107.842 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -112.19 95.94 5.75 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 172.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -65.63 155.64 85.2 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.443 171.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -68.35 164.46 32.44 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.629 2.22 . . . . 0.0 109.909 169.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.25 87.68 1.12 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 169.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -70.82 148.98 47.29 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -89.9 159.04 17.15 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 169.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.8 t -91.37 154.22 3.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 114.048 -1.433 . . . . 0.0 107.647 -169.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.8 m 66.26 6.19 4.1 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.433 1.493 . . . . 0.0 113.673 -175.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -80.06 158.63 26.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.988 1.315 . . . . 0.0 108.268 169.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -113.97 144.22 43.44 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.966 0.803 . . . . 0.0 110.847 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.4 mm -118.21 121.09 66.36 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 176.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.11 125.33 7.74 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 173.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.3 mt -123.27 141.17 52.27 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.317 1.047 . . . . 0.0 109.084 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -90.53 133.65 34.92 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 172.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -153.49 157.51 32.76 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 124.958 1.303 . . . . 0.0 107.895 172.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -61.04 -20.26 66.84 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.059 2.506 . . . . 0.0 114.705 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -62.51 -20.65 64.83 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.944 0.898 . . . . 0.0 112.067 172.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.54 145.71 7.04 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 -170.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.9 m -60.64 131.07 49.56 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 174.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 47.6 ttp -149.67 146.21 27.14 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -169.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.55 134.02 34.42 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 121.883 -0.511 . . . . 0.0 110.493 176.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -104.98 132.25 51.46 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 168.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.2 m -82.01 144.11 31.1 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.0 t -75.96 114.39 16.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -98.1 162.75 21.02 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 171.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -129.9 133.86 47.13 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 169.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.6 tp -143.84 145.97 32.71 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -176.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -59.5 134.88 57.42 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.789 0.435 . . . . 0.0 110.572 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.17 4.45 59.71 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 118.945 -0.919 . . . . 0.0 113.701 -177.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.4 t -124.7 -33.15 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 118.928 1.364 . . . . 0.0 109.746 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.7 m 57.39 -150.09 0.45 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.331 1.053 . . . . 0.0 108.445 -169.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -58.61 132.15 52.94 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.884 0.874 . . . . 0.0 110.579 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -154.5 179.41 9.05 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.365 1.866 . . . . 0.0 107.011 169.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.6 mp -113.47 144.36 42.95 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 121.131 -0.981 . . . . 0.0 109.217 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.8 p -142.86 154.58 44.28 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.571 1.148 . . . . 0.0 110.278 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 12.2 t -144.75 111.87 5.96 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 170.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.9 m -67.98 130.17 42.14 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.7 mt -96.38 -59.34 1.85 Allowed 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -176.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.87 170.28 12.4 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.342 1.457 . . . . 0.0 108.377 177.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 170.844 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 78.7 p . . . . . 0 C--O 1.236 0.373 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.575 ' H ' HD12 ' A' ' 120' ' ' ILE . 1.9 mp -58.34 -36.87 60.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 169.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -72.59 -44.99 61.29 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.572 0.749 . . . . 0.0 109.959 -174.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -64.23 -31.92 73.31 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.646 172.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.441 ' HA2' HD13 ' A' ' 57' ' ' ILE . . . -56.07 -58.39 14.42 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-N 119.455 1.025 . . . . 0.0 111.533 169.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -63.82 -48.55 76.4 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.043 0.922 . . . . 0.0 110.478 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -57.41 -45.44 84.59 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.935 1.294 . . . . 0.0 110.699 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.6 tp -78.35 -27.87 47.07 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.201 -174.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.9 m -65.83 -44.84 84.35 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.724 1.147 . . . . 0.0 109.173 173.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -65.68 -46.42 79.11 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.45 0.7 . . . . 0.0 111.299 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.04 -33.29 75.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.813 0.445 . . . . 0.0 110.548 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 19.0 m -68.22 -39.64 82.29 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.23 0.468 . . . . 0.0 110.797 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.478 ' CB ' ' CE2' ' A' ' 45' ' ' PHE . . . -65.23 -50.69 64.88 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 171.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -52.9 -51.36 61.52 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.065 0.848 . . . . 0.0 110.737 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 58.2 ttp -43.13 -48.23 6.27 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.152 2.181 . . . . 0.0 112.476 173.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 11.0 pt -92.78 -15.37 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 118.767 0.712 . . . . 0.0 112.513 -174.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 18.6 mt . . . . . 0 N--CA 1.456 -0.156 0 C-N-CA 124.384 1.074 . . . . 0.0 110.548 -175.677 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.64 133.08 70.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 169.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -153.14 164.0 38.84 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.232 1.013 . . . . 0.0 110.207 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 134.78 -150.54 20.14 Favored Glycine 0 C--N 1.341 0.828 0 C-N-CA 125.035 1.302 . . . . 0.0 110.368 176.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -84.54 -27.26 27.46 Favored 'General case' 0 C--O 1.221 -0.447 0 C-N-CA 125.061 1.344 . . . . 0.0 107.463 169.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 58.9 16.32 4.49 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 167.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.3 p -52.28 145.38 11.04 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.336 1.054 . . . . 0.0 112.069 -177.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -48.12 126.22 11.68 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 126.04 1.736 . . . . 0.0 111.146 -175.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -73.45 53.21 2.58 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.906 3.071 . . . . 0.0 112.036 174.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.7 tttm -47.66 -48.76 28.78 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.44 1.896 . . . . 0.0 112.998 -169.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.64 -41.19 88.66 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.275 0.489 . . . . 0.0 111.69 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -71.87 -38.75 70.0 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.926 0.49 . . . . 0.0 109.795 -176.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 71.7 t -61.63 -44.16 98.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 172.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -60.31 -53.74 54.08 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.58 0.627 . . . . 0.0 110.078 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.93 -40.09 96.59 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.613 0.642 . . . . 0.0 111.194 -176.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.61 -46.9 86.15 Favored 'General case' 0 C--N 1.339 0.126 0 O-C-N 122.064 -0.398 . . . . 0.0 110.019 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -68.79 -25.15 64.56 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 118.419 -0.8 . . . . 0.0 112.379 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -67.08 -33.19 74.96 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 119.504 1.047 . . . . 0.0 109.803 173.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -77.58 -45.99 23.56 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.746 -0.596 . . . . 0.0 109.888 176.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.0 mt -60.43 -39.73 81.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.09 -34.46 77.65 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.362 -0.836 . . . . 0.0 111.549 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -71.73 -43.19 66.28 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.052 0.842 . . . . 0.0 109.059 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? . . . . . 0 CA--C 1.533 0.303 0 C-N-CA 123.957 0.903 . . . . 0.0 111.152 175.235 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo . . . . . 0 N--CA 1.453 -0.883 0 N-CA-C 112.827 0.28 . . . . 0.0 112.827 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.2 m -67.06 152.92 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 168.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -140.53 155.56 46.59 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.453 1.024 . . . . 0.0 110.073 -175.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.4 t -139.54 114.28 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.2 m -78.86 142.0 37.2 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 168.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -125.37 134.74 52.07 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.401 1.48 . . . . 0.0 107.865 169.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.612 ' CE1' ' HB1' ' A' ' 131' ' ' ALA . 20.5 p90 -165.11 142.8 6.09 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -172.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.4 m 54.58 166.27 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.104 2.562 . . . . 0.0 116.312 167.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.0 tp -113.54 110.34 20.09 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 168.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -131.22 135.74 47.65 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.678 1.591 . . . . 0.0 107.089 -169.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 55.51 25.05 7.43 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 121.644 0.735 . . . . 0.0 110.51 -168.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.16 3.64 65.75 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 118.146 -1.363 . . . . 0.0 113.901 -174.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -115.34 154.86 28.39 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.599 1.699 . . . . 0.0 109.403 -173.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -74.59 137.66 42.47 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.683 -1.26 . . . . 0.0 108.997 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.79 155.97 18.19 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.667 1.122 . . . . 0.0 110.255 -173.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.15 171.58 41.25 Favored Glycine 0 CA--C 1.526 0.721 0 O-C-N 121.081 -1.012 . . . . 0.0 111.732 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 15.0 m -145.76 152.44 39.57 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 170.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.87 144.6 35.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 124.986 1.314 . . . . 0.0 107.466 173.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.9 tt -127.83 150.28 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 169.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.2 p -138.56 175.87 3.05 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 169.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -59.54 -30.42 92.4 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 CA-C-N 119.701 0.929 . . . . 0.0 110.835 168.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 48.4 p-90 -92.45 -25.59 18.38 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -171.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.51 170.45 21.93 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.42 1.464 . . . . 0.0 113.491 -175.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.6 tt -138.29 128.45 25.78 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 104.147 -2.538 . . . . 0.0 104.147 168.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.2 m -140.65 138.74 34.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.655 0.741 . . . . 0.0 109.622 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.63 146.58 51.57 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 168.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.0 m -138.84 144.85 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 C-N-CA 123.807 0.843 . . . . 0.0 108.786 175.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 52.2 mt -138.35 144.07 31.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -128.3 146.18 58.6 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-O 117.974 -1.012 . . . . 0.0 108.621 -175.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.64 134.65 21.83 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.469 2.779 . . . . 0.0 111.023 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.78 173.61 53.36 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 123.01 0.338 . . . . 0.0 112.878 -175.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -69.71 149.9 67.81 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 122.532 2.155 . . . . 0.0 110.296 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.0 t70 50.71 40.46 24.27 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.409 1.884 . . . . 0.0 112.696 169.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -128.27 131.12 48.74 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.3 mp -96.74 83.23 3.41 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 -175.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 3.7 m0 -66.33 140.4 96.73 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.645 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -66.86 161.68 41.12 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.842 1.695 . . . . 0.0 108.454 168.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.0 tp -67.38 106.44 2.09 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 169.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -73.77 155.13 39.19 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.335 0.588 . . . . 0.0 109.642 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -89.87 148.14 23.34 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 169.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.6 t -89.84 154.72 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -169.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.1 m 65.01 12.86 8.25 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.149 1.38 . . . . 0.0 113.713 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -85.96 158.97 19.76 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.114 1.365 . . . . 0.0 108.212 169.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -111.23 143.24 42.3 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 118.796 0.726 . . . . 0.0 110.504 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.9 mp -114.09 127.82 71.34 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 N-CA-C 104.775 -2.305 . . . . 0.0 104.775 170.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.51 121.09 5.54 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 170.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.8 mt -109.32 132.57 54.0 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 174.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -85.97 125.96 33.77 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 173.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 37.1 mt -133.6 148.52 68.97 Favored Pre-proline 0 C--O 1.233 0.224 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -59.12 -24.6 74.48 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.383 2.055 . . . . 0.0 112.802 169.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -58.05 -29.61 65.51 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.995 1.318 . . . . 0.0 112.158 169.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.32 142.15 4.84 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 -169.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.7 m -61.5 130.47 46.17 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 174.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 44.2 ttp -147.75 136.97 22.31 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -170.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.12 139.79 35.42 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.753 -0.592 . . . . 0.0 110.145 175.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -112.81 136.72 52.12 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 169.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.5 m -91.8 140.97 29.17 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.3 t -72.61 129.21 35.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -114.39 159.64 13.61 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 107.54 -2.224 . . . . 0.0 107.54 169.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -127.5 100.32 5.96 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 171.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.8 tp -79.11 121.79 25.43 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -171.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.09 129.98 44.07 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.042 0.537 . . . . 0.0 110.604 -172.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.88 5.81 70.98 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.669 -1.073 . . . . 0.0 113.632 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.9 t -124.75 -113.23 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 118.847 1.324 . . . . 0.0 107.611 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 11.8 m -152.98 174.45 14.13 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.793 1.237 . . . . 0.0 110.142 -169.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -75.49 145.78 41.13 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 169.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.16 167.52 30.16 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.501 1.52 . . . . 0.0 108.277 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.4 mp -110.51 137.85 47.67 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.9 m -136.84 152.13 49.91 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.586 0.754 . . . . 0.0 110.47 -174.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 43.0 t -144.81 124.11 13.02 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 169.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.0 m -65.09 143.49 57.87 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 176.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.6 mt -117.69 -47.9 2.6 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 118.576 -0.726 . . . . 0.0 111.131 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 19.0 ptp -160.07 165.19 32.29 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.036 0.835 . . . . 0.0 110.541 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.3 m . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 169.896 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 CA--C 1.528 0.121 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -63.68 -24.84 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 O-C-N 120.923 -1.111 . . . . 0.0 111.114 177.948 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -67.04 -37.44 84.1 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.569 -0.707 . . . . 0.0 110.05 173.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -69.74 -31.72 69.86 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 118.888 0.767 . . . . 0.0 109.728 170.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.33 -36.94 46.98 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 169.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -84.6 -52.38 6.15 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.23 -1.159 . . . . 0.0 110.821 173.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 60.1 ttp85 -65.58 -38.5 89.68 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -169.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.62 -31.24 46.93 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 119.677 1.126 . . . . 0.0 109.2 -173.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 m -67.43 -42.52 83.04 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 123.677 0.791 . . . . 0.0 109.061 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -66.75 -41.26 88.11 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.349 1.06 . . . . 0.0 111.828 173.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.97 -30.54 65.37 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 121.176 -0.952 . . . . 0.0 110.636 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 44.0 m -69.32 -43.02 74.6 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.974 0.51 . . . . 0.0 110.172 173.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.612 ' HB1' ' CE1' ' A' ' 45' ' ' PHE . . . -54.34 -49.76 68.98 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.217 1.007 . . . . 0.0 110.276 173.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.0 ttp-105 -68.49 -42.69 78.29 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.43 -0.794 . . . . 0.0 111.851 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 51.4 ttp -48.31 -56.4 8.17 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.312 1.045 . . . . 0.0 110.601 171.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.6 pt -78.36 -6.07 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 118.865 0.757 . . . . 0.0 112.961 -176.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 19.0 tp . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 170.007 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 . . . . . 0 CA--C 1.536 0.411 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 71.2 mt -131.82 129.93 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 174.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.59 145.66 36.69 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.149 0.499 . . . . 0.0 110.49 -178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.17 151.18 51.66 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.911 1.243 . . . . 0.0 112.422 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -86.45 131.14 34.27 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 170.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -74.02 -32.7 63.48 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 171.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 p -149.73 148.22 28.97 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.489 1.916 . . . . 0.0 107.488 169.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.6 m -59.84 150.67 67.38 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 126.816 2.046 . . . . 0.0 114.13 -169.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -80.6 42.28 1.3 Allowed 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 124.306 3.337 . . . . 0.0 111.737 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 tttm -52.83 -46.91 67.97 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.853 1.261 . . . . 0.0 112.04 -169.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.57 -41.05 98.41 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 122.57 0.348 . . . . 0.0 111.407 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -72.28 -38.63 68.74 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -175.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 99.3 t -61.35 -44.08 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 172.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -62.17 -50.44 71.83 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 118.849 -0.596 . . . . 0.0 110.579 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.62 -39.13 93.17 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.765 0.711 . . . . 0.0 111.032 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.43 -50.33 74.02 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -68.36 -28.19 66.91 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 118.172 -0.918 . . . . 0.0 112.594 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.8 -33.88 76.66 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 120.028 1.285 . . . . 0.0 109.582 175.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -80.05 -43.27 22.16 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.289 0.495 . . . . 0.0 110.352 176.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.1 mt -65.22 -37.96 81.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.263 -0.898 . . . . 0.0 109.117 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.31 -32.69 74.25 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.467 0.707 . . . . 0.0 110.707 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -72.53 -41.8 65.46 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.841 0.856 . . . . 0.0 109.459 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.274 0 C-N-CA 124.332 1.053 . . . . 0.0 110.266 173.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 N--CA 1.454 -0.818 0 N-CA-C 115.769 1.411 . . . . 0.0 115.769 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.433 HG13 HG22 ' A' ' 58' ' ' THR . 39.6 t -111.63 107.9 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 101.128 -3.656 . . . . 0.0 101.128 167.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -140.85 159.17 42.78 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.946 0.898 . . . . 0.0 110.197 -169.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.3 t -138.16 112.21 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.7 m -76.17 147.82 38.2 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.487 1.04 . . . . 0.0 108.982 169.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -144.26 130.18 19.4 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.679 1.192 . . . . 0.0 111.622 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 176.59 159.35 0.33 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.017 1.327 . . . . 0.0 113.398 -172.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 m 61.64 152.86 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 128.473 2.709 . . . . 0.0 114.688 168.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.5 mt -103.62 125.55 50.21 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 169.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -135.34 138.45 43.4 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 173.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 54.18 26.31 6.57 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.971 0.908 . . . . 0.0 111.017 -169.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.54 7.14 82.68 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.927 1.251 . . . . 0.0 114.263 -176.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -119.17 148.68 42.82 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.236 1.518 . . . . 0.0 109.322 -173.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -66.72 145.3 55.68 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.235 0.925 . . . . 0.0 110.134 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.87 160.19 19.03 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.911 0.862 . . . . 0.0 110.173 -172.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -176.31 178.59 47.66 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 13.6 m -142.04 150.25 41.02 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 169.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.1 p -114.87 147.12 18.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 169.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.6 tt -130.08 151.34 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 169.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.433 HG22 HG13 ' A' ' 40' ' ' VAL . 44.5 p -142.41 172.06 6.35 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 169.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -73.89 21.06 0.38 Allowed 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 121.344 1.363 . . . . 0.0 112.063 169.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -138.13 -23.27 1.02 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.288 0.949 . . . . 0.0 113.403 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.18 164.71 37.57 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 120.363 1.438 . . . . 0.0 111.733 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 tt -137.61 125.87 23.18 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 168.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.3 m -138.18 134.18 34.21 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 123.332 0.395 . . . . 0.0 110.084 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.1 141.41 56.12 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 168.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 m -138.76 144.83 28.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 51.5 mt -141.33 134.35 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 -170.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -119.95 145.05 38.81 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.33 -172.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -44.68 125.8 6.62 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.738 2.959 . . . . 0.0 112.18 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.65 176.45 28.47 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 123.364 0.507 . . . . 0.0 113.193 -175.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -67.19 135.14 36.1 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.125 2.55 . . . . 0.0 110.411 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.7 t70 49.1 32.57 4.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.925 1.69 . . . . 0.0 113.259 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 -91.37 151.85 20.67 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 172.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -118.42 88.72 2.98 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 172.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 22.9 m0 -65.28 150.66 95.37 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 169.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.58 168.21 23.27 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.706 1.604 . . . . 0.0 108.375 169.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.8 tp -71.09 91.36 0.9 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 170.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -75.55 151.79 37.85 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.418 0.628 . . . . 0.0 109.679 -176.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -89.83 149.88 22.48 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 173.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.8 t -91.88 154.86 3.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 124.311 1.044 . . . . 0.0 108.281 -169.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.9 m 62.45 23.52 13.96 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.637 1.175 . . . . 0.0 112.667 -176.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -99.43 151.71 20.8 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.206 1.802 . . . . 0.0 107.648 169.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -106.2 143.63 34.06 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.503 0.592 . . . . 0.0 110.345 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 9.8 mt -123.92 128.41 74.18 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.85 123.14 6.89 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.8 mt -109.57 131.56 54.95 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 172.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.64 127.75 34.0 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 172.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.9 mt -135.2 153.62 78.33 Favored Pre-proline 0 C--O 1.234 0.275 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.79 -26.06 82.32 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.71 2.274 . . . . 0.0 112.759 174.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -65.37 -23.3 66.94 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.123 1.369 . . . . 0.0 111.911 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 129.69 147.15 6.2 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 126.176 1.846 . . . . 0.0 108.835 -169.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.7 m -62.78 133.86 55.39 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 55.7 ttm -144.47 136.09 25.72 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -169.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.42 130.11 35.11 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.521 -0.737 . . . . 0.0 109.169 173.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -106.06 136.48 45.65 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 169.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.8 m -87.58 137.88 31.96 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.1 t -71.02 114.81 9.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -101.47 163.31 17.74 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 169.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -130.58 97.8 4.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 170.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.5 tp -78.06 128.05 33.25 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -169.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -58.92 130.9 49.2 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.172 0.589 . . . . 0.0 110.52 -176.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.5 3.65 72.43 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.646 -1.086 . . . . 0.0 113.818 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.3 t -126.19 -121.0 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 119.143 1.471 . . . . 0.0 107.188 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.4 m -151.65 -176.79 5.76 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.776 1.63 . . . . 0.0 109.019 -169.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -72.91 148.62 44.17 Favored 'General case' 0 C--N 1.34 0.188 0 O-C-N 121.748 -0.595 . . . . 0.0 110.155 169.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -154.49 163.29 40.42 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.123 1.769 . . . . 0.0 108.03 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.4 mt -104.44 130.55 52.34 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.6 m -137.61 151.89 48.8 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.018 0.527 . . . . 0.0 110.884 -171.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 25.8 t -142.44 123.77 14.74 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 170.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.2 m -70.97 135.27 47.78 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 176.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.5 mt -110.48 -50.68 2.94 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.359 0.664 . . . . 0.0 111.165 -173.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 9.4 ptp -159.75 172.31 17.93 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.708 0.803 . . . . 0.0 109.982 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 CA--C 1.539 0.539 0 C-N-CA 124.044 0.938 . . . . 0.0 109.648 -177.051 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.7 t . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.565 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.6 OUTLIER -57.08 -36.59 51.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 119.09 0.859 . . . . 0.0 109.905 177.45 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -71.67 -32.41 67.84 Favored 'General case' 0 C--O 1.223 -0.308 0 O-C-N 121.652 -0.655 . . . . 0.0 110.462 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -73.73 -42.25 61.42 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.992 0.814 . . . . 0.0 109.372 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -49.01 -30.86 9.94 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 123.756 0.693 . . . . 0.0 113.882 169.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -90.33 -57.62 2.78 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.602 1.201 . . . . 0.0 111.481 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 71.8 ttt-85 -68.79 -32.58 72.41 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -168.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.6 mp -76.74 -38.34 54.37 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.757 1.162 . . . . 0.0 108.464 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.0 m -63.14 -43.58 97.93 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.3 1.04 . . . . 0.0 109.301 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.71 -55.0 39.81 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 118.657 -0.687 . . . . 0.0 110.801 171.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.27 -34.86 75.86 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.138 0.881 . . . . 0.0 111.408 -174.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 99.5 m -73.39 -27.14 61.3 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 122.11 -0.369 . . . . 0.0 111.854 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.52 -41.19 40.1 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.484 -0.76 . . . . 0.0 109.101 169.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -57.81 -55.34 36.11 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.262 1.425 . . . . 0.0 110.277 -173.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 17.3 ptt? -48.95 -34.09 12.21 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.655 1.582 . . . . 0.0 112.56 177.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 34.3 pt -93.53 2.5 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 119.863 1.21 . . . . 0.0 112.435 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 26.5 mt . . . . . 0 N--CA 1.465 0.316 0 C-N-CA 125.304 1.442 . . . . 0.0 112.844 -169.69 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 . . . . . 0 CA--C 1.544 0.74 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.0 mt -134.08 139.09 49.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 126.831 2.052 . . . . 0.0 106.19 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.28 150.61 45.02 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.931 -0.481 . . . . 0.0 111.307 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.24 163.1 42.63 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.301 0.953 . . . . 0.0 112.508 172.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -115.94 155.58 27.76 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.271 1.428 . . . . 0.0 109.736 175.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -88.63 -22.76 23.29 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.302 0.641 . . . . 0.0 111.659 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.3 p -159.2 -178.01 6.89 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 129.393 3.077 . . . . 0.0 106.323 172.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 m -57.19 134.99 80.92 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 121.247 -0.908 . . . . 0.0 109.534 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -74.19 63.48 5.23 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 124.537 3.491 . . . . 0.0 110.295 172.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -53.01 -50.74 63.6 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 124.266 1.026 . . . . 0.0 111.559 -169.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.32 -41.23 89.98 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 123.317 0.385 . . . . 0.0 110.708 -171.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -65.51 -45.91 81.7 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.595 0.758 . . . . 0.0 109.919 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 71.3 t -62.81 -41.12 91.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -62.98 -52.85 61.39 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.873 0.869 . . . . 0.0 109.996 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.77 -40.54 97.62 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.719 0.69 . . . . 0.0 110.648 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.04 71.56 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -68.06 -26.95 66.11 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 118.068 -0.968 . . . . 0.0 112.639 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -66.27 -31.1 71.71 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.826 1.194 . . . . 0.0 110.15 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -83.67 -41.63 17.53 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.243 0.617 . . . . 0.0 110.525 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.5 mt -65.52 -36.7 78.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 120.912 -1.117 . . . . 0.0 108.064 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.1 -27.78 68.61 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.228 -0.92 . . . . 0.0 112.244 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 62.9 ttp85 -76.41 -32.99 58.82 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.151 0.887 . . . . 0.0 109.665 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 . . . . . 0 CA--C 1.533 0.31 0 CA-C-O 118.904 -0.569 . . . . 0.0 110.857 171.293 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo . . . . . 0 N--CA 1.452 -0.92 0 N-CA-C 113.696 0.614 . . . . 0.0 113.696 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.3 t -99.49 106.98 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 1 N-CA-C 99.943 -4.095 . . . . 0.0 99.943 167.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -150.59 161.68 42.11 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.959 0.904 . . . . 0.0 109.944 -169.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 t -138.91 127.32 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.064 0.946 . . . . 0.0 108.748 -176.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.3 m -93.18 148.74 21.76 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.934 0.894 . . . . 0.0 109.039 168.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -121.9 141.28 51.45 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.361 1.865 . . . . 0.0 110.1 -176.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.419 ' CE2' ' CB ' ' A' ' 131' ' ' ALA . 91.1 m-85 -148.89 174.73 11.93 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.927 1.291 . . . . 0.0 113.053 -169.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.0 t -45.99 167.22 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 129.765 3.226 . . . . 0.0 115.121 -171.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.2 tp -84.76 107.1 16.77 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 105.69 -1.966 . . . . 0.0 105.69 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -76.64 -55.68 5.3 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 117.905 0.321 . . . . 0.0 111.578 -169.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.35 55.52 1.03 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.434 1.494 . . . . 0.0 109.347 177.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.83 10.25 79.34 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.075 -177.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -138.37 143.43 39.83 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.565 1.946 . . . . 0.0 107.362 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -74.79 152.08 39.04 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.679 0.672 . . . . 0.0 109.719 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.89 156.23 18.92 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.5 171.65 41.52 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.3 m -138.37 145.8 41.51 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 169.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 p -115.89 148.04 18.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 170.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.8 tt -129.73 152.11 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.885 1.274 . . . . 0.0 107.598 169.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.0 p -143.46 178.21 1.55 Allowed Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 125.337 1.455 . . . . 0.0 107.181 170.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.3 -24.57 77.84 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 121.331 1.354 . . . . 0.0 111.896 168.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.5 p-90 -104.3 -22.44 13.36 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -169.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.74 169.73 24.06 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 120.278 1.399 . . . . 0.0 112.608 -175.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.1 tt -138.29 126.4 22.82 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 103.946 -2.612 . . . . 0.0 103.946 168.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.6 m -138.89 134.69 33.6 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.16 147.48 46.57 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 168.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.4 m -139.04 148.41 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 124.574 1.15 . . . . 0.0 108.58 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 50.7 mt -138.57 137.85 42.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -126.31 148.33 63.36 Favored Pre-proline 0 N--CA 1.466 0.335 0 C-N-CA 124.042 0.937 . . . . 0.0 109.841 -173.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.4 133.86 31.32 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.709 2.273 . . . . 0.0 111.265 172.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.18 -171.35 16.47 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 123.756 0.693 . . . . 0.0 111.918 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.31 157.45 33.25 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.611 2.207 . . . . 0.0 111.297 -177.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.2 t0 43.76 56.33 4.62 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.747 2.019 . . . . 0.0 113.388 169.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -149.35 160.48 43.38 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.266 1.027 . . . . 0.0 109.315 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -111.7 105.69 14.27 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 169.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -70.67 143.45 89.8 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 172.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.16 150.25 85.12 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.049 1.833 . . . . 0.0 110.379 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.3 tp -76.12 92.9 3.26 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 170.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -79.36 171.49 15.1 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.032 0.933 . . . . 0.0 110.271 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -99.01 162.13 13.24 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 123.546 1.641 . . . . 0.0 107.481 168.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 87.9 t -89.84 154.27 3.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 113.044 -1.889 . . . . 0.0 107.112 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.9 m 67.11 5.82 4.38 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.058 1.343 . . . . 0.0 113.732 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -71.69 150.09 44.86 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 169.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -116.17 138.18 51.49 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.598 0.636 . . . . 0.0 110.032 177.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.6 mp -111.03 122.27 65.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 103.696 -2.705 . . . . 0.0 103.696 175.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.61 116.87 4.61 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 173.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.6 tp -106.72 132.36 52.79 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -87.53 127.58 35.25 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 172.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 mp -134.76 155.0 79.76 Favored Pre-proline 0 C--O 1.234 0.283 0 C-N-CA 125.426 1.49 . . . . 0.0 107.304 172.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -64.52 -23.93 63.95 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 CA-C-N 120.757 1.306 . . . . 0.0 112.402 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -55.25 -30.33 59.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.826 1.651 . . . . 0.0 111.763 169.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.06 148.32 5.54 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 108.116 -1.993 . . . . 0.0 108.116 -171.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.1 m -65.1 131.46 46.62 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 171.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 45.4 ttp -146.21 135.59 22.94 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -171.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.26 134.47 35.28 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 118.54 0.609 . . . . 0.0 110.021 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -103.48 134.13 47.35 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 168.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.6 m -94.9 141.49 28.58 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 92.5 t -74.16 123.83 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 171.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -113.0 156.74 15.41 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 169.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -115.08 98.53 6.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 169.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.1 tp -75.14 124.29 26.76 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -169.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -61.12 128.78 38.09 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.416 0.686 . . . . 0.0 110.219 -173.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.42 4.74 84.88 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.645 -1.086 . . . . 0.0 113.857 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.7 t -127.72 -118.99 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 119.069 1.435 . . . . 0.0 107.282 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.2 m -151.39 -179.57 7.49 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.174 1.79 . . . . 0.0 108.31 -169.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -70.66 146.14 50.16 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 121.671 -0.643 . . . . 0.0 109.691 169.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.82 167.64 26.87 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.671 1.588 . . . . 0.0 108.511 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.6 mt -103.43 138.63 39.89 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 174.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.5 p -154.93 160.59 41.26 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 119.298 0.954 . . . . 0.0 111.821 -177.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 9.5 p -149.17 135.63 19.36 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 168.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.2 p -74.17 145.63 44.07 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.457 0.703 . . . . 0.0 109.463 176.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.6 mt -116.36 -70.29 0.8 Allowed 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.768 0.827 . . . . 0.0 109.387 -173.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -148.53 161.16 42.21 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.077 0.951 . . . . 0.0 109.892 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 CA--C 1.544 0.728 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 168.761 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 96.6 p . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.544 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -61.85 -32.07 52.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 O-C-N 121.186 -0.946 . . . . 0.0 110.222 170.041 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -75.35 -43.95 47.79 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.472 0.578 . . . . 0.0 109.664 -177.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -62.66 -31.58 72.48 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.32 170.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.88 -50.64 61.99 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 119.97 1.259 . . . . 0.0 111.158 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -62.43 -50.88 69.74 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.988 -0.713 . . . . 0.0 109.87 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 66.0 ttp85 -61.61 -38.63 88.34 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 123.465 0.706 . . . . 0.0 110.927 -175.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.5 tp -80.51 -24.33 39.45 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 117.817 -1.087 . . . . 0.0 111.248 -174.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.9 m -65.42 -44.18 88.2 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 120.463 1.483 . . . . 0.0 108.724 170.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.96 -53.84 47.83 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 118.761 -0.638 . . . . 0.0 109.939 174.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -61.49 -32.22 72.23 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.615 0.643 . . . . 0.0 111.129 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 57.3 m -73.26 -30.47 63.47 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.994 -0.441 . . . . 0.0 111.621 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.419 ' CB ' ' CE2' ' A' ' 45' ' ' PHE . . . -73.8 -49.13 26.78 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 119.231 0.923 . . . . 0.0 109.57 170.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -46.82 -58.22 4.12 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 127.465 2.306 . . . . 0.0 110.469 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 15.8 ptt? -51.84 -42.68 62.77 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.601 1.161 . . . . 0.0 112.25 178.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 22.8 pt -84.24 -25.93 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 119.693 1.133 . . . . 0.0 111.789 -175.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 72.7 mt . . . . . 0 CA--C 1.538 0.49 0 C-N-CA 123.472 0.709 . . . . 0.0 109.306 169.281 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.543 0.71 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.7 mt -132.35 130.46 60.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.33 123.7 32.58 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.8 159.65 47.97 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 123.361 0.505 . . . . 0.0 111.902 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -111.09 164.75 12.51 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.427 1.491 . . . . 0.0 110.648 -169.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -76.03 -13.93 60.22 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.206 1.002 . . . . 0.0 112.336 -177.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 p -152.88 168.86 24.36 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 127.652 2.381 . . . . 0.0 106.959 171.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.9 m -64.76 145.53 98.78 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 169.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.92 65.94 7.67 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 124.554 3.503 . . . . 0.0 110.628 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -52.83 -48.61 66.85 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 123.912 0.885 . . . . 0.0 112.255 -169.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.8 -36.59 84.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.095 0.474 . . . . 0.0 110.95 -173.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -74.43 -41.75 60.31 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.034 0.934 . . . . 0.0 109.848 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.7 t -60.23 -45.32 96.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 172.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -62.19 -50.25 72.55 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.348 1.059 . . . . 0.0 110.402 -177.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.34 -39.2 93.88 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.778 0.717 . . . . 0.0 110.957 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.27 -47.02 84.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.176 -0.327 . . . . 0.0 110.32 175.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -68.05 -24.97 65.14 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 118.354 -0.831 . . . . 0.0 112.362 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -69.78 -32.42 70.9 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.857 1.208 . . . . 0.0 109.544 175.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -72.94 -46.89 49.95 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 173.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mt -64.6 -40.88 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 121.632 -0.668 . . . . 0.0 109.731 -176.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.1 -27.03 67.75 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.528 0.731 . . . . 0.0 111.302 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 51.9 ttm-85 -78.17 -45.26 23.64 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.72 0.808 . . . . 0.0 109.325 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 . . . . . 0 CA--C 1.534 0.344 0 C-N-CA 125.02 1.328 . . . . 0.0 111.092 177.918 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 120' ' ' ILE . 84.7 Cg_endo . . . . . 0 N--CA 1.449 -1.117 0 CA-C-O 120.576 0.157 . . . . 0.0 112.356 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.6 t -94.86 101.52 12.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 100.505 -3.887 . . . . 0.0 100.505 167.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -147.12 159.12 43.98 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.51 1.124 . . . . 0.0 109.855 -169.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.3 t -137.48 139.03 44.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.428 1.091 . . . . 0.0 108.161 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.0 m -106.79 152.01 24.41 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.949 1.299 . . . . 0.0 108.666 169.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -149.37 129.54 13.63 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.38 1.472 . . . . 0.0 109.838 -175.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -179.99 155.25 0.59 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.695 1.198 . . . . 0.0 112.468 -169.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.6 m 64.16 151.0 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.818 2.447 . . . . 0.0 112.613 170.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.6 tp -111.36 59.65 0.62 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.996 0.918 . . . . 0.0 109.409 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.31 134.26 50.04 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 123.566 0.746 . . . . 0.0 109.921 -175.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 54.96 23.46 5.09 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.827 0.851 . . . . 0.0 111.632 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.82 14.29 81.14 Favored Glycine 0 CA--C 1.537 1.427 0 CA-C-O 118.489 -1.173 . . . . 0.0 113.68 -176.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -132.75 149.23 52.3 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.621 1.71 . . . . 0.0 108.708 -171.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -70.4 135.74 49.01 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.034 -1.041 . . . . 0.0 109.665 -175.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.1 156.09 16.75 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -168.7 176.21 43.03 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 175.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 43.9 m -144.91 151.75 39.17 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 169.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.5 p -118.68 144.26 27.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 169.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.3 145.63 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 170.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.8 p -142.71 175.35 2.96 Favored Pre-proline 0 C--N 1.321 -0.655 0 C-N-CA 125.451 1.5 . . . . 0.0 107.034 169.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.57 -30.1 91.53 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 120.895 1.063 . . . . 0.0 111.44 168.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 48.1 p-90 -95.51 -25.23 16.29 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 118.128 -0.939 . . . . 0.0 113.292 -169.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.89 168.12 28.41 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-N 120.282 1.401 . . . . 0.0 113.206 -175.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.9 tt -137.32 121.9 18.48 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 168.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.1 m -134.13 130.75 37.81 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.198 0.523 . . . . 0.0 109.82 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.38 143.27 53.74 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 168.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.22 150.83 29.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.7 mm -134.06 134.51 55.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -125.8 143.03 43.87 Favored Pre-proline 0 CA--C 1.537 0.442 0 CA-C-O 118.318 -0.849 . . . . 0.0 111.044 -171.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -48.22 129.72 19.43 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.931 3.087 . . . . 0.0 113.829 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.48 177.02 34.1 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.247 1.403 . . . . 0.0 114.489 -171.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -61.86 118.53 5.42 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.854 3.036 . . . . 0.0 112.253 -169.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.5 t70 52.17 29.87 7.05 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.119 1.768 . . . . 0.0 113.602 175.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -82.68 146.94 28.78 Favored 'General case' 0 C--N 1.34 0.195 0 O-C-N 121.435 -0.79 . . . . 0.0 109.021 175.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.7 mp -101.26 82.58 2.36 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -67.3 145.84 98.67 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.531 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -64.6 157.71 53.95 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.274 1.982 . . . . 0.0 109.872 171.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.1 tp -77.07 77.3 3.62 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -64.63 148.18 51.44 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.07 0.548 . . . . 0.0 110.393 -174.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -92.08 151.04 20.63 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.1 t -88.43 153.03 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 125.452 1.501 . . . . 0.0 111.131 -168.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.8 m 68.27 7.49 5.96 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.068 1.747 . . . . 0.0 114.116 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -83.28 163.47 20.67 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 168.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -115.41 150.71 35.98 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.202 0.91 . . . . 0.0 111.574 175.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.2 mm -122.61 123.96 69.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.21 124.1 6.58 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 108.656 -1.777 . . . . 0.0 108.656 173.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.4 mt -116.79 138.22 51.65 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.481 1.112 . . . . 0.0 108.031 173.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -91.21 124.1 35.17 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mp -132.98 156.65 79.85 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 125.027 1.331 . . . . 0.0 108.162 170.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -67.01 -21.82 48.93 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 CA-C-N 120.625 1.259 . . . . 0.0 112.865 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -55.99 -31.45 63.05 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.816 1.247 . . . . 0.0 111.233 169.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.49 150.92 5.52 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.86 2.171 . . . . 0.0 107.776 -172.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.1 m -64.47 132.58 50.39 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 171.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 54.6 ttm -133.95 130.58 37.9 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -169.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.04 114.13 20.39 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 171.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -89.08 142.93 27.22 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 169.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.6 m -92.3 141.96 27.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.27 119.6 23.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 171.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -109.35 167.35 12.86 Favored Glycine 0 CA--C 1.52 0.361 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 169.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -117.57 117.09 28.47 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 169.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.0 119.19 21.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 176.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.34 131.62 51.53 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 122.721 0.408 . . . . 0.0 111.379 -171.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.55 3.56 72.4 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-O 118.968 -0.907 . . . . 0.0 113.526 -178.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.1 t -122.33 -110.58 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.0 m -154.71 173.54 16.27 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 119.776 1.171 . . . . 0.0 109.765 -169.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -66.96 142.24 57.33 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 169.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.02 173.19 16.33 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.084 1.754 . . . . 0.0 107.429 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.9 mp -109.07 140.0 43.21 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -176.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.0 t -142.08 152.94 43.78 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.489 1.115 . . . . 0.0 109.588 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 35.5 t -149.19 118.43 6.82 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 172.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.7 m -71.75 136.16 47.04 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -85.75 -62.96 1.4 Allowed 'General case' 0 C--O 1.231 0.112 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 172.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.92 175.72 5.75 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.529 1.532 . . . . 0.0 108.634 -175.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 CA--C 1.542 0.636 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 169.815 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 84.3 p . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.486 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 23.4 pt -66.19 -25.49 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 121.507 -0.746 . . . . 0.0 111.731 170.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -76.67 -45.59 29.1 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -63.05 -31.75 72.96 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.503 170.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.16 -60.79 8.32 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 120.16 1.346 . . . . 0.0 110.679 172.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -62.16 -48.71 78.89 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 117.412 0.606 . . . . 0.0 110.779 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 61.1 ttt-85 -61.2 -35.1 76.27 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 123.622 0.769 . . . . 0.0 110.817 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.5 tp -78.35 -23.91 46.71 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 117.607 -1.187 . . . . 0.0 111.407 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -46.6 85.43 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.88 1.673 . . . . 0.0 109.037 169.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -66.02 -46.77 76.71 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 122.609 0.364 . . . . 0.0 111.251 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -66.2 -33.21 75.25 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 119.248 -0.406 . . . . 0.0 110.778 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 28.4 m -67.07 -36.93 83.08 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.608 0.64 . . . . 0.0 110.435 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.05 -52.23 50.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 173.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 41.1 tpt85 -52.47 -46.03 66.35 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.961 0.905 . . . . 0.0 111.138 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 56.7 ttp -49.39 -52.53 27.89 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.959 1.704 . . . . 0.0 111.145 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 11.0 pt -88.93 -24.79 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 118.743 0.701 . . . . 0.0 112.612 -172.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 76.3 mt . . . . . 0 CA--C 1.532 0.285 0 C-N-CA 124.003 0.921 . . . . 0.0 109.074 171.729 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 C--O 1.239 0.531 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.3 mp -104.81 118.89 52.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 -174.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.51 119.61 20.59 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 169.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.87 177.6 54.21 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 121.423 0.457 . . . . 0.0 113.694 -175.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -115.67 169.51 9.14 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.985 1.714 . . . . 0.0 110.267 -169.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -72.88 -13.76 61.34 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -174.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.2 p -151.31 174.05 13.77 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 127.867 2.467 . . . . 0.0 106.404 169.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.4 m -61.93 147.69 89.39 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 169.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.53 67.43 6.36 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 124.752 3.635 . . . . 0.0 110.293 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.435 ' HE3' ' O ' ' A' ' 42' ' ' VAL . 45.5 mtpt -52.74 -52.43 56.41 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.513 1.125 . . . . 0.0 112.201 -169.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.01 -38.89 92.74 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 118.762 0.71 . . . . 0.0 110.968 -172.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -69.06 -42.71 75.92 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.746 1.219 . . . . 0.0 109.848 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.6 t -63.04 -42.21 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 174.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -61.36 -52.38 64.89 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.71 -49.47 75.06 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.762 0.825 . . . . 0.0 110.203 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.5 -49.83 75.04 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -70.01 -24.52 63.3 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 117.901 -1.047 . . . . 0.0 112.642 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -66.93 -33.17 74.99 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 120.05 1.296 . . . . 0.0 109.199 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -74.68 -49.09 22.57 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.391 -0.818 . . . . 0.0 109.544 173.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.1 mt -61.85 -30.68 49.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.42 -31.96 64.14 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 124.182 0.993 . . . . 0.0 112.014 173.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 53.6 ttp85 -72.05 -41.23 67.67 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.92 1.236 . . . . 0.0 109.594 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 124.289 1.035 . . . . 0.0 109.983 168.751 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo . . . . . 0 N--CA 1.451 -1.008 0 N-CA-C 110.376 -0.663 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 m -61.06 147.92 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 169.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -143.78 152.67 41.53 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 120.966 -1.084 . . . . 0.0 109.811 -177.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.435 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 7.1 p -135.89 127.05 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 124.488 1.115 . . . . 0.0 110.79 -175.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.9 m -92.54 146.81 23.39 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.649 1.18 . . . . 0.0 109.421 169.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -119.97 137.96 53.76 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.532 1.533 . . . . 0.0 107.786 169.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.43 ' CE1' ' HB1' ' A' ' 131' ' ' ALA . 29.4 p90 -164.87 146.29 7.84 Favored 'General case' 0 C--O 1.218 -0.569 0 C-N-CA 123.351 0.66 . . . . 0.0 111.715 -176.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.8 m 58.37 154.13 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.826 2.45 . . . . 0.0 115.52 168.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.4 tp -105.75 109.32 21.23 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 169.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -103.04 95.9 6.44 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.258 2.223 . . . . 0.0 108.107 -173.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 55.06 45.73 25.61 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.455 1.102 . . . . 0.0 111.658 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.59 22.44 62.13 Favored Glycine 0 CA--C 1.531 1.085 0 O-C-N 121.853 -0.529 . . . . 0.0 113.315 176.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -136.59 144.56 44.18 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 125.68 1.592 . . . . 0.0 107.121 -177.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -74.33 141.05 45.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 120.514 1.506 . . . . 0.0 109.399 172.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.02 154.68 19.25 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 172.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.84 168.73 35.66 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 175.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 36.1 m -142.42 148.43 37.79 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 p -129.32 135.0 62.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.0 tt -111.23 151.11 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.751 1.22 . . . . 0.0 108.032 171.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.1 p -136.86 175.11 3.74 Favored Pre-proline 0 N--CA 1.444 -0.739 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 172.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.42 -10.6 28.26 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 CA-C-N 121.132 1.44 . . . . 0.0 112.009 169.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -110.16 -25.6 10.1 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -173.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.37 171.48 20.31 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 120.306 1.412 . . . . 0.0 112.368 -175.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.3 tt -136.98 123.03 20.3 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 167.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.2 m -130.91 134.79 47.08 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.398 0.679 . . . . 0.0 109.925 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.05 149.4 35.8 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 168.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.9 m -138.74 146.55 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.61 1.164 . . . . 0.0 108.172 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.6 mm -130.76 114.85 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -115.0 146.66 36.65 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.314 1.046 . . . . 0.0 112.229 -168.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -39.08 128.56 1.39 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 125.178 3.918 . . . . 0.0 115.256 173.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.45 -178.51 49.92 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.219 0.914 . . . . 0.0 114.415 -173.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.02 106.42 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 124.084 3.189 . . . . 0.0 111.7 -169.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.6 t70 50.07 28.39 2.96 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.621 1.568 . . . . 0.0 112.658 -175.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -89.22 142.46 27.63 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -91.69 91.34 7.95 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 31.1 t90 -70.16 131.97 88.46 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.59 153.36 77.75 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.387 2.058 . . . . 0.0 111.811 -169.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 50.5 tp -61.77 130.23 44.78 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 169.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 69.8 mtt85 -125.55 156.67 38.7 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.881 0.873 . . . . 0.0 109.097 172.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -89.26 147.92 23.86 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 169.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.3 t -90.14 153.22 3.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 124.572 1.149 . . . . 0.0 110.809 -168.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.9 m 63.81 29.07 14.8 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.856 1.262 . . . . 0.0 112.461 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -104.47 155.3 18.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.518 1.927 . . . . 0.0 107.311 169.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -107.43 142.34 37.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.844 0.747 . . . . 0.0 110.191 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 35.4 mm -123.1 128.81 75.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.15 120.86 6.01 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 173.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.3 mt -105.0 139.35 39.81 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 170.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -90.48 129.14 36.68 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 173.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mp -135.79 155.76 77.79 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 125.151 1.381 . . . . 0.0 107.593 175.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.84 -23.94 68.45 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 121.541 1.494 . . . . 0.0 112.395 173.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -56.71 -30.7 63.75 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.062 1.345 . . . . 0.0 111.733 169.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 133.12 149.7 6.2 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 108.099 -2.0 . . . . 0.0 108.099 -170.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.0 m -64.37 133.34 52.42 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 41.4 ttp -147.2 139.42 24.54 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -171.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.33 134.05 36.61 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 118.747 0.703 . . . . 0.0 109.777 176.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -109.2 130.88 55.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 169.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.6 m -83.02 139.52 33.22 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.3 t -70.48 119.01 15.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 170.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -110.21 158.36 14.5 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 171.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -127.83 84.62 2.27 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.2 tp -65.23 125.29 24.56 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -172.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.3 136.33 58.01 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.466 0.706 . . . . 0.0 110.418 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.39 2.85 64.3 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.283 -0.731 . . . . 0.0 113.27 -176.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.0 t -128.81 -119.68 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.6 p -163.45 -175.09 4.04 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.166 1.387 . . . . 0.0 108.935 -171.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -70.05 144.81 52.07 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.633 -0.667 . . . . 0.0 110.725 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.38 165.11 36.04 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.717 1.607 . . . . 0.0 109.011 174.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.9 mp -102.7 126.11 49.68 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 174.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.9 m -144.65 156.45 44.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 119.594 1.088 . . . . 0.0 110.858 -170.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 18.8 p -145.37 139.88 27.29 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.453 -0.779 . . . . 0.0 110.008 170.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.3 m -75.14 137.48 41.38 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 171.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 85.2 mt -124.07 -30.16 3.52 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -171.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 14.9 ptp -159.44 167.21 29.27 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.057 0.943 . . . . 0.0 109.28 175.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.5 m . . . . . 0 CA--C 1.536 0.432 0 C-N-CA 124.349 1.059 . . . . 0.0 108.985 179.218 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 81.9 p . . . . . 0 C--O 1.235 0.331 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.505 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -60.68 -34.38 58.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 121.213 -0.93 . . . . 0.0 109.171 172.215 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -64.54 -45.49 86.91 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 123.601 0.76 . . . . 0.0 110.148 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -67.39 -29.67 69.24 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.369 0.986 . . . . 0.0 110.621 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.27 -37.29 64.5 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.788 -0.57 . . . . 0.0 111.773 169.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -82.69 -54.62 5.0 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.928 -1.337 . . . . 0.0 110.208 174.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 61.0 mtm-85 -67.56 -29.82 69.29 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 118.116 -0.945 . . . . 0.0 113.31 -169.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.8 tp -82.89 -27.17 30.89 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 120.525 1.511 . . . . 0.0 109.886 -176.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.2 m -71.19 -40.4 71.24 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.69 -44.19 82.38 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.224 1.01 . . . . 0.0 111.752 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.36 -39.28 92.62 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 121.175 -0.953 . . . . 0.0 109.752 175.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 37.9 t -63.13 -44.95 94.14 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.43 ' HB1' ' CE1' ' A' ' 45' ' ' PHE . . . -52.34 -50.76 61.69 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.953 1.301 . . . . 0.0 110.897 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.0 ptt85 -82.6 -24.47 33.88 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 15.5 tmm? -55.98 -44.31 78.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 118.648 -0.691 . . . . 0.0 109.812 171.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 6.8 pt -81.94 0.3 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.3 mt . . . . . 0 C--N 1.342 0.269 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 169.56 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 CA--C 1.534 0.351 0 N-CA-C 110.733 -0.099 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.8 mt -141.06 134.28 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.25 128.25 35.07 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 169.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.97 163.34 47.8 Favored Glycine 0 CA--C 1.537 1.454 0 N-CA-C 112.061 -0.415 . . . . 0.0 112.061 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -73.15 126.77 30.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.463 0.705 . . . . 0.0 109.516 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -67.62 -32.05 72.5 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 119.121 -0.466 . . . . 0.0 110.516 175.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.8 p -150.72 153.9 36.4 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 126.308 1.843 . . . . 0.0 107.857 169.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -56.8 137.95 78.3 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 125.388 1.475 . . . . 0.0 113.108 -169.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -80.34 43.89 1.62 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 124.626 3.551 . . . . 0.0 111.412 174.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -53.52 -45.21 69.67 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.086 1.354 . . . . 0.0 112.257 -169.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.09 -41.86 99.48 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 122.963 0.505 . . . . 0.0 111.606 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -72.48 -40.32 67.03 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -175.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.7 t -60.07 -46.12 94.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 172.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -59.74 -54.93 40.61 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.132 0.573 . . . . 0.0 110.347 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.02 -41.76 97.34 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.467 0.707 . . . . 0.0 110.853 -173.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.54 -39.25 77.59 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 118.511 0.596 . . . . 0.0 110.718 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -67.57 -31.17 71.05 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 121.317 -0.864 . . . . 0.0 111.738 173.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -68.95 -29.39 67.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.321 0.964 . . . . 0.0 111.107 173.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -70.41 -48.64 55.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mt -59.36 -41.89 85.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.566 0.746 . . . . 0.0 109.453 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.99 -23.79 67.32 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.769 0.828 . . . . 0.0 112.862 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -80.72 -45.22 17.44 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 171.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 . . . . . 0 C--N 1.33 -0.275 0 C-N-CA 124.794 1.238 . . . . 0.0 112.611 -174.468 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo . . . . . 0 N--CA 1.453 -0.895 0 CA-C-O 121.122 0.384 . . . . 0.0 113.039 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.1 t -75.4 139.23 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 168.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -139.61 154.03 47.48 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.641 0.777 . . . . 0.0 109.88 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.1 t -137.71 119.11 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 123.995 0.918 . . . . 0.0 109.265 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.1 m -82.22 143.88 31.06 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 168.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -126.63 134.29 50.79 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.552 1.541 . . . . 0.0 109.258 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -170.6 149.74 3.26 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 123.373 0.669 . . . . 0.0 112.737 -170.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.5 m 55.66 165.53 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 128.739 2.816 . . . . 0.0 116.257 167.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 30.3 mt -116.53 66.46 0.72 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.792 1.237 . . . . 0.0 108.705 171.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.12 136.14 42.94 Favored 'General case' 0 N--CA 1.457 -0.083 0 O-C-N 121.726 -0.609 . . . . 0.0 109.599 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 56.74 22.78 7.23 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.792 0.837 . . . . 0.0 111.247 -172.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.29 12.53 83.5 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.658 1.123 . . . . 0.0 113.474 -175.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -121.33 143.86 48.96 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.815 1.646 . . . . 0.0 108.202 -173.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -61.38 133.13 55.47 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 118.318 -0.849 . . . . 0.0 109.154 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.84 157.53 16.24 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 122.207 1.004 . . . . 0.0 108.56 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.75 167.83 39.3 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 56.4 m -141.43 150.56 42.47 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 169.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.91 139.77 50.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 175.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.6 tt -116.46 147.03 20.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 169.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.7 p -138.37 172.2 7.05 Favored Pre-proline 0 N--CA 1.439 -0.979 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 171.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -63.24 -22.63 72.5 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 CA-C-N 119.928 1.01 . . . . 0.0 111.074 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 44.4 p-90 -94.45 -26.27 16.55 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -174.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.94 173.51 12.57 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 120.527 1.512 . . . . 0.0 112.71 -173.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.5 tt -135.43 128.48 31.62 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 167.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 77.7 p -138.03 142.61 40.35 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 122.029 0.919 . . . . 0.0 110.728 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.02 144.41 47.18 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 167.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.9 m -135.39 151.32 30.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 39.9 mt -136.59 139.77 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -116.61 139.66 25.77 Favored Pre-proline 0 C--O 1.234 0.266 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -54.86 131.17 44.56 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 121.629 1.552 . . . . 0.0 109.018 177.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.57 -179.46 27.72 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.509 1.052 . . . . 0.0 114.596 -169.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.16 158.25 41.67 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.365 2.71 . . . . 0.0 111.096 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.4 t0 46.04 45.58 12.36 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.795 2.038 . . . . 0.0 113.604 169.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -150.12 147.68 28.05 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.6 mp -104.3 107.26 18.09 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -72.22 157.82 88.62 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.186 -0.916 . . . . 0.0 108.776 169.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.31 166.93 28.63 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.1 1.867 . . . . 0.0 108.972 169.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 61.3 tp -69.2 82.53 0.35 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 169.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -75.46 139.78 42.47 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -173.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -90.86 141.89 28.35 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 122.812 1.291 . . . . 0.0 108.175 176.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -68.93 156.08 7.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 127.992 2.517 . . . . 0.0 109.152 174.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.0 m 69.93 0.74 3.18 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 128.336 2.655 . . . . 0.0 114.437 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -81.52 158.02 24.61 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 169.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -110.08 143.09 40.62 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.0 0.52 . . . . 0.0 110.0 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.5 mt -121.08 118.8 57.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -74.61 123.66 7.7 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 174.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 72.8 mt -125.2 151.76 45.42 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.667 1.187 . . . . 0.0 108.654 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -108.65 128.11 54.56 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.377 1.071 . . . . 0.0 108.753 -175.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.0 mp -137.06 168.95 14.61 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 125.331 1.452 . . . . 0.0 108.641 175.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -58.83 -23.26 66.23 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.366 2.044 . . . . 0.0 113.979 173.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -56.43 -38.32 71.42 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.603 0.761 . . . . 0.0 111.805 170.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.85 -167.55 24.27 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 -169.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 m -80.05 135.14 36.28 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 172.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 20.6 ptp -144.16 148.79 35.5 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 169.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.92 128.62 35.68 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 173.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -96.33 128.05 42.89 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 168.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.4 m -77.79 138.95 39.27 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 171.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.9 t -72.2 121.92 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 170.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -103.64 165.76 15.67 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -121.81 127.61 50.77 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.099 -2.185 . . . . 0.0 105.099 169.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.5 tp -141.19 142.61 33.99 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.063 0.847 . . . . 0.0 109.849 -176.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -59.04 135.02 57.49 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.312 0.645 . . . . 0.0 111.023 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.83 -2.12 50.85 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.044 0.831 . . . . 0.0 113.668 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.5 t -125.59 -31.49 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 118.638 1.219 . . . . 0.0 109.91 -173.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.0 m 54.58 -122.71 1.99 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.348 1.059 . . . . 0.0 109.001 -169.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -82.73 130.35 35.11 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.512 1.051 . . . . 0.0 109.861 -169.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -156.25 179.54 9.14 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 126.294 1.838 . . . . 0.0 106.993 176.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp -119.23 143.15 47.45 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.981 0.913 . . . . 0.0 109.217 -175.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.9 m -139.73 148.52 42.41 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.925 1.29 . . . . 0.0 110.123 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 20.2 t -140.34 110.1 6.4 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 171.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.7 m -73.1 135.91 44.83 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 71.5 mt -121.31 -47.85 2.23 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 119.374 -0.346 . . . . 0.0 111.26 -169.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.24 167.27 29.43 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.63 1.172 . . . . 0.0 108.286 175.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.0 m . . . . . 0 CA--C 1.54 0.588 0 C-N-CA 123.777 0.831 . . . . 0.0 110.194 -178.376 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 65.1 p . . . . . 0 C--O 1.234 0.289 0 CA-C-O 120.818 0.342 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.494 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -63.76 -26.01 39.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 121.863 -0.523 . . . . 0.0 109.708 169.584 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -68.18 -43.05 79.03 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.315 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -64.89 -30.08 71.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.308 0.958 . . . . 0.0 110.604 169.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.19 -61.07 7.79 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -61.59 -51.25 69.32 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.809 -0.818 . . . . 0.0 110.534 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 65.6 ttt-85 -63.4 -30.18 71.35 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.226 1.01 . . . . 0.0 111.867 -174.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.7 tp -89.38 -24.81 21.85 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 120.477 1.489 . . . . 0.0 110.294 -177.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.6 m -70.32 -40.77 73.97 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 170.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -70.03 -41.95 73.58 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.788 0.835 . . . . 0.0 111.582 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.98 -30.33 71.31 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 121.127 -0.983 . . . . 0.0 110.217 172.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 37.0 t -66.3 -45.89 78.81 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.931 0.787 . . . . 0.0 109.053 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -54.39 -51.1 65.9 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.473 1.109 . . . . 0.0 109.79 174.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -58.21 -54.77 43.25 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 123.115 0.566 . . . . 0.0 110.19 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 50.9 ttp -47.17 -41.4 17.78 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.867 1.667 . . . . 0.0 112.012 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.9 pt -86.12 -14.55 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.278 0.944 . . . . 0.0 113.433 -176.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.6 pp . . . . . 0 N--CA 1.449 -0.506 0 C-N-CA 125.461 1.504 . . . . 0.0 108.457 174.368 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 . . . . . 0 CA--C 1.534 0.362 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.7 mt -119.66 136.57 56.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 171.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.7 146.82 54.2 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.87 135.53 17.03 Favored Glycine 0 C--N 1.336 0.557 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 170.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -96.4 138.64 33.69 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.863 0.865 . . . . 0.0 109.056 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -71.78 -37.38 70.45 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.0 p -157.48 168.54 27.01 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 129.732 3.213 . . . . 0.0 106.31 169.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.9 m -51.91 130.57 38.84 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.736 0.814 . . . . 0.0 111.498 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -77.01 63.66 7.67 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 125.179 3.919 . . . . 0.0 111.525 -176.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -52.97 -51.62 60.9 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.739 0.815 . . . . 0.0 111.497 -171.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.78 -39.76 91.32 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 123.315 0.384 . . . . 0.0 110.79 -170.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -67.17 -47.01 72.28 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.646 0.778 . . . . 0.0 109.903 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.0 t -63.06 -40.37 88.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.46 -53.17 58.76 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.743 0.817 . . . . 0.0 109.831 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.03 -40.51 97.96 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.47 0.577 . . . . 0.0 110.759 -176.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.71 -50.5 73.24 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -71.7 -24.09 61.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 118.033 -0.984 . . . . 0.0 112.597 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -66.58 -33.8 76.48 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.267 1.394 . . . . 0.0 110.273 172.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -74.38 -47.19 35.62 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.0 mt -61.05 -40.73 86.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.22 -28.38 69.33 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.587 0.755 . . . . 0.0 112.189 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -70.81 -44.19 67.07 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 172.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 . . . . . 0 CA--C 1.536 0.43 0 C-N-CA 124.628 1.171 . . . . 0.0 112.51 -175.785 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo . . . . . 0 N--CA 1.453 -0.911 0 N-CA-C 114.435 0.898 . . . . 0.0 114.435 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.7 t -61.75 137.49 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 169.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -149.71 159.27 44.48 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.926 0.89 . . . . 0.0 109.487 -175.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.7 t -136.87 141.05 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.1 m -110.79 152.25 26.86 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.227 1.411 . . . . 0.0 108.788 169.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -120.52 143.29 48.65 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 127.248 2.219 . . . . 0.0 110.813 -176.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -145.98 173.35 12.24 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.608 1.163 . . . . 0.0 111.651 -172.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.5 t -52.17 160.31 0.79 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.92 2.088 . . . . 0.0 115.323 -168.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -75.66 106.01 6.99 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 169.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -75.98 -53.98 7.56 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -168.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.91 -42.86 0.74 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.344 1.858 . . . . 0.0 110.226 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.55 -0.21 0.09 OUTLIER Glycine 0 CA--C 1.534 1.256 0 C-N-CA 127.82 2.629 . . . . 0.0 110.684 175.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -137.39 134.94 36.49 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 119.247 1.523 . . . . 0.0 109.112 -170.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -60.64 152.27 26.86 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.861 0.864 . . . . 0.0 110.337 170.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.23 163.2 12.58 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.301 1.04 . . . . 0.0 109.732 172.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.47 170.92 41.28 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 171.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 7.0 m -140.5 131.04 25.44 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.4 p -103.5 149.2 7.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 173.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.7 tt -131.19 149.65 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 169.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.401 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 30.8 p -139.74 175.75 3.01 Favored Pre-proline 0 N--CA 1.444 -0.764 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 172.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 37.4 Cg_endo -63.13 -19.67 69.34 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 CA-C-N 120.528 1.224 . . . . 0.0 111.145 168.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.0 p-90 -102.73 -24.43 13.74 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -172.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.68 170.35 22.58 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.547 1.521 . . . . 0.0 112.806 -175.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 tt -137.41 125.84 23.44 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 168.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.8 m -138.26 133.2 32.83 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.359 0.599 . . . . 0.0 110.256 -176.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.93 144.78 52.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 168.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 m -139.46 149.17 22.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 124.14 0.976 . . . . 0.0 108.565 -176.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.2 mt -143.38 141.54 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -170.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -134.79 138.23 29.23 Favored Pre-proline 0 N--CA 1.468 0.468 0 CA-C-O 117.839 -1.077 . . . . 0.0 110.517 -170.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -48.4 139.44 22.53 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.718 2.945 . . . . 0.0 112.548 173.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.38 175.79 28.56 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 123.974 0.797 . . . . 0.0 113.856 -174.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.4 140.65 44.58 Favored 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 122.818 2.345 . . . . 0.0 110.095 -174.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.6 t70 50.94 34.92 11.36 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.518 1.527 . . . . 0.0 113.31 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -132.55 131.81 41.94 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.124 1.37 . . . . 0.0 107.522 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.37 99.64 9.34 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -175.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.79 145.15 97.8 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 169.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.36 148.52 61.37 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 121.606 1.537 . . . . 0.0 109.898 171.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.4 tp -63.21 140.06 58.83 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.72 158.69 25.97 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.826 0.739 . . . . 0.0 109.355 174.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.43 140.52 44.72 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.1 t -79.48 159.24 4.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 124.422 1.089 . . . . 0.0 109.038 -169.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.0 m 63.7 23.32 13.46 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.941 1.296 . . . . 0.0 112.92 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -100.57 154.56 18.47 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.226 1.811 . . . . 0.0 107.516 169.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -111.19 141.22 44.99 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.434 0.561 . . . . 0.0 110.666 -177.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 23.7 mm -112.87 128.62 69.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 176.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.42 118.97 5.42 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 173.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.4 tp -108.04 143.61 36.52 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 172.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -105.05 125.49 51.04 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.6 mp -135.77 157.54 75.91 Favored Pre-proline 0 C--O 1.234 0.265 0 C-N-CA 125.25 1.42 . . . . 0.0 107.288 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -66.59 -22.82 50.48 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 CA-C-N 120.609 1.253 . . . . 0.0 112.853 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -54.87 -35.98 64.63 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.592 1.157 . . . . 0.0 111.156 169.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 145.85 157.27 7.21 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 108.026 -2.03 . . . . 0.0 108.026 -173.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.1 m -67.45 133.41 49.49 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 171.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 58.6 ttm -140.72 128.36 21.54 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -170.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.69 132.97 38.43 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 173.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -108.14 130.39 55.12 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 169.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.5 m -80.72 142.37 33.92 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.102 0.961 . . . . 0.0 108.554 177.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 75.7 t -76.45 118.92 23.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 169.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -105.33 161.45 14.71 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 170.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -128.93 93.81 3.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 170.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.9 tp -79.33 127.8 32.53 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -169.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.0 133.78 56.42 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.149 0.58 . . . . 0.0 110.397 -176.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.14 3.47 69.58 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-O 118.635 -1.092 . . . . 0.0 113.473 -177.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.6 t -124.81 -118.68 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.8 t -159.6 -169.27 2.52 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.024 1.33 . . . . 0.0 108.025 -176.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -70.36 143.86 51.8 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.275 0.559 . . . . 0.0 109.688 169.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.78 173.79 16.28 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.176 1.79 . . . . 0.0 107.508 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.7 mp -108.42 142.69 38.41 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 176.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.9 p -142.48 155.42 45.06 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.942 0.897 . . . . 0.0 110.579 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 41.9 t -144.85 116.43 8.12 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 172.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.3 m -69.49 133.03 47.21 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.0 mt -102.08 -66.58 0.91 Allowed 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -175.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.93 164.08 25.97 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.963 0.905 . . . . 0.0 109.753 176.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.9 m . . . . . 0 CA--C 1.541 0.611 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 169.59 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 CA--C 1.529 0.169 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 41.8 pt -67.43 -24.32 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 121.582 -0.698 . . . . 0.0 111.518 169.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -75.4 -44.58 43.93 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -62.76 -34.51 77.37 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.869 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.35 -52.27 54.2 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 120.196 1.362 . . . . 0.0 111.636 176.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -72.38 -36.97 68.83 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 117.574 0.687 . . . . 0.0 111.268 -177.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 22.9 tpp85 -66.46 -34.42 77.89 Favored 'General case' 0 C--N 1.339 0.11 0 O-C-N 121.053 -1.03 . . . . 0.0 109.823 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 21.4 tp -84.38 -24.94 29.45 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 116.948 -1.501 . . . . 0.0 111.684 -175.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.7 p -66.26 -44.41 83.71 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 121.794 2.088 . . . . 0.0 108.283 169.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -62.42 -50.45 71.47 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 122.773 0.429 . . . . 0.0 111.547 176.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -64.21 -34.5 78.24 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 118.758 -0.639 . . . . 0.0 110.534 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 32.9 m -69.25 -39.5 78.43 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.524 0.602 . . . . 0.0 111.109 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.3 -50.74 62.63 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 175.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -59.51 -46.58 88.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 118.738 -0.649 . . . . 0.0 111.582 -176.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 50.6 ttp -39.55 -48.81 2.1 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.204 1.801 . . . . 0.0 111.23 169.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 23.6 pt -92.09 -20.74 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 118.776 0.716 . . . . 0.0 112.719 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.2 mt . . . . . 0 C--N 1.345 0.372 0 CA-C-N 119.26 0.936 . . . . 0.0 109.039 171.062 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.3 mm -127.92 128.59 69.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 126.773 2.029 . . . . 0.0 105.636 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.37 133.9 35.97 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 172.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.83 -179.14 35.46 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.159 0.885 . . . . 0.0 112.795 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -119.04 156.88 28.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.934 1.294 . . . . 0.0 112.23 -169.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -72.0 -30.4 65.19 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.137 0.975 . . . . 0.0 111.547 -178.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.4 p -158.57 -175.17 5.16 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 130.477 3.511 . . . . 0.0 105.537 172.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.1 m -56.95 146.44 59.46 Favored Pre-proline 0 CA--C 1.545 0.75 0 O-C-N 120.959 -1.088 . . . . 0.0 109.295 169.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -71.14 56.64 2.03 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 124.439 3.426 . . . . 0.0 109.945 169.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 42' ' ' VAL . 27.8 tttm -47.22 -50.93 20.0 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 126.667 1.987 . . . . 0.0 113.623 -168.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.6 -41.06 96.48 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.187 0.903 . . . . 0.0 111.567 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -70.96 -40.18 72.13 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.193 0.597 . . . . 0.0 109.768 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 94.0 t -60.11 -44.9 96.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 172.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -60.78 -55.81 28.65 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 118.744 0.702 . . . . 0.0 110.368 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.65 -41.07 98.27 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.418 0.553 . . . . 0.0 110.826 -173.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.73 -51.81 60.43 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -67.41 -28.74 68.16 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 118.161 -0.923 . . . . 0.0 111.648 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -66.72 -37.58 84.98 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 119.76 1.164 . . . . 0.0 110.108 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -72.79 -42.47 63.87 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.858 0.753 . . . . 0.0 109.23 178.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.7 mt -62.84 -45.59 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.84 -38.48 85.62 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 123.512 0.725 . . . . 0.0 111.054 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.4 ttt-85 -68.25 -48.73 64.29 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -175.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.373 0 C-N-CA 124.26 1.024 . . . . 0.0 110.674 175.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo . . . . . 0 N--CA 1.455 -0.786 0 CA-C-O 120.353 0.064 . . . . 0.0 111.939 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 36.1 t -61.47 127.59 21.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 169.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -139.02 149.3 44.49 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 124.066 0.947 . . . . 0.0 109.078 -174.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.447 ' O ' ' HE2' ' A' ' 13' ' ' LYS . 2.5 p -139.71 131.13 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 125.71 1.604 . . . . 0.0 109.5 -176.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 p -108.61 151.46 26.09 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.276 0.63 . . . . 0.0 109.81 169.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -116.24 142.63 46.58 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.596 1.959 . . . . 0.0 109.337 -172.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -147.58 167.42 24.57 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -168.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.5 m -4.4 132.09 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.446 1 C-N-CA 133.537 4.735 . . . . 0.0 118.319 169.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.0 tp -81.13 99.22 8.41 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 168.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -86.41 -55.46 3.89 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.337 0.517 . . . . 0.0 111.525 -169.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -140.96 71.55 1.37 Allowed 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.495 1.518 . . . . 0.0 108.316 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 64.14 16.32 59.81 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.677 0.656 . . . . 0.0 112.946 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -146.27 142.51 28.41 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.438 1.895 . . . . 0.0 107.077 -170.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -81.73 155.38 25.53 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.298 1.039 . . . . 0.0 109.785 174.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.4 162.28 13.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.229 1.014 . . . . 0.0 109.343 169.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.52 161.53 34.99 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 107.207 -2.357 . . . . 0.0 107.207 171.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 60.9 m -133.52 149.22 51.7 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 169.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.7 p -131.63 149.14 32.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 173.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.2 tt -130.56 150.78 34.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 124.899 1.279 . . . . 0.0 107.798 173.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.8 p -143.54 174.78 3.29 Favored Pre-proline 0 N--CA 1.443 -0.776 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -62.05 -21.42 72.37 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 CA-C-N 120.067 1.06 . . . . 0.0 111.619 168.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 42.5 p-90 -100.25 -26.46 13.91 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -172.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.61 172.15 17.66 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 120.285 1.402 . . . . 0.0 112.379 -174.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 tt -132.63 128.51 37.26 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 168.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.1 p -140.57 143.19 35.17 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 122.273 1.035 . . . . 0.0 110.839 177.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.16 143.78 35.11 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 167.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.4 m -132.87 144.44 36.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 125.061 1.345 . . . . 0.0 108.055 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 30.2 mt -141.45 143.92 26.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 C-N-CA 124.837 1.255 . . . . 0.0 107.901 -169.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -141.54 144.04 31.98 Favored Pre-proline 0 N--CA 1.467 0.382 0 CA-C-O 117.552 -1.213 . . . . 0.0 108.92 -172.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -63.13 150.26 89.11 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.178 1.919 . . . . 0.0 111.815 174.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.97 -179.38 39.75 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.472 1.034 . . . . 0.0 114.31 -172.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -62.14 126.53 18.88 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.001 2.467 . . . . 0.0 111.783 -170.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.3 t70 50.5 31.08 5.19 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.47 1.508 . . . . 0.0 113.249 175.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -87.0 141.97 28.28 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 171.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -103.48 90.99 3.85 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -71.94 159.58 85.06 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.363 169.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -68.77 166.45 26.17 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.448 2.099 . . . . 0.0 110.644 172.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 63.2 tp -69.26 95.54 0.78 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 170.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -74.98 146.52 41.6 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -102.48 159.64 15.26 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 122.404 1.097 . . . . 0.0 108.646 169.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 90.6 t -83.48 153.14 3.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 113.674 -1.603 . . . . 0.0 108.09 -169.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.9 m 65.84 6.46 3.99 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.905 1.682 . . . . 0.0 114.078 -176.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -80.68 161.56 24.58 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.468 1.107 . . . . 0.0 108.738 169.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -118.97 143.22 47.17 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.602 -0.686 . . . . 0.0 110.586 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.0 mp -113.84 127.16 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 170.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.29 120.18 5.52 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.5 mt -111.05 129.05 56.03 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.49 131.01 35.93 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 169.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.7 mt -140.99 155.04 68.94 Favored Pre-proline 0 C--N 1.332 -0.182 0 C-N-CA 125.69 1.596 . . . . 0.0 107.181 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -64.32 -22.81 66.13 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.058 1.839 . . . . 0.0 112.51 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -62.02 -26.48 68.26 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.149 1.38 . . . . 0.0 112.221 170.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 123.75 148.71 7.58 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -169.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.3 m -63.47 131.31 47.74 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 41.9 ttp -149.68 143.32 25.4 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -172.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.03 138.98 34.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 121.702 -0.623 . . . . 0.0 110.48 176.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -110.35 136.15 49.97 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 168.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.4 m -91.85 142.39 27.63 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -177.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.9 t -75.31 121.72 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 172.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -109.54 171.86 15.51 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 107.518 -2.233 . . . . 0.0 107.518 168.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -118.28 118.29 31.41 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 168.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.9 tp -74.45 131.27 40.91 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -58.9 123.36 16.25 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 122.607 0.363 . . . . 0.0 110.89 -170.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.99 8.1 84.65 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-O 118.672 -1.071 . . . . 0.0 113.994 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.1 t -126.03 -120.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 119.204 1.502 . . . . 0.0 107.914 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.4 m -148.05 -175.7 4.99 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.725 1.61 . . . . 0.0 109.912 -169.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -58.65 145.19 40.73 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.797 0.839 . . . . 0.0 110.542 172.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.12 165.37 35.85 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.572 1.949 . . . . 0.0 107.721 172.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.7 mp -105.33 139.45 39.95 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.7 m -140.28 153.43 46.49 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.891 0.877 . . . . 0.0 110.379 -176.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 41.2 t -143.43 118.04 9.79 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 169.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.8 m -69.72 133.42 47.48 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 174.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.6 mt -106.36 -65.35 1.08 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.432 0.693 . . . . 0.0 109.513 -172.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -145.1 161.3 39.79 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.64 1.176 . . . . 0.0 108.982 -177.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.4 m . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 169.121 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 38.8 m . . . . . 0 CA--C 1.533 0.326 0 CA-C-O 122.631 1.205 . . . . 0.0 113.916 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.47 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -63.87 -22.55 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.552 1.141 . . . . 0.0 112.262 -172.847 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -69.13 -46.97 66.3 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 119.393 0.997 . . . . 0.0 108.892 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.98 -39.95 83.33 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.63 1.104 . . . . 0.0 109.0 169.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.68 -35.18 37.54 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 123.821 0.724 . . . . 0.0 112.973 175.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -95.61 -54.05 3.51 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.876 1.338 . . . . 0.0 110.77 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -67.07 -33.04 74.64 Favored 'General case' 0 C--O 1.227 -0.094 0 C-N-CA 124.594 1.158 . . . . 0.0 112.301 -169.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.2 mt -77.9 -39.41 43.13 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 119.351 0.978 . . . . 0.0 109.073 -177.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.8 m -60.77 -47.18 87.49 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.535 1.134 . . . . 0.0 109.376 176.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.64 -48.53 80.43 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.58 1.152 . . . . 0.0 111.393 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -60.41 -40.17 90.01 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 122.614 0.365 . . . . 0.0 110.291 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 73.0 m -66.81 -24.0 66.12 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -73.18 -53.97 9.63 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.381 170.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -59.41 -37.91 79.24 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 121.306 1.866 . . . . 0.0 110.268 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 61.0 ttp -44.66 -35.9 2.85 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.987 172.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 9.0 pt -112.73 1.68 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 124.508 1.123 . . . . 0.0 113.04 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 C--O 1.233 0.199 0 C-N-CA 128.397 2.679 . . . . 0.0 105.278 175.593 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 122.673 1.225 . . . . 0.0 112.218 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.7 mt -71.12 129.27 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 126.085 1.754 . . . . 0.0 108.943 -169.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.02 129.79 40.98 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.33 143.44 16.91 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 169.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -116.2 173.16 6.74 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.801 1.24 . . . . 0.0 111.897 -169.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -72.39 -11.28 60.62 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.743 1.617 . . . . 0.0 112.173 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 p -148.19 157.55 43.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.991 1.717 . . . . 0.0 107.991 170.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 m -62.68 158.29 52.17 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 169.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.31 55.32 4.07 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.679 3.586 . . . . 0.0 111.328 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -50.08 -49.46 51.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.95 2.1 . . . . 0.0 112.073 -169.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.55 -42.12 83.15 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 122.513 0.325 . . . . 0.0 111.24 -176.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -70.53 -39.31 74.11 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -176.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.4 t -58.91 -46.99 91.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 171.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -62.31 -50.97 69.55 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-O 118.969 -0.538 . . . . 0.0 110.885 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.34 -38.5 90.32 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.772 0.714 . . . . 0.0 111.073 -175.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.93 -49.38 75.01 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 175.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -66.91 -28.11 68.04 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 118.398 -0.811 . . . . 0.0 112.402 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -66.58 -37.88 85.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.554 1.07 . . . . 0.0 110.074 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -73.41 -41.61 63.09 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.626 -0.671 . . . . 0.0 109.35 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.8 mt -60.68 -45.83 96.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.21 -31.84 72.42 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.673 0.789 . . . . 0.0 112.045 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -65.73 -38.46 89.21 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 . . . . . 0 CA--C 1.533 0.299 0 C-N-CA 125.169 1.387 . . . . 0.0 112.646 -175.928 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo . . . . . 0 N--CA 1.454 -0.851 0 N-CA-C 118.625 2.51 . . . . 0.0 118.625 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.668 HG13 HG22 ' A' ' 58' ' ' THR . 45.7 t -106.99 102.2 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 100.257 -3.979 . . . . 0.0 100.257 166.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -132.6 155.74 48.16 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.746 0.818 . . . . 0.0 110.885 -169.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.0 t -134.42 120.07 32.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.081 0.953 . . . . 0.0 108.676 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.9 m -91.65 143.87 26.11 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.429 1.092 . . . . 0.0 108.568 169.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -123.69 146.82 47.96 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.347 1.859 . . . . 0.0 110.128 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.485 ' CE1' ' CB ' ' A' ' 131' ' ' ALA . 81.6 m-85 -149.15 172.77 14.28 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -168.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.4 m -14.99 144.7 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.479 1 C-N-CA 133.851 4.861 . . . . 0.0 116.834 169.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.9 tp -78.85 71.08 5.29 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.159 0.984 . . . . 0.0 109.514 172.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -70.04 119.92 14.98 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.518 1.527 . . . . 0.0 108.686 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 50.72 36.2 13.67 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.944 0.898 . . . . 0.0 111.914 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.87 10.84 80.37 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-O 118.379 -1.234 . . . . 0.0 114.418 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -142.24 141.95 32.56 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 120.11 1.955 . . . . 0.0 109.849 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -67.1 140.14 57.56 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 121.164 -0.96 . . . . 0.0 109.788 -173.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.66 162.21 15.72 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 171.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -171.01 167.34 40.51 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 176.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 3.5 m -141.72 147.26 37.13 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 169.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.7 p -120.41 141.88 38.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 169.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.7 tt -123.04 148.52 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 169.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.668 HG22 HG13 ' A' ' 40' ' ' VAL . 40.6 p -141.61 175.61 2.91 Favored Pre-proline 0 N--CA 1.441 -0.876 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 169.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -65.71 -21.65 58.39 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.184 1.256 . . . . 0.0 111.817 169.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 42.6 p-90 -97.94 -21.87 16.62 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.46 177.78 9.75 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.878 1.672 . . . . 0.0 112.906 -176.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 tt -143.75 127.28 16.95 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 103.102 -2.925 . . . . 0.0 103.102 168.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.5 m -137.25 130.62 31.18 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 124.167 0.917 . . . . 0.0 109.215 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.51 147.79 43.69 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 168.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.89 151.85 29.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 72.4 mt -135.83 134.01 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 105.553 -2.018 . . . . 0.0 105.553 177.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -129.62 141.42 41.78 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 118.117 -0.944 . . . . 0.0 110.872 -169.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -54.43 142.17 70.7 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.906 2.404 . . . . 0.0 113.76 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.18 173.92 53.64 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.342 0.972 . . . . 0.0 112.825 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -65.83 148.41 86.35 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.266 2.644 . . . . 0.0 112.035 -175.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.5 t70 53.15 44.26 30.52 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.249 1.419 . . . . 0.0 111.857 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -118.67 148.14 43.05 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.838 1.255 . . . . 0.0 108.249 173.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.43 84.31 2.11 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 172.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 8.8 t90 -71.45 121.65 84.92 Favored Pre-proline 0 C--O 1.235 0.316 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -170.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -56.17 147.88 63.04 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.171 1.914 . . . . 0.0 112.274 -175.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 40.7 tp -58.5 128.06 35.26 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 169.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -109.95 159.47 17.23 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.145 0.978 . . . . 0.0 109.698 -178.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -86.3 142.69 28.34 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 168.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.8 t -88.96 154.91 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -169.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.2 m 65.87 10.32 6.79 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.242 1.417 . . . . 0.0 113.706 -177.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -80.93 153.74 27.37 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.833 1.253 . . . . 0.0 108.131 169.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -107.76 142.73 37.32 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.383 0.538 . . . . 0.0 110.214 176.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.6 mm -118.46 124.21 72.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 173.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.94 120.95 5.6 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 176.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 72.3 mt -106.58 124.75 50.07 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.86 79.46 9.24 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 55.9 mt -74.92 145.93 81.97 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 172.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -60.32 -25.61 80.67 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 121.662 1.575 . . . . 0.0 112.763 170.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -55.4 -30.38 60.31 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.527 1.531 . . . . 0.0 111.952 170.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.72 143.21 4.57 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 107.974 -2.05 . . . . 0.0 107.974 -171.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.8 m -61.45 131.25 49.58 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 60.1 ttm -140.22 129.97 24.47 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.28 132.66 35.87 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 118.721 0.691 . . . . 0.0 109.22 173.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -106.24 135.1 48.31 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 169.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.3 m -87.93 137.88 31.94 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 70.1 t -68.96 122.1 19.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 170.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -107.25 157.05 15.7 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 171.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -122.42 95.42 4.63 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 170.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.9 tt -72.77 115.84 12.55 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -175.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.46 131.68 51.51 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 122.633 0.373 . . . . 0.0 111.378 -173.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.66 2.96 71.27 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 118.888 -0.951 . . . . 0.0 113.402 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.3 t -123.72 -103.33 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.5 p -164.01 171.69 14.88 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.719 1.6 . . . . 0.0 111.089 -173.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -73.49 144.7 46.1 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 169.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.54 179.68 8.39 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.826 1.65 . . . . 0.0 108.594 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.2 mt -109.22 137.87 46.44 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.5 m -140.62 158.24 44.28 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.092 0.957 . . . . 0.0 111.275 -173.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 38.7 t -143.44 108.95 5.08 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 169.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.2 m -85.75 143.82 28.12 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.991 0.916 . . . . 0.0 109.942 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.43 -10.7 0.73 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -172.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 10.0 tpp -125.0 147.14 49.08 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 120.592 1.542 . . . . 0.0 111.778 -170.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 CA--C 1.544 0.719 0 C-N-CA 124.584 1.154 . . . . 0.0 111.158 177.806 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.6 p . . . . . 0 CA--C 1.53 0.188 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -62.32 -28.57 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 O-C-N 121.472 -0.768 . . . . 0.0 110.624 169.675 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -68.03 -49.0 64.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -65.91 -39.37 90.51 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.668 0.667 . . . . 0.0 110.017 177.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.12 -25.31 59.69 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.569 1.08 . . . . 0.0 112.696 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -96.33 -52.37 4.01 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.321 1.06 . . . . 0.0 110.672 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 44.1 mtm-85 -65.2 -41.71 94.23 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.648 -0.658 . . . . 0.0 112.199 -170.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.72 -35.74 60.18 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 119.406 1.003 . . . . 0.0 110.596 -170.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.64 -45.56 93.62 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.851 0.75 . . . . 0.0 109.067 175.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -66.63 -48.44 69.46 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.012 1.325 . . . . 0.0 111.46 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.61 -38.93 92.71 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.43 -0.794 . . . . 0.0 111.793 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 88.8 m -71.21 -24.16 62.16 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 119.499 -0.286 . . . . 0.0 111.276 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.485 ' CB ' ' CE1' ' A' ' 45' ' ' PHE . . . -78.96 -47.17 16.84 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 118.845 0.748 . . . . 0.0 109.037 169.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.1 ttp-105 -55.74 -41.95 74.68 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.731 0.812 . . . . 0.0 112.025 -177.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 16.9 ptt? -55.1 -50.09 70.09 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 118.613 0.642 . . . . 0.0 110.658 175.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 42.8 pt -75.81 -19.8 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 O-C-N 120.957 -1.089 . . . . 0.0 111.376 -177.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.6 tp . . . . . 0 CA--C 1.538 0.517 0 C-N-CA 126.857 2.063 . . . . 0.0 110.337 169.31 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 CA--C 1.535 0.374 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.2 mm -123.64 128.61 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 173.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.69 142.44 42.51 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.6 151.74 50.56 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.487 1.041 . . . . 0.0 112.052 176.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -102.91 154.72 18.93 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.733 1.213 . . . . 0.0 109.996 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -84.73 -21.12 30.2 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.694 -0.629 . . . . 0.0 112.265 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.9 p -158.39 -176.67 6.03 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 129.476 3.11 . . . . 0.0 105.987 170.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.0 m -58.44 145.17 76.68 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 168.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -73.59 59.23 4.03 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.817 3.011 . . . . 0.0 108.943 169.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.5 tttm -50.54 -51.62 46.22 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.638 1.975 . . . . 0.0 112.481 -168.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.93 -40.89 91.83 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.6 0.36 . . . . 0.0 111.707 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -69.3 -45.32 69.86 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.887 0.875 . . . . 0.0 109.773 -174.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 73.7 t -62.13 -42.97 97.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.372 1.069 . . . . 0.0 108.471 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -59.64 -54.01 51.39 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.469 0.577 . . . . 0.0 110.041 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.0 -39.68 93.81 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.194 0.598 . . . . 0.0 111.112 -175.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.03 -46.32 78.3 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -70.86 -27.17 63.64 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-O 117.918 -1.039 . . . . 0.0 112.071 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -61.69 -38.27 87.22 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 120.055 1.298 . . . . 0.0 110.211 171.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -73.8 -41.71 61.97 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 121.702 -0.624 . . . . 0.0 109.389 -177.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.6 mt -61.27 -43.88 97.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.3 -27.28 68.92 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.077 0.853 . . . . 0.0 112.146 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -79.81 -42.32 24.61 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.019 0.928 . . . . 0.0 109.17 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 . . . . . 0 C--N 1.328 -0.331 0 C-N-CA 123.788 0.835 . . . . 0.0 111.702 178.879 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo . . . . . 0 N--CA 1.452 -0.933 0 CA-C-O 121.0 0.333 . . . . 0.0 112.342 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.8 t -73.58 139.4 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 169.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -142.65 154.39 44.31 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.968 0.907 . . . . 0.0 108.923 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.2 t -141.09 125.21 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.748 0.819 . . . . 0.0 108.895 -173.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.4 m -89.15 144.02 26.42 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.203 1.001 . . . . 0.0 108.745 168.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -119.96 135.82 54.76 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.792 1.637 . . . . 0.0 108.035 169.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -167.57 143.33 4.03 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -176.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.7 m 57.17 166.4 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.525 2.33 . . . . 0.0 115.341 167.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.1 tp -120.99 66.63 0.86 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.806 1.242 . . . . 0.0 108.521 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.2 131.27 42.53 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.646 -0.658 . . . . 0.0 110.117 -175.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 52.38 31.5 9.67 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.477 1.111 . . . . 0.0 111.87 -175.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.65 11.06 85.82 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 118.153 -1.359 . . . . 0.0 113.613 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -125.36 143.76 50.82 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.893 1.847 . . . . 0.0 108.062 -174.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -67.97 138.39 55.88 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.416 1.007 . . . . 0.0 109.549 -176.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.65 155.39 17.34 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.95 171.43 37.87 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 173.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 45.0 m -140.32 150.62 44.23 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 169.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.4 p -127.66 141.76 45.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 124.853 1.261 . . . . 0.0 107.602 175.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.0 tt -118.52 149.04 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 169.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.6 p -142.83 172.61 5.51 Favored Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 171.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.36 -19.09 65.18 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 CA-C-N 120.149 1.089 . . . . 0.0 111.646 168.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 37.8 p-90 -102.16 -23.36 14.05 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.518 1.054 . . . . 0.0 113.836 -172.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.74 166.06 24.77 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.819 1.247 . . . . 0.0 111.882 -175.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 tt -132.94 124.74 28.37 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 104.2 -2.518 . . . . 0.0 104.2 168.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.2 m -137.63 133.15 34.01 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.367 0.604 . . . . 0.0 110.891 -176.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.35 148.28 49.9 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 168.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.4 m -139.97 151.88 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 123.946 0.898 . . . . 0.0 109.038 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.6 mt -138.32 145.63 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -133.15 142.49 44.67 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.191 -176.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -44.8 129.42 9.46 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 124.012 3.142 . . . . 0.0 112.447 174.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.97 178.62 15.56 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.085 0.85 . . . . 0.0 114.525 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -67.33 131.16 24.16 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.381 2.721 . . . . 0.0 111.141 -172.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.8 t70 51.15 31.34 6.56 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.538 1.535 . . . . 0.0 113.219 175.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -88.96 155.63 19.39 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -116.8 88.12 2.83 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 170.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -67.24 151.18 97.4 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.164 174.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.38 159.42 49.37 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.256 1.97 . . . . 0.0 109.284 169.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 51.9 tp -64.53 118.75 9.26 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 169.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -88.95 158.98 17.86 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.41 138.26 31.9 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 168.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.7 t -83.13 154.98 3.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 123.834 0.853 . . . . 0.0 108.704 -169.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.1 m 66.23 9.97 6.77 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.295 1.438 . . . . 0.0 113.828 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -83.8 163.0 20.42 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.807 1.243 . . . . 0.0 107.891 168.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -110.93 142.16 43.39 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 118.923 0.783 . . . . 0.0 111.02 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 30.4 mm -113.45 130.96 66.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.08 123.09 6.01 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -109.97 155.31 21.94 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.897 1.279 . . . . 0.0 108.328 170.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.0 tp60 -126.7 131.74 51.31 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 169.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -155.57 166.14 16.89 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 126.067 1.747 . . . . 0.0 107.199 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -57.72 -22.54 53.29 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.697 2.265 . . . . 0.0 115.0 -174.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -58.29 -33.51 69.53 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.681 0.792 . . . . 0.0 111.715 172.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.24 177.89 15.67 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.677 1.608 . . . . 0.0 110.03 -176.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.2 m -67.01 128.13 35.2 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 169.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 41.0 ttp -147.35 130.74 16.64 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.25 141.71 33.85 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 172.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -113.17 135.92 53.29 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 169.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.2 m -80.26 143.81 33.39 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 176.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 62.6 t -76.14 125.72 36.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 170.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -108.97 156.02 15.82 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -133.95 123.32 24.44 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 170.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.6 tp -141.23 144.08 34.52 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.36 0.527 . . . . 0.0 110.171 -172.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -54.27 131.55 41.88 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.32 1.048 . . . . 0.0 110.788 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.8 -1.36 58.77 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 118.717 -1.046 . . . . 0.0 113.591 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 44.8 t -121.57 -28.64 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 119.441 1.62 . . . . 0.0 109.947 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.1 m 60.11 -144.86 0.51 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.804 1.241 . . . . 0.0 108.279 -170.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -83.44 136.6 34.25 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.847 0.749 . . . . 0.0 110.654 -175.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -156.91 175.72 13.7 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.257 1.823 . . . . 0.0 107.869 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.2 mp -116.53 147.09 42.13 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.323 1.049 . . . . 0.0 108.501 -177.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.6 p -143.65 153.04 42.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.754 1.222 . . . . 0.0 110.615 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.8 t -147.28 121.93 9.83 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 170.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.9 m -72.97 137.57 45.56 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.334 0.515 . . . . 0.0 109.99 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -89.17 -66.78 0.89 Allowed 'General case' 0 C--N 1.338 0.102 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 171.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.78 174.64 7.44 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.031 1.332 . . . . 0.0 108.859 -175.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 CA--C 1.542 0.663 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 169.676 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 CA--C 1.53 0.206 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.49 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -57.1 -27.17 26.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.674 -0.641 . . . . 0.0 111.619 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.39 -42.26 96.23 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.977 0.511 . . . . 0.0 110.148 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -67.88 -29.28 68.36 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.043 0.937 . . . . 0.0 110.482 171.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.85 -60.87 8.02 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 169.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -65.06 -49.61 69.39 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.864 -0.786 . . . . 0.0 110.279 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -58.08 -45.34 87.3 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 124.439 1.096 . . . . 0.0 110.688 -175.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.5 tp -79.66 -25.76 41.22 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 119.858 1.208 . . . . 0.0 111.668 -173.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.4 m -69.61 -42.88 73.8 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.829 1.195 . . . . 0.0 109.197 173.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.51 -41.55 79.83 Favored 'General case' 0 N--CA 1.461 0.095 0 C-N-CA 123.165 0.586 . . . . 0.0 111.358 177.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -66.22 -29.64 69.94 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.351 -0.843 . . . . 0.0 110.267 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 20.0 m -69.53 -43.34 73.21 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.991 0.814 . . . . 0.0 110.239 175.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -56.41 -52.92 62.85 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.59 0.756 . . . . 0.0 109.698 171.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -52.61 -53.86 40.99 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.91 1.284 . . . . 0.0 110.559 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 54.0 ttp -49.24 -50.16 39.86 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.607 1.563 . . . . 0.0 110.922 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 6.4 pt -82.12 -19.93 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 119.027 0.83 . . . . 0.0 112.513 -174.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 74.4 mt . . . . . 0 CA--C 1.533 0.322 0 CA-C-N 118.387 0.54 . . . . 0.0 109.729 169.028 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 . . . . . 0 CA--C 1.537 0.464 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.4 mm -120.94 128.93 76.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 171.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.47 131.97 42.39 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.86 151.48 51.2 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.109 0.861 . . . . 0.0 111.096 174.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -93.84 138.45 31.99 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.282 1.033 . . . . 0.0 109.736 -175.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -71.1 -34.03 70.73 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.909 -0.567 . . . . 0.0 109.902 176.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.3 p -156.64 161.78 39.88 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 128.618 2.767 . . . . 0.0 106.812 169.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.0 m -51.82 137.44 34.75 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.226 1.011 . . . . 0.0 112.346 -174.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -76.55 46.71 1.92 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 124.907 3.738 . . . . 0.0 110.555 172.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -62.64 -31.77 72.69 Favored 'General case' 0 C--O 1.221 -0.438 0 O-C-N 120.498 -1.376 . . . . 0.0 113.232 -168.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.76 -42.64 94.97 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 118.762 0.71 . . . . 0.0 111.006 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -72.84 -39.3 66.67 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -177.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.2 t -58.46 -46.42 89.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 171.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -60.77 -53.18 60.52 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 123.526 0.73 . . . . 0.0 110.371 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.55 -40.36 95.44 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.694 0.679 . . . . 0.0 110.931 -174.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.21 -41.82 80.73 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.013 -0.43 . . . . 0.0 110.506 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -69.52 -27.33 65.08 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-O 118.331 -0.843 . . . . 0.0 112.415 175.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -63.22 -36.74 84.64 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.569 1.077 . . . . 0.0 109.104 172.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -71.48 -46.25 60.33 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.2 mt -61.01 -36.87 75.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 123.491 0.717 . . . . 0.0 109.845 177.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.74 -36.39 78.32 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.196 -0.94 . . . . 0.0 110.614 176.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.7 ttm105 -70.57 -34.8 72.62 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.448 1.099 . . . . 0.0 110.061 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? . . . . . 0 CA--C 1.545 0.757 0 C-N-CA 125.092 1.357 . . . . 0.0 111.645 169.142 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo . . . . . 0 N--CA 1.45 -1.046 0 N-CA-C 108.562 -1.361 . . . . 0.0 108.562 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.47 HG13 HG22 ' A' ' 58' ' ' THR . 97.1 t -65.62 108.66 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 169.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -149.53 155.73 40.8 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.36 1.464 . . . . 0.0 109.256 -168.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.7 t -140.12 120.1 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.9 m -85.39 148.4 26.03 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.851 0.86 . . . . 0.0 109.792 169.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -125.28 141.86 51.84 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.828 2.051 . . . . 0.0 110.567 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.454 ' CE2' ' CB ' ' A' ' 131' ' ' ALA . 98.4 m-85 -149.61 171.16 17.1 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -169.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.8 m -6.64 135.99 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.357 1 C-N-CA 133.43 4.692 . . . . 0.0 117.285 169.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.0 tt -78.53 103.61 8.59 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 168.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -84.92 -138.65 0.07 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.026 1.73 . . . . 0.0 107.872 -174.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -73.46 74.21 1.41 Allowed 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.823 -1.173 . . . . 0.0 110.129 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.79 16.33 78.05 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.542 1.068 . . . . 0.0 113.665 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -153.69 140.43 19.02 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.687 1.243 . . . . 0.0 109.862 -172.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -77.32 148.02 35.88 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.996 1.318 . . . . 0.0 110.063 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.58 158.29 15.86 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.61 0.719 . . . . 0.0 110.374 175.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -167.05 168.88 40.62 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 175.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 15.4 m -143.43 142.82 31.35 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 169.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.6 p -114.27 149.96 16.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 124.958 1.303 . . . . 0.0 107.678 172.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.4 tt -136.59 156.67 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 169.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.47 HG22 HG13 ' A' ' 40' ' ' VAL . 44.6 p -146.47 177.35 1.8 Allowed Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 126.353 1.861 . . . . 0.0 106.816 175.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -59.49 -28.88 88.6 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 CA-C-N 120.154 1.091 . . . . 0.0 111.015 168.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 50.0 p-90 -97.19 -19.41 18.64 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -171.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.67 172.81 15.64 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.804 1.638 . . . . 0.0 113.717 -176.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 tt -135.68 126.15 26.81 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 103.523 -2.769 . . . . 0.0 103.523 167.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.8 m -135.33 134.25 39.64 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.21 146.5 47.29 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 169.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.1 m -139.35 147.12 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 123.639 0.775 . . . . 0.0 109.335 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.9 mm -140.64 142.94 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -171.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -132.81 140.11 36.69 Favored Pre-proline 0 N--CA 1.468 0.43 0 CA-C-O 117.482 -1.247 . . . . 0.0 109.445 -175.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -57.14 142.35 94.39 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.151 1.901 . . . . 0.0 111.29 175.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.99 -179.3 29.16 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.731 1.158 . . . . 0.0 114.24 -171.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.87 145.34 56.21 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.35 2.7 . . . . 0.0 111.779 -171.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.6 t0 43.16 57.08 3.89 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.395 1.878 . . . . 0.0 112.395 174.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -142.84 146.59 34.29 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -172.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -117.12 101.0 8.1 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -76.12 154.72 84.56 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 169.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -69.97 158.9 55.18 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.187 1.924 . . . . 0.0 110.798 172.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 66.0 tp -64.09 136.74 57.53 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 169.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -118.79 160.49 21.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.109 0.868 . . . . 0.0 109.052 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -86.11 149.56 25.04 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 169.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 36.0 t -90.6 154.73 3.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -169.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.0 m 61.67 28.25 17.44 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.798 0.839 . . . . 0.0 112.344 -175.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -107.46 154.38 21.44 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.819 2.047 . . . . 0.0 107.264 169.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -104.76 147.88 27.22 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.333 0.969 . . . . 0.0 111.463 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.6 mm -122.97 132.12 72.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 176.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -81.75 123.33 6.02 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.5 mp -106.26 134.0 50.08 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 169.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -89.93 116.6 28.12 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 169.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.1 mt -106.12 155.53 38.34 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 169.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.31 -28.03 55.39 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 CA-C-N 120.187 1.102 . . . . 0.0 111.136 169.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -52.46 -38.66 59.82 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.688 1.595 . . . . 0.0 111.517 169.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 153.53 169.88 19.03 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -174.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.3 m -71.74 130.39 41.01 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 173.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 60.4 ttm -138.23 123.43 19.26 Favored 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.35 136.36 37.68 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.483 -0.761 . . . . 0.0 109.135 170.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -111.49 140.76 45.82 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 169.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.5 m -90.12 141.45 28.68 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.2 t -70.49 119.1 16.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 169.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -102.53 158.39 18.0 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 108.052 -2.019 . . . . 0.0 108.052 169.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -132.81 122.28 24.23 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 169.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.6 tp -138.26 147.81 44.07 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.794 0.838 . . . . 0.0 109.127 -169.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -58.1 128.91 39.47 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.227 0.611 . . . . 0.0 111.503 -172.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.53 -30.64 1.94 Allowed Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.731 1.634 . . . . 0.0 112.812 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.4 t -79.58 -29.15 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.847 1.659 . . . . 0.0 110.003 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.0 m 56.75 -139.36 0.92 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 -169.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -84.18 138.36 33.03 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.155 0.889 . . . . 0.0 110.956 -175.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -155.98 169.1 25.23 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.936 2.094 . . . . 0.0 107.115 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.8 mp -112.06 140.68 46.54 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.2 m -138.3 151.14 47.31 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.29 1.036 . . . . 0.0 110.211 -173.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 44.3 t -138.92 115.67 10.72 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 169.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.5 m -67.44 123.93 21.78 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.28 -47.32 4.98 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.237 0.615 . . . . 0.0 110.47 -170.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 16.2 ptp -159.62 163.9 34.58 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.103 0.961 . . . . 0.0 109.413 175.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.9 m . . . . . 0 CA--C 1.542 0.662 0 CA-C-O 117.643 -1.17 . . . . 0.0 112.217 -179.477 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 43.1 m . . . . . 0 CA--C 1.539 0.541 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.3 pt -60.52 -25.49 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -174.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -75.72 -47.28 26.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 30.0 mp0 -61.47 -35.36 77.41 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.365 1.066 . . . . 0.0 109.623 169.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.84 -54.06 41.13 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 120.197 1.362 . . . . 0.0 110.842 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -64.81 -48.2 75.28 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.528 -0.983 . . . . 0.0 110.275 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 75.5 mtp85 -64.11 -30.85 71.89 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 122.785 0.434 . . . . 0.0 111.387 -177.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.2 tp -82.57 -22.68 34.78 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-O 118.003 -0.999 . . . . 0.0 111.311 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.2 m -64.28 -46.24 84.55 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.304 1.411 . . . . 0.0 107.762 169.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -64.53 -51.29 63.66 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.006 0.922 . . . . 0.0 111.659 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -61.44 -36.03 79.23 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.628 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 21.8 m -64.01 -39.59 94.44 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.252 0.478 . . . . 0.0 110.211 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.454 ' CB ' ' CE2' ' A' ' 45' ' ' PHE . . . -65.81 -48.81 70.46 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 121.635 -0.666 . . . . 0.0 110.59 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.5 ptt85 -67.32 -27.26 67.0 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.444 1.474 . . . . 0.0 112.641 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -56.61 -45.5 81.43 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.324 169.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 12.7 pt -81.84 -25.38 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 119.731 1.151 . . . . 0.0 113.118 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 70.8 mt . . . . . 0 N--CA 1.469 0.514 0 CA-C-N 119.845 1.202 . . . . 0.0 109.154 169.681 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.9 mt -119.29 138.77 48.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 171.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.35 160.81 31.6 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.159 0.583 . . . . 0.0 110.865 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.03 160.73 52.89 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.631 -0.587 . . . . 0.0 111.631 171.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -120.53 144.39 48.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.81 1.244 . . . . 0.0 111.918 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -104.96 81.25 1.72 Allowed 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.203 -1.776 . . . . 0.0 106.203 169.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.9 p 63.58 176.16 0.16 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 127.249 2.22 . . . . 0.0 111.28 -169.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.1 m -59.9 150.32 69.41 Favored Pre-proline 0 CA--C 1.541 0.625 0 O-C-N 121.713 -0.617 . . . . 0.0 111.17 -171.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.18 54.66 3.29 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 124.639 3.56 . . . . 0.0 109.972 169.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.4 tttm -52.12 -50.0 62.54 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 127.357 2.263 . . . . 0.0 111.962 -169.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.79 -41.49 95.78 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 122.644 0.377 . . . . 0.0 111.463 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -73.49 -38.9 65.23 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -174.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.7 t -61.91 -42.64 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 172.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -62.02 -51.2 68.97 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 118.305 0.502 . . . . 0.0 110.271 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.67 -40.19 96.2 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.502 0.721 . . . . 0.0 110.907 -176.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.08 -51.27 68.61 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.011 176.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -66.6 -31.69 72.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 118.287 -0.863 . . . . 0.0 111.881 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.86 -31.62 72.68 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.586 1.084 . . . . 0.0 110.086 176.034 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -82.7 -44.49 15.61 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.41 0.684 . . . . 0.0 110.617 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.0 mt -65.95 -40.16 86.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 O-C-N 121.027 -1.046 . . . . 0.0 109.016 -175.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.9 -30.14 69.99 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.734 -0.604 . . . . 0.0 111.102 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.9 ttp-105 -81.25 -41.78 21.7 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.386 1.074 . . . . 0.0 109.917 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 . . . . . 0 CA--C 1.535 0.392 0 C-N-CA 123.366 0.666 . . . . 0.0 110.586 173.726 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 120' ' ' ILE . 73.7 Cg_endo . . . . . 0 N--CA 1.453 -0.869 0 N-CA-C 114.687 0.995 . . . . 0.0 114.687 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.511 HG13 HG22 ' A' ' 58' ' ' THR . 78.8 t -110.84 101.88 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 1 N-CA-C 98.888 -4.486 . . . . 0.0 98.888 166.918 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -141.99 157.25 45.16 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.64 1.176 . . . . 0.0 110.066 -168.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.0 t -140.39 120.16 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.472 0.709 . . . . 0.0 109.192 -172.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.1 m -84.02 142.9 30.13 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 168.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -120.91 137.03 54.79 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 125.682 1.593 . . . . 0.0 108.865 170.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.41 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 44.1 p90 -169.01 146.17 3.64 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -173.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.8 m 57.34 161.35 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.1 2.56 . . . . 0.0 115.86 167.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.2 tp -112.68 84.33 1.96 Allowed 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 170.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -76.17 118.63 19.1 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.57 1.148 . . . . 0.0 108.806 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 51.83 35.4 15.39 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.356 1.062 . . . . 0.0 112.336 176.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.37 17.66 73.24 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 118.859 -0.967 . . . . 0.0 113.992 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -133.57 138.64 46.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.809 1.644 . . . . 0.0 107.853 -176.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -71.62 142.49 49.96 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.645 -1.284 . . . . 0.0 108.973 -177.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.41 ' HB ' ' CE2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -103.66 157.9 16.74 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.497 1.044 . . . . 0.0 109.56 -179.686 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.89 169.62 38.15 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 171.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 36.1 m -137.04 146.9 45.78 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 169.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 p -123.62 140.86 45.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 175.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.469 HD13 ' HA2' ' A' ' 123' ' ' GLY . 11.6 tt -119.83 152.06 22.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 168.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.511 HG22 HG13 ' A' ' 40' ' ' VAL . 48.6 p -140.53 176.79 2.29 Favored Pre-proline 0 C--N 1.32 -0.701 0 C-N-CA 125.595 1.558 . . . . 0.0 107.237 169.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -59.78 -6.05 4.2 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.501 2.134 . . . . 0.0 114.297 169.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.0 p-90 -130.09 -21.75 2.93 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -169.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.12 166.1 32.69 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 120.089 1.313 . . . . 0.0 112.721 -177.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.81 122.39 18.53 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 168.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.2 m -136.51 135.38 38.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.326 0.584 . . . . 0.0 109.973 -175.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.65 145.11 52.68 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 168.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.5 m -137.61 146.08 28.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.9 mt -141.19 146.44 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -174.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -134.21 157.09 78.36 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-O 117.438 -1.267 . . . . 0.0 110.376 -172.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -57.2 9.21 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 0.989 1 C-N-CA 126.053 4.502 . . . . 0.0 120.001 -169.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.27 -155.85 44.46 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 117.86 -1.522 . . . . 0.0 111.43 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -65.42 -146.91 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.815 1 C-N-CA 125.324 4.016 . . . . 0.0 113.383 -174.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -74.43 58.1 0.74 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.457 1.503 . . . . 0.0 111.059 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -102.87 135.76 43.95 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 127.178 2.191 . . . . 0.0 106.855 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -108.11 88.19 2.67 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -177.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -69.23 149.79 97.42 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-O 118.847 -0.596 . . . . 0.0 109.407 172.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -67.76 157.21 62.79 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 N-CA-C 107.708 -1.689 . . . . 0.0 107.708 168.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 40.2 tp -62.94 122.99 17.39 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -88.27 159.23 18.2 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -174.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -86.03 152.65 22.73 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 168.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 83.9 t -99.74 155.08 4.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.342 -1.299 . . . . 0.0 107.862 -169.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.4 m 65.14 7.49 4.15 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.581 1.552 . . . . 0.0 113.489 -173.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -78.27 157.99 29.06 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.344 1.457 . . . . 0.0 107.967 169.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -122.86 141.29 52.03 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 123.054 0.542 . . . . 0.0 110.471 -177.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.2 mm -117.2 121.25 67.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -74.28 122.44 7.38 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.655 -1.778 . . . . 0.0 108.655 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.4 tp -120.36 132.35 55.24 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 124.443 1.097 . . . . 0.0 108.637 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.48 127.8 35.23 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 173.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mp -135.89 157.91 75.03 Favored Pre-proline 0 C--O 1.235 0.296 0 C-N-CA 125.295 1.438 . . . . 0.0 107.91 173.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -61.66 -20.24 68.15 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.367 2.044 . . . . 0.0 114.243 171.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -58.22 -32.26 68.13 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.504 0.722 . . . . 0.0 111.147 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 133.17 157.31 8.37 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 106.621 -2.592 . . . . 0.0 106.621 -169.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.1 m -66.53 130.02 41.79 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 58.5 mtm -137.46 141.16 41.57 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -176.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.77 129.88 34.77 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 170.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -99.21 124.75 44.51 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 169.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.6 m -81.07 140.43 35.11 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.3 t -75.38 120.11 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 169.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -109.48 163.54 12.5 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 172.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -125.3 95.04 4.33 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 170.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.7 tp -74.25 125.76 29.14 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -169.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -59.34 128.57 37.73 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.625 0.77 . . . . 0.0 110.108 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.77 3.91 84.53 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.689 -1.062 . . . . 0.0 113.869 -177.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.4 t -126.64 -119.92 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 119.263 1.531 . . . . 0.0 107.596 177.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.2 m -150.73 -179.31 7.15 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.622 1.569 . . . . 0.0 108.791 -169.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -69.85 143.44 52.85 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 169.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.26 172.57 16.79 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.437 1.495 . . . . 0.0 108.559 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.6 mp -106.52 142.6 35.91 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 172.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.3 p -142.11 152.65 43.46 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.693 0.797 . . . . 0.0 110.411 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 15.7 t -144.43 119.69 10.19 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 171.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.0 m -67.68 129.09 38.82 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 81.4 mt -92.3 -52.57 4.61 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.72 175.32 12.11 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.455 1.502 . . . . 0.0 108.102 171.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 CA--C 1.543 0.69 0 C-N-CA 124.633 1.173 . . . . 0.0 110.69 -175.647 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 93.5 p . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 121.767 0.794 . . . . 0.0 112.286 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 1.1 pp -64.64 -20.09 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 124.871 1.268 . . . . 0.0 112.215 169.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -79.63 -55.39 5.06 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -66.1 -30.85 71.43 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 123.591 0.757 . . . . 0.0 110.584 177.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.469 ' HA2' HD13 ' A' ' 57' ' ' ILE . . . -64.15 -52.18 46.57 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 119.804 1.184 . . . . 0.0 111.596 175.186 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -65.75 -46.82 77.4 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.164 0.982 . . . . 0.0 110.082 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -58.55 -43.82 89.47 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 118.423 -0.799 . . . . 0.0 110.566 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.0 tp -76.74 -28.34 55.72 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 119.365 0.984 . . . . 0.0 111.619 -173.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -69.08 -39.75 78.87 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 120.083 1.31 . . . . 0.0 109.498 174.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.21 -43.87 66.52 Favored 'General case' 0 N--CA 1.46 0.052 0 C-N-CA 122.985 0.514 . . . . 0.0 111.332 176.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -57.92 -39.14 77.25 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 121.176 -0.952 . . . . 0.0 109.612 173.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 20.0 m -64.33 -34.53 78.36 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 119.424 -0.322 . . . . 0.0 110.758 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.69 -56.79 15.93 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.397 0.679 . . . . 0.0 109.926 174.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -42.16 97.94 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 119.412 1.006 . . . . 0.0 109.556 -177.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 53.1 ttp -49.31 -55.39 12.93 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.956 1.302 . . . . 0.0 110.192 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 6.7 pt -80.3 -21.99 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 119.879 1.218 . . . . 0.0 112.604 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 24.5 mt . . . . . 0 C--O 1.231 0.11 0 CA-C-N 118.615 0.643 . . . . 0.0 110.947 177.866 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 mt -117.91 138.59 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 174.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.07 154.6 39.13 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.744 0.417 . . . . 0.0 110.55 176.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.22 156.65 34.14 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 169.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -125.07 151.48 45.61 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.474 1.11 . . . . 0.0 110.007 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -85.21 -21.16 29.25 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.941 0.896 . . . . 0.0 111.844 -176.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.4 p -159.06 -178.73 7.44 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 128.739 2.815 . . . . 0.0 105.897 173.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.7 m -59.49 139.91 88.87 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 168.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.16 54.45 4.19 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 124.553 3.502 . . . . 0.0 107.807 169.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.7 pttm -60.41 -34.89 74.59 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.634 1.174 . . . . 0.0 113.13 -168.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.58 -42.34 87.13 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.207 0.912 . . . . 0.0 110.614 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -70.9 -41.08 71.74 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 81.3 t -59.97 -42.55 89.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 172.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -60.74 -53.55 56.06 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 123.479 0.712 . . . . 0.0 109.71 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.57 -40.97 98.55 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.367 0.53 . . . . 0.0 110.857 -176.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.74 -46.81 83.66 Favored 'General case' 0 N--CA 1.456 -0.126 0 O-C-N 122.238 -0.289 . . . . 0.0 110.466 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -70.96 -28.25 64.33 Favored 'General case' 0 C--O 1.23 0.065 0 CA-C-O 118.65 -0.69 . . . . 0.0 112.446 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.8 -37.24 83.64 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.114 0.87 . . . . 0.0 109.615 174.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -65.73 -41.49 92.18 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.721 -0.657 . . . . 0.0 110.448 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.6 mm -64.76 -41.86 93.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 119.717 1.144 . . . . 0.0 109.559 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.6 -26.54 66.31 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.939 0.495 . . . . 0.0 111.459 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 55.5 ttp85 -71.93 -47.88 49.35 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 172.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.541 0.602 0 C-N-CA 125.487 1.515 . . . . 0.0 114.132 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo . . . . . 0 N--CA 1.453 -0.86 0 N-CA-C 111.671 -0.165 . . . . 0.0 111.671 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.46 128.68 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 169.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -148.55 150.82 34.02 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.583 1.153 . . . . 0.0 108.634 -170.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.6 t -141.73 121.15 10.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.2 p -96.82 154.93 17.0 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 118.849 0.749 . . . . 0.0 110.939 169.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -119.52 142.87 47.93 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.743 2.017 . . . . 0.0 109.614 -171.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -147.22 167.73 23.47 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -169.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.7 m -14.3 139.82 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 1 C-N-CA 133.208 4.603 . . . . 0.0 117.149 169.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.0 tp -78.4 127.95 32.93 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 169.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -147.6 146.07 29.24 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 125.47 1.508 . . . . 0.0 107.311 175.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 53.91 26.63 6.4 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 120.482 1.492 . . . . 0.0 112.876 -175.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.18 25.4 75.47 Favored Glycine 0 CA--C 1.535 1.303 0 O-C-N 121.228 -0.92 . . . . 0.0 113.446 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -148.36 149.06 31.12 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.222 1.409 . . . . 0.0 110.056 -173.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -79.75 140.35 36.96 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 121.212 -0.93 . . . . 0.0 109.122 -177.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.0 160.09 20.11 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.805 0.812 . . . . 0.0 108.857 170.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -167.19 162.74 36.53 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 107.581 -2.208 . . . . 0.0 107.581 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 13.0 m -138.92 147.03 41.78 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 169.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 p -122.23 147.65 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 125.108 1.363 . . . . 0.0 107.817 172.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.4 tt -128.31 151.24 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 169.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.0 p -141.98 177.7 1.8 Allowed Pre-proline 0 C--N 1.32 -0.706 0 C-N-CA 125.331 1.452 . . . . 0.0 107.282 171.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -60.23 -30.37 91.06 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 CA-C-N 119.99 1.032 . . . . 0.0 110.552 168.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -94.29 -25.24 17.1 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -169.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.57 170.36 22.59 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 120.506 1.503 . . . . 0.0 112.965 -174.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 tt -137.72 123.98 20.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 168.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.7 m -137.36 134.51 36.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.438 0.637 . . . . 0.0 110.451 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.32 139.62 44.3 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 168.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 m -139.21 140.16 38.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -172.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.6 mm -135.73 138.53 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -169.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -131.02 145.63 58.6 Favored Pre-proline 0 N--CA 1.474 0.729 0 CA-C-O 117.692 -1.147 . . . . 0.0 111.867 -169.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -51.02 137.6 44.26 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.15 2.567 . . . . 0.0 112.698 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.52 179.83 28.92 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 123.427 0.537 . . . . 0.0 113.306 -175.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.43 123.4 11.73 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.992 2.461 . . . . 0.0 110.191 -173.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.1 t70 49.69 35.7 9.37 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.218 1.407 . . . . 0.0 113.15 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -95.87 127.77 42.18 Favored 'General case' 0 C--N 1.344 0.341 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.49 75.74 0.94 Allowed 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -170.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 48.7 m0 -68.58 149.07 98.1 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.192 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.31 151.84 80.09 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.011 1.807 . . . . 0.0 109.053 169.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.8 tp -56.04 131.91 48.69 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.557 -0.715 . . . . 0.0 109.254 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.41 157.95 16.06 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -90.3 148.86 22.61 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 169.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.2 t -91.6 154.81 3.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -169.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.5 m 60.72 33.7 20.13 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.911 0.884 . . . . 0.0 111.98 -176.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -112.27 155.6 23.79 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 127.019 2.128 . . . . 0.0 106.989 169.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -105.77 142.22 35.87 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.289 0.949 . . . . 0.0 110.546 178.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.7 mm -121.19 131.58 72.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.11 126.36 8.26 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 174.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.8 mt -113.01 124.87 53.62 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 172.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.64 133.36 43.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 169.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.4 mt -141.19 158.22 64.79 Favored Pre-proline 0 C--O 1.234 0.254 0 C-N-CA 124.13 0.972 . . . . 0.0 108.465 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -57.77 -29.63 86.48 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.738 2.292 . . . . 0.0 112.81 170.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -64.38 -18.5 64.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.45 1.1 . . . . 0.0 113.023 173.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 110.47 154.54 14.13 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 107.821 -2.112 . . . . 0.0 107.821 -168.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.1 m -65.03 132.35 48.98 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -175.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 64.3 mtm -141.12 145.75 36.16 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.846 1.258 . . . . 0.0 108.345 -178.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.41 136.91 37.09 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 121.597 -0.689 . . . . 0.0 109.33 172.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -115.34 139.7 49.76 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 169.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.7 m -87.12 137.18 32.57 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 52.5 t -68.08 122.56 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 170.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -109.34 163.11 12.57 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 107.565 -2.214 . . . . 0.0 107.565 169.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -133.38 94.25 3.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 171.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.5 tp -80.28 126.44 31.14 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -170.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -59.81 132.4 53.83 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.219 0.608 . . . . 0.0 110.451 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.94 5.43 75.34 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.659 -1.078 . . . . 0.0 113.482 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.9 t -125.62 -115.27 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.8 p -159.23 178.67 9.74 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 119.742 1.155 . . . . 0.0 110.236 -169.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -73.64 138.05 44.56 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 169.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.87 165.15 36.99 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.777 1.631 . . . . 0.0 107.684 -175.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.4 mp -111.47 130.35 55.75 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.5 m -131.23 150.46 52.14 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.519 0.728 . . . . 0.0 110.913 -170.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 40.4 t -143.14 121.47 12.31 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 169.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.1 m -76.2 137.55 40.08 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -90.41 -67.49 0.84 Allowed 'General case' 0 C--N 1.339 0.119 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 175.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.14 173.2 8.1 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.908 1.283 . . . . 0.0 109.054 -175.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.2 m . . . . . 0 CA--C 1.54 0.56 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 169.354 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 62.6 m . . . . . 0 CA--C 1.53 0.202 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.36 -38.42 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.778 1.231 . . . . 0.0 111.394 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -75.74 -35.01 60.34 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.898 0.479 . . . . 0.0 109.751 -174.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -68.15 -28.87 67.67 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 124.6 1.16 . . . . 0.0 110.585 169.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.76 -55.54 30.27 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 120.235 1.379 . . . . 0.0 110.13 171.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -63.56 -51.35 65.75 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.557 -0.966 . . . . 0.0 110.189 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -68.41 -17.61 64.26 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 117.979 -1.01 . . . . 0.0 112.908 -175.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 32.8 tp -88.53 -25.86 22.32 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 120.257 1.389 . . . . 0.0 109.56 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.8 m -63.57 -48.74 76.21 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 169.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -61.06 -49.37 77.64 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 124.58 1.152 . . . . 0.0 111.933 175.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -62.47 -33.82 75.6 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.636 0.653 . . . . 0.0 110.469 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 34.8 m -69.99 -28.47 65.55 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.444 0.565 . . . . 0.0 111.216 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.03 -51.07 13.1 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.884 0.765 . . . . 0.0 109.564 170.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -51.84 -49.88 61.98 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.042 0.937 . . . . 0.0 110.147 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -56.79 -39.69 74.55 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.055 -178.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 22.4 pt -82.77 -22.62 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 119.722 1.147 . . . . 0.0 111.928 -178.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 52.2 mt . . . . . 0 CA--C 1.537 0.48 0 C-N-CA 123.414 0.686 . . . . 0.0 109.491 169.114 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 . . . . . 0 CA--C 1.54 0.59 0 CA-C-O 121.938 0.875 . . . . 0.0 112.711 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.1 mm -71.24 138.29 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.36 132.27 47.35 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.6 -0.687 . . . . 0.0 109.244 176.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.12 145.76 49.29 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 173.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -91.88 147.08 23.24 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.632 0.773 . . . . 0.0 109.65 -174.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -74.07 -29.48 61.9 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 118.969 -0.539 . . . . 0.0 110.756 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.1 p -154.88 164.03 39.43 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 127.337 2.255 . . . . 0.0 107.962 171.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.4 m -45.85 135.77 6.36 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 125.644 1.578 . . . . 0.0 111.801 173.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.11 52.41 3.82 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.201 3.267 . . . . 0.0 110.525 172.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -53.54 -49.69 67.07 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.202 1.801 . . . . 0.0 111.675 -169.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.58 -41.34 96.33 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.609 0.363 . . . . 0.0 111.284 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -71.51 -41.57 69.06 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.877 0.471 . . . . 0.0 109.764 -174.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 89.9 t -62.31 -45.95 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 172.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -58.85 -53.12 62.02 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.096 0.862 . . . . 0.0 110.872 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.52 -42.46 95.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.901 0.773 . . . . 0.0 111.034 -174.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.25 -46.26 87.73 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -71.21 -25.34 62.47 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 118.147 -0.93 . . . . 0.0 112.014 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -62.91 -34.29 77.11 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.98 1.264 . . . . 0.0 109.579 172.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -79.65 -46.91 16.29 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.718 0.407 . . . . 0.0 110.554 177.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.4 mt -59.93 -39.97 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.447 0.699 . . . . 0.0 109.185 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.79 -36.3 82.68 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.445 -0.784 . . . . 0.0 111.183 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -74.36 -40.42 62.14 Favored 'General case' 0 N--CA 1.46 0.06 0 C-N-CA 123.252 0.621 . . . . 0.0 109.955 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? . . . . . 0 CA--C 1.534 0.331 0 C-N-CA 123.677 0.791 . . . . 0.0 110.831 170.343 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.413 ' HD3' HG22 ' A' ' 120' ' ' ILE . 92.8 Cg_endo . . . . . 0 N--CA 1.451 -1.021 0 CA-C-O 121.037 0.349 . . . . 0.0 112.509 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.457 HG13 HG22 ' A' ' 58' ' ' THR . 97.7 t -104.51 105.89 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 102.058 -3.312 . . . . 0.0 102.058 167.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -142.43 156.33 45.18 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.574 1.15 . . . . 0.0 109.109 -169.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.0 t -137.38 117.24 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -176.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.6 p -78.27 150.06 33.44 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.394 0.997 . . . . 0.0 108.893 168.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.96 131.98 49.25 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.77 1.628 . . . . 0.0 108.64 173.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.769 ' CE1' ' HB1' ' A' ' 131' ' ' ALA . 5.3 p90 -168.78 150.6 4.79 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 123.645 0.778 . . . . 0.0 112.408 -176.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 95.1 m 55.65 157.36 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 128.571 2.748 . . . . 0.0 116.591 167.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.2 tt -111.87 116.15 30.17 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 169.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -139.44 141.82 37.44 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.219 1.408 . . . . 0.0 108.966 -172.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 53.94 26.41 6.27 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.538 1.135 . . . . 0.0 112.297 -172.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.64 5.43 83.2 Favored Glycine 0 CA--C 1.536 1.346 0 O-C-N 120.957 -1.089 . . . . 0.0 113.576 -175.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -118.16 165.92 13.2 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.603 2.361 . . . . 0.0 109.732 -173.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -85.52 148.76 25.8 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.692 1.133 . . . . 0.0 109.866 172.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.19 157.45 19.41 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.494 1.043 . . . . 0.0 110.23 -174.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -171.3 175.76 44.78 Favored Glycine 0 N--CA 1.449 -0.458 0 O-C-N 120.826 -1.171 . . . . 0.0 110.574 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 31.3 m -140.07 154.79 47.17 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 169.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 p -124.88 144.37 35.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.5 tt -124.65 150.79 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 168.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.457 HG22 HG13 ' A' ' 40' ' ' VAL . 26.5 p -142.52 177.16 1.97 Allowed Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 171.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.26 -14.31 44.38 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 CA-C-N 121.179 1.457 . . . . 0.0 111.593 168.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.4 p-90 -108.56 -21.91 12.51 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -172.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 21.9 ptt? -157.59 164.96 36.73 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 120.421 1.464 . . . . 0.0 112.669 -177.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 tt -134.68 123.99 24.59 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 103.185 -2.895 . . . . 0.0 103.185 167.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.7 m -142.17 134.46 27.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.029 0.377 . . . . 0.0 110.069 -172.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.76 143.32 57.58 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 168.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.3 m -140.12 145.79 25.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 37.8 mt -139.83 133.05 35.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 -172.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -122.1 154.04 61.39 Favored Pre-proline 0 N--CA 1.467 0.394 0 CA-C-O 117.785 -1.102 . . . . 0.0 111.023 -169.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -47.96 118.91 3.42 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.546 2.831 . . . . 0.0 112.466 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.43 179.09 26.19 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 123.246 0.342 . . . . 0.0 112.478 -177.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.6 160.18 31.68 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.021 2.481 . . . . 0.0 111.571 -174.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.8 t0 42.91 52.09 5.2 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.805 2.042 . . . . 0.0 113.776 169.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -152.31 160.68 43.29 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.525 1.13 . . . . 0.0 108.526 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -103.73 112.19 25.03 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 169.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.0 130.13 91.7 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.76 147.51 81.28 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.883 1.722 . . . . 0.0 109.825 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 34.0 tp -69.29 121.91 17.82 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 173.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.82 159.83 18.61 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.688 1.195 . . . . 0.0 108.924 176.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -80.27 151.23 29.69 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 169.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.4 t -99.34 151.31 4.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -169.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.9 m 59.92 24.66 13.75 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.116 0.967 . . . . 0.0 112.324 -175.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -109.82 157.63 18.99 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 128.652 2.781 . . . . 0.0 105.023 169.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -108.77 147.55 31.87 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.03 0.832 . . . . 0.0 111.606 -176.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.7 mm -122.16 131.98 71.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.35 124.65 7.73 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 173.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.1 mt -111.67 137.26 49.79 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 171.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -90.71 129.43 36.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 174.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -153.86 159.24 32.27 Favored Pre-proline 0 C--O 1.235 0.307 0 C-N-CA 125.06 1.344 . . . . 0.0 108.562 172.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -67.08 -15.7 47.28 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.224 1.949 . . . . 0.0 114.219 -170.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -58.39 -26.01 62.72 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.299 0.64 . . . . 0.0 111.042 169.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.57 148.02 7.59 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 106.41 -2.676 . . . . 0.0 106.41 -169.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.0 m -60.26 130.85 48.69 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 49.9 mtm -134.15 141.92 47.27 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 124.025 0.93 . . . . 0.0 108.649 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.96 113.29 19.77 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 172.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -91.9 136.71 32.95 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 171.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.1 m -83.48 137.92 33.67 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.5 t -73.39 125.81 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 173.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -106.74 154.83 16.65 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.197 -2.361 . . . . 0.0 107.197 169.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -129.12 103.03 6.75 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 170.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.8 tp -85.26 122.39 29.36 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -176.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -60.38 131.35 50.49 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.265 0.626 . . . . 0.0 110.687 -173.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.01 3.59 69.21 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 118.759 -1.023 . . . . 0.0 113.66 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.9 t -120.61 -103.87 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 119.074 1.437 . . . . 0.0 107.24 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.8 p -163.97 173.94 12.01 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 119.952 1.251 . . . . 0.0 110.737 -171.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -78.8 142.01 37.29 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 168.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -154.26 177.65 10.89 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.027 1.331 . . . . 0.0 108.029 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.3 mt -124.45 137.79 54.41 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.18 0.992 . . . . 0.0 108.922 -173.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.7 m -135.66 147.39 48.56 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.627 1.171 . . . . 0.0 110.028 -173.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 36.6 t -140.52 118.28 11.7 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 172.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.9 m -67.99 135.05 51.73 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.242 0.617 . . . . 0.0 109.438 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.8 mt -109.22 -47.77 3.36 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 123.646 0.778 . . . . 0.0 110.636 -176.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 17.7 ptp -160.42 169.46 23.01 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.918 0.887 . . . . 0.0 110.111 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.2 m . . . . . 0 CA--C 1.541 0.617 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 169.625 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 29.8 m . . . . . 0 C--O 1.23 0.074 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.413 HG22 ' HD3' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -69.33 -21.0 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 O-C-N 121.066 -1.021 . . . . 0.0 112.771 -176.236 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -70.63 -44.72 66.59 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 173.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -60.5 -39.55 88.13 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 118.278 -0.868 . . . . 0.0 109.313 172.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.68 -54.96 33.21 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 119.595 1.088 . . . . 0.0 111.521 177.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -62.36 -49.23 76.38 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.671 -0.9 . . . . 0.0 110.358 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 83.6 mtt-85 -69.97 -19.17 63.37 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.62 -0.675 . . . . 0.0 111.985 -175.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.1 tp -89.06 -18.94 26.28 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 124.138 0.975 . . . . 0.0 109.447 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.5 m -69.64 -44.99 69.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 169.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -66.94 -42.53 85.14 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.577 -0.702 . . . . 0.0 112.003 174.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -69.64 -29.76 67.31 Favored 'General case' 0 C--N 1.334 -0.067 0 O-C-N 121.176 -0.953 . . . . 0.0 110.731 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 22.8 m -70.27 -43.02 71.34 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.378 0.535 . . . . 0.0 110.281 174.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.769 ' HB1' ' CE1' ' A' ' 45' ' ' PHE . . . -53.67 -45.79 70.41 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.296 1.039 . . . . 0.0 109.922 173.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.5 ttp-105 -69.75 -50.09 46.77 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.354 -0.841 . . . . 0.0 111.578 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.88 -26.68 67.59 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.53 1.059 . . . . 0.0 112.764 -171.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 10.7 pt -77.31 -11.52 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 120.2 1.364 . . . . 0.0 113.376 174.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 75.4 mt . . . . . 0 N--CA 1.467 0.401 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 169.021 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.4 mt -132.15 131.89 61.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 175.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.75 128.22 35.03 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 170.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.67 146.07 48.75 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -93.03 138.79 31.18 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.701 0.8 . . . . 0.0 111.034 -169.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -69.14 -24.32 64.08 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.566 0.747 . . . . 0.0 111.151 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -162.12 172.42 15.87 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.86 1.264 . . . . 0.0 108.984 171.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.2 m -61.08 138.22 94.24 Favored Pre-proline 0 C--N 1.324 -0.502 0 C-N-CA 125.776 1.63 . . . . 0.0 110.432 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -69.77 48.14 0.61 Allowed 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 124.607 3.538 . . . . 0.0 112.706 169.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 42' ' ' VAL . 82.7 tttt -50.97 -57.15 9.32 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.025 1.73 . . . . 0.0 112.771 -169.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.85 -38.18 79.59 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 117.821 0.282 . . . . 0.0 110.273 -177.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -61.01 -45.37 95.07 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.627 0.771 . . . . 0.0 110.842 178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.0 t -64.57 -42.6 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -61.15 -51.54 68.62 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.839 0.745 . . . . 0.0 110.427 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.85 -39.41 93.51 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.006 0.922 . . . . 0.0 110.837 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.84 -46.17 90.62 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 175.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -72.81 -26.09 61.38 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 118.208 -0.901 . . . . 0.0 112.703 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -65.55 -28.87 69.47 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 120.084 1.311 . . . . 0.0 109.636 172.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -81.78 -47.52 12.76 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.244 1.018 . . . . 0.0 109.713 176.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.8 mt -67.9 -38.5 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 O-C-N 121.277 -0.889 . . . . 0.0 109.674 -175.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.6 -30.33 71.35 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.413 -0.804 . . . . 0.0 110.676 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.9 ttm105 -76.62 -37.5 56.27 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 123.518 0.727 . . . . 0.0 109.713 174.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 . . . . . 0 CA--C 1.535 0.396 0 C-N-CA 123.915 0.886 . . . . 0.0 110.923 173.306 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo . . . . . 0 N--CA 1.454 -0.84 0 N-CA-C 114.351 0.866 . . . . 0.0 114.351 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.9 t -92.58 111.8 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 101.441 -3.541 . . . . 0.0 101.441 167.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -145.4 158.94 43.74 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.075 0.95 . . . . 0.0 110.152 -169.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.408 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 41.1 t -139.27 124.0 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.577 0.751 . . . . 0.0 109.61 -175.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.0 m -90.18 154.51 19.7 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.252 1.021 . . . . 0.0 110.57 168.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -118.83 147.08 44.31 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 127.78 2.432 . . . . 0.0 111.013 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.453 ' CE2' ' HB3' ' A' ' 131' ' ' ALA . 55.0 m-85 -155.65 170.37 22.18 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.919 1.452 . . . . 0.0 114.919 -170.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.1 m -17.17 153.72 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.566 1 C-N-CA 134.413 5.085 . . . . 0.0 118.486 169.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.9 mt -85.97 118.56 25.53 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 169.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -121.89 108.9 13.98 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.813 2.045 . . . . 0.0 106.688 -173.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 52.12 37.93 22.94 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.566 1.146 . . . . 0.0 111.06 -170.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.27 13.77 82.41 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 118.856 -0.969 . . . . 0.0 113.907 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -121.34 134.77 55.14 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.101 1.451 . . . . 0.0 108.608 -177.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -63.28 142.08 58.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 120.354 1.434 . . . . 0.0 109.654 173.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.42 162.93 13.45 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 122.236 1.017 . . . . 0.0 108.748 169.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.84 173.15 40.7 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 107.87 -2.092 . . . . 0.0 107.87 169.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 1.3 m -136.04 145.89 46.51 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 169.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 p -118.4 141.36 38.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 169.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.0 tt -122.75 151.93 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 169.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.1 p -141.19 179.05 1.32 Allowed Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 172.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -68.73 -13.19 36.5 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 CA-C-N 121.602 1.608 . . . . 0.0 111.585 169.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -111.76 -21.09 11.83 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -169.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -157.36 160.57 38.6 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 120.161 1.346 . . . . 0.0 112.172 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 tt -130.77 123.21 28.67 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 103.351 -2.833 . . . . 0.0 103.351 167.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.4 m -134.4 131.81 38.64 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 123.875 0.734 . . . . 0.0 109.765 -177.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.01 145.28 50.09 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 168.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.4 m -135.62 147.84 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -177.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 58.6 mt -139.7 138.87 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -173.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -130.97 139.05 34.39 Favored Pre-proline 0 N--CA 1.466 0.332 0 CA-C-O 117.595 -1.193 . . . . 0.0 108.98 -177.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.37 130.1 34.47 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.567 2.178 . . . . 0.0 110.827 172.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.64 -166.84 33.47 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 119.602 -0.554 . . . . 0.0 112.426 -174.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -71.6 164.44 35.7 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.892 2.395 . . . . 0.0 112.915 -175.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.4 t0 42.57 55.69 4.09 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.397 2.279 . . . . 0.0 113.755 169.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -152.55 148.61 27.57 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.173 0.989 . . . . 0.0 109.35 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.9 mp -110.74 95.0 5.28 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.28 150.7 85.34 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.267 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -66.9 145.78 75.57 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.01 1.807 . . . . 0.0 110.763 171.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.1 tp -66.68 127.03 30.85 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 169.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -98.46 161.79 13.5 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.577 0.626 . . . . 0.0 110.074 -176.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.1 tmtm? -96.05 139.18 32.61 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 169.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.0 t -82.62 154.34 3.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 123.662 0.785 . . . . 0.0 109.332 -169.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.4 m 66.09 8.97 5.87 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.91 1.684 . . . . 0.0 113.769 -177.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -79.86 160.69 25.97 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.466 1.106 . . . . 0.0 108.136 168.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -112.9 142.33 45.69 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.708 -0.62 . . . . 0.0 110.41 177.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.6 mm -118.23 121.13 66.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 177.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.44 125.31 8.01 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 108.619 -1.793 . . . . 0.0 108.619 175.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.4 mt -120.51 141.81 49.89 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 124.344 1.057 . . . . 0.0 108.642 174.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -91.18 128.38 36.98 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 174.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 mp -135.07 162.01 60.22 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 124.763 1.225 . . . . 0.0 108.809 177.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -60.23 -21.89 68.28 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.527 2.151 . . . . 0.0 114.004 172.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -72.67 -4.21 29.72 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.599 1.16 . . . . 0.0 112.366 174.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.81 161.88 26.82 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 107.957 -2.057 . . . . 0.0 107.957 -168.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.8 m -68.84 131.99 46.03 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 69.8 mtm -139.9 144.04 36.97 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -177.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.68 132.29 35.18 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 172.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -102.17 132.66 47.94 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 169.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.5 m -83.95 142.19 30.7 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 66.5 t -74.59 124.83 33.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 170.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -112.02 161.4 12.75 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 170.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -132.59 93.78 3.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 171.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.9 tp -77.58 135.21 38.14 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -169.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.17 123.17 15.06 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.312 0.645 . . . . 0.0 111.691 -169.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.5 -3.4 33.27 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 118.688 -1.062 . . . . 0.0 113.998 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.8 t -101.31 -119.75 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 119.68 1.74 . . . . 0.0 106.337 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.3 m -148.17 174.99 11.41 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.629 1.571 . . . . 0.0 108.921 -169.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -72.53 142.31 48.49 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 168.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -153.48 171.8 18.12 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.1 1.36 . . . . 0.0 108.055 -178.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.4 mp -111.41 142.0 44.23 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.1 p -141.82 153.87 44.8 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.627 0.771 . . . . 0.0 110.588 -178.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.3 t -144.0 115.28 7.99 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 173.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.1 m -73.79 135.18 43.5 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 175.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.7 mt -123.95 -35.03 2.9 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.914 -1.041 . . . . 0.0 113.47 -169.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 13.4 ptp -159.64 169.62 23.34 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 120.249 1.386 . . . . 0.0 110.913 176.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 CA--C 1.546 0.806 0 C-N-CA 124.808 1.243 . . . . 0.0 108.425 169.921 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.4 p . . . . . 0 CA--C 1.533 0.302 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.728 ' H ' HD12 ' A' ' 120' ' ' ILE . 2.7 mp -53.82 -39.78 41.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.443 1.097 . . . . 0.0 109.59 171.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.69 -43.61 65.68 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.545 0.738 . . . . 0.0 109.456 -175.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -66.87 -28.48 68.36 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.079 173.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.61 -57.97 16.77 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 172.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -64.21 -52.73 57.42 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.647 -0.914 . . . . 0.0 110.778 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -66.83 -24.8 66.2 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 117.963 -1.017 . . . . 0.0 112.099 -173.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.7 tp -86.38 -29.9 22.57 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 120.748 1.613 . . . . 0.0 109.588 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.9 m -58.96 -48.19 82.42 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 169.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -64.0 -51.37 64.56 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.004 1.322 . . . . 0.0 112.083 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -65.5 -33.5 76.07 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.699 -0.626 . . . . 0.0 110.789 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 40.6 t -70.9 -34.03 71.16 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -178.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.453 ' HB3' ' CE2' ' A' ' 45' ' ' PHE . . . -68.13 -52.81 30.61 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 43.3 tpt85 -53.95 -46.84 71.71 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 123.539 0.736 . . . . 0.0 111.898 -175.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 15.2 ptt? -57.38 -27.25 62.14 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.58 1.082 . . . . 0.0 112.007 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 19.8 pt -102.2 9.9 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.421 1.089 . . . . 0.0 111.242 178.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 16.8 tp . . . . . 0 N--CA 1.455 -0.184 0 C-N-CA 125.863 1.665 . . . . 0.0 109.108 -168.071 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 . . . . . 0 CA--C 1.535 0.386 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.4 mm -126.26 125.74 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 170.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.48 150.23 33.0 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.962 0.41 . . . . 0.0 110.092 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.18 156.71 47.65 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.589 1.09 . . . . 0.0 112.848 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -112.81 150.5 31.57 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.874 1.27 . . . . 0.0 110.101 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -82.35 -29.15 31.14 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.671 0.788 . . . . 0.0 111.368 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.8 p -158.52 -177.86 6.84 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 129.966 3.306 . . . . 0.0 105.601 172.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.8 m -57.59 144.23 73.22 Favored Pre-proline 0 CA--C 1.541 0.616 0 O-C-N 120.95 -1.094 . . . . 0.0 110.137 169.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.45 58.48 3.77 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 124.811 3.674 . . . . 0.0 109.652 169.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HE2' ' O ' ' A' ' 42' ' ' VAL . 41.1 tttm -50.55 -52.76 35.87 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.77 2.428 . . . . 0.0 112.692 -169.082 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.88 95.59 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.656 0.383 . . . . 0.0 111.144 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -70.11 -39.81 75.26 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -176.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 81.3 t -62.97 -40.79 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -62.54 -52.43 63.46 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.496 0.589 . . . . 0.0 110.195 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.2 -39.29 94.22 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.762 0.825 . . . . 0.0 110.899 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.34 -50.39 73.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -72.43 -29.4 63.67 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 117.84 -1.076 . . . . 0.0 112.493 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -59.95 -35.22 74.49 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.293 1.406 . . . . 0.0 109.886 169.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -76.53 -52.59 9.48 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.594 0.634 . . . . 0.0 109.378 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.0 mt -61.28 -39.06 81.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.907 1.283 . . . . 0.0 110.425 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.12 -24.04 67.54 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.351 -0.843 . . . . 0.0 112.272 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.4 ttp85 -99.89 -30.34 12.08 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 125.465 1.506 . . . . 0.0 109.494 -175.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 . . . . . 0 C--N 1.339 0.134 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 169.101 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo . . . . . 0 N--CA 1.454 -0.804 0 N-CA-C 114.205 0.81 . . . . 0.0 114.205 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.1 t -63.91 136.94 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 168.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -142.49 156.08 45.12 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.028 0.831 . . . . 0.0 110.102 -171.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.41 ' O ' ' HE2' ' A' ' 13' ' ' LYS . 34.5 t -140.03 127.78 24.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -178.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.5 m -100.55 151.62 21.38 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.146 0.979 . . . . 0.0 109.772 169.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -123.95 143.24 50.51 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.136 1.774 . . . . 0.0 110.292 -176.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -145.3 170.2 16.77 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.239 1.415 . . . . 0.0 114.153 -169.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.8 t -54.19 169.29 0.18 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.226 2.611 . . . . 0.0 115.468 -169.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.6 tp -77.31 124.4 27.81 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.753 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -104.52 -125.12 0.22 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.969 2.108 . . . . 0.0 107.172 -175.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -77.29 70.75 3.72 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.701 1.137 . . . . 0.0 109.814 177.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.06 15.58 65.32 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.335 0.969 . . . . 0.0 113.315 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -143.32 143.34 31.64 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 125.637 1.575 . . . . 0.0 108.104 -169.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -72.18 153.88 41.37 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.083 0.856 . . . . 0.0 110.27 174.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.52 158.39 16.11 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 169.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.71 168.51 39.02 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 108.056 -2.017 . . . . 0.0 108.056 173.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 48.2 m -140.39 145.14 36.69 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 169.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.07 144.11 25.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 171.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.9 tt -131.17 152.82 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 172.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.4 p -144.5 178.75 1.34 Allowed Pre-proline 0 N--CA 1.446 -0.662 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -63.84 1.0 1.64 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.437 2.092 . . . . 0.0 113.601 168.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.4 p-90 -138.6 -19.54 1.06 Allowed 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 -169.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -153.78 164.44 38.34 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 120.589 1.54 . . . . 0.0 111.703 -176.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 tp -136.49 116.57 13.37 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 169.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.1 m -136.26 122.52 20.49 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -172.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.05 145.87 55.35 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 169.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.6 m -139.5 146.64 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.887 1.275 . . . . 0.0 108.585 -177.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 45.4 mt -142.2 140.94 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -170.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -137.0 144.37 46.1 Favored Pre-proline 0 N--CA 1.469 0.512 0 CA-C-O 117.638 -1.172 . . . . 0.0 110.065 -170.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -52.49 137.95 57.35 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.312 2.675 . . . . 0.0 112.919 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.41 -178.78 25.58 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 123.815 0.721 . . . . 0.0 112.943 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -64.16 140.7 72.74 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.017 2.478 . . . . 0.0 112.8 -171.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.7 t70 52.84 26.86 4.88 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.832 1.653 . . . . 0.0 114.035 170.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -87.02 152.98 21.9 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 171.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.7 83.65 2.03 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 170.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -66.87 152.9 95.16 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.896 172.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -71.56 159.1 52.18 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.901 1.734 . . . . 0.0 109.634 169.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.5 tp -66.78 117.24 8.64 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 169.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -85.78 154.78 21.35 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -177.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -84.19 142.33 30.39 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.4 t -89.23 154.55 3.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -168.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.3 m 66.12 8.62 5.63 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.702 1.601 . . . . 0.0 113.683 -176.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -78.74 161.55 26.78 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.687 1.195 . . . . 0.0 108.088 169.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -113.46 143.26 44.81 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 121.427 -0.795 . . . . 0.0 110.329 175.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.2 mm -118.33 126.13 74.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 176.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.24 123.8 7.42 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 174.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.8 mt -116.24 143.87 44.95 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.604 1.162 . . . . 0.0 108.167 174.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -96.14 128.01 42.67 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 175.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mp -138.54 155.17 73.78 Favored Pre-proline 0 C--O 1.236 0.376 0 C-N-CA 124.809 1.244 . . . . 0.0 107.702 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -63.43 -20.92 70.93 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 121.96 1.774 . . . . 0.0 113.619 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -58.86 -28.98 66.62 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.654 0.781 . . . . 0.0 111.535 169.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 129.03 155.78 8.68 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 106.679 -2.568 . . . . 0.0 106.679 -169.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.1 m -64.29 131.2 46.61 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 176.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 62.9 mtm -141.26 144.13 34.51 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.485 1.114 . . . . 0.0 108.349 -176.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.98 135.14 35.82 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 121.932 -0.48 . . . . 0.0 109.879 172.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -108.61 138.6 44.66 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 168.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.2 m -87.7 140.71 29.24 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.3 t -73.24 126.77 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 169.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -119.27 163.14 13.46 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 171.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -126.06 93.83 3.93 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 173.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.6 tp -75.36 124.89 27.9 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -169.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -59.97 132.79 55.04 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.101 0.56 . . . . 0.0 110.468 -176.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.24 3.7 70.99 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-O 118.752 -1.026 . . . . 0.0 113.581 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.3 t -127.49 -120.13 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.7 m -152.49 -178.6 6.94 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.744 1.618 . . . . 0.0 108.846 -169.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -68.79 143.3 54.66 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 169.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -150.51 169.45 21.46 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.548 1.539 . . . . 0.0 108.679 177.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.5 mp -104.4 141.8 35.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 170.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.8 p -141.13 155.4 46.11 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.705 0.802 . . . . 0.0 110.486 -177.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 48.0 t -144.99 110.83 5.42 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 171.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.7 m -71.22 127.73 33.55 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 24.0 mt -119.76 -40.2 2.78 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 118.677 -0.678 . . . . 0.0 112.33 -169.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 23.8 mtm -141.79 161.5 37.8 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.182 0.993 . . . . 0.0 108.724 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.2 p . . . . . 0 CA--C 1.545 0.752 0 C-N-CA 125.042 1.337 . . . . 0.0 110.117 -179.04 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.5 p . . . . . 0 CA--C 1.528 0.1 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.502 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -67.48 -26.55 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 120.986 -1.071 . . . . 0.0 110.33 170.163 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -67.05 -44.19 80.82 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 174.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -65.59 -30.13 70.82 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.204 0.911 . . . . 0.0 110.571 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.88 -27.63 50.9 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.674 1.13 . . . . 0.0 112.323 171.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -95.5 -55.04 3.16 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.332 1.066 . . . . 0.0 110.828 171.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -71.01 -29.68 65.69 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -169.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.5 tp -83.03 -29.72 28.64 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 120.152 1.342 . . . . 0.0 109.608 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -64.75 -43.23 94.01 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -64.0 -48.53 76.03 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.167 0.587 . . . . 0.0 111.972 172.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -69.8 -25.71 63.91 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.115 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 35.3 t -64.32 -42.41 96.33 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.68 -47.23 73.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 174.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 50.1 ttt-85 -57.0 -46.63 82.15 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.336 0.971 . . . . 0.0 111.315 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 52.6 ttp -47.4 -31.3 3.95 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.565 1.546 . . . . 0.0 112.229 174.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 25.7 pt -104.15 -18.98 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 120.066 1.303 . . . . 0.0 113.009 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . 0.299 3.5 pp . . . . . 0 N--CA 1.47 0.526 0 CA-C-N 120.087 1.312 . . . . 0.0 108.074 168.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.0 ttp . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.0 p -82.59 -21.85 35.06 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.712 0.805 . . . . 0.0 112.555 -174.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -88.66 133.48 34.19 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -170.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -148.78 164.39 34.55 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.837 1.255 . . . . 0.0 109.86 -169.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.8 mm -119.37 126.01 74.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 169.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.67 145.28 38.87 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.029 0.442 . . . . 0.0 109.816 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.02 146.2 50.34 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.795 1.188 . . . . 0.0 111.456 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -89.57 139.84 30.14 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.323 1.049 . . . . 0.0 108.912 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -71.42 -38.86 71.36 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.7 p -155.1 166.2 34.32 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 128.162 2.585 . . . . 0.0 107.847 170.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.5 m -54.08 141.02 51.21 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.419 1.088 . . . . 0.0 112.203 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -75.89 49.38 2.48 Favored 'Trans proline' 0 CA--C 1.541 0.844 1 C-N-CA 125.429 4.086 . . . . 0.0 110.872 170.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -54.21 -46.15 72.4 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.879 1.672 . . . . 0.0 112.032 -169.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.95 98.53 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 122.506 0.323 . . . . 0.0 111.259 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -40.19 69.44 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 119.074 -0.488 . . . . 0.0 109.804 -174.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 84.2 t -58.22 -45.67 88.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 171.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -61.17 -53.86 51.61 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.861 0.755 . . . . 0.0 110.95 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.0 -39.25 93.17 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.713 0.688 . . . . 0.0 111.128 -174.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.26 -47.54 81.96 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -70.69 -24.42 62.66 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-O 118.289 -0.862 . . . . 0.0 112.592 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -62.11 -37.35 84.78 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.342 0.974 . . . . 0.0 108.979 172.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -80.46 -45.24 17.9 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.8 mt -61.92 -31.9 52.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 O-C-N 120.896 -1.128 . . . . 0.0 110.219 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.99 -24.7 63.35 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.282 -0.886 . . . . 0.0 112.201 174.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.9 ttm105 -83.71 -41.64 17.47 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.936 0.894 . . . . 0.0 109.632 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.75 119.0 6.82 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -177.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.9 m -154.8 114.37 3.73 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 49.4 ttp -83.67 172.28 12.43 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.849 1.26 . . . . 0.0 110.048 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.556 ' CG ' ' H ' ' A' ' 30' ' ' ASP . 47.1 t60 63.02 -169.01 0.19 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.744 1.617 . . . . 0.0 111.415 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.556 ' H ' ' CG ' ' A' ' 29' ' ' HIS . 36.6 t70 -63.96 -8.49 11.56 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.109 1.764 . . . . 0.0 113.771 -169.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -61.07 -31.02 70.69 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.797 0.839 . . . . 0.0 110.564 170.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.4 m 61.68 157.56 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.075 2.15 . . . . 0.0 113.623 -173.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -81.88 56.33 3.05 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.689 1.195 . . . . 0.0 110.387 -177.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.7 mt -61.69 149.7 38.81 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.253 1.021 . . . . 0.0 109.81 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -66.53 157.77 81.39 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 123.498 0.719 . . . . 0.0 110.667 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -65.84 -29.11 50.55 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.65 1.566 . . . . 0.0 114.876 -169.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.0 m 60.1 10.59 2.33 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.718 1.607 . . . . 0.0 113.965 -176.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 4.5 tmm? -155.6 110.64 2.19 Favored Pre-proline 0 C--O 1.234 0.246 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -55.51 121.32 9.72 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.823 2.349 . . . . 0.0 111.746 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 m -65.59 148.31 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 171.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -143.11 157.75 44.23 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 124.06 0.944 . . . . 0.0 109.076 -175.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.2 t -138.99 126.62 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -177.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.6 p -89.01 150.67 22.69 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 169.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -132.61 132.79 42.87 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.561 1.544 . . . . 0.0 108.24 173.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.43 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 43.1 p90 -169.9 145.76 3.02 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.354 0.662 . . . . 0.0 112.704 -171.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.8 m 58.52 165.14 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 128.014 2.525 . . . . 0.0 115.409 167.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.2 tp -115.84 58.3 0.74 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.07 1.348 . . . . 0.0 109.157 175.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.91 137.21 47.25 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.025 0.93 . . . . 0.0 110.042 -173.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 55.15 22.85 4.88 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.367 1.067 . . . . 0.0 111.874 -171.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.07 20.61 77.37 Favored Glycine 0 CA--C 1.531 1.053 0 O-C-N 121.223 -0.923 . . . . 0.0 112.874 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -135.79 143.11 45.04 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.223 1.511 . . . . 0.0 108.118 -172.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -65.7 135.39 54.9 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.303 -0.873 . . . . 0.0 108.961 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.43 ' HB ' ' CE2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -103.09 160.07 14.97 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.857 0.837 . . . . 0.0 109.514 -177.299 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -169.35 168.81 41.54 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 56.4 m -135.96 146.82 47.68 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 168.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.1 p -111.81 143.55 21.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 171.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.85 141.64 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 169.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.3 p -136.8 173.83 5.1 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 171.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.9 -25.7 74.31 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 CA-C-N 121.386 1.531 . . . . 0.0 111.238 169.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.4 p-90 -93.41 -26.57 17.17 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 118.155 -0.926 . . . . 0.0 113.215 -172.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.97 170.21 23.05 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 120.256 1.389 . . . . 0.0 113.057 -174.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 tt -137.57 127.96 26.45 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 168.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.6 m -140.68 137.52 33.6 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 123.04 0.536 . . . . 0.0 110.017 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.6 146.82 48.14 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 168.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.3 m -138.48 144.18 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.23 1.412 . . . . 0.0 108.178 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 31.7 mt -142.69 141.91 27.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 125.37 1.468 . . . . 0.0 107.283 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -130.33 133.79 25.32 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-O 117.646 -1.168 . . . . 0.0 108.203 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.85 137.78 21.4 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.282 2.655 . . . . 0.0 111.899 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.56 179.07 34.26 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.302 0.953 . . . . 0.0 112.756 -173.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.67 145.05 56.47 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.982 2.455 . . . . 0.0 111.019 -172.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.1 t0 50.63 57.69 6.34 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.381 1.472 . . . . 0.0 112.188 177.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -128.76 148.93 50.89 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.385 1.474 . . . . 0.0 108.223 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -124.34 83.03 2.1 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 175.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.71 150.91 97.51 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 172.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.34 155.23 70.98 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.901 1.734 . . . . 0.0 109.972 170.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 68.9 tp -63.85 129.25 39.33 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 170.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -104.61 163.38 12.51 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.474 0.579 . . . . 0.0 109.559 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -89.52 157.18 18.19 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 169.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.1 t -86.5 153.41 3.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -169.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . 0.254 42.7 m 65.84 11.84 7.92 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.229 1.411 . . . . 0.0 113.58 -174.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -74.85 158.16 33.88 Favored 'General case' 0 C--N 1.346 0.42 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 168.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -112.27 141.03 46.47 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.624 -0.673 . . . . 0.0 109.976 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.5 mm -120.38 123.92 71.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.09 121.99 6.4 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.8 mt -113.26 143.12 44.96 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.24 1.016 . . . . 0.0 108.299 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -95.05 127.41 41.09 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mp -135.59 153.96 77.92 Favored Pre-proline 0 C--O 1.234 0.288 0 C-N-CA 125.595 1.558 . . . . 0.0 107.282 174.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -64.58 -21.82 65.35 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.236 1.291 . . . . 0.0 112.497 172.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -58.7 -23.51 59.69 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.67 1.588 . . . . 0.0 111.524 169.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 129.65 148.35 6.49 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.979 2.228 . . . . 0.0 108.066 -173.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.0 m -63.11 130.92 46.74 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 170.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 43.7 ttp -144.61 138.76 27.63 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -169.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.54 130.95 35.45 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -104.4 131.68 51.49 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 169.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.8 m -85.25 139.26 31.77 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 97.7 t -70.82 110.86 4.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 172.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -94.24 155.91 22.02 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 106.91 -2.476 . . . . 0.0 106.91 169.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -134.55 122.32 22.21 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 169.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.6 tp -142.3 145.65 34.21 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.885 0.474 . . . . 0.0 110.411 -169.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -58.71 132.07 52.76 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.917 0.887 . . . . 0.0 111.062 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.93 0.3 50.19 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.046 0.831 . . . . 0.0 113.688 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 87.2 t -122.23 -27.11 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.267 1.427 . . . . 0.0 109.852 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.2 m 60.16 -150.52 0.42 Allowed 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.236 1.415 . . . . 0.0 108.691 -174.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -78.06 137.28 38.16 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.368 0.531 . . . . 0.0 110.152 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -152.44 166.81 30.79 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.974 1.71 . . . . 0.0 107.988 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.0 mp -117.81 122.32 43.1 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.1 m -143.79 158.36 43.73 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.008 0.822 . . . . 0.0 111.305 -169.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 15.6 p -149.4 140.38 22.89 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.844 -0.535 . . . . 0.0 109.816 169.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.0 m -67.09 138.25 56.98 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 174.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.0 mt -107.83 -48.45 3.4 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.174 0.99 . . . . 0.0 110.145 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 13.3 ptp -164.09 172.5 13.68 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.858 0.863 . . . . 0.0 110.329 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.1 m -112.01 111.58 53.38 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -81.59 59.42 7.24 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.693 2.928 . . . . 0.0 111.151 -172.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 91.8 mt -93.17 28.47 2.16 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.907 1.283 . . . . 0.0 111.883 -172.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 7.0 m -73.45 146.74 44.78 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.451 1.101 . . . . 0.0 109.415 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -77.97 -19.41 54.59 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.21 -0.931 . . . . 0.0 111.527 176.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.9 p -76.21 -3.65 37.52 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.492 1.517 . . . . 0.0 112.353 172.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.2 tpt -61.65 143.31 56.32 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.743 1.217 . . . . 0.0 110.747 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.3 t -157.17 167.52 30.14 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.447 1.899 . . . . 0.0 106.826 177.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -59.7 -31.17 46.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 123.618 0.767 . . . . 0.0 110.708 179.162 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.93 -46.72 73.92 Favored 'General case' 0 C--O 1.226 -0.166 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -63.24 -33.42 75.47 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.103 173.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.46 -62.13 6.63 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 171.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -65.07 -43.27 92.75 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 117.742 0.771 . . . . 0.0 111.282 -175.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -58.67 -40.98 85.09 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.37 0.668 . . . . 0.0 109.722 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.8 tp -81.28 -21.98 38.96 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 117.783 -1.104 . . . . 0.0 111.684 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.14 -42.71 79.74 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.837 1.653 . . . . 0.0 108.75 169.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -70.07 -41.2 74.44 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.262 0.625 . . . . 0.0 111.699 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -66.9 -31.04 71.36 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.064 -1.022 . . . . 0.0 110.653 174.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 21.1 m -69.31 -41.27 76.96 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.793 0.724 . . . . 0.0 110.257 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.417 ' HB2' ' CE1' ' A' ' 45' ' ' PHE . . . -55.89 -54.11 48.67 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.657 0.783 . . . . 0.0 109.549 172.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -52.27 -54.09 35.71 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.066 0.947 . . . . 0.0 109.974 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 57.0 ttp -49.42 -55.24 13.75 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.65 1.58 . . . . 0.0 111.271 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.7 pt -78.68 -25.34 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 118.955 0.798 . . . . 0.0 112.233 -171.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.1 mt -71.6 -33.95 69.46 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.671 0.669 . . . . 0.0 110.452 169.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.9 m 56.74 26.09 10.97 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.113 1.765 . . . . 0.0 112.133 -169.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 92.5 mt -142.2 150.57 55.88 Favored Pre-proline 0 C--O 1.236 0.351 0 C-N-CA 127.608 2.363 . . . . 0.0 107.773 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -58.7 150.84 67.68 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.345 2.696 . . . . 0.0 111.212 175.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.02 152.49 11.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 125.061 1.345 . . . . 0.0 107.889 -176.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 65.5 m -61.34 119.0 7.64 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.308 0.643 . . . . 0.0 109.347 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -72.59 126.4 90.83 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 169.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -82.45 58.56 6.58 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.829 2.353 . . . . 0.0 112.889 -169.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -142.89 42.0 1.56 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.76 1.624 . . . . 0.0 109.739 172.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.4 m -78.52 171.37 12.68 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 124.215 1.006 . . . . 0.0 109.888 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -49.21 159.73 1.04 Allowed 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 124.008 3.139 . . . . 0.0 114.681 170.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -63.77 120.1 11.22 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 171.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -94.79 -13.98 25.11 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.556 0.742 . . . . 0.0 112.469 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.26 146.09 45.43 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 91.5 mmt-85 -143.0 160.77 39.73 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.827 1.651 . . . . 0.0 108.011 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -66.48 145.52 55.56 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 172.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.72 140.65 30.33 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 169.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.0 168.09 28.53 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.879 1.671 . . . . 0.0 109.023 177.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.8 tt 51.72 59.71 4.37 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.498 1.519 . . . . 0.0 109.727 -175.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -66.35 148.95 51.12 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.001 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 173.99 -175.53 46.5 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.9 ttp180 -147.7 148.38 30.95 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 175.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -69.9 128.27 35.8 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 169.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 61.0 m -138.39 150.17 46.27 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.92 1.288 . . . . 0.0 108.715 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 136.48 -96.58 0.25 Allowed Glycine 0 C--N 1.336 0.567 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -66.03 -35.65 81.13 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 170.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -76.53 123.17 25.65 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 169.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 C-N-CA 123.516 0.726 . . . . 0.0 109.236 -178.503 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 tpt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.4 p -74.21 155.1 38.68 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.211 1.005 . . . . 0.0 110.199 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -86.49 18.97 3.0 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.79 0.805 . . . . 0.0 111.126 174.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -146.88 155.49 42.35 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.589 2.356 . . . . 0.0 108.063 -173.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.8 mm -118.4 131.62 70.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 126.627 1.971 . . . . 0.0 106.03 175.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.57 142.0 44.71 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 120.701 0.286 . . . . 0.0 110.373 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.8 151.57 51.04 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.209 0.909 . . . . 0.0 111.945 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -93.03 151.2 20.03 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.304 1.041 . . . . 0.0 109.669 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -94.19 -19.25 20.93 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.779 -0.629 . . . . 0.0 112.105 176.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.2 p -156.94 164.42 38.05 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 127.344 2.258 . . . . 0.0 107.734 169.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.1 m -56.9 133.49 79.57 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-O 118.236 -0.888 . . . . 0.0 109.614 169.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.401 ' HD2' ' CE1' ' A' ' 67' ' ' PHE . 33.3 Cg_exo -70.83 50.14 1.05 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.433 3.422 . . . . 0.0 112.648 170.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.6 tttm -51.69 -48.68 63.39 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.831 1.652 . . . . 0.0 112.061 -169.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.2 94.93 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 122.705 0.402 . . . . 0.0 111.128 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -73.17 -40.13 65.07 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.384 0.674 . . . . 0.0 109.834 -175.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 80.9 t -61.11 -47.12 95.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -59.41 -50.49 73.76 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 118.923 -0.56 . . . . 0.0 110.872 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.74 -43.27 98.14 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.771 0.714 . . . . 0.0 110.423 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.18 -49.77 76.6 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.058 0.39 . . . . 0.0 110.234 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -66.05 -26.15 67.37 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.943 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -67.64 -29.18 68.42 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 120.098 1.317 . . . . 0.0 111.539 174.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -77.39 -54.82 5.99 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.172 0.896 . . . . 0.0 109.095 171.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.3 mt -60.52 -44.78 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 123.944 0.897 . . . . 0.0 109.851 -169.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.11 -28.71 70.25 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.953 -0.467 . . . . 0.0 111.346 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -81.79 -43.15 18.72 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 118.751 0.705 . . . . 0.0 109.828 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -54.77 -46.15 74.36 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.112 0.565 . . . . 0.0 110.316 172.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.6 m -70.15 -57.18 5.23 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 119.216 -0.421 . . . . 0.0 110.933 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . 0.25 22.3 ptt? 42.56 -150.51 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.054 1.742 . . . . 0.0 111.281 -169.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -138.26 166.91 23.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.787 1.635 . . . . 0.0 107.636 177.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -62.64 -32.09 73.07 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -170.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.62 4.1 17.03 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.41 1.084 . . . . 0.0 113.317 176.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.0 m 65.0 -42.78 0.32 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 129.102 2.961 . . . . 0.0 116.823 174.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -74.14 -19.9 60.41 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 120.183 1.356 . . . . 0.0 113.829 -169.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.3 mt -80.83 94.54 6.46 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 172.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -142.85 -161.73 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 127.603 2.361 . . . . 0.0 106.1 -177.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -58.79 13.5 0.04 OUTLIER 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 122.998 2.465 . . . . 0.0 117.824 176.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 p -60.08 -45.85 91.54 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 167.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 52.8 mtt -79.69 148.38 69.1 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 168.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -68.34 146.0 67.48 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 121.952 1.768 . . . . 0.0 114.924 -169.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.3 m -109.04 56.58 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 104.629 -2.359 . . . . 0.0 104.629 167.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -83.93 156.86 22.15 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.548 1.139 . . . . 0.0 111.63 -168.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.0 t -140.07 127.14 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 123.695 0.798 . . . . 0.0 109.431 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.0 m -91.41 145.36 24.69 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.084 0.954 . . . . 0.0 108.952 168.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -125.6 138.22 53.92 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.873 1.669 . . . . 0.0 108.277 170.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -162.03 130.65 4.25 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -175.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 t 47.97 -179.78 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 129.992 3.317 . . . . 0.0 117.071 168.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.9 tp -117.58 86.4 2.51 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 171.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -74.6 -38.8 62.52 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -168.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.07 56.75 1.13 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 122.323 1.059 . . . . 0.0 108.495 -176.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 62.98 20.94 63.03 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.627 -175.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -144.15 139.94 29.09 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 126.616 1.966 . . . . 0.0 105.834 -174.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -74.75 143.58 44.02 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.41 153.42 26.09 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.581 0.705 . . . . 0.0 109.299 -173.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -163.5 167.81 37.86 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 35.4 m -140.94 152.76 45.26 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 169.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.2 t -128.09 143.98 39.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.403 HG21 ' HA2' ' A' ' 123' ' ' GLY . 15.8 tt -127.14 148.19 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 169.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 49.3 p -137.78 177.83 1.96 Allowed Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 175.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -61.38 -6.31 6.64 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.63 2.22 . . . . 0.0 113.387 169.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.1 p-90 -131.14 -23.51 2.43 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -169.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.9 169.63 21.81 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.256 1.389 . . . . 0.0 112.13 -176.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 tt -139.27 123.13 17.66 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 168.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.7 m -139.56 134.16 31.77 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.236 0.541 . . . . 0.0 110.141 -175.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.99 146.25 54.92 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 168.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.4 m -137.17 141.76 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.7 mt -143.81 144.45 23.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -169.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.401 ' CE1' ' HD2' ' A' ' 12' ' ' PRO . 25.5 m-85 -132.59 136.81 28.51 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 118.196 -0.907 . . . . 0.0 109.387 -173.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -46.75 138.49 14.91 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 124.007 3.138 . . . . 0.0 112.166 169.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.89 -179.92 46.32 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 123.734 0.683 . . . . 0.0 113.043 -174.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.71 145.76 52.51 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 123.518 2.812 . . . . 0.0 110.917 -173.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.2 t0 50.76 54.56 10.99 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.284 1.434 . . . . 0.0 111.986 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -124.32 154.32 40.47 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.941 1.297 . . . . 0.0 107.769 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 92.2 mt -129.16 85.3 2.3 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 8.8 m0 -65.67 153.09 91.53 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -62.86 155.04 62.44 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.658 2.239 . . . . 0.0 111.131 171.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.43 129.76 43.24 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 169.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -144.45 160.03 41.76 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -124.17 172.93 8.66 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 122.985 1.374 . . . . 0.0 110.529 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 70.1 t -70.03 150.93 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 112.461 -2.154 . . . . 0.0 109.645 -169.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.0 m 68.89 1.09 2.98 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.244 1.818 . . . . 0.0 114.096 -177.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -73.47 155.77 38.9 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 169.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -119.75 143.77 47.62 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 118.615 0.643 . . . . 0.0 110.122 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 48.3 mm -117.56 123.92 72.37 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.81 118.02 7.34 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 108.006 -2.038 . . . . 0.0 108.006 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.4 tp -123.75 130.46 52.66 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.907 0.883 . . . . 0.0 108.759 -172.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.34 128.53 34.58 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 174.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 mp -133.98 159.46 72.3 Favored Pre-proline 0 C--O 1.234 0.253 0 C-N-CA 124.721 1.209 . . . . 0.0 108.875 172.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -58.41 -26.45 77.78 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.13 1.887 . . . . 0.0 113.464 170.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -65.28 -9.43 24.07 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.389 1.075 . . . . 0.0 113.198 173.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.43 157.1 18.84 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 108.025 -2.03 . . . . 0.0 108.025 -169.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.8 m -67.48 130.94 44.64 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 49.5 mtm -142.54 145.05 33.23 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -177.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.53 123.52 25.62 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 170.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -95.64 135.97 36.63 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 169.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.0 m -89.05 144.03 26.44 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 70.5 t -76.57 119.26 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 169.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -106.7 169.85 15.6 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 169.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -138.2 141.55 40.02 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 169.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 19.0 mt -132.35 152.95 51.2 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 169.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.07 135.14 57.07 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.52 3.72 72.75 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 118.816 -0.991 . . . . 0.0 113.467 -175.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.91 -33.47 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 119.18 1.49 . . . . 0.0 109.933 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.1 m 59.66 -156.01 0.35 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -169.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -58.71 136.29 57.66 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.37 0.532 . . . . 0.0 110.327 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -148.76 166.59 27.97 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.838 1.655 . . . . 0.0 107.448 170.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.4 mp -102.76 143.67 32.1 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.3 p -146.31 160.2 42.34 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.778 0.831 . . . . 0.0 110.645 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 30.8 t -147.78 128.84 14.55 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 171.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.5 m -66.9 134.78 52.73 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.3 mt -105.94 -59.68 1.74 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.986 0.914 . . . . 0.0 108.701 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -142.03 166.84 23.61 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.751 1.22 . . . . 0.0 108.878 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 28.6 m -121.68 65.28 17.85 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.346 1.058 . . . . 0.0 109.906 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -60.75 132.97 45.37 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.459 2.106 . . . . 0.0 110.442 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 40.0 tp -156.48 81.94 0.97 Allowed 'General case' 0 C--O 1.236 0.363 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 172.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.7 m -141.95 148.2 38.26 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 124.32 1.048 . . . . 0.0 108.218 -170.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -81.31 -15.94 53.93 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.135 -0.978 . . . . 0.0 112.427 -178.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.9 m -72.16 -11.11 60.59 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.664 0.786 . . . . 0.0 111.867 170.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.55 141.11 58.89 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.616 1.567 . . . . 0.0 108.688 176.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 90.4 p -156.74 174.57 15.28 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.529 0.732 . . . . 0.0 110.075 -173.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -57.78 -22.5 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.157 0.983 . . . . 0.0 111.793 168.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -85.26 -45.6 11.81 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.328 1.051 . . . . 0.0 109.507 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -63.13 -32.05 73.33 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.277 0.49 . . . . 0.0 110.039 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.403 ' HA2' HG21 ' A' ' 57' ' ' ILE . . . -60.51 -54.76 34.46 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 175.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -65.28 -47.78 75.48 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 117.298 0.549 . . . . 0.0 110.08 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 83.9 mtm-85 -65.33 -46.7 79.23 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 118.852 -0.594 . . . . 0.0 111.398 -175.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.1 tp -76.82 -28.87 55.72 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 118.058 -0.973 . . . . 0.0 111.697 -171.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.8 m -71.64 -36.98 70.88 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.977 1.262 . . . . 0.0 109.546 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -70.37 -41.25 73.34 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.359 0.663 . . . . 0.0 111.529 174.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -65.24 -31.07 72.04 Favored 'General case' 0 CA--C 1.53 0.212 0 O-C-N 121.114 -0.991 . . . . 0.0 110.52 173.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 34.1 m -69.94 -40.06 75.7 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 121.922 -0.486 . . . . 0.0 110.227 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.17 -50.87 72.01 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.718 0.407 . . . . 0.0 110.074 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -55.26 -55.78 27.51 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 123.902 0.881 . . . . 0.0 110.057 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 16.3 ptt? -59.42 -39.4 83.38 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 117.992 -1.004 . . . . 0.0 111.038 -172.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . 0.274 6.6 pt -79.83 -21.69 12.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 119.761 1.164 . . . . 0.0 112.248 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 30.8 mt -74.08 -27.2 60.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.914 0.779 . . . . 0.0 108.951 168.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.2 m 55.6 20.67 3.98 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.446 1.898 . . . . 0.0 113.334 -175.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 99.5 mt -150.74 149.77 26.52 Favored Pre-proline 0 C--O 1.236 0.389 0 C-N-CA 128.455 2.702 . . . . 0.0 107.525 -173.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -63.35 160.1 36.8 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.688 2.259 . . . . 0.0 110.452 169.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 23.3 m -76.12 173.7 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 123.258 0.623 . . . . 0.0 110.463 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 8.1 m -50.19 139.36 14.74 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.678 1.591 . . . . 0.0 111.355 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -126.67 119.26 22.8 Favored Pre-proline 0 C--O 1.237 0.407 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 170.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -73.19 163.58 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.499 2.133 . . . . 0.0 111.736 -176.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -139.75 131.5 27.43 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.532 1.533 . . . . 0.0 107.89 171.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.7 t -145.78 147.81 33.97 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -173.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.51 161.19 15.03 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.055 2.503 . . . . 0.0 111.757 169.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 66.6 t-80 -60.89 138.86 58.12 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.37 171.35 12.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.699 0.799 . . . . 0.0 110.87 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -69.29 -13.77 68.01 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-O 119.329 -0.706 . . . . 0.0 113.722 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -132.51 160.38 36.68 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.879 1.671 . . . . 0.0 108.845 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -65.28 153.25 41.62 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 172.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.05 131.44 46.56 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.4 pp -151.76 164.98 35.83 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.46 1.104 . . . . 0.0 110.101 -173.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 47.7 tp -91.01 -25.07 19.87 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.504 0.722 . . . . 0.0 112.503 -171.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -73.58 158.8 34.13 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.29 0.636 . . . . 0.0 111.567 -173.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 72.77 12.43 78.33 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 123.637 0.637 . . . . 0.0 114.046 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -85.94 149.43 25.2 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 118.504 1.152 . . . . 0.0 108.31 174.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -108.41 4.19 24.1 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -173.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 13.2 m 53.83 40.81 31.96 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.746 1.218 . . . . 0.0 112.39 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -66.85 -16.66 66.39 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 123.524 0.583 . . . . 0.0 113.591 -174.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -81.01 -10.41 59.71 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.165 0.982 . . . . 0.0 111.763 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -70.16 149.17 47.82 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.688 0.676 . . . . 0.0 110.148 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.263 0 C-N-CA 123.576 0.75 . . . . 0.0 109.649 175.656 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.4 mtm . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.6 t -140.16 138.43 35.19 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 169.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -98.73 4.25 47.74 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -172.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 53.85 167.24 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 130.251 3.42 . . . . 0.0 116.511 169.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.2 mt -132.61 143.84 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.594 1.957 . . . . 0.0 105.786 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.76 147.06 41.64 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.801 0.728 . . . . 0.0 110.501 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.79 163.73 51.8 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.476 1.036 . . . . 0.0 111.439 170.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -126.52 142.01 51.68 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.042 1.337 . . . . 0.0 109.852 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -73.63 -19.77 60.77 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 122.951 0.501 . . . . 0.0 111.817 -173.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 p -146.82 154.08 40.93 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.85 1.66 . . . . 0.0 108.303 171.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -67.02 148.92 98.78 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 171.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.61 54.91 5.27 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 124.943 3.762 . . . . 0.0 111.002 175.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.3 tttm -53.83 -43.92 69.83 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.184 1.394 . . . . 0.0 111.993 -169.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.0 -40.77 97.12 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 118.43 0.559 . . . . 0.0 111.224 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -74.98 -35.44 62.05 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.101 -177.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.45 -45.77 96.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 170.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -60.29 -50.12 74.9 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.104 0.562 . . . . 0.0 110.144 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.76 -39.53 93.77 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.593 0.633 . . . . 0.0 111.352 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.46 -49.51 76.52 Favored 'General case' 0 C--N 1.337 0.065 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -71.49 -28.56 64.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 118.032 -0.985 . . . . 0.0 112.183 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -60.29 -40.59 90.99 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.85 1.204 . . . . 0.0 109.32 170.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -71.93 -46.41 57.67 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -175.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.2 mt -57.89 -45.8 87.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.0 -34.94 79.14 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.68 -0.638 . . . . 0.0 111.516 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -72.41 -36.02 68.53 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.96 0.904 . . . . 0.0 109.244 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -63.35 -42.01 98.88 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.297 1.039 . . . . 0.0 110.659 169.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 53.3 m -68.03 -50.34 55.94 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.261 0.937 . . . . 0.0 111.956 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.95 154.5 39.33 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.251 0.62 . . . . 0.0 110.485 -178.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -148.54 153.48 38.46 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.163 0.985 . . . . 0.0 109.114 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.9 t70 63.55 -50.57 0.24 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 128.495 2.718 . . . . 0.0 115.378 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -81.39 -7.23 59.54 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.977 0.808 . . . . 0.0 112.917 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.5 m -69.24 142.96 54.06 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.123 0.969 . . . . 0.0 110.092 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -116.21 57.06 0.77 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.595 1.158 . . . . 0.0 107.97 175.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 98.0 mt 55.89 15.73 1.82 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.671 1.988 . . . . 0.0 112.472 -169.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -153.86 153.01 28.09 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 128.715 2.806 . . . . 0.0 105.365 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.93 166.25 12.65 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.403 2.069 . . . . 0.0 113.068 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 p -61.69 -32.78 72.99 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.135 1.374 . . . . 0.0 112.898 -174.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 62.0 mtt -136.17 147.72 61.64 Favored Pre-proline 0 C--O 1.235 0.336 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.443 ' CD ' HG23 ' A' ' 120' ' ' ILE . 73.5 Cg_endo -67.16 135.22 36.45 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.082 1.855 . . . . 0.0 110.332 -170.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.406 HG13 HG22 ' A' ' 58' ' ' THR . 34.8 t -71.02 130.03 34.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 169.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -138.8 150.16 45.76 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.166 0.986 . . . . 0.0 108.801 -169.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.2 t -141.55 124.08 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -172.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.8 m -91.55 134.75 34.4 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 168.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -121.7 135.61 54.95 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.854 1.262 . . . . 0.0 107.885 169.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.448 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 25.8 p90 -167.66 142.21 3.69 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -169.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m 58.46 158.33 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.935 2.494 . . . . 0.0 115.735 167.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.1 tp -111.19 66.04 0.62 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 169.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -57.11 -33.67 67.57 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 -165.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -136.42 26.65 3.14 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.226 0.61 . . . . 0.0 111.255 175.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.13 15.91 60.09 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 119.378 -0.679 . . . . 0.0 112.302 -169.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -136.94 143.92 43.14 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 174.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -69.22 143.56 53.94 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.448 ' HB ' ' CE2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -107.48 155.1 20.43 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -177.11 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.9 163.41 36.37 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 67.2 m -140.73 146.96 38.43 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 p -124.95 144.19 35.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 175.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.7 tt -126.76 150.18 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 169.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.406 HG22 HG13 ' A' ' 40' ' ' VAL . 30.5 p -140.87 178.03 1.73 Allowed Pre-proline 0 N--CA 1.442 -0.87 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 173.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -61.82 -28.6 81.79 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 CA-C-N 119.286 0.781 . . . . 0.0 110.941 168.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.5 p-90 -95.4 -25.36 16.3 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -170.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.19 170.77 21.73 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.623 1.556 . . . . 0.0 113.416 -175.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 tt -136.04 125.46 24.99 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 103.07 -2.937 . . . . 0.0 103.07 167.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.2 m -137.05 133.94 36.0 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 122.991 0.517 . . . . 0.0 109.992 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.37 145.15 41.89 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 168.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.2 m -138.09 146.83 26.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.7 mt -137.94 135.45 45.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -174.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -122.99 150.43 59.21 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.435 1.094 . . . . 0.0 110.872 -169.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -44.38 152.51 0.43 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 124.736 3.624 . . . . 0.0 114.962 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.41 175.21 15.89 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 123.898 0.761 . . . . 0.0 113.697 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.82 -49.03 10.9 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.578 2.852 . . . . 0.0 114.305 -169.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -161.42 89.57 0.77 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.314 1.445 . . . . 0.0 107.231 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -155.79 -178.01 6.98 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.727 1.611 . . . . 0.0 106.688 178.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -95.7 136.71 35.76 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 168.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -107.97 144.04 28.56 Favored Pre-proline 0 C--N 1.324 -0.513 0 C-N-CA 126.656 1.983 . . . . 0.0 107.207 173.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.2 136.61 44.7 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.015 1.81 . . . . 0.0 110.606 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 64.1 tp -77.54 130.31 36.78 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 169.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.37 158.37 44.42 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 119.175 0.898 . . . . 0.0 109.956 -174.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -73.45 150.93 41.31 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.6 t -91.05 155.92 3.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -170.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.0 m 61.44 33.2 18.75 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.83 0.852 . . . . 0.0 111.658 -175.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -111.76 151.19 29.26 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 126.804 2.041 . . . . 0.0 106.983 169.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -105.26 142.37 35.15 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.092 0.86 . . . . 0.0 111.031 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.2 mm -118.86 130.04 74.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 174.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.21 123.2 6.77 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.9 mt -112.94 140.79 47.45 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.25 127.7 35.79 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 171.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mp -134.95 158.43 74.94 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 124.812 1.245 . . . . 0.0 107.774 174.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -60.81 -23.58 76.96 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.141 1.894 . . . . 0.0 113.98 172.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -64.2 -17.02 63.14 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.996 1.318 . . . . 0.0 111.949 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.94 152.12 9.12 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 107.881 -2.088 . . . . 0.0 107.881 -169.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.5 m -64.63 131.96 48.42 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 38.8 ttp -149.01 138.01 21.4 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -170.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.94 134.66 37.83 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -111.09 137.99 48.07 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 169.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.1 m -85.89 138.21 32.19 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 72.2 t -70.14 117.07 12.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 169.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -104.98 157.94 16.33 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 108.044 -2.022 . . . . 0.0 108.044 171.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -127.49 81.66 2.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 171.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.6 tp -66.1 128.89 37.88 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -169.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.66 131.38 50.52 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 122.832 0.453 . . . . 0.0 110.724 -172.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.36 4.92 75.71 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-O 118.607 -1.107 . . . . 0.0 113.576 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.2 t -122.39 -121.87 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.5 m -151.12 175.97 11.62 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.277 1.431 . . . . 0.0 109.544 -169.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -69.56 141.78 53.73 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 169.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -157.08 -179.15 7.93 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.308 1.443 . . . . 0.0 108.532 178.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 13.6 mt -113.78 136.66 52.61 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.2 p -139.75 153.59 47.22 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.793 0.837 . . . . 0.0 110.672 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 43.8 t -141.26 116.11 9.76 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 173.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.3 m -75.92 135.75 40.09 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 175.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 69.6 mt -116.7 -42.64 2.96 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.92 0.488 . . . . 0.0 112.276 -169.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 20.0 ptp -159.03 164.91 35.05 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.639 0.775 . . . . 0.0 109.746 -176.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.3 m -113.32 93.78 28.16 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 170.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -82.77 37.03 0.64 Allowed 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 124.128 3.219 . . . . 0.0 112.553 -169.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 34.7 tp -80.46 71.06 7.27 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.917 -1.115 . . . . 0.0 108.18 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.5 m -138.57 162.48 34.46 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.34 1.456 . . . . 0.0 111.077 -169.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -76.02 -18.33 59.3 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.802 -0.561 . . . . 0.0 111.038 171.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 m -76.63 15.68 0.6 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.225 1.41 . . . . 0.0 112.159 170.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 10.1 tpt -130.34 148.52 52.17 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.272 2.229 . . . . 0.0 106.84 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.6 p -160.92 -179.97 7.99 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.368 1.467 . . . . 0.0 108.534 -172.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.479 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -56.25 -41.01 68.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 123.679 0.791 . . . . 0.0 109.293 169.717 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -71.31 -44.27 65.47 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.097 0.559 . . . . 0.0 109.629 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -68.24 -22.33 64.78 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.645 -0.66 . . . . 0.0 110.998 175.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.29 -48.77 81.56 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 169.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -68.97 -54.05 17.39 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.71 -0.877 . . . . 0.0 110.584 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -65.5 -42.18 92.39 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 118.588 -0.72 . . . . 0.0 112.028 -169.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.9 tp -76.6 -27.15 55.66 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 119.896 1.225 . . . . 0.0 111.246 -171.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.2 m -71.45 -38.05 71.34 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.008 1.276 . . . . 0.0 109.232 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.85 -41.12 78.91 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.897 -0.502 . . . . 0.0 111.637 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -65.21 -34.97 79.63 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 121.022 -1.049 . . . . 0.0 110.325 173.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 18.0 t -67.71 -34.0 76.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.424 ' HB2' ' CE1' ' A' ' 45' ' ' PHE . . . -66.3 -51.73 54.46 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.363 0.665 . . . . 0.0 109.678 170.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 35.6 tpt85 -52.9 -50.08 64.63 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.55 0.74 . . . . 0.0 110.542 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 13.7 ptt? -59.53 -26.55 65.43 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 118.989 0.813 . . . . 0.0 112.306 -172.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 24.3 pt -96.16 5.49 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-N 119.166 0.894 . . . . 0.0 111.898 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.1 mt -115.73 31.39 6.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.951 1.7 . . . . 0.0 112.078 -174.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.6 m -78.29 64.11 3.34 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.734 -1.228 . . . . 0.0 110.809 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.6 mp 64.6 77.26 0.3 Allowed Pre-proline 0 N--CA 1.47 0.544 0 C-N-CA 127.933 2.493 . . . . 0.0 109.634 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -74.37 167.06 28.03 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.346 2.697 . . . . 0.0 111.968 -175.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.5 m -68.97 -29.75 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 122.961 0.504 . . . . 0.0 112.29 -169.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 11.2 m -114.59 56.64 0.72 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.969 1.308 . . . . 0.0 107.774 174.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -62.43 121.45 67.08 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 169.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -61.65 135.83 59.0 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.975 1.783 . . . . 0.0 112.974 -169.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -159.06 148.3 18.66 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.4 1.88 . . . . 0.0 107.731 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.44 149.31 26.12 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.825 0.85 . . . . 0.0 109.285 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -58.04 177.95 0.24 Allowed 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 124.301 3.334 . . . . 0.0 111.858 168.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -61.67 121.24 12.31 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 169.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.42 168.99 19.08 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.208 0.603 . . . . 0.0 110.5 -176.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -168.69 177.52 42.56 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.589 1.09 . . . . 0.0 110.398 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -68.68 151.91 46.05 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.216 0.606 . . . . 0.0 110.023 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -123.07 47.17 2.02 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.016 1.326 . . . . 0.0 108.666 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.07 126.05 26.84 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 174.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 86.0 mt -145.29 159.47 42.98 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.757 1.623 . . . . 0.0 108.309 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 64.3 tp -66.45 123.43 20.0 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -75.82 150.2 37.74 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.085 0.554 . . . . 0.0 110.083 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -175.78 154.15 16.67 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 173.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -145.66 97.53 2.99 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 72.6 ttp85 -65.76 -40.49 92.09 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 119.103 -0.475 . . . . 0.0 111.152 -169.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.5 m -85.93 147.16 26.38 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.223 0.609 . . . . 0.0 109.804 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 73.49 -83.21 0.67 Allowed Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.238 0.923 . . . . 0.0 111.421 174.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -68.39 -32.64 72.85 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.629 1.172 . . . . 0.0 110.818 -177.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 53.22 43.17 31.89 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.426 1.49 . . . . 0.0 111.996 -174.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.249 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 169.87 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.3 tpp . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.5 p -134.93 150.11 50.35 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.283 1.433 . . . . 0.0 108.63 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -87.88 42.82 1.07 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.352 1.061 . . . . 0.0 109.632 -177.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -142.25 157.82 44.42 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.385 1.474 . . . . 0.0 110.198 -170.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.0 mm -128.56 125.9 64.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 172.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -72.7 128.59 35.99 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 173.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.46 153.51 52.91 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -84.08 136.07 34.16 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.136 0.974 . . . . 0.0 109.74 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -72.26 -33.03 67.18 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.806 -0.616 . . . . 0.0 110.075 173.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.8 p -150.72 155.32 39.06 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.427 1.891 . . . . 0.0 108.543 169.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.6 m -53.26 138.59 47.77 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 125.573 1.549 . . . . 0.0 113.703 -170.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -81.89 44.65 1.76 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 124.909 3.739 . . . . 0.0 110.88 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -61.63 -35.04 76.77 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.212 -1.555 . . . . 0.0 112.688 -168.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.58 -42.38 95.65 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 123.155 0.582 . . . . 0.0 110.983 176.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -68.45 -41.65 79.96 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.336 0.654 . . . . 0.0 109.343 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.6 t -59.44 -46.48 92.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 173.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -60.69 -53.4 57.93 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.284 0.634 . . . . 0.0 110.452 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.73 -44.75 95.39 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.941 0.496 . . . . 0.0 110.832 -172.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.58 -47.27 86.92 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -67.87 -26.26 65.93 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 118.37 -0.824 . . . . 0.0 112.31 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -63.76 -34.5 78.04 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.851 1.205 . . . . 0.0 110.051 176.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -70.91 -50.12 38.32 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.808 0.731 . . . . 0.0 109.34 174.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.8 mt -65.69 -39.67 85.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 123.988 0.915 . . . . 0.0 110.594 -169.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.3 -26.37 65.61 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.082 0.553 . . . . 0.0 111.51 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -85.25 -100.3 0.06 Allowed 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 172.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 48.36 27.05 1.26 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.569 1.548 . . . . 0.0 114.273 -173.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.9 p -131.39 9.62 4.75 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.086 1.754 . . . . 0.0 111.466 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -83.93 144.76 28.97 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.534 0.734 . . . . 0.0 110.443 -173.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -113.28 -28.87 7.44 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.137 0.975 . . . . 0.0 111.566 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -126.15 136.6 53.07 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 169.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.6 mt -73.88 -0.83 17.2 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -169.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.3 m -65.83 -26.02 67.48 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.786 0.721 . . . . 0.0 110.5 169.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -95.34 32.16 1.81 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.545 1.138 . . . . 0.0 110.891 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.06 -30.66 69.35 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.236 1.014 . . . . 0.0 112.393 -177.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -68.81 134.3 90.17 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.466 1.106 . . . . 0.0 111.496 -173.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -62.46 155.12 59.79 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.006 2.471 . . . . 0.0 110.607 169.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.3 m -78.58 -12.3 60.01 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -172.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.6 mmt -141.28 159.21 61.99 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 127.291 2.236 . . . . 0.0 105.854 173.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -65.48 137.18 49.71 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.936 1.757 . . . . 0.0 114.204 -169.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.9 t -108.3 112.02 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 167.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -148.86 151.77 35.3 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.645 0.778 . . . . 0.0 109.65 -169.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.2 t -137.67 116.24 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 123.669 0.788 . . . . 0.0 109.187 -173.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.0 m -80.62 157.3 26.03 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.913 0.885 . . . . 0.0 110.318 169.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.88 140.5 52.92 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.76 2.024 . . . . 0.0 109.498 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.478 ' CE2' ' CB ' ' A' ' 131' ' ' ALA . 60.1 m-85 -147.06 169.7 18.7 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -169.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.8 t -52.03 167.45 0.12 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 129.132 2.973 . . . . 0.0 114.505 -169.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.9 tp -77.99 125.5 29.44 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 174.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.89 135.7 33.15 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.18 1.792 . . . . 0.0 107.299 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 55.38 24.16 6.37 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.864 0.866 . . . . 0.0 111.992 -170.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.23 5.88 78.12 Favored Glycine 0 CA--C 1.534 1.233 0 O-C-N 121.026 -1.046 . . . . 0.0 113.817 -174.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -119.14 157.22 28.34 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.191 1.796 . . . . 0.0 108.952 -175.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -79.3 147.76 32.36 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.311 -1.493 . . . . 0.0 110.091 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.58 162.82 12.94 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 122.506 1.146 . . . . 0.0 109.885 169.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.14 172.13 39.88 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 107.49 -2.244 . . . . 0.0 107.49 169.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 11.6 m -138.93 152.4 47.69 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 105.591 -2.004 . . . . 0.0 105.591 169.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.71 138.86 52.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 175.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.441 HD13 ' HA2' ' A' ' 123' ' ' GLY . 13.6 tt -116.1 146.22 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 167.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.4 t -154.8 157.11 31.97 Favored Pre-proline 0 N--CA 1.442 -0.863 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 175.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -50.23 -29.7 23.69 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.934 2.422 . . . . 0.0 113.646 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -93.14 -19.88 21.04 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -174.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -166.69 159.45 13.99 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.911 1.687 . . . . 0.0 112.66 -175.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.4 tt -124.57 124.88 43.19 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 103.848 -2.649 . . . . 0.0 103.848 167.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.8 m -137.65 134.46 35.49 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.35 0.595 . . . . 0.0 109.724 -172.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.84 144.2 52.65 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 167.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.7 m -136.11 150.44 28.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 32.1 mt -135.92 143.4 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -123.89 139.43 32.41 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -53.98 132.16 48.41 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.868 1.712 . . . . 0.0 108.928 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.4 -175.91 31.27 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.292 0.948 . . . . 0.0 114.68 -169.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -71.17 153.79 62.17 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.203 2.602 . . . . 0.0 110.204 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.0 t0 46.67 44.59 13.88 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.067 1.747 . . . . 0.0 113.068 172.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -133.62 143.52 48.67 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.103 1.361 . . . . 0.0 107.842 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -112.19 95.94 5.75 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 172.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -65.63 155.64 85.2 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.443 171.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -68.35 164.46 32.44 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.629 2.22 . . . . 0.0 109.909 169.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.25 87.68 1.12 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 169.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -70.82 148.98 47.29 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -89.9 159.04 17.15 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 169.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.8 t -91.37 154.22 3.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 114.048 -1.433 . . . . 0.0 107.647 -169.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.8 m 66.26 6.19 4.1 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.433 1.493 . . . . 0.0 113.673 -175.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -80.06 158.63 26.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.988 1.315 . . . . 0.0 108.268 169.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -113.97 144.22 43.44 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.966 0.803 . . . . 0.0 110.847 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.4 mm -118.21 121.09 66.36 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 176.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.11 125.33 7.74 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 173.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.3 mt -123.27 141.17 52.27 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.317 1.047 . . . . 0.0 109.084 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -90.53 133.65 34.92 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 172.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -153.49 157.51 32.76 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 124.958 1.303 . . . . 0.0 107.895 172.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -61.04 -20.26 66.84 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.059 2.506 . . . . 0.0 114.705 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -62.51 -20.65 64.83 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.944 0.898 . . . . 0.0 112.067 172.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.54 145.71 7.04 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 -170.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.9 m -60.64 131.07 49.56 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 174.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 47.6 ttp -149.67 146.21 27.14 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -169.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.55 134.02 34.42 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 121.883 -0.511 . . . . 0.0 110.493 176.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -104.98 132.25 51.46 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 168.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.2 m -82.01 144.11 31.1 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.0 t -75.96 114.39 16.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -98.1 162.75 21.02 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 171.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -129.9 133.86 47.13 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 169.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.6 tp -143.84 145.97 32.71 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -176.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -59.5 134.88 57.42 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.789 0.435 . . . . 0.0 110.572 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.17 4.45 59.71 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 118.945 -0.919 . . . . 0.0 113.701 -177.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.4 t -124.7 -33.15 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 118.928 1.364 . . . . 0.0 109.746 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.7 m 57.39 -150.09 0.45 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.331 1.053 . . . . 0.0 108.445 -169.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -58.61 132.15 52.94 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.884 0.874 . . . . 0.0 110.579 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -154.5 179.41 9.05 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.365 1.866 . . . . 0.0 107.011 169.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.6 mp -113.47 144.36 42.95 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 121.131 -0.981 . . . . 0.0 109.217 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.8 p -142.86 154.58 44.28 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.571 1.148 . . . . 0.0 110.278 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 12.2 t -144.75 111.87 5.96 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 170.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.9 m -67.98 130.17 42.14 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.7 mt -96.38 -59.34 1.85 Allowed 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -176.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.87 170.28 12.4 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.342 1.457 . . . . 0.0 108.377 177.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.9 m -86.71 132.08 43.47 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 170.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -68.67 164.65 32.34 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.11 1.873 . . . . 0.0 110.043 169.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 56.8 tp -133.64 141.61 47.7 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.251 1.02 . . . . 0.0 109.313 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.9 m -62.44 -17.7 60.0 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.924 1.29 . . . . 0.0 113.639 -172.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -60.17 115.12 3.26 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.785 0.834 . . . . 0.0 110.059 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.4 m 54.6 20.73 3.03 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.679 1.592 . . . . 0.0 114.04 -176.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.0 mmm -76.43 154.15 35.05 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.361 -0.837 . . . . 0.0 110.238 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 78.7 p -159.0 177.07 11.53 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.377 1.471 . . . . 0.0 108.021 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.575 ' H ' HD12 ' A' ' 120' ' ' ILE . 1.9 mp -58.34 -36.87 60.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 169.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -72.59 -44.99 61.29 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.572 0.749 . . . . 0.0 109.959 -174.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -64.23 -31.92 73.31 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.646 172.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.441 ' HA2' HD13 ' A' ' 57' ' ' ILE . . . -56.07 -58.39 14.42 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-N 119.455 1.025 . . . . 0.0 111.533 169.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -63.82 -48.55 76.4 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.043 0.922 . . . . 0.0 110.478 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -57.41 -45.44 84.59 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.935 1.294 . . . . 0.0 110.699 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.6 tp -78.35 -27.87 47.07 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.201 -174.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.9 m -65.83 -44.84 84.35 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.724 1.147 . . . . 0.0 109.173 173.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -65.68 -46.42 79.11 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.45 0.7 . . . . 0.0 111.299 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.04 -33.29 75.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.813 0.445 . . . . 0.0 110.548 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 19.0 m -68.22 -39.64 82.29 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.23 0.468 . . . . 0.0 110.797 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.478 ' CB ' ' CE2' ' A' ' 45' ' ' PHE . . . -65.23 -50.69 64.88 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 171.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -52.9 -51.36 61.52 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.065 0.848 . . . . 0.0 110.737 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 58.2 ttp -43.13 -48.23 6.27 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.152 2.181 . . . . 0.0 112.476 173.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 11.0 pt -92.78 -15.37 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 118.767 0.712 . . . . 0.0 112.513 -174.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 18.6 mt -81.94 -73.38 0.39 Allowed 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.384 1.074 . . . . 0.0 110.548 -175.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.6 m -147.57 30.26 0.91 Allowed 'General case' 0 C--O 1.234 0.255 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -168.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 12.6 tp -48.92 124.71 13.02 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 123.743 0.817 . . . . 0.0 111.088 176.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.91 167.22 22.42 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.848 2.365 . . . . 0.0 112.179 -172.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 44.5 t -127.31 145.25 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 169.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 9.4 m -60.67 133.77 56.43 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.261 0.624 . . . . 0.0 110.39 -174.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -146.27 115.74 4.65 Favored Pre-proline 0 C--O 1.236 0.38 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 169.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.13 132.55 18.23 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.836 1.691 . . . . 0.0 109.796 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -156.01 151.36 26.8 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 126.114 1.766 . . . . 0.0 108.652 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.3 p -145.56 142.73 18.45 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 124.35 1.06 . . . . 0.0 108.596 176.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -68.17 -175.68 0.88 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.87 3.047 . . . . 0.0 110.988 170.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -57.18 123.21 14.52 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 169.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -81.21 125.54 30.42 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 71.35 176.8 25.14 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 121.725 0.625 . . . . 0.0 112.029 -173.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -71.24 162.57 29.21 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.401 0.68 . . . . 0.0 110.171 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -57.17 143.95 36.96 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 171.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.83 108.45 2.54 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 170.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 59.4 tp -156.85 141.5 16.84 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.859 1.264 . . . . 0.0 108.053 -169.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 58.8 tp -149.56 147.5 28.23 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.268 1.027 . . . . 0.0 108.871 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -129.42 159.25 36.81 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.358 1.463 . . . . 0.0 108.687 173.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -175.63 -173.37 41.29 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -71.41 -21.54 61.98 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.313 0.645 . . . . 0.0 112.141 -175.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 53.11 52.11 14.37 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.562 1.145 . . . . 0.0 109.422 -174.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.3 m -57.53 140.76 49.94 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.218 1.007 . . . . 0.0 110.493 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 79.48 112.13 0.24 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.581 1.086 . . . . 0.0 110.619 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 50.43 52.41 14.86 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.284 1.433 . . . . 0.0 110.766 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -62.6 122.22 15.27 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.397 0 C-N-CA 126.541 1.937 . . . . 0.0 107.112 175.206 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 120.645 0.26 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.7 p -72.47 156.98 38.47 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.198 0.999 . . . . 0.0 110.249 174.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -87.68 54.03 2.98 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.131 0.973 . . . . 0.0 108.584 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -150.52 157.89 43.53 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.531 1.932 . . . . 0.0 109.042 -171.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.64 133.08 70.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 169.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -153.14 164.0 38.84 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.232 1.013 . . . . 0.0 110.207 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 134.78 -150.54 20.14 Favored Glycine 0 C--N 1.341 0.828 0 C-N-CA 125.035 1.302 . . . . 0.0 110.368 176.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -84.54 -27.26 27.46 Favored 'General case' 0 C--O 1.221 -0.447 0 C-N-CA 125.061 1.344 . . . . 0.0 107.463 169.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 58.9 16.32 4.49 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 167.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.3 p -52.28 145.38 11.04 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.336 1.054 . . . . 0.0 112.069 -177.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -48.12 126.22 11.68 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 126.04 1.736 . . . . 0.0 111.146 -175.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -73.45 53.21 2.58 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.906 3.071 . . . . 0.0 112.036 174.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.7 tttm -47.66 -48.76 28.78 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.44 1.896 . . . . 0.0 112.998 -169.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.64 -41.19 88.66 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.275 0.489 . . . . 0.0 111.69 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -71.87 -38.75 70.0 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.926 0.49 . . . . 0.0 109.795 -176.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 71.7 t -61.63 -44.16 98.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 172.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -60.31 -53.74 54.08 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.58 0.627 . . . . 0.0 110.078 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.93 -40.09 96.59 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.613 0.642 . . . . 0.0 111.194 -176.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.61 -46.9 86.15 Favored 'General case' 0 C--N 1.339 0.126 0 O-C-N 122.064 -0.398 . . . . 0.0 110.019 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -68.79 -25.15 64.56 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 118.419 -0.8 . . . . 0.0 112.379 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -67.08 -33.19 74.96 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 119.504 1.047 . . . . 0.0 109.803 173.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -77.58 -45.99 23.56 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.746 -0.596 . . . . 0.0 109.888 176.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.0 mt -60.43 -39.73 81.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.09 -34.46 77.65 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.362 -0.836 . . . . 0.0 111.549 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -71.73 -43.19 66.28 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.052 0.842 . . . . 0.0 109.059 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -58.81 -41.42 86.74 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.957 0.903 . . . . 0.0 111.152 175.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.2 m -67.55 -47.9 68.5 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.147 0.885 . . . . 0.0 110.553 176.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 56.6 mtm -92.18 44.35 1.16 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.643 1.177 . . . . 0.0 111.025 -175.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.0 p-80 -70.82 -3.31 18.3 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -172.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.36 -26.02 67.55 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.053 0.842 . . . . 0.0 110.43 169.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -81.96 9.23 8.65 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.038 1.335 . . . . 0.0 111.633 174.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.9 m 53.54 -133.11 1.84 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.934 1.294 . . . . 0.0 110.216 -176.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -81.02 -2.13 46.75 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.97 0.804 . . . . 0.0 113.099 -173.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.74 146.87 53.05 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.306 0.957 . . . . 0.0 110.161 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -70.06 160.79 79.19 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 123.733 0.813 . . . . 0.0 109.52 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -58.24 148.17 80.31 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.344 2.029 . . . . 0.0 112.7 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.9 m -65.17 -25.62 67.81 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.92 0.888 . . . . 0.0 112.49 -169.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 61.3 mtt -136.35 137.63 24.85 Favored Pre-proline 0 C--O 1.236 0.343 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 170.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -49.84 130.9 28.25 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.168 2.579 . . . . 0.0 112.827 175.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.2 m -67.06 152.92 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 168.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -140.53 155.56 46.59 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.453 1.024 . . . . 0.0 110.073 -175.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.4 t -139.54 114.28 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.2 m -78.86 142.0 37.2 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 168.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -125.37 134.74 52.07 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.401 1.48 . . . . 0.0 107.865 169.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.612 ' CE1' ' HB1' ' A' ' 131' ' ' ALA . 20.5 p90 -165.11 142.8 6.09 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -172.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.4 m 54.58 166.27 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.104 2.562 . . . . 0.0 116.312 167.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.0 tp -113.54 110.34 20.09 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 168.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -131.22 135.74 47.65 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.678 1.591 . . . . 0.0 107.089 -169.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 55.51 25.05 7.43 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 121.644 0.735 . . . . 0.0 110.51 -168.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.16 3.64 65.75 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 118.146 -1.363 . . . . 0.0 113.901 -174.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -115.34 154.86 28.39 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.599 1.699 . . . . 0.0 109.403 -173.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -74.59 137.66 42.47 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.683 -1.26 . . . . 0.0 108.997 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.79 155.97 18.19 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.667 1.122 . . . . 0.0 110.255 -173.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.15 171.58 41.25 Favored Glycine 0 CA--C 1.526 0.721 0 O-C-N 121.081 -1.012 . . . . 0.0 111.732 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 15.0 m -145.76 152.44 39.57 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 170.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.87 144.6 35.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 124.986 1.314 . . . . 0.0 107.466 173.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.9 tt -127.83 150.28 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 169.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.2 p -138.56 175.87 3.05 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 169.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -59.54 -30.42 92.4 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 CA-C-N 119.701 0.929 . . . . 0.0 110.835 168.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 48.4 p-90 -92.45 -25.59 18.38 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -171.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.51 170.45 21.93 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.42 1.464 . . . . 0.0 113.491 -175.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.6 tt -138.29 128.45 25.78 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 104.147 -2.538 . . . . 0.0 104.147 168.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.2 m -140.65 138.74 34.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.655 0.741 . . . . 0.0 109.622 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.63 146.58 51.57 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 168.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.0 m -138.84 144.85 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 C-N-CA 123.807 0.843 . . . . 0.0 108.786 175.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 52.2 mt -138.35 144.07 31.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -128.3 146.18 58.6 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-O 117.974 -1.012 . . . . 0.0 108.621 -175.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.64 134.65 21.83 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.469 2.779 . . . . 0.0 111.023 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.78 173.61 53.36 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 123.01 0.338 . . . . 0.0 112.878 -175.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -69.71 149.9 67.81 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 122.532 2.155 . . . . 0.0 110.296 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.0 t70 50.71 40.46 24.27 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.409 1.884 . . . . 0.0 112.696 169.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -128.27 131.12 48.74 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.3 mp -96.74 83.23 3.41 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 -175.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 3.7 m0 -66.33 140.4 96.73 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.645 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -66.86 161.68 41.12 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.842 1.695 . . . . 0.0 108.454 168.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.0 tp -67.38 106.44 2.09 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 169.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -73.77 155.13 39.19 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.335 0.588 . . . . 0.0 109.642 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -89.87 148.14 23.34 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 169.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.6 t -89.84 154.72 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -169.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.1 m 65.01 12.86 8.25 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.149 1.38 . . . . 0.0 113.713 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -85.96 158.97 19.76 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.114 1.365 . . . . 0.0 108.212 169.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -111.23 143.24 42.3 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 118.796 0.726 . . . . 0.0 110.504 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.9 mp -114.09 127.82 71.34 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 N-CA-C 104.775 -2.305 . . . . 0.0 104.775 170.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.51 121.09 5.54 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 170.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.8 mt -109.32 132.57 54.0 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 174.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -85.97 125.96 33.77 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 173.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 37.1 mt -133.6 148.52 68.97 Favored Pre-proline 0 C--O 1.233 0.224 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -59.12 -24.6 74.48 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.383 2.055 . . . . 0.0 112.802 169.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -58.05 -29.61 65.51 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.995 1.318 . . . . 0.0 112.158 169.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.32 142.15 4.84 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 -169.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.7 m -61.5 130.47 46.17 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 174.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 44.2 ttp -147.75 136.97 22.31 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -170.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.12 139.79 35.42 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.753 -0.592 . . . . 0.0 110.145 175.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -112.81 136.72 52.12 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 169.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.5 m -91.8 140.97 29.17 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.3 t -72.61 129.21 35.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -114.39 159.64 13.61 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 107.54 -2.224 . . . . 0.0 107.54 169.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -127.5 100.32 5.96 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 171.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.8 tp -79.11 121.79 25.43 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -171.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.09 129.98 44.07 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.042 0.537 . . . . 0.0 110.604 -172.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.88 5.81 70.98 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.669 -1.073 . . . . 0.0 113.632 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.9 t -124.75 -113.23 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 118.847 1.324 . . . . 0.0 107.611 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 11.8 m -152.98 174.45 14.13 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.793 1.237 . . . . 0.0 110.142 -169.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -75.49 145.78 41.13 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 169.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.16 167.52 30.16 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.501 1.52 . . . . 0.0 108.277 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.4 mp -110.51 137.85 47.67 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.9 m -136.84 152.13 49.91 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.586 0.754 . . . . 0.0 110.47 -174.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 43.0 t -144.81 124.11 13.02 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 169.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.0 m -65.09 143.49 57.87 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 176.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.6 mt -117.69 -47.9 2.6 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 118.576 -0.726 . . . . 0.0 111.131 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 19.0 ptp -160.07 165.19 32.29 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.036 0.835 . . . . 0.0 110.541 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.3 m -119.5 95.5 49.28 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 169.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -77.32 -71.29 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.266 1.977 . . . . 0.0 111.942 -169.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.8 tp 46.0 36.74 3.19 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.69 1.596 . . . . 0.0 112.111 -171.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.2 m -75.31 148.56 39.24 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.107 0.963 . . . . 0.0 109.965 -174.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -78.11 -23.15 47.98 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.529 -0.732 . . . . 0.0 111.311 174.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.3 m -77.69 -0.15 25.67 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.236 1.014 . . . . 0.0 112.221 173.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.7 tpt -60.75 142.05 56.31 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.398 1.079 . . . . 0.0 109.636 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.7 m -143.28 157.56 44.38 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 125.807 1.643 . . . . 0.0 107.15 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -63.68 -24.84 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 O-C-N 120.923 -1.111 . . . . 0.0 111.114 177.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -67.04 -37.44 84.1 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.569 -0.707 . . . . 0.0 110.05 173.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -69.74 -31.72 69.86 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 118.888 0.767 . . . . 0.0 109.728 170.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.33 -36.94 46.98 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 169.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -84.6 -52.38 6.15 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.23 -1.159 . . . . 0.0 110.821 173.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 60.1 ttp85 -65.58 -38.5 89.68 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -169.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.62 -31.24 46.93 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 119.677 1.126 . . . . 0.0 109.2 -173.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 m -67.43 -42.52 83.04 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 123.677 0.791 . . . . 0.0 109.061 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -66.75 -41.26 88.11 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.349 1.06 . . . . 0.0 111.828 173.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.97 -30.54 65.37 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 121.176 -0.952 . . . . 0.0 110.636 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 44.0 m -69.32 -43.02 74.6 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.974 0.51 . . . . 0.0 110.172 173.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.612 ' HB1' ' CE1' ' A' ' 45' ' ' PHE . . . -54.34 -49.76 68.98 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.217 1.007 . . . . 0.0 110.276 173.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.0 ttp-105 -68.49 -42.69 78.29 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.43 -0.794 . . . . 0.0 111.851 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 51.4 ttp -48.31 -56.4 8.17 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.312 1.045 . . . . 0.0 110.601 171.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.6 pt -78.36 -6.07 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 118.865 0.757 . . . . 0.0 112.961 -176.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 19.0 tp -74.9 -83.8 0.05 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 170.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.3 m -155.78 10.36 0.28 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.5 tp 41.97 52.01 6.44 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 124.728 1.211 . . . . 0.0 113.812 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -60.45 154.95 49.93 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.131 1.887 . . . . 0.0 111.349 172.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.9 t -133.79 140.19 47.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 172.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 7.0 m -64.77 132.57 49.94 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.346 0.658 . . . . 0.0 109.466 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -152.14 118.75 3.13 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 124.811 1.244 . . . . 0.0 108.042 174.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -60.03 140.09 90.91 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.429 2.086 . . . . 0.0 111.659 177.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -155.6 141.43 18.09 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.351 1.46 . . . . 0.0 108.694 175.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -149.8 137.79 11.89 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.568 1.147 . . . . 0.0 108.682 176.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -48.17 113.28 0.76 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 124.491 3.46 . . . . 0.0 112.905 174.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 23.6 t60 49.9 25.42 1.6 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.684 1.994 . . . . 0.0 113.556 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 48.01 32.74 3.02 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.202 1.401 . . . . 0.0 113.526 -170.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.54 136.14 33.85 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -138.61 150.87 46.73 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.803 1.641 . . . . 0.0 108.406 -176.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.21 -37.06 69.3 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 119.098 -0.477 . . . . 0.0 110.93 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . 48.87 39.17 13.69 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.283 1.433 . . . . 0.0 112.004 -175.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -76.76 167.55 21.64 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.738 0.815 . . . . 0.0 111.771 -177.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 66.3 tp -125.7 130.96 52.57 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -76.09 154.56 35.48 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 122.946 0.498 . . . . 0.0 110.577 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.51 177.74 43.16 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 123.887 0.756 . . . . 0.0 112.004 176.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -135.59 138.09 42.61 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.402 1.481 . . . . 0.0 108.358 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -79.4 -34.92 41.4 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 122.566 0.346 . . . . 0.0 110.207 177.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 11.6 m -73.69 127.72 33.56 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.154 0.582 . . . . 0.0 109.542 -172.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 173.36 146.3 5.44 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 107.538 -2.225 . . . . 0.0 107.538 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -87.66 154.87 20.25 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.354 0.661 . . . . 0.0 109.93 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -146.07 147.5 31.66 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.018 1.327 . . . . 0.0 108.789 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.348 0 C-N-CA 125.457 1.503 . . . . 0.0 107.992 177.424 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.4 tpt . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 p -78.05 -40.6 38.2 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.708 0.803 . . . . 0.0 110.976 -177.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 57.71 49.78 11.8 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.85 1.26 . . . . 0.0 110.125 -169.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -140.61 164.59 29.75 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.466 1.906 . . . . 0.0 109.088 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 71.2 mt -131.82 129.93 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 174.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.59 145.66 36.69 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.149 0.499 . . . . 0.0 110.49 -178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.17 151.18 51.66 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.911 1.243 . . . . 0.0 112.422 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -86.45 131.14 34.27 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 170.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -74.02 -32.7 63.48 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 171.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 p -149.73 148.22 28.97 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.489 1.916 . . . . 0.0 107.488 169.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.6 m -59.84 150.67 67.38 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 126.816 2.046 . . . . 0.0 114.13 -169.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -80.6 42.28 1.3 Allowed 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 124.306 3.337 . . . . 0.0 111.737 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 tttm -52.83 -46.91 67.97 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.853 1.261 . . . . 0.0 112.04 -169.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.57 -41.05 98.41 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 122.57 0.348 . . . . 0.0 111.407 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -72.28 -38.63 68.74 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -175.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 99.3 t -61.35 -44.08 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 172.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -62.17 -50.44 71.83 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 118.849 -0.596 . . . . 0.0 110.579 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.62 -39.13 93.17 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.765 0.711 . . . . 0.0 111.032 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.43 -50.33 74.02 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -68.36 -28.19 66.91 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 118.172 -0.918 . . . . 0.0 112.594 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.8 -33.88 76.66 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 120.028 1.285 . . . . 0.0 109.582 175.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -80.05 -43.27 22.16 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.289 0.495 . . . . 0.0 110.352 176.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.1 mt -65.22 -37.96 81.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.263 -0.898 . . . . 0.0 109.117 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.31 -32.69 74.25 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.467 0.707 . . . . 0.0 110.707 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -72.53 -41.8 65.46 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.841 0.856 . . . . 0.0 109.459 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -57.92 -39.03 77.0 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.332 1.053 . . . . 0.0 110.266 173.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.9 m -79.56 58.81 2.8 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.811 1.644 . . . . 0.0 110.522 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 55.5 mtt -61.66 108.8 1.05 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.774 0.83 . . . . 0.0 109.677 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -81.13 -20.1 42.12 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.034 0.533 . . . . 0.0 110.155 170.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -137.09 140.62 42.08 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 169.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -76.26 1.78 15.08 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.805 0.73 . . . . 0.0 112.805 -169.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.5 m -119.27 17.44 13.09 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.547 1.539 . . . . 0.0 110.769 169.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -61.16 -40.48 94.02 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.944 0.898 . . . . 0.0 110.933 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.2 mt 49.91 -135.4 1.32 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.499 1.519 . . . . 0.0 110.452 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -66.21 143.88 98.51 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 119.27 0.941 . . . . 0.0 109.862 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -56.43 129.64 35.84 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.452 2.101 . . . . 0.0 114.006 -169.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.0 m -82.14 -9.26 59.58 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.438 1.095 . . . . 0.0 112.407 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 7.9 mmt -135.23 156.49 78.05 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 126.426 1.89 . . . . 0.0 107.184 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -63.34 132.37 35.77 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.666 2.244 . . . . 0.0 115.769 -168.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.433 HG13 HG22 ' A' ' 58' ' ' THR . 39.6 t -111.63 107.9 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 101.128 -3.656 . . . . 0.0 101.128 167.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -140.85 159.17 42.78 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.946 0.898 . . . . 0.0 110.197 -169.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.3 t -138.16 112.21 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.7 m -76.17 147.82 38.2 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.487 1.04 . . . . 0.0 108.982 169.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -144.26 130.18 19.4 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.679 1.192 . . . . 0.0 111.622 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 176.59 159.35 0.33 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.017 1.327 . . . . 0.0 113.398 -172.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 m 61.64 152.86 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 128.473 2.709 . . . . 0.0 114.688 168.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.5 mt -103.62 125.55 50.21 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 169.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -135.34 138.45 43.4 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 173.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 54.18 26.31 6.57 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.971 0.908 . . . . 0.0 111.017 -169.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.54 7.14 82.68 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.927 1.251 . . . . 0.0 114.263 -176.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -119.17 148.68 42.82 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.236 1.518 . . . . 0.0 109.322 -173.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -66.72 145.3 55.68 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.235 0.925 . . . . 0.0 110.134 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.87 160.19 19.03 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.911 0.862 . . . . 0.0 110.173 -172.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -176.31 178.59 47.66 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 13.6 m -142.04 150.25 41.02 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 169.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.1 p -114.87 147.12 18.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 169.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.6 tt -130.08 151.34 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 169.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.433 HG22 HG13 ' A' ' 40' ' ' VAL . 44.5 p -142.41 172.06 6.35 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 169.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -73.89 21.06 0.38 Allowed 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 121.344 1.363 . . . . 0.0 112.063 169.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -138.13 -23.27 1.02 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.288 0.949 . . . . 0.0 113.403 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.18 164.71 37.57 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 120.363 1.438 . . . . 0.0 111.733 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 tt -137.61 125.87 23.18 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 168.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.3 m -138.18 134.18 34.21 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 123.332 0.395 . . . . 0.0 110.084 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.1 141.41 56.12 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 168.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 m -138.76 144.83 28.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 51.5 mt -141.33 134.35 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 -170.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -119.95 145.05 38.81 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.33 -172.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -44.68 125.8 6.62 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.738 2.959 . . . . 0.0 112.18 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.65 176.45 28.47 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 123.364 0.507 . . . . 0.0 113.193 -175.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -67.19 135.14 36.1 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.125 2.55 . . . . 0.0 110.411 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.7 t70 49.1 32.57 4.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.925 1.69 . . . . 0.0 113.259 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 -91.37 151.85 20.67 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 172.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -118.42 88.72 2.98 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 172.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 22.9 m0 -65.28 150.66 95.37 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 169.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.58 168.21 23.27 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.706 1.604 . . . . 0.0 108.375 169.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.8 tp -71.09 91.36 0.9 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 170.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -75.55 151.79 37.85 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.418 0.628 . . . . 0.0 109.679 -176.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -89.83 149.88 22.48 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 173.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.8 t -91.88 154.86 3.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 124.311 1.044 . . . . 0.0 108.281 -169.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.9 m 62.45 23.52 13.96 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.637 1.175 . . . . 0.0 112.667 -176.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -99.43 151.71 20.8 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.206 1.802 . . . . 0.0 107.648 169.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -106.2 143.63 34.06 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.503 0.592 . . . . 0.0 110.345 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 9.8 mt -123.92 128.41 74.18 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.85 123.14 6.89 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.8 mt -109.57 131.56 54.95 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 172.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.64 127.75 34.0 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 172.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.9 mt -135.2 153.62 78.33 Favored Pre-proline 0 C--O 1.234 0.275 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.79 -26.06 82.32 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.71 2.274 . . . . 0.0 112.759 174.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -65.37 -23.3 66.94 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.123 1.369 . . . . 0.0 111.911 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 129.69 147.15 6.2 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 126.176 1.846 . . . . 0.0 108.835 -169.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.7 m -62.78 133.86 55.39 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 55.7 ttm -144.47 136.09 25.72 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -169.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.42 130.11 35.11 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.521 -0.737 . . . . 0.0 109.169 173.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -106.06 136.48 45.65 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 169.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.8 m -87.58 137.88 31.96 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.1 t -71.02 114.81 9.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -101.47 163.31 17.74 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 169.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -130.58 97.8 4.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 170.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.5 tp -78.06 128.05 33.25 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -169.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -58.92 130.9 49.2 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.172 0.589 . . . . 0.0 110.52 -176.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.5 3.65 72.43 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.646 -1.086 . . . . 0.0 113.818 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.3 t -126.19 -121.0 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 119.143 1.471 . . . . 0.0 107.188 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.4 m -151.65 -176.79 5.76 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.776 1.63 . . . . 0.0 109.019 -169.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -72.91 148.62 44.17 Favored 'General case' 0 C--N 1.34 0.188 0 O-C-N 121.748 -0.595 . . . . 0.0 110.155 169.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -154.49 163.29 40.42 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.123 1.769 . . . . 0.0 108.03 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.4 mt -104.44 130.55 52.34 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.6 m -137.61 151.89 48.8 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.018 0.527 . . . . 0.0 110.884 -171.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 25.8 t -142.44 123.77 14.74 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 170.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.2 m -70.97 135.27 47.78 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 176.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.5 mt -110.48 -50.68 2.94 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.359 0.664 . . . . 0.0 111.165 -173.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 9.4 ptp -159.75 172.31 17.93 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.708 0.803 . . . . 0.0 109.982 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.9 m -119.74 80.5 24.42 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.044 0.938 . . . . 0.0 109.648 -177.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -62.67 161.26 29.08 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.48 2.12 . . . . 0.0 110.407 169.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 47.9 tp -137.66 154.83 49.65 Favored 'General case' 0 CA--C 1.526 0.052 0 C-N-CA 125.004 1.322 . . . . 0.0 107.67 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.6 m -48.49 -30.73 5.47 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.13 1.772 . . . . 0.0 114.589 -175.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -70.44 -28.5 65.07 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.441 0.564 . . . . 0.0 112.175 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.8 m -106.35 36.7 2.51 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.2 1.4 . . . . 0.0 109.605 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 65.0 mmm -133.99 155.5 49.86 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.668 1.187 . . . . 0.0 110.291 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.7 t -159.67 166.61 30.24 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 127.968 2.507 . . . . 0.0 104.632 170.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.565 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.6 OUTLIER -57.08 -36.59 51.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 119.09 0.859 . . . . 0.0 109.905 177.45 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -71.67 -32.41 67.84 Favored 'General case' 0 C--O 1.223 -0.308 0 O-C-N 121.652 -0.655 . . . . 0.0 110.462 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -73.73 -42.25 61.42 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.992 0.814 . . . . 0.0 109.372 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -49.01 -30.86 9.94 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 123.756 0.693 . . . . 0.0 113.882 169.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -90.33 -57.62 2.78 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.602 1.201 . . . . 0.0 111.481 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 71.8 ttt-85 -68.79 -32.58 72.41 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -168.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.6 mp -76.74 -38.34 54.37 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.757 1.162 . . . . 0.0 108.464 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.0 m -63.14 -43.58 97.93 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.3 1.04 . . . . 0.0 109.301 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.71 -55.0 39.81 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 118.657 -0.687 . . . . 0.0 110.801 171.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.27 -34.86 75.86 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.138 0.881 . . . . 0.0 111.408 -174.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 99.5 m -73.39 -27.14 61.3 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 122.11 -0.369 . . . . 0.0 111.854 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.52 -41.19 40.1 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.484 -0.76 . . . . 0.0 109.101 169.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -57.81 -55.34 36.11 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.262 1.425 . . . . 0.0 110.277 -173.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 17.3 ptt? -48.95 -34.09 12.21 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.655 1.582 . . . . 0.0 112.56 177.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 34.3 pt -93.53 2.5 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 119.863 1.21 . . . . 0.0 112.435 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 26.5 mt -124.34 -71.11 0.73 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.304 1.442 . . . . 0.0 112.844 -169.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.6 m -82.94 0.97 41.96 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -168.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 67.3 tp -66.31 115.47 24.08 Favored Pre-proline 0 N--CA 1.441 -0.899 0 C-N-CA 126.353 1.861 . . . . 0.0 106.319 169.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -71.23 155.01 61.49 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.131 1.888 . . . . 0.0 113.754 -169.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.3 p -149.86 151.77 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 126.445 1.898 . . . . 0.0 106.626 170.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.8 m -68.03 127.22 32.07 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -154.73 119.72 2.62 Favored Pre-proline 0 C--O 1.236 0.391 0 C-N-CA 124.776 1.23 . . . . 0.0 107.894 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -58.6 135.39 67.12 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.682 2.255 . . . . 0.0 111.302 176.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -73.96 -29.67 62.12 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 122.945 0.498 . . . . 0.0 112.009 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.6 m -110.37 149.14 39.77 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 125.401 1.48 . . . . 0.0 110.645 -174.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -76.66 -24.82 9.95 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.545 2.164 . . . . 0.0 112.194 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -146.39 148.46 32.35 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.112 1.765 . . . . 0.0 107.618 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.83 -19.11 61.38 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -173.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 69.86 -153.24 52.08 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 53.82 41.34 32.08 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.627 1.171 . . . . 0.0 112.254 170.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -69.32 -28.28 66.11 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 119.075 -0.488 . . . . 0.0 111.123 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . 51.95 40.46 28.22 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.406 1.482 . . . . 0.0 112.327 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.84 162.57 28.99 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.109 0.564 . . . . 0.0 110.413 174.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -137.12 155.4 49.66 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.791 1.236 . . . . 0.0 109.492 171.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -95.89 158.32 15.5 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.01 0.924 . . . . 0.0 110.269 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -72.9 174.15 46.82 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 170.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.33 132.93 16.78 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 175.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -80.09 130.1 34.99 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.2 m 59.41 -172.65 0.11 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.033 1.333 . . . . 0.0 112.433 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -174.68 173.6 46.2 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -72.19 142.19 49.04 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -147.53 157.2 43.46 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 125.121 1.368 . . . . 0.0 108.591 176.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.282 0 C-N-CA 123.463 0.705 . . . . 0.0 109.666 175.325 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 tmt? . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.3 m -139.66 146.98 40.37 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.86 162.6 39.68 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.099 1.36 . . . . 0.0 107.58 176.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 57.13 154.05 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 130.529 3.532 . . . . 0.0 116.403 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.0 mt -134.08 139.09 49.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 126.831 2.052 . . . . 0.0 106.19 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.28 150.61 45.02 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.931 -0.481 . . . . 0.0 111.307 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.24 163.1 42.63 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.301 0.953 . . . . 0.0 112.508 172.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -115.94 155.58 27.76 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.271 1.428 . . . . 0.0 109.736 175.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -88.63 -22.76 23.29 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.302 0.641 . . . . 0.0 111.659 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.3 p -159.2 -178.01 6.89 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 129.393 3.077 . . . . 0.0 106.323 172.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 m -57.19 134.99 80.92 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 121.247 -0.908 . . . . 0.0 109.534 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -74.19 63.48 5.23 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 124.537 3.491 . . . . 0.0 110.295 172.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -53.01 -50.74 63.6 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 124.266 1.026 . . . . 0.0 111.559 -169.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.32 -41.23 89.98 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 123.317 0.385 . . . . 0.0 110.708 -171.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -65.51 -45.91 81.7 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.595 0.758 . . . . 0.0 109.919 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 71.3 t -62.81 -41.12 91.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -62.98 -52.85 61.39 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.873 0.869 . . . . 0.0 109.996 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.77 -40.54 97.62 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.719 0.69 . . . . 0.0 110.648 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.04 71.56 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -68.06 -26.95 66.11 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 118.068 -0.968 . . . . 0.0 112.639 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -66.27 -31.1 71.71 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.826 1.194 . . . . 0.0 110.15 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -83.67 -41.63 17.53 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.243 0.617 . . . . 0.0 110.525 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.5 mt -65.52 -36.7 78.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 120.912 -1.117 . . . . 0.0 108.064 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.1 -27.78 68.61 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.228 -0.92 . . . . 0.0 112.244 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 62.9 ttp85 -76.41 -32.99 58.82 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.151 0.887 . . . . 0.0 109.665 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -71.91 -39.7 69.35 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.904 -0.569 . . . . 0.0 110.857 171.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 63.4 m -69.3 -44.59 71.45 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.673 0.789 . . . . 0.0 112.426 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.6 mmm -133.62 153.88 51.33 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.58 1.552 . . . . 0.0 109.344 -169.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -128.2 164.12 23.22 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.148 0.979 . . . . 0.0 109.557 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.1 t70 55.55 40.2 31.08 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.125 1.37 . . . . 0.0 112.697 178.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -122.17 19.64 10.69 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.14 1.376 . . . . 0.0 113.031 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.9 m 52.42 59.07 4.76 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.835 1.254 . . . . 0.0 111.57 177.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -57.99 -21.09 42.96 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -169.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 93.9 mt -70.03 -27.36 64.6 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.859 0.754 . . . . 0.0 111.768 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 67.0 t60 -148.93 80.93 7.83 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 173.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -58.19 146.32 89.08 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.044 2.496 . . . . 0.0 113.966 -169.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.1 m -70.75 -17.7 62.8 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.988 0.915 . . . . 0.0 113.026 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 68.4 mtt -131.42 149.49 73.73 Favored Pre-proline 0 N--CA 1.464 0.26 0 N-CA-C 105.769 -1.938 . . . . 0.0 105.769 170.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.22 138.59 33.58 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.179 1.253 . . . . 0.0 113.696 -169.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.3 t -99.49 106.98 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 1 N-CA-C 99.943 -4.095 . . . . 0.0 99.943 167.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -150.59 161.68 42.11 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.959 0.904 . . . . 0.0 109.944 -169.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 t -138.91 127.32 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.064 0.946 . . . . 0.0 108.748 -176.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.3 m -93.18 148.74 21.76 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.934 0.894 . . . . 0.0 109.039 168.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -121.9 141.28 51.45 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.361 1.865 . . . . 0.0 110.1 -176.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.419 ' CE2' ' CB ' ' A' ' 131' ' ' ALA . 91.1 m-85 -148.89 174.73 11.93 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.927 1.291 . . . . 0.0 113.053 -169.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.0 t -45.99 167.22 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 129.765 3.226 . . . . 0.0 115.121 -171.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.2 tp -84.76 107.1 16.77 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 105.69 -1.966 . . . . 0.0 105.69 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -76.64 -55.68 5.3 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 117.905 0.321 . . . . 0.0 111.578 -169.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.35 55.52 1.03 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.434 1.494 . . . . 0.0 109.347 177.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.83 10.25 79.34 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.075 -177.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -138.37 143.43 39.83 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.565 1.946 . . . . 0.0 107.362 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -74.79 152.08 39.04 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.679 0.672 . . . . 0.0 109.719 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.89 156.23 18.92 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.5 171.65 41.52 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.3 m -138.37 145.8 41.51 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 169.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 p -115.89 148.04 18.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 170.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.8 tt -129.73 152.11 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.885 1.274 . . . . 0.0 107.598 169.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.0 p -143.46 178.21 1.55 Allowed Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 125.337 1.455 . . . . 0.0 107.181 170.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.3 -24.57 77.84 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 121.331 1.354 . . . . 0.0 111.896 168.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.5 p-90 -104.3 -22.44 13.36 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -169.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.74 169.73 24.06 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 120.278 1.399 . . . . 0.0 112.608 -175.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.1 tt -138.29 126.4 22.82 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 103.946 -2.612 . . . . 0.0 103.946 168.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.6 m -138.89 134.69 33.6 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.16 147.48 46.57 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 168.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.4 m -139.04 148.41 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 124.574 1.15 . . . . 0.0 108.58 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 50.7 mt -138.57 137.85 42.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -126.31 148.33 63.36 Favored Pre-proline 0 N--CA 1.466 0.335 0 C-N-CA 124.042 0.937 . . . . 0.0 109.841 -173.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.4 133.86 31.32 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.709 2.273 . . . . 0.0 111.265 172.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.18 -171.35 16.47 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 123.756 0.693 . . . . 0.0 111.918 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.31 157.45 33.25 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.611 2.207 . . . . 0.0 111.297 -177.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.2 t0 43.76 56.33 4.62 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.747 2.019 . . . . 0.0 113.388 169.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -149.35 160.48 43.38 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.266 1.027 . . . . 0.0 109.315 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -111.7 105.69 14.27 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 169.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -70.67 143.45 89.8 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 172.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.16 150.25 85.12 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.049 1.833 . . . . 0.0 110.379 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.3 tp -76.12 92.9 3.26 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 170.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -79.36 171.49 15.1 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.032 0.933 . . . . 0.0 110.271 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -99.01 162.13 13.24 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 123.546 1.641 . . . . 0.0 107.481 168.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 87.9 t -89.84 154.27 3.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 113.044 -1.889 . . . . 0.0 107.112 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.9 m 67.11 5.82 4.38 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.058 1.343 . . . . 0.0 113.732 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -71.69 150.09 44.86 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 169.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -116.17 138.18 51.49 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.598 0.636 . . . . 0.0 110.032 177.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.6 mp -111.03 122.27 65.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 103.696 -2.705 . . . . 0.0 103.696 175.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.61 116.87 4.61 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 173.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.6 tp -106.72 132.36 52.79 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -87.53 127.58 35.25 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 172.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 mp -134.76 155.0 79.76 Favored Pre-proline 0 C--O 1.234 0.283 0 C-N-CA 125.426 1.49 . . . . 0.0 107.304 172.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -64.52 -23.93 63.95 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 CA-C-N 120.757 1.306 . . . . 0.0 112.402 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -55.25 -30.33 59.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.826 1.651 . . . . 0.0 111.763 169.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.06 148.32 5.54 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 108.116 -1.993 . . . . 0.0 108.116 -171.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.1 m -65.1 131.46 46.62 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 171.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 45.4 ttp -146.21 135.59 22.94 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -171.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.26 134.47 35.28 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 118.54 0.609 . . . . 0.0 110.021 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -103.48 134.13 47.35 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 168.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.6 m -94.9 141.49 28.58 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 92.5 t -74.16 123.83 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 171.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -113.0 156.74 15.41 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 169.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -115.08 98.53 6.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 169.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.1 tp -75.14 124.29 26.76 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -169.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -61.12 128.78 38.09 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.416 0.686 . . . . 0.0 110.219 -173.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.42 4.74 84.88 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.645 -1.086 . . . . 0.0 113.857 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.7 t -127.72 -118.99 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 119.069 1.435 . . . . 0.0 107.282 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.2 m -151.39 -179.57 7.49 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.174 1.79 . . . . 0.0 108.31 -169.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -70.66 146.14 50.16 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 121.671 -0.643 . . . . 0.0 109.691 169.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.82 167.64 26.87 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.671 1.588 . . . . 0.0 108.511 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.6 mt -103.43 138.63 39.89 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 174.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.5 p -154.93 160.59 41.26 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 119.298 0.954 . . . . 0.0 111.821 -177.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 9.5 p -149.17 135.63 19.36 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 168.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.2 p -74.17 145.63 44.07 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.457 0.703 . . . . 0.0 109.463 176.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.6 mt -116.36 -70.29 0.8 Allowed 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.768 0.827 . . . . 0.0 109.387 -173.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -148.53 161.16 42.21 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.077 0.951 . . . . 0.0 109.892 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.9 m -87.8 118.99 70.4 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 168.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -83.18 -9.13 10.64 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.642 2.228 . . . . 0.0 115.19 -169.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.285 2.3 pt? -74.41 30.61 0.08 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 116.045 1.869 . . . . 0.0 116.045 -169.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.8 m -61.73 155.05 23.81 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.79 0.836 . . . . 0.0 109.685 169.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -66.82 -23.73 66.08 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.353 -1.467 . . . . 0.0 112.86 -170.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.9 m -71.65 -8.94 57.2 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.031 0.932 . . . . 0.0 112.891 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.8 tpt -63.63 150.71 43.58 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.767 1.627 . . . . 0.0 111.258 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 96.6 p -153.88 176.38 12.23 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.987 1.715 . . . . 0.0 107.815 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.544 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -61.85 -32.07 52.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 O-C-N 121.186 -0.946 . . . . 0.0 110.222 170.041 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -75.35 -43.95 47.79 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.472 0.578 . . . . 0.0 109.664 -177.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -62.66 -31.58 72.48 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.32 170.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.88 -50.64 61.99 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 119.97 1.259 . . . . 0.0 111.158 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -62.43 -50.88 69.74 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.988 -0.713 . . . . 0.0 109.87 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 66.0 ttp85 -61.61 -38.63 88.34 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 123.465 0.706 . . . . 0.0 110.927 -175.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.5 tp -80.51 -24.33 39.45 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 117.817 -1.087 . . . . 0.0 111.248 -174.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.9 m -65.42 -44.18 88.2 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 120.463 1.483 . . . . 0.0 108.724 170.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.96 -53.84 47.83 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 118.761 -0.638 . . . . 0.0 109.939 174.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -61.49 -32.22 72.23 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.615 0.643 . . . . 0.0 111.129 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 57.3 m -73.26 -30.47 63.47 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.994 -0.441 . . . . 0.0 111.621 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.419 ' CB ' ' CE2' ' A' ' 45' ' ' PHE . . . -73.8 -49.13 26.78 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 119.231 0.923 . . . . 0.0 109.57 170.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -46.82 -58.22 4.12 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 127.465 2.306 . . . . 0.0 110.469 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 15.8 ptt? -51.84 -42.68 62.77 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.601 1.161 . . . . 0.0 112.25 178.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 22.8 pt -84.24 -25.93 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 119.693 1.133 . . . . 0.0 111.789 -175.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 72.7 mt -69.06 -24.02 64.11 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.472 0.709 . . . . 0.0 109.306 169.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.7 m 59.38 39.5 22.1 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.943 1.697 . . . . 0.0 112.629 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.6 mp 49.54 75.99 0.6 Allowed Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 126.786 2.034 . . . . 0.0 111.507 175.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.57 145.15 82.35 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.088 2.526 . . . . 0.0 112.143 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.5 m -74.03 -33.51 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 122.523 0.329 . . . . 0.0 111.132 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 42.9 m -79.39 121.13 24.77 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 174.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -86.22 121.51 72.6 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.042 -0.98 . . . . 0.0 108.5 172.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -69.73 131.6 21.61 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.359 2.039 . . . . 0.0 109.767 173.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -81.89 69.9 8.68 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.305 1.042 . . . . 0.0 110.112 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.0 m -64.74 154.14 86.06 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 124.923 1.289 . . . . 0.0 110.772 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.74 -17.74 61.16 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.504 2.136 . . . . 0.0 112.717 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -75.27 -7.63 54.43 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.356 1.062 . . . . 0.0 112.36 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.1 167.19 14.53 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.591 0.756 . . . . 0.0 111.047 178.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -75.3 3.93 44.2 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.281 0.943 . . . . 0.0 115.046 -174.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -60.86 133.84 56.5 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.417 1.608 . . . . 0.0 109.124 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.31 142.43 39.42 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -101.12 130.26 47.15 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 169.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -114.64 137.45 51.88 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.932 0.893 . . . . 0.0 108.641 -174.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 63.8 tp -75.69 -38.47 58.65 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.063 0.545 . . . . 0.0 110.802 177.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -90.22 160.11 16.37 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.909 0.884 . . . . 0.0 111.109 -169.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -175.38 -175.52 42.88 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.538 1.542 . . . . 0.0 109.836 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -135.82 113.94 11.38 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -62.51 125.98 25.77 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -170.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.5 m 51.84 26.64 3.68 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.867 1.267 . . . . 0.0 113.797 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 62.11 15.58 50.74 Favored Glycine 0 CA--C 1.535 1.3 0 O-C-N 121.486 -0.759 . . . . 0.0 113.256 -175.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 52.45 31.22 9.4 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.239 1.816 . . . . 0.0 112.362 -169.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -67.32 138.47 56.83 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.653 0.781 . . . . 0.0 109.699 174.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.08 0 C-N-CA 125.484 1.513 . . . . 0.0 107.871 177.006 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 p -70.68 114.81 9.13 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.924 0.889 . . . . 0.0 108.761 174.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -127.68 5.83 6.15 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.513 1.125 . . . . 0.0 113.173 -175.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 53.83 173.43 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 129.444 3.098 . . . . 0.0 115.428 171.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.7 mt -132.35 130.46 60.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.33 123.7 32.58 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.8 159.65 47.97 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 123.361 0.505 . . . . 0.0 111.902 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -111.09 164.75 12.51 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.427 1.491 . . . . 0.0 110.648 -169.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -76.03 -13.93 60.22 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.206 1.002 . . . . 0.0 112.336 -177.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 p -152.88 168.86 24.36 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 127.652 2.381 . . . . 0.0 106.959 171.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.9 m -64.76 145.53 98.78 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 169.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.92 65.94 7.67 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 124.554 3.503 . . . . 0.0 110.628 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -52.83 -48.61 66.85 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 123.912 0.885 . . . . 0.0 112.255 -169.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.8 -36.59 84.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.095 0.474 . . . . 0.0 110.95 -173.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -74.43 -41.75 60.31 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.034 0.934 . . . . 0.0 109.848 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.7 t -60.23 -45.32 96.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 172.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -62.19 -50.25 72.55 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.348 1.059 . . . . 0.0 110.402 -177.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.34 -39.2 93.88 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.778 0.717 . . . . 0.0 110.957 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.27 -47.02 84.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.176 -0.327 . . . . 0.0 110.32 175.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -68.05 -24.97 65.14 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 118.354 -0.831 . . . . 0.0 112.362 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -69.78 -32.42 70.9 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.857 1.208 . . . . 0.0 109.544 175.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -72.94 -46.89 49.95 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 173.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mt -64.6 -40.88 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 121.632 -0.668 . . . . 0.0 109.731 -176.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.1 -27.03 67.75 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.528 0.731 . . . . 0.0 111.302 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 51.9 ttm-85 -78.17 -45.26 23.64 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.72 0.808 . . . . 0.0 109.325 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -52.55 -41.24 63.37 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.02 1.328 . . . . 0.0 111.092 177.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.8 m -73.65 81.28 1.53 Allowed 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 169.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 12.8 tpt -56.18 128.66 36.67 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.5 1.12 . . . . 0.0 112.594 -169.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -150.57 117.03 5.73 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 102.808 -3.034 . . . . 0.0 102.808 169.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.94 -35.92 73.92 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.647 0.658 . . . . 0.0 112.376 -169.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -65.54 -43.32 90.29 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.4 m -74.35 -26.51 60.18 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.099 0.56 . . . . 0.0 111.673 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -66.36 -34.78 78.75 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.577 0.626 . . . . 0.0 109.704 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.5 mt -84.27 56.6 3.84 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.113 1.365 . . . . 0.0 109.764 172.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 30.5 t60 66.39 134.14 0.04 OUTLIER Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 128.415 2.686 . . . . 0.0 112.647 -169.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -52.96 134.09 54.11 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 123.14 2.56 . . . . 0.0 113.892 -175.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.7 m -74.09 -15.83 61.04 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.935 0.894 . . . . 0.0 112.566 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 67.2 mtt -138.58 154.16 73.06 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 120' ' ' ILE . 84.7 Cg_endo -74.05 138.22 25.22 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.622 1.548 . . . . 0.0 112.356 -168.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.6 t -94.86 101.52 12.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 100.505 -3.887 . . . . 0.0 100.505 167.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -147.12 159.12 43.98 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.51 1.124 . . . . 0.0 109.855 -169.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.3 t -137.48 139.03 44.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.428 1.091 . . . . 0.0 108.161 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.0 m -106.79 152.01 24.41 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.949 1.299 . . . . 0.0 108.666 169.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -149.37 129.54 13.63 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.38 1.472 . . . . 0.0 109.838 -175.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -179.99 155.25 0.59 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.695 1.198 . . . . 0.0 112.468 -169.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.6 m 64.16 151.0 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.818 2.447 . . . . 0.0 112.613 170.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.6 tp -111.36 59.65 0.62 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.996 0.918 . . . . 0.0 109.409 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.31 134.26 50.04 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 123.566 0.746 . . . . 0.0 109.921 -175.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 54.96 23.46 5.09 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.827 0.851 . . . . 0.0 111.632 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.82 14.29 81.14 Favored Glycine 0 CA--C 1.537 1.427 0 CA-C-O 118.489 -1.173 . . . . 0.0 113.68 -176.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -132.75 149.23 52.3 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.621 1.71 . . . . 0.0 108.708 -171.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -70.4 135.74 49.01 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.034 -1.041 . . . . 0.0 109.665 -175.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.1 156.09 16.75 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -168.7 176.21 43.03 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 175.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 43.9 m -144.91 151.75 39.17 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 169.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.5 p -118.68 144.26 27.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 169.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.3 145.63 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 170.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.8 p -142.71 175.35 2.96 Favored Pre-proline 0 C--N 1.321 -0.655 0 C-N-CA 125.451 1.5 . . . . 0.0 107.034 169.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.57 -30.1 91.53 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 120.895 1.063 . . . . 0.0 111.44 168.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 48.1 p-90 -95.51 -25.23 16.29 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 118.128 -0.939 . . . . 0.0 113.292 -169.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.89 168.12 28.41 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-N 120.282 1.401 . . . . 0.0 113.206 -175.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.9 tt -137.32 121.9 18.48 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 168.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.1 m -134.13 130.75 37.81 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.198 0.523 . . . . 0.0 109.82 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.38 143.27 53.74 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 168.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.22 150.83 29.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.7 mm -134.06 134.51 55.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -125.8 143.03 43.87 Favored Pre-proline 0 CA--C 1.537 0.442 0 CA-C-O 118.318 -0.849 . . . . 0.0 111.044 -171.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -48.22 129.72 19.43 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.931 3.087 . . . . 0.0 113.829 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.48 177.02 34.1 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.247 1.403 . . . . 0.0 114.489 -171.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -61.86 118.53 5.42 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.854 3.036 . . . . 0.0 112.253 -169.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.5 t70 52.17 29.87 7.05 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.119 1.768 . . . . 0.0 113.602 175.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -82.68 146.94 28.78 Favored 'General case' 0 C--N 1.34 0.195 0 O-C-N 121.435 -0.79 . . . . 0.0 109.021 175.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.7 mp -101.26 82.58 2.36 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -67.3 145.84 98.67 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.531 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -64.6 157.71 53.95 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.274 1.982 . . . . 0.0 109.872 171.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.1 tp -77.07 77.3 3.62 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -64.63 148.18 51.44 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.07 0.548 . . . . 0.0 110.393 -174.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -92.08 151.04 20.63 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.1 t -88.43 153.03 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 125.452 1.501 . . . . 0.0 111.131 -168.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.8 m 68.27 7.49 5.96 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.068 1.747 . . . . 0.0 114.116 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -83.28 163.47 20.67 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 168.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -115.41 150.71 35.98 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.202 0.91 . . . . 0.0 111.574 175.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.2 mm -122.61 123.96 69.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.21 124.1 6.58 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 108.656 -1.777 . . . . 0.0 108.656 173.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.4 mt -116.79 138.22 51.65 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.481 1.112 . . . . 0.0 108.031 173.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -91.21 124.1 35.17 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mp -132.98 156.65 79.85 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 125.027 1.331 . . . . 0.0 108.162 170.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -67.01 -21.82 48.93 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 CA-C-N 120.625 1.259 . . . . 0.0 112.865 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -55.99 -31.45 63.05 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.816 1.247 . . . . 0.0 111.233 169.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.49 150.92 5.52 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.86 2.171 . . . . 0.0 107.776 -172.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.1 m -64.47 132.58 50.39 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 171.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 54.6 ttm -133.95 130.58 37.9 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -169.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.04 114.13 20.39 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 171.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -89.08 142.93 27.22 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 169.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.6 m -92.3 141.96 27.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.27 119.6 23.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 171.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -109.35 167.35 12.86 Favored Glycine 0 CA--C 1.52 0.361 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 169.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -117.57 117.09 28.47 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 169.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.0 119.19 21.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 176.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.34 131.62 51.53 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 122.721 0.408 . . . . 0.0 111.379 -171.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.55 3.56 72.4 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-O 118.968 -0.907 . . . . 0.0 113.526 -178.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.1 t -122.33 -110.58 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.0 m -154.71 173.54 16.27 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 119.776 1.171 . . . . 0.0 109.765 -169.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -66.96 142.24 57.33 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 169.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.02 173.19 16.33 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.084 1.754 . . . . 0.0 107.429 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.9 mp -109.07 140.0 43.21 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -176.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.0 t -142.08 152.94 43.78 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.489 1.115 . . . . 0.0 109.588 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 35.5 t -149.19 118.43 6.82 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 172.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.7 m -71.75 136.16 47.04 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -85.75 -62.96 1.4 Allowed 'General case' 0 C--O 1.231 0.112 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 172.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.92 175.72 5.75 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.529 1.532 . . . . 0.0 108.634 -175.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.1 m -90.29 118.89 69.16 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 169.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -85.92 19.97 1.31 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.562 2.841 . . . . 0.0 112.759 -171.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 17.7 tp -82.18 43.97 0.83 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.922 1.289 . . . . 0.0 111.123 -171.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.1 m -73.02 163.18 28.55 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.92 1.288 . . . . 0.0 110.178 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -78.36 -37.01 45.32 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.837 -0.54 . . . . 0.0 110.605 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.5 m -83.83 69.7 10.27 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.591 1.156 . . . . 0.0 108.375 176.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.1 tpt -148.02 154.36 40.16 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.583 1.553 . . . . 0.0 108.735 -171.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 84.3 p -152.59 174.97 13.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.461 1.504 . . . . 0.0 108.202 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.486 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 23.4 pt -66.19 -25.49 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 121.507 -0.746 . . . . 0.0 111.731 170.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -76.67 -45.59 29.1 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -63.05 -31.75 72.96 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.503 170.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.16 -60.79 8.32 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 120.16 1.346 . . . . 0.0 110.679 172.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -62.16 -48.71 78.89 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 117.412 0.606 . . . . 0.0 110.779 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 61.1 ttt-85 -61.2 -35.1 76.27 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 123.622 0.769 . . . . 0.0 110.817 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.5 tp -78.35 -23.91 46.71 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 117.607 -1.187 . . . . 0.0 111.407 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -46.6 85.43 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.88 1.673 . . . . 0.0 109.037 169.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -66.02 -46.77 76.71 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 122.609 0.364 . . . . 0.0 111.251 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -66.2 -33.21 75.25 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 119.248 -0.406 . . . . 0.0 110.778 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 28.4 m -67.07 -36.93 83.08 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.608 0.64 . . . . 0.0 110.435 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.05 -52.23 50.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 173.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 41.1 tpt85 -52.47 -46.03 66.35 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.961 0.905 . . . . 0.0 111.138 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 56.7 ttp -49.39 -52.53 27.89 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.959 1.704 . . . . 0.0 111.145 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 11.0 pt -88.93 -24.79 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 118.743 0.701 . . . . 0.0 112.612 -172.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 76.3 mt -65.56 -38.74 90.44 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.003 0.921 . . . . 0.0 109.074 171.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.3 m 57.77 33.72 23.57 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.441 1.497 . . . . 0.0 114.536 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.4 tp 46.26 65.38 6.82 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.894 1.278 . . . . 0.0 113.705 169.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -65.36 144.1 78.96 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.713 2.275 . . . . 0.0 111.751 -171.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.2 m -140.74 178.46 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 126.117 1.767 . . . . 0.0 108.659 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.1 m -49.66 137.06 16.27 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.282 1.433 . . . . 0.0 110.603 173.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -133.35 117.77 14.64 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 124.622 1.169 . . . . 0.0 108.726 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -61.08 141.7 94.85 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.88 2.387 . . . . 0.0 111.331 171.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -139.2 131.86 28.93 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.714 1.606 . . . . 0.0 107.58 172.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 10.8 m -135.02 149.03 69.25 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.53 1.532 . . . . 0.0 109.124 -169.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.01 -22.27 42.0 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.355 2.037 . . . . 0.0 113.977 -169.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -82.22 -9.76 59.38 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.652 0.66 . . . . 0.0 112.653 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.88 125.61 25.39 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.299 0.954 . . . . 0.0 109.144 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 69.09 11.19 63.34 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-O 119.354 -0.692 . . . . 0.0 113.382 -176.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -127.95 46.71 2.51 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.96 1.704 . . . . 0.0 108.983 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -116.66 153.98 31.35 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.234 1.414 . . . . 0.0 108.052 173.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.32 142.78 55.41 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.68 164.64 36.5 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.749 1.619 . . . . 0.0 108.054 -175.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 26.1 tp 51.39 56.64 7.61 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.634 1.574 . . . . 0.0 110.758 176.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -64.13 146.2 54.63 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.926 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.91 150.91 49.74 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 175.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 26.1 ptt-85 -131.81 42.9 3.11 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.679 1.191 . . . . 0.0 110.354 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 56.01 37.48 28.89 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.004 0.922 . . . . 0.0 109.116 -168.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.3 m -58.55 131.2 50.08 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.639 1.176 . . . . 0.0 109.769 -170.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 98.06 -39.52 2.74 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.917 1.246 . . . . 0.0 111.181 -176.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -81.83 -32.39 31.25 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.424 1.112 . . . . 0.0 108.673 169.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -120.25 149.34 42.44 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 128.863 2.865 . . . . 0.0 107.86 175.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.205 0 C-N-CA 123.679 0.791 . . . . 0.0 110.525 -177.895 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 119.801 -0.142 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.6 p -75.91 159.83 30.52 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.154 0.982 . . . . 0.0 109.895 177.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -84.45 50.83 1.96 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.344 1.058 . . . . 0.0 111.403 -173.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -54.1 147.31 13.02 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 126.518 1.927 . . . . 0.0 108.843 169.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.3 mp -104.81 118.89 52.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 -174.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.51 119.61 20.59 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 169.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.87 177.6 54.21 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 121.423 0.457 . . . . 0.0 113.694 -175.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -115.67 169.51 9.14 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.985 1.714 . . . . 0.0 110.267 -169.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -72.88 -13.76 61.34 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -174.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.2 p -151.31 174.05 13.77 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 127.867 2.467 . . . . 0.0 106.404 169.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.4 m -61.93 147.69 89.39 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 169.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.53 67.43 6.36 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 124.752 3.635 . . . . 0.0 110.293 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.435 ' HE3' ' O ' ' A' ' 42' ' ' VAL . 45.5 mtpt -52.74 -52.43 56.41 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.513 1.125 . . . . 0.0 112.201 -169.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.01 -38.89 92.74 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 118.762 0.71 . . . . 0.0 110.968 -172.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -69.06 -42.71 75.92 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.746 1.219 . . . . 0.0 109.848 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.6 t -63.04 -42.21 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 174.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -61.36 -52.38 64.89 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.71 -49.47 75.06 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.762 0.825 . . . . 0.0 110.203 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.5 -49.83 75.04 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -70.01 -24.52 63.3 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 117.901 -1.047 . . . . 0.0 112.642 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -66.93 -33.17 74.99 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 120.05 1.296 . . . . 0.0 109.199 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -74.68 -49.09 22.57 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.391 -0.818 . . . . 0.0 109.544 173.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.1 mt -61.85 -30.68 49.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.42 -31.96 64.14 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 124.182 0.993 . . . . 0.0 112.014 173.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 53.6 ttp85 -72.05 -41.23 67.67 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.92 1.236 . . . . 0.0 109.594 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -65.53 -21.38 66.61 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.289 1.035 . . . . 0.0 109.983 168.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.0 m 47.54 52.83 11.94 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 127.455 2.302 . . . . 0.0 108.51 -174.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 46.0 ttm 65.89 -72.79 0.07 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.758 2.023 . . . . 0.0 108.497 -168.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -148.89 4.48 0.65 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.962 1.305 . . . . 0.0 110.973 169.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.15 -15.66 56.59 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.842 -1.161 . . . . 0.0 111.878 -174.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.7 tp 52.2 40.6 29.21 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.718 2.007 . . . . 0.0 112.371 170.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 p -104.07 -44.08 5.1 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.351 1.061 . . . . 0.0 112.031 -169.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -85.16 49.02 1.66 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.091 0.956 . . . . 0.0 110.139 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.1 mt -58.31 130.98 49.25 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 170.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 40.1 t60 52.33 73.85 0.88 Allowed Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.557 1.143 . . . . 0.0 108.147 -169.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -51.56 123.23 11.74 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.461 2.774 . . . . 0.0 112.214 -169.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 m -70.27 -19.31 63.12 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.051 0.941 . . . . 0.0 112.322 -169.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 20.3 mmt -125.69 121.6 24.57 Favored Pre-proline 0 N--CA 1.453 -0.294 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 172.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -50.7 128.69 24.78 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.333 2.022 . . . . 0.0 110.376 169.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 m -61.06 147.92 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 169.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -143.78 152.67 41.53 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 120.966 -1.084 . . . . 0.0 109.811 -177.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.435 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 7.1 p -135.89 127.05 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 124.488 1.115 . . . . 0.0 110.79 -175.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.9 m -92.54 146.81 23.39 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.649 1.18 . . . . 0.0 109.421 169.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -119.97 137.96 53.76 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.532 1.533 . . . . 0.0 107.786 169.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.43 ' CE1' ' HB1' ' A' ' 131' ' ' ALA . 29.4 p90 -164.87 146.29 7.84 Favored 'General case' 0 C--O 1.218 -0.569 0 C-N-CA 123.351 0.66 . . . . 0.0 111.715 -176.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.8 m 58.37 154.13 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.826 2.45 . . . . 0.0 115.52 168.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.4 tp -105.75 109.32 21.23 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 169.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -103.04 95.9 6.44 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.258 2.223 . . . . 0.0 108.107 -173.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 55.06 45.73 25.61 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.455 1.102 . . . . 0.0 111.658 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.59 22.44 62.13 Favored Glycine 0 CA--C 1.531 1.085 0 O-C-N 121.853 -0.529 . . . . 0.0 113.315 176.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -136.59 144.56 44.18 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 125.68 1.592 . . . . 0.0 107.121 -177.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -74.33 141.05 45.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 120.514 1.506 . . . . 0.0 109.399 172.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.02 154.68 19.25 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 172.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.84 168.73 35.66 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 175.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 36.1 m -142.42 148.43 37.79 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 p -129.32 135.0 62.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.0 tt -111.23 151.11 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.751 1.22 . . . . 0.0 108.032 171.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.1 p -136.86 175.11 3.74 Favored Pre-proline 0 N--CA 1.444 -0.739 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 172.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.42 -10.6 28.26 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 CA-C-N 121.132 1.44 . . . . 0.0 112.009 169.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -110.16 -25.6 10.1 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -173.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.37 171.48 20.31 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 120.306 1.412 . . . . 0.0 112.368 -175.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.3 tt -136.98 123.03 20.3 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 167.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.2 m -130.91 134.79 47.08 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.398 0.679 . . . . 0.0 109.925 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.05 149.4 35.8 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 168.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.9 m -138.74 146.55 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.61 1.164 . . . . 0.0 108.172 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.6 mm -130.76 114.85 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -115.0 146.66 36.65 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.314 1.046 . . . . 0.0 112.229 -168.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -39.08 128.56 1.39 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 125.178 3.918 . . . . 0.0 115.256 173.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.45 -178.51 49.92 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.219 0.914 . . . . 0.0 114.415 -173.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.02 106.42 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 124.084 3.189 . . . . 0.0 111.7 -169.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.6 t70 50.07 28.39 2.96 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.621 1.568 . . . . 0.0 112.658 -175.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -89.22 142.46 27.63 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -91.69 91.34 7.95 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 31.1 t90 -70.16 131.97 88.46 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.59 153.36 77.75 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.387 2.058 . . . . 0.0 111.811 -169.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 50.5 tp -61.77 130.23 44.78 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 169.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 69.8 mtt85 -125.55 156.67 38.7 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.881 0.873 . . . . 0.0 109.097 172.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -89.26 147.92 23.86 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 169.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.3 t -90.14 153.22 3.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 124.572 1.149 . . . . 0.0 110.809 -168.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.9 m 63.81 29.07 14.8 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.856 1.262 . . . . 0.0 112.461 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -104.47 155.3 18.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.518 1.927 . . . . 0.0 107.311 169.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -107.43 142.34 37.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.844 0.747 . . . . 0.0 110.191 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 35.4 mm -123.1 128.81 75.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.15 120.86 6.01 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 173.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.3 mt -105.0 139.35 39.81 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 170.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -90.48 129.14 36.68 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 173.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mp -135.79 155.76 77.79 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 125.151 1.381 . . . . 0.0 107.593 175.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.84 -23.94 68.45 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 121.541 1.494 . . . . 0.0 112.395 173.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -56.71 -30.7 63.75 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.062 1.345 . . . . 0.0 111.733 169.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 133.12 149.7 6.2 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 108.099 -2.0 . . . . 0.0 108.099 -170.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.0 m -64.37 133.34 52.42 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 41.4 ttp -147.2 139.42 24.54 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -171.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.33 134.05 36.61 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 118.747 0.703 . . . . 0.0 109.777 176.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -109.2 130.88 55.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 169.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.6 m -83.02 139.52 33.22 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.3 t -70.48 119.01 15.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 170.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -110.21 158.36 14.5 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 171.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -127.83 84.62 2.27 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.2 tp -65.23 125.29 24.56 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -172.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.3 136.33 58.01 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.466 0.706 . . . . 0.0 110.418 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.39 2.85 64.3 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.283 -0.731 . . . . 0.0 113.27 -176.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.0 t -128.81 -119.68 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.6 p -163.45 -175.09 4.04 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.166 1.387 . . . . 0.0 108.935 -171.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -70.05 144.81 52.07 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.633 -0.667 . . . . 0.0 110.725 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.38 165.11 36.04 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.717 1.607 . . . . 0.0 109.011 174.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.9 mp -102.7 126.11 49.68 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 174.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.9 m -144.65 156.45 44.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 119.594 1.088 . . . . 0.0 110.858 -170.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 18.8 p -145.37 139.88 27.29 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.453 -0.779 . . . . 0.0 110.008 170.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.3 m -75.14 137.48 41.38 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 171.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 85.2 mt -124.07 -30.16 3.52 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -171.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 14.9 ptp -159.44 167.21 29.27 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.057 0.943 . . . . 0.0 109.28 175.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.5 m -122.69 92.79 48.9 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 124.349 1.059 . . . . 0.0 108.985 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.17 171.36 5.24 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.566 2.844 . . . . 0.0 112.048 172.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 64.0 tp -148.34 133.71 18.54 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 169.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 9.5 m -50.45 -27.41 6.44 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.947 1.699 . . . . 0.0 114.925 -170.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -59.6 -33.29 71.28 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.683 0.674 . . . . 0.0 112.19 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.5 m -106.16 30.22 6.1 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.841 1.256 . . . . 0.0 110.714 -177.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 93.8 mtp -133.94 168.38 18.88 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.628 1.171 . . . . 0.0 110.905 -174.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 81.9 p -151.96 169.15 23.02 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.103 2.161 . . . . 0.0 105.424 169.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.505 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -60.68 -34.38 58.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 121.213 -0.93 . . . . 0.0 109.171 172.215 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -64.54 -45.49 86.91 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 123.601 0.76 . . . . 0.0 110.148 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -67.39 -29.67 69.24 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.369 0.986 . . . . 0.0 110.621 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.27 -37.29 64.5 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.788 -0.57 . . . . 0.0 111.773 169.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -82.69 -54.62 5.0 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.928 -1.337 . . . . 0.0 110.208 174.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 61.0 mtm-85 -67.56 -29.82 69.29 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 118.116 -0.945 . . . . 0.0 113.31 -169.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.8 tp -82.89 -27.17 30.89 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 120.525 1.511 . . . . 0.0 109.886 -176.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.2 m -71.19 -40.4 71.24 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.69 -44.19 82.38 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.224 1.01 . . . . 0.0 111.752 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.36 -39.28 92.62 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 121.175 -0.953 . . . . 0.0 109.752 175.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 37.9 t -63.13 -44.95 94.14 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.43 ' HB1' ' CE1' ' A' ' 45' ' ' PHE . . . -52.34 -50.76 61.69 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.953 1.301 . . . . 0.0 110.897 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.0 ptt85 -82.6 -24.47 33.88 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 15.5 tmm? -55.98 -44.31 78.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 118.648 -0.691 . . . . 0.0 109.812 171.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 6.8 pt -81.94 0.3 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.3 mt -89.75 -89.75 0.15 Allowed 'General case' 0 C--N 1.342 0.269 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 169.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.0 p -163.63 26.17 0.08 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.038 1.735 . . . . 0.0 110.942 -172.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.4 mt 49.27 45.78 3.16 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 126.956 2.102 . . . . 0.0 116.408 -169.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.71 178.1 3.6 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.02 1.813 . . . . 0.0 109.584 168.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.9 p -114.99 139.52 40.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.833 0.853 . . . . 0.0 109.404 173.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.2 m -83.21 154.42 24.23 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.636 1.174 . . . . 0.0 109.167 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -117.65 76.99 10.71 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 169.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -71.66 151.91 58.56 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.428 2.085 . . . . 0.0 111.248 -173.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -151.59 129.83 11.98 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.537 1.535 . . . . 0.0 107.769 169.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.4 p -155.88 150.54 20.35 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.842 1.257 . . . . 0.0 108.052 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -53.49 -42.77 63.09 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.717 2.944 . . . . 0.0 113.883 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -155.61 157.96 37.59 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.862 1.265 . . . . 0.0 109.152 172.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -108.6 170.96 7.7 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.938 1.295 . . . . 0.0 109.735 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 74.49 28.06 64.29 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.551 -0.583 . . . . 0.0 113.814 170.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 42.1 ttm105 -139.35 147.33 41.4 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.551 1.141 . . . . 0.0 108.084 172.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.2 mtm180 -67.87 164.67 19.24 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.622 0.369 . . . . 0.0 110.357 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.21 -26.71 65.85 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 122.536 0.334 . . . . 0.0 111.303 171.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -130.09 125.92 36.34 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.999 1.32 . . . . 0.0 109.135 174.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -154.7 124.12 6.46 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 45.8 t80 60.68 171.18 0.09 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.299 1.84 . . . . 0.0 113.156 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 172.33 161.79 23.41 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.255 1.407 . . . . 0.0 110.1 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -141.79 145.73 35.09 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 175.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -71.03 135.26 47.69 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 14.5 m -67.03 153.72 42.96 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.379 0.671 . . . . 0.0 109.887 171.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -174.74 -148.67 6.76 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -68.03 151.6 46.82 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 122.861 0.464 . . . . 0.0 109.817 171.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -70.64 139.46 51.33 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 172.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.222 0 C-N-CA 125.378 1.471 . . . . 0.0 107.966 176.847 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.8 p -75.51 154.45 36.9 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.179 0.992 . . . . 0.0 109.742 173.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -134.45 63.33 1.63 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -175.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -146.24 165.18 29.97 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.666 1.586 . . . . 0.0 110.733 -170.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.8 mt -141.06 134.28 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.25 128.25 35.07 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 169.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.97 163.34 47.8 Favored Glycine 0 CA--C 1.537 1.454 0 N-CA-C 112.061 -0.415 . . . . 0.0 112.061 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -73.15 126.77 30.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.463 0.705 . . . . 0.0 109.516 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -67.62 -32.05 72.5 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 119.121 -0.466 . . . . 0.0 110.516 175.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.8 p -150.72 153.9 36.4 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 126.308 1.843 . . . . 0.0 107.857 169.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -56.8 137.95 78.3 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 125.388 1.475 . . . . 0.0 113.108 -169.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -80.34 43.89 1.62 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 124.626 3.551 . . . . 0.0 111.412 174.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -53.52 -45.21 69.67 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.086 1.354 . . . . 0.0 112.257 -169.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.09 -41.86 99.48 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 122.963 0.505 . . . . 0.0 111.606 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -72.48 -40.32 67.03 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -175.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.7 t -60.07 -46.12 94.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 172.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -59.74 -54.93 40.61 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.132 0.573 . . . . 0.0 110.347 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.02 -41.76 97.34 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.467 0.707 . . . . 0.0 110.853 -173.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.54 -39.25 77.59 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 118.511 0.596 . . . . 0.0 110.718 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -67.57 -31.17 71.05 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 121.317 -0.864 . . . . 0.0 111.738 173.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -68.95 -29.39 67.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.321 0.964 . . . . 0.0 111.107 173.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -70.41 -48.64 55.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mt -59.36 -41.89 85.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.566 0.746 . . . . 0.0 109.453 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.99 -23.79 67.32 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.769 0.828 . . . . 0.0 112.862 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -80.72 -45.22 17.44 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 171.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -71.87 -1.46 14.33 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.794 1.238 . . . . 0.0 112.611 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.9 m -59.54 -29.89 68.22 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.688 1.131 . . . . 0.0 110.326 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -98.29 46.55 1.0 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.153 1.381 . . . . 0.0 109.865 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -64.8 -13.82 56.94 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -169.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -58.6 -26.63 63.86 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.437 0.695 . . . . 0.0 111.823 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.13 -24.71 0.44 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -178.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.5 m 56.25 7.03 0.29 Allowed 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 116.396 1.998 . . . . 0.0 116.396 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -78.21 -29.58 48.44 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.704 1.138 . . . . 0.0 110.791 173.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.78 153.07 44.46 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 172.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -137.74 166.64 24.87 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 125.354 1.462 . . . . 0.0 109.802 -169.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -56.66 -34.84 96.72 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.199 2.599 . . . . 0.0 114.546 -169.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.2 m 61.61 4.81 1.1 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.877 1.671 . . . . 0.0 114.353 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 35.8 tpp -153.97 119.97 2.8 Favored Pre-proline 0 N--CA 1.453 -0.281 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 170.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -55.05 138.86 79.6 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.172 1.915 . . . . 0.0 113.039 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.1 t -75.4 139.23 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 168.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -139.61 154.03 47.48 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.641 0.777 . . . . 0.0 109.88 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.1 t -137.71 119.11 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 123.995 0.918 . . . . 0.0 109.265 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.1 m -82.22 143.88 31.06 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 168.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -126.63 134.29 50.79 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.552 1.541 . . . . 0.0 109.258 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -170.6 149.74 3.26 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 123.373 0.669 . . . . 0.0 112.737 -170.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.5 m 55.66 165.53 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 128.739 2.816 . . . . 0.0 116.257 167.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 30.3 mt -116.53 66.46 0.72 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.792 1.237 . . . . 0.0 108.705 171.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.12 136.14 42.94 Favored 'General case' 0 N--CA 1.457 -0.083 0 O-C-N 121.726 -0.609 . . . . 0.0 109.599 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 56.74 22.78 7.23 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.792 0.837 . . . . 0.0 111.247 -172.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.29 12.53 83.5 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.658 1.123 . . . . 0.0 113.474 -175.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -121.33 143.86 48.96 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.815 1.646 . . . . 0.0 108.202 -173.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -61.38 133.13 55.47 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 118.318 -0.849 . . . . 0.0 109.154 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.84 157.53 16.24 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 122.207 1.004 . . . . 0.0 108.56 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.75 167.83 39.3 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 56.4 m -141.43 150.56 42.47 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 169.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.91 139.77 50.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 175.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.6 tt -116.46 147.03 20.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 169.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.7 p -138.37 172.2 7.05 Favored Pre-proline 0 N--CA 1.439 -0.979 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 171.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -63.24 -22.63 72.5 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 CA-C-N 119.928 1.01 . . . . 0.0 111.074 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 44.4 p-90 -94.45 -26.27 16.55 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -174.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.94 173.51 12.57 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 120.527 1.512 . . . . 0.0 112.71 -173.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.5 tt -135.43 128.48 31.62 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 167.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 77.7 p -138.03 142.61 40.35 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 122.029 0.919 . . . . 0.0 110.728 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.02 144.41 47.18 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 167.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.9 m -135.39 151.32 30.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 39.9 mt -136.59 139.77 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -116.61 139.66 25.77 Favored Pre-proline 0 C--O 1.234 0.266 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -54.86 131.17 44.56 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 121.629 1.552 . . . . 0.0 109.018 177.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.57 -179.46 27.72 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.509 1.052 . . . . 0.0 114.596 -169.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.16 158.25 41.67 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.365 2.71 . . . . 0.0 111.096 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.4 t0 46.04 45.58 12.36 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.795 2.038 . . . . 0.0 113.604 169.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -150.12 147.68 28.05 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.6 mp -104.3 107.26 18.09 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -72.22 157.82 88.62 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.186 -0.916 . . . . 0.0 108.776 169.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.31 166.93 28.63 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.1 1.867 . . . . 0.0 108.972 169.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 61.3 tp -69.2 82.53 0.35 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 169.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -75.46 139.78 42.47 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -173.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -90.86 141.89 28.35 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 122.812 1.291 . . . . 0.0 108.175 176.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -68.93 156.08 7.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 127.992 2.517 . . . . 0.0 109.152 174.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.0 m 69.93 0.74 3.18 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 128.336 2.655 . . . . 0.0 114.437 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -81.52 158.02 24.61 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 169.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -110.08 143.09 40.62 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.0 0.52 . . . . 0.0 110.0 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.5 mt -121.08 118.8 57.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -74.61 123.66 7.7 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 174.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 72.8 mt -125.2 151.76 45.42 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.667 1.187 . . . . 0.0 108.654 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -108.65 128.11 54.56 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.377 1.071 . . . . 0.0 108.753 -175.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.0 mp -137.06 168.95 14.61 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 125.331 1.452 . . . . 0.0 108.641 175.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -58.83 -23.26 66.23 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.366 2.044 . . . . 0.0 113.979 173.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -56.43 -38.32 71.42 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.603 0.761 . . . . 0.0 111.805 170.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.85 -167.55 24.27 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 -169.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 m -80.05 135.14 36.28 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 172.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 20.6 ptp -144.16 148.79 35.5 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 169.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.92 128.62 35.68 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 173.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -96.33 128.05 42.89 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 168.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.4 m -77.79 138.95 39.27 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 171.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.9 t -72.2 121.92 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 170.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -103.64 165.76 15.67 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -121.81 127.61 50.77 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.099 -2.185 . . . . 0.0 105.099 169.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.5 tp -141.19 142.61 33.99 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.063 0.847 . . . . 0.0 109.849 -176.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -59.04 135.02 57.49 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.312 0.645 . . . . 0.0 111.023 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.83 -2.12 50.85 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.044 0.831 . . . . 0.0 113.668 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.5 t -125.59 -31.49 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 118.638 1.219 . . . . 0.0 109.91 -173.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.0 m 54.58 -122.71 1.99 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.348 1.059 . . . . 0.0 109.001 -169.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -82.73 130.35 35.11 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.512 1.051 . . . . 0.0 109.861 -169.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -156.25 179.54 9.14 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 126.294 1.838 . . . . 0.0 106.993 176.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp -119.23 143.15 47.45 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.981 0.913 . . . . 0.0 109.217 -175.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.9 m -139.73 148.52 42.41 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.925 1.29 . . . . 0.0 110.123 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 20.2 t -140.34 110.1 6.4 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 171.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.7 m -73.1 135.91 44.83 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 71.5 mt -121.31 -47.85 2.23 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 119.374 -0.346 . . . . 0.0 111.26 -169.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.24 167.27 29.43 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.63 1.172 . . . . 0.0 108.286 175.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.0 m -123.94 66.9 41.05 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 123.777 0.831 . . . . 0.0 110.194 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.53 136.64 40.17 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.001 2.467 . . . . 0.0 110.433 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 45.9 tp -150.92 63.85 0.92 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 169.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.8 m -65.02 149.1 50.46 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.244 0.618 . . . . 0.0 110.244 -172.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 11.8 p-80 -61.85 135.24 57.5 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.6 m 53.76 31.61 13.28 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.753 1.221 . . . . 0.0 113.472 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 25.2 ptm -66.31 159.0 27.64 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.522 -0.736 . . . . 0.0 110.133 173.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 65.1 p -120.47 169.47 10.29 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.114 1.366 . . . . 0.0 110.369 -174.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.494 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -63.76 -26.01 39.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 121.863 -0.523 . . . . 0.0 109.708 169.584 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -68.18 -43.05 79.03 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.315 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -64.89 -30.08 71.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.308 0.958 . . . . 0.0 110.604 169.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.19 -61.07 7.79 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -61.59 -51.25 69.32 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.809 -0.818 . . . . 0.0 110.534 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 65.6 ttt-85 -63.4 -30.18 71.35 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.226 1.01 . . . . 0.0 111.867 -174.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.7 tp -89.38 -24.81 21.85 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 120.477 1.489 . . . . 0.0 110.294 -177.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.6 m -70.32 -40.77 73.97 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 170.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -70.03 -41.95 73.58 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.788 0.835 . . . . 0.0 111.582 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.98 -30.33 71.31 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 121.127 -0.983 . . . . 0.0 110.217 172.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 37.0 t -66.3 -45.89 78.81 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.931 0.787 . . . . 0.0 109.053 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -54.39 -51.1 65.9 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.473 1.109 . . . . 0.0 109.79 174.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -58.21 -54.77 43.25 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 123.115 0.566 . . . . 0.0 110.19 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 50.9 ttp -47.17 -41.4 17.78 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.867 1.667 . . . . 0.0 112.012 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.9 pt -86.12 -14.55 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.278 0.944 . . . . 0.0 113.433 -176.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.6 pp -143.04 75.48 1.48 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.461 1.504 . . . . 0.0 108.457 174.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.8 m -66.21 56.35 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 129.739 3.216 . . . . 0.0 113.104 -177.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 95.4 mt -141.84 169.7 10.62 Favored Pre-proline 0 C--N 1.321 -0.649 0 C-N-CA 130.577 3.551 . . . . 0.0 106.756 -175.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.92 123.68 14.04 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.203 1.936 . . . . 0.0 109.214 169.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.0 p -76.14 148.29 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -177.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 97.1 m -102.57 117.31 34.4 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -177.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -142.92 97.61 5.8 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 170.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.61 179.59 6.35 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.578 2.185 . . . . 0.0 109.85 170.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -75.24 82.42 2.38 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 169.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.91 147.03 98.63 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 123.748 0.819 . . . . 0.0 110.6 -169.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -56.64 170.33 1.38 Allowed 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 124.532 3.488 . . . . 0.0 112.009 168.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 76.0 t60 -61.34 151.54 31.87 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.959 0.504 . . . . 0.0 110.396 177.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -92.05 -138.89 0.18 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.223 1.409 . . . . 0.0 109.521 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 74.42 25.89 69.33 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 121.705 -0.622 . . . . 0.0 112.654 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -85.35 162.97 18.84 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.271 1.028 . . . . 0.0 109.919 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 23.1 tpt85 -142.54 124.51 15.25 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -92.54 135.35 34.14 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 168.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.32 169.33 22.28 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.231 1.012 . . . . 0.0 110.27 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 57.3 tp -138.16 126.85 23.65 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 169.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -91.73 156.18 17.75 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.372 0.669 . . . . 0.0 109.927 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -173.02 161.14 32.2 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -137.07 145.35 43.86 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.326 1.45 . . . . 0.0 107.87 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 51.6 ttt85 -77.86 -36.02 50.36 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 122.326 0.25 . . . . 0.0 110.834 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 13.0 m -69.26 143.57 53.86 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.419 0.688 . . . . 0.0 110.747 -175.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -73.14 154.95 50.1 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 169.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -150.96 150.02 30.3 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.844 1.258 . . . . 0.0 107.94 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -68.09 138.18 55.56 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 122.637 0.375 . . . . 0.0 110.223 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.269 0 C-N-CA 125.555 1.542 . . . . 0.0 107.955 174.916 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 tpt . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.8 p -71.27 -25.77 62.6 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.166 -0.959 . . . . 0.0 112.145 -176.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -82.68 35.6 0.47 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.972 1.309 . . . . 0.0 111.28 -177.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -140.83 160.83 39.22 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.946 1.698 . . . . 0.0 109.207 -174.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.7 mt -119.66 136.57 56.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 171.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.7 146.82 54.2 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.87 135.53 17.03 Favored Glycine 0 C--N 1.336 0.557 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 170.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -96.4 138.64 33.69 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.863 0.865 . . . . 0.0 109.056 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -71.78 -37.38 70.45 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.0 p -157.48 168.54 27.01 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 129.732 3.213 . . . . 0.0 106.31 169.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.9 m -51.91 130.57 38.84 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.736 0.814 . . . . 0.0 111.498 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -77.01 63.66 7.67 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 125.179 3.919 . . . . 0.0 111.525 -176.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -52.97 -51.62 60.9 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.739 0.815 . . . . 0.0 111.497 -171.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.78 -39.76 91.32 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 123.315 0.384 . . . . 0.0 110.79 -170.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -67.17 -47.01 72.28 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.646 0.778 . . . . 0.0 109.903 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.0 t -63.06 -40.37 88.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.46 -53.17 58.76 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.743 0.817 . . . . 0.0 109.831 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.03 -40.51 97.96 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.47 0.577 . . . . 0.0 110.759 -176.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.71 -50.5 73.24 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -71.7 -24.09 61.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 118.033 -0.984 . . . . 0.0 112.597 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -66.58 -33.8 76.48 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.267 1.394 . . . . 0.0 110.273 172.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -74.38 -47.19 35.62 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.0 mt -61.05 -40.73 86.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.22 -28.38 69.33 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.587 0.755 . . . . 0.0 112.189 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -70.81 -44.19 67.07 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 172.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -72.16 -7.48 49.36 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.628 1.171 . . . . 0.0 112.51 -175.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.8 m -70.22 0.15 6.85 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.569 1.148 . . . . 0.0 112.09 168.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 6.2 tpt 64.44 23.92 13.05 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.956 1.702 . . . . 0.0 113.432 171.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -144.85 146.19 31.95 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.641 1.576 . . . . 0.0 106.842 169.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 39.7 t0 51.13 38.7 21.61 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 122.816 1.293 . . . . 0.0 111.103 -169.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -87.67 0.07 56.2 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.848 1.659 . . . . 0.0 112.768 -175.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 m -63.36 161.91 13.25 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.574 1.55 . . . . 0.0 112.677 -170.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -73.63 -19.92 60.72 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.46 0.704 . . . . 0.0 112.026 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.1 mt -68.15 167.7 13.63 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.047 0.939 . . . . 0.0 109.728 173.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -60.9 146.05 87.84 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -65.95 154.99 71.7 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.411 2.074 . . . . 0.0 111.247 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.7 m -65.71 -28.45 69.07 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.893 0.877 . . . . 0.0 111.998 -178.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 16.7 ptp -149.16 103.76 3.34 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 173.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -47.3 134.93 19.95 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 124.212 3.275 . . . . 0.0 114.435 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.7 t -61.75 137.49 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 169.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -149.71 159.27 44.48 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.926 0.89 . . . . 0.0 109.487 -175.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.7 t -136.87 141.05 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.1 m -110.79 152.25 26.86 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.227 1.411 . . . . 0.0 108.788 169.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -120.52 143.29 48.65 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 127.248 2.219 . . . . 0.0 110.813 -176.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -145.98 173.35 12.24 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.608 1.163 . . . . 0.0 111.651 -172.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.5 t -52.17 160.31 0.79 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.92 2.088 . . . . 0.0 115.323 -168.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -75.66 106.01 6.99 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 169.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -75.98 -53.98 7.56 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -168.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.91 -42.86 0.74 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.344 1.858 . . . . 0.0 110.226 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.55 -0.21 0.09 OUTLIER Glycine 0 CA--C 1.534 1.256 0 C-N-CA 127.82 2.629 . . . . 0.0 110.684 175.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -137.39 134.94 36.49 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 119.247 1.523 . . . . 0.0 109.112 -170.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -60.64 152.27 26.86 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.861 0.864 . . . . 0.0 110.337 170.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.23 163.2 12.58 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.301 1.04 . . . . 0.0 109.732 172.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.47 170.92 41.28 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 171.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 7.0 m -140.5 131.04 25.44 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.4 p -103.5 149.2 7.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 173.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.7 tt -131.19 149.65 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 169.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.401 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 30.8 p -139.74 175.75 3.01 Favored Pre-proline 0 N--CA 1.444 -0.764 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 172.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 37.4 Cg_endo -63.13 -19.67 69.34 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 CA-C-N 120.528 1.224 . . . . 0.0 111.145 168.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.0 p-90 -102.73 -24.43 13.74 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -172.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.68 170.35 22.58 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.547 1.521 . . . . 0.0 112.806 -175.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 tt -137.41 125.84 23.44 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 168.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.8 m -138.26 133.2 32.83 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.359 0.599 . . . . 0.0 110.256 -176.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.93 144.78 52.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 168.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 m -139.46 149.17 22.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 124.14 0.976 . . . . 0.0 108.565 -176.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.2 mt -143.38 141.54 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -170.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -134.79 138.23 29.23 Favored Pre-proline 0 N--CA 1.468 0.468 0 CA-C-O 117.839 -1.077 . . . . 0.0 110.517 -170.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -48.4 139.44 22.53 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.718 2.945 . . . . 0.0 112.548 173.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.38 175.79 28.56 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 123.974 0.797 . . . . 0.0 113.856 -174.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.4 140.65 44.58 Favored 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 122.818 2.345 . . . . 0.0 110.095 -174.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.6 t70 50.94 34.92 11.36 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.518 1.527 . . . . 0.0 113.31 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -132.55 131.81 41.94 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.124 1.37 . . . . 0.0 107.522 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.37 99.64 9.34 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -175.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.79 145.15 97.8 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 169.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.36 148.52 61.37 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 121.606 1.537 . . . . 0.0 109.898 171.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.4 tp -63.21 140.06 58.83 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.72 158.69 25.97 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.826 0.739 . . . . 0.0 109.355 174.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.43 140.52 44.72 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.1 t -79.48 159.24 4.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 124.422 1.089 . . . . 0.0 109.038 -169.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.0 m 63.7 23.32 13.46 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.941 1.296 . . . . 0.0 112.92 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -100.57 154.56 18.47 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.226 1.811 . . . . 0.0 107.516 169.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -111.19 141.22 44.99 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.434 0.561 . . . . 0.0 110.666 -177.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 23.7 mm -112.87 128.62 69.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 176.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.42 118.97 5.42 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 173.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.4 tp -108.04 143.61 36.52 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 172.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -105.05 125.49 51.04 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.6 mp -135.77 157.54 75.91 Favored Pre-proline 0 C--O 1.234 0.265 0 C-N-CA 125.25 1.42 . . . . 0.0 107.288 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -66.59 -22.82 50.48 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 CA-C-N 120.609 1.253 . . . . 0.0 112.853 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -54.87 -35.98 64.63 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.592 1.157 . . . . 0.0 111.156 169.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 145.85 157.27 7.21 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 108.026 -2.03 . . . . 0.0 108.026 -173.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.1 m -67.45 133.41 49.49 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 171.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 58.6 ttm -140.72 128.36 21.54 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -170.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.69 132.97 38.43 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 173.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -108.14 130.39 55.12 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 169.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.5 m -80.72 142.37 33.92 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.102 0.961 . . . . 0.0 108.554 177.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 75.7 t -76.45 118.92 23.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 169.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -105.33 161.45 14.71 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 170.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -128.93 93.81 3.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 170.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.9 tp -79.33 127.8 32.53 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -169.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.0 133.78 56.42 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.149 0.58 . . . . 0.0 110.397 -176.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.14 3.47 69.58 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-O 118.635 -1.092 . . . . 0.0 113.473 -177.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.6 t -124.81 -118.68 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.8 t -159.6 -169.27 2.52 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.024 1.33 . . . . 0.0 108.025 -176.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -70.36 143.86 51.8 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.275 0.559 . . . . 0.0 109.688 169.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.78 173.79 16.28 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.176 1.79 . . . . 0.0 107.508 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.7 mp -108.42 142.69 38.41 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 176.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.9 p -142.48 155.42 45.06 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.942 0.897 . . . . 0.0 110.579 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 41.9 t -144.85 116.43 8.12 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 172.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.3 m -69.49 133.03 47.21 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.0 mt -102.08 -66.58 0.91 Allowed 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -175.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.93 164.08 25.97 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.963 0.905 . . . . 0.0 109.753 176.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.9 m -75.49 126.9 87.0 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 169.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -87.23 -11.35 5.27 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.117 2.544 . . . . 0.0 113.545 -174.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 56.8 tp -70.61 113.49 7.77 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.054 0.843 . . . . 0.0 110.048 -171.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 52.1 m -145.03 168.09 21.12 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.337 2.255 . . . . 0.0 106.877 173.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -71.94 -32.0 66.89 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.453 -0.779 . . . . 0.0 110.337 173.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.6 m -80.81 75.36 7.75 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 169.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.6 tpt -152.38 149.9 29.11 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.418 1.487 . . . . 0.0 108.207 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 92.3 p -155.37 174.71 14.84 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.288 1.435 . . . . 0.0 107.827 173.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 41.8 pt -67.43 -24.32 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 121.582 -0.698 . . . . 0.0 111.518 169.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -75.4 -44.58 43.93 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -62.76 -34.51 77.37 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.869 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.35 -52.27 54.2 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 120.196 1.362 . . . . 0.0 111.636 176.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -72.38 -36.97 68.83 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 117.574 0.687 . . . . 0.0 111.268 -177.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 22.9 tpp85 -66.46 -34.42 77.89 Favored 'General case' 0 C--N 1.339 0.11 0 O-C-N 121.053 -1.03 . . . . 0.0 109.823 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 21.4 tp -84.38 -24.94 29.45 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 116.948 -1.501 . . . . 0.0 111.684 -175.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.7 p -66.26 -44.41 83.71 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 121.794 2.088 . . . . 0.0 108.283 169.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -62.42 -50.45 71.47 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 122.773 0.429 . . . . 0.0 111.547 176.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -64.21 -34.5 78.24 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 118.758 -0.639 . . . . 0.0 110.534 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 32.9 m -69.25 -39.5 78.43 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.524 0.602 . . . . 0.0 111.109 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.3 -50.74 62.63 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 175.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -59.51 -46.58 88.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 118.738 -0.649 . . . . 0.0 111.582 -176.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 50.6 ttp -39.55 -48.81 2.1 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.204 1.801 . . . . 0.0 111.23 169.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 23.6 pt -92.09 -20.74 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 118.776 0.716 . . . . 0.0 112.719 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.2 mt -61.65 -44.94 96.03 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.26 0.936 . . . . 0.0 109.039 171.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.9 m 51.08 36.65 15.98 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.13 0.972 . . . . 0.0 111.743 -171.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.3 tp -55.9 134.39 73.25 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 125.329 1.452 . . . . 0.0 112.767 -169.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -60.59 163.2 16.01 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.169 2.579 . . . . 0.0 112.366 169.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.5 p -63.78 145.55 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 172.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 4.7 m -63.09 142.73 58.27 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.835 0.854 . . . . 0.0 110.187 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -132.6 112.76 13.97 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 172.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -80.47 37.56 0.69 Allowed 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.843 3.029 . . . . 0.0 112.668 -173.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -152.77 141.42 20.91 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.21 1.804 . . . . 0.0 108.317 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.5 p -153.2 149.1 20.92 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 124.998 1.319 . . . . 0.0 108.397 176.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -55.04 167.25 1.74 Allowed 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.979 3.119 . . . . 0.0 112.695 169.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -59.82 132.88 55.32 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 169.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -147.75 160.54 42.61 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.568 1.147 . . . . 0.0 109.805 -172.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 73.07 -179.08 39.56 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 123.788 0.709 . . . . 0.0 112.233 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -151.37 158.32 43.6 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.4 1.48 . . . . 0.0 109.06 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -73.66 -52.21 14.09 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . 46.87 39.79 8.02 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.587 1.555 . . . . 0.0 112.617 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 97.0 mt -82.61 149.53 27.37 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.194 0.597 . . . . 0.0 109.508 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 63.0 tp -140.07 115.82 10.2 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 171.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -89.24 -22.46 22.73 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.807 0.443 . . . . 0.0 112.08 -172.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.43 -155.96 49.02 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -175.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -133.58 141.67 47.79 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 172.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 26.2 mtp-105 -117.39 3.4 12.52 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.606 0.762 . . . . 0.0 113.018 -173.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 11.6 m 61.02 173.45 0.1 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.625 1.57 . . . . 0.0 112.934 -175.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 65.92 28.97 74.11 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 119.59 -0.561 . . . . 0.0 112.458 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 54.07 52.09 13.41 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.794 1.237 . . . . 0.0 109.468 -170.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 57.9 t30 51.26 62.04 2.92 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 126.392 1.877 . . . . 0.0 111.29 -173.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.252 0 C-N-CA 124.24 1.016 . . . . 0.0 111.167 -175.571 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.3 m -66.79 146.21 54.68 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.074 0.95 . . . . 0.0 108.923 176.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -82.85 27.56 0.53 Allowed 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.399 -0.813 . . . . 0.0 111.307 -178.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -142.82 157.47 44.58 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.279 1.831 . . . . 0.0 109.32 -174.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.3 mm -127.92 128.59 69.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 126.773 2.029 . . . . 0.0 105.636 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.37 133.9 35.97 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 172.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.83 -179.14 35.46 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.159 0.885 . . . . 0.0 112.795 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -119.04 156.88 28.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.934 1.294 . . . . 0.0 112.23 -169.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -72.0 -30.4 65.19 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.137 0.975 . . . . 0.0 111.547 -178.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.4 p -158.57 -175.17 5.16 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 130.477 3.511 . . . . 0.0 105.537 172.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.1 m -56.95 146.44 59.46 Favored Pre-proline 0 CA--C 1.545 0.75 0 O-C-N 120.959 -1.088 . . . . 0.0 109.295 169.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -71.14 56.64 2.03 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 124.439 3.426 . . . . 0.0 109.945 169.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 42' ' ' VAL . 27.8 tttm -47.22 -50.93 20.0 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 126.667 1.987 . . . . 0.0 113.623 -168.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.6 -41.06 96.48 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.187 0.903 . . . . 0.0 111.567 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -70.96 -40.18 72.13 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.193 0.597 . . . . 0.0 109.768 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 94.0 t -60.11 -44.9 96.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 172.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -60.78 -55.81 28.65 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 118.744 0.702 . . . . 0.0 110.368 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.65 -41.07 98.27 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.418 0.553 . . . . 0.0 110.826 -173.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.73 -51.81 60.43 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -67.41 -28.74 68.16 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 118.161 -0.923 . . . . 0.0 111.648 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -66.72 -37.58 84.98 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 119.76 1.164 . . . . 0.0 110.108 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -72.79 -42.47 63.87 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.858 0.753 . . . . 0.0 109.23 178.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.7 mt -62.84 -45.59 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.84 -38.48 85.62 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 123.512 0.725 . . . . 0.0 111.054 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.4 ttt-85 -68.25 -48.73 64.29 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -175.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -41.77 71.58 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.26 1.024 . . . . 0.0 110.674 175.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.1 m -65.2 -42.36 93.62 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.538 1.063 . . . . 0.0 111.371 174.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -66.61 -20.4 65.99 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.483 0.713 . . . . 0.0 112.398 -175.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -60.28 -21.18 61.63 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.098 -1.001 . . . . 0.0 112.595 173.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -58.11 -24.76 59.93 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.144 0.884 . . . . 0.0 111.99 176.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.4 pp -120.58 27.27 8.65 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.486 1.514 . . . . 0.0 111.238 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.8 m 66.33 18.33 10.87 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.362 1.865 . . . . 0.0 114.009 171.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -82.7 97.57 8.62 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 169.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.6 mt -69.51 -18.04 63.64 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.161 0.984 . . . . 0.0 112.436 175.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 49.9 t60 -135.76 140.13 32.77 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 125.345 1.458 . . . . 0.0 107.743 174.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.15 120.21 6.45 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.656 2.237 . . . . 0.0 110.385 -176.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.4 m -75.78 -18.22 59.6 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.162 0.585 . . . . 0.0 112.435 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -103.88 115.88 62.63 Favored Pre-proline 0 C--O 1.235 0.302 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 173.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -62.82 117.66 4.56 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.326 2.017 . . . . 0.0 111.939 -177.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 36.1 t -61.47 127.59 21.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 169.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -139.02 149.3 44.49 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 124.066 0.947 . . . . 0.0 109.078 -174.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.447 ' O ' ' HE2' ' A' ' 13' ' ' LYS . 2.5 p -139.71 131.13 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 125.71 1.604 . . . . 0.0 109.5 -176.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 p -108.61 151.46 26.09 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.276 0.63 . . . . 0.0 109.81 169.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -116.24 142.63 46.58 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.596 1.959 . . . . 0.0 109.337 -172.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -147.58 167.42 24.57 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -168.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.5 m -4.4 132.09 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.446 1 C-N-CA 133.537 4.735 . . . . 0.0 118.319 169.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.0 tp -81.13 99.22 8.41 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 168.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -86.41 -55.46 3.89 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.337 0.517 . . . . 0.0 111.525 -169.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -140.96 71.55 1.37 Allowed 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.495 1.518 . . . . 0.0 108.316 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 64.14 16.32 59.81 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.677 0.656 . . . . 0.0 112.946 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -146.27 142.51 28.41 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.438 1.895 . . . . 0.0 107.077 -170.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -81.73 155.38 25.53 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.298 1.039 . . . . 0.0 109.785 174.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.4 162.28 13.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.229 1.014 . . . . 0.0 109.343 169.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.52 161.53 34.99 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 107.207 -2.357 . . . . 0.0 107.207 171.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 60.9 m -133.52 149.22 51.7 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 169.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.7 p -131.63 149.14 32.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 173.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.2 tt -130.56 150.78 34.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 124.899 1.279 . . . . 0.0 107.798 173.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.8 p -143.54 174.78 3.29 Favored Pre-proline 0 N--CA 1.443 -0.776 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -62.05 -21.42 72.37 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 CA-C-N 120.067 1.06 . . . . 0.0 111.619 168.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 42.5 p-90 -100.25 -26.46 13.91 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -172.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.61 172.15 17.66 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 120.285 1.402 . . . . 0.0 112.379 -174.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 tt -132.63 128.51 37.26 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 168.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.1 p -140.57 143.19 35.17 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 122.273 1.035 . . . . 0.0 110.839 177.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.16 143.78 35.11 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 167.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.4 m -132.87 144.44 36.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 125.061 1.345 . . . . 0.0 108.055 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 30.2 mt -141.45 143.92 26.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 C-N-CA 124.837 1.255 . . . . 0.0 107.901 -169.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -141.54 144.04 31.98 Favored Pre-proline 0 N--CA 1.467 0.382 0 CA-C-O 117.552 -1.213 . . . . 0.0 108.92 -172.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -63.13 150.26 89.11 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.178 1.919 . . . . 0.0 111.815 174.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.97 -179.38 39.75 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.472 1.034 . . . . 0.0 114.31 -172.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -62.14 126.53 18.88 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.001 2.467 . . . . 0.0 111.783 -170.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.3 t70 50.5 31.08 5.19 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.47 1.508 . . . . 0.0 113.249 175.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -87.0 141.97 28.28 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 171.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -103.48 90.99 3.85 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -71.94 159.58 85.06 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.363 169.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -68.77 166.45 26.17 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.448 2.099 . . . . 0.0 110.644 172.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 63.2 tp -69.26 95.54 0.78 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 170.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -74.98 146.52 41.6 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -102.48 159.64 15.26 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 122.404 1.097 . . . . 0.0 108.646 169.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 90.6 t -83.48 153.14 3.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 113.674 -1.603 . . . . 0.0 108.09 -169.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.9 m 65.84 6.46 3.99 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.905 1.682 . . . . 0.0 114.078 -176.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -80.68 161.56 24.58 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.468 1.107 . . . . 0.0 108.738 169.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -118.97 143.22 47.17 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.602 -0.686 . . . . 0.0 110.586 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.0 mp -113.84 127.16 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 170.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.29 120.18 5.52 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.5 mt -111.05 129.05 56.03 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.49 131.01 35.93 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 169.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.7 mt -140.99 155.04 68.94 Favored Pre-proline 0 C--N 1.332 -0.182 0 C-N-CA 125.69 1.596 . . . . 0.0 107.181 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -64.32 -22.81 66.13 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.058 1.839 . . . . 0.0 112.51 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -62.02 -26.48 68.26 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.149 1.38 . . . . 0.0 112.221 170.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 123.75 148.71 7.58 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -169.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.3 m -63.47 131.31 47.74 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 41.9 ttp -149.68 143.32 25.4 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -172.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.03 138.98 34.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 121.702 -0.623 . . . . 0.0 110.48 176.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -110.35 136.15 49.97 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 168.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.4 m -91.85 142.39 27.63 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -177.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.9 t -75.31 121.72 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 172.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -109.54 171.86 15.51 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 107.518 -2.233 . . . . 0.0 107.518 168.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -118.28 118.29 31.41 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 168.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.9 tp -74.45 131.27 40.91 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -58.9 123.36 16.25 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 122.607 0.363 . . . . 0.0 110.89 -170.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.99 8.1 84.65 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-O 118.672 -1.071 . . . . 0.0 113.994 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.1 t -126.03 -120.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 119.204 1.502 . . . . 0.0 107.914 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.4 m -148.05 -175.7 4.99 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.725 1.61 . . . . 0.0 109.912 -169.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -58.65 145.19 40.73 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.797 0.839 . . . . 0.0 110.542 172.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.12 165.37 35.85 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.572 1.949 . . . . 0.0 107.721 172.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.7 mp -105.33 139.45 39.95 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.7 m -140.28 153.43 46.49 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.891 0.877 . . . . 0.0 110.379 -176.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 41.2 t -143.43 118.04 9.79 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 169.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.8 m -69.72 133.42 47.48 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 174.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.6 mt -106.36 -65.35 1.08 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.432 0.693 . . . . 0.0 109.513 -172.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -145.1 161.3 39.79 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.64 1.176 . . . . 0.0 108.982 -177.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.4 m -97.47 109.38 50.01 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 169.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.14 174.28 13.07 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.144 2.562 . . . . 0.0 111.002 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 65.3 tp -59.57 133.83 56.45 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 169.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.8 p -95.79 -28.4 14.77 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -169.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -135.88 156.58 48.55 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 125.222 1.409 . . . . 0.0 109.663 -172.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.5 m 52.68 43.12 31.65 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.726 0.81 . . . . 0.0 110.558 -173.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -130.23 129.6 43.55 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 -171.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 38.8 m -113.32 171.36 7.61 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 122.631 1.205 . . . . 0.0 113.916 -168.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.47 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -63.87 -22.55 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.552 1.141 . . . . 0.0 112.262 -172.847 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -69.13 -46.97 66.3 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 119.393 0.997 . . . . 0.0 108.892 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.98 -39.95 83.33 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.63 1.104 . . . . 0.0 109.0 169.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.68 -35.18 37.54 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 123.821 0.724 . . . . 0.0 112.973 175.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -95.61 -54.05 3.51 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.876 1.338 . . . . 0.0 110.77 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -67.07 -33.04 74.64 Favored 'General case' 0 C--O 1.227 -0.094 0 C-N-CA 124.594 1.158 . . . . 0.0 112.301 -169.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.2 mt -77.9 -39.41 43.13 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 119.351 0.978 . . . . 0.0 109.073 -177.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.8 m -60.77 -47.18 87.49 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.535 1.134 . . . . 0.0 109.376 176.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.64 -48.53 80.43 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.58 1.152 . . . . 0.0 111.393 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -60.41 -40.17 90.01 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 122.614 0.365 . . . . 0.0 110.291 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 73.0 m -66.81 -24.0 66.12 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -73.18 -53.97 9.63 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.381 170.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -59.41 -37.91 79.24 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 121.306 1.866 . . . . 0.0 110.268 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 61.0 ttp -44.66 -35.9 2.85 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.987 172.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 9.0 pt -112.73 1.68 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 124.508 1.123 . . . . 0.0 113.04 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -126.19 66.86 1.21 Allowed 'General case' 0 C--O 1.233 0.199 0 C-N-CA 128.397 2.679 . . . . 0.0 105.278 175.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.5 m -71.29 32.94 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.348 1.459 . . . . 0.0 113.148 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -153.06 156.45 32.69 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 127.972 2.509 . . . . 0.0 109.171 -175.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -59.08 139.93 92.84 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.008 2.472 . . . . 0.0 112.5 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.2 p -74.63 -39.22 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.641 0.776 . . . . 0.0 109.901 173.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 8.4 m -73.52 137.06 44.18 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.586 0.754 . . . . 0.0 109.098 -175.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -146.54 118.64 4.89 Favored Pre-proline 0 C--O 1.236 0.378 0 CA-C-O 117.911 -1.042 . . . . 0.0 108.356 173.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -61.07 149.67 87.98 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.644 2.229 . . . . 0.0 112.11 176.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -77.55 118.21 19.75 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 172.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.8 t -145.17 149.68 42.56 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -51.23 -33.54 45.17 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 124.751 3.634 . . . . 0.0 115.152 173.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 64.0 t-80 -143.31 151.36 40.41 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.055 1.342 . . . . 0.0 107.592 175.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.89 139.87 57.86 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 122.779 0.431 . . . . 0.0 110.046 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -74.1 -26.96 67.3 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 119.642 -0.532 . . . . 0.0 112.542 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 78.9 mtp85 50.58 43.04 27.54 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.229 1.412 . . . . 0.0 111.582 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -69.66 153.42 43.43 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -79.46 -4.4 51.02 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.532 0.733 . . . . 0.0 112.62 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -145.42 160.23 41.87 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.892 1.677 . . . . 0.0 109.969 -176.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -88.0 122.38 31.53 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 169.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -106.37 145.84 31.19 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.427 1.091 . . . . 0.0 109.044 175.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.24 144.01 43.81 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -175.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 78.4 ttt-85 -63.64 137.95 58.3 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 48.72 38.49 11.75 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.697 1.199 . . . . 0.0 111.072 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.6 m 55.15 20.8 3.54 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.121 1.368 . . . . 0.0 114.296 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 68.77 17.8 71.62 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 121.477 -0.764 . . . . 0.0 112.961 -177.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -64.92 139.35 58.75 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 118.629 1.214 . . . . 0.0 109.435 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -69.97 139.24 52.8 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.066 0.546 . . . . 0.0 110.596 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 C-N-CA 125.618 1.567 . . . . 0.0 107.855 174.954 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.3 m -67.92 140.6 56.48 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.954 0.902 . . . . 0.0 109.364 178.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -151.13 156.92 42.01 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.21 1.404 . . . . 0.0 108.585 173.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 35.59 75.74 0.06 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 128.161 2.584 . . . . 0.0 112.218 169.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.7 mt -71.12 129.27 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 126.085 1.754 . . . . 0.0 108.943 -169.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.02 129.79 40.98 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.33 143.44 16.91 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 169.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -116.2 173.16 6.74 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.801 1.24 . . . . 0.0 111.897 -169.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -72.39 -11.28 60.62 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.743 1.617 . . . . 0.0 112.173 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 p -148.19 157.55 43.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.991 1.717 . . . . 0.0 107.991 170.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 m -62.68 158.29 52.17 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 169.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.31 55.32 4.07 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.679 3.586 . . . . 0.0 111.328 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -50.08 -49.46 51.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.95 2.1 . . . . 0.0 112.073 -169.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.55 -42.12 83.15 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 122.513 0.325 . . . . 0.0 111.24 -176.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -70.53 -39.31 74.11 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -176.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.4 t -58.91 -46.99 91.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 171.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -62.31 -50.97 69.55 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-O 118.969 -0.538 . . . . 0.0 110.885 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.34 -38.5 90.32 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.772 0.714 . . . . 0.0 111.073 -175.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.93 -49.38 75.01 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 175.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -66.91 -28.11 68.04 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 118.398 -0.811 . . . . 0.0 112.402 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -66.58 -37.88 85.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.554 1.07 . . . . 0.0 110.074 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -73.41 -41.61 63.09 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.626 -0.671 . . . . 0.0 109.35 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.8 mt -60.68 -45.83 96.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.21 -31.84 72.42 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.673 0.789 . . . . 0.0 112.045 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -65.73 -38.46 89.21 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -86.23 -13.46 46.79 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.169 1.387 . . . . 0.0 112.646 -175.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.1 m -59.73 -42.74 93.8 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.686 1.13 . . . . 0.0 111.629 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.5 mmt 45.06 52.7 8.23 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.896 1.278 . . . . 0.0 111.655 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -65.26 -22.99 66.93 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 122.001 -0.437 . . . . 0.0 111.017 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -120.12 138.27 53.67 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 168.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 45.3 mt -75.55 -0.03 18.94 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -169.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.0 m -123.76 22.31 9.01 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.781 1.632 . . . . 0.0 110.582 171.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -58.82 -43.25 90.59 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.726 0.811 . . . . 0.0 111.257 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.8 mt 51.25 -117.95 1.19 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.508 1.523 . . . . 0.0 111.271 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 31.3 t-80 -74.54 140.25 75.22 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 118.998 0.817 . . . . 0.0 110.145 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.83 69.17 2.26 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.341 2.694 . . . . 0.0 112.51 170.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.2 m -70.68 -21.53 62.58 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.578 1.151 . . . . 0.0 111.521 170.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 61.0 tpp -84.56 129.07 58.78 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 171.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -53.11 129.21 32.27 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 N-CA-C 118.625 2.51 . . . . 0.0 118.625 -168.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.668 HG13 HG22 ' A' ' 58' ' ' THR . 45.7 t -106.99 102.2 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 100.257 -3.979 . . . . 0.0 100.257 166.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -132.6 155.74 48.16 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.746 0.818 . . . . 0.0 110.885 -169.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.0 t -134.42 120.07 32.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.081 0.953 . . . . 0.0 108.676 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.9 m -91.65 143.87 26.11 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.429 1.092 . . . . 0.0 108.568 169.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -123.69 146.82 47.96 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.347 1.859 . . . . 0.0 110.128 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.485 ' CE1' ' CB ' ' A' ' 131' ' ' ALA . 81.6 m-85 -149.15 172.77 14.28 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -168.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.4 m -14.99 144.7 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.479 1 C-N-CA 133.851 4.861 . . . . 0.0 116.834 169.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.9 tp -78.85 71.08 5.29 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.159 0.984 . . . . 0.0 109.514 172.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -70.04 119.92 14.98 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.518 1.527 . . . . 0.0 108.686 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 50.72 36.2 13.67 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.944 0.898 . . . . 0.0 111.914 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.87 10.84 80.37 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-O 118.379 -1.234 . . . . 0.0 114.418 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -142.24 141.95 32.56 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 120.11 1.955 . . . . 0.0 109.849 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -67.1 140.14 57.56 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 121.164 -0.96 . . . . 0.0 109.788 -173.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.66 162.21 15.72 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 171.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -171.01 167.34 40.51 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 176.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 3.5 m -141.72 147.26 37.13 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 169.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.7 p -120.41 141.88 38.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 169.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.7 tt -123.04 148.52 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 169.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.668 HG22 HG13 ' A' ' 40' ' ' VAL . 40.6 p -141.61 175.61 2.91 Favored Pre-proline 0 N--CA 1.441 -0.876 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 169.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -65.71 -21.65 58.39 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.184 1.256 . . . . 0.0 111.817 169.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 42.6 p-90 -97.94 -21.87 16.62 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.46 177.78 9.75 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.878 1.672 . . . . 0.0 112.906 -176.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 tt -143.75 127.28 16.95 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 103.102 -2.925 . . . . 0.0 103.102 168.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.5 m -137.25 130.62 31.18 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 124.167 0.917 . . . . 0.0 109.215 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.51 147.79 43.69 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 168.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.89 151.85 29.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 72.4 mt -135.83 134.01 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 105.553 -2.018 . . . . 0.0 105.553 177.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -129.62 141.42 41.78 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 118.117 -0.944 . . . . 0.0 110.872 -169.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -54.43 142.17 70.7 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.906 2.404 . . . . 0.0 113.76 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.18 173.92 53.64 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.342 0.972 . . . . 0.0 112.825 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -65.83 148.41 86.35 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.266 2.644 . . . . 0.0 112.035 -175.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.5 t70 53.15 44.26 30.52 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.249 1.419 . . . . 0.0 111.857 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -118.67 148.14 43.05 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.838 1.255 . . . . 0.0 108.249 173.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.43 84.31 2.11 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 172.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 8.8 t90 -71.45 121.65 84.92 Favored Pre-proline 0 C--O 1.235 0.316 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -170.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -56.17 147.88 63.04 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.171 1.914 . . . . 0.0 112.274 -175.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 40.7 tp -58.5 128.06 35.26 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 169.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -109.95 159.47 17.23 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.145 0.978 . . . . 0.0 109.698 -178.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -86.3 142.69 28.34 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 168.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.8 t -88.96 154.91 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -169.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.2 m 65.87 10.32 6.79 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.242 1.417 . . . . 0.0 113.706 -177.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -80.93 153.74 27.37 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.833 1.253 . . . . 0.0 108.131 169.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -107.76 142.73 37.32 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.383 0.538 . . . . 0.0 110.214 176.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.6 mm -118.46 124.21 72.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 173.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.94 120.95 5.6 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 176.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 72.3 mt -106.58 124.75 50.07 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.86 79.46 9.24 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 55.9 mt -74.92 145.93 81.97 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 172.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -60.32 -25.61 80.67 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 121.662 1.575 . . . . 0.0 112.763 170.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -55.4 -30.38 60.31 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.527 1.531 . . . . 0.0 111.952 170.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.72 143.21 4.57 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 107.974 -2.05 . . . . 0.0 107.974 -171.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.8 m -61.45 131.25 49.58 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 60.1 ttm -140.22 129.97 24.47 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.28 132.66 35.87 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 118.721 0.691 . . . . 0.0 109.22 173.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -106.24 135.1 48.31 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 169.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.3 m -87.93 137.88 31.94 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 70.1 t -68.96 122.1 19.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 170.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -107.25 157.05 15.7 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 171.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -122.42 95.42 4.63 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 170.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.9 tt -72.77 115.84 12.55 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -175.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.46 131.68 51.51 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 122.633 0.373 . . . . 0.0 111.378 -173.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.66 2.96 71.27 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 118.888 -0.951 . . . . 0.0 113.402 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.3 t -123.72 -103.33 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.5 p -164.01 171.69 14.88 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.719 1.6 . . . . 0.0 111.089 -173.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -73.49 144.7 46.1 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 169.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.54 179.68 8.39 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.826 1.65 . . . . 0.0 108.594 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.2 mt -109.22 137.87 46.44 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.5 m -140.62 158.24 44.28 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.092 0.957 . . . . 0.0 111.275 -173.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 38.7 t -143.44 108.95 5.08 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 169.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.2 m -85.75 143.82 28.12 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.991 0.916 . . . . 0.0 109.942 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.43 -10.7 0.73 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -172.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 10.0 tpp -125.0 147.14 49.08 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 120.592 1.542 . . . . 0.0 111.778 -170.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.1 m -92.05 166.83 16.51 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.584 1.154 . . . . 0.0 111.158 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -63.16 156.34 55.9 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.65 2.233 . . . . 0.0 113.77 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 24.4 tp 49.88 69.14 0.64 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 126.713 2.005 . . . . 0.0 111.52 172.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.9 m -58.12 150.49 21.11 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.26 172.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -78.95 146.7 33.3 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.8 m 55.63 27.24 10.23 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.684 1.194 . . . . 0.0 112.736 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.13 140.87 56.19 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -177.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.6 p -161.48 178.85 8.73 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.119 1.368 . . . . 0.0 108.594 -170.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -62.32 -28.57 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 O-C-N 121.472 -0.768 . . . . 0.0 110.624 169.675 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -68.03 -49.0 64.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -65.91 -39.37 90.51 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.668 0.667 . . . . 0.0 110.017 177.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.12 -25.31 59.69 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.569 1.08 . . . . 0.0 112.696 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -96.33 -52.37 4.01 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.321 1.06 . . . . 0.0 110.672 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 44.1 mtm-85 -65.2 -41.71 94.23 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.648 -0.658 . . . . 0.0 112.199 -170.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.72 -35.74 60.18 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 119.406 1.003 . . . . 0.0 110.596 -170.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.64 -45.56 93.62 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.851 0.75 . . . . 0.0 109.067 175.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -66.63 -48.44 69.46 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.012 1.325 . . . . 0.0 111.46 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.61 -38.93 92.71 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.43 -0.794 . . . . 0.0 111.793 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 88.8 m -71.21 -24.16 62.16 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 119.499 -0.286 . . . . 0.0 111.276 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.485 ' CB ' ' CE1' ' A' ' 45' ' ' PHE . . . -78.96 -47.17 16.84 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 118.845 0.748 . . . . 0.0 109.037 169.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.1 ttp-105 -55.74 -41.95 74.68 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.731 0.812 . . . . 0.0 112.025 -177.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 16.9 ptt? -55.1 -50.09 70.09 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 118.613 0.642 . . . . 0.0 110.658 175.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 42.8 pt -75.81 -19.8 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 O-C-N 120.957 -1.089 . . . . 0.0 111.376 -177.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.6 tp -65.08 -3.47 3.7 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.857 2.063 . . . . 0.0 110.337 169.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.0 m 63.2 26.97 15.45 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.918 2.087 . . . . 0.0 112.779 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.2 mp -96.82 157.31 35.37 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 124.994 1.318 . . . . 0.0 107.748 169.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.19 155.6 19.06 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 123.222 2.615 . . . . 0.0 111.5 169.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.6 m -69.28 165.1 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 121.637 0.732 . . . . 0.0 109.872 175.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 92.2 m -55.53 133.17 50.06 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.119 1.368 . . . . 0.0 111.923 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -90.58 122.64 66.88 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 105.339 -2.096 . . . . 0.0 105.339 168.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.64 156.88 62.5 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.168 1.912 . . . . 0.0 112.634 -169.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -69.24 130.53 42.88 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 170.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.3 m -138.52 157.35 72.39 Favored Pre-proline 0 C--O 1.239 0.51 0 C-N-CA 125.038 1.335 . . . . 0.0 110.165 -169.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -68.14 149.56 76.57 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.455 2.103 . . . . 0.0 111.955 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 19.1 t60 54.27 24.82 5.3 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.595 1.958 . . . . 0.0 113.914 173.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -159.57 -41.12 0.05 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.489 -0.757 . . . . 0.0 111.967 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -71.11 129.68 18.24 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -176.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -83.24 127.97 34.1 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 169.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -73.64 141.37 46.51 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -176.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -141.93 25.86 1.92 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.472 1.109 . . . . 0.0 110.773 177.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -81.46 150.88 28.11 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.278 0.631 . . . . 0.0 110.446 -175.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -150.54 148.59 28.87 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 126.188 1.795 . . . . 0.0 107.544 169.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -135.65 167.43 21.14 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.222 1.009 . . . . 0.0 110.711 -169.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 76.84 173.19 37.51 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.099 0.857 . . . . 0.0 113.371 172.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -144.59 162.81 35.68 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.49 2.316 . . . . 0.0 106.207 174.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -62.76 130.96 47.21 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.9 m -61.53 150.24 36.51 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.701 0.8 . . . . 0.0 111.496 -175.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -160.54 -120.25 0.55 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 107.926 -2.07 . . . . 0.0 107.926 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -63.35 -39.52 94.78 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 172.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -87.47 133.14 33.8 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 169.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.344 0 C-N-CA 125.153 1.381 . . . . 0.0 107.723 175.739 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.3 p -73.04 151.84 41.55 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.925 0.89 . . . . 0.0 109.819 176.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -84.33 16.44 3.05 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 122.007 0.908 . . . . 0.0 112.46 175.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -144.48 159.49 42.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.731 2.412 . . . . 0.0 108.226 -175.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.2 mm -123.64 128.61 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 173.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.69 142.44 42.51 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.6 151.74 50.56 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.487 1.041 . . . . 0.0 112.052 176.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -102.91 154.72 18.93 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.733 1.213 . . . . 0.0 109.996 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -84.73 -21.12 30.2 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.694 -0.629 . . . . 0.0 112.265 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.9 p -158.39 -176.67 6.03 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 129.476 3.11 . . . . 0.0 105.987 170.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.0 m -58.44 145.17 76.68 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 168.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -73.59 59.23 4.03 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.817 3.011 . . . . 0.0 108.943 169.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.5 tttm -50.54 -51.62 46.22 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.638 1.975 . . . . 0.0 112.481 -168.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.93 -40.89 91.83 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.6 0.36 . . . . 0.0 111.707 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -69.3 -45.32 69.86 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.887 0.875 . . . . 0.0 109.773 -174.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 73.7 t -62.13 -42.97 97.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.372 1.069 . . . . 0.0 108.471 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -59.64 -54.01 51.39 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.469 0.577 . . . . 0.0 110.041 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.0 -39.68 93.81 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.194 0.598 . . . . 0.0 111.112 -175.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.03 -46.32 78.3 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -70.86 -27.17 63.64 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-O 117.918 -1.039 . . . . 0.0 112.071 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -61.69 -38.27 87.22 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 120.055 1.298 . . . . 0.0 110.211 171.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -73.8 -41.71 61.97 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 121.702 -0.624 . . . . 0.0 109.389 -177.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.6 mt -61.27 -43.88 97.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.3 -27.28 68.92 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.077 0.853 . . . . 0.0 112.146 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -79.81 -42.32 24.61 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.019 0.928 . . . . 0.0 109.17 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -76.92 -25.48 52.98 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.788 0.835 . . . . 0.0 111.702 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.3 m -72.14 102.3 3.0 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.3 mpt? 64.91 -34.39 0.17 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 128.585 2.754 . . . . 0.0 116.594 169.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -68.25 -57.17 6.4 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 120.012 1.278 . . . . 0.0 109.87 -176.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.2 t0 48.56 38.23 10.76 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.237 1.415 . . . . 0.0 111.704 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.4 tp -151.99 -25.71 0.18 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.414 1.485 . . . . 0.0 111.415 -169.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.87 20.07 0.19 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.57 1.148 . . . . 0.0 113.806 -169.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -78.07 -24.06 47.82 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.912 -1.117 . . . . 0.0 109.322 169.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.4 mt -68.35 -51.98 38.34 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.549 0.739 . . . . 0.0 109.169 174.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -160.76 152.17 16.08 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 127.177 2.191 . . . . 0.0 107.092 175.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -63.68 146.36 92.23 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.05 1.833 . . . . 0.0 110.606 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.4 p -65.99 -46.55 77.6 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.876 0.871 . . . . 0.0 109.237 173.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.1 tpp -146.57 126.85 6.93 Favored Pre-proline 0 C--O 1.234 0.254 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 169.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.03 131.54 45.2 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.25 1.966 . . . . 0.0 112.342 178.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.8 t -73.58 139.4 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 169.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -142.65 154.39 44.31 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.968 0.907 . . . . 0.0 108.923 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.2 t -141.09 125.21 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.748 0.819 . . . . 0.0 108.895 -173.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.4 m -89.15 144.02 26.42 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.203 1.001 . . . . 0.0 108.745 168.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -119.96 135.82 54.76 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.792 1.637 . . . . 0.0 108.035 169.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -167.57 143.33 4.03 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -176.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.7 m 57.17 166.4 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.525 2.33 . . . . 0.0 115.341 167.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.1 tp -120.99 66.63 0.86 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.806 1.242 . . . . 0.0 108.521 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.2 131.27 42.53 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.646 -0.658 . . . . 0.0 110.117 -175.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 52.38 31.5 9.67 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.477 1.111 . . . . 0.0 111.87 -175.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.65 11.06 85.82 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 118.153 -1.359 . . . . 0.0 113.613 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -125.36 143.76 50.82 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.893 1.847 . . . . 0.0 108.062 -174.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -67.97 138.39 55.88 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.416 1.007 . . . . 0.0 109.549 -176.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.65 155.39 17.34 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.95 171.43 37.87 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 173.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 45.0 m -140.32 150.62 44.23 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 169.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.4 p -127.66 141.76 45.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 124.853 1.261 . . . . 0.0 107.602 175.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.0 tt -118.52 149.04 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 169.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.6 p -142.83 172.61 5.51 Favored Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 171.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.36 -19.09 65.18 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 CA-C-N 120.149 1.089 . . . . 0.0 111.646 168.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 37.8 p-90 -102.16 -23.36 14.05 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.518 1.054 . . . . 0.0 113.836 -172.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.74 166.06 24.77 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.819 1.247 . . . . 0.0 111.882 -175.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 tt -132.94 124.74 28.37 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 104.2 -2.518 . . . . 0.0 104.2 168.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.2 m -137.63 133.15 34.01 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.367 0.604 . . . . 0.0 110.891 -176.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.35 148.28 49.9 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 168.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.4 m -139.97 151.88 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 123.946 0.898 . . . . 0.0 109.038 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.6 mt -138.32 145.63 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -133.15 142.49 44.67 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.191 -176.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -44.8 129.42 9.46 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 124.012 3.142 . . . . 0.0 112.447 174.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.97 178.62 15.56 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.085 0.85 . . . . 0.0 114.525 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -67.33 131.16 24.16 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.381 2.721 . . . . 0.0 111.141 -172.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.8 t70 51.15 31.34 6.56 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.538 1.535 . . . . 0.0 113.219 175.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -88.96 155.63 19.39 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -116.8 88.12 2.83 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 170.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -67.24 151.18 97.4 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.164 174.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.38 159.42 49.37 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.256 1.97 . . . . 0.0 109.284 169.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 51.9 tp -64.53 118.75 9.26 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 169.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -88.95 158.98 17.86 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.41 138.26 31.9 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 168.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.7 t -83.13 154.98 3.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 123.834 0.853 . . . . 0.0 108.704 -169.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.1 m 66.23 9.97 6.77 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.295 1.438 . . . . 0.0 113.828 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -83.8 163.0 20.42 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.807 1.243 . . . . 0.0 107.891 168.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -110.93 142.16 43.39 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 118.923 0.783 . . . . 0.0 111.02 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 30.4 mm -113.45 130.96 66.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.08 123.09 6.01 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -109.97 155.31 21.94 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.897 1.279 . . . . 0.0 108.328 170.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.0 tp60 -126.7 131.74 51.31 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 169.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -155.57 166.14 16.89 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 126.067 1.747 . . . . 0.0 107.199 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -57.72 -22.54 53.29 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.697 2.265 . . . . 0.0 115.0 -174.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -58.29 -33.51 69.53 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.681 0.792 . . . . 0.0 111.715 172.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.24 177.89 15.67 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.677 1.608 . . . . 0.0 110.03 -176.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.2 m -67.01 128.13 35.2 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 169.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 41.0 ttp -147.35 130.74 16.64 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.25 141.71 33.85 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 172.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -113.17 135.92 53.29 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 169.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.2 m -80.26 143.81 33.39 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 176.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 62.6 t -76.14 125.72 36.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 170.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -108.97 156.02 15.82 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -133.95 123.32 24.44 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 170.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.6 tp -141.23 144.08 34.52 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.36 0.527 . . . . 0.0 110.171 -172.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -54.27 131.55 41.88 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.32 1.048 . . . . 0.0 110.788 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.8 -1.36 58.77 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 118.717 -1.046 . . . . 0.0 113.591 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 44.8 t -121.57 -28.64 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 119.441 1.62 . . . . 0.0 109.947 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.1 m 60.11 -144.86 0.51 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.804 1.241 . . . . 0.0 108.279 -170.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -83.44 136.6 34.25 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.847 0.749 . . . . 0.0 110.654 -175.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -156.91 175.72 13.7 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.257 1.823 . . . . 0.0 107.869 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.2 mp -116.53 147.09 42.13 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.323 1.049 . . . . 0.0 108.501 -177.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.6 p -143.65 153.04 42.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.754 1.222 . . . . 0.0 110.615 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.8 t -147.28 121.93 9.83 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 170.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.9 m -72.97 137.57 45.56 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.334 0.515 . . . . 0.0 109.99 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -89.17 -66.78 0.89 Allowed 'General case' 0 C--N 1.338 0.102 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 171.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.78 174.64 7.44 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.031 1.332 . . . . 0.0 108.859 -175.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.6 m -85.37 121.29 73.72 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 169.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -88.64 4.71 5.41 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.372 2.715 . . . . 0.0 113.091 -173.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 57.2 tp -67.15 117.72 9.57 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.727 0.694 . . . . 0.0 110.531 -170.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.8 m -144.24 159.52 42.53 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.849 2.06 . . . . 0.0 106.662 171.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -82.97 -29.94 28.63 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.126 0.421 . . . . 0.0 111.29 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.9 m -82.92 60.14 5.25 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.634 1.173 . . . . 0.0 109.032 174.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.22 138.67 35.28 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.276 1.43 . . . . 0.0 108.053 -170.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.3 m -145.16 167.96 21.5 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.726 1.61 . . . . 0.0 108.141 -175.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.49 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -57.1 -27.17 26.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.674 -0.641 . . . . 0.0 111.619 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.39 -42.26 96.23 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.977 0.511 . . . . 0.0 110.148 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -67.88 -29.28 68.36 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.043 0.937 . . . . 0.0 110.482 171.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.85 -60.87 8.02 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 169.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -65.06 -49.61 69.39 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.864 -0.786 . . . . 0.0 110.279 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -58.08 -45.34 87.3 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 124.439 1.096 . . . . 0.0 110.688 -175.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.5 tp -79.66 -25.76 41.22 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 119.858 1.208 . . . . 0.0 111.668 -173.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.4 m -69.61 -42.88 73.8 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.829 1.195 . . . . 0.0 109.197 173.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.51 -41.55 79.83 Favored 'General case' 0 N--CA 1.461 0.095 0 C-N-CA 123.165 0.586 . . . . 0.0 111.358 177.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -66.22 -29.64 69.94 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.351 -0.843 . . . . 0.0 110.267 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 20.0 m -69.53 -43.34 73.21 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.991 0.814 . . . . 0.0 110.239 175.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -56.41 -52.92 62.85 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.59 0.756 . . . . 0.0 109.698 171.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -52.61 -53.86 40.99 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.91 1.284 . . . . 0.0 110.559 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 54.0 ttp -49.24 -50.16 39.86 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.607 1.563 . . . . 0.0 110.922 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 6.4 pt -82.12 -19.93 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 119.027 0.83 . . . . 0.0 112.513 -174.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 74.4 mt -72.89 -33.21 65.89 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.387 0.54 . . . . 0.0 109.729 169.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.5 m 55.26 28.51 11.34 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.516 1.926 . . . . 0.0 113.685 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 84.9 mt -85.69 147.09 45.38 Favored Pre-proline 0 C--O 1.236 0.353 0 C-N-CA 124.411 1.084 . . . . 0.0 109.445 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -62.78 155.57 58.8 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 123.637 2.892 . . . . 0.0 111.286 174.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.0 p -60.82 139.13 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 123.529 0.731 . . . . 0.0 110.284 -173.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 2.7 m -73.87 147.17 43.5 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.749 0.819 . . . . 0.0 109.261 -177.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -108.23 105.94 57.59 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 169.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -82.14 35.53 0.58 Allowed 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.726 2.95 . . . . 0.0 112.505 -170.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -153.26 140.67 19.69 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.02 1.728 . . . . 0.0 108.665 177.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.6 t -143.85 147.74 39.69 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 175.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -52.59 156.13 9.18 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.758 2.972 . . . . 0.0 111.667 168.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -62.74 138.87 58.62 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 175.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.18 147.71 38.25 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.02 0.528 . . . . 0.0 110.27 -176.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -74.24 160.17 53.05 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 173.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -147.63 141.18 25.46 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.254 1.421 . . . . 0.0 107.33 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.55 142.21 48.46 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -130.38 21.66 5.19 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.137 1.375 . . . . 0.0 110.646 173.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.5 pp -80.8 160.3 24.88 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.212 1.005 . . . . 0.0 110.853 -176.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -144.29 157.26 44.37 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.372 1.469 . . . . 0.0 108.515 170.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -72.16 129.74 39.21 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.09 138.65 29.84 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.2 mpt_? -86.34 149.75 24.82 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 171.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -128.86 19.03 6.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.262 1.025 . . . . 0.0 112.545 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.6 m 59.35 179.6 0.08 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.322 1.449 . . . . 0.0 112.177 -173.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -174.14 -127.02 0.96 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.68 -30.52 71.54 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.056 0.428 . . . . 0.0 110.214 171.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -93.47 133.48 36.71 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 169.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.28 0 C-N-CA 125.63 1.572 . . . . 0.0 107.753 176.783 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 120.765 0.317 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.1 p -72.69 157.65 37.13 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.192 0.997 . . . . 0.0 110.032 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -138.32 41.35 2.24 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.485 1.114 . . . . 0.0 108.518 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -142.25 158.84 43.27 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.192 1.397 . . . . 0.0 109.317 -172.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.4 mm -120.94 128.93 76.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 171.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.47 131.97 42.39 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.86 151.48 51.2 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.109 0.861 . . . . 0.0 111.096 174.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -93.84 138.45 31.99 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.282 1.033 . . . . 0.0 109.736 -175.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -71.1 -34.03 70.73 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.909 -0.567 . . . . 0.0 109.902 176.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.3 p -156.64 161.78 39.88 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 128.618 2.767 . . . . 0.0 106.812 169.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.0 m -51.82 137.44 34.75 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.226 1.011 . . . . 0.0 112.346 -174.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -76.55 46.71 1.92 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 124.907 3.738 . . . . 0.0 110.555 172.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -62.64 -31.77 72.69 Favored 'General case' 0 C--O 1.221 -0.438 0 O-C-N 120.498 -1.376 . . . . 0.0 113.232 -168.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.76 -42.64 94.97 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 118.762 0.71 . . . . 0.0 111.006 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -72.84 -39.3 66.67 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -177.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.2 t -58.46 -46.42 89.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 171.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -60.77 -53.18 60.52 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 123.526 0.73 . . . . 0.0 110.371 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.55 -40.36 95.44 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.694 0.679 . . . . 0.0 110.931 -174.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.21 -41.82 80.73 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.013 -0.43 . . . . 0.0 110.506 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -69.52 -27.33 65.08 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-O 118.331 -0.843 . . . . 0.0 112.415 175.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -63.22 -36.74 84.64 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.569 1.077 . . . . 0.0 109.104 172.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -71.48 -46.25 60.33 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.2 mt -61.01 -36.87 75.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 123.491 0.717 . . . . 0.0 109.845 177.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.74 -36.39 78.32 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.196 -0.94 . . . . 0.0 110.614 176.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.7 ttm105 -70.57 -34.8 72.62 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.448 1.099 . . . . 0.0 110.061 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -65.31 -2.44 3.1 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.092 1.357 . . . . 0.0 111.645 169.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.6 m 54.3 72.71 0.44 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.496 1.918 . . . . 0.0 113.234 169.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 4.5 tmm? -62.93 -52.81 61.62 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 169.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -81.01 164.08 22.78 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 168.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -86.96 106.18 17.63 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.1 mt -79.19 85.0 5.1 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -174.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.1 m -46.25 160.71 0.06 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.416 1.487 . . . . 0.0 111.974 169.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -63.45 -9.87 14.71 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -169.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.0 mt -65.13 166.02 10.3 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.591 0.756 . . . . 0.0 110.888 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -65.64 160.54 59.91 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 170.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -55.31 123.45 13.83 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.304 2.003 . . . . 0.0 111.017 -176.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.6 p -72.95 -28.18 62.27 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 123.572 0.749 . . . . 0.0 112.29 -170.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 76.4 mtm -142.62 134.19 13.04 Favored Pre-proline 0 N--CA 1.45 -0.442 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 170.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -72.64 144.03 38.98 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 N-CA-C 108.562 -1.361 . . . . 0.0 108.562 -172.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.47 HG13 HG22 ' A' ' 58' ' ' THR . 97.1 t -65.62 108.66 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 169.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -149.53 155.73 40.8 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.36 1.464 . . . . 0.0 109.256 -168.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.7 t -140.12 120.1 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.9 m -85.39 148.4 26.03 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.851 0.86 . . . . 0.0 109.792 169.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -125.28 141.86 51.84 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.828 2.051 . . . . 0.0 110.567 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.454 ' CE2' ' CB ' ' A' ' 131' ' ' ALA . 98.4 m-85 -149.61 171.16 17.1 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -169.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.8 m -6.64 135.99 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.357 1 C-N-CA 133.43 4.692 . . . . 0.0 117.285 169.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.0 tt -78.53 103.61 8.59 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 168.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -84.92 -138.65 0.07 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.026 1.73 . . . . 0.0 107.872 -174.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -73.46 74.21 1.41 Allowed 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.823 -1.173 . . . . 0.0 110.129 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.79 16.33 78.05 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.542 1.068 . . . . 0.0 113.665 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -153.69 140.43 19.02 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.687 1.243 . . . . 0.0 109.862 -172.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -77.32 148.02 35.88 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.996 1.318 . . . . 0.0 110.063 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.58 158.29 15.86 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.61 0.719 . . . . 0.0 110.374 175.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -167.05 168.88 40.62 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 175.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 15.4 m -143.43 142.82 31.35 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 169.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.6 p -114.27 149.96 16.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 124.958 1.303 . . . . 0.0 107.678 172.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.4 tt -136.59 156.67 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 169.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.47 HG22 HG13 ' A' ' 40' ' ' VAL . 44.6 p -146.47 177.35 1.8 Allowed Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 126.353 1.861 . . . . 0.0 106.816 175.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -59.49 -28.88 88.6 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 CA-C-N 120.154 1.091 . . . . 0.0 111.015 168.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 50.0 p-90 -97.19 -19.41 18.64 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -171.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.67 172.81 15.64 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.804 1.638 . . . . 0.0 113.717 -176.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 tt -135.68 126.15 26.81 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 103.523 -2.769 . . . . 0.0 103.523 167.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.8 m -135.33 134.25 39.64 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.21 146.5 47.29 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 169.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.1 m -139.35 147.12 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 123.639 0.775 . . . . 0.0 109.335 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.9 mm -140.64 142.94 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -171.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -132.81 140.11 36.69 Favored Pre-proline 0 N--CA 1.468 0.43 0 CA-C-O 117.482 -1.247 . . . . 0.0 109.445 -175.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -57.14 142.35 94.39 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.151 1.901 . . . . 0.0 111.29 175.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.99 -179.3 29.16 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.731 1.158 . . . . 0.0 114.24 -171.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.87 145.34 56.21 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.35 2.7 . . . . 0.0 111.779 -171.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.6 t0 43.16 57.08 3.89 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.395 1.878 . . . . 0.0 112.395 174.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -142.84 146.59 34.29 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -172.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -117.12 101.0 8.1 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -76.12 154.72 84.56 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 169.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -69.97 158.9 55.18 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.187 1.924 . . . . 0.0 110.798 172.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 66.0 tp -64.09 136.74 57.53 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 169.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -118.79 160.49 21.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.109 0.868 . . . . 0.0 109.052 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -86.11 149.56 25.04 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 169.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 36.0 t -90.6 154.73 3.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -169.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.0 m 61.67 28.25 17.44 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.798 0.839 . . . . 0.0 112.344 -175.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -107.46 154.38 21.44 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.819 2.047 . . . . 0.0 107.264 169.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -104.76 147.88 27.22 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.333 0.969 . . . . 0.0 111.463 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.6 mm -122.97 132.12 72.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 176.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -81.75 123.33 6.02 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.5 mp -106.26 134.0 50.08 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 169.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -89.93 116.6 28.12 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 169.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.1 mt -106.12 155.53 38.34 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 169.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.31 -28.03 55.39 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 CA-C-N 120.187 1.102 . . . . 0.0 111.136 169.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -52.46 -38.66 59.82 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.688 1.595 . . . . 0.0 111.517 169.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 153.53 169.88 19.03 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -174.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.3 m -71.74 130.39 41.01 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 173.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 60.4 ttm -138.23 123.43 19.26 Favored 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.35 136.36 37.68 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.483 -0.761 . . . . 0.0 109.135 170.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -111.49 140.76 45.82 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 169.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.5 m -90.12 141.45 28.68 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.2 t -70.49 119.1 16.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 169.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -102.53 158.39 18.0 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 108.052 -2.019 . . . . 0.0 108.052 169.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -132.81 122.28 24.23 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 169.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.6 tp -138.26 147.81 44.07 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.794 0.838 . . . . 0.0 109.127 -169.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -58.1 128.91 39.47 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.227 0.611 . . . . 0.0 111.503 -172.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.53 -30.64 1.94 Allowed Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.731 1.634 . . . . 0.0 112.812 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.4 t -79.58 -29.15 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.847 1.659 . . . . 0.0 110.003 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.0 m 56.75 -139.36 0.92 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 -169.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -84.18 138.36 33.03 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.155 0.889 . . . . 0.0 110.956 -175.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -155.98 169.1 25.23 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.936 2.094 . . . . 0.0 107.115 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.8 mp -112.06 140.68 46.54 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.2 m -138.3 151.14 47.31 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.29 1.036 . . . . 0.0 110.211 -173.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 44.3 t -138.92 115.67 10.72 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 169.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.5 m -67.44 123.93 21.78 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.28 -47.32 4.98 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.237 0.615 . . . . 0.0 110.47 -170.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 16.2 ptp -159.62 163.9 34.58 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.103 0.961 . . . . 0.0 109.413 175.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.519 ' H ' ' HD2' ' A' ' 113' ' ' PRO . 13.9 m -123.01 -57.63 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 117.643 -1.17 . . . . 0.0 112.217 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.519 ' HD2' ' H ' ' A' ' 112' ' ' SER . 61.3 Cg_endo -68.32 150.76 76.46 Favored 'Trans proline' 0 C--N 1.353 0.804 0 CA-C-N 121.616 1.613 . . . . 0.0 112.074 -174.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 19.5 tp -74.21 129.88 38.66 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 172.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 38.0 m -69.89 138.98 52.93 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 172.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -43.38 -52.25 6.01 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.391 1.476 . . . . 0.0 113.655 -169.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.2 m -99.59 10.78 40.74 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.25 0.62 . . . . 0.0 112.513 -171.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 5.2 ptm -93.56 146.73 23.58 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.495 0.718 . . . . 0.0 110.19 -175.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 43.1 m -136.67 -166.7 1.94 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.982 1.713 . . . . 0.0 108.527 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.3 pt -60.52 -25.49 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -174.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -75.72 -47.28 26.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 30.0 mp0 -61.47 -35.36 77.41 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.365 1.066 . . . . 0.0 109.623 169.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.84 -54.06 41.13 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 120.197 1.362 . . . . 0.0 110.842 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -64.81 -48.2 75.28 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.528 -0.983 . . . . 0.0 110.275 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 75.5 mtp85 -64.11 -30.85 71.89 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 122.785 0.434 . . . . 0.0 111.387 -177.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.2 tp -82.57 -22.68 34.78 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-O 118.003 -0.999 . . . . 0.0 111.311 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.2 m -64.28 -46.24 84.55 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.304 1.411 . . . . 0.0 107.762 169.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -64.53 -51.29 63.66 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.006 0.922 . . . . 0.0 111.659 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -61.44 -36.03 79.23 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.628 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 21.8 m -64.01 -39.59 94.44 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.252 0.478 . . . . 0.0 110.211 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.454 ' CB ' ' CE2' ' A' ' 45' ' ' PHE . . . -65.81 -48.81 70.46 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 121.635 -0.666 . . . . 0.0 110.59 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.5 ptt85 -67.32 -27.26 67.0 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.444 1.474 . . . . 0.0 112.641 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -56.61 -45.5 81.43 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.324 169.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 12.7 pt -81.84 -25.38 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 119.731 1.151 . . . . 0.0 113.118 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 70.8 mt -62.7 -38.08 89.03 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.845 1.202 . . . . 0.0 109.154 169.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.6 m 56.74 20.27 4.99 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.534 1.934 . . . . 0.0 112.837 -169.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 98.3 mt -153.35 156.1 32.22 Favored Pre-proline 0 C--O 1.236 0.389 0 C-N-CA 128.844 2.858 . . . . 0.0 107.65 -170.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.11 164.21 23.19 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.771 2.314 . . . . 0.0 109.75 168.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.5 t -65.53 143.71 15.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 20.2 m -127.59 127.05 43.21 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.173 0.989 . . . . 0.0 109.593 -169.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -77.78 127.15 82.95 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 168.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -59.76 131.31 39.23 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 121.994 1.796 . . . . 0.0 112.606 -171.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -159.04 147.5 18.14 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.088 1.755 . . . . 0.0 107.91 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.2 p -149.84 148.34 25.08 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 124.145 0.978 . . . . 0.0 108.829 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -55.48 168.13 1.67 Allowed 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.975 3.117 . . . . 0.0 112.583 169.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -64.08 113.88 3.8 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -89.35 -12.9 39.16 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.623 0.769 . . . . 0.0 112.556 -172.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 68.09 -163.64 47.83 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -171.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -148.16 143.99 27.46 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.04 1.336 . . . . 0.0 108.004 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 27.4 mmt85 -71.17 153.63 42.34 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.41 119.2 19.17 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 169.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -153.88 165.6 35.57 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.105 1.362 . . . . 0.0 109.662 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 62.5 tp -145.32 140.12 27.52 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 173.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -79.01 119.4 22.11 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 172.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 62.61 -157.81 37.25 Favored Glycine 0 CA--C 1.532 1.145 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -172.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -150.86 146.41 26.31 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.22 -1.771 . . . . 0.0 106.22 172.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -65.63 136.6 56.54 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.9 m -74.75 -1.02 20.11 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.446 1.099 . . . . 0.0 113.857 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 82.21 -57.62 4.98 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.484 1.516 . . . . 0.0 111.24 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -78.55 -19.82 52.0 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.548 0.739 . . . . 0.0 111.633 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -75.66 137.79 40.93 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.212 0.605 . . . . 0.0 109.455 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 C-N-CA 125.52 1.528 . . . . 0.0 107.794 177.108 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.7 m 65.87 158.92 0.12 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.691 1.596 . . . . 0.0 111.877 -176.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -121.25 133.82 55.16 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 174.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -146.87 169.87 18.23 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.587 1.155 . . . . 0.0 109.905 -169.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.9 mt -119.29 138.77 48.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 171.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.35 160.81 31.6 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.159 0.583 . . . . 0.0 110.865 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.03 160.73 52.89 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.631 -0.587 . . . . 0.0 111.631 171.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -120.53 144.39 48.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.81 1.244 . . . . 0.0 111.918 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -104.96 81.25 1.72 Allowed 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.203 -1.776 . . . . 0.0 106.203 169.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.9 p 63.58 176.16 0.16 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 127.249 2.22 . . . . 0.0 111.28 -169.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.1 m -59.9 150.32 69.41 Favored Pre-proline 0 CA--C 1.541 0.625 0 O-C-N 121.713 -0.617 . . . . 0.0 111.17 -171.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.18 54.66 3.29 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 124.639 3.56 . . . . 0.0 109.972 169.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.4 tttm -52.12 -50.0 62.54 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 127.357 2.263 . . . . 0.0 111.962 -169.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.79 -41.49 95.78 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 122.644 0.377 . . . . 0.0 111.463 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -73.49 -38.9 65.23 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -174.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.7 t -61.91 -42.64 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 172.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -62.02 -51.2 68.97 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 118.305 0.502 . . . . 0.0 110.271 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.67 -40.19 96.2 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.502 0.721 . . . . 0.0 110.907 -176.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.08 -51.27 68.61 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.011 176.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -66.6 -31.69 72.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 118.287 -0.863 . . . . 0.0 111.881 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.86 -31.62 72.68 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.586 1.084 . . . . 0.0 110.086 176.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -82.7 -44.49 15.61 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.41 0.684 . . . . 0.0 110.617 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.0 mt -65.95 -40.16 86.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 O-C-N 121.027 -1.046 . . . . 0.0 109.016 -175.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.9 -30.14 69.99 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.734 -0.604 . . . . 0.0 111.102 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.9 ttp-105 -81.25 -41.78 21.7 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.386 1.074 . . . . 0.0 109.917 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 -58.58 -37.37 75.64 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.366 0.666 . . . . 0.0 110.586 173.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.1 m -82.35 -0.77 47.35 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.109 0.964 . . . . 0.0 113.433 174.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 85.7 mtp 54.79 38.46 30.23 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.542 1.937 . . . . 0.0 113.361 176.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.2 m-70 -82.6 56.33 3.3 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.849 0.86 . . . . 0.0 110.531 177.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -88.01 -28.38 21.44 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.412 0.685 . . . . 0.0 112.25 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . 0.276 1.0 OUTLIER 40.7 44.3 1.82 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.298 1.839 . . . . 0.0 113.525 -176.078 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.3 m 60.44 18.74 8.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.179 1.791 . . . . 0.0 114.36 177.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -67.42 -33.42 75.14 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.689 1.131 . . . . 0.0 110.578 169.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.0 mt 52.26 19.91 1.22 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.953 2.101 . . . . 0.0 113.062 -173.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -163.38 158.01 17.37 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 127.353 2.261 . . . . 0.0 107.25 -175.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -69.99 40.12 0.3 Allowed 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 124.09 3.193 . . . . 0.0 114.825 174.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.4 m -60.76 -27.84 68.26 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.642 1.177 . . . . 0.0 112.448 -175.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 28.4 ttt -111.24 122.7 37.02 Favored Pre-proline 0 N--CA 1.454 -0.227 0 N-CA-C 103.039 -2.949 . . . . 0.0 103.039 169.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 120' ' ' ILE . 73.7 Cg_endo -77.79 160.43 30.97 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 121.517 1.478 . . . . 0.0 114.687 -168.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.511 HG13 HG22 ' A' ' 58' ' ' THR . 78.8 t -110.84 101.88 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 1 N-CA-C 98.888 -4.486 . . . . 0.0 98.888 166.918 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -141.99 157.25 45.16 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.64 1.176 . . . . 0.0 110.066 -168.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.0 t -140.39 120.16 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.472 0.709 . . . . 0.0 109.192 -172.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.1 m -84.02 142.9 30.13 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 168.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -120.91 137.03 54.79 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 125.682 1.593 . . . . 0.0 108.865 170.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.41 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 44.1 p90 -169.01 146.17 3.64 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -173.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.8 m 57.34 161.35 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.1 2.56 . . . . 0.0 115.86 167.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.2 tp -112.68 84.33 1.96 Allowed 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 170.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -76.17 118.63 19.1 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.57 1.148 . . . . 0.0 108.806 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 51.83 35.4 15.39 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.356 1.062 . . . . 0.0 112.336 176.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.37 17.66 73.24 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 118.859 -0.967 . . . . 0.0 113.992 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -133.57 138.64 46.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.809 1.644 . . . . 0.0 107.853 -176.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -71.62 142.49 49.96 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.645 -1.284 . . . . 0.0 108.973 -177.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.41 ' HB ' ' CE2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -103.66 157.9 16.74 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.497 1.044 . . . . 0.0 109.56 -179.686 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.89 169.62 38.15 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 171.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 36.1 m -137.04 146.9 45.78 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 169.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 p -123.62 140.86 45.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 175.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.469 HD13 ' HA2' ' A' ' 123' ' ' GLY . 11.6 tt -119.83 152.06 22.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 168.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.511 HG22 HG13 ' A' ' 40' ' ' VAL . 48.6 p -140.53 176.79 2.29 Favored Pre-proline 0 C--N 1.32 -0.701 0 C-N-CA 125.595 1.558 . . . . 0.0 107.237 169.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -59.78 -6.05 4.2 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.501 2.134 . . . . 0.0 114.297 169.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.0 p-90 -130.09 -21.75 2.93 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -169.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.12 166.1 32.69 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 120.089 1.313 . . . . 0.0 112.721 -177.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.81 122.39 18.53 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 168.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.2 m -136.51 135.38 38.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.326 0.584 . . . . 0.0 109.973 -175.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.65 145.11 52.68 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 168.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.5 m -137.61 146.08 28.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.9 mt -141.19 146.44 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -174.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -134.21 157.09 78.36 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-O 117.438 -1.267 . . . . 0.0 110.376 -172.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -57.2 9.21 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 0.989 1 C-N-CA 126.053 4.502 . . . . 0.0 120.001 -169.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.27 -155.85 44.46 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 117.86 -1.522 . . . . 0.0 111.43 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -65.42 -146.91 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.815 1 C-N-CA 125.324 4.016 . . . . 0.0 113.383 -174.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -74.43 58.1 0.74 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.457 1.503 . . . . 0.0 111.059 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -102.87 135.76 43.95 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 127.178 2.191 . . . . 0.0 106.855 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -108.11 88.19 2.67 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -177.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -69.23 149.79 97.42 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-O 118.847 -0.596 . . . . 0.0 109.407 172.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -67.76 157.21 62.79 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 N-CA-C 107.708 -1.689 . . . . 0.0 107.708 168.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 40.2 tp -62.94 122.99 17.39 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -88.27 159.23 18.2 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -174.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -86.03 152.65 22.73 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 168.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 83.9 t -99.74 155.08 4.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.342 -1.299 . . . . 0.0 107.862 -169.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.4 m 65.14 7.49 4.15 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.581 1.552 . . . . 0.0 113.489 -173.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -78.27 157.99 29.06 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.344 1.457 . . . . 0.0 107.967 169.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -122.86 141.29 52.03 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 123.054 0.542 . . . . 0.0 110.471 -177.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.2 mm -117.2 121.25 67.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -74.28 122.44 7.38 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.655 -1.778 . . . . 0.0 108.655 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.4 tp -120.36 132.35 55.24 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 124.443 1.097 . . . . 0.0 108.637 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.48 127.8 35.23 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 173.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mp -135.89 157.91 75.03 Favored Pre-proline 0 C--O 1.235 0.296 0 C-N-CA 125.295 1.438 . . . . 0.0 107.91 173.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -61.66 -20.24 68.15 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.367 2.044 . . . . 0.0 114.243 171.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -58.22 -32.26 68.13 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.504 0.722 . . . . 0.0 111.147 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 133.17 157.31 8.37 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 106.621 -2.592 . . . . 0.0 106.621 -169.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.1 m -66.53 130.02 41.79 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 58.5 mtm -137.46 141.16 41.57 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -176.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.77 129.88 34.77 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 170.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -99.21 124.75 44.51 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 169.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.6 m -81.07 140.43 35.11 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.3 t -75.38 120.11 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 169.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -109.48 163.54 12.5 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 172.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -125.3 95.04 4.33 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 170.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.7 tp -74.25 125.76 29.14 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -169.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -59.34 128.57 37.73 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.625 0.77 . . . . 0.0 110.108 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.77 3.91 84.53 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.689 -1.062 . . . . 0.0 113.869 -177.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.4 t -126.64 -119.92 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 119.263 1.531 . . . . 0.0 107.596 177.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.2 m -150.73 -179.31 7.15 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.622 1.569 . . . . 0.0 108.791 -169.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -69.85 143.44 52.85 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 169.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.26 172.57 16.79 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.437 1.495 . . . . 0.0 108.559 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.6 mp -106.52 142.6 35.91 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 172.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.3 p -142.11 152.65 43.46 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.693 0.797 . . . . 0.0 110.411 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 15.7 t -144.43 119.69 10.19 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 171.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.0 m -67.68 129.09 38.82 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 81.4 mt -92.3 -52.57 4.61 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.72 175.32 12.11 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.455 1.502 . . . . 0.0 108.102 171.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.3 m -116.64 62.79 2.71 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.633 1.173 . . . . 0.0 110.69 -175.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -64.33 129.7 24.81 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.297 1.998 . . . . 0.0 109.771 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.2 tt -151.84 110.33 3.78 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 171.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.7 m -148.37 144.1 27.28 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -176.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -82.13 -25.59 34.26 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.332 0.514 . . . . 0.0 109.935 173.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.5 m -80.29 63.95 4.94 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.773 1.229 . . . . 0.0 109.046 170.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.87 161.2 41.78 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.946 1.699 . . . . 0.0 107.745 -175.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 93.5 p -152.37 172.23 16.8 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.767 0.794 . . . . 0.0 112.286 -169.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 1.1 pp -64.64 -20.09 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 124.871 1.268 . . . . 0.0 112.215 169.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -79.63 -55.39 5.06 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -66.1 -30.85 71.43 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 123.591 0.757 . . . . 0.0 110.584 177.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.469 ' HA2' HD13 ' A' ' 57' ' ' ILE . . . -64.15 -52.18 46.57 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 119.804 1.184 . . . . 0.0 111.596 175.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -65.75 -46.82 77.4 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.164 0.982 . . . . 0.0 110.082 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -58.55 -43.82 89.47 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 118.423 -0.799 . . . . 0.0 110.566 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.0 tp -76.74 -28.34 55.72 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 119.365 0.984 . . . . 0.0 111.619 -173.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -69.08 -39.75 78.87 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 120.083 1.31 . . . . 0.0 109.498 174.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.21 -43.87 66.52 Favored 'General case' 0 N--CA 1.46 0.052 0 C-N-CA 122.985 0.514 . . . . 0.0 111.332 176.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -57.92 -39.14 77.25 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 121.176 -0.952 . . . . 0.0 109.612 173.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 20.0 m -64.33 -34.53 78.36 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 119.424 -0.322 . . . . 0.0 110.758 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.69 -56.79 15.93 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.397 0.679 . . . . 0.0 109.926 174.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -42.16 97.94 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 119.412 1.006 . . . . 0.0 109.556 -177.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 53.1 ttp -49.31 -55.39 12.93 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.956 1.302 . . . . 0.0 110.192 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 6.7 pt -80.3 -21.99 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 119.879 1.218 . . . . 0.0 112.604 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 24.5 mt -67.16 -56.53 9.56 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.615 0.643 . . . . 0.0 110.947 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.8 m -143.93 6.7 1.39 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -169.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.9 tp 44.86 54.18 12.5 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.137 1.375 . . . . 0.0 114.255 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -66.33 162.24 37.12 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.777 2.318 . . . . 0.0 111.355 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 43.1 t -123.59 148.46 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.306 1.442 . . . . 0.0 107.256 174.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 7.8 m -57.29 133.1 54.81 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.013 0.925 . . . . 0.0 110.217 -176.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -147.85 121.5 4.84 Favored Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 124.925 1.29 . . . . 0.0 107.684 175.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -59.54 150.74 74.05 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.745 2.297 . . . . 0.0 111.915 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -141.0 145.69 36.27 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.315 1.446 . . . . 0.0 109.93 -176.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.27 146.62 20.27 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.591 1.557 . . . . 0.0 107.44 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -59.67 -39.79 70.72 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.746 2.298 . . . . 0.0 112.489 178.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -153.07 125.15 7.97 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.877 1.271 . . . . 0.0 108.044 173.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.32 -31.6 48.83 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.403 0.281 . . . . 0.0 111.293 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 71.5 -178.01 35.93 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.106 0.86 . . . . 0.0 111.995 -176.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 89.0 mmt-85 -145.91 157.55 43.89 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 126.034 1.733 . . . . 0.0 107.693 172.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -83.22 64.99 8.02 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 171.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -60.89 -31.43 70.92 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.097 0.559 . . . . 0.0 112.316 -169.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -81.35 -2.71 50.23 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -178.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 37.6 tp -84.08 66.75 9.4 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -70.63 -32.0 69.16 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.474 0.709 . . . . 0.0 111.58 -175.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 66.7 -162.12 45.5 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -172.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 68.76 139.53 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.273 2.229 . . . . 0.0 110.351 -170.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 53.3 29.77 9.1 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.074 0.95 . . . . 0.0 111.549 -169.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.8 m -58.71 139.24 56.43 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.744 0.818 . . . . 0.0 111.077 -169.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 100.13 -48.91 1.18 Allowed Glycine 0 CA--C 1.528 0.89 0 C-N-CA 125.08 1.324 . . . . 0.0 110.032 -175.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -77.7 -45.13 25.75 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 169.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -87.39 127.84 35.2 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.737 1.615 . . . . 0.0 107.006 169.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 C-N-CA 125.583 1.553 . . . . 0.0 107.772 178.04 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 tpt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 120.662 0.267 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.4 p -70.19 -25.52 63.46 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.034 -1.041 . . . . 0.0 112.276 -176.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -84.54 39.35 0.73 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.659 1.184 . . . . 0.0 111.004 -177.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -138.94 162.24 35.36 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.88 1.672 . . . . 0.0 109.374 -177.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 mt -117.91 138.59 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 174.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.07 154.6 39.13 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.744 0.417 . . . . 0.0 110.55 176.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.22 156.65 34.14 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 169.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -125.07 151.48 45.61 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.474 1.11 . . . . 0.0 110.007 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -85.21 -21.16 29.25 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.941 0.896 . . . . 0.0 111.844 -176.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.4 p -159.06 -178.73 7.44 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 128.739 2.815 . . . . 0.0 105.897 173.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.7 m -59.49 139.91 88.87 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 168.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.16 54.45 4.19 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 124.553 3.502 . . . . 0.0 107.807 169.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.7 pttm -60.41 -34.89 74.59 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.634 1.174 . . . . 0.0 113.13 -168.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.58 -42.34 87.13 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.207 0.912 . . . . 0.0 110.614 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -70.9 -41.08 71.74 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 81.3 t -59.97 -42.55 89.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 172.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -60.74 -53.55 56.06 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 123.479 0.712 . . . . 0.0 109.71 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.57 -40.97 98.55 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.367 0.53 . . . . 0.0 110.857 -176.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.74 -46.81 83.66 Favored 'General case' 0 N--CA 1.456 -0.126 0 O-C-N 122.238 -0.289 . . . . 0.0 110.466 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -70.96 -28.25 64.33 Favored 'General case' 0 C--O 1.23 0.065 0 CA-C-O 118.65 -0.69 . . . . 0.0 112.446 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.8 -37.24 83.64 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.114 0.87 . . . . 0.0 109.615 174.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -65.73 -41.49 92.18 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.721 -0.657 . . . . 0.0 110.448 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.6 mm -64.76 -41.86 93.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 119.717 1.144 . . . . 0.0 109.559 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.6 -26.54 66.31 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.939 0.495 . . . . 0.0 111.459 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 55.5 ttp85 -71.93 -47.88 49.35 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 172.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.08 -16.34 1.93 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.487 1.515 . . . . 0.0 114.132 175.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.5 m -62.95 -22.73 67.0 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 119.799 1.181 . . . . 0.0 112.084 172.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 21.2 ptt? -110.97 169.59 8.67 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.48 1.512 . . . . 0.0 108.962 169.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -62.44 153.66 30.74 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.021 0.439 . . . . 0.0 110.106 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -63.29 -29.96 71.19 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -169.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -83.49 -8.9 59.27 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.1 m -79.85 147.72 31.64 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 119.028 0.831 . . . . 0.0 109.377 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -136.7 30.84 2.82 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.811 0.844 . . . . 0.0 110.94 -175.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -64.04 147.12 52.89 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.659 -0.65 . . . . 0.0 109.445 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -69.64 140.88 89.76 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-O 118.447 -0.787 . . . . 0.0 109.513 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -66.35 -32.39 41.23 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.21 1.94 . . . . 0.0 113.851 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.3 m 65.64 -4.87 0.54 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.3 2.24 . . . . 0.0 114.464 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 22.4 mmt -141.61 90.49 8.77 Favored Pre-proline 0 N--CA 1.458 -0.069 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 170.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -51.58 134.72 47.12 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.976 2.451 . . . . 0.0 111.671 -176.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.46 128.68 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 169.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -148.55 150.82 34.02 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.583 1.153 . . . . 0.0 108.634 -170.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.6 t -141.73 121.15 10.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.2 p -96.82 154.93 17.0 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 118.849 0.749 . . . . 0.0 110.939 169.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -119.52 142.87 47.93 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.743 2.017 . . . . 0.0 109.614 -171.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -147.22 167.73 23.47 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -169.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.7 m -14.3 139.82 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 1 C-N-CA 133.208 4.603 . . . . 0.0 117.149 169.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.0 tp -78.4 127.95 32.93 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 169.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -147.6 146.07 29.24 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 125.47 1.508 . . . . 0.0 107.311 175.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 53.91 26.63 6.4 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 120.482 1.492 . . . . 0.0 112.876 -175.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.18 25.4 75.47 Favored Glycine 0 CA--C 1.535 1.303 0 O-C-N 121.228 -0.92 . . . . 0.0 113.446 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -148.36 149.06 31.12 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.222 1.409 . . . . 0.0 110.056 -173.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -79.75 140.35 36.96 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 121.212 -0.93 . . . . 0.0 109.122 -177.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.0 160.09 20.11 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.805 0.812 . . . . 0.0 108.857 170.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -167.19 162.74 36.53 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 107.581 -2.208 . . . . 0.0 107.581 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 13.0 m -138.92 147.03 41.78 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 169.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 p -122.23 147.65 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 125.108 1.363 . . . . 0.0 107.817 172.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.4 tt -128.31 151.24 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 169.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.0 p -141.98 177.7 1.8 Allowed Pre-proline 0 C--N 1.32 -0.706 0 C-N-CA 125.331 1.452 . . . . 0.0 107.282 171.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -60.23 -30.37 91.06 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 CA-C-N 119.99 1.032 . . . . 0.0 110.552 168.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -94.29 -25.24 17.1 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -169.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.57 170.36 22.59 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 120.506 1.503 . . . . 0.0 112.965 -174.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 tt -137.72 123.98 20.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 168.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.7 m -137.36 134.51 36.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.438 0.637 . . . . 0.0 110.451 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.32 139.62 44.3 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 168.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 m -139.21 140.16 38.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -172.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.6 mm -135.73 138.53 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -169.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -131.02 145.63 58.6 Favored Pre-proline 0 N--CA 1.474 0.729 0 CA-C-O 117.692 -1.147 . . . . 0.0 111.867 -169.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -51.02 137.6 44.26 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.15 2.567 . . . . 0.0 112.698 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.52 179.83 28.92 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 123.427 0.537 . . . . 0.0 113.306 -175.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.43 123.4 11.73 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.992 2.461 . . . . 0.0 110.191 -173.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.1 t70 49.69 35.7 9.37 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.218 1.407 . . . . 0.0 113.15 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -95.87 127.77 42.18 Favored 'General case' 0 C--N 1.344 0.341 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.49 75.74 0.94 Allowed 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -170.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 48.7 m0 -68.58 149.07 98.1 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.192 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.31 151.84 80.09 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.011 1.807 . . . . 0.0 109.053 169.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.8 tp -56.04 131.91 48.69 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.557 -0.715 . . . . 0.0 109.254 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.41 157.95 16.06 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -90.3 148.86 22.61 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 169.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.2 t -91.6 154.81 3.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -169.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.5 m 60.72 33.7 20.13 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.911 0.884 . . . . 0.0 111.98 -176.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -112.27 155.6 23.79 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 127.019 2.128 . . . . 0.0 106.989 169.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -105.77 142.22 35.87 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.289 0.949 . . . . 0.0 110.546 178.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.7 mm -121.19 131.58 72.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.11 126.36 8.26 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 174.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.8 mt -113.01 124.87 53.62 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 172.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.64 133.36 43.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 169.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.4 mt -141.19 158.22 64.79 Favored Pre-proline 0 C--O 1.234 0.254 0 C-N-CA 124.13 0.972 . . . . 0.0 108.465 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -57.77 -29.63 86.48 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.738 2.292 . . . . 0.0 112.81 170.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -64.38 -18.5 64.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.45 1.1 . . . . 0.0 113.023 173.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 110.47 154.54 14.13 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 107.821 -2.112 . . . . 0.0 107.821 -168.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.1 m -65.03 132.35 48.98 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -175.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 64.3 mtm -141.12 145.75 36.16 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.846 1.258 . . . . 0.0 108.345 -178.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.41 136.91 37.09 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 121.597 -0.689 . . . . 0.0 109.33 172.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -115.34 139.7 49.76 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 169.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.7 m -87.12 137.18 32.57 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 52.5 t -68.08 122.56 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 170.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -109.34 163.11 12.57 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 107.565 -2.214 . . . . 0.0 107.565 169.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -133.38 94.25 3.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 171.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.5 tp -80.28 126.44 31.14 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -170.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -59.81 132.4 53.83 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.219 0.608 . . . . 0.0 110.451 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.94 5.43 75.34 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.659 -1.078 . . . . 0.0 113.482 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.9 t -125.62 -115.27 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.8 p -159.23 178.67 9.74 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 119.742 1.155 . . . . 0.0 110.236 -169.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -73.64 138.05 44.56 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 169.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.87 165.15 36.99 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.777 1.631 . . . . 0.0 107.684 -175.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.4 mp -111.47 130.35 55.75 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.5 m -131.23 150.46 52.14 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.519 0.728 . . . . 0.0 110.913 -170.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 40.4 t -143.14 121.47 12.31 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 169.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.1 m -76.2 137.55 40.08 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -90.41 -67.49 0.84 Allowed 'General case' 0 C--N 1.339 0.119 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 175.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.14 173.2 8.1 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.908 1.283 . . . . 0.0 109.054 -175.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.2 m -83.63 124.89 74.8 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 169.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -82.1 41.23 1.09 Allowed 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.61 2.873 . . . . 0.0 112.0 -171.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.2 mt -87.17 42.6 1.04 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.36 1.464 . . . . 0.0 110.242 -173.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.0 m -66.45 155.36 37.75 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.128 0.971 . . . . 0.0 110.418 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -72.17 -56.79 4.97 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 175.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.1 m -84.95 99.44 10.97 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.36 139.58 15.61 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -169.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 62.6 m -148.68 163.9 35.95 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.142 1.777 . . . . 0.0 107.993 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.36 -38.42 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.778 1.231 . . . . 0.0 111.394 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -75.74 -35.01 60.34 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.898 0.479 . . . . 0.0 109.751 -174.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -68.15 -28.87 67.67 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 124.6 1.16 . . . . 0.0 110.585 169.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.76 -55.54 30.27 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 120.235 1.379 . . . . 0.0 110.13 171.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -63.56 -51.35 65.75 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.557 -0.966 . . . . 0.0 110.189 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -68.41 -17.61 64.26 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 117.979 -1.01 . . . . 0.0 112.908 -175.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 32.8 tp -88.53 -25.86 22.32 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 120.257 1.389 . . . . 0.0 109.56 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.8 m -63.57 -48.74 76.21 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 169.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -61.06 -49.37 77.64 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 124.58 1.152 . . . . 0.0 111.933 175.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -62.47 -33.82 75.6 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.636 0.653 . . . . 0.0 110.469 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 34.8 m -69.99 -28.47 65.55 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.444 0.565 . . . . 0.0 111.216 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.03 -51.07 13.1 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.884 0.765 . . . . 0.0 109.564 170.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -51.84 -49.88 61.98 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.042 0.937 . . . . 0.0 110.147 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -56.79 -39.69 74.55 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.055 -178.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 22.4 pt -82.77 -22.62 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 119.722 1.147 . . . . 0.0 111.928 -178.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 52.2 mt -74.45 -24.93 59.13 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.414 0.686 . . . . 0.0 109.491 169.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.4 m 55.25 18.2 2.37 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.15 2.58 . . . . 0.0 114.993 176.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 96.6 mt -151.08 140.66 13.94 Favored Pre-proline 0 C--O 1.234 0.249 0 C-N-CA 127.04 2.136 . . . . 0.0 108.058 -174.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -71.67 124.89 10.62 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.277 1.985 . . . . 0.0 107.985 169.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.2 p -153.46 144.57 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 7.3 m -86.5 144.89 27.03 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.276 1.03 . . . . 0.0 109.185 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -141.13 104.84 6.1 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 169.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -60.32 136.09 65.9 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.561 2.174 . . . . 0.0 111.429 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.51 140.33 38.58 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 170.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.5 t -141.79 146.51 41.37 Favored Pre-proline 0 C--O 1.238 0.467 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.53 147.13 49.61 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.668 2.912 . . . . 0.0 109.928 168.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -69.03 125.09 25.56 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.53 156.94 28.98 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.334 0.654 . . . . 0.0 110.14 -174.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 70.54 18.35 75.45 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.384 -0.676 . . . . 0.0 114.108 170.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 62.5 mtm180 -64.6 147.46 52.88 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.9 1.35 . . . . 0.0 109.455 174.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 -68.96 153.84 43.1 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.45 -8.02 59.38 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.451 0.701 . . . . 0.0 112.31 175.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -143.35 159.93 41.46 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.336 1.454 . . . . 0.0 110.183 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 94.1 mt -107.11 162.72 13.62 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.457 1.103 . . . . 0.0 109.154 172.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -122.33 148.68 44.75 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.955 1.302 . . . . 0.0 109.428 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -97.74 -177.07 33.87 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 173.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -66.08 -32.96 74.74 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.852 -0.793 . . . . 0.0 111.014 176.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -74.73 -19.64 60.16 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.5 m -67.68 153.74 43.03 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.462 0.705 . . . . 0.0 110.772 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -178.23 166.49 36.55 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -138.6 158.73 43.7 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.637 1.575 . . . . 0.0 108.492 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -74.88 143.71 43.71 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 122.862 0.465 . . . . 0.0 109.975 174.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.2 0 C-N-CA 126.084 1.754 . . . . 0.0 110.599 -178.593 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.495 1.811 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.4 p -80.09 -29.95 39.13 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.943 0.897 . . . . 0.0 111.253 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -66.46 137.95 57.19 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 46.81 80.76 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.738 2.015 . . . . 0.0 112.711 174.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.1 mm -71.24 138.29 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.36 132.27 47.35 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.6 -0.687 . . . . 0.0 109.244 176.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.12 145.76 49.29 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 173.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -91.88 147.08 23.24 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.632 0.773 . . . . 0.0 109.65 -174.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -74.07 -29.48 61.9 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 118.969 -0.539 . . . . 0.0 110.756 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.1 p -154.88 164.03 39.43 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 127.337 2.255 . . . . 0.0 107.962 171.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.4 m -45.85 135.77 6.36 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 125.644 1.578 . . . . 0.0 111.801 173.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.11 52.41 3.82 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.201 3.267 . . . . 0.0 110.525 172.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -53.54 -49.69 67.07 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.202 1.801 . . . . 0.0 111.675 -169.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.58 -41.34 96.33 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.609 0.363 . . . . 0.0 111.284 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -71.51 -41.57 69.06 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.877 0.471 . . . . 0.0 109.764 -174.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 89.9 t -62.31 -45.95 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 172.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -58.85 -53.12 62.02 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.096 0.862 . . . . 0.0 110.872 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.52 -42.46 95.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.901 0.773 . . . . 0.0 111.034 -174.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.25 -46.26 87.73 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -71.21 -25.34 62.47 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 118.147 -0.93 . . . . 0.0 112.014 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -62.91 -34.29 77.11 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.98 1.264 . . . . 0.0 109.579 172.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -79.65 -46.91 16.29 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.718 0.407 . . . . 0.0 110.554 177.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.4 mt -59.93 -39.97 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.447 0.699 . . . . 0.0 109.185 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.79 -36.3 82.68 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.445 -0.784 . . . . 0.0 111.183 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -74.36 -40.42 62.14 Favored 'General case' 0 N--CA 1.46 0.06 0 C-N-CA 123.252 0.621 . . . . 0.0 109.955 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -59.57 -40.65 88.02 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.677 0.791 . . . . 0.0 110.831 170.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 64.6 m -77.49 -44.24 29.48 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.259 0.624 . . . . 0.0 112.441 -172.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 47.5 tpp -79.85 146.21 32.34 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 122.975 0.51 . . . . 0.0 110.221 -172.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -116.77 167.0 11.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.893 1.277 . . . . 0.0 110.03 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.3 t70 57.28 35.05 25.63 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 122.924 1.345 . . . . 0.0 109.978 -169.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.9 tp -111.06 41.1 1.89 Allowed 'General case' 0 C--N 1.342 0.263 0 C-N-CA 126.333 1.853 . . . . 0.0 108.878 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.5 m -59.06 -15.5 14.04 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.688 1.195 . . . . 0.0 113.641 -177.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -69.16 -14.58 63.07 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.682 1.193 . . . . 0.0 112.323 170.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 98.7 mt 55.29 27.61 10.09 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.855 2.462 . . . . 0.0 113.943 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 67.7 t60 -142.78 145.91 35.73 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -52.88 142.88 50.92 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.121 2.548 . . . . 0.0 114.349 -178.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 p -79.7 -19.77 48.12 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.784 1.633 . . . . 0.0 112.619 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 68.6 mtm -138.24 159.73 66.91 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 128.147 2.579 . . . . 0.0 104.22 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.413 ' HD3' HG22 ' A' ' 120' ' ' ILE . 92.8 Cg_endo -69.62 142.99 50.09 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.221 1.281 . . . . 0.0 112.509 -168.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.457 HG13 HG22 ' A' ' 58' ' ' THR . 97.7 t -104.51 105.89 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 102.058 -3.312 . . . . 0.0 102.058 167.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -142.43 156.33 45.18 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.574 1.15 . . . . 0.0 109.109 -169.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.0 t -137.38 117.24 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -176.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.6 p -78.27 150.06 33.44 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.394 0.997 . . . . 0.0 108.893 168.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.96 131.98 49.25 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.77 1.628 . . . . 0.0 108.64 173.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.769 ' CE1' ' HB1' ' A' ' 131' ' ' ALA . 5.3 p90 -168.78 150.6 4.79 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 123.645 0.778 . . . . 0.0 112.408 -176.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 95.1 m 55.65 157.36 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 128.571 2.748 . . . . 0.0 116.591 167.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.2 tt -111.87 116.15 30.17 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 169.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -139.44 141.82 37.44 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.219 1.408 . . . . 0.0 108.966 -172.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 53.94 26.41 6.27 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.538 1.135 . . . . 0.0 112.297 -172.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.64 5.43 83.2 Favored Glycine 0 CA--C 1.536 1.346 0 O-C-N 120.957 -1.089 . . . . 0.0 113.576 -175.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -118.16 165.92 13.2 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.603 2.361 . . . . 0.0 109.732 -173.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -85.52 148.76 25.8 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.692 1.133 . . . . 0.0 109.866 172.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.19 157.45 19.41 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.494 1.043 . . . . 0.0 110.23 -174.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -171.3 175.76 44.78 Favored Glycine 0 N--CA 1.449 -0.458 0 O-C-N 120.826 -1.171 . . . . 0.0 110.574 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 31.3 m -140.07 154.79 47.17 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 169.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 p -124.88 144.37 35.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.5 tt -124.65 150.79 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 168.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.457 HG22 HG13 ' A' ' 40' ' ' VAL . 26.5 p -142.52 177.16 1.97 Allowed Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 171.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.26 -14.31 44.38 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 CA-C-N 121.179 1.457 . . . . 0.0 111.593 168.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.4 p-90 -108.56 -21.91 12.51 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -172.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 21.9 ptt? -157.59 164.96 36.73 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 120.421 1.464 . . . . 0.0 112.669 -177.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 tt -134.68 123.99 24.59 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 103.185 -2.895 . . . . 0.0 103.185 167.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.7 m -142.17 134.46 27.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.029 0.377 . . . . 0.0 110.069 -172.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.76 143.32 57.58 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 168.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.3 m -140.12 145.79 25.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 37.8 mt -139.83 133.05 35.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 -172.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -122.1 154.04 61.39 Favored Pre-proline 0 N--CA 1.467 0.394 0 CA-C-O 117.785 -1.102 . . . . 0.0 111.023 -169.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -47.96 118.91 3.42 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.546 2.831 . . . . 0.0 112.466 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.43 179.09 26.19 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 123.246 0.342 . . . . 0.0 112.478 -177.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.6 160.18 31.68 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.021 2.481 . . . . 0.0 111.571 -174.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.8 t0 42.91 52.09 5.2 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.805 2.042 . . . . 0.0 113.776 169.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -152.31 160.68 43.29 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.525 1.13 . . . . 0.0 108.526 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -103.73 112.19 25.03 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 169.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.0 130.13 91.7 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.76 147.51 81.28 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.883 1.722 . . . . 0.0 109.825 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 34.0 tp -69.29 121.91 17.82 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 173.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.82 159.83 18.61 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.688 1.195 . . . . 0.0 108.924 176.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -80.27 151.23 29.69 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 169.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.4 t -99.34 151.31 4.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -169.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.9 m 59.92 24.66 13.75 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.116 0.967 . . . . 0.0 112.324 -175.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -109.82 157.63 18.99 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 128.652 2.781 . . . . 0.0 105.023 169.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -108.77 147.55 31.87 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.03 0.832 . . . . 0.0 111.606 -176.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.7 mm -122.16 131.98 71.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.35 124.65 7.73 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 173.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.1 mt -111.67 137.26 49.79 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 171.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -90.71 129.43 36.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 174.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -153.86 159.24 32.27 Favored Pre-proline 0 C--O 1.235 0.307 0 C-N-CA 125.06 1.344 . . . . 0.0 108.562 172.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -67.08 -15.7 47.28 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.224 1.949 . . . . 0.0 114.219 -170.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -58.39 -26.01 62.72 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.299 0.64 . . . . 0.0 111.042 169.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.57 148.02 7.59 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 106.41 -2.676 . . . . 0.0 106.41 -169.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.0 m -60.26 130.85 48.69 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 49.9 mtm -134.15 141.92 47.27 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 124.025 0.93 . . . . 0.0 108.649 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.96 113.29 19.77 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 172.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -91.9 136.71 32.95 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 171.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.1 m -83.48 137.92 33.67 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.5 t -73.39 125.81 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 173.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -106.74 154.83 16.65 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.197 -2.361 . . . . 0.0 107.197 169.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -129.12 103.03 6.75 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 170.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.8 tp -85.26 122.39 29.36 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -176.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -60.38 131.35 50.49 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.265 0.626 . . . . 0.0 110.687 -173.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.01 3.59 69.21 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 118.759 -1.023 . . . . 0.0 113.66 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.9 t -120.61 -103.87 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 119.074 1.437 . . . . 0.0 107.24 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.8 p -163.97 173.94 12.01 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 119.952 1.251 . . . . 0.0 110.737 -171.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -78.8 142.01 37.29 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 168.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -154.26 177.65 10.89 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.027 1.331 . . . . 0.0 108.029 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.3 mt -124.45 137.79 54.41 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.18 0.992 . . . . 0.0 108.922 -173.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.7 m -135.66 147.39 48.56 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.627 1.171 . . . . 0.0 110.028 -173.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 36.6 t -140.52 118.28 11.7 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 172.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.9 m -67.99 135.05 51.73 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.242 0.617 . . . . 0.0 109.438 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.8 mt -109.22 -47.77 3.36 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 123.646 0.778 . . . . 0.0 110.636 -176.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 17.7 ptp -160.42 169.46 23.01 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.918 0.887 . . . . 0.0 110.111 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.2 m -111.68 108.5 56.07 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 169.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -69.12 161.25 46.62 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.569 2.18 . . . . 0.0 111.084 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -143.61 158.23 43.82 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 124.822 1.249 . . . . 0.0 109.563 175.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.5 m -69.01 -17.53 63.93 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -169.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -82.57 140.84 33.03 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 118.775 0.716 . . . . 0.0 109.999 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.9 m 54.19 38.21 28.74 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.323 1.049 . . . . 0.0 111.111 -176.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 8.3 tpt -148.64 144.36 27.13 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.272 1.429 . . . . 0.0 109.12 -169.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 29.8 m -145.02 164.76 30.18 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 125.977 1.711 . . . . 0.0 107.178 173.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.413 HG22 ' HD3' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -69.33 -21.0 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 O-C-N 121.066 -1.021 . . . . 0.0 112.771 -176.236 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -70.63 -44.72 66.59 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 173.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -60.5 -39.55 88.13 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 118.278 -0.868 . . . . 0.0 109.313 172.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.68 -54.96 33.21 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 119.595 1.088 . . . . 0.0 111.521 177.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -62.36 -49.23 76.38 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.671 -0.9 . . . . 0.0 110.358 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 83.6 mtt-85 -69.97 -19.17 63.37 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.62 -0.675 . . . . 0.0 111.985 -175.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.1 tp -89.06 -18.94 26.28 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 124.138 0.975 . . . . 0.0 109.447 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.5 m -69.64 -44.99 69.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 169.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -66.94 -42.53 85.14 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.577 -0.702 . . . . 0.0 112.003 174.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -69.64 -29.76 67.31 Favored 'General case' 0 C--N 1.334 -0.067 0 O-C-N 121.176 -0.953 . . . . 0.0 110.731 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 22.8 m -70.27 -43.02 71.34 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.378 0.535 . . . . 0.0 110.281 174.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.769 ' HB1' ' CE1' ' A' ' 45' ' ' PHE . . . -53.67 -45.79 70.41 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.296 1.039 . . . . 0.0 109.922 173.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.5 ttp-105 -69.75 -50.09 46.77 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.354 -0.841 . . . . 0.0 111.578 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.88 -26.68 67.59 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.53 1.059 . . . . 0.0 112.764 -171.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 10.7 pt -77.31 -11.52 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 120.2 1.364 . . . . 0.0 113.376 174.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 75.4 mt -73.78 -32.59 63.85 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 169.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.9 m 54.1 24.85 5.1 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.387 1.875 . . . . 0.0 114.89 173.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 92.4 mt -144.45 150.59 48.26 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.197 1.799 . . . . 0.0 108.969 -174.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -70.02 168.9 20.55 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.182 2.588 . . . . 0.0 110.697 170.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 44.6 t -67.23 137.81 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 173.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 3.8 m -65.08 144.62 57.13 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.12 0.968 . . . . 0.0 110.228 -176.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -125.65 84.88 59.78 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 171.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.25 160.57 48.5 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.983 2.455 . . . . 0.0 111.356 -175.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -148.2 132.87 17.84 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.944 1.697 . . . . 0.0 107.823 170.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.5 m -139.94 157.11 70.12 Favored Pre-proline 0 C--O 1.24 0.585 0 C-N-CA 124.898 1.279 . . . . 0.0 110.542 -169.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -67.61 174.22 7.78 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.773 2.315 . . . . 0.0 110.631 169.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -55.79 131.58 47.17 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.13 0.572 . . . . 0.0 109.708 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.53 -39.47 45.98 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.6 0.36 . . . . 0.0 110.311 176.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -90.35 -149.47 22.38 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.658 1.123 . . . . 0.0 110.715 173.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -61.63 161.86 9.24 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.176 0.59 . . . . 0.0 111.194 173.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -64.33 145.84 55.37 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 169.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -79.77 -9.21 59.62 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 175.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 11.3 mp -63.73 148.88 48.01 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.461 1.104 . . . . 0.0 109.577 177.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -73.56 122.05 21.62 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 169.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -151.56 161.39 42.76 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.332 1.053 . . . . 0.0 109.143 -173.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 73.9 25.3 72.0 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 119.467 -0.63 . . . . 0.0 113.252 174.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -127.91 140.79 51.79 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.339 1.056 . . . . 0.0 108.625 174.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -80.15 -31.83 38.92 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 122.986 0.514 . . . . 0.0 110.633 177.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.3 m -65.33 144.03 57.38 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.882 0.873 . . . . 0.0 111.083 -173.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -81.01 -171.51 44.88 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 169.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -142.79 145.99 33.79 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.986 1.314 . . . . 0.0 107.804 175.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -68.84 137.1 53.65 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 122.922 0.489 . . . . 0.0 110.096 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.303 0 C-N-CA 125.527 1.531 . . . . 0.0 107.89 176.389 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tpt . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 119.604 -0.236 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.2 p -75.19 160.03 30.88 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.045 0.938 . . . . 0.0 110.281 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -85.82 55.94 3.75 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.051 0.94 . . . . 0.0 109.201 177.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -143.34 161.68 37.7 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.98 1.712 . . . . 0.0 109.383 -172.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.4 mt -132.15 131.89 61.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 175.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.75 128.22 35.03 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 170.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.67 146.07 48.75 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -93.03 138.79 31.18 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.701 0.8 . . . . 0.0 111.034 -169.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -69.14 -24.32 64.08 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.566 0.747 . . . . 0.0 111.151 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -162.12 172.42 15.87 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.86 1.264 . . . . 0.0 108.984 171.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.2 m -61.08 138.22 94.24 Favored Pre-proline 0 C--N 1.324 -0.502 0 C-N-CA 125.776 1.63 . . . . 0.0 110.432 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -69.77 48.14 0.61 Allowed 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 124.607 3.538 . . . . 0.0 112.706 169.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 42' ' ' VAL . 82.7 tttt -50.97 -57.15 9.32 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.025 1.73 . . . . 0.0 112.771 -169.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.454 ' HB3' ' CD2' ' A' ' 146' ' ' HIS . . . -68.85 -38.18 79.59 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 117.821 0.282 . . . . 0.0 110.273 -177.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -61.01 -45.37 95.07 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.627 0.771 . . . . 0.0 110.842 178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.0 t -64.57 -42.6 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -61.15 -51.54 68.62 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.839 0.745 . . . . 0.0 110.427 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.85 -39.41 93.51 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.006 0.922 . . . . 0.0 110.837 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.84 -46.17 90.62 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 175.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -72.81 -26.09 61.38 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 118.208 -0.901 . . . . 0.0 112.703 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -65.55 -28.87 69.47 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 120.084 1.311 . . . . 0.0 109.636 172.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -81.78 -47.52 12.76 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.244 1.018 . . . . 0.0 109.713 176.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.8 mt -67.9 -38.5 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 O-C-N 121.277 -0.889 . . . . 0.0 109.674 -175.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.6 -30.33 71.35 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.413 -0.804 . . . . 0.0 110.676 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.9 ttm105 -76.62 -37.5 56.27 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 123.518 0.727 . . . . 0.0 109.713 174.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -54.93 -38.89 68.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.915 0.886 . . . . 0.0 110.923 173.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.2 m -67.88 -8.79 39.46 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 174.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 60.9 mtt -122.21 33.97 5.31 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.132 2.173 . . . . 0.0 109.088 176.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.26 151.99 11.75 Favored 'General case' 0 C--N 1.34 0.189 0 O-C-N 121.478 -0.764 . . . . 0.0 111.478 -178.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.4 t70 68.41 -33.08 0.23 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 127.726 2.41 . . . . 0.0 112.685 -169.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 mp -89.25 23.92 2.34 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.453 1.501 . . . . 0.0 109.076 169.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.4 m -60.38 -17.22 42.28 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.832 1.653 . . . . 0.0 114.0 -169.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -66.58 -18.1 65.18 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.853 1.261 . . . . 0.0 112.501 174.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.0 mt -66.38 160.21 25.24 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.477 0.711 . . . . 0.0 110.662 177.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -119.26 157.07 52.09 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 125.683 1.593 . . . . 0.0 108.54 169.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -57.44 134.61 64.65 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.538 2.159 . . . . 0.0 112.309 -177.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.2 m -71.42 -15.38 62.35 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.049 0.94 . . . . 0.0 112.638 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 35.2 tpp -144.8 144.41 24.27 Favored Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 174.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -52.77 139.71 58.37 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.014 1.809 . . . . 0.0 114.351 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.9 t -92.58 111.8 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 101.441 -3.541 . . . . 0.0 101.441 167.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -145.4 158.94 43.74 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.075 0.95 . . . . 0.0 110.152 -169.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.408 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 41.1 t -139.27 124.0 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.577 0.751 . . . . 0.0 109.61 -175.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.0 m -90.18 154.51 19.7 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.252 1.021 . . . . 0.0 110.57 168.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -118.83 147.08 44.31 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 127.78 2.432 . . . . 0.0 111.013 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.453 ' CE2' ' HB3' ' A' ' 131' ' ' ALA . 55.0 m-85 -155.65 170.37 22.18 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.919 1.452 . . . . 0.0 114.919 -170.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.1 m -17.17 153.72 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.566 1 C-N-CA 134.413 5.085 . . . . 0.0 118.486 169.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.9 mt -85.97 118.56 25.53 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 169.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -121.89 108.9 13.98 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.813 2.045 . . . . 0.0 106.688 -173.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 52.12 37.93 22.94 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.566 1.146 . . . . 0.0 111.06 -170.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.27 13.77 82.41 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 118.856 -0.969 . . . . 0.0 113.907 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -121.34 134.77 55.14 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.101 1.451 . . . . 0.0 108.608 -177.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -63.28 142.08 58.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 120.354 1.434 . . . . 0.0 109.654 173.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.42 162.93 13.45 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 122.236 1.017 . . . . 0.0 108.748 169.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.84 173.15 40.7 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 107.87 -2.092 . . . . 0.0 107.87 169.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 1.3 m -136.04 145.89 46.51 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 169.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 p -118.4 141.36 38.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 169.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.0 tt -122.75 151.93 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 169.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.1 p -141.19 179.05 1.32 Allowed Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 172.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -68.73 -13.19 36.5 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 CA-C-N 121.602 1.608 . . . . 0.0 111.585 169.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -111.76 -21.09 11.83 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -169.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -157.36 160.57 38.6 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 120.161 1.346 . . . . 0.0 112.172 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 tt -130.77 123.21 28.67 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 103.351 -2.833 . . . . 0.0 103.351 167.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.4 m -134.4 131.81 38.64 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 123.875 0.734 . . . . 0.0 109.765 -177.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.01 145.28 50.09 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 168.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.4 m -135.62 147.84 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -177.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 58.6 mt -139.7 138.87 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -173.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -130.97 139.05 34.39 Favored Pre-proline 0 N--CA 1.466 0.332 0 CA-C-O 117.595 -1.193 . . . . 0.0 108.98 -177.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.37 130.1 34.47 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.567 2.178 . . . . 0.0 110.827 172.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.64 -166.84 33.47 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 119.602 -0.554 . . . . 0.0 112.426 -174.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -71.6 164.44 35.7 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.892 2.395 . . . . 0.0 112.915 -175.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.4 t0 42.57 55.69 4.09 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.397 2.279 . . . . 0.0 113.755 169.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -152.55 148.61 27.57 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.173 0.989 . . . . 0.0 109.35 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.9 mp -110.74 95.0 5.28 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.28 150.7 85.34 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.267 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -66.9 145.78 75.57 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.01 1.807 . . . . 0.0 110.763 171.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.1 tp -66.68 127.03 30.85 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 169.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -98.46 161.79 13.5 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.577 0.626 . . . . 0.0 110.074 -176.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.1 tmtm? -96.05 139.18 32.61 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 169.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.0 t -82.62 154.34 3.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 123.662 0.785 . . . . 0.0 109.332 -169.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.4 m 66.09 8.97 5.87 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.91 1.684 . . . . 0.0 113.769 -177.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -79.86 160.69 25.97 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.466 1.106 . . . . 0.0 108.136 168.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -112.9 142.33 45.69 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.708 -0.62 . . . . 0.0 110.41 177.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.6 mm -118.23 121.13 66.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 177.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.44 125.31 8.01 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 108.619 -1.793 . . . . 0.0 108.619 175.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.4 mt -120.51 141.81 49.89 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 124.344 1.057 . . . . 0.0 108.642 174.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -91.18 128.38 36.98 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 174.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 mp -135.07 162.01 60.22 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 124.763 1.225 . . . . 0.0 108.809 177.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -60.23 -21.89 68.28 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.527 2.151 . . . . 0.0 114.004 172.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -72.67 -4.21 29.72 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.599 1.16 . . . . 0.0 112.366 174.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.81 161.88 26.82 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 107.957 -2.057 . . . . 0.0 107.957 -168.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.8 m -68.84 131.99 46.03 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 69.8 mtm -139.9 144.04 36.97 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -177.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.68 132.29 35.18 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 172.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -102.17 132.66 47.94 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 169.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.5 m -83.95 142.19 30.7 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 66.5 t -74.59 124.83 33.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 170.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -112.02 161.4 12.75 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 170.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -132.59 93.78 3.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 171.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.9 tp -77.58 135.21 38.14 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -169.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.17 123.17 15.06 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.312 0.645 . . . . 0.0 111.691 -169.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.5 -3.4 33.27 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 118.688 -1.062 . . . . 0.0 113.998 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.8 t -101.31 -119.75 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 119.68 1.74 . . . . 0.0 106.337 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.3 m -148.17 174.99 11.41 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.629 1.571 . . . . 0.0 108.921 -169.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -72.53 142.31 48.49 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 168.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -153.48 171.8 18.12 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.1 1.36 . . . . 0.0 108.055 -178.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.4 mp -111.41 142.0 44.23 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.1 p -141.82 153.87 44.8 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.627 0.771 . . . . 0.0 110.588 -178.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.3 t -144.0 115.28 7.99 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 173.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.1 m -73.79 135.18 43.5 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 175.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.7 mt -123.95 -35.03 2.9 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.914 -1.041 . . . . 0.0 113.47 -169.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 13.4 ptp -159.64 169.62 23.34 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 120.249 1.386 . . . . 0.0 110.913 176.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.5 m -100.24 120.15 57.29 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.808 1.243 . . . . 0.0 108.425 169.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -70.8 -156.52 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 124.808 3.672 . . . . 0.0 113.313 174.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 62.91 41.09 8.9 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.275 1.43 . . . . 0.0 110.771 -174.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 m -73.18 157.65 36.76 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.926 -0.484 . . . . 0.0 109.854 172.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -63.89 -29.07 70.29 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.535 -0.728 . . . . 0.0 112.346 -170.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.2 m -89.22 -0.03 57.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.014 0.926 . . . . 0.0 112.836 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 42.4 mtp -73.58 156.47 38.04 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.275 0.943 . . . . 0.0 111.96 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.4 ' H ' ' HB2' ' A' ' 122' ' ' GLU . 80.4 p -156.93 176.71 12.4 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.384 2.274 . . . . 0.0 107.426 -175.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.728 ' H ' HD12 ' A' ' 120' ' ' ILE . 2.7 mp -53.82 -39.78 41.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.443 1.097 . . . . 0.0 109.59 171.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.69 -43.61 65.68 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.545 0.738 . . . . 0.0 109.456 -175.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.4 ' HB2' ' H ' ' A' ' 119' ' ' SER . 30.7 mm-40 -66.87 -28.48 68.36 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.079 173.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.61 -57.97 16.77 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 172.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -64.21 -52.73 57.42 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.647 -0.914 . . . . 0.0 110.778 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -66.83 -24.8 66.2 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 117.963 -1.017 . . . . 0.0 112.099 -173.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.7 tp -86.38 -29.9 22.57 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 120.748 1.613 . . . . 0.0 109.588 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.9 m -58.96 -48.19 82.42 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 169.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -64.0 -51.37 64.56 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.004 1.322 . . . . 0.0 112.083 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -65.5 -33.5 76.07 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.699 -0.626 . . . . 0.0 110.789 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 40.6 t -70.9 -34.03 71.16 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -178.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.453 ' HB3' ' CE2' ' A' ' 45' ' ' PHE . . . -68.13 -52.81 30.61 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 43.3 tpt85 -53.95 -46.84 71.71 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 123.539 0.736 . . . . 0.0 111.898 -175.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 15.2 ptt? -57.38 -27.25 62.14 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.58 1.082 . . . . 0.0 112.007 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 19.8 pt -102.2 9.9 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.421 1.089 . . . . 0.0 111.242 178.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 16.8 tp -151.06 69.97 0.97 Allowed 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.863 1.665 . . . . 0.0 109.108 -168.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.1 m -73.12 32.08 0.07 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.27 126.36 4.75 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 124.12 0.968 . . . . 0.0 109.647 169.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -101.15 146.11 0.3 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.05 2.5 . . . . 0.0 111.249 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.7 p -152.65 157.66 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.154 0.981 . . . . 0.0 108.376 169.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 7.4 m -56.25 146.63 23.05 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.527 1.531 . . . . 0.0 111.361 -177.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -131.13 126.15 21.4 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.18 1.392 . . . . 0.0 107.948 170.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -62.43 160.43 31.63 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.274 2.649 . . . . 0.0 113.304 177.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -135.06 143.25 46.6 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.22 1.808 . . . . 0.0 108.953 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 27.9 m -134.05 160.85 66.93 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 126.33 1.852 . . . . 0.0 109.051 -173.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.36 117.06 3.83 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 N-CA-C 104.116 -3.071 . . . . 0.0 104.116 167.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' HIS . . . . . 0.454 ' CD2' ' HB3' ' A' ' 14' ' ' ALA . 3.8 t60 -62.59 137.96 58.38 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -167.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.64 145.52 38.78 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.453 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.79 149.61 46.66 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 175.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -66.36 152.3 45.32 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 117.363 0.582 . . . . 0.0 110.543 175.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -68.71 141.71 55.22 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.5 134.47 34.84 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 169.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -158.27 167.29 30.17 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.942 1.297 . . . . 0.0 110.02 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -142.5 124.45 15.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 169.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -150.69 157.4 42.92 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.463 1.105 . . . . 0.0 108.985 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -169.56 148.79 12.33 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 171.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -87.76 58.03 4.67 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.97 0.908 . . . . 0.0 109.5 -176.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 44.2 mmm-85 -74.31 -25.69 59.72 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.08 -0.387 . . . . 0.0 110.995 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 14.9 m -67.07 132.53 48.05 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 70.43 16.44 73.63 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 119.65 -0.528 . . . . 0.0 113.394 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -67.87 134.07 50.24 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.278 1.039 . . . . 0.0 108.926 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -78.43 138.95 38.74 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.049 0.54 . . . . 0.0 110.013 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.493 0 C-N-CA 125.452 1.501 . . . . 0.0 108.114 175.355 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 119.159 -0.448 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 m 57.93 43.32 21.54 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.285 1.034 . . . . 0.0 111.293 171.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -86.21 45.5 1.23 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.398 1.079 . . . . 0.0 109.343 -178.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -142.98 159.45 42.21 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.535 1.534 . . . . 0.0 110.022 -169.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.4 mm -126.26 125.74 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 170.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.48 150.23 33.0 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.962 0.41 . . . . 0.0 110.092 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.18 156.71 47.65 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.589 1.09 . . . . 0.0 112.848 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -112.81 150.5 31.57 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.874 1.27 . . . . 0.0 110.101 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -82.35 -29.15 31.14 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.671 0.788 . . . . 0.0 111.368 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.8 p -158.52 -177.86 6.84 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 129.966 3.306 . . . . 0.0 105.601 172.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.8 m -57.59 144.23 73.22 Favored Pre-proline 0 CA--C 1.541 0.616 0 O-C-N 120.95 -1.094 . . . . 0.0 110.137 169.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.45 58.48 3.77 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 124.811 3.674 . . . . 0.0 109.652 169.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HE2' ' O ' ' A' ' 42' ' ' VAL . 41.1 tttm -50.55 -52.76 35.87 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.77 2.428 . . . . 0.0 112.692 -169.082 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.88 95.59 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.656 0.383 . . . . 0.0 111.144 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -70.11 -39.81 75.26 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -176.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 81.3 t -62.97 -40.79 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -62.54 -52.43 63.46 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.496 0.589 . . . . 0.0 110.195 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.2 -39.29 94.22 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.762 0.825 . . . . 0.0 110.899 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.34 -50.39 73.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -72.43 -29.4 63.67 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 117.84 -1.076 . . . . 0.0 112.493 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -59.95 -35.22 74.49 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.293 1.406 . . . . 0.0 109.886 169.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -76.53 -52.59 9.48 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.594 0.634 . . . . 0.0 109.378 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.0 mt -61.28 -39.06 81.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.907 1.283 . . . . 0.0 110.425 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.12 -24.04 67.54 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.351 -0.843 . . . . 0.0 112.272 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.4 ttp85 -99.89 -30.34 12.08 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 125.465 1.506 . . . . 0.0 109.494 -175.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -61.21 -43.17 99.31 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 169.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.3 m -63.0 119.72 9.99 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 173.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 11.6 tmm? -65.86 117.47 8.29 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -177.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -140.34 164.23 30.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 127.119 2.168 . . . . 0.0 106.669 175.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.24 -35.7 76.08 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.41 -0.806 . . . . 0.0 110.869 173.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.8 pp -65.95 -18.35 65.28 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.533 0.733 . . . . 0.0 112.944 175.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.6 m -70.86 -21.94 62.36 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 120.388 1.449 . . . . 0.0 111.566 -176.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -91.94 -9.98 41.09 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.357 1.063 . . . . 0.0 111.991 177.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.6 mt -129.46 7.57 5.35 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.234 1.414 . . . . 0.0 112.305 -169.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . 0.266 0.1 OUTLIER 64.67 157.76 0.12 Allowed Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 128.37 2.668 . . . . 0.0 112.29 -169.018 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -49.62 135.1 34.05 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.484 2.789 . . . . 0.0 113.551 -174.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 p -65.28 -37.89 88.55 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.553 1.141 . . . . 0.0 111.07 -176.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 67.6 mtt -137.43 133.44 18.13 Favored Pre-proline 0 N--CA 1.455 -0.204 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 174.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -47.22 129.4 15.61 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.394 2.729 . . . . 0.0 114.205 178.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.1 t -63.91 136.94 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 168.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -142.49 156.08 45.12 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.028 0.831 . . . . 0.0 110.102 -171.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.41 ' O ' ' HE2' ' A' ' 13' ' ' LYS . 34.5 t -140.03 127.78 24.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -178.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.5 m -100.55 151.62 21.38 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.146 0.979 . . . . 0.0 109.772 169.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -123.95 143.24 50.51 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.136 1.774 . . . . 0.0 110.292 -176.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -145.3 170.2 16.77 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.239 1.415 . . . . 0.0 114.153 -169.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.8 t -54.19 169.29 0.18 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.226 2.611 . . . . 0.0 115.468 -169.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.6 tp -77.31 124.4 27.81 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.753 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -104.52 -125.12 0.22 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.969 2.108 . . . . 0.0 107.172 -175.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -77.29 70.75 3.72 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.701 1.137 . . . . 0.0 109.814 177.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.06 15.58 65.32 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.335 0.969 . . . . 0.0 113.315 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -143.32 143.34 31.64 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 125.637 1.575 . . . . 0.0 108.104 -169.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -72.18 153.88 41.37 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.083 0.856 . . . . 0.0 110.27 174.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.52 158.39 16.11 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 169.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.71 168.51 39.02 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 108.056 -2.017 . . . . 0.0 108.056 173.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 48.2 m -140.39 145.14 36.69 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 169.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.07 144.11 25.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 171.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.9 tt -131.17 152.82 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 172.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.4 p -144.5 178.75 1.34 Allowed Pre-proline 0 N--CA 1.446 -0.662 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -63.84 1.0 1.64 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.437 2.092 . . . . 0.0 113.601 168.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.4 p-90 -138.6 -19.54 1.06 Allowed 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 -169.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -153.78 164.44 38.34 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 120.589 1.54 . . . . 0.0 111.703 -176.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 tp -136.49 116.57 13.37 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 169.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.1 m -136.26 122.52 20.49 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -172.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.05 145.87 55.35 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 169.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.6 m -139.5 146.64 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.887 1.275 . . . . 0.0 108.585 -177.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 45.4 mt -142.2 140.94 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -170.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -137.0 144.37 46.1 Favored Pre-proline 0 N--CA 1.469 0.512 0 CA-C-O 117.638 -1.172 . . . . 0.0 110.065 -170.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -52.49 137.95 57.35 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.312 2.675 . . . . 0.0 112.919 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.41 -178.78 25.58 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 123.815 0.721 . . . . 0.0 112.943 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -64.16 140.7 72.74 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.017 2.478 . . . . 0.0 112.8 -171.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.7 t70 52.84 26.86 4.88 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.832 1.653 . . . . 0.0 114.035 170.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -87.02 152.98 21.9 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 171.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.7 83.65 2.03 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 170.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -66.87 152.9 95.16 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.896 172.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -71.56 159.1 52.18 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.901 1.734 . . . . 0.0 109.634 169.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.5 tp -66.78 117.24 8.64 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 169.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -85.78 154.78 21.35 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -177.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -84.19 142.33 30.39 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.4 t -89.23 154.55 3.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -168.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.3 m 66.12 8.62 5.63 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.702 1.601 . . . . 0.0 113.683 -176.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -78.74 161.55 26.78 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.687 1.195 . . . . 0.0 108.088 169.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -113.46 143.26 44.81 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 121.427 -0.795 . . . . 0.0 110.329 175.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.2 mm -118.33 126.13 74.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 176.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.24 123.8 7.42 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 174.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.8 mt -116.24 143.87 44.95 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.604 1.162 . . . . 0.0 108.167 174.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -96.14 128.01 42.67 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 175.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mp -138.54 155.17 73.78 Favored Pre-proline 0 C--O 1.236 0.376 0 C-N-CA 124.809 1.244 . . . . 0.0 107.702 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -63.43 -20.92 70.93 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 121.96 1.774 . . . . 0.0 113.619 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -58.86 -28.98 66.62 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.654 0.781 . . . . 0.0 111.535 169.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 129.03 155.78 8.68 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 106.679 -2.568 . . . . 0.0 106.679 -169.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.1 m -64.29 131.2 46.61 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 176.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 62.9 mtm -141.26 144.13 34.51 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.485 1.114 . . . . 0.0 108.349 -176.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.98 135.14 35.82 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 121.932 -0.48 . . . . 0.0 109.879 172.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -108.61 138.6 44.66 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 168.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.2 m -87.7 140.71 29.24 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.3 t -73.24 126.77 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 169.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -119.27 163.14 13.46 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 171.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -126.06 93.83 3.93 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 173.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.6 tp -75.36 124.89 27.9 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -169.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -59.97 132.79 55.04 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.101 0.56 . . . . 0.0 110.468 -176.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.24 3.7 70.99 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-O 118.752 -1.026 . . . . 0.0 113.581 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.3 t -127.49 -120.13 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.7 m -152.49 -178.6 6.94 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.744 1.618 . . . . 0.0 108.846 -169.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -68.79 143.3 54.66 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 169.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -150.51 169.45 21.46 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.548 1.539 . . . . 0.0 108.679 177.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.5 mp -104.4 141.8 35.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 170.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.8 p -141.13 155.4 46.11 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.705 0.802 . . . . 0.0 110.486 -177.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 48.0 t -144.99 110.83 5.42 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 171.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.7 m -71.22 127.73 33.55 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 24.0 mt -119.76 -40.2 2.78 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 118.677 -0.678 . . . . 0.0 112.33 -169.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 23.8 mtm -141.79 161.5 37.8 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.182 0.993 . . . . 0.0 108.724 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.2 p -123.16 66.19 30.94 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.042 1.337 . . . . 0.0 110.117 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -60.87 153.25 64.56 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.591 2.194 . . . . 0.0 110.699 174.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 95.9 mt -130.57 152.81 49.54 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.633 1.573 . . . . 0.0 106.767 172.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.1 m -73.68 58.45 0.61 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.352 1.461 . . . . 0.0 112.977 -174.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -136.39 -67.28 0.52 Allowed 'General case' 0 C--O 1.231 0.115 0 C-N-CA 124.872 1.269 . . . . 0.0 109.405 172.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.6 m -87.84 51.52 2.23 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.6 tpt -159.3 162.46 36.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 128.047 2.539 . . . . 0.0 106.976 -168.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.5 p -151.2 171.59 17.17 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 174.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.502 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -67.48 -26.55 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 120.986 -1.071 . . . . 0.0 110.33 170.163 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -67.05 -44.19 80.82 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 174.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -65.59 -30.13 70.82 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.204 0.911 . . . . 0.0 110.571 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.88 -27.63 50.9 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.674 1.13 . . . . 0.0 112.323 171.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -95.5 -55.04 3.16 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.332 1.066 . . . . 0.0 110.828 171.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -71.01 -29.68 65.69 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -169.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.5 tp -83.03 -29.72 28.64 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 120.152 1.342 . . . . 0.0 109.608 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -64.75 -43.23 94.01 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -64.0 -48.53 76.03 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.167 0.587 . . . . 0.0 111.972 172.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -69.8 -25.71 63.91 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.115 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 35.3 t -64.32 -42.41 96.33 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.68 -47.23 73.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 174.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 50.1 ttt-85 -57.0 -46.63 82.15 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.336 0.971 . . . . 0.0 111.315 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 52.6 ttp -47.4 -31.3 3.95 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.565 1.546 . . . . 0.0 112.229 174.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 25.7 pt -104.15 -18.98 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 120.066 1.303 . . . . 0.0 113.009 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . 0.299 3.5 pp -99.99 43.79 1.04 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 120.087 1.312 . . . . 0.0 108.074 168.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.3 p -76.59 52.71 0.82 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.746 2.418 . . . . 0.0 112.325 -169.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -66.76 144.03 98.38 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.067 173.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -81.76 56.55 5.95 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 124.455 3.437 . . . . 0.0 111.841 -174.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.7 t 66.12 153.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 126.708 2.003 . . . . 0.0 111.568 -173.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 6.8 m -62.07 140.9 58.36 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.105 0.962 . . . . 0.0 109.516 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -140.68 116.48 7.59 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.937 1.295 . . . . 0.0 107.835 174.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -80.21 65.19 8.92 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.553 2.835 . . . . 0.0 110.041 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 30.8 t70 63.23 -46.11 0.22 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 129.158 2.983 . . . . 0.0 114.487 -170.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.4 p -149.09 148.03 25.68 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 125.043 1.337 . . . . 0.0 108.843 174.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -54.58 166.02 2.1 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.843 3.028 . . . . 0.0 112.654 169.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -62.91 122.72 16.68 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 169.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -115.04 3.18 14.39 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.364 1.066 . . . . 0.0 112.215 -173.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.35 142.77 41.53 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -71.16 140.37 50.52 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -86.24 162.56 18.23 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 175.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -60.25 -31.01 69.81 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.949 0.5 . . . . 0.0 112.179 -177.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.44 13.07 14.62 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -178.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 37.8 tp -107.69 103.82 13.19 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 171.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -153.6 157.02 39.06 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.539 1.136 . . . . 0.0 109.473 173.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.7 -161.67 35.45 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 123.848 0.737 . . . . 0.0 111.509 -175.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -74.34 -54.48 7.56 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 173.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -145.33 30.77 1.12 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.511 1.124 . . . . 0.0 109.675 172.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 9.6 m -71.94 -40.5 68.66 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -85.09 144.32 20.87 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 107.542 -2.223 . . . . 0.0 107.542 169.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.66 23.07 3.21 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -169.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -54.99 -36.62 65.6 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.704 0.802 . . . . 0.0 111.417 172.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 C-N-CA 124.66 1.184 . . . . 0.0 107.897 172.378 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.8 mm -119.37 126.01 74.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 169.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.67 145.28 38.87 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.029 0.442 . . . . 0.0 109.816 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.02 146.2 50.34 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.795 1.188 . . . . 0.0 111.456 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -89.57 139.84 30.14 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.323 1.049 . . . . 0.0 108.912 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -71.42 -38.86 71.36 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.7 p -155.1 166.2 34.32 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 128.162 2.585 . . . . 0.0 107.847 170.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.5 m -54.08 141.02 51.21 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.419 1.088 . . . . 0.0 112.203 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -75.89 49.38 2.48 Favored 'Trans proline' 0 CA--C 1.541 0.844 1 C-N-CA 125.429 4.086 . . . . 0.0 110.872 170.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -54.21 -46.15 72.4 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.879 1.672 . . . . 0.0 112.032 -169.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.95 98.53 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 122.506 0.323 . . . . 0.0 111.259 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -40.19 69.44 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 119.074 -0.488 . . . . 0.0 109.804 -174.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 84.2 t -58.22 -45.67 88.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 171.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -61.17 -53.86 51.61 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.861 0.755 . . . . 0.0 110.95 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.0 -39.25 93.17 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.713 0.688 . . . . 0.0 111.128 -174.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.26 -47.54 81.96 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -70.69 -24.42 62.66 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-O 118.289 -0.862 . . . . 0.0 112.592 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -62.11 -37.35 84.78 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.342 0.974 . . . . 0.0 108.979 172.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -80.46 -45.24 17.9 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.8 mt -61.92 -31.9 52.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 O-C-N 120.896 -1.128 . . . . 0.0 110.219 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.99 -24.7 63.35 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.282 -0.886 . . . . 0.0 112.201 174.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.9 ttm105 -83.71 -41.64 17.47 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.936 0.894 . . . . 0.0 109.632 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo . . . . . 0 N--CA 1.457 -0.66 0 CA-C-O 120.638 0.182 . . . . 0.0 111.746 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 m -65.59 148.31 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 171.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -143.11 157.75 44.23 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 124.06 0.944 . . . . 0.0 109.076 -175.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.2 t -138.99 126.62 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -177.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.6 p -89.01 150.67 22.69 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 169.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -132.61 132.79 42.87 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.561 1.544 . . . . 0.0 108.24 173.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.43 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 43.1 p90 -169.9 145.76 3.02 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.354 0.662 . . . . 0.0 112.704 -171.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.8 m 58.52 165.14 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 128.014 2.525 . . . . 0.0 115.409 167.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.2 tp -115.84 58.3 0.74 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.07 1.348 . . . . 0.0 109.157 175.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.91 137.21 47.25 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.025 0.93 . . . . 0.0 110.042 -173.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 55.15 22.85 4.88 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.367 1.067 . . . . 0.0 111.874 -171.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.07 20.61 77.37 Favored Glycine 0 CA--C 1.531 1.053 0 O-C-N 121.223 -0.923 . . . . 0.0 112.874 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -135.79 143.11 45.04 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.223 1.511 . . . . 0.0 108.118 -172.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -65.7 135.39 54.9 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.303 -0.873 . . . . 0.0 108.961 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.43 ' HB ' ' CE2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -103.09 160.07 14.97 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.857 0.837 . . . . 0.0 109.514 -177.299 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -169.35 168.81 41.54 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 56.4 m -135.96 146.82 47.68 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 168.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.1 p -111.81 143.55 21.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 171.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.85 141.64 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 169.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.3 p -136.8 173.83 5.1 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 171.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.9 -25.7 74.31 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 CA-C-N 121.386 1.531 . . . . 0.0 111.238 169.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.4 p-90 -93.41 -26.57 17.17 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 118.155 -0.926 . . . . 0.0 113.215 -172.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.97 170.21 23.05 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 120.256 1.389 . . . . 0.0 113.057 -174.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 tt -137.57 127.96 26.45 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 168.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.6 m -140.68 137.52 33.6 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 123.04 0.536 . . . . 0.0 110.017 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.6 146.82 48.14 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 168.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.3 m -138.48 144.18 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.23 1.412 . . . . 0.0 108.178 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 31.7 mt -142.69 141.91 27.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 125.37 1.468 . . . . 0.0 107.283 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -130.33 133.79 25.32 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-O 117.646 -1.168 . . . . 0.0 108.203 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.85 137.78 21.4 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.282 2.655 . . . . 0.0 111.899 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.56 179.07 34.26 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.302 0.953 . . . . 0.0 112.756 -173.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.67 145.05 56.47 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.982 2.455 . . . . 0.0 111.019 -172.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.1 t0 50.63 57.69 6.34 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.381 1.472 . . . . 0.0 112.188 177.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -128.76 148.93 50.89 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.385 1.474 . . . . 0.0 108.223 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -124.34 83.03 2.1 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 175.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.71 150.91 97.51 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 172.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.34 155.23 70.98 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.901 1.734 . . . . 0.0 109.972 170.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 68.9 tp -63.85 129.25 39.33 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 170.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -104.61 163.38 12.51 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.474 0.579 . . . . 0.0 109.559 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -89.52 157.18 18.19 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 169.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.1 t -86.5 153.41 3.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -169.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . 0.254 42.7 m 65.84 11.84 7.92 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.229 1.411 . . . . 0.0 113.58 -174.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -74.85 158.16 33.88 Favored 'General case' 0 C--N 1.346 0.42 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 168.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -112.27 141.03 46.47 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.624 -0.673 . . . . 0.0 109.976 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.5 mm -120.38 123.92 71.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.09 121.99 6.4 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.8 mt -113.26 143.12 44.96 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.24 1.016 . . . . 0.0 108.299 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -95.05 127.41 41.09 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mp -135.59 153.96 77.92 Favored Pre-proline 0 C--O 1.234 0.288 0 C-N-CA 125.595 1.558 . . . . 0.0 107.282 174.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -64.58 -21.82 65.35 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.236 1.291 . . . . 0.0 112.497 172.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -58.7 -23.51 59.69 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.67 1.588 . . . . 0.0 111.524 169.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 129.65 148.35 6.49 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.979 2.228 . . . . 0.0 108.066 -173.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.0 m -63.11 130.92 46.74 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 170.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 43.7 ttp -144.61 138.76 27.63 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -169.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.54 130.95 35.45 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -104.4 131.68 51.49 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 169.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.8 m -85.25 139.26 31.77 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 97.7 t -70.82 110.86 4.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 172.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -94.24 155.91 22.02 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 106.91 -2.476 . . . . 0.0 106.91 169.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -134.55 122.32 22.21 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 169.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.6 tp -142.3 145.65 34.21 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.885 0.474 . . . . 0.0 110.411 -169.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -58.71 132.07 52.76 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.917 0.887 . . . . 0.0 111.062 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.93 0.3 50.19 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.046 0.831 . . . . 0.0 113.688 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 87.2 t -122.23 -27.11 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.267 1.427 . . . . 0.0 109.852 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.2 m 60.16 -150.52 0.42 Allowed 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.236 1.415 . . . . 0.0 108.691 -174.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -78.06 137.28 38.16 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.368 0.531 . . . . 0.0 110.152 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -152.44 166.81 30.79 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.974 1.71 . . . . 0.0 107.988 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.0 mp -117.81 122.32 43.1 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.1 m -143.79 158.36 43.73 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.008 0.822 . . . . 0.0 111.305 -169.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 15.6 p -149.4 140.38 22.89 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.844 -0.535 . . . . 0.0 109.816 169.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.0 m -67.09 138.25 56.98 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 174.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.0 mt -107.83 -48.45 3.4 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.174 0.99 . . . . 0.0 110.145 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 13.3 ptp -164.09 172.5 13.68 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.858 0.863 . . . . 0.0 110.329 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.1 m . . . . . 0 CA--C 1.541 0.611 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.627 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.3 t . . . . . 0 CA--C 1.535 0.391 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -59.7 -31.17 46.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 123.618 0.767 . . . . 0.0 110.708 179.162 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.93 -46.72 73.92 Favored 'General case' 0 C--O 1.226 -0.166 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -63.24 -33.42 75.47 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.103 173.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.46 -62.13 6.63 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 171.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -65.07 -43.27 92.75 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 117.742 0.771 . . . . 0.0 111.282 -175.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -58.67 -40.98 85.09 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.37 0.668 . . . . 0.0 109.722 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.8 tp -81.28 -21.98 38.96 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 117.783 -1.104 . . . . 0.0 111.684 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.14 -42.71 79.74 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.837 1.653 . . . . 0.0 108.75 169.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -70.07 -41.2 74.44 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.262 0.625 . . . . 0.0 111.699 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -66.9 -31.04 71.36 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.064 -1.022 . . . . 0.0 110.653 174.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 21.1 m -69.31 -41.27 76.96 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.793 0.724 . . . . 0.0 110.257 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.417 ' HB2' ' CE1' ' A' ' 45' ' ' PHE . . . -55.89 -54.11 48.67 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.657 0.783 . . . . 0.0 109.549 172.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -52.27 -54.09 35.71 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.066 0.947 . . . . 0.0 109.974 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 57.0 ttp -49.42 -55.24 13.75 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.65 1.58 . . . . 0.0 111.271 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.7 pt -78.68 -25.34 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 118.955 0.798 . . . . 0.0 112.233 -171.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.1 mt . . . . . 0 CA--C 1.53 0.201 0 CA-C-N 118.671 0.669 . . . . 0.0 110.452 169.814 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.8 mm -118.4 131.62 70.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 126.627 1.971 . . . . 0.0 106.03 175.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.57 142.0 44.71 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 120.701 0.286 . . . . 0.0 110.373 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.8 151.57 51.04 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.209 0.909 . . . . 0.0 111.945 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -93.03 151.2 20.03 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.304 1.041 . . . . 0.0 109.669 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -94.19 -19.25 20.93 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.779 -0.629 . . . . 0.0 112.105 176.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.2 p -156.94 164.42 38.05 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 127.344 2.258 . . . . 0.0 107.734 169.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.1 m -56.9 133.49 79.57 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-O 118.236 -0.888 . . . . 0.0 109.614 169.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.401 ' HD2' ' CE1' ' A' ' 67' ' ' PHE . 33.3 Cg_exo -70.83 50.14 1.05 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.433 3.422 . . . . 0.0 112.648 170.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.6 tttm -51.69 -48.68 63.39 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.831 1.652 . . . . 0.0 112.061 -169.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.2 94.93 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 122.705 0.402 . . . . 0.0 111.128 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -73.17 -40.13 65.07 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.384 0.674 . . . . 0.0 109.834 -175.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 80.9 t -61.11 -47.12 95.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -59.41 -50.49 73.76 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 118.923 -0.56 . . . . 0.0 110.872 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.74 -43.27 98.14 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.771 0.714 . . . . 0.0 110.423 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.18 -49.77 76.6 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.058 0.39 . . . . 0.0 110.234 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -66.05 -26.15 67.37 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.943 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -67.64 -29.18 68.42 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 120.098 1.317 . . . . 0.0 111.539 174.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -77.39 -54.82 5.99 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.172 0.896 . . . . 0.0 109.095 171.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.3 mt -60.52 -44.78 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 123.944 0.897 . . . . 0.0 109.851 -169.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.11 -28.71 70.25 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.953 -0.467 . . . . 0.0 111.346 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -81.79 -43.15 18.72 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 118.751 0.705 . . . . 0.0 109.828 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? . . . . . 0 N--CA 1.465 0.286 0 C-N-CA 123.112 0.565 . . . . 0.0 110.316 172.871 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo . . . . . 0 CA--C 1.536 0.601 0 N-CA-C 114.924 1.086 . . . . 0.0 114.924 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.3 m -109.04 56.58 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 104.629 -2.359 . . . . 0.0 104.629 167.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -83.93 156.86 22.15 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.548 1.139 . . . . 0.0 111.63 -168.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.0 t -140.07 127.14 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 123.695 0.798 . . . . 0.0 109.431 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.0 m -91.41 145.36 24.69 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.084 0.954 . . . . 0.0 108.952 168.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -125.6 138.22 53.92 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.873 1.669 . . . . 0.0 108.277 170.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -162.03 130.65 4.25 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -175.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 t 47.97 -179.78 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 129.992 3.317 . . . . 0.0 117.071 168.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.9 tp -117.58 86.4 2.51 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 171.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -74.6 -38.8 62.52 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -168.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.07 56.75 1.13 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 122.323 1.059 . . . . 0.0 108.495 -176.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 62.98 20.94 63.03 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.627 -175.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -144.15 139.94 29.09 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 126.616 1.966 . . . . 0.0 105.834 -174.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -74.75 143.58 44.02 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.41 153.42 26.09 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.581 0.705 . . . . 0.0 109.299 -173.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -163.5 167.81 37.86 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 35.4 m -140.94 152.76 45.26 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 169.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.2 t -128.09 143.98 39.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.403 HG21 ' HA2' ' A' ' 123' ' ' GLY . 15.8 tt -127.14 148.19 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 169.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 49.3 p -137.78 177.83 1.96 Allowed Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 175.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -61.38 -6.31 6.64 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.63 2.22 . . . . 0.0 113.387 169.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.1 p-90 -131.14 -23.51 2.43 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -169.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.9 169.63 21.81 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.256 1.389 . . . . 0.0 112.13 -176.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 tt -139.27 123.13 17.66 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 168.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.7 m -139.56 134.16 31.77 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.236 0.541 . . . . 0.0 110.141 -175.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.99 146.25 54.92 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 168.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.4 m -137.17 141.76 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.7 mt -143.81 144.45 23.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -169.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.401 ' CE1' ' HD2' ' A' ' 12' ' ' PRO . 25.5 m-85 -132.59 136.81 28.51 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 118.196 -0.907 . . . . 0.0 109.387 -173.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -46.75 138.49 14.91 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 124.007 3.138 . . . . 0.0 112.166 169.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.89 -179.92 46.32 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 123.734 0.683 . . . . 0.0 113.043 -174.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.71 145.76 52.51 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 123.518 2.812 . . . . 0.0 110.917 -173.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.2 t0 50.76 54.56 10.99 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.284 1.434 . . . . 0.0 111.986 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -124.32 154.32 40.47 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.941 1.297 . . . . 0.0 107.769 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 92.2 mt -129.16 85.3 2.3 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 8.8 m0 -65.67 153.09 91.53 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -62.86 155.04 62.44 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.658 2.239 . . . . 0.0 111.131 171.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.43 129.76 43.24 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 169.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -144.45 160.03 41.76 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -124.17 172.93 8.66 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 122.985 1.374 . . . . 0.0 110.529 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 70.1 t -70.03 150.93 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 112.461 -2.154 . . . . 0.0 109.645 -169.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.0 m 68.89 1.09 2.98 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.244 1.818 . . . . 0.0 114.096 -177.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -73.47 155.77 38.9 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 169.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -119.75 143.77 47.62 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 118.615 0.643 . . . . 0.0 110.122 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 48.3 mm -117.56 123.92 72.37 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.81 118.02 7.34 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 108.006 -2.038 . . . . 0.0 108.006 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.4 tp -123.75 130.46 52.66 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.907 0.883 . . . . 0.0 108.759 -172.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.34 128.53 34.58 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 174.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 mp -133.98 159.46 72.3 Favored Pre-proline 0 C--O 1.234 0.253 0 C-N-CA 124.721 1.209 . . . . 0.0 108.875 172.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -58.41 -26.45 77.78 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.13 1.887 . . . . 0.0 113.464 170.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -65.28 -9.43 24.07 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.389 1.075 . . . . 0.0 113.198 173.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.43 157.1 18.84 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 108.025 -2.03 . . . . 0.0 108.025 -169.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.8 m -67.48 130.94 44.64 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 49.5 mtm -142.54 145.05 33.23 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -177.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.53 123.52 25.62 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 170.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -95.64 135.97 36.63 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 169.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.0 m -89.05 144.03 26.44 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 70.5 t -76.57 119.26 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 169.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -106.7 169.85 15.6 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 169.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -138.2 141.55 40.02 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 169.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 19.0 mt -132.35 152.95 51.2 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 169.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.07 135.14 57.07 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.52 3.72 72.75 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 118.816 -0.991 . . . . 0.0 113.467 -175.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.91 -33.47 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 119.18 1.49 . . . . 0.0 109.933 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.1 m 59.66 -156.01 0.35 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -169.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -58.71 136.29 57.66 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.37 0.532 . . . . 0.0 110.327 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -148.76 166.59 27.97 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.838 1.655 . . . . 0.0 107.448 170.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.4 mp -102.76 143.67 32.1 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.3 p -146.31 160.2 42.34 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.778 0.831 . . . . 0.0 110.645 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 30.8 t -147.78 128.84 14.55 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 171.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.5 m -66.9 134.78 52.73 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.3 mt -105.94 -59.68 1.74 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.986 0.914 . . . . 0.0 108.701 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -142.03 166.84 23.61 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.751 1.22 . . . . 0.0 108.878 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 28.6 m . . . . . 0 CA--C 1.541 0.608 0 C-N-CA 124.346 1.058 . . . . 0.0 109.906 176.51 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 90.4 p . . . . . 0 N--CA 1.457 -0.122 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -57.78 -22.5 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.157 0.983 . . . . 0.0 111.793 168.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -85.26 -45.6 11.81 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.328 1.051 . . . . 0.0 109.507 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -63.13 -32.05 73.33 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.277 0.49 . . . . 0.0 110.039 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.403 ' HA2' HG21 ' A' ' 57' ' ' ILE . . . -60.51 -54.76 34.46 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 175.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -65.28 -47.78 75.48 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 117.298 0.549 . . . . 0.0 110.08 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 83.9 mtm-85 -65.33 -46.7 79.23 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 118.852 -0.594 . . . . 0.0 111.398 -175.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.1 tp -76.82 -28.87 55.72 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 118.058 -0.973 . . . . 0.0 111.697 -171.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.8 m -71.64 -36.98 70.88 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.977 1.262 . . . . 0.0 109.546 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -70.37 -41.25 73.34 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.359 0.663 . . . . 0.0 111.529 174.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -65.24 -31.07 72.04 Favored 'General case' 0 CA--C 1.53 0.212 0 O-C-N 121.114 -0.991 . . . . 0.0 110.52 173.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 34.1 m -69.94 -40.06 75.7 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 121.922 -0.486 . . . . 0.0 110.227 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.17 -50.87 72.01 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.718 0.407 . . . . 0.0 110.074 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -55.26 -55.78 27.51 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 123.902 0.881 . . . . 0.0 110.057 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 16.3 ptt? -59.42 -39.4 83.38 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 117.992 -1.004 . . . . 0.0 111.038 -172.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . 0.274 6.6 pt -79.83 -21.69 12.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 119.761 1.164 . . . . 0.0 112.248 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 30.8 mt . . . . . 0 N--CA 1.468 0.437 0 CA-C-N 118.914 0.779 . . . . 0.0 108.951 168.19 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.2 mt -132.61 143.84 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.594 1.957 . . . . 0.0 105.786 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.76 147.06 41.64 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.801 0.728 . . . . 0.0 110.501 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.79 163.73 51.8 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.476 1.036 . . . . 0.0 111.439 170.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -126.52 142.01 51.68 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.042 1.337 . . . . 0.0 109.852 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -73.63 -19.77 60.77 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 122.951 0.501 . . . . 0.0 111.817 -173.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 p -146.82 154.08 40.93 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.85 1.66 . . . . 0.0 108.303 171.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -67.02 148.92 98.78 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 171.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.61 54.91 5.27 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 124.943 3.762 . . . . 0.0 111.002 175.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.3 tttm -53.83 -43.92 69.83 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.184 1.394 . . . . 0.0 111.993 -169.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.0 -40.77 97.12 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 118.43 0.559 . . . . 0.0 111.224 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -74.98 -35.44 62.05 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.101 -177.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.45 -45.77 96.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 170.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -60.29 -50.12 74.9 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.104 0.562 . . . . 0.0 110.144 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.76 -39.53 93.77 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.593 0.633 . . . . 0.0 111.352 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.46 -49.51 76.52 Favored 'General case' 0 C--N 1.337 0.065 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -71.49 -28.56 64.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 118.032 -0.985 . . . . 0.0 112.183 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -60.29 -40.59 90.99 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.85 1.204 . . . . 0.0 109.32 170.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -71.93 -46.41 57.67 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -175.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.2 mt -57.89 -45.8 87.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.0 -34.94 79.14 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.68 -0.638 . . . . 0.0 111.516 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -72.41 -36.02 68.53 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.96 0.904 . . . . 0.0 109.244 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? . . . . . 0 CA--C 1.536 0.405 0 C-N-CA 124.297 1.039 . . . . 0.0 110.659 169.856 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.443 ' CD ' HG23 ' A' ' 120' ' ' ILE . 73.5 Cg_endo . . . . . 0 N--CA 1.452 -0.937 0 N-CA-C 110.332 -0.68 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.406 HG13 HG22 ' A' ' 58' ' ' THR . 34.8 t -71.02 130.03 34.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 169.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -138.8 150.16 45.76 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.166 0.986 . . . . 0.0 108.801 -169.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.2 t -141.55 124.08 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -172.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.8 m -91.55 134.75 34.4 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 168.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -121.7 135.61 54.95 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.854 1.262 . . . . 0.0 107.885 169.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.448 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 25.8 p90 -167.66 142.21 3.69 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -169.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m 58.46 158.33 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.935 2.494 . . . . 0.0 115.735 167.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.1 tp -111.19 66.04 0.62 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 169.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -57.11 -33.67 67.57 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 -165.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -136.42 26.65 3.14 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.226 0.61 . . . . 0.0 111.255 175.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.13 15.91 60.09 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 119.378 -0.679 . . . . 0.0 112.302 -169.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -136.94 143.92 43.14 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 174.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -69.22 143.56 53.94 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.448 ' HB ' ' CE2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -107.48 155.1 20.43 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -177.11 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.9 163.41 36.37 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 67.2 m -140.73 146.96 38.43 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 p -124.95 144.19 35.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 175.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.7 tt -126.76 150.18 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 169.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.406 HG22 HG13 ' A' ' 40' ' ' VAL . 30.5 p -140.87 178.03 1.73 Allowed Pre-proline 0 N--CA 1.442 -0.87 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 173.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -61.82 -28.6 81.79 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 CA-C-N 119.286 0.781 . . . . 0.0 110.941 168.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.5 p-90 -95.4 -25.36 16.3 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -170.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.19 170.77 21.73 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.623 1.556 . . . . 0.0 113.416 -175.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 tt -136.04 125.46 24.99 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 103.07 -2.937 . . . . 0.0 103.07 167.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.2 m -137.05 133.94 36.0 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 122.991 0.517 . . . . 0.0 109.992 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.37 145.15 41.89 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 168.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.2 m -138.09 146.83 26.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.7 mt -137.94 135.45 45.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -174.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -122.99 150.43 59.21 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.435 1.094 . . . . 0.0 110.872 -169.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -44.38 152.51 0.43 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 124.736 3.624 . . . . 0.0 114.962 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.41 175.21 15.89 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 123.898 0.761 . . . . 0.0 113.697 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.82 -49.03 10.9 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.578 2.852 . . . . 0.0 114.305 -169.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -161.42 89.57 0.77 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.314 1.445 . . . . 0.0 107.231 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -155.79 -178.01 6.98 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.727 1.611 . . . . 0.0 106.688 178.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -95.7 136.71 35.76 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 168.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -107.97 144.04 28.56 Favored Pre-proline 0 C--N 1.324 -0.513 0 C-N-CA 126.656 1.983 . . . . 0.0 107.207 173.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.2 136.61 44.7 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.015 1.81 . . . . 0.0 110.606 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 64.1 tp -77.54 130.31 36.78 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 169.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.37 158.37 44.42 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 119.175 0.898 . . . . 0.0 109.956 -174.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -73.45 150.93 41.31 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.6 t -91.05 155.92 3.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -170.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.0 m 61.44 33.2 18.75 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.83 0.852 . . . . 0.0 111.658 -175.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -111.76 151.19 29.26 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 126.804 2.041 . . . . 0.0 106.983 169.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -105.26 142.37 35.15 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.092 0.86 . . . . 0.0 111.031 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.2 mm -118.86 130.04 74.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 174.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.21 123.2 6.77 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.9 mt -112.94 140.79 47.45 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.25 127.7 35.79 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 171.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mp -134.95 158.43 74.94 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 124.812 1.245 . . . . 0.0 107.774 174.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -60.81 -23.58 76.96 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.141 1.894 . . . . 0.0 113.98 172.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -64.2 -17.02 63.14 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.996 1.318 . . . . 0.0 111.949 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.94 152.12 9.12 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 107.881 -2.088 . . . . 0.0 107.881 -169.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.5 m -64.63 131.96 48.42 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 38.8 ttp -149.01 138.01 21.4 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -170.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.94 134.66 37.83 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -111.09 137.99 48.07 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 169.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.1 m -85.89 138.21 32.19 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 72.2 t -70.14 117.07 12.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 169.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -104.98 157.94 16.33 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 108.044 -2.022 . . . . 0.0 108.044 171.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -127.49 81.66 2.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 171.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.6 tp -66.1 128.89 37.88 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -169.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.66 131.38 50.52 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 122.832 0.453 . . . . 0.0 110.724 -172.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.36 4.92 75.71 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-O 118.607 -1.107 . . . . 0.0 113.576 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.2 t -122.39 -121.87 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.5 m -151.12 175.97 11.62 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.277 1.431 . . . . 0.0 109.544 -169.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -69.56 141.78 53.73 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 169.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -157.08 -179.15 7.93 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.308 1.443 . . . . 0.0 108.532 178.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 13.6 mt -113.78 136.66 52.61 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.2 p -139.75 153.59 47.22 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.793 0.837 . . . . 0.0 110.672 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 43.8 t -141.26 116.11 9.76 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 173.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.3 m -75.92 135.75 40.09 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 175.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 69.6 mt -116.7 -42.64 2.96 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.92 0.488 . . . . 0.0 112.276 -169.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 20.0 ptp -159.03 164.91 35.05 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.639 0.775 . . . . 0.0 109.746 -176.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.3 m . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 170.193 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.6 p . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.479 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -56.25 -41.01 68.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 123.679 0.791 . . . . 0.0 109.293 169.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -71.31 -44.27 65.47 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.097 0.559 . . . . 0.0 109.629 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -68.24 -22.33 64.78 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.645 -0.66 . . . . 0.0 110.998 175.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.29 -48.77 81.56 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 169.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -68.97 -54.05 17.39 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.71 -0.877 . . . . 0.0 110.584 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -65.5 -42.18 92.39 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 118.588 -0.72 . . . . 0.0 112.028 -169.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.9 tp -76.6 -27.15 55.66 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 119.896 1.225 . . . . 0.0 111.246 -171.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.2 m -71.45 -38.05 71.34 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.008 1.276 . . . . 0.0 109.232 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.85 -41.12 78.91 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.897 -0.502 . . . . 0.0 111.637 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -65.21 -34.97 79.63 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 121.022 -1.049 . . . . 0.0 110.325 173.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 18.0 t -67.71 -34.0 76.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.424 ' HB2' ' CE1' ' A' ' 45' ' ' PHE . . . -66.3 -51.73 54.46 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.363 0.665 . . . . 0.0 109.678 170.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 35.6 tpt85 -52.9 -50.08 64.63 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.55 0.74 . . . . 0.0 110.542 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 13.7 ptt? -59.53 -26.55 65.43 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 118.989 0.813 . . . . 0.0 112.306 -172.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 24.3 pt -96.16 5.49 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-N 119.166 0.894 . . . . 0.0 111.898 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.1 mt . . . . . 0 CA--C 1.542 0.647 0 C-N-CA 125.951 1.7 . . . . 0.0 112.078 -174.692 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 CA--C 1.534 0.36 0 CA-C-O 120.833 0.349 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.0 mm -128.56 125.9 64.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 172.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -72.7 128.59 35.99 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 173.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.46 153.51 52.91 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -84.08 136.07 34.16 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.136 0.974 . . . . 0.0 109.74 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -72.26 -33.03 67.18 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.806 -0.616 . . . . 0.0 110.075 173.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.8 p -150.72 155.32 39.06 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.427 1.891 . . . . 0.0 108.543 169.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.6 m -53.26 138.59 47.77 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 125.573 1.549 . . . . 0.0 113.703 -170.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -81.89 44.65 1.76 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 124.909 3.739 . . . . 0.0 110.88 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -61.63 -35.04 76.77 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.212 -1.555 . . . . 0.0 112.688 -168.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.58 -42.38 95.65 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 123.155 0.582 . . . . 0.0 110.983 176.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -68.45 -41.65 79.96 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.336 0.654 . . . . 0.0 109.343 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.6 t -59.44 -46.48 92.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 173.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -60.69 -53.4 57.93 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.284 0.634 . . . . 0.0 110.452 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.73 -44.75 95.39 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.941 0.496 . . . . 0.0 110.832 -172.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.58 -47.27 86.92 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -67.87 -26.26 65.93 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 118.37 -0.824 . . . . 0.0 112.31 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -63.76 -34.5 78.04 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.851 1.205 . . . . 0.0 110.051 176.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -70.91 -50.12 38.32 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.808 0.731 . . . . 0.0 109.34 174.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.8 mt -65.69 -39.67 85.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 123.988 0.915 . . . . 0.0 110.594 -169.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.3 -26.37 65.61 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.082 0.553 . . . . 0.0 111.51 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -85.25 -100.3 0.06 Allowed 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 172.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.546 0.817 0 C-N-CA 125.569 1.548 . . . . 0.0 114.273 -173.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 N--CA 1.456 -0.734 0 N-CA-C 114.204 0.809 . . . . 0.0 114.204 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.9 t -108.3 112.02 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 167.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -148.86 151.77 35.3 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.645 0.778 . . . . 0.0 109.65 -169.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.2 t -137.67 116.24 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 123.669 0.788 . . . . 0.0 109.187 -173.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.0 m -80.62 157.3 26.03 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.913 0.885 . . . . 0.0 110.318 169.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.88 140.5 52.92 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.76 2.024 . . . . 0.0 109.498 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.478 ' CE2' ' CB ' ' A' ' 131' ' ' ALA . 60.1 m-85 -147.06 169.7 18.7 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -169.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.8 t -52.03 167.45 0.12 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 129.132 2.973 . . . . 0.0 114.505 -169.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.9 tp -77.99 125.5 29.44 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 174.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.89 135.7 33.15 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.18 1.792 . . . . 0.0 107.299 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 55.38 24.16 6.37 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.864 0.866 . . . . 0.0 111.992 -170.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.23 5.88 78.12 Favored Glycine 0 CA--C 1.534 1.233 0 O-C-N 121.026 -1.046 . . . . 0.0 113.817 -174.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -119.14 157.22 28.34 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.191 1.796 . . . . 0.0 108.952 -175.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -79.3 147.76 32.36 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.311 -1.493 . . . . 0.0 110.091 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.58 162.82 12.94 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 122.506 1.146 . . . . 0.0 109.885 169.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.14 172.13 39.88 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 107.49 -2.244 . . . . 0.0 107.49 169.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 11.6 m -138.93 152.4 47.69 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 105.591 -2.004 . . . . 0.0 105.591 169.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.71 138.86 52.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 175.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.441 HD13 ' HA2' ' A' ' 123' ' ' GLY . 13.6 tt -116.1 146.22 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 167.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.4 t -154.8 157.11 31.97 Favored Pre-proline 0 N--CA 1.442 -0.863 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 175.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -50.23 -29.7 23.69 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.934 2.422 . . . . 0.0 113.646 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -93.14 -19.88 21.04 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -174.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -166.69 159.45 13.99 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.911 1.687 . . . . 0.0 112.66 -175.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.4 tt -124.57 124.88 43.19 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 103.848 -2.649 . . . . 0.0 103.848 167.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.8 m -137.65 134.46 35.49 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.35 0.595 . . . . 0.0 109.724 -172.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.84 144.2 52.65 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 167.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.7 m -136.11 150.44 28.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 32.1 mt -135.92 143.4 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -123.89 139.43 32.41 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -53.98 132.16 48.41 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.868 1.712 . . . . 0.0 108.928 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.4 -175.91 31.27 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.292 0.948 . . . . 0.0 114.68 -169.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -71.17 153.79 62.17 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.203 2.602 . . . . 0.0 110.204 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.0 t0 46.67 44.59 13.88 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.067 1.747 . . . . 0.0 113.068 172.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -133.62 143.52 48.67 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.103 1.361 . . . . 0.0 107.842 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -112.19 95.94 5.75 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 172.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -65.63 155.64 85.2 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.443 171.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -68.35 164.46 32.44 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.629 2.22 . . . . 0.0 109.909 169.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.25 87.68 1.12 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 169.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -70.82 148.98 47.29 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -89.9 159.04 17.15 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 169.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.8 t -91.37 154.22 3.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 114.048 -1.433 . . . . 0.0 107.647 -169.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.8 m 66.26 6.19 4.1 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.433 1.493 . . . . 0.0 113.673 -175.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -80.06 158.63 26.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.988 1.315 . . . . 0.0 108.268 169.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -113.97 144.22 43.44 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.966 0.803 . . . . 0.0 110.847 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.4 mm -118.21 121.09 66.36 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 176.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.11 125.33 7.74 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 173.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.3 mt -123.27 141.17 52.27 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.317 1.047 . . . . 0.0 109.084 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -90.53 133.65 34.92 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 172.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -153.49 157.51 32.76 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 124.958 1.303 . . . . 0.0 107.895 172.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -61.04 -20.26 66.84 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.059 2.506 . . . . 0.0 114.705 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -62.51 -20.65 64.83 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.944 0.898 . . . . 0.0 112.067 172.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.54 145.71 7.04 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 -170.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.9 m -60.64 131.07 49.56 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 174.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 47.6 ttp -149.67 146.21 27.14 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -169.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.55 134.02 34.42 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 121.883 -0.511 . . . . 0.0 110.493 176.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -104.98 132.25 51.46 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 168.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.2 m -82.01 144.11 31.1 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.0 t -75.96 114.39 16.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -98.1 162.75 21.02 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 171.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -129.9 133.86 47.13 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 169.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.6 tp -143.84 145.97 32.71 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -176.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -59.5 134.88 57.42 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.789 0.435 . . . . 0.0 110.572 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.17 4.45 59.71 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 118.945 -0.919 . . . . 0.0 113.701 -177.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.4 t -124.7 -33.15 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 118.928 1.364 . . . . 0.0 109.746 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.7 m 57.39 -150.09 0.45 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.331 1.053 . . . . 0.0 108.445 -169.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -58.61 132.15 52.94 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.884 0.874 . . . . 0.0 110.579 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -154.5 179.41 9.05 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.365 1.866 . . . . 0.0 107.011 169.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.6 mp -113.47 144.36 42.95 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 121.131 -0.981 . . . . 0.0 109.217 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.8 p -142.86 154.58 44.28 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.571 1.148 . . . . 0.0 110.278 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 12.2 t -144.75 111.87 5.96 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 170.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.9 m -67.98 130.17 42.14 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.7 mt -96.38 -59.34 1.85 Allowed 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -176.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.87 170.28 12.4 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.342 1.457 . . . . 0.0 108.377 177.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 170.844 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 78.7 p . . . . . 0 C--O 1.236 0.373 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.575 ' H ' HD12 ' A' ' 120' ' ' ILE . 1.9 mp -58.34 -36.87 60.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 169.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -72.59 -44.99 61.29 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.572 0.749 . . . . 0.0 109.959 -174.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -64.23 -31.92 73.31 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.646 172.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.441 ' HA2' HD13 ' A' ' 57' ' ' ILE . . . -56.07 -58.39 14.42 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-N 119.455 1.025 . . . . 0.0 111.533 169.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -63.82 -48.55 76.4 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.043 0.922 . . . . 0.0 110.478 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -57.41 -45.44 84.59 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.935 1.294 . . . . 0.0 110.699 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.6 tp -78.35 -27.87 47.07 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.201 -174.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.9 m -65.83 -44.84 84.35 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.724 1.147 . . . . 0.0 109.173 173.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -65.68 -46.42 79.11 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.45 0.7 . . . . 0.0 111.299 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.04 -33.29 75.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.813 0.445 . . . . 0.0 110.548 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 19.0 m -68.22 -39.64 82.29 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.23 0.468 . . . . 0.0 110.797 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.478 ' CB ' ' CE2' ' A' ' 45' ' ' PHE . . . -65.23 -50.69 64.88 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 171.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -52.9 -51.36 61.52 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.065 0.848 . . . . 0.0 110.737 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 58.2 ttp -43.13 -48.23 6.27 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.152 2.181 . . . . 0.0 112.476 173.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 11.0 pt -92.78 -15.37 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 118.767 0.712 . . . . 0.0 112.513 -174.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 18.6 mt . . . . . 0 N--CA 1.456 -0.156 0 C-N-CA 124.384 1.074 . . . . 0.0 110.548 -175.677 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.64 133.08 70.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 169.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -153.14 164.0 38.84 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.232 1.013 . . . . 0.0 110.207 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 134.78 -150.54 20.14 Favored Glycine 0 C--N 1.341 0.828 0 C-N-CA 125.035 1.302 . . . . 0.0 110.368 176.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -84.54 -27.26 27.46 Favored 'General case' 0 C--O 1.221 -0.447 0 C-N-CA 125.061 1.344 . . . . 0.0 107.463 169.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 58.9 16.32 4.49 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 167.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.3 p -52.28 145.38 11.04 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.336 1.054 . . . . 0.0 112.069 -177.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -48.12 126.22 11.68 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 126.04 1.736 . . . . 0.0 111.146 -175.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -73.45 53.21 2.58 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.906 3.071 . . . . 0.0 112.036 174.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.7 tttm -47.66 -48.76 28.78 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.44 1.896 . . . . 0.0 112.998 -169.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.64 -41.19 88.66 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.275 0.489 . . . . 0.0 111.69 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -71.87 -38.75 70.0 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.926 0.49 . . . . 0.0 109.795 -176.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 71.7 t -61.63 -44.16 98.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 172.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -60.31 -53.74 54.08 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.58 0.627 . . . . 0.0 110.078 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.93 -40.09 96.59 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.613 0.642 . . . . 0.0 111.194 -176.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.61 -46.9 86.15 Favored 'General case' 0 C--N 1.339 0.126 0 O-C-N 122.064 -0.398 . . . . 0.0 110.019 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -68.79 -25.15 64.56 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 118.419 -0.8 . . . . 0.0 112.379 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -67.08 -33.19 74.96 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 119.504 1.047 . . . . 0.0 109.803 173.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -77.58 -45.99 23.56 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.746 -0.596 . . . . 0.0 109.888 176.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.0 mt -60.43 -39.73 81.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.09 -34.46 77.65 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.362 -0.836 . . . . 0.0 111.549 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -71.73 -43.19 66.28 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.052 0.842 . . . . 0.0 109.059 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? . . . . . 0 CA--C 1.533 0.303 0 C-N-CA 123.957 0.903 . . . . 0.0 111.152 175.235 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo . . . . . 0 N--CA 1.453 -0.883 0 N-CA-C 112.827 0.28 . . . . 0.0 112.827 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.2 m -67.06 152.92 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 168.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -140.53 155.56 46.59 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.453 1.024 . . . . 0.0 110.073 -175.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.4 t -139.54 114.28 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.2 m -78.86 142.0 37.2 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 168.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -125.37 134.74 52.07 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.401 1.48 . . . . 0.0 107.865 169.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.612 ' CE1' ' HB1' ' A' ' 131' ' ' ALA . 20.5 p90 -165.11 142.8 6.09 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -172.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.4 m 54.58 166.27 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.104 2.562 . . . . 0.0 116.312 167.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.0 tp -113.54 110.34 20.09 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 168.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -131.22 135.74 47.65 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.678 1.591 . . . . 0.0 107.089 -169.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 55.51 25.05 7.43 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 121.644 0.735 . . . . 0.0 110.51 -168.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.16 3.64 65.75 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 118.146 -1.363 . . . . 0.0 113.901 -174.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -115.34 154.86 28.39 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.599 1.699 . . . . 0.0 109.403 -173.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -74.59 137.66 42.47 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.683 -1.26 . . . . 0.0 108.997 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.79 155.97 18.19 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.667 1.122 . . . . 0.0 110.255 -173.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.15 171.58 41.25 Favored Glycine 0 CA--C 1.526 0.721 0 O-C-N 121.081 -1.012 . . . . 0.0 111.732 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 15.0 m -145.76 152.44 39.57 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 170.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.87 144.6 35.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 124.986 1.314 . . . . 0.0 107.466 173.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.9 tt -127.83 150.28 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 169.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.2 p -138.56 175.87 3.05 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 169.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -59.54 -30.42 92.4 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 CA-C-N 119.701 0.929 . . . . 0.0 110.835 168.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 48.4 p-90 -92.45 -25.59 18.38 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -171.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.51 170.45 21.93 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.42 1.464 . . . . 0.0 113.491 -175.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.6 tt -138.29 128.45 25.78 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 104.147 -2.538 . . . . 0.0 104.147 168.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.2 m -140.65 138.74 34.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.655 0.741 . . . . 0.0 109.622 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.63 146.58 51.57 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 168.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.0 m -138.84 144.85 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 C-N-CA 123.807 0.843 . . . . 0.0 108.786 175.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 52.2 mt -138.35 144.07 31.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -128.3 146.18 58.6 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-O 117.974 -1.012 . . . . 0.0 108.621 -175.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.64 134.65 21.83 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.469 2.779 . . . . 0.0 111.023 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.78 173.61 53.36 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 123.01 0.338 . . . . 0.0 112.878 -175.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -69.71 149.9 67.81 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 122.532 2.155 . . . . 0.0 110.296 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.0 t70 50.71 40.46 24.27 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.409 1.884 . . . . 0.0 112.696 169.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -128.27 131.12 48.74 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.3 mp -96.74 83.23 3.41 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 -175.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 3.7 m0 -66.33 140.4 96.73 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.645 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -66.86 161.68 41.12 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.842 1.695 . . . . 0.0 108.454 168.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.0 tp -67.38 106.44 2.09 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 169.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -73.77 155.13 39.19 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.335 0.588 . . . . 0.0 109.642 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -89.87 148.14 23.34 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 169.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.6 t -89.84 154.72 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -169.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.1 m 65.01 12.86 8.25 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.149 1.38 . . . . 0.0 113.713 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -85.96 158.97 19.76 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.114 1.365 . . . . 0.0 108.212 169.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -111.23 143.24 42.3 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 118.796 0.726 . . . . 0.0 110.504 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.9 mp -114.09 127.82 71.34 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 N-CA-C 104.775 -2.305 . . . . 0.0 104.775 170.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.51 121.09 5.54 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 170.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.8 mt -109.32 132.57 54.0 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 174.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -85.97 125.96 33.77 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 173.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 37.1 mt -133.6 148.52 68.97 Favored Pre-proline 0 C--O 1.233 0.224 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -59.12 -24.6 74.48 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.383 2.055 . . . . 0.0 112.802 169.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -58.05 -29.61 65.51 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.995 1.318 . . . . 0.0 112.158 169.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.32 142.15 4.84 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 -169.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.7 m -61.5 130.47 46.17 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 174.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 44.2 ttp -147.75 136.97 22.31 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -170.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.12 139.79 35.42 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.753 -0.592 . . . . 0.0 110.145 175.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -112.81 136.72 52.12 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 169.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.5 m -91.8 140.97 29.17 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.3 t -72.61 129.21 35.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -114.39 159.64 13.61 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 107.54 -2.224 . . . . 0.0 107.54 169.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -127.5 100.32 5.96 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 171.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.8 tp -79.11 121.79 25.43 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -171.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.09 129.98 44.07 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.042 0.537 . . . . 0.0 110.604 -172.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.88 5.81 70.98 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.669 -1.073 . . . . 0.0 113.632 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.9 t -124.75 -113.23 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 118.847 1.324 . . . . 0.0 107.611 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 11.8 m -152.98 174.45 14.13 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.793 1.237 . . . . 0.0 110.142 -169.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -75.49 145.78 41.13 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 169.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.16 167.52 30.16 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.501 1.52 . . . . 0.0 108.277 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.4 mp -110.51 137.85 47.67 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.9 m -136.84 152.13 49.91 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.586 0.754 . . . . 0.0 110.47 -174.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 43.0 t -144.81 124.11 13.02 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 169.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.0 m -65.09 143.49 57.87 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 176.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.6 mt -117.69 -47.9 2.6 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 118.576 -0.726 . . . . 0.0 111.131 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 19.0 ptp -160.07 165.19 32.29 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.036 0.835 . . . . 0.0 110.541 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.3 m . . . . . 0 CA--C 1.539 0.532 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 169.896 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 CA--C 1.528 0.121 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -63.68 -24.84 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 O-C-N 120.923 -1.111 . . . . 0.0 111.114 177.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -67.04 -37.44 84.1 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.569 -0.707 . . . . 0.0 110.05 173.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -69.74 -31.72 69.86 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 118.888 0.767 . . . . 0.0 109.728 170.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.33 -36.94 46.98 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 169.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -84.6 -52.38 6.15 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.23 -1.159 . . . . 0.0 110.821 173.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 60.1 ttp85 -65.58 -38.5 89.68 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -169.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.62 -31.24 46.93 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 119.677 1.126 . . . . 0.0 109.2 -173.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 m -67.43 -42.52 83.04 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 123.677 0.791 . . . . 0.0 109.061 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -66.75 -41.26 88.11 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.349 1.06 . . . . 0.0 111.828 173.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.97 -30.54 65.37 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 121.176 -0.952 . . . . 0.0 110.636 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 44.0 m -69.32 -43.02 74.6 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.974 0.51 . . . . 0.0 110.172 173.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.612 ' HB1' ' CE1' ' A' ' 45' ' ' PHE . . . -54.34 -49.76 68.98 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.217 1.007 . . . . 0.0 110.276 173.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.0 ttp-105 -68.49 -42.69 78.29 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.43 -0.794 . . . . 0.0 111.851 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 51.4 ttp -48.31 -56.4 8.17 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.312 1.045 . . . . 0.0 110.601 171.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.6 pt -78.36 -6.07 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 118.865 0.757 . . . . 0.0 112.961 -176.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 19.0 tp . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 170.007 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 . . . . . 0 CA--C 1.536 0.411 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 71.2 mt -131.82 129.93 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 174.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.59 145.66 36.69 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.149 0.499 . . . . 0.0 110.49 -178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.17 151.18 51.66 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.911 1.243 . . . . 0.0 112.422 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -86.45 131.14 34.27 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 170.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -74.02 -32.7 63.48 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 171.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 p -149.73 148.22 28.97 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.489 1.916 . . . . 0.0 107.488 169.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.6 m -59.84 150.67 67.38 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 126.816 2.046 . . . . 0.0 114.13 -169.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -80.6 42.28 1.3 Allowed 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 124.306 3.337 . . . . 0.0 111.737 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 tttm -52.83 -46.91 67.97 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.853 1.261 . . . . 0.0 112.04 -169.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.57 -41.05 98.41 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 122.57 0.348 . . . . 0.0 111.407 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -72.28 -38.63 68.74 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -175.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 99.3 t -61.35 -44.08 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 172.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -62.17 -50.44 71.83 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 118.849 -0.596 . . . . 0.0 110.579 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.62 -39.13 93.17 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.765 0.711 . . . . 0.0 111.032 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.43 -50.33 74.02 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -68.36 -28.19 66.91 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 118.172 -0.918 . . . . 0.0 112.594 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.8 -33.88 76.66 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 120.028 1.285 . . . . 0.0 109.582 175.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -80.05 -43.27 22.16 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.289 0.495 . . . . 0.0 110.352 176.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.1 mt -65.22 -37.96 81.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.263 -0.898 . . . . 0.0 109.117 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.31 -32.69 74.25 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.467 0.707 . . . . 0.0 110.707 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -72.53 -41.8 65.46 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.841 0.856 . . . . 0.0 109.459 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.274 0 C-N-CA 124.332 1.053 . . . . 0.0 110.266 173.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 N--CA 1.454 -0.818 0 N-CA-C 115.769 1.411 . . . . 0.0 115.769 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.433 HG13 HG22 ' A' ' 58' ' ' THR . 39.6 t -111.63 107.9 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 101.128 -3.656 . . . . 0.0 101.128 167.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -140.85 159.17 42.78 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.946 0.898 . . . . 0.0 110.197 -169.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.3 t -138.16 112.21 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.7 m -76.17 147.82 38.2 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.487 1.04 . . . . 0.0 108.982 169.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -144.26 130.18 19.4 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.679 1.192 . . . . 0.0 111.622 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 176.59 159.35 0.33 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.017 1.327 . . . . 0.0 113.398 -172.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 m 61.64 152.86 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 128.473 2.709 . . . . 0.0 114.688 168.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.5 mt -103.62 125.55 50.21 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 169.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -135.34 138.45 43.4 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 173.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 54.18 26.31 6.57 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.971 0.908 . . . . 0.0 111.017 -169.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.54 7.14 82.68 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.927 1.251 . . . . 0.0 114.263 -176.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -119.17 148.68 42.82 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.236 1.518 . . . . 0.0 109.322 -173.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -66.72 145.3 55.68 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.235 0.925 . . . . 0.0 110.134 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.87 160.19 19.03 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.911 0.862 . . . . 0.0 110.173 -172.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -176.31 178.59 47.66 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 13.6 m -142.04 150.25 41.02 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 169.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.1 p -114.87 147.12 18.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 169.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.6 tt -130.08 151.34 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 169.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.433 HG22 HG13 ' A' ' 40' ' ' VAL . 44.5 p -142.41 172.06 6.35 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 169.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -73.89 21.06 0.38 Allowed 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 121.344 1.363 . . . . 0.0 112.063 169.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -138.13 -23.27 1.02 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.288 0.949 . . . . 0.0 113.403 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.18 164.71 37.57 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 120.363 1.438 . . . . 0.0 111.733 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 tt -137.61 125.87 23.18 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 168.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.3 m -138.18 134.18 34.21 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 123.332 0.395 . . . . 0.0 110.084 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.1 141.41 56.12 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 168.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 m -138.76 144.83 28.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 51.5 mt -141.33 134.35 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 -170.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -119.95 145.05 38.81 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.33 -172.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -44.68 125.8 6.62 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.738 2.959 . . . . 0.0 112.18 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.65 176.45 28.47 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 123.364 0.507 . . . . 0.0 113.193 -175.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -67.19 135.14 36.1 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.125 2.55 . . . . 0.0 110.411 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.7 t70 49.1 32.57 4.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.925 1.69 . . . . 0.0 113.259 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 -91.37 151.85 20.67 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 172.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -118.42 88.72 2.98 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 172.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 22.9 m0 -65.28 150.66 95.37 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 169.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.58 168.21 23.27 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.706 1.604 . . . . 0.0 108.375 169.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.8 tp -71.09 91.36 0.9 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 170.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -75.55 151.79 37.85 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.418 0.628 . . . . 0.0 109.679 -176.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -89.83 149.88 22.48 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 173.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.8 t -91.88 154.86 3.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 124.311 1.044 . . . . 0.0 108.281 -169.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.9 m 62.45 23.52 13.96 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.637 1.175 . . . . 0.0 112.667 -176.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -99.43 151.71 20.8 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.206 1.802 . . . . 0.0 107.648 169.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -106.2 143.63 34.06 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.503 0.592 . . . . 0.0 110.345 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 9.8 mt -123.92 128.41 74.18 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.85 123.14 6.89 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.8 mt -109.57 131.56 54.95 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 172.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.64 127.75 34.0 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 172.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.9 mt -135.2 153.62 78.33 Favored Pre-proline 0 C--O 1.234 0.275 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.79 -26.06 82.32 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.71 2.274 . . . . 0.0 112.759 174.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -65.37 -23.3 66.94 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.123 1.369 . . . . 0.0 111.911 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 129.69 147.15 6.2 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 126.176 1.846 . . . . 0.0 108.835 -169.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.7 m -62.78 133.86 55.39 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 55.7 ttm -144.47 136.09 25.72 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -169.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.42 130.11 35.11 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.521 -0.737 . . . . 0.0 109.169 173.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -106.06 136.48 45.65 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 169.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.8 m -87.58 137.88 31.96 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.1 t -71.02 114.81 9.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -101.47 163.31 17.74 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 169.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -130.58 97.8 4.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 170.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.5 tp -78.06 128.05 33.25 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -169.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -58.92 130.9 49.2 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.172 0.589 . . . . 0.0 110.52 -176.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.5 3.65 72.43 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.646 -1.086 . . . . 0.0 113.818 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.3 t -126.19 -121.0 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 119.143 1.471 . . . . 0.0 107.188 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.4 m -151.65 -176.79 5.76 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.776 1.63 . . . . 0.0 109.019 -169.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -72.91 148.62 44.17 Favored 'General case' 0 C--N 1.34 0.188 0 O-C-N 121.748 -0.595 . . . . 0.0 110.155 169.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -154.49 163.29 40.42 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.123 1.769 . . . . 0.0 108.03 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.4 mt -104.44 130.55 52.34 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.6 m -137.61 151.89 48.8 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.018 0.527 . . . . 0.0 110.884 -171.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 25.8 t -142.44 123.77 14.74 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 170.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.2 m -70.97 135.27 47.78 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 176.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.5 mt -110.48 -50.68 2.94 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.359 0.664 . . . . 0.0 111.165 -173.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 9.4 ptp -159.75 172.31 17.93 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.708 0.803 . . . . 0.0 109.982 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 CA--C 1.539 0.539 0 C-N-CA 124.044 0.938 . . . . 0.0 109.648 -177.051 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.7 t . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.565 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.6 OUTLIER -57.08 -36.59 51.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 119.09 0.859 . . . . 0.0 109.905 177.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -71.67 -32.41 67.84 Favored 'General case' 0 C--O 1.223 -0.308 0 O-C-N 121.652 -0.655 . . . . 0.0 110.462 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -73.73 -42.25 61.42 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.992 0.814 . . . . 0.0 109.372 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -49.01 -30.86 9.94 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 123.756 0.693 . . . . 0.0 113.882 169.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -90.33 -57.62 2.78 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.602 1.201 . . . . 0.0 111.481 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 71.8 ttt-85 -68.79 -32.58 72.41 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -168.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.6 mp -76.74 -38.34 54.37 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.757 1.162 . . . . 0.0 108.464 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.0 m -63.14 -43.58 97.93 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.3 1.04 . . . . 0.0 109.301 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.71 -55.0 39.81 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 118.657 -0.687 . . . . 0.0 110.801 171.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.27 -34.86 75.86 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.138 0.881 . . . . 0.0 111.408 -174.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 99.5 m -73.39 -27.14 61.3 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 122.11 -0.369 . . . . 0.0 111.854 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.52 -41.19 40.1 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.484 -0.76 . . . . 0.0 109.101 169.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -57.81 -55.34 36.11 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.262 1.425 . . . . 0.0 110.277 -173.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 17.3 ptt? -48.95 -34.09 12.21 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.655 1.582 . . . . 0.0 112.56 177.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 34.3 pt -93.53 2.5 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 119.863 1.21 . . . . 0.0 112.435 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 26.5 mt . . . . . 0 N--CA 1.465 0.316 0 C-N-CA 125.304 1.442 . . . . 0.0 112.844 -169.69 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 . . . . . 0 CA--C 1.544 0.74 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.0 mt -134.08 139.09 49.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 126.831 2.052 . . . . 0.0 106.19 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.28 150.61 45.02 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.931 -0.481 . . . . 0.0 111.307 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.24 163.1 42.63 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.301 0.953 . . . . 0.0 112.508 172.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -115.94 155.58 27.76 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.271 1.428 . . . . 0.0 109.736 175.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -88.63 -22.76 23.29 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.302 0.641 . . . . 0.0 111.659 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.3 p -159.2 -178.01 6.89 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 129.393 3.077 . . . . 0.0 106.323 172.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 m -57.19 134.99 80.92 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 121.247 -0.908 . . . . 0.0 109.534 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -74.19 63.48 5.23 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 124.537 3.491 . . . . 0.0 110.295 172.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -53.01 -50.74 63.6 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 124.266 1.026 . . . . 0.0 111.559 -169.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.32 -41.23 89.98 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 123.317 0.385 . . . . 0.0 110.708 -171.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -65.51 -45.91 81.7 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.595 0.758 . . . . 0.0 109.919 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 71.3 t -62.81 -41.12 91.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -62.98 -52.85 61.39 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.873 0.869 . . . . 0.0 109.996 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.77 -40.54 97.62 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.719 0.69 . . . . 0.0 110.648 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.04 71.56 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -68.06 -26.95 66.11 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 118.068 -0.968 . . . . 0.0 112.639 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -66.27 -31.1 71.71 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.826 1.194 . . . . 0.0 110.15 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -83.67 -41.63 17.53 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.243 0.617 . . . . 0.0 110.525 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.5 mt -65.52 -36.7 78.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 120.912 -1.117 . . . . 0.0 108.064 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.1 -27.78 68.61 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.228 -0.92 . . . . 0.0 112.244 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 62.9 ttp85 -76.41 -32.99 58.82 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.151 0.887 . . . . 0.0 109.665 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 . . . . . 0 CA--C 1.533 0.31 0 CA-C-O 118.904 -0.569 . . . . 0.0 110.857 171.293 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo . . . . . 0 N--CA 1.452 -0.92 0 N-CA-C 113.696 0.614 . . . . 0.0 113.696 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.3 t -99.49 106.98 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 1 N-CA-C 99.943 -4.095 . . . . 0.0 99.943 167.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -150.59 161.68 42.11 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.959 0.904 . . . . 0.0 109.944 -169.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 t -138.91 127.32 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.064 0.946 . . . . 0.0 108.748 -176.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.3 m -93.18 148.74 21.76 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.934 0.894 . . . . 0.0 109.039 168.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -121.9 141.28 51.45 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.361 1.865 . . . . 0.0 110.1 -176.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.419 ' CE2' ' CB ' ' A' ' 131' ' ' ALA . 91.1 m-85 -148.89 174.73 11.93 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.927 1.291 . . . . 0.0 113.053 -169.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.0 t -45.99 167.22 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 129.765 3.226 . . . . 0.0 115.121 -171.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.2 tp -84.76 107.1 16.77 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 105.69 -1.966 . . . . 0.0 105.69 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -76.64 -55.68 5.3 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 117.905 0.321 . . . . 0.0 111.578 -169.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.35 55.52 1.03 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.434 1.494 . . . . 0.0 109.347 177.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.83 10.25 79.34 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.075 -177.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -138.37 143.43 39.83 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.565 1.946 . . . . 0.0 107.362 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -74.79 152.08 39.04 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.679 0.672 . . . . 0.0 109.719 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.89 156.23 18.92 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.5 171.65 41.52 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.3 m -138.37 145.8 41.51 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 169.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 p -115.89 148.04 18.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 170.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.8 tt -129.73 152.11 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.885 1.274 . . . . 0.0 107.598 169.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.0 p -143.46 178.21 1.55 Allowed Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 125.337 1.455 . . . . 0.0 107.181 170.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.3 -24.57 77.84 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 121.331 1.354 . . . . 0.0 111.896 168.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.5 p-90 -104.3 -22.44 13.36 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -169.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.74 169.73 24.06 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 120.278 1.399 . . . . 0.0 112.608 -175.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.1 tt -138.29 126.4 22.82 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 103.946 -2.612 . . . . 0.0 103.946 168.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.6 m -138.89 134.69 33.6 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.16 147.48 46.57 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 168.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.4 m -139.04 148.41 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 124.574 1.15 . . . . 0.0 108.58 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 50.7 mt -138.57 137.85 42.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -126.31 148.33 63.36 Favored Pre-proline 0 N--CA 1.466 0.335 0 C-N-CA 124.042 0.937 . . . . 0.0 109.841 -173.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.4 133.86 31.32 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.709 2.273 . . . . 0.0 111.265 172.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.18 -171.35 16.47 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 123.756 0.693 . . . . 0.0 111.918 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.31 157.45 33.25 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.611 2.207 . . . . 0.0 111.297 -177.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.2 t0 43.76 56.33 4.62 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.747 2.019 . . . . 0.0 113.388 169.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -149.35 160.48 43.38 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.266 1.027 . . . . 0.0 109.315 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -111.7 105.69 14.27 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 169.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -70.67 143.45 89.8 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 172.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.16 150.25 85.12 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.049 1.833 . . . . 0.0 110.379 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.3 tp -76.12 92.9 3.26 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 170.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -79.36 171.49 15.1 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.032 0.933 . . . . 0.0 110.271 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -99.01 162.13 13.24 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 123.546 1.641 . . . . 0.0 107.481 168.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 87.9 t -89.84 154.27 3.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 113.044 -1.889 . . . . 0.0 107.112 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.9 m 67.11 5.82 4.38 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.058 1.343 . . . . 0.0 113.732 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -71.69 150.09 44.86 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 169.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -116.17 138.18 51.49 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.598 0.636 . . . . 0.0 110.032 177.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.6 mp -111.03 122.27 65.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 103.696 -2.705 . . . . 0.0 103.696 175.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.61 116.87 4.61 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 173.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.6 tp -106.72 132.36 52.79 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -87.53 127.58 35.25 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 172.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 mp -134.76 155.0 79.76 Favored Pre-proline 0 C--O 1.234 0.283 0 C-N-CA 125.426 1.49 . . . . 0.0 107.304 172.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -64.52 -23.93 63.95 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 CA-C-N 120.757 1.306 . . . . 0.0 112.402 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -55.25 -30.33 59.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.826 1.651 . . . . 0.0 111.763 169.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.06 148.32 5.54 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 108.116 -1.993 . . . . 0.0 108.116 -171.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.1 m -65.1 131.46 46.62 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 171.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 45.4 ttp -146.21 135.59 22.94 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -171.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.26 134.47 35.28 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 118.54 0.609 . . . . 0.0 110.021 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -103.48 134.13 47.35 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 168.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.6 m -94.9 141.49 28.58 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 92.5 t -74.16 123.83 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 171.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -113.0 156.74 15.41 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 169.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -115.08 98.53 6.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 169.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.1 tp -75.14 124.29 26.76 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -169.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -61.12 128.78 38.09 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.416 0.686 . . . . 0.0 110.219 -173.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.42 4.74 84.88 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.645 -1.086 . . . . 0.0 113.857 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.7 t -127.72 -118.99 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 119.069 1.435 . . . . 0.0 107.282 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.2 m -151.39 -179.57 7.49 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.174 1.79 . . . . 0.0 108.31 -169.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -70.66 146.14 50.16 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 121.671 -0.643 . . . . 0.0 109.691 169.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.82 167.64 26.87 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.671 1.588 . . . . 0.0 108.511 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.6 mt -103.43 138.63 39.89 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 174.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.5 p -154.93 160.59 41.26 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 119.298 0.954 . . . . 0.0 111.821 -177.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 9.5 p -149.17 135.63 19.36 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 168.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.2 p -74.17 145.63 44.07 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.457 0.703 . . . . 0.0 109.463 176.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.6 mt -116.36 -70.29 0.8 Allowed 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.768 0.827 . . . . 0.0 109.387 -173.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -148.53 161.16 42.21 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.077 0.951 . . . . 0.0 109.892 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 CA--C 1.544 0.728 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 168.761 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 96.6 p . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.544 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -61.85 -32.07 52.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 O-C-N 121.186 -0.946 . . . . 0.0 110.222 170.041 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -75.35 -43.95 47.79 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.472 0.578 . . . . 0.0 109.664 -177.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -62.66 -31.58 72.48 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.32 170.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.88 -50.64 61.99 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 119.97 1.259 . . . . 0.0 111.158 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -62.43 -50.88 69.74 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.988 -0.713 . . . . 0.0 109.87 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 66.0 ttp85 -61.61 -38.63 88.34 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 123.465 0.706 . . . . 0.0 110.927 -175.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.5 tp -80.51 -24.33 39.45 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 117.817 -1.087 . . . . 0.0 111.248 -174.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.9 m -65.42 -44.18 88.2 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 120.463 1.483 . . . . 0.0 108.724 170.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.96 -53.84 47.83 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 118.761 -0.638 . . . . 0.0 109.939 174.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -61.49 -32.22 72.23 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.615 0.643 . . . . 0.0 111.129 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 57.3 m -73.26 -30.47 63.47 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.994 -0.441 . . . . 0.0 111.621 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.419 ' CB ' ' CE2' ' A' ' 45' ' ' PHE . . . -73.8 -49.13 26.78 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 119.231 0.923 . . . . 0.0 109.57 170.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -46.82 -58.22 4.12 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 127.465 2.306 . . . . 0.0 110.469 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 15.8 ptt? -51.84 -42.68 62.77 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.601 1.161 . . . . 0.0 112.25 178.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 22.8 pt -84.24 -25.93 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 119.693 1.133 . . . . 0.0 111.789 -175.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 72.7 mt . . . . . 0 CA--C 1.538 0.49 0 C-N-CA 123.472 0.709 . . . . 0.0 109.306 169.281 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.543 0.71 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.7 mt -132.35 130.46 60.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.33 123.7 32.58 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.8 159.65 47.97 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 123.361 0.505 . . . . 0.0 111.902 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -111.09 164.75 12.51 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.427 1.491 . . . . 0.0 110.648 -169.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -76.03 -13.93 60.22 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.206 1.002 . . . . 0.0 112.336 -177.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 p -152.88 168.86 24.36 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 127.652 2.381 . . . . 0.0 106.959 171.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.9 m -64.76 145.53 98.78 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 169.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.92 65.94 7.67 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 124.554 3.503 . . . . 0.0 110.628 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -52.83 -48.61 66.85 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 123.912 0.885 . . . . 0.0 112.255 -169.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.8 -36.59 84.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.095 0.474 . . . . 0.0 110.95 -173.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -74.43 -41.75 60.31 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.034 0.934 . . . . 0.0 109.848 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.7 t -60.23 -45.32 96.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 172.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -62.19 -50.25 72.55 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.348 1.059 . . . . 0.0 110.402 -177.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.34 -39.2 93.88 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.778 0.717 . . . . 0.0 110.957 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.27 -47.02 84.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.176 -0.327 . . . . 0.0 110.32 175.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -68.05 -24.97 65.14 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 118.354 -0.831 . . . . 0.0 112.362 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -69.78 -32.42 70.9 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.857 1.208 . . . . 0.0 109.544 175.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -72.94 -46.89 49.95 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 173.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mt -64.6 -40.88 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 121.632 -0.668 . . . . 0.0 109.731 -176.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.1 -27.03 67.75 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.528 0.731 . . . . 0.0 111.302 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 51.9 ttm-85 -78.17 -45.26 23.64 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.72 0.808 . . . . 0.0 109.325 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 . . . . . 0 CA--C 1.534 0.344 0 C-N-CA 125.02 1.328 . . . . 0.0 111.092 177.918 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 120' ' ' ILE . 84.7 Cg_endo . . . . . 0 N--CA 1.449 -1.117 0 CA-C-O 120.576 0.157 . . . . 0.0 112.356 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.6 t -94.86 101.52 12.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 100.505 -3.887 . . . . 0.0 100.505 167.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -147.12 159.12 43.98 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.51 1.124 . . . . 0.0 109.855 -169.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.3 t -137.48 139.03 44.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.428 1.091 . . . . 0.0 108.161 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.0 m -106.79 152.01 24.41 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.949 1.299 . . . . 0.0 108.666 169.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -149.37 129.54 13.63 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.38 1.472 . . . . 0.0 109.838 -175.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -179.99 155.25 0.59 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.695 1.198 . . . . 0.0 112.468 -169.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.6 m 64.16 151.0 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.818 2.447 . . . . 0.0 112.613 170.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.6 tp -111.36 59.65 0.62 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.996 0.918 . . . . 0.0 109.409 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.31 134.26 50.04 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 123.566 0.746 . . . . 0.0 109.921 -175.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 54.96 23.46 5.09 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.827 0.851 . . . . 0.0 111.632 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.82 14.29 81.14 Favored Glycine 0 CA--C 1.537 1.427 0 CA-C-O 118.489 -1.173 . . . . 0.0 113.68 -176.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -132.75 149.23 52.3 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.621 1.71 . . . . 0.0 108.708 -171.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -70.4 135.74 49.01 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.034 -1.041 . . . . 0.0 109.665 -175.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.1 156.09 16.75 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -168.7 176.21 43.03 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 175.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 43.9 m -144.91 151.75 39.17 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 169.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.5 p -118.68 144.26 27.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 169.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.3 145.63 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 170.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.8 p -142.71 175.35 2.96 Favored Pre-proline 0 C--N 1.321 -0.655 0 C-N-CA 125.451 1.5 . . . . 0.0 107.034 169.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.57 -30.1 91.53 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 120.895 1.063 . . . . 0.0 111.44 168.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 48.1 p-90 -95.51 -25.23 16.29 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 118.128 -0.939 . . . . 0.0 113.292 -169.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.89 168.12 28.41 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-N 120.282 1.401 . . . . 0.0 113.206 -175.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.9 tt -137.32 121.9 18.48 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 168.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.1 m -134.13 130.75 37.81 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.198 0.523 . . . . 0.0 109.82 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.38 143.27 53.74 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 168.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.22 150.83 29.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.7 mm -134.06 134.51 55.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -125.8 143.03 43.87 Favored Pre-proline 0 CA--C 1.537 0.442 0 CA-C-O 118.318 -0.849 . . . . 0.0 111.044 -171.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -48.22 129.72 19.43 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.931 3.087 . . . . 0.0 113.829 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.48 177.02 34.1 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.247 1.403 . . . . 0.0 114.489 -171.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -61.86 118.53 5.42 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.854 3.036 . . . . 0.0 112.253 -169.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.5 t70 52.17 29.87 7.05 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.119 1.768 . . . . 0.0 113.602 175.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -82.68 146.94 28.78 Favored 'General case' 0 C--N 1.34 0.195 0 O-C-N 121.435 -0.79 . . . . 0.0 109.021 175.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.7 mp -101.26 82.58 2.36 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -67.3 145.84 98.67 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.531 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -64.6 157.71 53.95 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.274 1.982 . . . . 0.0 109.872 171.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.1 tp -77.07 77.3 3.62 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -64.63 148.18 51.44 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.07 0.548 . . . . 0.0 110.393 -174.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -92.08 151.04 20.63 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.1 t -88.43 153.03 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 125.452 1.501 . . . . 0.0 111.131 -168.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.8 m 68.27 7.49 5.96 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.068 1.747 . . . . 0.0 114.116 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -83.28 163.47 20.67 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 168.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -115.41 150.71 35.98 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.202 0.91 . . . . 0.0 111.574 175.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.2 mm -122.61 123.96 69.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.21 124.1 6.58 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 108.656 -1.777 . . . . 0.0 108.656 173.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.4 mt -116.79 138.22 51.65 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.481 1.112 . . . . 0.0 108.031 173.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -91.21 124.1 35.17 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mp -132.98 156.65 79.85 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 125.027 1.331 . . . . 0.0 108.162 170.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -67.01 -21.82 48.93 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 CA-C-N 120.625 1.259 . . . . 0.0 112.865 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -55.99 -31.45 63.05 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.816 1.247 . . . . 0.0 111.233 169.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.49 150.92 5.52 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.86 2.171 . . . . 0.0 107.776 -172.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.1 m -64.47 132.58 50.39 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 171.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 54.6 ttm -133.95 130.58 37.9 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -169.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.04 114.13 20.39 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 171.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -89.08 142.93 27.22 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 169.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.6 m -92.3 141.96 27.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.27 119.6 23.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 171.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -109.35 167.35 12.86 Favored Glycine 0 CA--C 1.52 0.361 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 169.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -117.57 117.09 28.47 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 169.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.0 119.19 21.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 176.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.34 131.62 51.53 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 122.721 0.408 . . . . 0.0 111.379 -171.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.55 3.56 72.4 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-O 118.968 -0.907 . . . . 0.0 113.526 -178.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.1 t -122.33 -110.58 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.0 m -154.71 173.54 16.27 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 119.776 1.171 . . . . 0.0 109.765 -169.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -66.96 142.24 57.33 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 169.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.02 173.19 16.33 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.084 1.754 . . . . 0.0 107.429 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.9 mp -109.07 140.0 43.21 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -176.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.0 t -142.08 152.94 43.78 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.489 1.115 . . . . 0.0 109.588 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 35.5 t -149.19 118.43 6.82 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 172.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.7 m -71.75 136.16 47.04 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -85.75 -62.96 1.4 Allowed 'General case' 0 C--O 1.231 0.112 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 172.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.92 175.72 5.75 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.529 1.532 . . . . 0.0 108.634 -175.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 CA--C 1.542 0.636 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 169.815 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 84.3 p . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.486 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 23.4 pt -66.19 -25.49 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 121.507 -0.746 . . . . 0.0 111.731 170.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -76.67 -45.59 29.1 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -63.05 -31.75 72.96 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.503 170.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.16 -60.79 8.32 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 120.16 1.346 . . . . 0.0 110.679 172.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -62.16 -48.71 78.89 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 117.412 0.606 . . . . 0.0 110.779 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 61.1 ttt-85 -61.2 -35.1 76.27 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 123.622 0.769 . . . . 0.0 110.817 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.5 tp -78.35 -23.91 46.71 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 117.607 -1.187 . . . . 0.0 111.407 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -46.6 85.43 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.88 1.673 . . . . 0.0 109.037 169.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -66.02 -46.77 76.71 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 122.609 0.364 . . . . 0.0 111.251 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -66.2 -33.21 75.25 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 119.248 -0.406 . . . . 0.0 110.778 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 28.4 m -67.07 -36.93 83.08 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.608 0.64 . . . . 0.0 110.435 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.05 -52.23 50.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 173.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 41.1 tpt85 -52.47 -46.03 66.35 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.961 0.905 . . . . 0.0 111.138 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 56.7 ttp -49.39 -52.53 27.89 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.959 1.704 . . . . 0.0 111.145 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 11.0 pt -88.93 -24.79 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 118.743 0.701 . . . . 0.0 112.612 -172.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 76.3 mt . . . . . 0 CA--C 1.532 0.285 0 C-N-CA 124.003 0.921 . . . . 0.0 109.074 171.729 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 C--O 1.239 0.531 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.3 mp -104.81 118.89 52.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 -174.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.51 119.61 20.59 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 169.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.87 177.6 54.21 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 121.423 0.457 . . . . 0.0 113.694 -175.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -115.67 169.51 9.14 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.985 1.714 . . . . 0.0 110.267 -169.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -72.88 -13.76 61.34 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -174.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.2 p -151.31 174.05 13.77 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 127.867 2.467 . . . . 0.0 106.404 169.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.4 m -61.93 147.69 89.39 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 169.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.53 67.43 6.36 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 124.752 3.635 . . . . 0.0 110.293 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.435 ' HE3' ' O ' ' A' ' 42' ' ' VAL . 45.5 mtpt -52.74 -52.43 56.41 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.513 1.125 . . . . 0.0 112.201 -169.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.01 -38.89 92.74 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 118.762 0.71 . . . . 0.0 110.968 -172.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -69.06 -42.71 75.92 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.746 1.219 . . . . 0.0 109.848 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.6 t -63.04 -42.21 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 174.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -61.36 -52.38 64.89 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.71 -49.47 75.06 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.762 0.825 . . . . 0.0 110.203 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.5 -49.83 75.04 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -70.01 -24.52 63.3 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 117.901 -1.047 . . . . 0.0 112.642 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -66.93 -33.17 74.99 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 120.05 1.296 . . . . 0.0 109.199 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -74.68 -49.09 22.57 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.391 -0.818 . . . . 0.0 109.544 173.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.1 mt -61.85 -30.68 49.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.42 -31.96 64.14 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 124.182 0.993 . . . . 0.0 112.014 173.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 53.6 ttp85 -72.05 -41.23 67.67 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.92 1.236 . . . . 0.0 109.594 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 124.289 1.035 . . . . 0.0 109.983 168.751 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo . . . . . 0 N--CA 1.451 -1.008 0 N-CA-C 110.376 -0.663 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 m -61.06 147.92 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 169.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -143.78 152.67 41.53 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 120.966 -1.084 . . . . 0.0 109.811 -177.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.435 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 7.1 p -135.89 127.05 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 124.488 1.115 . . . . 0.0 110.79 -175.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.9 m -92.54 146.81 23.39 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.649 1.18 . . . . 0.0 109.421 169.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -119.97 137.96 53.76 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.532 1.533 . . . . 0.0 107.786 169.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.43 ' CE1' ' HB1' ' A' ' 131' ' ' ALA . 29.4 p90 -164.87 146.29 7.84 Favored 'General case' 0 C--O 1.218 -0.569 0 C-N-CA 123.351 0.66 . . . . 0.0 111.715 -176.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.8 m 58.37 154.13 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.826 2.45 . . . . 0.0 115.52 168.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.4 tp -105.75 109.32 21.23 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 169.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -103.04 95.9 6.44 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.258 2.223 . . . . 0.0 108.107 -173.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 55.06 45.73 25.61 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.455 1.102 . . . . 0.0 111.658 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.59 22.44 62.13 Favored Glycine 0 CA--C 1.531 1.085 0 O-C-N 121.853 -0.529 . . . . 0.0 113.315 176.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -136.59 144.56 44.18 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 125.68 1.592 . . . . 0.0 107.121 -177.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -74.33 141.05 45.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 120.514 1.506 . . . . 0.0 109.399 172.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.02 154.68 19.25 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 172.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.84 168.73 35.66 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 175.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 36.1 m -142.42 148.43 37.79 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 p -129.32 135.0 62.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.0 tt -111.23 151.11 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.751 1.22 . . . . 0.0 108.032 171.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.1 p -136.86 175.11 3.74 Favored Pre-proline 0 N--CA 1.444 -0.739 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 172.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.42 -10.6 28.26 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 CA-C-N 121.132 1.44 . . . . 0.0 112.009 169.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -110.16 -25.6 10.1 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -173.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.37 171.48 20.31 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 120.306 1.412 . . . . 0.0 112.368 -175.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.3 tt -136.98 123.03 20.3 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 167.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.2 m -130.91 134.79 47.08 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.398 0.679 . . . . 0.0 109.925 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.05 149.4 35.8 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 168.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.9 m -138.74 146.55 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.61 1.164 . . . . 0.0 108.172 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.6 mm -130.76 114.85 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -115.0 146.66 36.65 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.314 1.046 . . . . 0.0 112.229 -168.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -39.08 128.56 1.39 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 125.178 3.918 . . . . 0.0 115.256 173.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.45 -178.51 49.92 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.219 0.914 . . . . 0.0 114.415 -173.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.02 106.42 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 124.084 3.189 . . . . 0.0 111.7 -169.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.6 t70 50.07 28.39 2.96 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.621 1.568 . . . . 0.0 112.658 -175.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -89.22 142.46 27.63 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -91.69 91.34 7.95 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 31.1 t90 -70.16 131.97 88.46 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.59 153.36 77.75 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.387 2.058 . . . . 0.0 111.811 -169.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 50.5 tp -61.77 130.23 44.78 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 169.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 69.8 mtt85 -125.55 156.67 38.7 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.881 0.873 . . . . 0.0 109.097 172.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -89.26 147.92 23.86 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 169.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.3 t -90.14 153.22 3.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 124.572 1.149 . . . . 0.0 110.809 -168.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.9 m 63.81 29.07 14.8 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.856 1.262 . . . . 0.0 112.461 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -104.47 155.3 18.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.518 1.927 . . . . 0.0 107.311 169.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -107.43 142.34 37.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.844 0.747 . . . . 0.0 110.191 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 35.4 mm -123.1 128.81 75.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.15 120.86 6.01 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 173.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.3 mt -105.0 139.35 39.81 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 170.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -90.48 129.14 36.68 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 173.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mp -135.79 155.76 77.79 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 125.151 1.381 . . . . 0.0 107.593 175.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.84 -23.94 68.45 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 121.541 1.494 . . . . 0.0 112.395 173.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -56.71 -30.7 63.75 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.062 1.345 . . . . 0.0 111.733 169.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 133.12 149.7 6.2 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 108.099 -2.0 . . . . 0.0 108.099 -170.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.0 m -64.37 133.34 52.42 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 41.4 ttp -147.2 139.42 24.54 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -171.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.33 134.05 36.61 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 118.747 0.703 . . . . 0.0 109.777 176.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -109.2 130.88 55.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 169.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.6 m -83.02 139.52 33.22 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.3 t -70.48 119.01 15.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 170.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -110.21 158.36 14.5 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 171.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -127.83 84.62 2.27 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.2 tp -65.23 125.29 24.56 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -172.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.3 136.33 58.01 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.466 0.706 . . . . 0.0 110.418 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.39 2.85 64.3 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.283 -0.731 . . . . 0.0 113.27 -176.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.0 t -128.81 -119.68 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.6 p -163.45 -175.09 4.04 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.166 1.387 . . . . 0.0 108.935 -171.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -70.05 144.81 52.07 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.633 -0.667 . . . . 0.0 110.725 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.38 165.11 36.04 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.717 1.607 . . . . 0.0 109.011 174.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.9 mp -102.7 126.11 49.68 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 174.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.9 m -144.65 156.45 44.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 119.594 1.088 . . . . 0.0 110.858 -170.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 18.8 p -145.37 139.88 27.29 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.453 -0.779 . . . . 0.0 110.008 170.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.3 m -75.14 137.48 41.38 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 171.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 85.2 mt -124.07 -30.16 3.52 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -171.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 14.9 ptp -159.44 167.21 29.27 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.057 0.943 . . . . 0.0 109.28 175.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.5 m . . . . . 0 CA--C 1.536 0.432 0 C-N-CA 124.349 1.059 . . . . 0.0 108.985 179.218 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 81.9 p . . . . . 0 C--O 1.235 0.331 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.505 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -60.68 -34.38 58.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 121.213 -0.93 . . . . 0.0 109.171 172.215 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -64.54 -45.49 86.91 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 123.601 0.76 . . . . 0.0 110.148 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -67.39 -29.67 69.24 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.369 0.986 . . . . 0.0 110.621 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.27 -37.29 64.5 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.788 -0.57 . . . . 0.0 111.773 169.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -82.69 -54.62 5.0 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.928 -1.337 . . . . 0.0 110.208 174.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 61.0 mtm-85 -67.56 -29.82 69.29 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 118.116 -0.945 . . . . 0.0 113.31 -169.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.8 tp -82.89 -27.17 30.89 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 120.525 1.511 . . . . 0.0 109.886 -176.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.2 m -71.19 -40.4 71.24 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.69 -44.19 82.38 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.224 1.01 . . . . 0.0 111.752 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.36 -39.28 92.62 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 121.175 -0.953 . . . . 0.0 109.752 175.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 37.9 t -63.13 -44.95 94.14 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.43 ' HB1' ' CE1' ' A' ' 45' ' ' PHE . . . -52.34 -50.76 61.69 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.953 1.301 . . . . 0.0 110.897 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.0 ptt85 -82.6 -24.47 33.88 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 15.5 tmm? -55.98 -44.31 78.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 118.648 -0.691 . . . . 0.0 109.812 171.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 6.8 pt -81.94 0.3 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.3 mt . . . . . 0 C--N 1.342 0.269 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 169.56 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 CA--C 1.534 0.351 0 N-CA-C 110.733 -0.099 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.8 mt -141.06 134.28 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.25 128.25 35.07 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 169.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.97 163.34 47.8 Favored Glycine 0 CA--C 1.537 1.454 0 N-CA-C 112.061 -0.415 . . . . 0.0 112.061 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -73.15 126.77 30.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.463 0.705 . . . . 0.0 109.516 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -67.62 -32.05 72.5 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 119.121 -0.466 . . . . 0.0 110.516 175.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.8 p -150.72 153.9 36.4 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 126.308 1.843 . . . . 0.0 107.857 169.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -56.8 137.95 78.3 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 125.388 1.475 . . . . 0.0 113.108 -169.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -80.34 43.89 1.62 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 124.626 3.551 . . . . 0.0 111.412 174.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -53.52 -45.21 69.67 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.086 1.354 . . . . 0.0 112.257 -169.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.09 -41.86 99.48 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 122.963 0.505 . . . . 0.0 111.606 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -72.48 -40.32 67.03 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -175.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.7 t -60.07 -46.12 94.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 172.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -59.74 -54.93 40.61 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.132 0.573 . . . . 0.0 110.347 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.02 -41.76 97.34 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.467 0.707 . . . . 0.0 110.853 -173.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.54 -39.25 77.59 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 118.511 0.596 . . . . 0.0 110.718 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -67.57 -31.17 71.05 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 121.317 -0.864 . . . . 0.0 111.738 173.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -68.95 -29.39 67.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.321 0.964 . . . . 0.0 111.107 173.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -70.41 -48.64 55.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mt -59.36 -41.89 85.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.566 0.746 . . . . 0.0 109.453 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.99 -23.79 67.32 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.769 0.828 . . . . 0.0 112.862 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -80.72 -45.22 17.44 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 171.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 . . . . . 0 C--N 1.33 -0.275 0 C-N-CA 124.794 1.238 . . . . 0.0 112.611 -174.468 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo . . . . . 0 N--CA 1.453 -0.895 0 CA-C-O 121.122 0.384 . . . . 0.0 113.039 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.1 t -75.4 139.23 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 168.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -139.61 154.03 47.48 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.641 0.777 . . . . 0.0 109.88 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.1 t -137.71 119.11 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 123.995 0.918 . . . . 0.0 109.265 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.1 m -82.22 143.88 31.06 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 168.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -126.63 134.29 50.79 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.552 1.541 . . . . 0.0 109.258 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -170.6 149.74 3.26 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 123.373 0.669 . . . . 0.0 112.737 -170.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.5 m 55.66 165.53 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 128.739 2.816 . . . . 0.0 116.257 167.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 30.3 mt -116.53 66.46 0.72 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.792 1.237 . . . . 0.0 108.705 171.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.12 136.14 42.94 Favored 'General case' 0 N--CA 1.457 -0.083 0 O-C-N 121.726 -0.609 . . . . 0.0 109.599 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 56.74 22.78 7.23 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.792 0.837 . . . . 0.0 111.247 -172.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.29 12.53 83.5 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.658 1.123 . . . . 0.0 113.474 -175.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -121.33 143.86 48.96 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.815 1.646 . . . . 0.0 108.202 -173.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -61.38 133.13 55.47 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 118.318 -0.849 . . . . 0.0 109.154 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.84 157.53 16.24 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 122.207 1.004 . . . . 0.0 108.56 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.75 167.83 39.3 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 56.4 m -141.43 150.56 42.47 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 169.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.91 139.77 50.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 175.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.6 tt -116.46 147.03 20.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 169.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.7 p -138.37 172.2 7.05 Favored Pre-proline 0 N--CA 1.439 -0.979 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 171.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -63.24 -22.63 72.5 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 CA-C-N 119.928 1.01 . . . . 0.0 111.074 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 44.4 p-90 -94.45 -26.27 16.55 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -174.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.94 173.51 12.57 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 120.527 1.512 . . . . 0.0 112.71 -173.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.5 tt -135.43 128.48 31.62 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 167.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 77.7 p -138.03 142.61 40.35 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 122.029 0.919 . . . . 0.0 110.728 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.02 144.41 47.18 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 167.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.9 m -135.39 151.32 30.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 39.9 mt -136.59 139.77 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -116.61 139.66 25.77 Favored Pre-proline 0 C--O 1.234 0.266 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -54.86 131.17 44.56 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 121.629 1.552 . . . . 0.0 109.018 177.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.57 -179.46 27.72 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.509 1.052 . . . . 0.0 114.596 -169.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.16 158.25 41.67 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.365 2.71 . . . . 0.0 111.096 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.4 t0 46.04 45.58 12.36 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.795 2.038 . . . . 0.0 113.604 169.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -150.12 147.68 28.05 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.6 mp -104.3 107.26 18.09 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -72.22 157.82 88.62 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.186 -0.916 . . . . 0.0 108.776 169.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.31 166.93 28.63 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.1 1.867 . . . . 0.0 108.972 169.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 61.3 tp -69.2 82.53 0.35 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 169.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -75.46 139.78 42.47 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -173.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -90.86 141.89 28.35 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 122.812 1.291 . . . . 0.0 108.175 176.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -68.93 156.08 7.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 127.992 2.517 . . . . 0.0 109.152 174.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.0 m 69.93 0.74 3.18 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 128.336 2.655 . . . . 0.0 114.437 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -81.52 158.02 24.61 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 169.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -110.08 143.09 40.62 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.0 0.52 . . . . 0.0 110.0 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.5 mt -121.08 118.8 57.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -74.61 123.66 7.7 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 174.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 72.8 mt -125.2 151.76 45.42 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.667 1.187 . . . . 0.0 108.654 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -108.65 128.11 54.56 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.377 1.071 . . . . 0.0 108.753 -175.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.0 mp -137.06 168.95 14.61 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 125.331 1.452 . . . . 0.0 108.641 175.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -58.83 -23.26 66.23 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.366 2.044 . . . . 0.0 113.979 173.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -56.43 -38.32 71.42 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.603 0.761 . . . . 0.0 111.805 170.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.85 -167.55 24.27 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 -169.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 m -80.05 135.14 36.28 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 172.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 20.6 ptp -144.16 148.79 35.5 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 169.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.92 128.62 35.68 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 173.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -96.33 128.05 42.89 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 168.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.4 m -77.79 138.95 39.27 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 171.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.9 t -72.2 121.92 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 170.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -103.64 165.76 15.67 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -121.81 127.61 50.77 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.099 -2.185 . . . . 0.0 105.099 169.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.5 tp -141.19 142.61 33.99 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.063 0.847 . . . . 0.0 109.849 -176.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -59.04 135.02 57.49 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.312 0.645 . . . . 0.0 111.023 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.83 -2.12 50.85 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.044 0.831 . . . . 0.0 113.668 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.5 t -125.59 -31.49 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 118.638 1.219 . . . . 0.0 109.91 -173.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.0 m 54.58 -122.71 1.99 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.348 1.059 . . . . 0.0 109.001 -169.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -82.73 130.35 35.11 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.512 1.051 . . . . 0.0 109.861 -169.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -156.25 179.54 9.14 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 126.294 1.838 . . . . 0.0 106.993 176.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp -119.23 143.15 47.45 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.981 0.913 . . . . 0.0 109.217 -175.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.9 m -139.73 148.52 42.41 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.925 1.29 . . . . 0.0 110.123 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 20.2 t -140.34 110.1 6.4 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 171.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.7 m -73.1 135.91 44.83 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 71.5 mt -121.31 -47.85 2.23 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 119.374 -0.346 . . . . 0.0 111.26 -169.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.24 167.27 29.43 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.63 1.172 . . . . 0.0 108.286 175.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.0 m . . . . . 0 CA--C 1.54 0.588 0 C-N-CA 123.777 0.831 . . . . 0.0 110.194 -178.376 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 65.1 p . . . . . 0 C--O 1.234 0.289 0 CA-C-O 120.818 0.342 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.494 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -63.76 -26.01 39.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 121.863 -0.523 . . . . 0.0 109.708 169.584 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -68.18 -43.05 79.03 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.315 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -64.89 -30.08 71.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.308 0.958 . . . . 0.0 110.604 169.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.19 -61.07 7.79 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -61.59 -51.25 69.32 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.809 -0.818 . . . . 0.0 110.534 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 65.6 ttt-85 -63.4 -30.18 71.35 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.226 1.01 . . . . 0.0 111.867 -174.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.7 tp -89.38 -24.81 21.85 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 120.477 1.489 . . . . 0.0 110.294 -177.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.6 m -70.32 -40.77 73.97 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 170.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -70.03 -41.95 73.58 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.788 0.835 . . . . 0.0 111.582 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.98 -30.33 71.31 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 121.127 -0.983 . . . . 0.0 110.217 172.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 37.0 t -66.3 -45.89 78.81 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.931 0.787 . . . . 0.0 109.053 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -54.39 -51.1 65.9 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.473 1.109 . . . . 0.0 109.79 174.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -58.21 -54.77 43.25 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 123.115 0.566 . . . . 0.0 110.19 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 50.9 ttp -47.17 -41.4 17.78 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.867 1.667 . . . . 0.0 112.012 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.9 pt -86.12 -14.55 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.278 0.944 . . . . 0.0 113.433 -176.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.6 pp . . . . . 0 N--CA 1.449 -0.506 0 C-N-CA 125.461 1.504 . . . . 0.0 108.457 174.368 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 . . . . . 0 CA--C 1.534 0.362 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.7 mt -119.66 136.57 56.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 171.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.7 146.82 54.2 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.87 135.53 17.03 Favored Glycine 0 C--N 1.336 0.557 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 170.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -96.4 138.64 33.69 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.863 0.865 . . . . 0.0 109.056 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -71.78 -37.38 70.45 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.0 p -157.48 168.54 27.01 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 129.732 3.213 . . . . 0.0 106.31 169.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.9 m -51.91 130.57 38.84 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.736 0.814 . . . . 0.0 111.498 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -77.01 63.66 7.67 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 125.179 3.919 . . . . 0.0 111.525 -176.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -52.97 -51.62 60.9 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.739 0.815 . . . . 0.0 111.497 -171.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.78 -39.76 91.32 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 123.315 0.384 . . . . 0.0 110.79 -170.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -67.17 -47.01 72.28 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.646 0.778 . . . . 0.0 109.903 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.0 t -63.06 -40.37 88.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.46 -53.17 58.76 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.743 0.817 . . . . 0.0 109.831 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.03 -40.51 97.96 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.47 0.577 . . . . 0.0 110.759 -176.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.71 -50.5 73.24 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -71.7 -24.09 61.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 118.033 -0.984 . . . . 0.0 112.597 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -66.58 -33.8 76.48 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.267 1.394 . . . . 0.0 110.273 172.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -74.38 -47.19 35.62 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.0 mt -61.05 -40.73 86.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.22 -28.38 69.33 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.587 0.755 . . . . 0.0 112.189 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -70.81 -44.19 67.07 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 172.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 . . . . . 0 CA--C 1.536 0.43 0 C-N-CA 124.628 1.171 . . . . 0.0 112.51 -175.785 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo . . . . . 0 N--CA 1.453 -0.911 0 N-CA-C 114.435 0.898 . . . . 0.0 114.435 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.7 t -61.75 137.49 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 169.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -149.71 159.27 44.48 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.926 0.89 . . . . 0.0 109.487 -175.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.7 t -136.87 141.05 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.1 m -110.79 152.25 26.86 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.227 1.411 . . . . 0.0 108.788 169.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -120.52 143.29 48.65 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 127.248 2.219 . . . . 0.0 110.813 -176.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -145.98 173.35 12.24 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.608 1.163 . . . . 0.0 111.651 -172.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.5 t -52.17 160.31 0.79 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.92 2.088 . . . . 0.0 115.323 -168.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -75.66 106.01 6.99 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 169.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -75.98 -53.98 7.56 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -168.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.91 -42.86 0.74 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.344 1.858 . . . . 0.0 110.226 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.55 -0.21 0.09 OUTLIER Glycine 0 CA--C 1.534 1.256 0 C-N-CA 127.82 2.629 . . . . 0.0 110.684 175.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -137.39 134.94 36.49 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 119.247 1.523 . . . . 0.0 109.112 -170.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -60.64 152.27 26.86 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.861 0.864 . . . . 0.0 110.337 170.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.23 163.2 12.58 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.301 1.04 . . . . 0.0 109.732 172.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.47 170.92 41.28 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 171.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 7.0 m -140.5 131.04 25.44 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.4 p -103.5 149.2 7.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 173.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.7 tt -131.19 149.65 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 169.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.401 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 30.8 p -139.74 175.75 3.01 Favored Pre-proline 0 N--CA 1.444 -0.764 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 172.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 37.4 Cg_endo -63.13 -19.67 69.34 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 CA-C-N 120.528 1.224 . . . . 0.0 111.145 168.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.0 p-90 -102.73 -24.43 13.74 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -172.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.68 170.35 22.58 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.547 1.521 . . . . 0.0 112.806 -175.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 tt -137.41 125.84 23.44 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 168.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.8 m -138.26 133.2 32.83 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.359 0.599 . . . . 0.0 110.256 -176.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.93 144.78 52.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 168.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 m -139.46 149.17 22.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 124.14 0.976 . . . . 0.0 108.565 -176.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.2 mt -143.38 141.54 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -170.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -134.79 138.23 29.23 Favored Pre-proline 0 N--CA 1.468 0.468 0 CA-C-O 117.839 -1.077 . . . . 0.0 110.517 -170.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -48.4 139.44 22.53 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.718 2.945 . . . . 0.0 112.548 173.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.38 175.79 28.56 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 123.974 0.797 . . . . 0.0 113.856 -174.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.4 140.65 44.58 Favored 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 122.818 2.345 . . . . 0.0 110.095 -174.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.6 t70 50.94 34.92 11.36 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.518 1.527 . . . . 0.0 113.31 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -132.55 131.81 41.94 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.124 1.37 . . . . 0.0 107.522 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.37 99.64 9.34 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -175.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.79 145.15 97.8 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 169.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.36 148.52 61.37 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 121.606 1.537 . . . . 0.0 109.898 171.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.4 tp -63.21 140.06 58.83 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.72 158.69 25.97 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.826 0.739 . . . . 0.0 109.355 174.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.43 140.52 44.72 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.1 t -79.48 159.24 4.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 124.422 1.089 . . . . 0.0 109.038 -169.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.0 m 63.7 23.32 13.46 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.941 1.296 . . . . 0.0 112.92 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -100.57 154.56 18.47 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.226 1.811 . . . . 0.0 107.516 169.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -111.19 141.22 44.99 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.434 0.561 . . . . 0.0 110.666 -177.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 23.7 mm -112.87 128.62 69.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 176.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.42 118.97 5.42 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 173.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.4 tp -108.04 143.61 36.52 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 172.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -105.05 125.49 51.04 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.6 mp -135.77 157.54 75.91 Favored Pre-proline 0 C--O 1.234 0.265 0 C-N-CA 125.25 1.42 . . . . 0.0 107.288 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -66.59 -22.82 50.48 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 CA-C-N 120.609 1.253 . . . . 0.0 112.853 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -54.87 -35.98 64.63 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.592 1.157 . . . . 0.0 111.156 169.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 145.85 157.27 7.21 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 108.026 -2.03 . . . . 0.0 108.026 -173.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.1 m -67.45 133.41 49.49 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 171.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 58.6 ttm -140.72 128.36 21.54 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -170.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.69 132.97 38.43 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 173.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -108.14 130.39 55.12 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 169.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.5 m -80.72 142.37 33.92 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.102 0.961 . . . . 0.0 108.554 177.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 75.7 t -76.45 118.92 23.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 169.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -105.33 161.45 14.71 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 170.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -128.93 93.81 3.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 170.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.9 tp -79.33 127.8 32.53 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -169.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.0 133.78 56.42 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.149 0.58 . . . . 0.0 110.397 -176.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.14 3.47 69.58 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-O 118.635 -1.092 . . . . 0.0 113.473 -177.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.6 t -124.81 -118.68 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.8 t -159.6 -169.27 2.52 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.024 1.33 . . . . 0.0 108.025 -176.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -70.36 143.86 51.8 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.275 0.559 . . . . 0.0 109.688 169.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.78 173.79 16.28 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.176 1.79 . . . . 0.0 107.508 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.7 mp -108.42 142.69 38.41 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 176.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.9 p -142.48 155.42 45.06 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.942 0.897 . . . . 0.0 110.579 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 41.9 t -144.85 116.43 8.12 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 172.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.3 m -69.49 133.03 47.21 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.0 mt -102.08 -66.58 0.91 Allowed 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -175.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.93 164.08 25.97 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.963 0.905 . . . . 0.0 109.753 176.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.9 m . . . . . 0 CA--C 1.541 0.611 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 169.59 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 92.3 p . . . . . 0 CA--C 1.529 0.169 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 41.8 pt -67.43 -24.32 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 121.582 -0.698 . . . . 0.0 111.518 169.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -75.4 -44.58 43.93 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -62.76 -34.51 77.37 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.869 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.35 -52.27 54.2 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 120.196 1.362 . . . . 0.0 111.636 176.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -72.38 -36.97 68.83 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 117.574 0.687 . . . . 0.0 111.268 -177.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 22.9 tpp85 -66.46 -34.42 77.89 Favored 'General case' 0 C--N 1.339 0.11 0 O-C-N 121.053 -1.03 . . . . 0.0 109.823 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 21.4 tp -84.38 -24.94 29.45 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 116.948 -1.501 . . . . 0.0 111.684 -175.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.7 p -66.26 -44.41 83.71 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 121.794 2.088 . . . . 0.0 108.283 169.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -62.42 -50.45 71.47 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 122.773 0.429 . . . . 0.0 111.547 176.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -64.21 -34.5 78.24 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 118.758 -0.639 . . . . 0.0 110.534 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 32.9 m -69.25 -39.5 78.43 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.524 0.602 . . . . 0.0 111.109 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.3 -50.74 62.63 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 175.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -59.51 -46.58 88.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 118.738 -0.649 . . . . 0.0 111.582 -176.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 50.6 ttp -39.55 -48.81 2.1 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.204 1.801 . . . . 0.0 111.23 169.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 23.6 pt -92.09 -20.74 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 118.776 0.716 . . . . 0.0 112.719 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.2 mt . . . . . 0 C--N 1.345 0.372 0 CA-C-N 119.26 0.936 . . . . 0.0 109.039 171.062 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.3 mm -127.92 128.59 69.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 126.773 2.029 . . . . 0.0 105.636 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.37 133.9 35.97 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 172.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.83 -179.14 35.46 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.159 0.885 . . . . 0.0 112.795 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -119.04 156.88 28.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.934 1.294 . . . . 0.0 112.23 -169.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -72.0 -30.4 65.19 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.137 0.975 . . . . 0.0 111.547 -178.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.4 p -158.57 -175.17 5.16 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 130.477 3.511 . . . . 0.0 105.537 172.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.1 m -56.95 146.44 59.46 Favored Pre-proline 0 CA--C 1.545 0.75 0 O-C-N 120.959 -1.088 . . . . 0.0 109.295 169.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -71.14 56.64 2.03 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 124.439 3.426 . . . . 0.0 109.945 169.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 42' ' ' VAL . 27.8 tttm -47.22 -50.93 20.0 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 126.667 1.987 . . . . 0.0 113.623 -168.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.6 -41.06 96.48 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.187 0.903 . . . . 0.0 111.567 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -70.96 -40.18 72.13 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.193 0.597 . . . . 0.0 109.768 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 94.0 t -60.11 -44.9 96.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 172.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -60.78 -55.81 28.65 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 118.744 0.702 . . . . 0.0 110.368 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.65 -41.07 98.27 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.418 0.553 . . . . 0.0 110.826 -173.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.73 -51.81 60.43 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -67.41 -28.74 68.16 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 118.161 -0.923 . . . . 0.0 111.648 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -66.72 -37.58 84.98 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 119.76 1.164 . . . . 0.0 110.108 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -72.79 -42.47 63.87 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.858 0.753 . . . . 0.0 109.23 178.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.7 mt -62.84 -45.59 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.84 -38.48 85.62 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 123.512 0.725 . . . . 0.0 111.054 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.4 ttt-85 -68.25 -48.73 64.29 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -175.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.373 0 C-N-CA 124.26 1.024 . . . . 0.0 110.674 175.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo . . . . . 0 N--CA 1.455 -0.786 0 CA-C-O 120.353 0.064 . . . . 0.0 111.939 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 36.1 t -61.47 127.59 21.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 169.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -139.02 149.3 44.49 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 124.066 0.947 . . . . 0.0 109.078 -174.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.447 ' O ' ' HE2' ' A' ' 13' ' ' LYS . 2.5 p -139.71 131.13 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 125.71 1.604 . . . . 0.0 109.5 -176.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 p -108.61 151.46 26.09 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.276 0.63 . . . . 0.0 109.81 169.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -116.24 142.63 46.58 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.596 1.959 . . . . 0.0 109.337 -172.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -147.58 167.42 24.57 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -168.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.5 m -4.4 132.09 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.446 1 C-N-CA 133.537 4.735 . . . . 0.0 118.319 169.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.0 tp -81.13 99.22 8.41 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 168.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -86.41 -55.46 3.89 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.337 0.517 . . . . 0.0 111.525 -169.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -140.96 71.55 1.37 Allowed 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.495 1.518 . . . . 0.0 108.316 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 64.14 16.32 59.81 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.677 0.656 . . . . 0.0 112.946 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -146.27 142.51 28.41 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.438 1.895 . . . . 0.0 107.077 -170.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -81.73 155.38 25.53 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.298 1.039 . . . . 0.0 109.785 174.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.4 162.28 13.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.229 1.014 . . . . 0.0 109.343 169.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.52 161.53 34.99 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 107.207 -2.357 . . . . 0.0 107.207 171.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 60.9 m -133.52 149.22 51.7 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 169.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.7 p -131.63 149.14 32.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 173.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.2 tt -130.56 150.78 34.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 124.899 1.279 . . . . 0.0 107.798 173.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.8 p -143.54 174.78 3.29 Favored Pre-proline 0 N--CA 1.443 -0.776 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -62.05 -21.42 72.37 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 CA-C-N 120.067 1.06 . . . . 0.0 111.619 168.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 42.5 p-90 -100.25 -26.46 13.91 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -172.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.61 172.15 17.66 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 120.285 1.402 . . . . 0.0 112.379 -174.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 tt -132.63 128.51 37.26 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 168.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.1 p -140.57 143.19 35.17 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 122.273 1.035 . . . . 0.0 110.839 177.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.16 143.78 35.11 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 167.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.4 m -132.87 144.44 36.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 125.061 1.345 . . . . 0.0 108.055 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 30.2 mt -141.45 143.92 26.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 C-N-CA 124.837 1.255 . . . . 0.0 107.901 -169.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -141.54 144.04 31.98 Favored Pre-proline 0 N--CA 1.467 0.382 0 CA-C-O 117.552 -1.213 . . . . 0.0 108.92 -172.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -63.13 150.26 89.11 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.178 1.919 . . . . 0.0 111.815 174.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.97 -179.38 39.75 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.472 1.034 . . . . 0.0 114.31 -172.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -62.14 126.53 18.88 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.001 2.467 . . . . 0.0 111.783 -170.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.3 t70 50.5 31.08 5.19 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.47 1.508 . . . . 0.0 113.249 175.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -87.0 141.97 28.28 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 171.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -103.48 90.99 3.85 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -71.94 159.58 85.06 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.363 169.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -68.77 166.45 26.17 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.448 2.099 . . . . 0.0 110.644 172.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 63.2 tp -69.26 95.54 0.78 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 170.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -74.98 146.52 41.6 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -102.48 159.64 15.26 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 122.404 1.097 . . . . 0.0 108.646 169.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 90.6 t -83.48 153.14 3.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 113.674 -1.603 . . . . 0.0 108.09 -169.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.9 m 65.84 6.46 3.99 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.905 1.682 . . . . 0.0 114.078 -176.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -80.68 161.56 24.58 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.468 1.107 . . . . 0.0 108.738 169.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -118.97 143.22 47.17 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.602 -0.686 . . . . 0.0 110.586 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.0 mp -113.84 127.16 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 170.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.29 120.18 5.52 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.5 mt -111.05 129.05 56.03 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.49 131.01 35.93 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 169.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.7 mt -140.99 155.04 68.94 Favored Pre-proline 0 C--N 1.332 -0.182 0 C-N-CA 125.69 1.596 . . . . 0.0 107.181 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -64.32 -22.81 66.13 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.058 1.839 . . . . 0.0 112.51 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -62.02 -26.48 68.26 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.149 1.38 . . . . 0.0 112.221 170.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 123.75 148.71 7.58 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -169.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.3 m -63.47 131.31 47.74 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 41.9 ttp -149.68 143.32 25.4 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -172.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.03 138.98 34.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 121.702 -0.623 . . . . 0.0 110.48 176.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -110.35 136.15 49.97 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 168.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.4 m -91.85 142.39 27.63 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -177.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.9 t -75.31 121.72 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 172.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -109.54 171.86 15.51 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 107.518 -2.233 . . . . 0.0 107.518 168.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -118.28 118.29 31.41 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 168.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.9 tp -74.45 131.27 40.91 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -58.9 123.36 16.25 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 122.607 0.363 . . . . 0.0 110.89 -170.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.99 8.1 84.65 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-O 118.672 -1.071 . . . . 0.0 113.994 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.1 t -126.03 -120.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 119.204 1.502 . . . . 0.0 107.914 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.4 m -148.05 -175.7 4.99 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.725 1.61 . . . . 0.0 109.912 -169.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -58.65 145.19 40.73 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.797 0.839 . . . . 0.0 110.542 172.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.12 165.37 35.85 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.572 1.949 . . . . 0.0 107.721 172.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.7 mp -105.33 139.45 39.95 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.7 m -140.28 153.43 46.49 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.891 0.877 . . . . 0.0 110.379 -176.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 41.2 t -143.43 118.04 9.79 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 169.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.8 m -69.72 133.42 47.48 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 174.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.6 mt -106.36 -65.35 1.08 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.432 0.693 . . . . 0.0 109.513 -172.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -145.1 161.3 39.79 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.64 1.176 . . . . 0.0 108.982 -177.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.4 m . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 169.121 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 38.8 m . . . . . 0 CA--C 1.533 0.326 0 CA-C-O 122.631 1.205 . . . . 0.0 113.916 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.47 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -63.87 -22.55 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.552 1.141 . . . . 0.0 112.262 -172.847 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -69.13 -46.97 66.3 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 119.393 0.997 . . . . 0.0 108.892 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.98 -39.95 83.33 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.63 1.104 . . . . 0.0 109.0 169.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.68 -35.18 37.54 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 123.821 0.724 . . . . 0.0 112.973 175.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -95.61 -54.05 3.51 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.876 1.338 . . . . 0.0 110.77 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -67.07 -33.04 74.64 Favored 'General case' 0 C--O 1.227 -0.094 0 C-N-CA 124.594 1.158 . . . . 0.0 112.301 -169.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.2 mt -77.9 -39.41 43.13 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 119.351 0.978 . . . . 0.0 109.073 -177.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.8 m -60.77 -47.18 87.49 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.535 1.134 . . . . 0.0 109.376 176.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.64 -48.53 80.43 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.58 1.152 . . . . 0.0 111.393 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -60.41 -40.17 90.01 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 122.614 0.365 . . . . 0.0 110.291 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 73.0 m -66.81 -24.0 66.12 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -73.18 -53.97 9.63 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.381 170.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -59.41 -37.91 79.24 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 121.306 1.866 . . . . 0.0 110.268 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 61.0 ttp -44.66 -35.9 2.85 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.987 172.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 9.0 pt -112.73 1.68 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 124.508 1.123 . . . . 0.0 113.04 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 C--O 1.233 0.199 0 C-N-CA 128.397 2.679 . . . . 0.0 105.278 175.593 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 122.673 1.225 . . . . 0.0 112.218 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.7 mt -71.12 129.27 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 126.085 1.754 . . . . 0.0 108.943 -169.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.02 129.79 40.98 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.33 143.44 16.91 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 169.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -116.2 173.16 6.74 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.801 1.24 . . . . 0.0 111.897 -169.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -72.39 -11.28 60.62 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.743 1.617 . . . . 0.0 112.173 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 p -148.19 157.55 43.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.991 1.717 . . . . 0.0 107.991 170.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 m -62.68 158.29 52.17 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 169.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.31 55.32 4.07 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.679 3.586 . . . . 0.0 111.328 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -50.08 -49.46 51.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.95 2.1 . . . . 0.0 112.073 -169.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.55 -42.12 83.15 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 122.513 0.325 . . . . 0.0 111.24 -176.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -70.53 -39.31 74.11 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -176.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.4 t -58.91 -46.99 91.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 171.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -62.31 -50.97 69.55 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-O 118.969 -0.538 . . . . 0.0 110.885 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.34 -38.5 90.32 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.772 0.714 . . . . 0.0 111.073 -175.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.93 -49.38 75.01 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 175.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -66.91 -28.11 68.04 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 118.398 -0.811 . . . . 0.0 112.402 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -66.58 -37.88 85.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.554 1.07 . . . . 0.0 110.074 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -73.41 -41.61 63.09 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.626 -0.671 . . . . 0.0 109.35 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.8 mt -60.68 -45.83 96.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.21 -31.84 72.42 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.673 0.789 . . . . 0.0 112.045 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -65.73 -38.46 89.21 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 . . . . . 0 CA--C 1.533 0.299 0 C-N-CA 125.169 1.387 . . . . 0.0 112.646 -175.928 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo . . . . . 0 N--CA 1.454 -0.851 0 N-CA-C 118.625 2.51 . . . . 0.0 118.625 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.668 HG13 HG22 ' A' ' 58' ' ' THR . 45.7 t -106.99 102.2 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 100.257 -3.979 . . . . 0.0 100.257 166.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -132.6 155.74 48.16 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.746 0.818 . . . . 0.0 110.885 -169.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.0 t -134.42 120.07 32.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.081 0.953 . . . . 0.0 108.676 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.9 m -91.65 143.87 26.11 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.429 1.092 . . . . 0.0 108.568 169.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -123.69 146.82 47.96 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.347 1.859 . . . . 0.0 110.128 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.485 ' CE1' ' CB ' ' A' ' 131' ' ' ALA . 81.6 m-85 -149.15 172.77 14.28 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -168.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.4 m -14.99 144.7 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.479 1 C-N-CA 133.851 4.861 . . . . 0.0 116.834 169.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.9 tp -78.85 71.08 5.29 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.159 0.984 . . . . 0.0 109.514 172.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -70.04 119.92 14.98 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.518 1.527 . . . . 0.0 108.686 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 50.72 36.2 13.67 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.944 0.898 . . . . 0.0 111.914 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.87 10.84 80.37 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-O 118.379 -1.234 . . . . 0.0 114.418 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -142.24 141.95 32.56 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 120.11 1.955 . . . . 0.0 109.849 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -67.1 140.14 57.56 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 121.164 -0.96 . . . . 0.0 109.788 -173.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.66 162.21 15.72 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 171.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -171.01 167.34 40.51 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 176.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 3.5 m -141.72 147.26 37.13 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 169.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.7 p -120.41 141.88 38.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 169.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.7 tt -123.04 148.52 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 169.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.668 HG22 HG13 ' A' ' 40' ' ' VAL . 40.6 p -141.61 175.61 2.91 Favored Pre-proline 0 N--CA 1.441 -0.876 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 169.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -65.71 -21.65 58.39 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.184 1.256 . . . . 0.0 111.817 169.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 42.6 p-90 -97.94 -21.87 16.62 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.46 177.78 9.75 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.878 1.672 . . . . 0.0 112.906 -176.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 tt -143.75 127.28 16.95 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 103.102 -2.925 . . . . 0.0 103.102 168.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.5 m -137.25 130.62 31.18 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 124.167 0.917 . . . . 0.0 109.215 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.51 147.79 43.69 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 168.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.89 151.85 29.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 72.4 mt -135.83 134.01 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 105.553 -2.018 . . . . 0.0 105.553 177.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -129.62 141.42 41.78 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 118.117 -0.944 . . . . 0.0 110.872 -169.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -54.43 142.17 70.7 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.906 2.404 . . . . 0.0 113.76 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.18 173.92 53.64 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.342 0.972 . . . . 0.0 112.825 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -65.83 148.41 86.35 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.266 2.644 . . . . 0.0 112.035 -175.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.5 t70 53.15 44.26 30.52 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.249 1.419 . . . . 0.0 111.857 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -118.67 148.14 43.05 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.838 1.255 . . . . 0.0 108.249 173.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.43 84.31 2.11 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 172.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 8.8 t90 -71.45 121.65 84.92 Favored Pre-proline 0 C--O 1.235 0.316 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -170.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -56.17 147.88 63.04 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.171 1.914 . . . . 0.0 112.274 -175.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 40.7 tp -58.5 128.06 35.26 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 169.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -109.95 159.47 17.23 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.145 0.978 . . . . 0.0 109.698 -178.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -86.3 142.69 28.34 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 168.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.8 t -88.96 154.91 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -169.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.2 m 65.87 10.32 6.79 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.242 1.417 . . . . 0.0 113.706 -177.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -80.93 153.74 27.37 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.833 1.253 . . . . 0.0 108.131 169.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -107.76 142.73 37.32 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.383 0.538 . . . . 0.0 110.214 176.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.6 mm -118.46 124.21 72.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 173.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.94 120.95 5.6 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 176.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 72.3 mt -106.58 124.75 50.07 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.86 79.46 9.24 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 55.9 mt -74.92 145.93 81.97 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 172.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -60.32 -25.61 80.67 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 121.662 1.575 . . . . 0.0 112.763 170.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -55.4 -30.38 60.31 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.527 1.531 . . . . 0.0 111.952 170.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.72 143.21 4.57 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 107.974 -2.05 . . . . 0.0 107.974 -171.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.8 m -61.45 131.25 49.58 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 60.1 ttm -140.22 129.97 24.47 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.28 132.66 35.87 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 118.721 0.691 . . . . 0.0 109.22 173.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -106.24 135.1 48.31 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 169.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.3 m -87.93 137.88 31.94 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 70.1 t -68.96 122.1 19.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 170.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -107.25 157.05 15.7 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 171.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -122.42 95.42 4.63 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 170.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.9 tt -72.77 115.84 12.55 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -175.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.46 131.68 51.51 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 122.633 0.373 . . . . 0.0 111.378 -173.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.66 2.96 71.27 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 118.888 -0.951 . . . . 0.0 113.402 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.3 t -123.72 -103.33 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.5 p -164.01 171.69 14.88 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.719 1.6 . . . . 0.0 111.089 -173.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -73.49 144.7 46.1 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 169.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.54 179.68 8.39 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.826 1.65 . . . . 0.0 108.594 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.2 mt -109.22 137.87 46.44 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.5 m -140.62 158.24 44.28 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.092 0.957 . . . . 0.0 111.275 -173.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 38.7 t -143.44 108.95 5.08 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 169.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.2 m -85.75 143.82 28.12 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.991 0.916 . . . . 0.0 109.942 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.43 -10.7 0.73 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -172.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 10.0 tpp -125.0 147.14 49.08 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 120.592 1.542 . . . . 0.0 111.778 -170.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 CA--C 1.544 0.719 0 C-N-CA 124.584 1.154 . . . . 0.0 111.158 177.806 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.6 p . . . . . 0 CA--C 1.53 0.188 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -62.32 -28.57 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 O-C-N 121.472 -0.768 . . . . 0.0 110.624 169.675 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -68.03 -49.0 64.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -65.91 -39.37 90.51 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.668 0.667 . . . . 0.0 110.017 177.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.12 -25.31 59.69 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.569 1.08 . . . . 0.0 112.696 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -96.33 -52.37 4.01 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.321 1.06 . . . . 0.0 110.672 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 44.1 mtm-85 -65.2 -41.71 94.23 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.648 -0.658 . . . . 0.0 112.199 -170.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.72 -35.74 60.18 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 119.406 1.003 . . . . 0.0 110.596 -170.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.64 -45.56 93.62 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.851 0.75 . . . . 0.0 109.067 175.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -66.63 -48.44 69.46 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.012 1.325 . . . . 0.0 111.46 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.61 -38.93 92.71 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.43 -0.794 . . . . 0.0 111.793 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 88.8 m -71.21 -24.16 62.16 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 119.499 -0.286 . . . . 0.0 111.276 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.485 ' CB ' ' CE1' ' A' ' 45' ' ' PHE . . . -78.96 -47.17 16.84 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 118.845 0.748 . . . . 0.0 109.037 169.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.1 ttp-105 -55.74 -41.95 74.68 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.731 0.812 . . . . 0.0 112.025 -177.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 16.9 ptt? -55.1 -50.09 70.09 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 118.613 0.642 . . . . 0.0 110.658 175.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 42.8 pt -75.81 -19.8 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 O-C-N 120.957 -1.089 . . . . 0.0 111.376 -177.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.6 tp . . . . . 0 CA--C 1.538 0.517 0 C-N-CA 126.857 2.063 . . . . 0.0 110.337 169.31 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 CA--C 1.535 0.374 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.2 mm -123.64 128.61 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 173.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.69 142.44 42.51 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.6 151.74 50.56 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.487 1.041 . . . . 0.0 112.052 176.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -102.91 154.72 18.93 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.733 1.213 . . . . 0.0 109.996 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -84.73 -21.12 30.2 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.694 -0.629 . . . . 0.0 112.265 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.9 p -158.39 -176.67 6.03 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 129.476 3.11 . . . . 0.0 105.987 170.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.0 m -58.44 145.17 76.68 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 168.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -73.59 59.23 4.03 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.817 3.011 . . . . 0.0 108.943 169.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.5 tttm -50.54 -51.62 46.22 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.638 1.975 . . . . 0.0 112.481 -168.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.93 -40.89 91.83 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.6 0.36 . . . . 0.0 111.707 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -69.3 -45.32 69.86 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.887 0.875 . . . . 0.0 109.773 -174.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 73.7 t -62.13 -42.97 97.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.372 1.069 . . . . 0.0 108.471 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -59.64 -54.01 51.39 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.469 0.577 . . . . 0.0 110.041 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.0 -39.68 93.81 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.194 0.598 . . . . 0.0 111.112 -175.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.03 -46.32 78.3 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -70.86 -27.17 63.64 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-O 117.918 -1.039 . . . . 0.0 112.071 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -61.69 -38.27 87.22 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 120.055 1.298 . . . . 0.0 110.211 171.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -73.8 -41.71 61.97 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 121.702 -0.624 . . . . 0.0 109.389 -177.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.6 mt -61.27 -43.88 97.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.3 -27.28 68.92 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.077 0.853 . . . . 0.0 112.146 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -79.81 -42.32 24.61 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.019 0.928 . . . . 0.0 109.17 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 . . . . . 0 C--N 1.328 -0.331 0 C-N-CA 123.788 0.835 . . . . 0.0 111.702 178.879 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo . . . . . 0 N--CA 1.452 -0.933 0 CA-C-O 121.0 0.333 . . . . 0.0 112.342 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.8 t -73.58 139.4 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 169.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -142.65 154.39 44.31 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.968 0.907 . . . . 0.0 108.923 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.2 t -141.09 125.21 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.748 0.819 . . . . 0.0 108.895 -173.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.4 m -89.15 144.02 26.42 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.203 1.001 . . . . 0.0 108.745 168.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -119.96 135.82 54.76 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.792 1.637 . . . . 0.0 108.035 169.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -167.57 143.33 4.03 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -176.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.7 m 57.17 166.4 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.525 2.33 . . . . 0.0 115.341 167.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.1 tp -120.99 66.63 0.86 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.806 1.242 . . . . 0.0 108.521 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.2 131.27 42.53 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.646 -0.658 . . . . 0.0 110.117 -175.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 52.38 31.5 9.67 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.477 1.111 . . . . 0.0 111.87 -175.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.65 11.06 85.82 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 118.153 -1.359 . . . . 0.0 113.613 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -125.36 143.76 50.82 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.893 1.847 . . . . 0.0 108.062 -174.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -67.97 138.39 55.88 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.416 1.007 . . . . 0.0 109.549 -176.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.65 155.39 17.34 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.95 171.43 37.87 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 173.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 45.0 m -140.32 150.62 44.23 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 169.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.4 p -127.66 141.76 45.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 124.853 1.261 . . . . 0.0 107.602 175.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.0 tt -118.52 149.04 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 169.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.6 p -142.83 172.61 5.51 Favored Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 171.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.36 -19.09 65.18 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 CA-C-N 120.149 1.089 . . . . 0.0 111.646 168.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 37.8 p-90 -102.16 -23.36 14.05 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.518 1.054 . . . . 0.0 113.836 -172.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.74 166.06 24.77 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.819 1.247 . . . . 0.0 111.882 -175.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 tt -132.94 124.74 28.37 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 104.2 -2.518 . . . . 0.0 104.2 168.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.2 m -137.63 133.15 34.01 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.367 0.604 . . . . 0.0 110.891 -176.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.35 148.28 49.9 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 168.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.4 m -139.97 151.88 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 123.946 0.898 . . . . 0.0 109.038 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.6 mt -138.32 145.63 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -133.15 142.49 44.67 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.191 -176.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -44.8 129.42 9.46 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 124.012 3.142 . . . . 0.0 112.447 174.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.97 178.62 15.56 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.085 0.85 . . . . 0.0 114.525 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -67.33 131.16 24.16 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.381 2.721 . . . . 0.0 111.141 -172.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.8 t70 51.15 31.34 6.56 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.538 1.535 . . . . 0.0 113.219 175.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -88.96 155.63 19.39 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -116.8 88.12 2.83 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 170.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -67.24 151.18 97.4 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.164 174.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.38 159.42 49.37 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.256 1.97 . . . . 0.0 109.284 169.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 51.9 tp -64.53 118.75 9.26 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 169.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -88.95 158.98 17.86 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.41 138.26 31.9 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 168.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.7 t -83.13 154.98 3.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 123.834 0.853 . . . . 0.0 108.704 -169.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.1 m 66.23 9.97 6.77 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.295 1.438 . . . . 0.0 113.828 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -83.8 163.0 20.42 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.807 1.243 . . . . 0.0 107.891 168.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -110.93 142.16 43.39 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 118.923 0.783 . . . . 0.0 111.02 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 30.4 mm -113.45 130.96 66.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.08 123.09 6.01 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -109.97 155.31 21.94 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.897 1.279 . . . . 0.0 108.328 170.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.0 tp60 -126.7 131.74 51.31 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 169.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -155.57 166.14 16.89 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 126.067 1.747 . . . . 0.0 107.199 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -57.72 -22.54 53.29 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.697 2.265 . . . . 0.0 115.0 -174.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -58.29 -33.51 69.53 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.681 0.792 . . . . 0.0 111.715 172.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.24 177.89 15.67 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.677 1.608 . . . . 0.0 110.03 -176.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.2 m -67.01 128.13 35.2 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 169.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 41.0 ttp -147.35 130.74 16.64 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.25 141.71 33.85 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 172.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -113.17 135.92 53.29 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 169.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.2 m -80.26 143.81 33.39 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 176.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 62.6 t -76.14 125.72 36.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 170.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -108.97 156.02 15.82 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -133.95 123.32 24.44 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 170.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.6 tp -141.23 144.08 34.52 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.36 0.527 . . . . 0.0 110.171 -172.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -54.27 131.55 41.88 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.32 1.048 . . . . 0.0 110.788 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.8 -1.36 58.77 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 118.717 -1.046 . . . . 0.0 113.591 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 44.8 t -121.57 -28.64 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 119.441 1.62 . . . . 0.0 109.947 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.1 m 60.11 -144.86 0.51 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.804 1.241 . . . . 0.0 108.279 -170.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -83.44 136.6 34.25 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.847 0.749 . . . . 0.0 110.654 -175.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -156.91 175.72 13.7 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.257 1.823 . . . . 0.0 107.869 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.2 mp -116.53 147.09 42.13 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.323 1.049 . . . . 0.0 108.501 -177.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.6 p -143.65 153.04 42.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.754 1.222 . . . . 0.0 110.615 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.8 t -147.28 121.93 9.83 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 170.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.9 m -72.97 137.57 45.56 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.334 0.515 . . . . 0.0 109.99 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -89.17 -66.78 0.89 Allowed 'General case' 0 C--N 1.338 0.102 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 171.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.78 174.64 7.44 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.031 1.332 . . . . 0.0 108.859 -175.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 CA--C 1.542 0.663 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 169.676 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 CA--C 1.53 0.206 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.49 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -57.1 -27.17 26.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.674 -0.641 . . . . 0.0 111.619 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.39 -42.26 96.23 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.977 0.511 . . . . 0.0 110.148 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -67.88 -29.28 68.36 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.043 0.937 . . . . 0.0 110.482 171.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.85 -60.87 8.02 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 169.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -65.06 -49.61 69.39 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.864 -0.786 . . . . 0.0 110.279 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -58.08 -45.34 87.3 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 124.439 1.096 . . . . 0.0 110.688 -175.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.5 tp -79.66 -25.76 41.22 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 119.858 1.208 . . . . 0.0 111.668 -173.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.4 m -69.61 -42.88 73.8 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.829 1.195 . . . . 0.0 109.197 173.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.51 -41.55 79.83 Favored 'General case' 0 N--CA 1.461 0.095 0 C-N-CA 123.165 0.586 . . . . 0.0 111.358 177.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -66.22 -29.64 69.94 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.351 -0.843 . . . . 0.0 110.267 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 20.0 m -69.53 -43.34 73.21 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.991 0.814 . . . . 0.0 110.239 175.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -56.41 -52.92 62.85 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.59 0.756 . . . . 0.0 109.698 171.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -52.61 -53.86 40.99 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.91 1.284 . . . . 0.0 110.559 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 54.0 ttp -49.24 -50.16 39.86 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.607 1.563 . . . . 0.0 110.922 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 6.4 pt -82.12 -19.93 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 119.027 0.83 . . . . 0.0 112.513 -174.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 74.4 mt . . . . . 0 CA--C 1.533 0.322 0 CA-C-N 118.387 0.54 . . . . 0.0 109.729 169.028 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 . . . . . 0 CA--C 1.537 0.464 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.4 mm -120.94 128.93 76.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 171.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.47 131.97 42.39 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.86 151.48 51.2 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.109 0.861 . . . . 0.0 111.096 174.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -93.84 138.45 31.99 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.282 1.033 . . . . 0.0 109.736 -175.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -71.1 -34.03 70.73 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.909 -0.567 . . . . 0.0 109.902 176.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.3 p -156.64 161.78 39.88 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 128.618 2.767 . . . . 0.0 106.812 169.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.0 m -51.82 137.44 34.75 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.226 1.011 . . . . 0.0 112.346 -174.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -76.55 46.71 1.92 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 124.907 3.738 . . . . 0.0 110.555 172.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -62.64 -31.77 72.69 Favored 'General case' 0 C--O 1.221 -0.438 0 O-C-N 120.498 -1.376 . . . . 0.0 113.232 -168.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.76 -42.64 94.97 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 118.762 0.71 . . . . 0.0 111.006 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -72.84 -39.3 66.67 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -177.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.2 t -58.46 -46.42 89.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 171.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -60.77 -53.18 60.52 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 123.526 0.73 . . . . 0.0 110.371 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.55 -40.36 95.44 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.694 0.679 . . . . 0.0 110.931 -174.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.21 -41.82 80.73 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.013 -0.43 . . . . 0.0 110.506 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -69.52 -27.33 65.08 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-O 118.331 -0.843 . . . . 0.0 112.415 175.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -63.22 -36.74 84.64 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.569 1.077 . . . . 0.0 109.104 172.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -71.48 -46.25 60.33 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.2 mt -61.01 -36.87 75.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 123.491 0.717 . . . . 0.0 109.845 177.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.74 -36.39 78.32 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.196 -0.94 . . . . 0.0 110.614 176.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.7 ttm105 -70.57 -34.8 72.62 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.448 1.099 . . . . 0.0 110.061 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? . . . . . 0 CA--C 1.545 0.757 0 C-N-CA 125.092 1.357 . . . . 0.0 111.645 169.142 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo . . . . . 0 N--CA 1.45 -1.046 0 N-CA-C 108.562 -1.361 . . . . 0.0 108.562 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.47 HG13 HG22 ' A' ' 58' ' ' THR . 97.1 t -65.62 108.66 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 169.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -149.53 155.73 40.8 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.36 1.464 . . . . 0.0 109.256 -168.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.7 t -140.12 120.1 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.9 m -85.39 148.4 26.03 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.851 0.86 . . . . 0.0 109.792 169.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -125.28 141.86 51.84 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.828 2.051 . . . . 0.0 110.567 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.454 ' CE2' ' CB ' ' A' ' 131' ' ' ALA . 98.4 m-85 -149.61 171.16 17.1 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -169.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.8 m -6.64 135.99 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.357 1 C-N-CA 133.43 4.692 . . . . 0.0 117.285 169.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.0 tt -78.53 103.61 8.59 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 168.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -84.92 -138.65 0.07 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.026 1.73 . . . . 0.0 107.872 -174.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -73.46 74.21 1.41 Allowed 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.823 -1.173 . . . . 0.0 110.129 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.79 16.33 78.05 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.542 1.068 . . . . 0.0 113.665 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -153.69 140.43 19.02 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.687 1.243 . . . . 0.0 109.862 -172.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -77.32 148.02 35.88 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.996 1.318 . . . . 0.0 110.063 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.58 158.29 15.86 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.61 0.719 . . . . 0.0 110.374 175.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -167.05 168.88 40.62 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 175.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 15.4 m -143.43 142.82 31.35 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 169.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.6 p -114.27 149.96 16.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 124.958 1.303 . . . . 0.0 107.678 172.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.4 tt -136.59 156.67 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 169.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.47 HG22 HG13 ' A' ' 40' ' ' VAL . 44.6 p -146.47 177.35 1.8 Allowed Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 126.353 1.861 . . . . 0.0 106.816 175.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -59.49 -28.88 88.6 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 CA-C-N 120.154 1.091 . . . . 0.0 111.015 168.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 50.0 p-90 -97.19 -19.41 18.64 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -171.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.67 172.81 15.64 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.804 1.638 . . . . 0.0 113.717 -176.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 tt -135.68 126.15 26.81 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 103.523 -2.769 . . . . 0.0 103.523 167.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.8 m -135.33 134.25 39.64 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.21 146.5 47.29 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 169.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.1 m -139.35 147.12 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 123.639 0.775 . . . . 0.0 109.335 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.9 mm -140.64 142.94 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -171.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -132.81 140.11 36.69 Favored Pre-proline 0 N--CA 1.468 0.43 0 CA-C-O 117.482 -1.247 . . . . 0.0 109.445 -175.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -57.14 142.35 94.39 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.151 1.901 . . . . 0.0 111.29 175.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.99 -179.3 29.16 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.731 1.158 . . . . 0.0 114.24 -171.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.87 145.34 56.21 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.35 2.7 . . . . 0.0 111.779 -171.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.6 t0 43.16 57.08 3.89 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.395 1.878 . . . . 0.0 112.395 174.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -142.84 146.59 34.29 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -172.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -117.12 101.0 8.1 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -76.12 154.72 84.56 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 169.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -69.97 158.9 55.18 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.187 1.924 . . . . 0.0 110.798 172.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 66.0 tp -64.09 136.74 57.53 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 169.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -118.79 160.49 21.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.109 0.868 . . . . 0.0 109.052 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -86.11 149.56 25.04 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 169.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 36.0 t -90.6 154.73 3.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -169.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.0 m 61.67 28.25 17.44 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.798 0.839 . . . . 0.0 112.344 -175.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -107.46 154.38 21.44 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.819 2.047 . . . . 0.0 107.264 169.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -104.76 147.88 27.22 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.333 0.969 . . . . 0.0 111.463 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.6 mm -122.97 132.12 72.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 176.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -81.75 123.33 6.02 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.5 mp -106.26 134.0 50.08 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 169.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -89.93 116.6 28.12 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 169.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.1 mt -106.12 155.53 38.34 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 169.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.31 -28.03 55.39 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 CA-C-N 120.187 1.102 . . . . 0.0 111.136 169.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -52.46 -38.66 59.82 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.688 1.595 . . . . 0.0 111.517 169.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 153.53 169.88 19.03 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -174.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.3 m -71.74 130.39 41.01 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 173.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 60.4 ttm -138.23 123.43 19.26 Favored 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.35 136.36 37.68 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.483 -0.761 . . . . 0.0 109.135 170.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -111.49 140.76 45.82 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 169.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.5 m -90.12 141.45 28.68 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.2 t -70.49 119.1 16.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 169.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -102.53 158.39 18.0 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 108.052 -2.019 . . . . 0.0 108.052 169.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -132.81 122.28 24.23 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 169.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.6 tp -138.26 147.81 44.07 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.794 0.838 . . . . 0.0 109.127 -169.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -58.1 128.91 39.47 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.227 0.611 . . . . 0.0 111.503 -172.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.53 -30.64 1.94 Allowed Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.731 1.634 . . . . 0.0 112.812 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.4 t -79.58 -29.15 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.847 1.659 . . . . 0.0 110.003 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.0 m 56.75 -139.36 0.92 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 -169.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -84.18 138.36 33.03 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.155 0.889 . . . . 0.0 110.956 -175.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -155.98 169.1 25.23 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.936 2.094 . . . . 0.0 107.115 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.8 mp -112.06 140.68 46.54 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.2 m -138.3 151.14 47.31 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.29 1.036 . . . . 0.0 110.211 -173.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 44.3 t -138.92 115.67 10.72 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 169.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.5 m -67.44 123.93 21.78 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.28 -47.32 4.98 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.237 0.615 . . . . 0.0 110.47 -170.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 16.2 ptp -159.62 163.9 34.58 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.103 0.961 . . . . 0.0 109.413 175.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.9 m . . . . . 0 CA--C 1.542 0.662 0 CA-C-O 117.643 -1.17 . . . . 0.0 112.217 -179.477 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 43.1 m . . . . . 0 CA--C 1.539 0.541 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.3 pt -60.52 -25.49 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -174.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -75.72 -47.28 26.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 30.0 mp0 -61.47 -35.36 77.41 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.365 1.066 . . . . 0.0 109.623 169.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.84 -54.06 41.13 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 120.197 1.362 . . . . 0.0 110.842 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -64.81 -48.2 75.28 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.528 -0.983 . . . . 0.0 110.275 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 75.5 mtp85 -64.11 -30.85 71.89 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 122.785 0.434 . . . . 0.0 111.387 -177.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.2 tp -82.57 -22.68 34.78 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-O 118.003 -0.999 . . . . 0.0 111.311 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.2 m -64.28 -46.24 84.55 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.304 1.411 . . . . 0.0 107.762 169.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -64.53 -51.29 63.66 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.006 0.922 . . . . 0.0 111.659 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -61.44 -36.03 79.23 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.628 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 21.8 m -64.01 -39.59 94.44 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.252 0.478 . . . . 0.0 110.211 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.454 ' CB ' ' CE2' ' A' ' 45' ' ' PHE . . . -65.81 -48.81 70.46 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 121.635 -0.666 . . . . 0.0 110.59 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.5 ptt85 -67.32 -27.26 67.0 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.444 1.474 . . . . 0.0 112.641 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -56.61 -45.5 81.43 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.324 169.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 12.7 pt -81.84 -25.38 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 119.731 1.151 . . . . 0.0 113.118 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 70.8 mt . . . . . 0 N--CA 1.469 0.514 0 CA-C-N 119.845 1.202 . . . . 0.0 109.154 169.681 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.9 mt -119.29 138.77 48.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 171.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.35 160.81 31.6 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.159 0.583 . . . . 0.0 110.865 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.03 160.73 52.89 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.631 -0.587 . . . . 0.0 111.631 171.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -120.53 144.39 48.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.81 1.244 . . . . 0.0 111.918 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -104.96 81.25 1.72 Allowed 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.203 -1.776 . . . . 0.0 106.203 169.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.9 p 63.58 176.16 0.16 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 127.249 2.22 . . . . 0.0 111.28 -169.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.1 m -59.9 150.32 69.41 Favored Pre-proline 0 CA--C 1.541 0.625 0 O-C-N 121.713 -0.617 . . . . 0.0 111.17 -171.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.18 54.66 3.29 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 124.639 3.56 . . . . 0.0 109.972 169.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.4 tttm -52.12 -50.0 62.54 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 127.357 2.263 . . . . 0.0 111.962 -169.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.79 -41.49 95.78 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 122.644 0.377 . . . . 0.0 111.463 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -73.49 -38.9 65.23 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -174.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.7 t -61.91 -42.64 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 172.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -62.02 -51.2 68.97 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 118.305 0.502 . . . . 0.0 110.271 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.67 -40.19 96.2 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.502 0.721 . . . . 0.0 110.907 -176.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.08 -51.27 68.61 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.011 176.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -66.6 -31.69 72.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 118.287 -0.863 . . . . 0.0 111.881 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.86 -31.62 72.68 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.586 1.084 . . . . 0.0 110.086 176.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -82.7 -44.49 15.61 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.41 0.684 . . . . 0.0 110.617 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.0 mt -65.95 -40.16 86.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 O-C-N 121.027 -1.046 . . . . 0.0 109.016 -175.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.9 -30.14 69.99 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.734 -0.604 . . . . 0.0 111.102 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.9 ttp-105 -81.25 -41.78 21.7 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.386 1.074 . . . . 0.0 109.917 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 . . . . . 0 CA--C 1.535 0.392 0 C-N-CA 123.366 0.666 . . . . 0.0 110.586 173.726 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 120' ' ' ILE . 73.7 Cg_endo . . . . . 0 N--CA 1.453 -0.869 0 N-CA-C 114.687 0.995 . . . . 0.0 114.687 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.511 HG13 HG22 ' A' ' 58' ' ' THR . 78.8 t -110.84 101.88 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 1 N-CA-C 98.888 -4.486 . . . . 0.0 98.888 166.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -141.99 157.25 45.16 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.64 1.176 . . . . 0.0 110.066 -168.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.0 t -140.39 120.16 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.472 0.709 . . . . 0.0 109.192 -172.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.1 m -84.02 142.9 30.13 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 168.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -120.91 137.03 54.79 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 125.682 1.593 . . . . 0.0 108.865 170.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.41 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 44.1 p90 -169.01 146.17 3.64 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -173.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.8 m 57.34 161.35 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.1 2.56 . . . . 0.0 115.86 167.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.2 tp -112.68 84.33 1.96 Allowed 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 170.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -76.17 118.63 19.1 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.57 1.148 . . . . 0.0 108.806 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 51.83 35.4 15.39 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.356 1.062 . . . . 0.0 112.336 176.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.37 17.66 73.24 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 118.859 -0.967 . . . . 0.0 113.992 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -133.57 138.64 46.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.809 1.644 . . . . 0.0 107.853 -176.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -71.62 142.49 49.96 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.645 -1.284 . . . . 0.0 108.973 -177.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.41 ' HB ' ' CE2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -103.66 157.9 16.74 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.497 1.044 . . . . 0.0 109.56 -179.686 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.89 169.62 38.15 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 171.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 36.1 m -137.04 146.9 45.78 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 169.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 p -123.62 140.86 45.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 175.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.469 HD13 ' HA2' ' A' ' 123' ' ' GLY . 11.6 tt -119.83 152.06 22.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 168.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.511 HG22 HG13 ' A' ' 40' ' ' VAL . 48.6 p -140.53 176.79 2.29 Favored Pre-proline 0 C--N 1.32 -0.701 0 C-N-CA 125.595 1.558 . . . . 0.0 107.237 169.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -59.78 -6.05 4.2 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.501 2.134 . . . . 0.0 114.297 169.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.0 p-90 -130.09 -21.75 2.93 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -169.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.12 166.1 32.69 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 120.089 1.313 . . . . 0.0 112.721 -177.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.81 122.39 18.53 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 168.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.2 m -136.51 135.38 38.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.326 0.584 . . . . 0.0 109.973 -175.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.65 145.11 52.68 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 168.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.5 m -137.61 146.08 28.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.9 mt -141.19 146.44 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -174.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -134.21 157.09 78.36 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-O 117.438 -1.267 . . . . 0.0 110.376 -172.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -57.2 9.21 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 0.989 1 C-N-CA 126.053 4.502 . . . . 0.0 120.001 -169.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.27 -155.85 44.46 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 117.86 -1.522 . . . . 0.0 111.43 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -65.42 -146.91 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.815 1 C-N-CA 125.324 4.016 . . . . 0.0 113.383 -174.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -74.43 58.1 0.74 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.457 1.503 . . . . 0.0 111.059 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -102.87 135.76 43.95 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 127.178 2.191 . . . . 0.0 106.855 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -108.11 88.19 2.67 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -177.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -69.23 149.79 97.42 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-O 118.847 -0.596 . . . . 0.0 109.407 172.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -67.76 157.21 62.79 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 N-CA-C 107.708 -1.689 . . . . 0.0 107.708 168.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 40.2 tp -62.94 122.99 17.39 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -88.27 159.23 18.2 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -174.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -86.03 152.65 22.73 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 168.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 83.9 t -99.74 155.08 4.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.342 -1.299 . . . . 0.0 107.862 -169.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.4 m 65.14 7.49 4.15 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.581 1.552 . . . . 0.0 113.489 -173.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -78.27 157.99 29.06 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.344 1.457 . . . . 0.0 107.967 169.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -122.86 141.29 52.03 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 123.054 0.542 . . . . 0.0 110.471 -177.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.2 mm -117.2 121.25 67.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -74.28 122.44 7.38 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.655 -1.778 . . . . 0.0 108.655 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.4 tp -120.36 132.35 55.24 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 124.443 1.097 . . . . 0.0 108.637 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.48 127.8 35.23 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 173.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mp -135.89 157.91 75.03 Favored Pre-proline 0 C--O 1.235 0.296 0 C-N-CA 125.295 1.438 . . . . 0.0 107.91 173.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -61.66 -20.24 68.15 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.367 2.044 . . . . 0.0 114.243 171.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -58.22 -32.26 68.13 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.504 0.722 . . . . 0.0 111.147 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 133.17 157.31 8.37 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 106.621 -2.592 . . . . 0.0 106.621 -169.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.1 m -66.53 130.02 41.79 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 58.5 mtm -137.46 141.16 41.57 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -176.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.77 129.88 34.77 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 170.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -99.21 124.75 44.51 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 169.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.6 m -81.07 140.43 35.11 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.3 t -75.38 120.11 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 169.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -109.48 163.54 12.5 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 172.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -125.3 95.04 4.33 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 170.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.7 tp -74.25 125.76 29.14 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -169.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -59.34 128.57 37.73 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.625 0.77 . . . . 0.0 110.108 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.77 3.91 84.53 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.689 -1.062 . . . . 0.0 113.869 -177.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.4 t -126.64 -119.92 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 119.263 1.531 . . . . 0.0 107.596 177.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.2 m -150.73 -179.31 7.15 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.622 1.569 . . . . 0.0 108.791 -169.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -69.85 143.44 52.85 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 169.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.26 172.57 16.79 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.437 1.495 . . . . 0.0 108.559 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.6 mp -106.52 142.6 35.91 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 172.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.3 p -142.11 152.65 43.46 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.693 0.797 . . . . 0.0 110.411 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 15.7 t -144.43 119.69 10.19 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 171.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.0 m -67.68 129.09 38.82 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 81.4 mt -92.3 -52.57 4.61 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.72 175.32 12.11 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.455 1.502 . . . . 0.0 108.102 171.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 CA--C 1.543 0.69 0 C-N-CA 124.633 1.173 . . . . 0.0 110.69 -175.647 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 93.5 p . . . . . 0 CA--C 1.529 0.147 0 CA-C-O 121.767 0.794 . . . . 0.0 112.286 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 1.1 pp -64.64 -20.09 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 124.871 1.268 . . . . 0.0 112.215 169.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -79.63 -55.39 5.06 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -66.1 -30.85 71.43 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 123.591 0.757 . . . . 0.0 110.584 177.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.469 ' HA2' HD13 ' A' ' 57' ' ' ILE . . . -64.15 -52.18 46.57 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 119.804 1.184 . . . . 0.0 111.596 175.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -65.75 -46.82 77.4 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.164 0.982 . . . . 0.0 110.082 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -58.55 -43.82 89.47 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 118.423 -0.799 . . . . 0.0 110.566 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.0 tp -76.74 -28.34 55.72 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 119.365 0.984 . . . . 0.0 111.619 -173.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -69.08 -39.75 78.87 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 120.083 1.31 . . . . 0.0 109.498 174.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.21 -43.87 66.52 Favored 'General case' 0 N--CA 1.46 0.052 0 C-N-CA 122.985 0.514 . . . . 0.0 111.332 176.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -57.92 -39.14 77.25 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 121.176 -0.952 . . . . 0.0 109.612 173.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 20.0 m -64.33 -34.53 78.36 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 119.424 -0.322 . . . . 0.0 110.758 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.69 -56.79 15.93 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.397 0.679 . . . . 0.0 109.926 174.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -42.16 97.94 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 119.412 1.006 . . . . 0.0 109.556 -177.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 53.1 ttp -49.31 -55.39 12.93 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.956 1.302 . . . . 0.0 110.192 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 6.7 pt -80.3 -21.99 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 119.879 1.218 . . . . 0.0 112.604 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 24.5 mt . . . . . 0 C--O 1.231 0.11 0 CA-C-N 118.615 0.643 . . . . 0.0 110.947 177.866 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 mt -117.91 138.59 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 174.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.07 154.6 39.13 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.744 0.417 . . . . 0.0 110.55 176.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.22 156.65 34.14 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 169.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -125.07 151.48 45.61 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.474 1.11 . . . . 0.0 110.007 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -85.21 -21.16 29.25 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.941 0.896 . . . . 0.0 111.844 -176.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.4 p -159.06 -178.73 7.44 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 128.739 2.815 . . . . 0.0 105.897 173.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.7 m -59.49 139.91 88.87 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 168.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.16 54.45 4.19 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 124.553 3.502 . . . . 0.0 107.807 169.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.7 pttm -60.41 -34.89 74.59 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.634 1.174 . . . . 0.0 113.13 -168.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.58 -42.34 87.13 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.207 0.912 . . . . 0.0 110.614 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -70.9 -41.08 71.74 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 81.3 t -59.97 -42.55 89.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 172.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -60.74 -53.55 56.06 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 123.479 0.712 . . . . 0.0 109.71 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.57 -40.97 98.55 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.367 0.53 . . . . 0.0 110.857 -176.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.74 -46.81 83.66 Favored 'General case' 0 N--CA 1.456 -0.126 0 O-C-N 122.238 -0.289 . . . . 0.0 110.466 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -70.96 -28.25 64.33 Favored 'General case' 0 C--O 1.23 0.065 0 CA-C-O 118.65 -0.69 . . . . 0.0 112.446 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.8 -37.24 83.64 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.114 0.87 . . . . 0.0 109.615 174.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -65.73 -41.49 92.18 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.721 -0.657 . . . . 0.0 110.448 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.6 mm -64.76 -41.86 93.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 119.717 1.144 . . . . 0.0 109.559 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.6 -26.54 66.31 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.939 0.495 . . . . 0.0 111.459 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 55.5 ttp85 -71.93 -47.88 49.35 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 172.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.541 0.602 0 C-N-CA 125.487 1.515 . . . . 0.0 114.132 175.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo . . . . . 0 N--CA 1.453 -0.86 0 N-CA-C 111.671 -0.165 . . . . 0.0 111.671 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.46 128.68 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 169.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -148.55 150.82 34.02 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.583 1.153 . . . . 0.0 108.634 -170.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.6 t -141.73 121.15 10.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.2 p -96.82 154.93 17.0 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 118.849 0.749 . . . . 0.0 110.939 169.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -119.52 142.87 47.93 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.743 2.017 . . . . 0.0 109.614 -171.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -147.22 167.73 23.47 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -169.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.7 m -14.3 139.82 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 1 C-N-CA 133.208 4.603 . . . . 0.0 117.149 169.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.0 tp -78.4 127.95 32.93 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 169.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -147.6 146.07 29.24 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 125.47 1.508 . . . . 0.0 107.311 175.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 53.91 26.63 6.4 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 120.482 1.492 . . . . 0.0 112.876 -175.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.18 25.4 75.47 Favored Glycine 0 CA--C 1.535 1.303 0 O-C-N 121.228 -0.92 . . . . 0.0 113.446 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -148.36 149.06 31.12 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.222 1.409 . . . . 0.0 110.056 -173.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -79.75 140.35 36.96 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 121.212 -0.93 . . . . 0.0 109.122 -177.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.0 160.09 20.11 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.805 0.812 . . . . 0.0 108.857 170.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -167.19 162.74 36.53 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 107.581 -2.208 . . . . 0.0 107.581 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 13.0 m -138.92 147.03 41.78 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 169.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 p -122.23 147.65 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 125.108 1.363 . . . . 0.0 107.817 172.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.4 tt -128.31 151.24 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 169.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.0 p -141.98 177.7 1.8 Allowed Pre-proline 0 C--N 1.32 -0.706 0 C-N-CA 125.331 1.452 . . . . 0.0 107.282 171.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -60.23 -30.37 91.06 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 CA-C-N 119.99 1.032 . . . . 0.0 110.552 168.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -94.29 -25.24 17.1 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -169.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.57 170.36 22.59 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 120.506 1.503 . . . . 0.0 112.965 -174.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 tt -137.72 123.98 20.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 168.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.7 m -137.36 134.51 36.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.438 0.637 . . . . 0.0 110.451 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.32 139.62 44.3 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 168.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 m -139.21 140.16 38.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -172.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.6 mm -135.73 138.53 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -169.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -131.02 145.63 58.6 Favored Pre-proline 0 N--CA 1.474 0.729 0 CA-C-O 117.692 -1.147 . . . . 0.0 111.867 -169.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -51.02 137.6 44.26 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.15 2.567 . . . . 0.0 112.698 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.52 179.83 28.92 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 123.427 0.537 . . . . 0.0 113.306 -175.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.43 123.4 11.73 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.992 2.461 . . . . 0.0 110.191 -173.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.1 t70 49.69 35.7 9.37 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.218 1.407 . . . . 0.0 113.15 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -95.87 127.77 42.18 Favored 'General case' 0 C--N 1.344 0.341 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.49 75.74 0.94 Allowed 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -170.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 48.7 m0 -68.58 149.07 98.1 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.192 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.31 151.84 80.09 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.011 1.807 . . . . 0.0 109.053 169.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.8 tp -56.04 131.91 48.69 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.557 -0.715 . . . . 0.0 109.254 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.41 157.95 16.06 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -90.3 148.86 22.61 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 169.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.2 t -91.6 154.81 3.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -169.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.5 m 60.72 33.7 20.13 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.911 0.884 . . . . 0.0 111.98 -176.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -112.27 155.6 23.79 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 127.019 2.128 . . . . 0.0 106.989 169.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -105.77 142.22 35.87 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.289 0.949 . . . . 0.0 110.546 178.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.7 mm -121.19 131.58 72.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.11 126.36 8.26 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 174.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.8 mt -113.01 124.87 53.62 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 172.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.64 133.36 43.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 169.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.4 mt -141.19 158.22 64.79 Favored Pre-proline 0 C--O 1.234 0.254 0 C-N-CA 124.13 0.972 . . . . 0.0 108.465 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -57.77 -29.63 86.48 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.738 2.292 . . . . 0.0 112.81 170.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -64.38 -18.5 64.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.45 1.1 . . . . 0.0 113.023 173.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 110.47 154.54 14.13 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 107.821 -2.112 . . . . 0.0 107.821 -168.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.1 m -65.03 132.35 48.98 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -175.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 64.3 mtm -141.12 145.75 36.16 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.846 1.258 . . . . 0.0 108.345 -178.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.41 136.91 37.09 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 121.597 -0.689 . . . . 0.0 109.33 172.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -115.34 139.7 49.76 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 169.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.7 m -87.12 137.18 32.57 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 52.5 t -68.08 122.56 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 170.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -109.34 163.11 12.57 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 107.565 -2.214 . . . . 0.0 107.565 169.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -133.38 94.25 3.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 171.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.5 tp -80.28 126.44 31.14 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -170.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -59.81 132.4 53.83 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.219 0.608 . . . . 0.0 110.451 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.94 5.43 75.34 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.659 -1.078 . . . . 0.0 113.482 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.9 t -125.62 -115.27 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.8 p -159.23 178.67 9.74 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 119.742 1.155 . . . . 0.0 110.236 -169.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -73.64 138.05 44.56 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 169.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.87 165.15 36.99 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.777 1.631 . . . . 0.0 107.684 -175.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.4 mp -111.47 130.35 55.75 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.5 m -131.23 150.46 52.14 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.519 0.728 . . . . 0.0 110.913 -170.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 40.4 t -143.14 121.47 12.31 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 169.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.1 m -76.2 137.55 40.08 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -90.41 -67.49 0.84 Allowed 'General case' 0 C--N 1.339 0.119 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 175.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.14 173.2 8.1 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.908 1.283 . . . . 0.0 109.054 -175.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.2 m . . . . . 0 CA--C 1.54 0.56 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 169.354 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 62.6 m . . . . . 0 CA--C 1.53 0.202 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.36 -38.42 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.778 1.231 . . . . 0.0 111.394 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -75.74 -35.01 60.34 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.898 0.479 . . . . 0.0 109.751 -174.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -68.15 -28.87 67.67 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 124.6 1.16 . . . . 0.0 110.585 169.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.76 -55.54 30.27 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 120.235 1.379 . . . . 0.0 110.13 171.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -63.56 -51.35 65.75 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.557 -0.966 . . . . 0.0 110.189 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -68.41 -17.61 64.26 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 117.979 -1.01 . . . . 0.0 112.908 -175.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 32.8 tp -88.53 -25.86 22.32 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 120.257 1.389 . . . . 0.0 109.56 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.8 m -63.57 -48.74 76.21 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 169.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -61.06 -49.37 77.64 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 124.58 1.152 . . . . 0.0 111.933 175.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -62.47 -33.82 75.6 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.636 0.653 . . . . 0.0 110.469 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 34.8 m -69.99 -28.47 65.55 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.444 0.565 . . . . 0.0 111.216 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.03 -51.07 13.1 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.884 0.765 . . . . 0.0 109.564 170.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -51.84 -49.88 61.98 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.042 0.937 . . . . 0.0 110.147 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -56.79 -39.69 74.55 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.055 -178.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 22.4 pt -82.77 -22.62 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 119.722 1.147 . . . . 0.0 111.928 -178.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 52.2 mt . . . . . 0 CA--C 1.537 0.48 0 C-N-CA 123.414 0.686 . . . . 0.0 109.491 169.114 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 . . . . . 0 CA--C 1.54 0.59 0 CA-C-O 121.938 0.875 . . . . 0.0 112.711 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.1 mm -71.24 138.29 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.36 132.27 47.35 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.6 -0.687 . . . . 0.0 109.244 176.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.12 145.76 49.29 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 173.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -91.88 147.08 23.24 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.632 0.773 . . . . 0.0 109.65 -174.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -74.07 -29.48 61.9 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 118.969 -0.539 . . . . 0.0 110.756 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.1 p -154.88 164.03 39.43 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 127.337 2.255 . . . . 0.0 107.962 171.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.4 m -45.85 135.77 6.36 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 125.644 1.578 . . . . 0.0 111.801 173.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.11 52.41 3.82 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.201 3.267 . . . . 0.0 110.525 172.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -53.54 -49.69 67.07 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.202 1.801 . . . . 0.0 111.675 -169.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.58 -41.34 96.33 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.609 0.363 . . . . 0.0 111.284 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -71.51 -41.57 69.06 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.877 0.471 . . . . 0.0 109.764 -174.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 89.9 t -62.31 -45.95 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 172.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -58.85 -53.12 62.02 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.096 0.862 . . . . 0.0 110.872 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.52 -42.46 95.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.901 0.773 . . . . 0.0 111.034 -174.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.25 -46.26 87.73 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -71.21 -25.34 62.47 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 118.147 -0.93 . . . . 0.0 112.014 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -62.91 -34.29 77.11 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.98 1.264 . . . . 0.0 109.579 172.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -79.65 -46.91 16.29 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.718 0.407 . . . . 0.0 110.554 177.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.4 mt -59.93 -39.97 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.447 0.699 . . . . 0.0 109.185 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.79 -36.3 82.68 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.445 -0.784 . . . . 0.0 111.183 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -74.36 -40.42 62.14 Favored 'General case' 0 N--CA 1.46 0.06 0 C-N-CA 123.252 0.621 . . . . 0.0 109.955 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? . . . . . 0 CA--C 1.534 0.331 0 C-N-CA 123.677 0.791 . . . . 0.0 110.831 170.343 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.413 ' HD3' HG22 ' A' ' 120' ' ' ILE . 92.8 Cg_endo . . . . . 0 N--CA 1.451 -1.021 0 CA-C-O 121.037 0.349 . . . . 0.0 112.509 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.457 HG13 HG22 ' A' ' 58' ' ' THR . 97.7 t -104.51 105.89 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 102.058 -3.312 . . . . 0.0 102.058 167.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -142.43 156.33 45.18 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.574 1.15 . . . . 0.0 109.109 -169.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.0 t -137.38 117.24 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -176.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.6 p -78.27 150.06 33.44 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.394 0.997 . . . . 0.0 108.893 168.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.96 131.98 49.25 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.77 1.628 . . . . 0.0 108.64 173.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.769 ' CE1' ' HB1' ' A' ' 131' ' ' ALA . 5.3 p90 -168.78 150.6 4.79 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 123.645 0.778 . . . . 0.0 112.408 -176.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 95.1 m 55.65 157.36 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 128.571 2.748 . . . . 0.0 116.591 167.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.2 tt -111.87 116.15 30.17 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 169.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -139.44 141.82 37.44 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.219 1.408 . . . . 0.0 108.966 -172.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 53.94 26.41 6.27 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.538 1.135 . . . . 0.0 112.297 -172.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.64 5.43 83.2 Favored Glycine 0 CA--C 1.536 1.346 0 O-C-N 120.957 -1.089 . . . . 0.0 113.576 -175.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -118.16 165.92 13.2 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.603 2.361 . . . . 0.0 109.732 -173.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -85.52 148.76 25.8 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.692 1.133 . . . . 0.0 109.866 172.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.19 157.45 19.41 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.494 1.043 . . . . 0.0 110.23 -174.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -171.3 175.76 44.78 Favored Glycine 0 N--CA 1.449 -0.458 0 O-C-N 120.826 -1.171 . . . . 0.0 110.574 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 31.3 m -140.07 154.79 47.17 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 169.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 p -124.88 144.37 35.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.5 tt -124.65 150.79 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 168.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.457 HG22 HG13 ' A' ' 40' ' ' VAL . 26.5 p -142.52 177.16 1.97 Allowed Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 171.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.26 -14.31 44.38 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 CA-C-N 121.179 1.457 . . . . 0.0 111.593 168.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.4 p-90 -108.56 -21.91 12.51 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -172.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 21.9 ptt? -157.59 164.96 36.73 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 120.421 1.464 . . . . 0.0 112.669 -177.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 tt -134.68 123.99 24.59 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 103.185 -2.895 . . . . 0.0 103.185 167.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.7 m -142.17 134.46 27.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.029 0.377 . . . . 0.0 110.069 -172.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.76 143.32 57.58 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 168.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.3 m -140.12 145.79 25.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 37.8 mt -139.83 133.05 35.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 -172.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -122.1 154.04 61.39 Favored Pre-proline 0 N--CA 1.467 0.394 0 CA-C-O 117.785 -1.102 . . . . 0.0 111.023 -169.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -47.96 118.91 3.42 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.546 2.831 . . . . 0.0 112.466 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.43 179.09 26.19 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 123.246 0.342 . . . . 0.0 112.478 -177.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.6 160.18 31.68 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.021 2.481 . . . . 0.0 111.571 -174.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.8 t0 42.91 52.09 5.2 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.805 2.042 . . . . 0.0 113.776 169.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -152.31 160.68 43.29 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.525 1.13 . . . . 0.0 108.526 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -103.73 112.19 25.03 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 169.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.0 130.13 91.7 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.76 147.51 81.28 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.883 1.722 . . . . 0.0 109.825 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 34.0 tp -69.29 121.91 17.82 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 173.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.82 159.83 18.61 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.688 1.195 . . . . 0.0 108.924 176.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -80.27 151.23 29.69 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 169.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.4 t -99.34 151.31 4.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -169.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.9 m 59.92 24.66 13.75 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.116 0.967 . . . . 0.0 112.324 -175.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -109.82 157.63 18.99 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 128.652 2.781 . . . . 0.0 105.023 169.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -108.77 147.55 31.87 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.03 0.832 . . . . 0.0 111.606 -176.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.7 mm -122.16 131.98 71.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.35 124.65 7.73 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 173.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.1 mt -111.67 137.26 49.79 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 171.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -90.71 129.43 36.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 174.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -153.86 159.24 32.27 Favored Pre-proline 0 C--O 1.235 0.307 0 C-N-CA 125.06 1.344 . . . . 0.0 108.562 172.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -67.08 -15.7 47.28 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.224 1.949 . . . . 0.0 114.219 -170.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -58.39 -26.01 62.72 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.299 0.64 . . . . 0.0 111.042 169.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.57 148.02 7.59 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 106.41 -2.676 . . . . 0.0 106.41 -169.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.0 m -60.26 130.85 48.69 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 49.9 mtm -134.15 141.92 47.27 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 124.025 0.93 . . . . 0.0 108.649 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.96 113.29 19.77 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 172.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -91.9 136.71 32.95 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 171.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.1 m -83.48 137.92 33.67 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.5 t -73.39 125.81 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 173.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -106.74 154.83 16.65 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.197 -2.361 . . . . 0.0 107.197 169.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -129.12 103.03 6.75 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 170.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.8 tp -85.26 122.39 29.36 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -176.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -60.38 131.35 50.49 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.265 0.626 . . . . 0.0 110.687 -173.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.01 3.59 69.21 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 118.759 -1.023 . . . . 0.0 113.66 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.9 t -120.61 -103.87 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 119.074 1.437 . . . . 0.0 107.24 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.8 p -163.97 173.94 12.01 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 119.952 1.251 . . . . 0.0 110.737 -171.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -78.8 142.01 37.29 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 168.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -154.26 177.65 10.89 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.027 1.331 . . . . 0.0 108.029 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.3 mt -124.45 137.79 54.41 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.18 0.992 . . . . 0.0 108.922 -173.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.7 m -135.66 147.39 48.56 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.627 1.171 . . . . 0.0 110.028 -173.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 36.6 t -140.52 118.28 11.7 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 172.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.9 m -67.99 135.05 51.73 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.242 0.617 . . . . 0.0 109.438 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.8 mt -109.22 -47.77 3.36 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 123.646 0.778 . . . . 0.0 110.636 -176.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 17.7 ptp -160.42 169.46 23.01 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.918 0.887 . . . . 0.0 110.111 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.2 m . . . . . 0 CA--C 1.541 0.617 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 169.625 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 29.8 m . . . . . 0 C--O 1.23 0.074 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.413 HG22 ' HD3' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -69.33 -21.0 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 O-C-N 121.066 -1.021 . . . . 0.0 112.771 -176.236 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -70.63 -44.72 66.59 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 173.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -60.5 -39.55 88.13 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 118.278 -0.868 . . . . 0.0 109.313 172.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.68 -54.96 33.21 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 119.595 1.088 . . . . 0.0 111.521 177.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -62.36 -49.23 76.38 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.671 -0.9 . . . . 0.0 110.358 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 83.6 mtt-85 -69.97 -19.17 63.37 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.62 -0.675 . . . . 0.0 111.985 -175.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.1 tp -89.06 -18.94 26.28 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 124.138 0.975 . . . . 0.0 109.447 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.5 m -69.64 -44.99 69.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 169.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -66.94 -42.53 85.14 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.577 -0.702 . . . . 0.0 112.003 174.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -69.64 -29.76 67.31 Favored 'General case' 0 C--N 1.334 -0.067 0 O-C-N 121.176 -0.953 . . . . 0.0 110.731 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 22.8 m -70.27 -43.02 71.34 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.378 0.535 . . . . 0.0 110.281 174.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.769 ' HB1' ' CE1' ' A' ' 45' ' ' PHE . . . -53.67 -45.79 70.41 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.296 1.039 . . . . 0.0 109.922 173.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.5 ttp-105 -69.75 -50.09 46.77 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.354 -0.841 . . . . 0.0 111.578 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.88 -26.68 67.59 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.53 1.059 . . . . 0.0 112.764 -171.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 10.7 pt -77.31 -11.52 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 120.2 1.364 . . . . 0.0 113.376 174.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 75.4 mt . . . . . 0 N--CA 1.467 0.401 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 169.021 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.4 mt -132.15 131.89 61.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 175.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.75 128.22 35.03 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 170.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.67 146.07 48.75 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -93.03 138.79 31.18 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.701 0.8 . . . . 0.0 111.034 -169.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -69.14 -24.32 64.08 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.566 0.747 . . . . 0.0 111.151 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -162.12 172.42 15.87 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.86 1.264 . . . . 0.0 108.984 171.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.2 m -61.08 138.22 94.24 Favored Pre-proline 0 C--N 1.324 -0.502 0 C-N-CA 125.776 1.63 . . . . 0.0 110.432 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -69.77 48.14 0.61 Allowed 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 124.607 3.538 . . . . 0.0 112.706 169.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 42' ' ' VAL . 82.7 tttt -50.97 -57.15 9.32 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.025 1.73 . . . . 0.0 112.771 -169.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.85 -38.18 79.59 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 117.821 0.282 . . . . 0.0 110.273 -177.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -61.01 -45.37 95.07 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.627 0.771 . . . . 0.0 110.842 178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.0 t -64.57 -42.6 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -61.15 -51.54 68.62 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.839 0.745 . . . . 0.0 110.427 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.85 -39.41 93.51 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.006 0.922 . . . . 0.0 110.837 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.84 -46.17 90.62 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 175.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -72.81 -26.09 61.38 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 118.208 -0.901 . . . . 0.0 112.703 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -65.55 -28.87 69.47 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 120.084 1.311 . . . . 0.0 109.636 172.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -81.78 -47.52 12.76 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.244 1.018 . . . . 0.0 109.713 176.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.8 mt -67.9 -38.5 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 O-C-N 121.277 -0.889 . . . . 0.0 109.674 -175.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.6 -30.33 71.35 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.413 -0.804 . . . . 0.0 110.676 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.9 ttm105 -76.62 -37.5 56.27 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 123.518 0.727 . . . . 0.0 109.713 174.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 . . . . . 0 CA--C 1.535 0.396 0 C-N-CA 123.915 0.886 . . . . 0.0 110.923 173.306 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo . . . . . 0 N--CA 1.454 -0.84 0 N-CA-C 114.351 0.866 . . . . 0.0 114.351 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.9 t -92.58 111.8 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 101.441 -3.541 . . . . 0.0 101.441 167.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -145.4 158.94 43.74 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.075 0.95 . . . . 0.0 110.152 -169.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.408 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 41.1 t -139.27 124.0 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.577 0.751 . . . . 0.0 109.61 -175.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.0 m -90.18 154.51 19.7 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.252 1.021 . . . . 0.0 110.57 168.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -118.83 147.08 44.31 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 127.78 2.432 . . . . 0.0 111.013 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.453 ' CE2' ' HB3' ' A' ' 131' ' ' ALA . 55.0 m-85 -155.65 170.37 22.18 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.919 1.452 . . . . 0.0 114.919 -170.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.1 m -17.17 153.72 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.566 1 C-N-CA 134.413 5.085 . . . . 0.0 118.486 169.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.9 mt -85.97 118.56 25.53 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 169.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -121.89 108.9 13.98 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.813 2.045 . . . . 0.0 106.688 -173.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 52.12 37.93 22.94 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.566 1.146 . . . . 0.0 111.06 -170.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.27 13.77 82.41 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 118.856 -0.969 . . . . 0.0 113.907 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -121.34 134.77 55.14 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.101 1.451 . . . . 0.0 108.608 -177.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -63.28 142.08 58.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 120.354 1.434 . . . . 0.0 109.654 173.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.42 162.93 13.45 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 122.236 1.017 . . . . 0.0 108.748 169.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.84 173.15 40.7 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 107.87 -2.092 . . . . 0.0 107.87 169.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 1.3 m -136.04 145.89 46.51 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 169.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 p -118.4 141.36 38.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 169.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.0 tt -122.75 151.93 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 169.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.1 p -141.19 179.05 1.32 Allowed Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 172.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -68.73 -13.19 36.5 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 CA-C-N 121.602 1.608 . . . . 0.0 111.585 169.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -111.76 -21.09 11.83 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -169.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -157.36 160.57 38.6 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 120.161 1.346 . . . . 0.0 112.172 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 tt -130.77 123.21 28.67 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 103.351 -2.833 . . . . 0.0 103.351 167.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.4 m -134.4 131.81 38.64 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 123.875 0.734 . . . . 0.0 109.765 -177.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.01 145.28 50.09 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 168.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.4 m -135.62 147.84 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -177.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 58.6 mt -139.7 138.87 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -173.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -130.97 139.05 34.39 Favored Pre-proline 0 N--CA 1.466 0.332 0 CA-C-O 117.595 -1.193 . . . . 0.0 108.98 -177.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.37 130.1 34.47 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.567 2.178 . . . . 0.0 110.827 172.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.64 -166.84 33.47 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 119.602 -0.554 . . . . 0.0 112.426 -174.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -71.6 164.44 35.7 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.892 2.395 . . . . 0.0 112.915 -175.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.4 t0 42.57 55.69 4.09 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.397 2.279 . . . . 0.0 113.755 169.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -152.55 148.61 27.57 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.173 0.989 . . . . 0.0 109.35 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.9 mp -110.74 95.0 5.28 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.28 150.7 85.34 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.267 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -66.9 145.78 75.57 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.01 1.807 . . . . 0.0 110.763 171.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.1 tp -66.68 127.03 30.85 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 169.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -98.46 161.79 13.5 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.577 0.626 . . . . 0.0 110.074 -176.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.1 tmtm? -96.05 139.18 32.61 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 169.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.0 t -82.62 154.34 3.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 123.662 0.785 . . . . 0.0 109.332 -169.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.4 m 66.09 8.97 5.87 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.91 1.684 . . . . 0.0 113.769 -177.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -79.86 160.69 25.97 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.466 1.106 . . . . 0.0 108.136 168.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -112.9 142.33 45.69 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.708 -0.62 . . . . 0.0 110.41 177.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.6 mm -118.23 121.13 66.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 177.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.44 125.31 8.01 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 108.619 -1.793 . . . . 0.0 108.619 175.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.4 mt -120.51 141.81 49.89 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 124.344 1.057 . . . . 0.0 108.642 174.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -91.18 128.38 36.98 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 174.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 mp -135.07 162.01 60.22 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 124.763 1.225 . . . . 0.0 108.809 177.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -60.23 -21.89 68.28 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.527 2.151 . . . . 0.0 114.004 172.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -72.67 -4.21 29.72 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.599 1.16 . . . . 0.0 112.366 174.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.81 161.88 26.82 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 107.957 -2.057 . . . . 0.0 107.957 -168.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.8 m -68.84 131.99 46.03 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 69.8 mtm -139.9 144.04 36.97 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -177.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.68 132.29 35.18 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 172.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -102.17 132.66 47.94 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 169.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.5 m -83.95 142.19 30.7 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 66.5 t -74.59 124.83 33.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 170.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -112.02 161.4 12.75 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 170.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -132.59 93.78 3.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 171.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.9 tp -77.58 135.21 38.14 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -169.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.17 123.17 15.06 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.312 0.645 . . . . 0.0 111.691 -169.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.5 -3.4 33.27 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 118.688 -1.062 . . . . 0.0 113.998 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.8 t -101.31 -119.75 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 119.68 1.74 . . . . 0.0 106.337 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.3 m -148.17 174.99 11.41 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.629 1.571 . . . . 0.0 108.921 -169.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -72.53 142.31 48.49 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 168.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -153.48 171.8 18.12 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.1 1.36 . . . . 0.0 108.055 -178.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.4 mp -111.41 142.0 44.23 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.1 p -141.82 153.87 44.8 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.627 0.771 . . . . 0.0 110.588 -178.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.3 t -144.0 115.28 7.99 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 173.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.1 m -73.79 135.18 43.5 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 175.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.7 mt -123.95 -35.03 2.9 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.914 -1.041 . . . . 0.0 113.47 -169.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 13.4 ptp -159.64 169.62 23.34 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 120.249 1.386 . . . . 0.0 110.913 176.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 CA--C 1.546 0.806 0 C-N-CA 124.808 1.243 . . . . 0.0 108.425 169.921 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.4 p . . . . . 0 CA--C 1.533 0.302 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.728 ' H ' HD12 ' A' ' 120' ' ' ILE . 2.7 mp -53.82 -39.78 41.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.443 1.097 . . . . 0.0 109.59 171.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.69 -43.61 65.68 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.545 0.738 . . . . 0.0 109.456 -175.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -66.87 -28.48 68.36 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.079 173.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.61 -57.97 16.77 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 172.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -64.21 -52.73 57.42 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.647 -0.914 . . . . 0.0 110.778 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -66.83 -24.8 66.2 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 117.963 -1.017 . . . . 0.0 112.099 -173.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.7 tp -86.38 -29.9 22.57 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 120.748 1.613 . . . . 0.0 109.588 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.9 m -58.96 -48.19 82.42 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 169.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -64.0 -51.37 64.56 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.004 1.322 . . . . 0.0 112.083 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -65.5 -33.5 76.07 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.699 -0.626 . . . . 0.0 110.789 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 40.6 t -70.9 -34.03 71.16 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -178.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.453 ' HB3' ' CE2' ' A' ' 45' ' ' PHE . . . -68.13 -52.81 30.61 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 43.3 tpt85 -53.95 -46.84 71.71 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 123.539 0.736 . . . . 0.0 111.898 -175.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 15.2 ptt? -57.38 -27.25 62.14 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.58 1.082 . . . . 0.0 112.007 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 19.8 pt -102.2 9.9 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.421 1.089 . . . . 0.0 111.242 178.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 16.8 tp . . . . . 0 N--CA 1.455 -0.184 0 C-N-CA 125.863 1.665 . . . . 0.0 109.108 -168.071 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 . . . . . 0 CA--C 1.535 0.386 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.4 mm -126.26 125.74 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 170.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.48 150.23 33.0 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.962 0.41 . . . . 0.0 110.092 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.18 156.71 47.65 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.589 1.09 . . . . 0.0 112.848 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -112.81 150.5 31.57 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.874 1.27 . . . . 0.0 110.101 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -82.35 -29.15 31.14 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.671 0.788 . . . . 0.0 111.368 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.8 p -158.52 -177.86 6.84 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 129.966 3.306 . . . . 0.0 105.601 172.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.8 m -57.59 144.23 73.22 Favored Pre-proline 0 CA--C 1.541 0.616 0 O-C-N 120.95 -1.094 . . . . 0.0 110.137 169.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.45 58.48 3.77 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 124.811 3.674 . . . . 0.0 109.652 169.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HE2' ' O ' ' A' ' 42' ' ' VAL . 41.1 tttm -50.55 -52.76 35.87 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.77 2.428 . . . . 0.0 112.692 -169.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.88 95.59 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.656 0.383 . . . . 0.0 111.144 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -70.11 -39.81 75.26 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -176.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 81.3 t -62.97 -40.79 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -62.54 -52.43 63.46 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.496 0.589 . . . . 0.0 110.195 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.2 -39.29 94.22 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.762 0.825 . . . . 0.0 110.899 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.34 -50.39 73.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -72.43 -29.4 63.67 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 117.84 -1.076 . . . . 0.0 112.493 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -59.95 -35.22 74.49 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.293 1.406 . . . . 0.0 109.886 169.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -76.53 -52.59 9.48 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.594 0.634 . . . . 0.0 109.378 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.0 mt -61.28 -39.06 81.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.907 1.283 . . . . 0.0 110.425 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.12 -24.04 67.54 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.351 -0.843 . . . . 0.0 112.272 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.4 ttp85 -99.89 -30.34 12.08 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 125.465 1.506 . . . . 0.0 109.494 -175.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 . . . . . 0 C--N 1.339 0.134 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 169.101 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo . . . . . 0 N--CA 1.454 -0.804 0 N-CA-C 114.205 0.81 . . . . 0.0 114.205 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.1 t -63.91 136.94 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 168.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -142.49 156.08 45.12 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.028 0.831 . . . . 0.0 110.102 -171.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.41 ' O ' ' HE2' ' A' ' 13' ' ' LYS . 34.5 t -140.03 127.78 24.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -178.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.5 m -100.55 151.62 21.38 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.146 0.979 . . . . 0.0 109.772 169.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -123.95 143.24 50.51 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.136 1.774 . . . . 0.0 110.292 -176.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -145.3 170.2 16.77 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.239 1.415 . . . . 0.0 114.153 -169.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.8 t -54.19 169.29 0.18 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.226 2.611 . . . . 0.0 115.468 -169.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.6 tp -77.31 124.4 27.81 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.753 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -104.52 -125.12 0.22 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.969 2.108 . . . . 0.0 107.172 -175.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -77.29 70.75 3.72 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.701 1.137 . . . . 0.0 109.814 177.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.06 15.58 65.32 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.335 0.969 . . . . 0.0 113.315 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -143.32 143.34 31.64 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 125.637 1.575 . . . . 0.0 108.104 -169.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -72.18 153.88 41.37 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.083 0.856 . . . . 0.0 110.27 174.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.52 158.39 16.11 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 169.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.71 168.51 39.02 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 108.056 -2.017 . . . . 0.0 108.056 173.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 48.2 m -140.39 145.14 36.69 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 169.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.07 144.11 25.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 171.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.9 tt -131.17 152.82 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 172.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.4 p -144.5 178.75 1.34 Allowed Pre-proline 0 N--CA 1.446 -0.662 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -63.84 1.0 1.64 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.437 2.092 . . . . 0.0 113.601 168.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.4 p-90 -138.6 -19.54 1.06 Allowed 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 -169.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -153.78 164.44 38.34 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 120.589 1.54 . . . . 0.0 111.703 -176.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 tp -136.49 116.57 13.37 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 169.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.1 m -136.26 122.52 20.49 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -172.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.05 145.87 55.35 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 169.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.6 m -139.5 146.64 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.887 1.275 . . . . 0.0 108.585 -177.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 45.4 mt -142.2 140.94 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -170.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -137.0 144.37 46.1 Favored Pre-proline 0 N--CA 1.469 0.512 0 CA-C-O 117.638 -1.172 . . . . 0.0 110.065 -170.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -52.49 137.95 57.35 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.312 2.675 . . . . 0.0 112.919 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.41 -178.78 25.58 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 123.815 0.721 . . . . 0.0 112.943 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -64.16 140.7 72.74 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.017 2.478 . . . . 0.0 112.8 -171.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.7 t70 52.84 26.86 4.88 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.832 1.653 . . . . 0.0 114.035 170.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -87.02 152.98 21.9 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 171.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.7 83.65 2.03 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 170.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -66.87 152.9 95.16 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.896 172.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -71.56 159.1 52.18 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.901 1.734 . . . . 0.0 109.634 169.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.5 tp -66.78 117.24 8.64 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 169.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -85.78 154.78 21.35 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -177.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -84.19 142.33 30.39 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.4 t -89.23 154.55 3.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -168.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.3 m 66.12 8.62 5.63 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.702 1.601 . . . . 0.0 113.683 -176.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -78.74 161.55 26.78 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.687 1.195 . . . . 0.0 108.088 169.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -113.46 143.26 44.81 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 121.427 -0.795 . . . . 0.0 110.329 175.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.2 mm -118.33 126.13 74.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 176.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.24 123.8 7.42 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 174.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.8 mt -116.24 143.87 44.95 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.604 1.162 . . . . 0.0 108.167 174.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -96.14 128.01 42.67 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 175.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mp -138.54 155.17 73.78 Favored Pre-proline 0 C--O 1.236 0.376 0 C-N-CA 124.809 1.244 . . . . 0.0 107.702 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -63.43 -20.92 70.93 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 121.96 1.774 . . . . 0.0 113.619 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -58.86 -28.98 66.62 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.654 0.781 . . . . 0.0 111.535 169.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 129.03 155.78 8.68 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 106.679 -2.568 . . . . 0.0 106.679 -169.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.1 m -64.29 131.2 46.61 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 176.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 62.9 mtm -141.26 144.13 34.51 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.485 1.114 . . . . 0.0 108.349 -176.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.98 135.14 35.82 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 121.932 -0.48 . . . . 0.0 109.879 172.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -108.61 138.6 44.66 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 168.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.2 m -87.7 140.71 29.24 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.3 t -73.24 126.77 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 169.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -119.27 163.14 13.46 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 171.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -126.06 93.83 3.93 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 173.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.6 tp -75.36 124.89 27.9 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -169.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -59.97 132.79 55.04 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.101 0.56 . . . . 0.0 110.468 -176.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.24 3.7 70.99 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-O 118.752 -1.026 . . . . 0.0 113.581 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.3 t -127.49 -120.13 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.7 m -152.49 -178.6 6.94 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.744 1.618 . . . . 0.0 108.846 -169.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -68.79 143.3 54.66 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 169.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -150.51 169.45 21.46 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.548 1.539 . . . . 0.0 108.679 177.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.5 mp -104.4 141.8 35.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 170.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.8 p -141.13 155.4 46.11 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.705 0.802 . . . . 0.0 110.486 -177.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 48.0 t -144.99 110.83 5.42 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 171.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.7 m -71.22 127.73 33.55 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 24.0 mt -119.76 -40.2 2.78 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 118.677 -0.678 . . . . 0.0 112.33 -169.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 23.8 mtm -141.79 161.5 37.8 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.182 0.993 . . . . 0.0 108.724 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.2 p . . . . . 0 CA--C 1.545 0.752 0 C-N-CA 125.042 1.337 . . . . 0.0 110.117 -179.04 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.5 p . . . . . 0 CA--C 1.528 0.1 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.502 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -67.48 -26.55 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 120.986 -1.071 . . . . 0.0 110.33 170.163 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -67.05 -44.19 80.82 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 174.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -65.59 -30.13 70.82 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.204 0.911 . . . . 0.0 110.571 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.88 -27.63 50.9 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.674 1.13 . . . . 0.0 112.323 171.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -95.5 -55.04 3.16 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.332 1.066 . . . . 0.0 110.828 171.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -71.01 -29.68 65.69 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -169.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.5 tp -83.03 -29.72 28.64 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 120.152 1.342 . . . . 0.0 109.608 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -64.75 -43.23 94.01 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -64.0 -48.53 76.03 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.167 0.587 . . . . 0.0 111.972 172.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -69.8 -25.71 63.91 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.115 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 35.3 t -64.32 -42.41 96.33 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.68 -47.23 73.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 174.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 50.1 ttt-85 -57.0 -46.63 82.15 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.336 0.971 . . . . 0.0 111.315 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 52.6 ttp -47.4 -31.3 3.95 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.565 1.546 . . . . 0.0 112.229 174.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 25.7 pt -104.15 -18.98 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 120.066 1.303 . . . . 0.0 113.009 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . 0.299 3.5 pp . . . . . 0 N--CA 1.47 0.526 0 CA-C-N 120.087 1.312 . . . . 0.0 108.074 168.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.0 ttp . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.0 p -82.59 -21.85 35.06 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.712 0.805 . . . . 0.0 112.555 -174.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -88.66 133.48 34.19 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -170.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -148.78 164.39 34.55 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.837 1.255 . . . . 0.0 109.86 -169.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.8 mm -119.37 126.01 74.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 169.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.67 145.28 38.87 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.029 0.442 . . . . 0.0 109.816 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.02 146.2 50.34 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 124.795 1.188 . . . . 0.0 111.456 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -89.57 139.84 30.14 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.323 1.049 . . . . 0.0 108.912 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -71.42 -38.86 71.36 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.7 p -155.1 166.2 34.32 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 128.162 2.585 . . . . 0.0 107.847 170.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.5 m -54.08 141.02 51.21 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.419 1.088 . . . . 0.0 112.203 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -75.89 49.38 2.48 Favored 'Trans proline' 0 CA--C 1.541 0.844 1 C-N-CA 125.429 4.086 . . . . 0.0 110.872 170.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -54.21 -46.15 72.4 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.879 1.672 . . . . 0.0 112.032 -169.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.5 -41.95 98.53 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 122.506 0.323 . . . . 0.0 111.259 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -40.19 69.44 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 119.074 -0.488 . . . . 0.0 109.804 -174.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 84.2 t -58.22 -45.67 88.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 171.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -61.17 -53.86 51.61 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.861 0.755 . . . . 0.0 110.95 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.0 -39.25 93.17 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.713 0.688 . . . . 0.0 111.128 -174.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.26 -47.54 81.96 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -70.69 -24.42 62.66 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-O 118.289 -0.862 . . . . 0.0 112.592 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -62.11 -37.35 84.78 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.342 0.974 . . . . 0.0 108.979 172.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -80.46 -45.24 17.9 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.8 mt -61.92 -31.9 52.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 O-C-N 120.896 -1.128 . . . . 0.0 110.219 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.99 -24.7 63.35 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.282 -0.886 . . . . 0.0 112.201 174.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.9 ttm105 -83.71 -41.64 17.47 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.936 0.894 . . . . 0.0 109.632 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.75 119.0 6.82 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -177.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.9 m -154.8 114.37 3.73 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 49.4 ttp -83.67 172.28 12.43 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.849 1.26 . . . . 0.0 110.048 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.556 ' CG ' ' H ' ' A' ' 30' ' ' ASP . 47.1 t60 63.02 -169.01 0.19 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.744 1.617 . . . . 0.0 111.415 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.556 ' H ' ' CG ' ' A' ' 29' ' ' HIS . 36.6 t70 -63.96 -8.49 11.56 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.109 1.764 . . . . 0.0 113.771 -169.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -61.07 -31.02 70.69 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.797 0.839 . . . . 0.0 110.564 170.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.4 m 61.68 157.56 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.075 2.15 . . . . 0.0 113.623 -173.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -81.88 56.33 3.05 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.689 1.195 . . . . 0.0 110.387 -177.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.7 mt -61.69 149.7 38.81 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.253 1.021 . . . . 0.0 109.81 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -66.53 157.77 81.39 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 123.498 0.719 . . . . 0.0 110.667 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -65.84 -29.11 50.55 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.65 1.566 . . . . 0.0 114.876 -169.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.0 m 60.1 10.59 2.33 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.718 1.607 . . . . 0.0 113.965 -176.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 4.5 tmm? -155.6 110.64 2.19 Favored Pre-proline 0 C--O 1.234 0.246 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -55.51 121.32 9.72 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.823 2.349 . . . . 0.0 111.746 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 m -65.59 148.31 12.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 171.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -143.11 157.75 44.23 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 124.06 0.944 . . . . 0.0 109.076 -175.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.2 t -138.99 126.62 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -177.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.6 p -89.01 150.67 22.69 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 169.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -132.61 132.79 42.87 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.561 1.544 . . . . 0.0 108.24 173.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.43 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 43.1 p90 -169.9 145.76 3.02 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.354 0.662 . . . . 0.0 112.704 -171.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.8 m 58.52 165.14 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 128.014 2.525 . . . . 0.0 115.409 167.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.2 tp -115.84 58.3 0.74 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.07 1.348 . . . . 0.0 109.157 175.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.91 137.21 47.25 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.025 0.93 . . . . 0.0 110.042 -173.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 55.15 22.85 4.88 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.367 1.067 . . . . 0.0 111.874 -171.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.07 20.61 77.37 Favored Glycine 0 CA--C 1.531 1.053 0 O-C-N 121.223 -0.923 . . . . 0.0 112.874 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -135.79 143.11 45.04 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.223 1.511 . . . . 0.0 108.118 -172.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -65.7 135.39 54.9 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.303 -0.873 . . . . 0.0 108.961 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.43 ' HB ' ' CE2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -103.09 160.07 14.97 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.857 0.837 . . . . 0.0 109.514 -177.299 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -169.35 168.81 41.54 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 56.4 m -135.96 146.82 47.68 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 168.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.1 p -111.81 143.55 21.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 171.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.85 141.64 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 169.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.3 p -136.8 173.83 5.1 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 171.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.9 -25.7 74.31 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 CA-C-N 121.386 1.531 . . . . 0.0 111.238 169.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.4 p-90 -93.41 -26.57 17.17 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 118.155 -0.926 . . . . 0.0 113.215 -172.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.97 170.21 23.05 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 120.256 1.389 . . . . 0.0 113.057 -174.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.1 tt -137.57 127.96 26.45 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 168.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.6 m -140.68 137.52 33.6 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 123.04 0.536 . . . . 0.0 110.017 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.6 146.82 48.14 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 168.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.3 m -138.48 144.18 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.23 1.412 . . . . 0.0 108.178 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 31.7 mt -142.69 141.91 27.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 125.37 1.468 . . . . 0.0 107.283 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -130.33 133.79 25.32 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-O 117.646 -1.168 . . . . 0.0 108.203 -177.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -47.85 137.78 21.4 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.282 2.655 . . . . 0.0 111.899 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.56 179.07 34.26 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 124.302 0.953 . . . . 0.0 112.756 -173.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.67 145.05 56.47 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.982 2.455 . . . . 0.0 111.019 -172.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.1 t0 50.63 57.69 6.34 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.381 1.472 . . . . 0.0 112.188 177.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -128.76 148.93 50.89 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 125.385 1.474 . . . . 0.0 108.223 177.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -124.34 83.03 2.1 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 175.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.71 150.91 97.51 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 172.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.34 155.23 70.98 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.901 1.734 . . . . 0.0 109.972 170.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 68.9 tp -63.85 129.25 39.33 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 170.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -104.61 163.38 12.51 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.474 0.579 . . . . 0.0 109.559 171.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -89.52 157.18 18.19 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 169.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.1 t -86.5 153.41 3.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -169.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . 0.254 42.7 m 65.84 11.84 7.92 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.229 1.411 . . . . 0.0 113.58 -174.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -74.85 158.16 33.88 Favored 'General case' 0 C--N 1.346 0.42 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 168.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -112.27 141.03 46.47 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.624 -0.673 . . . . 0.0 109.976 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.5 mm -120.38 123.92 71.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.09 121.99 6.4 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.8 mt -113.26 143.12 44.96 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.24 1.016 . . . . 0.0 108.299 174.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -95.05 127.41 41.09 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mp -135.59 153.96 77.92 Favored Pre-proline 0 C--O 1.234 0.288 0 C-N-CA 125.595 1.558 . . . . 0.0 107.282 174.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -64.58 -21.82 65.35 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.236 1.291 . . . . 0.0 112.497 172.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -58.7 -23.51 59.69 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.67 1.588 . . . . 0.0 111.524 169.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 129.65 148.35 6.49 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 126.979 2.228 . . . . 0.0 108.066 -173.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.0 m -63.11 130.92 46.74 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 170.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 43.7 ttp -144.61 138.76 27.63 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -169.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -80.54 130.95 35.45 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 176.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -104.4 131.68 51.49 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 169.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.8 m -85.25 139.26 31.77 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 97.7 t -70.82 110.86 4.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 172.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -94.24 155.91 22.02 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 106.91 -2.476 . . . . 0.0 106.91 169.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -134.55 122.32 22.21 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 169.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.6 tp -142.3 145.65 34.21 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.885 0.474 . . . . 0.0 110.411 -169.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -58.71 132.07 52.76 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.917 0.887 . . . . 0.0 111.062 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.93 0.3 50.19 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.046 0.831 . . . . 0.0 113.688 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 87.2 t -122.23 -27.11 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.267 1.427 . . . . 0.0 109.852 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.2 m 60.16 -150.52 0.42 Allowed 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.236 1.415 . . . . 0.0 108.691 -174.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -78.06 137.28 38.16 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.368 0.531 . . . . 0.0 110.152 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -152.44 166.81 30.79 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.974 1.71 . . . . 0.0 107.988 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.0 mp -117.81 122.32 43.1 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.1 m -143.79 158.36 43.73 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.008 0.822 . . . . 0.0 111.305 -169.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 15.6 p -149.4 140.38 22.89 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.844 -0.535 . . . . 0.0 109.816 169.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.0 m -67.09 138.25 56.98 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 174.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 94.0 mt -107.83 -48.45 3.4 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.174 0.99 . . . . 0.0 110.145 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 13.3 ptp -164.09 172.5 13.68 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.858 0.863 . . . . 0.0 110.329 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.1 m -112.01 111.58 53.38 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -81.59 59.42 7.24 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.693 2.928 . . . . 0.0 111.151 -172.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 91.8 mt -93.17 28.47 2.16 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.907 1.283 . . . . 0.0 111.883 -172.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 7.0 m -73.45 146.74 44.78 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.451 1.101 . . . . 0.0 109.415 178.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -77.97 -19.41 54.59 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 121.21 -0.931 . . . . 0.0 111.527 176.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 3.9 p -76.21 -3.65 37.52 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.492 1.517 . . . . 0.0 112.353 172.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.2 tpt -61.65 143.31 56.32 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.743 1.217 . . . . 0.0 110.747 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.3 t -157.17 167.52 30.14 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.447 1.899 . . . . 0.0 106.826 177.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -59.7 -31.17 46.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 123.618 0.767 . . . . 0.0 110.708 179.162 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -66.93 -46.72 73.92 Favored 'General case' 0 C--O 1.226 -0.166 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -63.24 -33.42 75.47 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.103 173.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.46 -62.13 6.63 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 171.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -65.07 -43.27 92.75 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 117.742 0.771 . . . . 0.0 111.282 -175.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -58.67 -40.98 85.09 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 123.37 0.668 . . . . 0.0 109.722 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.8 tp -81.28 -21.98 38.96 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 117.783 -1.104 . . . . 0.0 111.684 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.14 -42.71 79.74 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.837 1.653 . . . . 0.0 108.75 169.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -70.07 -41.2 74.44 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.262 0.625 . . . . 0.0 111.699 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -66.9 -31.04 71.36 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 121.064 -1.022 . . . . 0.0 110.653 174.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 21.1 m -69.31 -41.27 76.96 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.793 0.724 . . . . 0.0 110.257 175.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.417 ' HB2' ' CE1' ' A' ' 45' ' ' PHE . . . -55.89 -54.11 48.67 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.657 0.783 . . . . 0.0 109.549 172.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -52.27 -54.09 35.71 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.066 0.947 . . . . 0.0 109.974 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 57.0 ttp -49.42 -55.24 13.75 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.65 1.58 . . . . 0.0 111.271 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.7 pt -78.68 -25.34 13.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 118.955 0.798 . . . . 0.0 112.233 -171.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.1 mt -71.6 -33.95 69.46 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.671 0.669 . . . . 0.0 110.452 169.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.9 m 56.74 26.09 10.97 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.113 1.765 . . . . 0.0 112.133 -169.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 92.5 mt -142.2 150.57 55.88 Favored Pre-proline 0 C--O 1.236 0.351 0 C-N-CA 127.608 2.363 . . . . 0.0 107.773 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -58.7 150.84 67.68 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.345 2.696 . . . . 0.0 111.212 175.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.02 152.49 11.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 125.061 1.345 . . . . 0.0 107.889 -176.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 65.5 m -61.34 119.0 7.64 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.308 0.643 . . . . 0.0 109.347 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -72.59 126.4 90.83 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 169.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -82.45 58.56 6.58 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.829 2.353 . . . . 0.0 112.889 -169.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -142.89 42.0 1.56 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.76 1.624 . . . . 0.0 109.739 172.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.4 m -78.52 171.37 12.68 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 124.215 1.006 . . . . 0.0 109.888 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -49.21 159.73 1.04 Allowed 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 124.008 3.139 . . . . 0.0 114.681 170.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -63.77 120.1 11.22 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 171.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -94.79 -13.98 25.11 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.556 0.742 . . . . 0.0 112.469 -172.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -68.26 146.09 45.43 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 91.5 mmt-85 -143.0 160.77 39.73 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.827 1.651 . . . . 0.0 108.011 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -66.48 145.52 55.56 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 172.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.72 140.65 30.33 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 169.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.0 168.09 28.53 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.879 1.671 . . . . 0.0 109.023 177.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.8 tt 51.72 59.71 4.37 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.498 1.519 . . . . 0.0 109.727 -175.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -66.35 148.95 51.12 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.001 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 173.99 -175.53 46.5 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.9 ttp180 -147.7 148.38 30.95 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 175.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 30.7 tpt180 -69.9 128.27 35.8 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 169.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 61.0 m -138.39 150.17 46.27 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.92 1.288 . . . . 0.0 108.715 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 136.48 -96.58 0.25 Allowed Glycine 0 C--N 1.336 0.567 0 N-CA-C 107.525 -2.23 . . . . 0.0 107.525 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -66.03 -35.65 81.13 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 170.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -76.53 123.17 25.65 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 169.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 C-N-CA 123.516 0.726 . . . . 0.0 109.236 -178.503 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 tpt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.4 p -74.21 155.1 38.68 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.211 1.005 . . . . 0.0 110.199 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -86.49 18.97 3.0 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.79 0.805 . . . . 0.0 111.126 174.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -146.88 155.49 42.35 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.589 2.356 . . . . 0.0 108.063 -173.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.8 mm -118.4 131.62 70.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 126.627 1.971 . . . . 0.0 106.03 175.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.57 142.0 44.71 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 120.701 0.286 . . . . 0.0 110.373 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.8 151.57 51.04 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.209 0.909 . . . . 0.0 111.945 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -93.03 151.2 20.03 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.304 1.041 . . . . 0.0 109.669 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -94.19 -19.25 20.93 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 118.779 -0.629 . . . . 0.0 112.105 176.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.2 p -156.94 164.42 38.05 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 127.344 2.258 . . . . 0.0 107.734 169.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.1 m -56.9 133.49 79.57 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-O 118.236 -0.888 . . . . 0.0 109.614 169.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.401 ' HD2' ' CE1' ' A' ' 67' ' ' PHE . 33.3 Cg_exo -70.83 50.14 1.05 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.433 3.422 . . . . 0.0 112.648 170.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.6 tttm -51.69 -48.68 63.39 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.831 1.652 . . . . 0.0 112.061 -169.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.2 94.93 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 122.705 0.402 . . . . 0.0 111.128 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -73.17 -40.13 65.07 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.384 0.674 . . . . 0.0 109.834 -175.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 80.9 t -61.11 -47.12 95.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -59.41 -50.49 73.76 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 118.923 -0.56 . . . . 0.0 110.872 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.74 -43.27 98.14 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.771 0.714 . . . . 0.0 110.423 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.18 -49.77 76.6 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.058 0.39 . . . . 0.0 110.234 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -66.05 -26.15 67.37 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.943 178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -67.64 -29.18 68.42 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 120.098 1.317 . . . . 0.0 111.539 174.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -77.39 -54.82 5.99 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.172 0.896 . . . . 0.0 109.095 171.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.3 mt -60.52 -44.78 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 123.944 0.897 . . . . 0.0 109.851 -169.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.11 -28.71 70.25 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.953 -0.467 . . . . 0.0 111.346 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -81.79 -43.15 18.72 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 118.751 0.705 . . . . 0.0 109.828 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? -54.77 -46.15 74.36 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.112 0.565 . . . . 0.0 110.316 172.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.6 m -70.15 -57.18 5.23 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 119.216 -0.421 . . . . 0.0 110.933 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . 0.25 22.3 ptt? 42.56 -150.51 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.054 1.742 . . . . 0.0 111.281 -169.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -138.26 166.91 23.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.787 1.635 . . . . 0.0 107.636 177.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -62.64 -32.09 73.07 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -170.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.62 4.1 17.03 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.41 1.084 . . . . 0.0 113.317 176.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.0 m 65.0 -42.78 0.32 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 129.102 2.961 . . . . 0.0 116.823 174.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -74.14 -19.9 60.41 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 120.183 1.356 . . . . 0.0 113.829 -169.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 63.3 mt -80.83 94.54 6.46 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 172.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -142.85 -161.73 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 127.603 2.361 . . . . 0.0 106.1 -177.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -58.79 13.5 0.04 OUTLIER 'Trans proline' 0 CA--C 1.548 1.21 0 C-N-CA 122.998 2.465 . . . . 0.0 117.824 176.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 p -60.08 -45.85 91.54 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 167.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 52.8 mtt -79.69 148.38 69.1 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 168.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -68.34 146.0 67.48 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 121.952 1.768 . . . . 0.0 114.924 -169.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.3 m -109.04 56.58 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 104.629 -2.359 . . . . 0.0 104.629 167.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -83.93 156.86 22.15 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.548 1.139 . . . . 0.0 111.63 -168.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.0 t -140.07 127.14 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 123.695 0.798 . . . . 0.0 109.431 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.0 m -91.41 145.36 24.69 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.084 0.954 . . . . 0.0 108.952 168.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -125.6 138.22 53.92 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.873 1.669 . . . . 0.0 108.277 170.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -162.03 130.65 4.25 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -175.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 t 47.97 -179.78 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 129.992 3.317 . . . . 0.0 117.071 168.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.9 tp -117.58 86.4 2.51 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 171.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -74.6 -38.8 62.52 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -168.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.07 56.75 1.13 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 122.323 1.059 . . . . 0.0 108.495 -176.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 62.98 20.94 63.03 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.627 -175.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -144.15 139.94 29.09 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 126.616 1.966 . . . . 0.0 105.834 -174.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -74.75 143.58 44.02 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.41 153.42 26.09 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.581 0.705 . . . . 0.0 109.299 -173.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -163.5 167.81 37.86 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 35.4 m -140.94 152.76 45.26 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 169.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 58.2 t -128.09 143.98 39.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.403 HG21 ' HA2' ' A' ' 123' ' ' GLY . 15.8 tt -127.14 148.19 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 169.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 49.3 p -137.78 177.83 1.96 Allowed Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 175.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -61.38 -6.31 6.64 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.63 2.22 . . . . 0.0 113.387 169.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.1 p-90 -131.14 -23.51 2.43 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -169.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.9 169.63 21.81 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.256 1.389 . . . . 0.0 112.13 -176.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 tt -139.27 123.13 17.66 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 168.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.7 m -139.56 134.16 31.77 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.236 0.541 . . . . 0.0 110.141 -175.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.99 146.25 54.92 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 168.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.4 m -137.17 141.76 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.7 mt -143.81 144.45 23.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -169.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.401 ' CE1' ' HD2' ' A' ' 12' ' ' PRO . 25.5 m-85 -132.59 136.81 28.51 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 118.196 -0.907 . . . . 0.0 109.387 -173.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -46.75 138.49 14.91 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 124.007 3.138 . . . . 0.0 112.166 169.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.89 -179.92 46.32 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 123.734 0.683 . . . . 0.0 113.043 -174.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.71 145.76 52.51 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 123.518 2.812 . . . . 0.0 110.917 -173.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.2 t0 50.76 54.56 10.99 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.284 1.434 . . . . 0.0 111.986 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -124.32 154.32 40.47 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.941 1.297 . . . . 0.0 107.769 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 92.2 mt -129.16 85.3 2.3 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 8.8 m0 -65.67 153.09 91.53 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -62.86 155.04 62.44 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.658 2.239 . . . . 0.0 111.131 171.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.43 129.76 43.24 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 169.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -144.45 160.03 41.76 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt -124.17 172.93 8.66 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 122.985 1.374 . . . . 0.0 110.529 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 70.1 t -70.03 150.93 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 112.461 -2.154 . . . . 0.0 109.645 -169.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.0 m 68.89 1.09 2.98 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.244 1.818 . . . . 0.0 114.096 -177.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -73.47 155.77 38.9 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 169.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -119.75 143.77 47.62 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 118.615 0.643 . . . . 0.0 110.122 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 48.3 mm -117.56 123.92 72.37 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.81 118.02 7.34 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 108.006 -2.038 . . . . 0.0 108.006 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.4 tp -123.75 130.46 52.66 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 123.907 0.883 . . . . 0.0 108.759 -172.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.34 128.53 34.58 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 174.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.5 mp -133.98 159.46 72.3 Favored Pre-proline 0 C--O 1.234 0.253 0 C-N-CA 124.721 1.209 . . . . 0.0 108.875 172.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -58.41 -26.45 77.78 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.13 1.887 . . . . 0.0 113.464 170.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -65.28 -9.43 24.07 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.389 1.075 . . . . 0.0 113.198 173.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.43 157.1 18.84 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 108.025 -2.03 . . . . 0.0 108.025 -169.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.8 m -67.48 130.94 44.64 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 49.5 mtm -142.54 145.05 33.23 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -177.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.53 123.52 25.62 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 170.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -95.64 135.97 36.63 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 169.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.0 m -89.05 144.03 26.44 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 70.5 t -76.57 119.26 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 169.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -106.7 169.85 15.6 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 169.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -138.2 141.55 40.02 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 169.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 19.0 mt -132.35 152.95 51.2 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 169.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.07 135.14 57.07 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 172.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.52 3.72 72.75 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 118.816 -0.991 . . . . 0.0 113.467 -175.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.4 t -122.91 -33.47 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 119.18 1.49 . . . . 0.0 109.933 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.1 m 59.66 -156.01 0.35 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -169.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -58.71 136.29 57.66 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.37 0.532 . . . . 0.0 110.327 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -148.76 166.59 27.97 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.838 1.655 . . . . 0.0 107.448 170.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 10.4 mp -102.76 143.67 32.1 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.3 p -146.31 160.2 42.34 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.778 0.831 . . . . 0.0 110.645 177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 30.8 t -147.78 128.84 14.55 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 171.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.5 m -66.9 134.78 52.73 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 92.3 mt -105.94 -59.68 1.74 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.986 0.914 . . . . 0.0 108.701 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -142.03 166.84 23.61 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.751 1.22 . . . . 0.0 108.878 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 28.6 m -121.68 65.28 17.85 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.346 1.058 . . . . 0.0 109.906 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -60.75 132.97 45.37 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.459 2.106 . . . . 0.0 110.442 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 40.0 tp -156.48 81.94 0.97 Allowed 'General case' 0 C--O 1.236 0.363 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 172.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.7 m -141.95 148.2 38.26 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 124.32 1.048 . . . . 0.0 108.218 -170.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -81.31 -15.94 53.93 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.135 -0.978 . . . . 0.0 112.427 -178.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.9 m -72.16 -11.11 60.59 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.664 0.786 . . . . 0.0 111.867 170.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.55 141.11 58.89 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.616 1.567 . . . . 0.0 108.688 176.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 90.4 p -156.74 174.57 15.28 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.529 0.732 . . . . 0.0 110.075 -173.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -57.78 -22.5 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.157 0.983 . . . . 0.0 111.793 168.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -85.26 -45.6 11.81 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.328 1.051 . . . . 0.0 109.507 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -63.13 -32.05 73.33 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.277 0.49 . . . . 0.0 110.039 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.403 ' HA2' HG21 ' A' ' 57' ' ' ILE . . . -60.51 -54.76 34.46 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 175.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -65.28 -47.78 75.48 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 117.298 0.549 . . . . 0.0 110.08 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 83.9 mtm-85 -65.33 -46.7 79.23 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 118.852 -0.594 . . . . 0.0 111.398 -175.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 13.1 tp -76.82 -28.87 55.72 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 118.058 -0.973 . . . . 0.0 111.697 -171.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.8 m -71.64 -36.98 70.88 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.977 1.262 . . . . 0.0 109.546 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -70.37 -41.25 73.34 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.359 0.663 . . . . 0.0 111.529 174.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -65.24 -31.07 72.04 Favored 'General case' 0 CA--C 1.53 0.212 0 O-C-N 121.114 -0.991 . . . . 0.0 110.52 173.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 34.1 m -69.94 -40.06 75.7 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 121.922 -0.486 . . . . 0.0 110.227 175.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -58.17 -50.87 72.01 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.718 0.407 . . . . 0.0 110.074 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -55.26 -55.78 27.51 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 123.902 0.881 . . . . 0.0 110.057 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 16.3 ptt? -59.42 -39.4 83.38 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 117.992 -1.004 . . . . 0.0 111.038 -172.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . 0.274 6.6 pt -79.83 -21.69 12.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 119.761 1.164 . . . . 0.0 112.248 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 30.8 mt -74.08 -27.2 60.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.914 0.779 . . . . 0.0 108.951 168.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.2 m 55.6 20.67 3.98 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.446 1.898 . . . . 0.0 113.334 -175.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 99.5 mt -150.74 149.77 26.52 Favored Pre-proline 0 C--O 1.236 0.389 0 C-N-CA 128.455 2.702 . . . . 0.0 107.525 -173.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -63.35 160.1 36.8 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.688 2.259 . . . . 0.0 110.452 169.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 23.3 m -76.12 173.7 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 123.258 0.623 . . . . 0.0 110.463 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 8.1 m -50.19 139.36 14.74 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.678 1.591 . . . . 0.0 111.355 178.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -126.67 119.26 22.8 Favored Pre-proline 0 C--O 1.237 0.407 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 170.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -73.19 163.58 37.66 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.499 2.133 . . . . 0.0 111.736 -176.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -139.75 131.5 27.43 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.532 1.533 . . . . 0.0 107.89 171.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.7 t -145.78 147.81 33.97 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -173.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.51 161.19 15.03 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.055 2.503 . . . . 0.0 111.757 169.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 66.6 t-80 -60.89 138.86 58.12 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.37 171.35 12.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.699 0.799 . . . . 0.0 110.87 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -69.29 -13.77 68.01 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-O 119.329 -0.706 . . . . 0.0 113.722 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 96.7 mtt-85 -132.51 160.38 36.68 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.879 1.671 . . . . 0.0 108.845 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -65.28 153.25 41.62 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 172.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.05 131.44 46.56 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.4 pp -151.76 164.98 35.83 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.46 1.104 . . . . 0.0 110.101 -173.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 47.7 tp -91.01 -25.07 19.87 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.504 0.722 . . . . 0.0 112.503 -171.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -73.58 158.8 34.13 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.29 0.636 . . . . 0.0 111.567 -173.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 72.77 12.43 78.33 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 123.637 0.637 . . . . 0.0 114.046 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -85.94 149.43 25.2 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 118.504 1.152 . . . . 0.0 108.31 174.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -108.41 4.19 24.1 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -173.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 13.2 m 53.83 40.81 31.96 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.746 1.218 . . . . 0.0 112.39 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -66.85 -16.66 66.39 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 123.524 0.583 . . . . 0.0 113.591 -174.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -81.01 -10.41 59.71 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 118.165 0.982 . . . . 0.0 111.763 177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -70.16 149.17 47.82 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.688 0.676 . . . . 0.0 110.148 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.263 0 C-N-CA 123.576 0.75 . . . . 0.0 109.649 175.656 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 79.4 mtm . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.6 t -140.16 138.43 35.19 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 169.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -98.73 4.25 47.74 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -172.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 53.85 167.24 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 130.251 3.42 . . . . 0.0 116.511 169.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.2 mt -132.61 143.84 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.594 1.957 . . . . 0.0 105.786 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.76 147.06 41.64 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.801 0.728 . . . . 0.0 110.501 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.79 163.73 51.8 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.476 1.036 . . . . 0.0 111.439 170.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -126.52 142.01 51.68 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.042 1.337 . . . . 0.0 109.852 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -73.63 -19.77 60.77 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 122.951 0.501 . . . . 0.0 111.817 -173.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 p -146.82 154.08 40.93 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.85 1.66 . . . . 0.0 108.303 171.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -67.02 148.92 98.78 Favored Pre-proline 0 CA--C 1.543 0.694 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 171.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.61 54.91 5.27 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 124.943 3.762 . . . . 0.0 111.002 175.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.3 tttm -53.83 -43.92 69.83 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.184 1.394 . . . . 0.0 111.993 -169.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.0 -40.77 97.12 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 118.43 0.559 . . . . 0.0 111.224 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -74.98 -35.44 62.05 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 119.296 -0.383 . . . . 0.0 110.101 -177.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.45 -45.77 96.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 170.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -60.29 -50.12 74.9 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.104 0.562 . . . . 0.0 110.144 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.76 -39.53 93.77 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.593 0.633 . . . . 0.0 111.352 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.46 -49.51 76.52 Favored 'General case' 0 C--N 1.337 0.065 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -71.49 -28.56 64.01 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 118.032 -0.985 . . . . 0.0 112.183 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -60.29 -40.59 90.99 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 119.85 1.204 . . . . 0.0 109.32 170.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -71.93 -46.41 57.67 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -175.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.2 mt -57.89 -45.8 87.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.0 -34.94 79.14 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.68 -0.638 . . . . 0.0 111.516 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -72.41 -36.02 68.53 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.96 0.904 . . . . 0.0 109.244 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -63.35 -42.01 98.88 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.297 1.039 . . . . 0.0 110.659 169.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 53.3 m -68.03 -50.34 55.94 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.261 0.937 . . . . 0.0 111.956 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.95 154.5 39.33 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.251 0.62 . . . . 0.0 110.485 -178.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -148.54 153.48 38.46 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.163 0.985 . . . . 0.0 109.114 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.9 t70 63.55 -50.57 0.24 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 128.495 2.718 . . . . 0.0 115.378 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -81.39 -7.23 59.54 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.977 0.808 . . . . 0.0 112.917 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.5 m -69.24 142.96 54.06 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.123 0.969 . . . . 0.0 110.092 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -116.21 57.06 0.77 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.595 1.158 . . . . 0.0 107.97 175.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 98.0 mt 55.89 15.73 1.82 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.671 1.988 . . . . 0.0 112.472 -169.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -153.86 153.01 28.09 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 128.715 2.806 . . . . 0.0 105.365 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -61.93 166.25 12.65 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.403 2.069 . . . . 0.0 113.068 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 p -61.69 -32.78 72.99 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.135 1.374 . . . . 0.0 112.898 -174.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 62.0 mtt -136.17 147.72 61.64 Favored Pre-proline 0 C--O 1.235 0.336 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.443 ' CD ' HG23 ' A' ' 120' ' ' ILE . 73.5 Cg_endo -67.16 135.22 36.45 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.082 1.855 . . . . 0.0 110.332 -170.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.406 HG13 HG22 ' A' ' 58' ' ' THR . 34.8 t -71.02 130.03 34.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 169.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -138.8 150.16 45.76 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 124.166 0.986 . . . . 0.0 108.801 -169.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.2 t -141.55 124.08 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -172.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.8 m -91.55 134.75 34.4 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 168.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -121.7 135.61 54.95 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.854 1.262 . . . . 0.0 107.885 169.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.448 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 25.8 p90 -167.66 142.21 3.69 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -169.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 m 58.46 158.33 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.935 2.494 . . . . 0.0 115.735 167.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.1 tp -111.19 66.04 0.62 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 103.946 -2.613 . . . . 0.0 103.946 169.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -57.11 -33.67 67.57 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 -165.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -136.42 26.65 3.14 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.226 0.61 . . . . 0.0 111.255 175.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.13 15.91 60.09 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 119.378 -0.679 . . . . 0.0 112.302 -169.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -136.94 143.92 43.14 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 174.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -69.22 143.56 53.94 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.448 ' HB ' ' CE2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -107.48 155.1 20.43 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -177.11 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.9 163.41 36.37 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 67.2 m -140.73 146.96 38.43 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 169.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.2 p -124.95 144.19 35.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 175.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.7 tt -126.76 150.18 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 169.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.406 HG22 HG13 ' A' ' 40' ' ' VAL . 30.5 p -140.87 178.03 1.73 Allowed Pre-proline 0 N--CA 1.442 -0.87 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 173.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -61.82 -28.6 81.79 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 CA-C-N 119.286 0.781 . . . . 0.0 110.941 168.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.5 p-90 -95.4 -25.36 16.3 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -170.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.19 170.77 21.73 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 120.623 1.556 . . . . 0.0 113.416 -175.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 tt -136.04 125.46 24.99 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 103.07 -2.937 . . . . 0.0 103.07 167.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.2 m -137.05 133.94 36.0 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 122.991 0.517 . . . . 0.0 109.992 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.37 145.15 41.89 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 168.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.2 m -138.09 146.83 26.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 80.7 mt -137.94 135.45 45.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -174.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -122.99 150.43 59.21 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.435 1.094 . . . . 0.0 110.872 -169.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -44.38 152.51 0.43 Allowed 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 124.736 3.624 . . . . 0.0 114.962 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.41 175.21 15.89 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 123.898 0.761 . . . . 0.0 113.697 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.82 -49.03 10.9 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.578 2.852 . . . . 0.0 114.305 -169.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -161.42 89.57 0.77 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.314 1.445 . . . . 0.0 107.231 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -155.79 -178.01 6.98 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.727 1.611 . . . . 0.0 106.688 178.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -95.7 136.71 35.76 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 168.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -107.97 144.04 28.56 Favored Pre-proline 0 C--N 1.324 -0.513 0 C-N-CA 126.656 1.983 . . . . 0.0 107.207 173.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.2 136.61 44.7 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.015 1.81 . . . . 0.0 110.606 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 64.1 tp -77.54 130.31 36.78 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 169.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.37 158.37 44.42 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 119.175 0.898 . . . . 0.0 109.956 -174.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -73.45 150.93 41.31 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 169.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.6 t -91.05 155.92 3.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -170.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.0 m 61.44 33.2 18.75 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.83 0.852 . . . . 0.0 111.658 -175.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -111.76 151.19 29.26 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 126.804 2.041 . . . . 0.0 106.983 169.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -105.26 142.37 35.15 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.092 0.86 . . . . 0.0 111.031 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.2 mm -118.86 130.04 74.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 174.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.21 123.2 6.77 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.9 mt -112.94 140.79 47.45 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.25 127.7 35.79 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 171.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mp -134.95 158.43 74.94 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 124.812 1.245 . . . . 0.0 107.774 174.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -60.81 -23.58 76.96 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.141 1.894 . . . . 0.0 113.98 172.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -64.2 -17.02 63.14 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.996 1.318 . . . . 0.0 111.949 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.94 152.12 9.12 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 107.881 -2.088 . . . . 0.0 107.881 -169.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.5 m -64.63 131.96 48.42 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 38.8 ttp -149.01 138.01 21.4 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -170.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -77.94 134.66 37.83 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -111.09 137.99 48.07 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 169.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.1 m -85.89 138.21 32.19 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 72.2 t -70.14 117.07 12.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 169.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -104.98 157.94 16.33 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 108.044 -2.022 . . . . 0.0 108.044 171.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -127.49 81.66 2.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 171.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.6 tp -66.1 128.89 37.88 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -169.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.66 131.38 50.52 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 122.832 0.453 . . . . 0.0 110.724 -172.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.36 4.92 75.71 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-O 118.607 -1.107 . . . . 0.0 113.576 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.2 t -122.39 -121.87 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.5 m -151.12 175.97 11.62 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.277 1.431 . . . . 0.0 109.544 -169.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -69.56 141.78 53.73 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 169.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -157.08 -179.15 7.93 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.308 1.443 . . . . 0.0 108.532 178.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 13.6 mt -113.78 136.66 52.61 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.2 p -139.75 153.59 47.22 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.793 0.837 . . . . 0.0 110.672 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 43.8 t -141.26 116.11 9.76 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 173.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.3 m -75.92 135.75 40.09 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 175.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 69.6 mt -116.7 -42.64 2.96 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.92 0.488 . . . . 0.0 112.276 -169.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 20.0 ptp -159.03 164.91 35.05 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.639 0.775 . . . . 0.0 109.746 -176.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.3 m -113.32 93.78 28.16 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 170.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -82.77 37.03 0.64 Allowed 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 124.128 3.219 . . . . 0.0 112.553 -169.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 34.7 tp -80.46 71.06 7.27 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 120.917 -1.115 . . . . 0.0 108.18 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.5 m -138.57 162.48 34.46 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.34 1.456 . . . . 0.0 111.077 -169.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -76.02 -18.33 59.3 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.802 -0.561 . . . . 0.0 111.038 171.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.8 m -76.63 15.68 0.6 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.225 1.41 . . . . 0.0 112.159 170.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 10.1 tpt -130.34 148.52 52.17 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.272 2.229 . . . . 0.0 106.84 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.6 p -160.92 -179.97 7.99 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.368 1.467 . . . . 0.0 108.534 -172.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.479 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -56.25 -41.01 68.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 123.679 0.791 . . . . 0.0 109.293 169.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -71.31 -44.27 65.47 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.097 0.559 . . . . 0.0 109.629 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -68.24 -22.33 64.78 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.645 -0.66 . . . . 0.0 110.998 175.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.29 -48.77 81.56 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 169.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -68.97 -54.05 17.39 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.71 -0.877 . . . . 0.0 110.584 175.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -65.5 -42.18 92.39 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 118.588 -0.72 . . . . 0.0 112.028 -169.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 12.9 tp -76.6 -27.15 55.66 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 119.896 1.225 . . . . 0.0 111.246 -171.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.2 m -71.45 -38.05 71.34 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.008 1.276 . . . . 0.0 109.232 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.85 -41.12 78.91 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.897 -0.502 . . . . 0.0 111.637 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -65.21 -34.97 79.63 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 121.022 -1.049 . . . . 0.0 110.325 173.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 18.0 t -67.71 -34.0 76.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.424 ' HB2' ' CE1' ' A' ' 45' ' ' PHE . . . -66.3 -51.73 54.46 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.363 0.665 . . . . 0.0 109.678 170.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 35.6 tpt85 -52.9 -50.08 64.63 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.55 0.74 . . . . 0.0 110.542 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 13.7 ptt? -59.53 -26.55 65.43 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 118.989 0.813 . . . . 0.0 112.306 -172.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 24.3 pt -96.16 5.49 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-N 119.166 0.894 . . . . 0.0 111.898 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 82.1 mt -115.73 31.39 6.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.951 1.7 . . . . 0.0 112.078 -174.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 17.6 m -78.29 64.11 3.34 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 120.734 -1.228 . . . . 0.0 110.809 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.6 mp 64.6 77.26 0.3 Allowed Pre-proline 0 N--CA 1.47 0.544 0 C-N-CA 127.933 2.493 . . . . 0.0 109.634 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -74.37 167.06 28.03 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.346 2.697 . . . . 0.0 111.968 -175.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.5 m -68.97 -29.75 44.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 122.961 0.504 . . . . 0.0 112.29 -169.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 11.2 m -114.59 56.64 0.72 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.969 1.308 . . . . 0.0 107.774 174.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -62.43 121.45 67.08 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 169.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -61.65 135.83 59.0 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.975 1.783 . . . . 0.0 112.974 -169.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -159.06 148.3 18.66 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.4 1.88 . . . . 0.0 107.731 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.1 p -150.44 149.31 26.12 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.825 0.85 . . . . 0.0 109.285 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -58.04 177.95 0.24 Allowed 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 124.301 3.334 . . . . 0.0 111.858 168.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -61.67 121.24 12.31 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 169.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.42 168.99 19.08 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.208 0.603 . . . . 0.0 110.5 -176.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -168.69 177.52 42.56 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.589 1.09 . . . . 0.0 110.398 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -68.68 151.91 46.05 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.216 0.606 . . . . 0.0 110.023 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -123.07 47.17 2.02 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.016 1.326 . . . . 0.0 108.666 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.07 126.05 26.84 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 174.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 86.0 mt -145.29 159.47 42.98 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.757 1.623 . . . . 0.0 108.309 -174.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 64.3 tp -66.45 123.43 20.0 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 175.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -75.82 150.2 37.74 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.085 0.554 . . . . 0.0 110.083 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -175.78 154.15 16.67 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 173.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 53.3 mtm180 -145.66 97.53 2.99 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 72.6 ttp85 -65.76 -40.49 92.09 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 119.103 -0.475 . . . . 0.0 111.152 -169.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.5 m -85.93 147.16 26.38 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.223 0.609 . . . . 0.0 109.804 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 73.49 -83.21 0.67 Allowed Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.238 0.923 . . . . 0.0 111.421 174.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -68.39 -32.64 72.85 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.629 1.172 . . . . 0.0 110.818 -177.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 53.22 43.17 31.89 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.426 1.49 . . . . 0.0 111.996 -174.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.249 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 169.87 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.3 tpp . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.5 p -134.93 150.11 50.35 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.283 1.433 . . . . 0.0 108.63 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -87.88 42.82 1.07 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.352 1.061 . . . . 0.0 109.632 -177.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -142.25 157.82 44.42 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.385 1.474 . . . . 0.0 110.198 -170.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.0 mm -128.56 125.9 64.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 172.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -72.7 128.59 35.99 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 173.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.46 153.51 52.91 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 111.231 -0.748 . . . . 0.0 111.231 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -84.08 136.07 34.16 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.136 0.974 . . . . 0.0 109.74 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -72.26 -33.03 67.18 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 118.806 -0.616 . . . . 0.0 110.075 173.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.8 p -150.72 155.32 39.06 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.427 1.891 . . . . 0.0 108.543 169.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.6 m -53.26 138.59 47.77 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 125.573 1.549 . . . . 0.0 113.703 -170.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -81.89 44.65 1.76 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 124.909 3.739 . . . . 0.0 110.88 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.4 pttm -61.63 -35.04 76.77 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.212 -1.555 . . . . 0.0 112.688 -168.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.58 -42.38 95.65 Favored 'General case' 0 C--O 1.226 -0.182 0 C-N-CA 123.155 0.582 . . . . 0.0 110.983 176.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -68.45 -41.65 79.96 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.336 0.654 . . . . 0.0 109.343 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.6 t -59.44 -46.48 92.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 173.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -60.69 -53.4 57.93 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.284 0.634 . . . . 0.0 110.452 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.73 -44.75 95.39 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.941 0.496 . . . . 0.0 110.832 -172.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.58 -47.27 86.92 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -67.87 -26.26 65.93 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 118.37 -0.824 . . . . 0.0 112.31 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -63.76 -34.5 78.04 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.851 1.205 . . . . 0.0 110.051 176.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -70.91 -50.12 38.32 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 118.808 0.731 . . . . 0.0 109.34 174.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.8 mt -65.69 -39.67 85.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 123.988 0.915 . . . . 0.0 110.594 -169.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.3 -26.37 65.61 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.082 0.553 . . . . 0.0 111.51 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -85.25 -100.3 0.06 Allowed 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 172.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 48.36 27.05 1.26 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.569 1.548 . . . . 0.0 114.273 -173.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.9 p -131.39 9.62 4.75 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.086 1.754 . . . . 0.0 111.466 -176.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -83.93 144.76 28.97 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.534 0.734 . . . . 0.0 110.443 -173.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -113.28 -28.87 7.44 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.137 0.975 . . . . 0.0 111.566 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -126.15 136.6 53.07 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 169.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.6 mt -73.88 -0.83 17.2 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -169.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.3 m -65.83 -26.02 67.48 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.786 0.721 . . . . 0.0 110.5 169.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -95.34 32.16 1.81 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.545 1.138 . . . . 0.0 110.891 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.06 -30.66 69.35 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.236 1.014 . . . . 0.0 112.393 -177.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -68.81 134.3 90.17 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 124.466 1.106 . . . . 0.0 111.496 -173.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -62.46 155.12 59.79 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.006 2.471 . . . . 0.0 110.607 169.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.3 m -78.58 -12.3 60.01 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -172.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.6 mmt -141.28 159.21 61.99 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 127.291 2.236 . . . . 0.0 105.854 173.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -65.48 137.18 49.71 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.936 1.757 . . . . 0.0 114.204 -169.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 61.9 t -108.3 112.02 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 167.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -148.86 151.77 35.3 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.645 0.778 . . . . 0.0 109.65 -169.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.2 t -137.67 116.24 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 123.669 0.788 . . . . 0.0 109.187 -173.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.0 m -80.62 157.3 26.03 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.913 0.885 . . . . 0.0 110.318 169.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.88 140.5 52.92 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.76 2.024 . . . . 0.0 109.498 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.478 ' CE2' ' CB ' ' A' ' 131' ' ' ALA . 60.1 m-85 -147.06 169.7 18.7 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -169.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.8 t -52.03 167.45 0.12 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 129.132 2.973 . . . . 0.0 114.505 -169.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.9 tp -77.99 125.5 29.44 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 174.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.89 135.7 33.15 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.18 1.792 . . . . 0.0 107.299 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 55.38 24.16 6.37 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.864 0.866 . . . . 0.0 111.992 -170.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.23 5.88 78.12 Favored Glycine 0 CA--C 1.534 1.233 0 O-C-N 121.026 -1.046 . . . . 0.0 113.817 -174.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -119.14 157.22 28.34 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.191 1.796 . . . . 0.0 108.952 -175.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -79.3 147.76 32.36 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.311 -1.493 . . . . 0.0 110.091 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.58 162.82 12.94 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 122.506 1.146 . . . . 0.0 109.885 169.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.14 172.13 39.88 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 107.49 -2.244 . . . . 0.0 107.49 169.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 11.6 m -138.93 152.4 47.69 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 105.591 -2.004 . . . . 0.0 105.591 169.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.71 138.86 52.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 175.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.441 HD13 ' HA2' ' A' ' 123' ' ' GLY . 13.6 tt -116.1 146.22 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 167.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.4 t -154.8 157.11 31.97 Favored Pre-proline 0 N--CA 1.442 -0.863 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 175.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -50.23 -29.7 23.69 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.934 2.422 . . . . 0.0 113.646 -177.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 9.1 p-90 -93.14 -19.88 21.04 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -174.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -166.69 159.45 13.99 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.911 1.687 . . . . 0.0 112.66 -175.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.4 tt -124.57 124.88 43.19 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 103.848 -2.649 . . . . 0.0 103.848 167.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.8 m -137.65 134.46 35.49 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 121.35 0.595 . . . . 0.0 109.724 -172.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.84 144.2 52.65 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 167.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.7 m -136.11 150.44 28.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 32.1 mt -135.92 143.4 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -123.89 139.43 32.41 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -53.98 132.16 48.41 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.868 1.712 . . . . 0.0 108.928 177.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.4 -175.91 31.27 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.292 0.948 . . . . 0.0 114.68 -169.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -71.17 153.79 62.17 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.203 2.602 . . . . 0.0 110.204 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.0 t0 46.67 44.59 13.88 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.067 1.747 . . . . 0.0 113.068 172.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -133.62 143.52 48.67 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.103 1.361 . . . . 0.0 107.842 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -112.19 95.94 5.75 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 172.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -65.63 155.64 85.2 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.443 171.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -68.35 164.46 32.44 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.629 2.22 . . . . 0.0 109.909 169.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.8 tp -72.25 87.68 1.12 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 169.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -70.82 148.98 47.29 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -89.9 159.04 17.15 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 169.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 94.8 t -91.37 154.22 3.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 114.048 -1.433 . . . . 0.0 107.647 -169.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.8 m 66.26 6.19 4.1 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.433 1.493 . . . . 0.0 113.673 -175.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -80.06 158.63 26.4 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.988 1.315 . . . . 0.0 108.268 169.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -113.97 144.22 43.44 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.966 0.803 . . . . 0.0 110.847 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.4 mm -118.21 121.09 66.36 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 176.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.11 125.33 7.74 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 173.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 82.3 mt -123.27 141.17 52.27 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.317 1.047 . . . . 0.0 109.084 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -90.53 133.65 34.92 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 172.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -153.49 157.51 32.76 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 124.958 1.303 . . . . 0.0 107.895 172.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -61.04 -20.26 66.84 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 123.059 2.506 . . . . 0.0 114.705 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -62.51 -20.65 64.83 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.944 0.898 . . . . 0.0 112.067 172.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.54 145.71 7.04 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 -170.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.9 m -60.64 131.07 49.56 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 174.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 47.6 ttp -149.67 146.21 27.14 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -169.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.55 134.02 34.42 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 121.883 -0.511 . . . . 0.0 110.493 176.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -104.98 132.25 51.46 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 168.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.2 m -82.01 144.11 31.1 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.0 t -75.96 114.39 16.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -98.1 162.75 21.02 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 171.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -129.9 133.86 47.13 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 169.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.6 tp -143.84 145.97 32.71 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -176.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -59.5 134.88 57.42 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.789 0.435 . . . . 0.0 110.572 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.17 4.45 59.71 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 118.945 -0.919 . . . . 0.0 113.701 -177.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.4 t -124.7 -33.15 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 118.928 1.364 . . . . 0.0 109.746 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.7 m 57.39 -150.09 0.45 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.331 1.053 . . . . 0.0 108.445 -169.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -58.61 132.15 52.94 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.884 0.874 . . . . 0.0 110.579 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -154.5 179.41 9.05 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.365 1.866 . . . . 0.0 107.011 169.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.6 mp -113.47 144.36 42.95 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 121.131 -0.981 . . . . 0.0 109.217 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.8 p -142.86 154.58 44.28 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.571 1.148 . . . . 0.0 110.278 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 12.2 t -144.75 111.87 5.96 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 170.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.9 m -67.98 130.17 42.14 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.7 mt -96.38 -59.34 1.85 Allowed 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -176.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.87 170.28 12.4 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.342 1.457 . . . . 0.0 108.377 177.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.9 m -86.71 132.08 43.47 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 170.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -68.67 164.65 32.34 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.11 1.873 . . . . 0.0 110.043 169.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 56.8 tp -133.64 141.61 47.7 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.251 1.02 . . . . 0.0 109.313 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.9 m -62.44 -17.7 60.0 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.924 1.29 . . . . 0.0 113.639 -172.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -60.17 115.12 3.26 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.785 0.834 . . . . 0.0 110.059 -178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.4 m 54.6 20.73 3.03 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.679 1.592 . . . . 0.0 114.04 -176.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.0 mmm -76.43 154.15 35.05 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 121.361 -0.837 . . . . 0.0 110.238 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 78.7 p -159.0 177.07 11.53 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.377 1.471 . . . . 0.0 108.021 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.575 ' H ' HD12 ' A' ' 120' ' ' ILE . 1.9 mp -58.34 -36.87 60.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 169.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -72.59 -44.99 61.29 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.572 0.749 . . . . 0.0 109.959 -174.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -64.23 -31.92 73.31 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.646 172.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.441 ' HA2' HD13 ' A' ' 57' ' ' ILE . . . -56.07 -58.39 14.42 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-N 119.455 1.025 . . . . 0.0 111.533 169.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -63.82 -48.55 76.4 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.043 0.922 . . . . 0.0 110.478 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -57.41 -45.44 84.59 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.935 1.294 . . . . 0.0 110.699 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.6 tp -78.35 -27.87 47.07 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.201 -174.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 10.9 m -65.83 -44.84 84.35 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 119.724 1.147 . . . . 0.0 109.173 173.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -65.68 -46.42 79.11 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.45 0.7 . . . . 0.0 111.299 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -63.04 -33.29 75.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.813 0.445 . . . . 0.0 110.548 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 19.0 m -68.22 -39.64 82.29 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.23 0.468 . . . . 0.0 110.797 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.478 ' CB ' ' CE2' ' A' ' 45' ' ' PHE . . . -65.23 -50.69 64.88 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 171.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -52.9 -51.36 61.52 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.065 0.848 . . . . 0.0 110.737 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 58.2 ttp -43.13 -48.23 6.27 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.152 2.181 . . . . 0.0 112.476 173.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 11.0 pt -92.78 -15.37 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 118.767 0.712 . . . . 0.0 112.513 -174.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 18.6 mt -81.94 -73.38 0.39 Allowed 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 124.384 1.074 . . . . 0.0 110.548 -175.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.6 m -147.57 30.26 0.91 Allowed 'General case' 0 C--O 1.234 0.255 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -168.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 12.6 tp -48.92 124.71 13.02 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 123.743 0.817 . . . . 0.0 111.088 176.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.91 167.22 22.42 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.848 2.365 . . . . 0.0 112.179 -172.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 44.5 t -127.31 145.25 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 169.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 9.4 m -60.67 133.77 56.43 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.261 0.624 . . . . 0.0 110.39 -174.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -146.27 115.74 4.65 Favored Pre-proline 0 C--O 1.236 0.38 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 169.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.13 132.55 18.23 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.836 1.691 . . . . 0.0 109.796 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -156.01 151.36 26.8 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 126.114 1.766 . . . . 0.0 108.652 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.3 p -145.56 142.73 18.45 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 124.35 1.06 . . . . 0.0 108.596 176.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -68.17 -175.68 0.88 Allowed 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.87 3.047 . . . . 0.0 110.988 170.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -57.18 123.21 14.52 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 169.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -81.21 125.54 30.42 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 71.35 176.8 25.14 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 121.725 0.625 . . . . 0.0 112.029 -173.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -71.24 162.57 29.21 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.401 0.68 . . . . 0.0 110.171 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -57.17 143.95 36.96 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 171.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.83 108.45 2.54 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 170.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 59.4 tp -156.85 141.5 16.84 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.859 1.264 . . . . 0.0 108.053 -169.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 58.8 tp -149.56 147.5 28.23 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.268 1.027 . . . . 0.0 108.871 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -129.42 159.25 36.81 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.358 1.463 . . . . 0.0 108.687 173.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -175.63 -173.37 41.29 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -71.41 -21.54 61.98 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.313 0.645 . . . . 0.0 112.141 -175.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 53.11 52.11 14.37 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.562 1.145 . . . . 0.0 109.422 -174.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.3 m -57.53 140.76 49.94 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.218 1.007 . . . . 0.0 110.493 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 79.48 112.13 0.24 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.581 1.086 . . . . 0.0 110.619 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 50.43 52.41 14.86 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.284 1.433 . . . . 0.0 110.766 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -62.6 122.22 15.27 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.397 0 C-N-CA 126.541 1.937 . . . . 0.0 107.112 175.206 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 120.645 0.26 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.7 p -72.47 156.98 38.47 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.198 0.999 . . . . 0.0 110.249 174.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -87.68 54.03 2.98 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.131 0.973 . . . . 0.0 108.584 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -150.52 157.89 43.53 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.531 1.932 . . . . 0.0 109.042 -171.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.64 133.08 70.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 169.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -153.14 164.0 38.84 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.232 1.013 . . . . 0.0 110.207 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 134.78 -150.54 20.14 Favored Glycine 0 C--N 1.341 0.828 0 C-N-CA 125.035 1.302 . . . . 0.0 110.368 176.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -84.54 -27.26 27.46 Favored 'General case' 0 C--O 1.221 -0.447 0 C-N-CA 125.061 1.344 . . . . 0.0 107.463 169.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 58.9 16.32 4.49 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 167.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 16.3 p -52.28 145.38 11.04 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.336 1.054 . . . . 0.0 112.069 -177.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 m -48.12 126.22 11.68 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 126.04 1.736 . . . . 0.0 111.146 -175.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -73.45 53.21 2.58 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.906 3.071 . . . . 0.0 112.036 174.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.7 tttm -47.66 -48.76 28.78 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.44 1.896 . . . . 0.0 112.998 -169.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.64 -41.19 88.66 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.275 0.489 . . . . 0.0 111.69 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -71.87 -38.75 70.0 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.926 0.49 . . . . 0.0 109.795 -176.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 71.7 t -61.63 -44.16 98.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 172.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -60.31 -53.74 54.08 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.58 0.627 . . . . 0.0 110.078 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.93 -40.09 96.59 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.613 0.642 . . . . 0.0 111.194 -176.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.61 -46.9 86.15 Favored 'General case' 0 C--N 1.339 0.126 0 O-C-N 122.064 -0.398 . . . . 0.0 110.019 177.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -68.79 -25.15 64.56 Favored 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 118.419 -0.8 . . . . 0.0 112.379 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -67.08 -33.19 74.96 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 119.504 1.047 . . . . 0.0 109.803 173.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -77.58 -45.99 23.56 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.746 -0.596 . . . . 0.0 109.888 176.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.0 mt -60.43 -39.73 81.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.09 -34.46 77.65 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.362 -0.836 . . . . 0.0 111.549 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -71.73 -43.19 66.28 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.052 0.842 . . . . 0.0 109.059 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -58.81 -41.42 86.74 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.957 0.903 . . . . 0.0 111.152 175.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.2 m -67.55 -47.9 68.5 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.147 0.885 . . . . 0.0 110.553 176.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 56.6 mtm -92.18 44.35 1.16 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.643 1.177 . . . . 0.0 111.025 -175.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.0 p-80 -70.82 -3.31 18.3 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -172.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.36 -26.02 67.55 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 119.053 0.842 . . . . 0.0 110.43 169.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -81.96 9.23 8.65 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.038 1.335 . . . . 0.0 111.633 174.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.9 m 53.54 -133.11 1.84 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.934 1.294 . . . . 0.0 110.216 -176.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -81.02 -2.13 46.75 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.97 0.804 . . . . 0.0 113.099 -173.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.74 146.87 53.05 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.306 0.957 . . . . 0.0 110.161 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -70.06 160.79 79.19 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 123.733 0.813 . . . . 0.0 109.52 175.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -58.24 148.17 80.31 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.344 2.029 . . . . 0.0 112.7 -177.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.9 m -65.17 -25.62 67.81 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.92 0.888 . . . . 0.0 112.49 -169.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 61.3 mtt -136.35 137.63 24.85 Favored Pre-proline 0 C--O 1.236 0.343 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 170.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -49.84 130.9 28.25 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 123.168 2.579 . . . . 0.0 112.827 175.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.2 m -67.06 152.92 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 168.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -140.53 155.56 46.59 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.453 1.024 . . . . 0.0 110.073 -175.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.4 t -139.54 114.28 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.2 m -78.86 142.0 37.2 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 168.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -125.37 134.74 52.07 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.401 1.48 . . . . 0.0 107.865 169.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.612 ' CE1' ' HB1' ' A' ' 131' ' ' ALA . 20.5 p90 -165.11 142.8 6.09 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -172.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.4 m 54.58 166.27 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.104 2.562 . . . . 0.0 116.312 167.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.0 tp -113.54 110.34 20.09 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 168.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -131.22 135.74 47.65 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.678 1.591 . . . . 0.0 107.089 -169.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 55.51 25.05 7.43 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 121.644 0.735 . . . . 0.0 110.51 -168.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.16 3.64 65.75 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 118.146 -1.363 . . . . 0.0 113.901 -174.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -115.34 154.86 28.39 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.599 1.699 . . . . 0.0 109.403 -173.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -74.59 137.66 42.47 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 120.683 -1.26 . . . . 0.0 108.997 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.79 155.97 18.19 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.667 1.122 . . . . 0.0 110.255 -173.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.15 171.58 41.25 Favored Glycine 0 CA--C 1.526 0.721 0 O-C-N 121.081 -1.012 . . . . 0.0 111.732 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 15.0 m -145.76 152.44 39.57 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 170.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.87 144.6 35.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 124.986 1.314 . . . . 0.0 107.466 173.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 15.9 tt -127.83 150.28 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 169.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.2 p -138.56 175.87 3.05 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 169.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -59.54 -30.42 92.4 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 CA-C-N 119.701 0.929 . . . . 0.0 110.835 168.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 48.4 p-90 -92.45 -25.59 18.38 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -171.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.51 170.45 21.93 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.42 1.464 . . . . 0.0 113.491 -175.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.6 tt -138.29 128.45 25.78 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 104.147 -2.538 . . . . 0.0 104.147 168.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.2 m -140.65 138.74 34.55 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.655 0.741 . . . . 0.0 109.622 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.63 146.58 51.57 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 168.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.0 m -138.84 144.85 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 C-N-CA 123.807 0.843 . . . . 0.0 108.786 175.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 52.2 mt -138.35 144.07 31.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 105.826 -1.916 . . . . 0.0 105.826 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -128.3 146.18 58.6 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-O 117.974 -1.012 . . . . 0.0 108.621 -175.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.64 134.65 21.83 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.469 2.779 . . . . 0.0 111.023 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.78 173.61 53.36 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 123.01 0.338 . . . . 0.0 112.878 -175.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -69.71 149.9 67.81 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 122.532 2.155 . . . . 0.0 110.296 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.0 t70 50.71 40.46 24.27 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.409 1.884 . . . . 0.0 112.696 169.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -128.27 131.12 48.74 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.3 mp -96.74 83.23 3.41 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 -175.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 3.7 m0 -66.33 140.4 96.73 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 114.257 -1.338 . . . . 0.0 108.645 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -66.86 161.68 41.12 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.842 1.695 . . . . 0.0 108.454 168.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.0 tp -67.38 106.44 2.09 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 169.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -73.77 155.13 39.19 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.335 0.588 . . . . 0.0 109.642 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -89.87 148.14 23.34 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 169.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.6 t -89.84 154.72 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -169.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.1 m 65.01 12.86 8.25 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.149 1.38 . . . . 0.0 113.713 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -85.96 158.97 19.76 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.114 1.365 . . . . 0.0 108.212 169.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -111.23 143.24 42.3 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 118.796 0.726 . . . . 0.0 110.504 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.9 mp -114.09 127.82 71.34 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 N-CA-C 104.775 -2.305 . . . . 0.0 104.775 170.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.51 121.09 5.54 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 170.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.8 mt -109.32 132.57 54.0 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 174.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -85.97 125.96 33.77 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 173.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 37.1 mt -133.6 148.52 68.97 Favored Pre-proline 0 C--O 1.233 0.224 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -59.12 -24.6 74.48 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.383 2.055 . . . . 0.0 112.802 169.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -58.05 -29.61 65.51 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.995 1.318 . . . . 0.0 112.158 169.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.32 142.15 4.84 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 -169.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 20.7 m -61.5 130.47 46.17 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 174.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 44.2 ttp -147.75 136.97 22.31 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -170.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.12 139.79 35.42 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 121.753 -0.592 . . . . 0.0 110.145 175.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -112.81 136.72 52.12 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 169.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.5 m -91.8 140.97 29.17 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.3 t -72.61 129.21 35.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -114.39 159.64 13.61 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 107.54 -2.224 . . . . 0.0 107.54 169.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -127.5 100.32 5.96 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 171.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.8 tp -79.11 121.79 25.43 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -171.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -61.09 129.98 44.07 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.042 0.537 . . . . 0.0 110.604 -172.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.88 5.81 70.98 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 118.669 -1.073 . . . . 0.0 113.632 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.9 t -124.75 -113.23 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 118.847 1.324 . . . . 0.0 107.611 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 11.8 m -152.98 174.45 14.13 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.793 1.237 . . . . 0.0 110.142 -169.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -75.49 145.78 41.13 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 169.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.16 167.52 30.16 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 125.501 1.52 . . . . 0.0 108.277 -178.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.4 mp -110.51 137.85 47.67 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.9 m -136.84 152.13 49.91 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.586 0.754 . . . . 0.0 110.47 -174.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 43.0 t -144.81 124.11 13.02 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 169.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.0 m -65.09 143.49 57.87 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 176.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.6 mt -117.69 -47.9 2.6 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 118.576 -0.726 . . . . 0.0 111.131 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 19.0 ptp -160.07 165.19 32.29 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 119.036 0.835 . . . . 0.0 110.541 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.3 m -119.5 95.5 49.28 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 169.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -77.32 -71.29 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.266 1.977 . . . . 0.0 111.942 -169.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 14.8 tp 46.0 36.74 3.19 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.69 1.596 . . . . 0.0 112.111 -171.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.2 m -75.31 148.56 39.24 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.107 0.963 . . . . 0.0 109.965 -174.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -78.11 -23.15 47.98 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.529 -0.732 . . . . 0.0 111.311 174.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.3 m -77.69 -0.15 25.67 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.236 1.014 . . . . 0.0 112.221 173.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 13.7 tpt -60.75 142.05 56.31 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.398 1.079 . . . . 0.0 109.636 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.7 m -143.28 157.56 44.38 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 125.807 1.643 . . . . 0.0 107.15 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -63.68 -24.84 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 O-C-N 120.923 -1.111 . . . . 0.0 111.114 177.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -67.04 -37.44 84.1 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.569 -0.707 . . . . 0.0 110.05 173.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -69.74 -31.72 69.86 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 118.888 0.767 . . . . 0.0 109.728 170.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -52.33 -36.94 46.98 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 169.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -84.6 -52.38 6.15 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.23 -1.159 . . . . 0.0 110.821 173.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 60.1 ttp85 -65.58 -38.5 89.68 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -169.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.62 -31.24 46.93 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 119.677 1.126 . . . . 0.0 109.2 -173.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.4 m -67.43 -42.52 83.04 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 123.677 0.791 . . . . 0.0 109.061 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -66.75 -41.26 88.11 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.349 1.06 . . . . 0.0 111.828 173.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.97 -30.54 65.37 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 121.176 -0.952 . . . . 0.0 110.636 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 44.0 m -69.32 -43.02 74.6 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 122.974 0.51 . . . . 0.0 110.172 173.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.612 ' HB1' ' CE1' ' A' ' 45' ' ' PHE . . . -54.34 -49.76 68.98 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.217 1.007 . . . . 0.0 110.276 173.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.0 ttp-105 -68.49 -42.69 78.29 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.43 -0.794 . . . . 0.0 111.851 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 51.4 ttp -48.31 -56.4 8.17 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.312 1.045 . . . . 0.0 110.601 171.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.6 pt -78.36 -6.07 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 118.865 0.757 . . . . 0.0 112.961 -176.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 19.0 tp -74.9 -83.8 0.05 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 170.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.3 m -155.78 10.36 0.28 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.5 tp 41.97 52.01 6.44 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 124.728 1.211 . . . . 0.0 113.812 -168.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -60.45 154.95 49.93 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.131 1.887 . . . . 0.0 111.349 172.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.9 t -133.79 140.19 47.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 172.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 7.0 m -64.77 132.57 49.94 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.346 0.658 . . . . 0.0 109.466 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -152.14 118.75 3.13 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 124.811 1.244 . . . . 0.0 108.042 174.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -60.03 140.09 90.91 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.429 2.086 . . . . 0.0 111.659 177.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -155.6 141.43 18.09 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.351 1.46 . . . . 0.0 108.694 175.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -149.8 137.79 11.89 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.568 1.147 . . . . 0.0 108.682 176.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -48.17 113.28 0.76 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 124.491 3.46 . . . . 0.0 112.905 174.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 23.6 t60 49.9 25.42 1.6 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.684 1.994 . . . . 0.0 113.556 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 48.01 32.74 3.02 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.202 1.401 . . . . 0.0 113.526 -170.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.54 136.14 33.85 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -138.61 150.87 46.73 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.803 1.641 . . . . 0.0 108.406 -176.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.21 -37.06 69.3 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 119.098 -0.477 . . . . 0.0 110.93 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . 48.87 39.17 13.69 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.283 1.433 . . . . 0.0 112.004 -175.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -76.76 167.55 21.64 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.738 0.815 . . . . 0.0 111.771 -177.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 66.3 tp -125.7 130.96 52.57 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 169.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -76.09 154.56 35.48 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 122.946 0.498 . . . . 0.0 110.577 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -73.51 177.74 43.16 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 123.887 0.756 . . . . 0.0 112.004 176.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -135.59 138.09 42.61 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 125.402 1.481 . . . . 0.0 108.358 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -79.4 -34.92 41.4 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 122.566 0.346 . . . . 0.0 110.207 177.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 11.6 m -73.69 127.72 33.56 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.154 0.582 . . . . 0.0 109.542 -172.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 173.36 146.3 5.44 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 107.538 -2.225 . . . . 0.0 107.538 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -87.66 154.87 20.25 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.354 0.661 . . . . 0.0 109.93 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -146.07 147.5 31.66 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.018 1.327 . . . . 0.0 108.789 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.348 0 C-N-CA 125.457 1.503 . . . . 0.0 107.992 177.424 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.4 tpt . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 p -78.05 -40.6 38.2 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.708 0.803 . . . . 0.0 110.976 -177.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 57.71 49.78 11.8 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.85 1.26 . . . . 0.0 110.125 -169.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -140.61 164.59 29.75 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.466 1.906 . . . . 0.0 109.088 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 71.2 mt -131.82 129.93 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 174.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.59 145.66 36.69 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.149 0.499 . . . . 0.0 110.49 -178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.17 151.18 51.66 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.911 1.243 . . . . 0.0 112.422 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -86.45 131.14 34.27 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 170.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -74.02 -32.7 63.48 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 171.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 p -149.73 148.22 28.97 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 126.489 1.916 . . . . 0.0 107.488 169.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.6 m -59.84 150.67 67.38 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 126.816 2.046 . . . . 0.0 114.13 -169.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -80.6 42.28 1.3 Allowed 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 124.306 3.337 . . . . 0.0 111.737 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.5 tttm -52.83 -46.91 67.97 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.853 1.261 . . . . 0.0 112.04 -169.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.57 -41.05 98.41 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 122.57 0.348 . . . . 0.0 111.407 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -72.28 -38.63 68.74 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -175.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 99.3 t -61.35 -44.08 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 172.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -62.17 -50.44 71.83 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 118.849 -0.596 . . . . 0.0 110.579 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.62 -39.13 93.17 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.765 0.711 . . . . 0.0 111.032 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.43 -50.33 74.02 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -68.36 -28.19 66.91 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 118.172 -0.918 . . . . 0.0 112.594 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.8 -33.88 76.66 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 120.028 1.285 . . . . 0.0 109.582 175.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -80.05 -43.27 22.16 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.289 0.495 . . . . 0.0 110.352 176.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.1 mt -65.22 -37.96 81.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.263 -0.898 . . . . 0.0 109.117 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.31 -32.69 74.25 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.467 0.707 . . . . 0.0 110.707 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -72.53 -41.8 65.46 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 123.841 0.856 . . . . 0.0 109.459 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -57.92 -39.03 77.0 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.332 1.053 . . . . 0.0 110.266 173.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.9 m -79.56 58.81 2.8 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.811 1.644 . . . . 0.0 110.522 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 55.5 mtt -61.66 108.8 1.05 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.774 0.83 . . . . 0.0 109.677 -177.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.9 m80 -81.13 -20.1 42.12 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.034 0.533 . . . . 0.0 110.155 170.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -137.09 140.62 42.08 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 169.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -76.26 1.78 15.08 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.805 0.73 . . . . 0.0 112.805 -169.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.5 m -119.27 17.44 13.09 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.547 1.539 . . . . 0.0 110.769 169.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -61.16 -40.48 94.02 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.944 0.898 . . . . 0.0 110.933 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.2 mt 49.91 -135.4 1.32 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.499 1.519 . . . . 0.0 110.452 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -66.21 143.88 98.51 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 119.27 0.941 . . . . 0.0 109.862 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -56.43 129.64 35.84 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.452 2.101 . . . . 0.0 114.006 -169.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.0 m -82.14 -9.26 59.58 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.438 1.095 . . . . 0.0 112.407 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 7.9 mmt -135.23 156.49 78.05 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 126.426 1.89 . . . . 0.0 107.184 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -63.34 132.37 35.77 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.666 2.244 . . . . 0.0 115.769 -168.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.433 HG13 HG22 ' A' ' 58' ' ' THR . 39.6 t -111.63 107.9 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 101.128 -3.656 . . . . 0.0 101.128 167.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -140.85 159.17 42.78 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.946 0.898 . . . . 0.0 110.197 -169.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.3 t -138.16 112.21 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.7 m -76.17 147.82 38.2 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.487 1.04 . . . . 0.0 108.982 169.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -144.26 130.18 19.4 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.679 1.192 . . . . 0.0 111.622 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 176.59 159.35 0.33 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.017 1.327 . . . . 0.0 113.398 -172.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 m 61.64 152.86 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 128.473 2.709 . . . . 0.0 114.688 168.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.5 mt -103.62 125.55 50.21 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 169.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -135.34 138.45 43.4 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 173.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 54.18 26.31 6.57 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.971 0.908 . . . . 0.0 111.017 -169.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.54 7.14 82.68 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.927 1.251 . . . . 0.0 114.263 -176.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.1 mm-40 -119.17 148.68 42.82 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.236 1.518 . . . . 0.0 109.322 -173.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -66.72 145.3 55.68 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.235 0.925 . . . . 0.0 110.134 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -113.87 160.19 19.03 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.911 0.862 . . . . 0.0 110.173 -172.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -176.31 178.59 47.66 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 13.6 m -142.04 150.25 41.02 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 169.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.1 p -114.87 147.12 18.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 169.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.6 tt -130.08 151.34 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 169.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.433 HG22 HG13 ' A' ' 40' ' ' VAL . 44.5 p -142.41 172.06 6.35 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 169.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -73.89 21.06 0.38 Allowed 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 121.344 1.363 . . . . 0.0 112.063 169.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -138.13 -23.27 1.02 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.288 0.949 . . . . 0.0 113.403 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.18 164.71 37.57 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 120.363 1.438 . . . . 0.0 111.733 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 tt -137.61 125.87 23.18 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 104.392 -2.447 . . . . 0.0 104.392 168.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.3 m -138.18 134.18 34.21 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 123.332 0.395 . . . . 0.0 110.084 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.1 141.41 56.12 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 168.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 m -138.76 144.83 28.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -177.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 51.5 mt -141.33 134.35 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 -170.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -119.95 145.05 38.81 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.33 -172.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -44.68 125.8 6.62 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.738 2.959 . . . . 0.0 112.18 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.65 176.45 28.47 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 123.364 0.507 . . . . 0.0 113.193 -175.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -67.19 135.14 36.1 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.125 2.55 . . . . 0.0 110.411 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.7 t70 49.1 32.57 4.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.925 1.69 . . . . 0.0 113.259 177.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 71.9 mm-40 -91.37 151.85 20.67 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 172.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -118.42 88.72 2.98 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 172.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 22.9 m0 -65.28 150.66 95.37 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 169.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.58 168.21 23.27 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.706 1.604 . . . . 0.0 108.375 169.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.8 tp -71.09 91.36 0.9 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 170.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -75.55 151.79 37.85 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.418 0.628 . . . . 0.0 109.679 -176.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -89.83 149.88 22.48 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 173.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.8 t -91.88 154.86 3.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 C-N-CA 124.311 1.044 . . . . 0.0 108.281 -169.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.9 m 62.45 23.52 13.96 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.637 1.175 . . . . 0.0 112.667 -176.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -99.43 151.71 20.8 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.206 1.802 . . . . 0.0 107.648 169.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -106.2 143.63 34.06 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.503 0.592 . . . . 0.0 110.345 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 9.8 mt -123.92 128.41 74.18 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.85 123.14 6.89 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.8 mt -109.57 131.56 54.95 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 172.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.64 127.75 34.0 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 172.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.9 mt -135.2 153.62 78.33 Favored Pre-proline 0 C--O 1.234 0.275 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -60.79 -26.06 82.32 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.71 2.274 . . . . 0.0 112.759 174.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -65.37 -23.3 66.94 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.123 1.369 . . . . 0.0 111.911 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 129.69 147.15 6.2 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 126.176 1.846 . . . . 0.0 108.835 -169.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.7 m -62.78 133.86 55.39 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 55.7 ttm -144.47 136.09 25.72 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -169.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.42 130.11 35.11 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.521 -0.737 . . . . 0.0 109.169 173.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -106.06 136.48 45.65 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 105.731 -1.952 . . . . 0.0 105.731 169.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.8 m -87.58 137.88 31.96 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.1 t -71.02 114.81 9.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -101.47 163.31 17.74 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 169.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -130.58 97.8 4.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 170.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.5 tp -78.06 128.05 33.25 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -169.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -58.92 130.9 49.2 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.172 0.589 . . . . 0.0 110.52 -176.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.5 3.65 72.43 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.646 -1.086 . . . . 0.0 113.818 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.3 t -126.19 -121.0 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 119.143 1.471 . . . . 0.0 107.188 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.4 m -151.65 -176.79 5.76 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.776 1.63 . . . . 0.0 109.019 -169.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -72.91 148.62 44.17 Favored 'General case' 0 C--N 1.34 0.188 0 O-C-N 121.748 -0.595 . . . . 0.0 110.155 169.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -154.49 163.29 40.42 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.123 1.769 . . . . 0.0 108.03 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 12.4 mt -104.44 130.55 52.34 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.6 m -137.61 151.89 48.8 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.018 0.527 . . . . 0.0 110.884 -171.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 25.8 t -142.44 123.77 14.74 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 170.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.2 m -70.97 135.27 47.78 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 176.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.5 mt -110.48 -50.68 2.94 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.359 0.664 . . . . 0.0 111.165 -173.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 9.4 ptp -159.75 172.31 17.93 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.708 0.803 . . . . 0.0 109.982 -178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.9 m -119.74 80.5 24.42 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.044 0.938 . . . . 0.0 109.648 -177.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -62.67 161.26 29.08 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.48 2.12 . . . . 0.0 110.407 169.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 47.9 tp -137.66 154.83 49.65 Favored 'General case' 0 CA--C 1.526 0.052 0 C-N-CA 125.004 1.322 . . . . 0.0 107.67 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.6 m -48.49 -30.73 5.47 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.13 1.772 . . . . 0.0 114.589 -175.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -70.44 -28.5 65.07 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.441 0.564 . . . . 0.0 112.175 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.8 m -106.35 36.7 2.51 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.2 1.4 . . . . 0.0 109.605 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 65.0 mmm -133.99 155.5 49.86 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.668 1.187 . . . . 0.0 110.291 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.7 t -159.67 166.61 30.24 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 127.968 2.507 . . . . 0.0 104.632 170.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.565 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.6 OUTLIER -57.08 -36.59 51.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 119.09 0.859 . . . . 0.0 109.905 177.45 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -71.67 -32.41 67.84 Favored 'General case' 0 C--O 1.223 -0.308 0 O-C-N 121.652 -0.655 . . . . 0.0 110.462 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -73.73 -42.25 61.42 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.992 0.814 . . . . 0.0 109.372 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -49.01 -30.86 9.94 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 123.756 0.693 . . . . 0.0 113.882 169.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -90.33 -57.62 2.78 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.602 1.201 . . . . 0.0 111.481 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 71.8 ttt-85 -68.79 -32.58 72.41 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -168.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 7.6 mp -76.74 -38.34 54.37 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.757 1.162 . . . . 0.0 108.464 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.0 m -63.14 -43.58 97.93 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 124.3 1.04 . . . . 0.0 109.301 176.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.71 -55.0 39.81 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 118.657 -0.687 . . . . 0.0 110.801 171.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -61.27 -34.86 75.86 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.138 0.881 . . . . 0.0 111.408 -174.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 99.5 m -73.39 -27.14 61.3 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 122.11 -0.369 . . . . 0.0 111.854 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.52 -41.19 40.1 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.484 -0.76 . . . . 0.0 109.101 169.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -57.81 -55.34 36.11 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.262 1.425 . . . . 0.0 110.277 -173.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 17.3 ptt? -48.95 -34.09 12.21 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.655 1.582 . . . . 0.0 112.56 177.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 34.3 pt -93.53 2.5 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 119.863 1.21 . . . . 0.0 112.435 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 26.5 mt -124.34 -71.11 0.73 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.304 1.442 . . . . 0.0 112.844 -169.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.6 m -82.94 0.97 41.96 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -168.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 67.3 tp -66.31 115.47 24.08 Favored Pre-proline 0 N--CA 1.441 -0.899 0 C-N-CA 126.353 1.861 . . . . 0.0 106.319 169.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -71.23 155.01 61.49 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.131 1.888 . . . . 0.0 113.754 -169.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.3 p -149.86 151.77 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 126.445 1.898 . . . . 0.0 106.626 170.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.8 m -68.03 127.22 32.07 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -154.73 119.72 2.62 Favored Pre-proline 0 C--O 1.236 0.391 0 C-N-CA 124.776 1.23 . . . . 0.0 107.894 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -58.6 135.39 67.12 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.682 2.255 . . . . 0.0 111.302 176.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -73.96 -29.67 62.12 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 122.945 0.498 . . . . 0.0 112.009 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.6 m -110.37 149.14 39.77 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 125.401 1.48 . . . . 0.0 110.645 -174.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -76.66 -24.82 9.95 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.545 2.164 . . . . 0.0 112.194 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -146.39 148.46 32.35 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.112 1.765 . . . . 0.0 107.618 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.83 -19.11 61.38 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -173.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 69.86 -153.24 52.08 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 53.82 41.34 32.08 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.627 1.171 . . . . 0.0 112.254 170.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -69.32 -28.28 66.11 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 119.075 -0.488 . . . . 0.0 111.123 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . 51.95 40.46 28.22 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.406 1.482 . . . . 0.0 112.327 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.84 162.57 28.99 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.109 0.564 . . . . 0.0 110.413 174.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -137.12 155.4 49.66 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.791 1.236 . . . . 0.0 109.492 171.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -95.89 158.32 15.5 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.01 0.924 . . . . 0.0 110.269 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -72.9 174.15 46.82 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 170.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.33 132.93 16.78 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 104.91 -2.256 . . . . 0.0 104.91 175.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -80.09 130.1 34.99 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.2 m 59.41 -172.65 0.11 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.033 1.333 . . . . 0.0 112.433 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -174.68 173.6 46.2 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -72.19 142.19 49.04 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -147.53 157.2 43.46 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 125.121 1.368 . . . . 0.0 108.591 176.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.282 0 C-N-CA 123.463 0.705 . . . . 0.0 109.666 175.325 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 tmt? . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.3 m -139.66 146.98 40.37 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.86 162.6 39.68 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.099 1.36 . . . . 0.0 107.58 176.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 57.13 154.05 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 130.529 3.532 . . . . 0.0 116.403 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.0 mt -134.08 139.09 49.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 126.831 2.052 . . . . 0.0 106.19 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.28 150.61 45.02 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.931 -0.481 . . . . 0.0 111.307 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.24 163.1 42.63 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 124.301 0.953 . . . . 0.0 112.508 172.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -115.94 155.58 27.76 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.271 1.428 . . . . 0.0 109.736 175.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -88.63 -22.76 23.29 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.302 0.641 . . . . 0.0 111.659 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.3 p -159.2 -178.01 6.89 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 129.393 3.077 . . . . 0.0 106.323 172.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.5 m -57.19 134.99 80.92 Favored Pre-proline 0 CA--C 1.541 0.623 0 O-C-N 121.247 -0.908 . . . . 0.0 109.534 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -74.19 63.48 5.23 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 124.537 3.491 . . . . 0.0 110.295 172.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -53.01 -50.74 63.6 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 124.266 1.026 . . . . 0.0 111.559 -169.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.32 -41.23 89.98 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 123.317 0.385 . . . . 0.0 110.708 -171.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -65.51 -45.91 81.7 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.595 0.758 . . . . 0.0 109.919 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 71.3 t -62.81 -41.12 91.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -62.98 -52.85 61.39 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.873 0.869 . . . . 0.0 109.996 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.77 -40.54 97.62 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.719 0.69 . . . . 0.0 110.648 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.04 71.56 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -68.06 -26.95 66.11 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 118.068 -0.968 . . . . 0.0 112.639 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -66.27 -31.1 71.71 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.826 1.194 . . . . 0.0 110.15 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -83.67 -41.63 17.53 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.243 0.617 . . . . 0.0 110.525 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.5 mt -65.52 -36.7 78.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 120.912 -1.117 . . . . 0.0 108.064 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.1 -27.78 68.61 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.228 -0.92 . . . . 0.0 112.244 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 62.9 ttp85 -76.41 -32.99 58.82 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.151 0.887 . . . . 0.0 109.665 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -71.91 -39.7 69.35 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.904 -0.569 . . . . 0.0 110.857 171.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 63.4 m -69.3 -44.59 71.45 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.673 0.789 . . . . 0.0 112.426 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 98.6 mmm -133.62 153.88 51.33 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.58 1.552 . . . . 0.0 109.344 -169.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -128.2 164.12 23.22 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.148 0.979 . . . . 0.0 109.557 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.1 t70 55.55 40.2 31.08 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.125 1.37 . . . . 0.0 112.697 178.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -122.17 19.64 10.69 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.14 1.376 . . . . 0.0 113.031 176.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.9 m 52.42 59.07 4.76 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.835 1.254 . . . . 0.0 111.57 177.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -57.99 -21.09 42.96 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -169.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 93.9 mt -70.03 -27.36 64.6 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.859 0.754 . . . . 0.0 111.768 176.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 67.0 t60 -148.93 80.93 7.83 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 173.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -58.19 146.32 89.08 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.044 2.496 . . . . 0.0 113.966 -169.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.1 m -70.75 -17.7 62.8 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.988 0.915 . . . . 0.0 113.026 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 68.4 mtt -131.42 149.49 73.73 Favored Pre-proline 0 N--CA 1.464 0.26 0 N-CA-C 105.769 -1.938 . . . . 0.0 105.769 170.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.22 138.59 33.58 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.179 1.253 . . . . 0.0 113.696 -169.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.3 t -99.49 106.98 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 1 N-CA-C 99.943 -4.095 . . . . 0.0 99.943 167.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -150.59 161.68 42.11 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.959 0.904 . . . . 0.0 109.944 -169.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 13.3 t -138.91 127.32 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.064 0.946 . . . . 0.0 108.748 -176.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.3 m -93.18 148.74 21.76 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.934 0.894 . . . . 0.0 109.039 168.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -121.9 141.28 51.45 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.361 1.865 . . . . 0.0 110.1 -176.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.419 ' CE2' ' CB ' ' A' ' 131' ' ' ALA . 91.1 m-85 -148.89 174.73 11.93 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.927 1.291 . . . . 0.0 113.053 -169.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.0 t -45.99 167.22 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 129.765 3.226 . . . . 0.0 115.121 -171.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.2 tp -84.76 107.1 16.77 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 105.69 -1.966 . . . . 0.0 105.69 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -76.64 -55.68 5.3 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 117.905 0.321 . . . . 0.0 111.578 -169.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.35 55.52 1.03 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.434 1.494 . . . . 0.0 109.347 177.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.83 10.25 79.34 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 115.824 -0.625 . . . . 0.0 113.075 -177.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -138.37 143.43 39.83 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.565 1.946 . . . . 0.0 107.362 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -74.79 152.08 39.04 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.679 0.672 . . . . 0.0 109.719 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.89 156.23 18.92 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.5 171.65 41.52 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 6.3 m -138.37 145.8 41.51 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 169.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 p -115.89 148.04 18.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 170.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.8 tt -129.73 152.11 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 124.885 1.274 . . . . 0.0 107.598 169.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.0 p -143.46 178.21 1.55 Allowed Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 125.337 1.455 . . . . 0.0 107.181 170.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.3 -24.57 77.84 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 121.331 1.354 . . . . 0.0 111.896 168.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.5 p-90 -104.3 -22.44 13.36 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -169.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.74 169.73 24.06 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 120.278 1.399 . . . . 0.0 112.608 -175.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.1 tt -138.29 126.4 22.82 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 103.946 -2.612 . . . . 0.0 103.946 168.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.6 m -138.89 134.69 33.6 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.16 147.48 46.57 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 168.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.4 m -139.04 148.41 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 124.574 1.15 . . . . 0.0 108.58 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 50.7 mt -138.57 137.85 42.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -126.31 148.33 63.36 Favored Pre-proline 0 N--CA 1.466 0.335 0 C-N-CA 124.042 0.937 . . . . 0.0 109.841 -173.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.4 133.86 31.32 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.709 2.273 . . . . 0.0 111.265 172.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.18 -171.35 16.47 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 123.756 0.693 . . . . 0.0 111.918 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.31 157.45 33.25 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.611 2.207 . . . . 0.0 111.297 -177.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.2 t0 43.76 56.33 4.62 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.747 2.019 . . . . 0.0 113.388 169.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -149.35 160.48 43.38 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.266 1.027 . . . . 0.0 109.315 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -111.7 105.69 14.27 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 169.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -70.67 143.45 89.8 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 172.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.16 150.25 85.12 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.049 1.833 . . . . 0.0 110.379 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.3 tp -76.12 92.9 3.26 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 170.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -79.36 171.49 15.1 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.032 0.933 . . . . 0.0 110.271 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -99.01 162.13 13.24 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 123.546 1.641 . . . . 0.0 107.481 168.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 87.9 t -89.84 154.27 3.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 113.044 -1.889 . . . . 0.0 107.112 -171.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.9 m 67.11 5.82 4.38 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.058 1.343 . . . . 0.0 113.732 -175.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -71.69 150.09 44.86 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 169.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -116.17 138.18 51.49 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.598 0.636 . . . . 0.0 110.032 177.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.6 mp -111.03 122.27 65.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 103.696 -2.705 . . . . 0.0 103.696 175.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.61 116.87 4.61 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 173.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.6 tp -106.72 132.36 52.79 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -87.53 127.58 35.25 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 172.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 mp -134.76 155.0 79.76 Favored Pre-proline 0 C--O 1.234 0.283 0 C-N-CA 125.426 1.49 . . . . 0.0 107.304 172.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -64.52 -23.93 63.95 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 CA-C-N 120.757 1.306 . . . . 0.0 112.402 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -55.25 -30.33 59.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.826 1.651 . . . . 0.0 111.763 169.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.06 148.32 5.54 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 108.116 -1.993 . . . . 0.0 108.116 -171.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.1 m -65.1 131.46 46.62 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 171.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 45.4 ttp -146.21 135.59 22.94 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -171.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.26 134.47 35.28 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 118.54 0.609 . . . . 0.0 110.021 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -103.48 134.13 47.35 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 168.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 19.6 m -94.9 141.49 28.58 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 92.5 t -74.16 123.83 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 171.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -113.0 156.74 15.41 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 169.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -115.08 98.53 6.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 169.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.1 tp -75.14 124.29 26.76 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -169.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -61.12 128.78 38.09 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.416 0.686 . . . . 0.0 110.219 -173.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.42 4.74 84.88 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 118.645 -1.086 . . . . 0.0 113.857 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.7 t -127.72 -118.99 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 119.069 1.435 . . . . 0.0 107.282 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.2 m -151.39 -179.57 7.49 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.174 1.79 . . . . 0.0 108.31 -169.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -70.66 146.14 50.16 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 121.671 -0.643 . . . . 0.0 109.691 169.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.82 167.64 26.87 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.671 1.588 . . . . 0.0 108.511 176.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.6 mt -103.43 138.63 39.89 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 174.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.5 p -154.93 160.59 41.26 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 119.298 0.954 . . . . 0.0 111.821 -177.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 9.5 p -149.17 135.63 19.36 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 168.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.2 p -74.17 145.63 44.07 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.457 0.703 . . . . 0.0 109.463 176.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.6 mt -116.36 -70.29 0.8 Allowed 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.768 0.827 . . . . 0.0 109.387 -173.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -148.53 161.16 42.21 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.077 0.951 . . . . 0.0 109.892 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.9 m -87.8 118.99 70.4 Favored Pre-proline 0 CA--C 1.544 0.728 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 168.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -83.18 -9.13 10.64 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 122.642 2.228 . . . . 0.0 115.19 -169.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . 0.285 2.3 pt? -74.41 30.61 0.08 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 116.045 1.869 . . . . 0.0 116.045 -169.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.8 m -61.73 155.05 23.81 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.79 0.836 . . . . 0.0 109.685 169.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -66.82 -23.73 66.08 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 120.353 -1.467 . . . . 0.0 112.86 -170.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.9 m -71.65 -8.94 57.2 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.031 0.932 . . . . 0.0 112.891 175.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.8 tpt -63.63 150.71 43.58 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.767 1.627 . . . . 0.0 111.258 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 96.6 p -153.88 176.38 12.23 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.987 1.715 . . . . 0.0 107.815 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.544 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -61.85 -32.07 52.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 O-C-N 121.186 -0.946 . . . . 0.0 110.222 170.041 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -75.35 -43.95 47.79 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.472 0.578 . . . . 0.0 109.664 -177.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -62.66 -31.58 72.48 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.32 170.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.88 -50.64 61.99 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 119.97 1.259 . . . . 0.0 111.158 176.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -62.43 -50.88 69.74 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.988 -0.713 . . . . 0.0 109.87 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 66.0 ttp85 -61.61 -38.63 88.34 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 123.465 0.706 . . . . 0.0 110.927 -175.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 22.5 tp -80.51 -24.33 39.45 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-O 117.817 -1.087 . . . . 0.0 111.248 -174.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.9 m -65.42 -44.18 88.2 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 120.463 1.483 . . . . 0.0 108.724 170.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -62.96 -53.84 47.83 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 118.761 -0.638 . . . . 0.0 109.939 174.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -61.49 -32.22 72.23 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.615 0.643 . . . . 0.0 111.129 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 57.3 m -73.26 -30.47 63.47 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.994 -0.441 . . . . 0.0 111.621 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.419 ' CB ' ' CE2' ' A' ' 45' ' ' PHE . . . -73.8 -49.13 26.78 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 119.231 0.923 . . . . 0.0 109.57 170.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.6 tpp180 -46.82 -58.22 4.12 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 127.465 2.306 . . . . 0.0 110.469 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 15.8 ptt? -51.84 -42.68 62.77 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.601 1.161 . . . . 0.0 112.25 178.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 22.8 pt -84.24 -25.93 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 119.693 1.133 . . . . 0.0 111.789 -175.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 72.7 mt -69.06 -24.02 64.11 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.472 0.709 . . . . 0.0 109.306 169.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.7 m 59.38 39.5 22.1 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.943 1.697 . . . . 0.0 112.629 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.6 mp 49.54 75.99 0.6 Allowed Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 126.786 2.034 . . . . 0.0 111.507 175.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.57 145.15 82.35 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.088 2.526 . . . . 0.0 112.143 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.5 m -74.03 -33.51 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 122.523 0.329 . . . . 0.0 111.132 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 42.9 m -79.39 121.13 24.77 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 174.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -86.22 121.51 72.6 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 118.042 -0.98 . . . . 0.0 108.5 172.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -69.73 131.6 21.61 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.359 2.039 . . . . 0.0 109.767 173.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -81.89 69.9 8.68 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.305 1.042 . . . . 0.0 110.112 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.0 m -64.74 154.14 86.06 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 124.923 1.289 . . . . 0.0 110.772 -178.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.74 -17.74 61.16 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.504 2.136 . . . . 0.0 112.717 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -75.27 -7.63 54.43 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.356 1.062 . . . . 0.0 112.36 176.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.1 167.19 14.53 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.591 0.756 . . . . 0.0 111.047 178.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -75.3 3.93 44.2 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.281 0.943 . . . . 0.0 115.046 -174.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -60.86 133.84 56.5 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.417 1.608 . . . . 0.0 109.124 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.31 142.43 39.42 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -101.12 130.26 47.15 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 169.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -114.64 137.45 51.88 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.932 0.893 . . . . 0.0 108.641 -174.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 63.8 tp -75.69 -38.47 58.65 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.063 0.545 . . . . 0.0 110.802 177.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -90.22 160.11 16.37 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.909 0.884 . . . . 0.0 111.109 -169.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -175.38 -175.52 42.88 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.538 1.542 . . . . 0.0 109.836 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -135.82 113.94 11.38 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -62.51 125.98 25.77 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -170.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.5 m 51.84 26.64 3.68 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.867 1.267 . . . . 0.0 113.797 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 62.11 15.58 50.74 Favored Glycine 0 CA--C 1.535 1.3 0 O-C-N 121.486 -0.759 . . . . 0.0 113.256 -175.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 52.45 31.22 9.4 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.239 1.816 . . . . 0.0 112.362 -169.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -67.32 138.47 56.83 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.653 0.781 . . . . 0.0 109.699 174.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.08 0 C-N-CA 125.484 1.513 . . . . 0.0 107.871 177.006 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.1 p -70.68 114.81 9.13 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.924 0.889 . . . . 0.0 108.761 174.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -127.68 5.83 6.15 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.513 1.125 . . . . 0.0 113.173 -175.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 53.83 173.43 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 129.444 3.098 . . . . 0.0 115.428 171.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.7 mt -132.35 130.46 60.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.33 123.7 32.58 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 171.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.8 159.65 47.97 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 123.361 0.505 . . . . 0.0 111.902 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -111.09 164.75 12.51 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.427 1.491 . . . . 0.0 110.648 -169.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -76.03 -13.93 60.22 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.206 1.002 . . . . 0.0 112.336 -177.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 p -152.88 168.86 24.36 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 127.652 2.381 . . . . 0.0 106.959 171.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.9 m -64.76 145.53 98.78 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 169.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.92 65.94 7.67 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 124.554 3.503 . . . . 0.0 110.628 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -52.83 -48.61 66.85 Favored 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 123.912 0.885 . . . . 0.0 112.255 -169.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.8 -36.59 84.8 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.095 0.474 . . . . 0.0 110.95 -173.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -74.43 -41.75 60.31 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.034 0.934 . . . . 0.0 109.848 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.7 t -60.23 -45.32 96.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 172.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -62.19 -50.25 72.55 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.348 1.059 . . . . 0.0 110.402 -177.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.34 -39.2 93.88 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.778 0.717 . . . . 0.0 110.957 -177.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.27 -47.02 84.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.176 -0.327 . . . . 0.0 110.32 175.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -68.05 -24.97 65.14 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 118.354 -0.831 . . . . 0.0 112.362 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -69.78 -32.42 70.9 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.857 1.208 . . . . 0.0 109.544 175.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -72.94 -46.89 49.95 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 173.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mt -64.6 -40.88 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 121.632 -0.668 . . . . 0.0 109.731 -176.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.1 -27.03 67.75 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.528 0.731 . . . . 0.0 111.302 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 51.9 ttm-85 -78.17 -45.26 23.64 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.72 0.808 . . . . 0.0 109.325 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -52.55 -41.24 63.37 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.02 1.328 . . . . 0.0 111.092 177.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.8 m -73.65 81.28 1.53 Allowed 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 169.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 12.8 tpt -56.18 128.66 36.67 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.5 1.12 . . . . 0.0 112.594 -169.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -150.57 117.03 5.73 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 102.808 -3.034 . . . . 0.0 102.808 169.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.94 -35.92 73.92 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.647 0.658 . . . . 0.0 112.376 -169.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -65.54 -43.32 90.29 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.4 m -74.35 -26.51 60.18 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.099 0.56 . . . . 0.0 111.673 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -66.36 -34.78 78.75 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.577 0.626 . . . . 0.0 109.704 177.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.5 mt -84.27 56.6 3.84 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.113 1.365 . . . . 0.0 109.764 172.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 30.5 t60 66.39 134.14 0.04 OUTLIER Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 128.415 2.686 . . . . 0.0 112.647 -169.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -52.96 134.09 54.11 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 123.14 2.56 . . . . 0.0 113.892 -175.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.7 m -74.09 -15.83 61.04 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.935 0.894 . . . . 0.0 112.566 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 67.2 mtt -138.58 154.16 73.06 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 104.649 -2.352 . . . . 0.0 104.649 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 120' ' ' ILE . 84.7 Cg_endo -74.05 138.22 25.22 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.622 1.548 . . . . 0.0 112.356 -168.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.6 t -94.86 101.52 12.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 100.505 -3.887 . . . . 0.0 100.505 167.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -147.12 159.12 43.98 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.51 1.124 . . . . 0.0 109.855 -169.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.3 t -137.48 139.03 44.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.428 1.091 . . . . 0.0 108.161 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.0 m -106.79 152.01 24.41 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.949 1.299 . . . . 0.0 108.666 169.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -149.37 129.54 13.63 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.38 1.472 . . . . 0.0 109.838 -175.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -179.99 155.25 0.59 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.695 1.198 . . . . 0.0 112.468 -169.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.6 m 64.16 151.0 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.818 2.447 . . . . 0.0 112.613 170.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.6 tp -111.36 59.65 0.62 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.996 0.918 . . . . 0.0 109.409 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.31 134.26 50.04 Favored 'General case' 0 CA--C 1.527 0.079 0 C-N-CA 123.566 0.746 . . . . 0.0 109.921 -175.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 54.96 23.46 5.09 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.827 0.851 . . . . 0.0 111.632 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.82 14.29 81.14 Favored Glycine 0 CA--C 1.537 1.427 0 CA-C-O 118.489 -1.173 . . . . 0.0 113.68 -176.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -132.75 149.23 52.3 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.621 1.71 . . . . 0.0 108.708 -171.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -70.4 135.74 49.01 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.034 -1.041 . . . . 0.0 109.665 -175.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.1 156.09 16.75 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 177.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -168.7 176.21 43.03 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 175.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 43.9 m -144.91 151.75 39.17 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 169.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.5 p -118.68 144.26 27.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 169.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.3 145.63 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 170.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.8 p -142.71 175.35 2.96 Favored Pre-proline 0 C--N 1.321 -0.655 0 C-N-CA 125.451 1.5 . . . . 0.0 107.034 169.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.57 -30.1 91.53 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 120.895 1.063 . . . . 0.0 111.44 168.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 48.1 p-90 -95.51 -25.23 16.29 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 118.128 -0.939 . . . . 0.0 113.292 -169.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.89 168.12 28.41 Favored 'General case' 0 C--N 1.343 0.306 0 CA-C-N 120.282 1.401 . . . . 0.0 113.206 -175.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.9 tt -137.32 121.9 18.48 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 168.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 49.1 m -134.13 130.75 37.81 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.198 0.523 . . . . 0.0 109.82 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.38 143.27 53.74 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 168.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.0 m -135.22 150.83 29.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.7 mm -134.06 134.51 55.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -125.8 143.03 43.87 Favored Pre-proline 0 CA--C 1.537 0.442 0 CA-C-O 118.318 -0.849 . . . . 0.0 111.044 -171.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -48.22 129.72 19.43 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.931 3.087 . . . . 0.0 113.829 178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.48 177.02 34.1 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 125.247 1.403 . . . . 0.0 114.489 -171.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -61.86 118.53 5.42 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.854 3.036 . . . . 0.0 112.253 -169.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.5 t70 52.17 29.87 7.05 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.119 1.768 . . . . 0.0 113.602 175.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -82.68 146.94 28.78 Favored 'General case' 0 C--N 1.34 0.195 0 O-C-N 121.435 -0.79 . . . . 0.0 109.021 175.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.7 mp -101.26 82.58 2.36 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -67.3 145.84 98.67 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.531 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -64.6 157.71 53.95 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.274 1.982 . . . . 0.0 109.872 171.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.1 tp -77.07 77.3 3.62 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -64.63 148.18 51.44 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.07 0.548 . . . . 0.0 110.393 -174.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -92.08 151.04 20.63 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 41.1 t -88.43 153.03 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 125.452 1.501 . . . . 0.0 111.131 -168.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.8 m 68.27 7.49 5.96 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.068 1.747 . . . . 0.0 114.116 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -83.28 163.47 20.67 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 168.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -115.41 150.71 35.98 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.202 0.91 . . . . 0.0 111.574 175.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.2 mm -122.61 123.96 69.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -78.21 124.1 6.58 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 108.656 -1.777 . . . . 0.0 108.656 173.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 74.4 mt -116.79 138.22 51.65 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.481 1.112 . . . . 0.0 108.031 173.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -91.21 124.1 35.17 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mp -132.98 156.65 79.85 Favored Pre-proline 0 C--O 1.237 0.43 0 C-N-CA 125.027 1.331 . . . . 0.0 108.162 170.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -67.01 -21.82 48.93 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 CA-C-N 120.625 1.259 . . . . 0.0 112.865 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -55.99 -31.45 63.05 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.816 1.247 . . . . 0.0 111.233 169.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.49 150.92 5.52 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.86 2.171 . . . . 0.0 107.776 -172.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.1 m -64.47 132.58 50.39 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 171.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 54.6 ttm -133.95 130.58 37.9 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -169.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.04 114.13 20.39 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 171.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -89.08 142.93 27.22 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 169.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.6 m -92.3 141.96 27.98 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.27 119.6 23.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 171.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -109.35 167.35 12.86 Favored Glycine 0 CA--C 1.52 0.361 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 169.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -117.57 117.09 28.47 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 169.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.0 119.19 21.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 176.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.34 131.62 51.53 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 122.721 0.408 . . . . 0.0 111.379 -171.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.55 3.56 72.4 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-O 118.968 -0.907 . . . . 0.0 113.526 -178.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.1 t -122.33 -110.58 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.0 m -154.71 173.54 16.27 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 119.776 1.171 . . . . 0.0 109.765 -169.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -66.96 142.24 57.33 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 169.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -154.02 173.19 16.33 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 126.084 1.754 . . . . 0.0 107.429 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.9 mp -109.07 140.0 43.21 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -176.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.0 t -142.08 152.94 43.78 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.489 1.115 . . . . 0.0 109.588 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 35.5 t -149.19 118.43 6.82 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 172.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 12.7 m -71.75 136.16 47.04 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -85.75 -62.96 1.4 Allowed 'General case' 0 C--O 1.231 0.112 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 172.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.92 175.72 5.75 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.529 1.532 . . . . 0.0 108.634 -175.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.1 m -90.29 118.89 69.16 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 169.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -85.92 19.97 1.31 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.562 2.841 . . . . 0.0 112.759 -171.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 17.7 tp -82.18 43.97 0.83 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.922 1.289 . . . . 0.0 111.123 -171.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.1 m -73.02 163.18 28.55 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.92 1.288 . . . . 0.0 110.178 176.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -78.36 -37.01 45.32 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.837 -0.54 . . . . 0.0 110.605 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.5 m -83.83 69.7 10.27 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.591 1.156 . . . . 0.0 108.375 176.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.1 tpt -148.02 154.36 40.16 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.583 1.553 . . . . 0.0 108.735 -171.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 84.3 p -152.59 174.97 13.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.461 1.504 . . . . 0.0 108.202 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.486 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 23.4 pt -66.19 -25.49 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 121.507 -0.746 . . . . 0.0 111.731 170.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -76.67 -45.59 29.1 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -63.05 -31.75 72.96 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.503 170.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.16 -60.79 8.32 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-N 120.16 1.346 . . . . 0.0 110.679 172.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -62.16 -48.71 78.89 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 117.412 0.606 . . . . 0.0 110.779 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 61.1 ttt-85 -61.2 -35.1 76.27 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 123.622 0.769 . . . . 0.0 110.817 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.5 tp -78.35 -23.91 46.71 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 117.607 -1.187 . . . . 0.0 111.407 -178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.47 -46.6 85.43 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 120.88 1.673 . . . . 0.0 109.037 169.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -66.02 -46.77 76.71 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 122.609 0.364 . . . . 0.0 111.251 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -66.2 -33.21 75.25 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 119.248 -0.406 . . . . 0.0 110.778 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 28.4 m -67.07 -36.93 83.08 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.608 0.64 . . . . 0.0 110.435 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.05 -52.23 50.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 173.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 41.1 tpt85 -52.47 -46.03 66.35 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.961 0.905 . . . . 0.0 111.138 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 56.7 ttp -49.39 -52.53 27.89 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.959 1.704 . . . . 0.0 111.145 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 11.0 pt -88.93 -24.79 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 118.743 0.701 . . . . 0.0 112.612 -172.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 76.3 mt -65.56 -38.74 90.44 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.003 0.921 . . . . 0.0 109.074 171.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.3 m 57.77 33.72 23.57 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.441 1.497 . . . . 0.0 114.536 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 7.4 tp 46.26 65.38 6.82 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.894 1.278 . . . . 0.0 113.705 169.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -65.36 144.1 78.96 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.713 2.275 . . . . 0.0 111.751 -171.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.2 m -140.74 178.46 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 126.117 1.767 . . . . 0.0 108.659 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.1 m -49.66 137.06 16.27 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.282 1.433 . . . . 0.0 110.603 173.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -133.35 117.77 14.64 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 124.622 1.169 . . . . 0.0 108.726 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -61.08 141.7 94.85 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.88 2.387 . . . . 0.0 111.331 171.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -139.2 131.86 28.93 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.714 1.606 . . . . 0.0 107.58 172.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 10.8 m -135.02 149.03 69.25 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.53 1.532 . . . . 0.0 109.124 -169.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.01 -22.27 42.0 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.355 2.037 . . . . 0.0 113.977 -169.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -82.22 -9.76 59.38 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.652 0.66 . . . . 0.0 112.653 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.88 125.61 25.39 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.299 0.954 . . . . 0.0 109.144 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 69.09 11.19 63.34 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-O 119.354 -0.692 . . . . 0.0 113.382 -176.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -127.95 46.71 2.51 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.96 1.704 . . . . 0.0 108.983 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -116.66 153.98 31.35 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.234 1.414 . . . . 0.0 108.052 173.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.32 142.78 55.41 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 174.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.68 164.64 36.5 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.749 1.619 . . . . 0.0 108.054 -175.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 26.1 tp 51.39 56.64 7.61 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.634 1.574 . . . . 0.0 110.758 176.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -64.13 146.2 54.63 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.926 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -69.91 150.91 49.74 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 175.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 26.1 ptt-85 -131.81 42.9 3.11 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.679 1.191 . . . . 0.0 110.354 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 56.01 37.48 28.89 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.004 0.922 . . . . 0.0 109.116 -168.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.3 m -58.55 131.2 50.08 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.639 1.176 . . . . 0.0 109.769 -170.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 98.06 -39.52 2.74 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.917 1.246 . . . . 0.0 111.181 -176.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -81.83 -32.39 31.25 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 118.424 1.112 . . . . 0.0 108.673 169.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -120.25 149.34 42.44 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 128.863 2.865 . . . . 0.0 107.86 175.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.205 0 C-N-CA 123.679 0.791 . . . . 0.0 110.525 -177.895 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 119.801 -0.142 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.6 p -75.91 159.83 30.52 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.154 0.982 . . . . 0.0 109.895 177.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -84.45 50.83 1.96 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.344 1.058 . . . . 0.0 111.403 -173.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -54.1 147.31 13.02 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 126.518 1.927 . . . . 0.0 108.843 169.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.3 mp -104.81 118.89 52.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 -174.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.51 119.61 20.59 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 169.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.87 177.6 54.21 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 121.423 0.457 . . . . 0.0 113.694 -175.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -115.67 169.51 9.14 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.985 1.714 . . . . 0.0 110.267 -169.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -72.88 -13.76 61.34 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -174.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.2 p -151.31 174.05 13.77 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 127.867 2.467 . . . . 0.0 106.404 169.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.4 m -61.93 147.69 89.39 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 169.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.53 67.43 6.36 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 124.752 3.635 . . . . 0.0 110.293 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.435 ' HE3' ' O ' ' A' ' 42' ' ' VAL . 45.5 mtpt -52.74 -52.43 56.41 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.513 1.125 . . . . 0.0 112.201 -169.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.01 -38.89 92.74 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 118.762 0.71 . . . . 0.0 110.968 -172.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -69.06 -42.71 75.92 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.746 1.219 . . . . 0.0 109.848 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.6 t -63.04 -42.21 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 174.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -61.36 -52.38 64.89 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.71 -49.47 75.06 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.762 0.825 . . . . 0.0 110.203 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.5 -49.83 75.04 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -70.01 -24.52 63.3 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 117.901 -1.047 . . . . 0.0 112.642 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -66.93 -33.17 74.99 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 120.05 1.296 . . . . 0.0 109.199 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -74.68 -49.09 22.57 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.391 -0.818 . . . . 0.0 109.544 173.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.1 mt -61.85 -30.68 49.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.42 -31.96 64.14 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 124.182 0.993 . . . . 0.0 112.014 173.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 53.6 ttp85 -72.05 -41.23 67.67 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.92 1.236 . . . . 0.0 109.594 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -65.53 -21.38 66.61 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.289 1.035 . . . . 0.0 109.983 168.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.0 m 47.54 52.83 11.94 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 127.455 2.302 . . . . 0.0 108.51 -174.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 46.0 ttm 65.89 -72.79 0.07 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.758 2.023 . . . . 0.0 108.497 -168.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -148.89 4.48 0.65 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.962 1.305 . . . . 0.0 110.973 169.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.15 -15.66 56.59 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 120.842 -1.161 . . . . 0.0 111.878 -174.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 13.7 tp 52.2 40.6 29.21 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.718 2.007 . . . . 0.0 112.371 170.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.7 p -104.07 -44.08 5.1 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.351 1.061 . . . . 0.0 112.031 -169.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -85.16 49.02 1.66 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.091 0.956 . . . . 0.0 110.139 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.1 mt -58.31 130.98 49.25 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 170.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 40.1 t60 52.33 73.85 0.88 Allowed Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.557 1.143 . . . . 0.0 108.147 -169.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -51.56 123.23 11.74 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.461 2.774 . . . . 0.0 112.214 -169.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 m -70.27 -19.31 63.12 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.051 0.941 . . . . 0.0 112.322 -169.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 20.3 mmt -125.69 121.6 24.57 Favored Pre-proline 0 N--CA 1.453 -0.294 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 172.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -50.7 128.69 24.78 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.333 2.022 . . . . 0.0 110.376 169.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.7 m -61.06 147.92 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 169.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -143.78 152.67 41.53 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 120.966 -1.084 . . . . 0.0 109.811 -177.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.435 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 7.1 p -135.89 127.05 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 124.488 1.115 . . . . 0.0 110.79 -175.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.9 m -92.54 146.81 23.39 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.649 1.18 . . . . 0.0 109.421 169.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -119.97 137.96 53.76 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.532 1.533 . . . . 0.0 107.786 169.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.43 ' CE1' ' HB1' ' A' ' 131' ' ' ALA . 29.4 p90 -164.87 146.29 7.84 Favored 'General case' 0 C--O 1.218 -0.569 0 C-N-CA 123.351 0.66 . . . . 0.0 111.715 -176.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.8 m 58.37 154.13 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.826 2.45 . . . . 0.0 115.52 168.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.4 tp -105.75 109.32 21.23 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 169.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -103.04 95.9 6.44 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.258 2.223 . . . . 0.0 108.107 -173.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 55.06 45.73 25.61 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.455 1.102 . . . . 0.0 111.658 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.59 22.44 62.13 Favored Glycine 0 CA--C 1.531 1.085 0 O-C-N 121.853 -0.529 . . . . 0.0 113.315 176.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -136.59 144.56 44.18 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 125.68 1.592 . . . . 0.0 107.121 -177.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -74.33 141.05 45.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 120.514 1.506 . . . . 0.0 109.399 172.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.02 154.68 19.25 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 172.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.84 168.73 35.66 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 175.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 36.1 m -142.42 148.43 37.79 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 p -129.32 135.0 62.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.0 tt -111.23 151.11 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.751 1.22 . . . . 0.0 108.032 171.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.1 p -136.86 175.11 3.74 Favored Pre-proline 0 N--CA 1.444 -0.739 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 172.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.42 -10.6 28.26 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 CA-C-N 121.132 1.44 . . . . 0.0 112.009 169.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -110.16 -25.6 10.1 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -173.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.37 171.48 20.31 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 120.306 1.412 . . . . 0.0 112.368 -175.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.3 tt -136.98 123.03 20.3 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 167.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 53.2 m -130.91 134.79 47.08 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.398 0.679 . . . . 0.0 109.925 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.05 149.4 35.8 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 168.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.9 m -138.74 146.55 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.61 1.164 . . . . 0.0 108.172 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.6 mm -130.76 114.85 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -115.0 146.66 36.65 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.314 1.046 . . . . 0.0 112.229 -168.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -39.08 128.56 1.39 Allowed 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 125.178 3.918 . . . . 0.0 115.256 173.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -78.45 -178.51 49.92 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.219 0.914 . . . . 0.0 114.415 -173.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.02 106.42 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 124.084 3.189 . . . . 0.0 111.7 -169.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.6 t70 50.07 28.39 2.96 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.621 1.568 . . . . 0.0 112.658 -175.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -89.22 142.46 27.63 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -91.69 91.34 7.95 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 31.1 t90 -70.16 131.97 88.46 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.59 153.36 77.75 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 122.387 2.058 . . . . 0.0 111.811 -169.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 50.5 tp -61.77 130.23 44.78 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 169.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 69.8 mtt85 -125.55 156.67 38.7 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.881 0.873 . . . . 0.0 109.097 172.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -89.26 147.92 23.86 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 169.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.3 t -90.14 153.22 3.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 124.572 1.149 . . . . 0.0 110.809 -168.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.9 m 63.81 29.07 14.8 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.856 1.262 . . . . 0.0 112.461 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -104.47 155.3 18.92 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.518 1.927 . . . . 0.0 107.311 169.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -107.43 142.34 37.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.844 0.747 . . . . 0.0 110.191 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 35.4 mm -123.1 128.81 75.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.15 120.86 6.01 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 173.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.3 mt -105.0 139.35 39.81 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 170.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -90.48 129.14 36.68 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 173.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mp -135.79 155.76 77.79 Favored Pre-proline 0 C--O 1.237 0.41 0 C-N-CA 125.151 1.381 . . . . 0.0 107.593 175.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.84 -23.94 68.45 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 121.541 1.494 . . . . 0.0 112.395 173.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -56.71 -30.7 63.75 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.062 1.345 . . . . 0.0 111.733 169.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 133.12 149.7 6.2 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 108.099 -2.0 . . . . 0.0 108.099 -170.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.0 m -64.37 133.34 52.42 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 41.4 ttp -147.2 139.42 24.54 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -171.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.33 134.05 36.61 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 118.747 0.703 . . . . 0.0 109.777 176.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -109.2 130.88 55.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 169.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.6 m -83.02 139.52 33.22 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.3 t -70.48 119.01 15.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 170.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -110.21 158.36 14.5 Favored Glycine 0 CA--C 1.519 0.291 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 171.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -127.83 84.62 2.27 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.2 tp -65.23 125.29 24.56 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -172.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -61.3 136.33 58.01 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.466 0.706 . . . . 0.0 110.418 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.39 2.85 64.3 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.283 -0.731 . . . . 0.0 113.27 -176.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.0 t -128.81 -119.68 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 105.691 -1.966 . . . . 0.0 105.691 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.6 p -163.45 -175.09 4.04 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.166 1.387 . . . . 0.0 108.935 -171.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -70.05 144.81 52.07 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.633 -0.667 . . . . 0.0 110.725 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.38 165.11 36.04 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.717 1.607 . . . . 0.0 109.011 174.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.9 mp -102.7 126.11 49.68 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 174.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.9 m -144.65 156.45 44.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 119.594 1.088 . . . . 0.0 110.858 -170.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 18.8 p -145.37 139.88 27.29 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.453 -0.779 . . . . 0.0 110.008 170.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.3 m -75.14 137.48 41.38 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 171.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 85.2 mt -124.07 -30.16 3.52 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -171.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 14.9 ptp -159.44 167.21 29.27 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.057 0.943 . . . . 0.0 109.28 175.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.5 m -122.69 92.79 48.9 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 124.349 1.059 . . . . 0.0 108.985 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.17 171.36 5.24 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.566 2.844 . . . . 0.0 112.048 172.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 64.0 tp -148.34 133.71 18.54 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 169.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 9.5 m -50.45 -27.41 6.44 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.947 1.699 . . . . 0.0 114.925 -170.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -59.6 -33.29 71.28 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.683 0.674 . . . . 0.0 112.19 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.5 m -106.16 30.22 6.1 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.841 1.256 . . . . 0.0 110.714 -177.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 93.8 mtp -133.94 168.38 18.88 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.628 1.171 . . . . 0.0 110.905 -174.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 81.9 p -151.96 169.15 23.02 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.103 2.161 . . . . 0.0 105.424 169.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.505 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -60.68 -34.38 58.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 O-C-N 121.213 -0.93 . . . . 0.0 109.171 172.215 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -64.54 -45.49 86.91 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 123.601 0.76 . . . . 0.0 110.148 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -67.39 -29.67 69.24 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.369 0.986 . . . . 0.0 110.621 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.27 -37.29 64.5 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.788 -0.57 . . . . 0.0 111.773 169.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -82.69 -54.62 5.0 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.928 -1.337 . . . . 0.0 110.208 174.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 61.0 mtm-85 -67.56 -29.82 69.29 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 118.116 -0.945 . . . . 0.0 113.31 -169.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 16.8 tp -82.89 -27.17 30.89 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 120.525 1.511 . . . . 0.0 109.886 -176.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.2 m -71.19 -40.4 71.24 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 175.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.69 -44.19 82.38 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.224 1.01 . . . . 0.0 111.752 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.36 -39.28 92.62 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 121.175 -0.953 . . . . 0.0 109.752 175.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 37.9 t -63.13 -44.95 94.14 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.43 ' HB1' ' CE1' ' A' ' 45' ' ' PHE . . . -52.34 -50.76 61.69 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.953 1.301 . . . . 0.0 110.897 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 3.0 ptt85 -82.6 -24.47 33.88 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 15.5 tmm? -55.98 -44.31 78.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 118.648 -0.691 . . . . 0.0 109.812 171.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 6.8 pt -81.94 0.3 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 87.3 mt -89.75 -89.75 0.15 Allowed 'General case' 0 C--N 1.342 0.269 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 169.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.0 p -163.63 26.17 0.08 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.038 1.735 . . . . 0.0 110.942 -172.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.4 mt 49.27 45.78 3.16 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 126.956 2.102 . . . . 0.0 116.408 -169.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.71 178.1 3.6 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 122.02 1.813 . . . . 0.0 109.584 168.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.9 p -114.99 139.52 40.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.833 0.853 . . . . 0.0 109.404 173.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 10.2 m -83.21 154.42 24.23 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.636 1.174 . . . . 0.0 109.167 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -117.65 76.99 10.71 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 169.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -71.66 151.91 58.56 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.428 2.085 . . . . 0.0 111.248 -173.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -151.59 129.83 11.98 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.537 1.535 . . . . 0.0 107.769 169.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.4 p -155.88 150.54 20.35 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.842 1.257 . . . . 0.0 108.052 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -53.49 -42.77 63.09 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.717 2.944 . . . . 0.0 113.883 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -155.61 157.96 37.59 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.862 1.265 . . . . 0.0 109.152 172.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -108.6 170.96 7.7 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.938 1.295 . . . . 0.0 109.735 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 74.49 28.06 64.29 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.551 -0.583 . . . . 0.0 113.814 170.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 42.1 ttm105 -139.35 147.33 41.4 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.551 1.141 . . . . 0.0 108.084 172.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.2 mtm180 -67.87 164.67 19.24 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.622 0.369 . . . . 0.0 110.357 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.21 -26.71 65.85 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 122.536 0.334 . . . . 0.0 111.303 171.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -130.09 125.92 36.34 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.999 1.32 . . . . 0.0 109.135 174.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -154.7 124.12 6.46 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 45.8 t80 60.68 171.18 0.09 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.299 1.84 . . . . 0.0 113.156 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 172.33 161.79 23.41 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.255 1.407 . . . . 0.0 110.1 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -141.79 145.73 35.09 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 175.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -71.03 135.26 47.69 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 14.5 m -67.03 153.72 42.96 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.379 0.671 . . . . 0.0 109.887 171.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -174.74 -148.67 6.76 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -68.03 151.6 46.82 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 122.861 0.464 . . . . 0.0 109.817 171.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -70.64 139.46 51.33 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 172.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.222 0 C-N-CA 125.378 1.471 . . . . 0.0 107.966 176.847 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 mmt . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.8 p -75.51 154.45 36.9 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.179 0.992 . . . . 0.0 109.742 173.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -134.45 63.33 1.63 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -175.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -146.24 165.18 29.97 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.666 1.586 . . . . 0.0 110.733 -170.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.8 mt -141.06 134.28 31.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.25 128.25 35.07 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 169.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.97 163.34 47.8 Favored Glycine 0 CA--C 1.537 1.454 0 N-CA-C 112.061 -0.415 . . . . 0.0 112.061 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -73.15 126.77 30.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.463 0.705 . . . . 0.0 109.516 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 17.8 mm100 -67.62 -32.05 72.5 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 119.121 -0.466 . . . . 0.0 110.516 175.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.8 p -150.72 153.9 36.4 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 126.308 1.843 . . . . 0.0 107.857 169.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -56.8 137.95 78.3 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 125.388 1.475 . . . . 0.0 113.108 -169.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -80.34 43.89 1.62 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 124.626 3.551 . . . . 0.0 111.412 174.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -53.52 -45.21 69.67 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.086 1.354 . . . . 0.0 112.257 -169.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.09 -41.86 99.48 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 122.963 0.505 . . . . 0.0 111.606 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -72.48 -40.32 67.03 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -175.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.7 t -60.07 -46.12 94.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 172.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -59.74 -54.93 40.61 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.132 0.573 . . . . 0.0 110.347 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.02 -41.76 97.34 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.467 0.707 . . . . 0.0 110.853 -173.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.54 -39.25 77.59 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 118.511 0.596 . . . . 0.0 110.718 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -67.57 -31.17 71.05 Favored 'General case' 0 N--CA 1.463 0.178 0 O-C-N 121.317 -0.864 . . . . 0.0 111.738 173.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -68.95 -29.39 67.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.321 0.964 . . . . 0.0 111.107 173.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -70.41 -48.64 55.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mt -59.36 -41.89 85.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.566 0.746 . . . . 0.0 109.453 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.99 -23.79 67.32 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.769 0.828 . . . . 0.0 112.862 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -80.72 -45.22 17.44 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 171.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -71.87 -1.46 14.33 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.794 1.238 . . . . 0.0 112.611 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.9 m -59.54 -29.89 68.22 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 119.688 1.131 . . . . 0.0 110.326 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -98.29 46.55 1.0 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.153 1.381 . . . . 0.0 109.865 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -64.8 -13.82 56.94 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -169.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -58.6 -26.63 63.86 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.437 0.695 . . . . 0.0 111.823 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.13 -24.71 0.44 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -178.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.5 m 56.25 7.03 0.29 Allowed 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 116.396 1.998 . . . . 0.0 116.396 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -78.21 -29.58 48.44 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.704 1.138 . . . . 0.0 110.791 173.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.78 153.07 44.46 Favored 'General case' 0 C--N 1.342 0.267 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 172.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -137.74 166.64 24.87 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 125.354 1.462 . . . . 0.0 109.802 -169.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -56.66 -34.84 96.72 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.199 2.599 . . . . 0.0 114.546 -169.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.2 m 61.61 4.81 1.1 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.877 1.671 . . . . 0.0 114.353 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 35.8 tpp -153.97 119.97 2.8 Favored Pre-proline 0 N--CA 1.453 -0.281 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 170.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -55.05 138.86 79.6 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.172 1.915 . . . . 0.0 113.039 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.1 t -75.4 139.23 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 168.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -139.61 154.03 47.48 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.641 0.777 . . . . 0.0 109.88 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.1 t -137.71 119.11 17.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 123.995 0.918 . . . . 0.0 109.265 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.1 m -82.22 143.88 31.06 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 168.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -126.63 134.29 50.79 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.552 1.541 . . . . 0.0 109.258 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -170.6 149.74 3.26 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 123.373 0.669 . . . . 0.0 112.737 -170.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.5 m 55.66 165.53 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 128.739 2.816 . . . . 0.0 116.257 167.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 30.3 mt -116.53 66.46 0.72 Allowed 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.792 1.237 . . . . 0.0 108.705 171.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.12 136.14 42.94 Favored 'General case' 0 N--CA 1.457 -0.083 0 O-C-N 121.726 -0.609 . . . . 0.0 109.599 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 56.74 22.78 7.23 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.792 0.837 . . . . 0.0 111.247 -172.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.29 12.53 83.5 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.658 1.123 . . . . 0.0 113.474 -175.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -121.33 143.86 48.96 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.815 1.646 . . . . 0.0 108.202 -173.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -61.38 133.13 55.47 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 118.318 -0.849 . . . . 0.0 109.154 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.84 157.53 16.24 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 122.207 1.004 . . . . 0.0 108.56 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.75 167.83 39.3 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 56.4 m -141.43 150.56 42.47 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 169.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.91 139.77 50.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 175.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.6 tt -116.46 147.03 20.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 169.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.7 p -138.37 172.2 7.05 Favored Pre-proline 0 N--CA 1.439 -0.979 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 171.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -63.24 -22.63 72.5 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 CA-C-N 119.928 1.01 . . . . 0.0 111.074 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 44.4 p-90 -94.45 -26.27 16.55 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -174.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.94 173.51 12.57 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 120.527 1.512 . . . . 0.0 112.71 -173.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.5 tt -135.43 128.48 31.62 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 167.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 77.7 p -138.03 142.61 40.35 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 122.029 0.919 . . . . 0.0 110.728 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.02 144.41 47.18 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 167.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.9 m -135.39 151.32 30.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 39.9 mt -136.59 139.77 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -116.61 139.66 25.77 Favored Pre-proline 0 C--O 1.234 0.266 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -54.86 131.17 44.56 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 121.629 1.552 . . . . 0.0 109.018 177.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.57 -179.46 27.72 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.509 1.052 . . . . 0.0 114.596 -169.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.16 158.25 41.67 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.365 2.71 . . . . 0.0 111.096 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 26.4 t0 46.04 45.58 12.36 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.795 2.038 . . . . 0.0 113.604 169.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -150.12 147.68 28.05 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.6 mp -104.3 107.26 18.09 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -72.22 157.82 88.62 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.186 -0.916 . . . . 0.0 108.776 169.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.31 166.93 28.63 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.1 1.867 . . . . 0.0 108.972 169.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 61.3 tp -69.2 82.53 0.35 Allowed 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 169.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.0 tpp180 -75.46 139.78 42.47 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -173.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.5 ttpp -90.86 141.89 28.35 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 122.812 1.291 . . . . 0.0 108.175 176.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -68.93 156.08 7.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 127.992 2.517 . . . . 0.0 109.152 174.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.0 m 69.93 0.74 3.18 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 128.336 2.655 . . . . 0.0 114.437 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -81.52 158.02 24.61 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 169.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -110.08 143.09 40.62 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.0 0.52 . . . . 0.0 110.0 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.5 mt -121.08 118.8 57.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -74.61 123.66 7.7 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 108.225 -1.95 . . . . 0.0 108.225 174.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 72.8 mt -125.2 151.76 45.42 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.667 1.187 . . . . 0.0 108.654 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -108.65 128.11 54.56 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.377 1.071 . . . . 0.0 108.753 -175.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.0 mp -137.06 168.95 14.61 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 125.331 1.452 . . . . 0.0 108.641 175.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -58.83 -23.26 66.23 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.366 2.044 . . . . 0.0 113.979 173.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -56.43 -38.32 71.42 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.603 0.761 . . . . 0.0 111.805 170.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.85 -167.55 24.27 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 -169.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.3 m -80.05 135.14 36.28 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 172.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 20.6 ptp -144.16 148.79 35.5 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 169.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.92 128.62 35.68 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 173.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -96.33 128.05 42.89 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 168.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.4 m -77.79 138.95 39.27 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 171.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.9 t -72.2 121.92 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 170.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -103.64 165.76 15.67 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -121.81 127.61 50.77 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.099 -2.185 . . . . 0.0 105.099 169.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.5 tp -141.19 142.61 33.99 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.063 0.847 . . . . 0.0 109.849 -176.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -59.04 135.02 57.49 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.312 0.645 . . . . 0.0 111.023 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.83 -2.12 50.85 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.044 0.831 . . . . 0.0 113.668 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.5 t -125.59 -31.49 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 118.638 1.219 . . . . 0.0 109.91 -173.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.0 m 54.58 -122.71 1.99 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.348 1.059 . . . . 0.0 109.001 -169.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -82.73 130.35 35.11 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.512 1.051 . . . . 0.0 109.861 -169.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -156.25 179.54 9.14 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 126.294 1.838 . . . . 0.0 106.993 176.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.8 mp -119.23 143.15 47.45 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.981 0.913 . . . . 0.0 109.217 -175.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.9 m -139.73 148.52 42.41 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.925 1.29 . . . . 0.0 110.123 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 20.2 t -140.34 110.1 6.4 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 171.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.7 m -73.1 135.91 44.83 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 71.5 mt -121.31 -47.85 2.23 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 119.374 -0.346 . . . . 0.0 111.26 -169.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.24 167.27 29.43 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.63 1.172 . . . . 0.0 108.286 175.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.0 m -123.94 66.9 41.05 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 123.777 0.831 . . . . 0.0 110.194 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.53 136.64 40.17 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.001 2.467 . . . . 0.0 110.433 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 45.9 tp -150.92 63.85 0.92 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 169.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.8 m -65.02 149.1 50.46 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.244 0.618 . . . . 0.0 110.244 -172.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 11.8 p-80 -61.85 135.24 57.5 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.6 m 53.76 31.61 13.28 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.753 1.221 . . . . 0.0 113.472 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 25.2 ptm -66.31 159.0 27.64 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.522 -0.736 . . . . 0.0 110.133 173.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 65.1 p -120.47 169.47 10.29 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.114 1.366 . . . . 0.0 110.369 -174.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.494 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -63.76 -26.01 39.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 121.863 -0.523 . . . . 0.0 109.708 169.584 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -68.18 -43.05 79.03 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.315 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -64.89 -30.08 71.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.308 0.958 . . . . 0.0 110.604 169.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.19 -61.07 7.79 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -61.59 -51.25 69.32 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.809 -0.818 . . . . 0.0 110.534 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 65.6 ttt-85 -63.4 -30.18 71.35 Favored 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 124.226 1.01 . . . . 0.0 111.867 -174.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.7 tp -89.38 -24.81 21.85 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 120.477 1.489 . . . . 0.0 110.294 -177.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 9.6 m -70.32 -40.77 73.97 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 170.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -70.03 -41.95 73.58 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.788 0.835 . . . . 0.0 111.582 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -64.98 -30.33 71.31 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 121.127 -0.983 . . . . 0.0 110.217 172.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 37.0 t -66.3 -45.89 78.81 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.931 0.787 . . . . 0.0 109.053 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -54.39 -51.1 65.9 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.473 1.109 . . . . 0.0 109.79 174.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -58.21 -54.77 43.25 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 123.115 0.566 . . . . 0.0 110.19 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 50.9 ttp -47.17 -41.4 17.78 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.867 1.667 . . . . 0.0 112.012 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 5.9 pt -86.12 -14.55 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.278 0.944 . . . . 0.0 113.433 -176.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.6 pp -143.04 75.48 1.48 Allowed 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.461 1.504 . . . . 0.0 108.457 174.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.8 m -66.21 56.35 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 129.739 3.216 . . . . 0.0 113.104 -177.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 95.4 mt -141.84 169.7 10.62 Favored Pre-proline 0 C--N 1.321 -0.649 0 C-N-CA 130.577 3.551 . . . . 0.0 106.756 -175.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.92 123.68 14.04 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.203 1.936 . . . . 0.0 109.214 169.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.0 p -76.14 148.29 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -177.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 97.1 m -102.57 117.31 34.4 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -177.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -142.92 97.61 5.8 Favored Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 170.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.61 179.59 6.35 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.578 2.185 . . . . 0.0 109.85 170.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -75.24 82.42 2.38 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 169.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.3 t -64.91 147.03 98.63 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 123.748 0.819 . . . . 0.0 110.6 -169.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -56.64 170.33 1.38 Allowed 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 124.532 3.488 . . . . 0.0 112.009 168.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 76.0 t60 -61.34 151.54 31.87 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.959 0.504 . . . . 0.0 110.396 177.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -92.05 -138.89 0.18 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.223 1.409 . . . . 0.0 109.521 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 74.42 25.89 69.33 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 121.705 -0.622 . . . . 0.0 112.654 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 -85.35 162.97 18.84 Favored 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.271 1.028 . . . . 0.0 109.919 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 23.1 tpt85 -142.54 124.51 15.25 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -92.54 135.35 34.14 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 105.119 -2.178 . . . . 0.0 105.119 168.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.32 169.33 22.28 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.231 1.012 . . . . 0.0 110.27 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 57.3 tp -138.16 126.85 23.65 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 169.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -91.73 156.18 17.75 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.372 0.669 . . . . 0.0 109.927 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -173.02 161.14 32.2 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 77.1 mtm180 -137.07 145.35 43.86 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.326 1.45 . . . . 0.0 107.87 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 51.6 ttt85 -77.86 -36.02 50.36 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 122.326 0.25 . . . . 0.0 110.834 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 13.0 m -69.26 143.57 53.86 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.419 0.688 . . . . 0.0 110.747 -175.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -73.14 154.95 50.1 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 169.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -150.96 150.02 30.3 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.844 1.258 . . . . 0.0 107.94 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -68.09 138.18 55.56 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 122.637 0.375 . . . . 0.0 110.223 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.269 0 C-N-CA 125.555 1.542 . . . . 0.0 107.955 174.916 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 tpt . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.8 p -71.27 -25.77 62.6 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.166 -0.959 . . . . 0.0 112.145 -176.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -82.68 35.6 0.47 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.972 1.309 . . . . 0.0 111.28 -177.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -140.83 160.83 39.22 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.946 1.698 . . . . 0.0 109.207 -174.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.7 mt -119.66 136.57 56.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 171.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.7 146.82 54.2 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.87 135.53 17.03 Favored Glycine 0 C--N 1.336 0.557 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 170.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -96.4 138.64 33.69 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.863 0.865 . . . . 0.0 109.056 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -71.78 -37.38 70.45 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.0 p -157.48 168.54 27.01 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 129.732 3.213 . . . . 0.0 106.31 169.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.9 m -51.91 130.57 38.84 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.736 0.814 . . . . 0.0 111.498 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -77.01 63.66 7.67 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 125.179 3.919 . . . . 0.0 111.525 -176.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -52.97 -51.62 60.9 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.739 0.815 . . . . 0.0 111.497 -171.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.78 -39.76 91.32 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 123.315 0.384 . . . . 0.0 110.79 -170.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -67.17 -47.01 72.28 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.646 0.778 . . . . 0.0 109.903 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.0 t -63.06 -40.37 88.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -62.46 -53.17 58.76 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.743 0.817 . . . . 0.0 109.831 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.03 -40.51 97.96 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 118.47 0.577 . . . . 0.0 110.759 -176.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.71 -50.5 73.24 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -71.7 -24.09 61.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 118.033 -0.984 . . . . 0.0 112.597 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -66.58 -33.8 76.48 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 120.267 1.394 . . . . 0.0 110.273 172.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -74.38 -47.19 35.62 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.0 mt -61.05 -40.73 86.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.22 -28.38 69.33 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.587 0.755 . . . . 0.0 112.189 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -70.81 -44.19 67.07 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 172.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -72.16 -7.48 49.36 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.628 1.171 . . . . 0.0 112.51 -175.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 7.8 m -70.22 0.15 6.85 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.569 1.148 . . . . 0.0 112.09 168.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 6.2 tpt 64.44 23.92 13.05 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.956 1.702 . . . . 0.0 113.432 171.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -144.85 146.19 31.95 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.641 1.576 . . . . 0.0 106.842 169.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 39.7 t0 51.13 38.7 21.61 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 122.816 1.293 . . . . 0.0 111.103 -169.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -87.67 0.07 56.2 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.848 1.659 . . . . 0.0 112.768 -175.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.9 m -63.36 161.91 13.25 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.574 1.55 . . . . 0.0 112.677 -170.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -73.63 -19.92 60.72 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.46 0.704 . . . . 0.0 112.026 177.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.1 mt -68.15 167.7 13.63 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.047 0.939 . . . . 0.0 109.728 173.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -60.9 146.05 87.84 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -65.95 154.99 71.7 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.411 2.074 . . . . 0.0 111.247 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.7 m -65.71 -28.45 69.07 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.893 0.877 . . . . 0.0 111.998 -178.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 16.7 ptp -149.16 103.76 3.34 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 173.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -47.3 134.93 19.95 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 124.212 3.275 . . . . 0.0 114.435 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.7 t -61.75 137.49 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 169.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -149.71 159.27 44.48 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.926 0.89 . . . . 0.0 109.487 -175.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.7 t -136.87 141.05 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.1 m -110.79 152.25 26.86 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.227 1.411 . . . . 0.0 108.788 169.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -120.52 143.29 48.65 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 127.248 2.219 . . . . 0.0 110.813 -176.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -145.98 173.35 12.24 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.608 1.163 . . . . 0.0 111.651 -172.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.5 t -52.17 160.31 0.79 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.92 2.088 . . . . 0.0 115.323 -168.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -75.66 106.01 6.99 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 169.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -75.98 -53.98 7.56 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -168.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.91 -42.86 0.74 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.344 1.858 . . . . 0.0 110.226 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.55 -0.21 0.09 OUTLIER Glycine 0 CA--C 1.534 1.256 0 C-N-CA 127.82 2.629 . . . . 0.0 110.684 175.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -137.39 134.94 36.49 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 119.247 1.523 . . . . 0.0 109.112 -170.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -60.64 152.27 26.86 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.861 0.864 . . . . 0.0 110.337 170.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.23 163.2 12.58 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.301 1.04 . . . . 0.0 109.732 172.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.47 170.92 41.28 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 171.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 7.0 m -140.5 131.04 25.44 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.4 p -103.5 149.2 7.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 173.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 13.7 tt -131.19 149.65 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 169.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.401 ' HB ' ' HD2' ' A' ' 59' ' ' PRO . 30.8 p -139.74 175.75 3.01 Favored Pre-proline 0 N--CA 1.444 -0.764 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 172.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 58' ' ' THR . 37.4 Cg_endo -63.13 -19.67 69.34 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 CA-C-N 120.528 1.224 . . . . 0.0 111.145 168.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.0 p-90 -102.73 -24.43 13.74 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -172.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.68 170.35 22.58 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.547 1.521 . . . . 0.0 112.806 -175.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.0 tt -137.41 125.84 23.44 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 168.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.8 m -138.26 133.2 32.83 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.359 0.599 . . . . 0.0 110.256 -176.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.93 144.78 52.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 168.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 m -139.46 149.17 22.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 124.14 0.976 . . . . 0.0 108.565 -176.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 22.2 mt -143.38 141.54 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -170.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -134.79 138.23 29.23 Favored Pre-proline 0 N--CA 1.468 0.468 0 CA-C-O 117.839 -1.077 . . . . 0.0 110.517 -170.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -48.4 139.44 22.53 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.718 2.945 . . . . 0.0 112.548 173.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -68.38 175.79 28.56 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 123.974 0.797 . . . . 0.0 113.856 -174.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.4 140.65 44.58 Favored 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 122.818 2.345 . . . . 0.0 110.095 -174.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.6 t70 50.94 34.92 11.36 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.518 1.527 . . . . 0.0 113.31 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -132.55 131.81 41.94 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.124 1.37 . . . . 0.0 107.522 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.37 99.64 9.34 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -175.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.79 145.15 97.8 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 169.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.36 148.52 61.37 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 121.606 1.537 . . . . 0.0 109.898 171.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.4 tp -63.21 140.06 58.83 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.72 158.69 25.97 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.826 0.739 . . . . 0.0 109.355 174.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.43 140.52 44.72 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 169.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 27.1 t -79.48 159.24 4.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 124.422 1.089 . . . . 0.0 109.038 -169.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.0 m 63.7 23.32 13.46 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.941 1.296 . . . . 0.0 112.92 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -100.57 154.56 18.47 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.226 1.811 . . . . 0.0 107.516 169.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -111.19 141.22 44.99 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.434 0.561 . . . . 0.0 110.666 -177.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 23.7 mm -112.87 128.62 69.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 176.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.42 118.97 5.42 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 173.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.4 tp -108.04 143.61 36.52 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 172.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -105.05 125.49 51.04 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.6 mp -135.77 157.54 75.91 Favored Pre-proline 0 C--O 1.234 0.265 0 C-N-CA 125.25 1.42 . . . . 0.0 107.288 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -66.59 -22.82 50.48 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 CA-C-N 120.609 1.253 . . . . 0.0 112.853 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -54.87 -35.98 64.63 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.592 1.157 . . . . 0.0 111.156 169.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 145.85 157.27 7.21 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 108.026 -2.03 . . . . 0.0 108.026 -173.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.1 m -67.45 133.41 49.49 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 171.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 58.6 ttm -140.72 128.36 21.54 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 -170.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.69 132.97 38.43 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 173.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -108.14 130.39 55.12 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 169.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.5 m -80.72 142.37 33.92 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.102 0.961 . . . . 0.0 108.554 177.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 75.7 t -76.45 118.92 23.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 169.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -105.33 161.45 14.71 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 170.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -128.93 93.81 3.69 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 170.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.9 tp -79.33 127.8 32.53 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -169.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.0 133.78 56.42 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.149 0.58 . . . . 0.0 110.397 -176.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.14 3.47 69.58 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-O 118.635 -1.092 . . . . 0.0 113.473 -177.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.6 t -124.81 -118.68 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.8 t -159.6 -169.27 2.52 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.024 1.33 . . . . 0.0 108.025 -176.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -70.36 143.86 51.8 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.275 0.559 . . . . 0.0 109.688 169.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.78 173.79 16.28 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.176 1.79 . . . . 0.0 107.508 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.7 mp -108.42 142.69 38.41 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 176.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 21.9 p -142.48 155.42 45.06 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.942 0.897 . . . . 0.0 110.579 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 41.9 t -144.85 116.43 8.12 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 172.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.3 m -69.49 133.03 47.21 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.0 mt -102.08 -66.58 0.91 Allowed 'General case' 0 C--O 1.232 0.179 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -175.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.93 164.08 25.97 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.963 0.905 . . . . 0.0 109.753 176.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.9 m -75.49 126.9 87.0 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 169.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -87.23 -11.35 5.27 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.117 2.544 . . . . 0.0 113.545 -174.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 56.8 tp -70.61 113.49 7.77 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.054 0.843 . . . . 0.0 110.048 -171.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 52.1 m -145.03 168.09 21.12 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.337 2.255 . . . . 0.0 106.877 173.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -71.94 -32.0 66.89 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.453 -0.779 . . . . 0.0 110.337 173.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.6 m -80.81 75.36 7.75 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 169.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.6 tpt -152.38 149.9 29.11 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.418 1.487 . . . . 0.0 108.207 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 92.3 p -155.37 174.71 14.84 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.288 1.435 . . . . 0.0 107.827 173.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 41.8 pt -67.43 -24.32 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 O-C-N 121.582 -0.698 . . . . 0.0 111.518 169.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -75.4 -44.58 43.93 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -62.76 -34.51 77.37 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.869 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.35 -52.27 54.2 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 120.196 1.362 . . . . 0.0 111.636 176.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -72.38 -36.97 68.83 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 117.574 0.687 . . . . 0.0 111.268 -177.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 22.9 tpp85 -66.46 -34.42 77.89 Favored 'General case' 0 C--N 1.339 0.11 0 O-C-N 121.053 -1.03 . . . . 0.0 109.823 175.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 21.4 tp -84.38 -24.94 29.45 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 116.948 -1.501 . . . . 0.0 111.684 -175.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.7 p -66.26 -44.41 83.71 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 121.794 2.088 . . . . 0.0 108.283 169.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -62.42 -50.45 71.47 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 122.773 0.429 . . . . 0.0 111.547 176.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -64.21 -34.5 78.24 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 118.758 -0.639 . . . . 0.0 110.534 -178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 32.9 m -69.25 -39.5 78.43 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.524 0.602 . . . . 0.0 111.109 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.3 -50.74 62.63 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 175.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -59.51 -46.58 88.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 118.738 -0.649 . . . . 0.0 111.582 -176.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 50.6 ttp -39.55 -48.81 2.1 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.204 1.801 . . . . 0.0 111.23 169.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 23.6 pt -92.09 -20.74 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 118.776 0.716 . . . . 0.0 112.719 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.2 mt -61.65 -44.94 96.03 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 119.26 0.936 . . . . 0.0 109.039 171.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.9 m 51.08 36.65 15.98 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.13 0.972 . . . . 0.0 111.743 -171.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.3 tp -55.9 134.39 73.25 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 125.329 1.452 . . . . 0.0 112.767 -169.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -60.59 163.2 16.01 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.169 2.579 . . . . 0.0 112.366 169.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.5 p -63.78 145.55 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 172.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 4.7 m -63.09 142.73 58.27 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.835 0.854 . . . . 0.0 110.187 -177.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -132.6 112.76 13.97 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 172.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -80.47 37.56 0.69 Allowed 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.843 3.029 . . . . 0.0 112.668 -173.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -152.77 141.42 20.91 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 126.21 1.804 . . . . 0.0 108.317 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.5 p -153.2 149.1 20.92 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 124.998 1.319 . . . . 0.0 108.397 176.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -55.04 167.25 1.74 Allowed 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.979 3.119 . . . . 0.0 112.695 169.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -59.82 132.88 55.32 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 169.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -147.75 160.54 42.61 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 124.568 1.147 . . . . 0.0 109.805 -172.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 73.07 -179.08 39.56 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 123.788 0.709 . . . . 0.0 112.233 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -151.37 158.32 43.6 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.4 1.48 . . . . 0.0 109.06 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -73.66 -52.21 14.09 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . 46.87 39.79 8.02 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.587 1.555 . . . . 0.0 112.617 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 97.0 mt -82.61 149.53 27.37 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.194 0.597 . . . . 0.0 109.508 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 63.0 tp -140.07 115.82 10.2 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 171.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -89.24 -22.46 22.73 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.807 0.443 . . . . 0.0 112.08 -172.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.43 -155.96 49.02 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 -175.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -133.58 141.67 47.79 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 172.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 26.2 mtp-105 -117.39 3.4 12.52 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.606 0.762 . . . . 0.0 113.018 -173.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 11.6 m 61.02 173.45 0.1 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.625 1.57 . . . . 0.0 112.934 -175.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 65.92 28.97 74.11 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 119.59 -0.561 . . . . 0.0 112.458 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 54.07 52.09 13.41 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.794 1.237 . . . . 0.0 109.468 -170.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 57.9 t30 51.26 62.04 2.92 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 126.392 1.877 . . . . 0.0 111.29 -173.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.252 0 C-N-CA 124.24 1.016 . . . . 0.0 111.167 -175.571 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.3 m -66.79 146.21 54.68 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.074 0.95 . . . . 0.0 108.923 176.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -82.85 27.56 0.53 Allowed 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.399 -0.813 . . . . 0.0 111.307 -178.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -142.82 157.47 44.58 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.279 1.831 . . . . 0.0 109.32 -174.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.3 mm -127.92 128.59 69.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 126.773 2.029 . . . . 0.0 105.636 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.37 133.9 35.97 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 172.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -72.83 -179.14 35.46 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.159 0.885 . . . . 0.0 112.795 176.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -119.04 156.88 28.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.934 1.294 . . . . 0.0 112.23 -169.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -72.0 -30.4 65.19 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.137 0.975 . . . . 0.0 111.547 -178.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.4 p -158.57 -175.17 5.16 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 130.477 3.511 . . . . 0.0 105.537 172.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.1 m -56.95 146.44 59.46 Favored Pre-proline 0 CA--C 1.545 0.75 0 O-C-N 120.959 -1.088 . . . . 0.0 109.295 169.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -71.14 56.64 2.03 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 124.439 3.426 . . . . 0.0 109.945 169.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 42' ' ' VAL . 27.8 tttm -47.22 -50.93 20.0 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 126.667 1.987 . . . . 0.0 113.623 -168.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.6 -41.06 96.48 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.187 0.903 . . . . 0.0 111.567 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -70.96 -40.18 72.13 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.193 0.597 . . . . 0.0 109.768 -177.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 94.0 t -60.11 -44.9 96.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 172.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -60.78 -55.81 28.65 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 118.744 0.702 . . . . 0.0 110.368 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.65 -41.07 98.27 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 118.418 0.553 . . . . 0.0 110.826 -173.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.73 -51.81 60.43 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -67.41 -28.74 68.16 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 118.161 -0.923 . . . . 0.0 111.648 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -66.72 -37.58 84.98 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 119.76 1.164 . . . . 0.0 110.108 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -72.79 -42.47 63.87 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.858 0.753 . . . . 0.0 109.23 178.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.7 mt -62.84 -45.59 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.84 -38.48 85.62 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 123.512 0.725 . . . . 0.0 111.054 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.4 ttt-85 -68.25 -48.73 64.29 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -175.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -41.77 71.58 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.26 1.024 . . . . 0.0 110.674 175.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 48.1 m -65.2 -42.36 93.62 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.538 1.063 . . . . 0.0 111.371 174.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -66.61 -20.4 65.99 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.483 0.713 . . . . 0.0 112.398 -175.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -60.28 -21.18 61.63 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.098 -1.001 . . . . 0.0 112.595 173.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -58.11 -24.76 59.93 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.144 0.884 . . . . 0.0 111.99 176.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.4 pp -120.58 27.27 8.65 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.486 1.514 . . . . 0.0 111.238 175.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.8 m 66.33 18.33 10.87 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.362 1.865 . . . . 0.0 114.009 171.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -82.7 97.57 8.62 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 169.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.6 mt -69.51 -18.04 63.64 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.161 0.984 . . . . 0.0 112.436 175.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 49.9 t60 -135.76 140.13 32.77 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 125.345 1.458 . . . . 0.0 107.743 174.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.15 120.21 6.45 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.656 2.237 . . . . 0.0 110.385 -176.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.4 m -75.78 -18.22 59.6 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.162 0.585 . . . . 0.0 112.435 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -103.88 115.88 62.63 Favored Pre-proline 0 C--O 1.235 0.302 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 173.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -62.82 117.66 4.56 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.326 2.017 . . . . 0.0 111.939 -177.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 36.1 t -61.47 127.59 21.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 169.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -139.02 149.3 44.49 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 124.066 0.947 . . . . 0.0 109.078 -174.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.447 ' O ' ' HE2' ' A' ' 13' ' ' LYS . 2.5 p -139.71 131.13 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 125.71 1.604 . . . . 0.0 109.5 -176.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 p -108.61 151.46 26.09 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.276 0.63 . . . . 0.0 109.81 169.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -116.24 142.63 46.58 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.596 1.959 . . . . 0.0 109.337 -172.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -147.58 167.42 24.57 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -168.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.5 m -4.4 132.09 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.446 1 C-N-CA 133.537 4.735 . . . . 0.0 118.319 169.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.0 tp -81.13 99.22 8.41 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 168.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -86.41 -55.46 3.89 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.337 0.517 . . . . 0.0 111.525 -169.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -140.96 71.55 1.37 Allowed 'General case' 0 C--O 1.233 0.201 0 C-N-CA 125.495 1.518 . . . . 0.0 108.316 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 64.14 16.32 59.81 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.677 0.656 . . . . 0.0 112.946 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -146.27 142.51 28.41 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.438 1.895 . . . . 0.0 107.077 -170.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -81.73 155.38 25.53 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.298 1.039 . . . . 0.0 109.785 174.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.4 162.28 13.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.229 1.014 . . . . 0.0 109.343 169.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.52 161.53 34.99 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 107.207 -2.357 . . . . 0.0 107.207 171.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 60.9 m -133.52 149.22 51.7 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 169.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.7 p -131.63 149.14 32.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 173.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.2 tt -130.56 150.78 34.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 124.899 1.279 . . . . 0.0 107.798 173.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.8 p -143.54 174.78 3.29 Favored Pre-proline 0 N--CA 1.443 -0.776 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -62.05 -21.42 72.37 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 CA-C-N 120.067 1.06 . . . . 0.0 111.619 168.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 42.5 p-90 -100.25 -26.46 13.91 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -172.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.61 172.15 17.66 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 120.285 1.402 . . . . 0.0 112.379 -174.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 tt -132.63 128.51 37.26 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 168.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 78.1 p -140.57 143.19 35.17 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 122.273 1.035 . . . . 0.0 110.839 177.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.16 143.78 35.11 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 167.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.4 m -132.87 144.44 36.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 125.061 1.345 . . . . 0.0 108.055 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 30.2 mt -141.45 143.92 26.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 C-N-CA 124.837 1.255 . . . . 0.0 107.901 -169.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -141.54 144.04 31.98 Favored Pre-proline 0 N--CA 1.467 0.382 0 CA-C-O 117.552 -1.213 . . . . 0.0 108.92 -172.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -63.13 150.26 89.11 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.178 1.919 . . . . 0.0 111.815 174.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -73.97 -179.38 39.75 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.472 1.034 . . . . 0.0 114.31 -172.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -62.14 126.53 18.88 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.001 2.467 . . . . 0.0 111.783 -170.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.3 t70 50.5 31.08 5.19 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.47 1.508 . . . . 0.0 113.249 175.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -87.0 141.97 28.28 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 171.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -103.48 90.99 3.85 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -71.94 159.58 85.06 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.363 169.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -68.77 166.45 26.17 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.448 2.099 . . . . 0.0 110.644 172.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 63.2 tp -69.26 95.54 0.78 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 170.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -74.98 146.52 41.6 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -102.48 159.64 15.26 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 122.404 1.097 . . . . 0.0 108.646 169.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 90.6 t -83.48 153.14 3.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 113.674 -1.603 . . . . 0.0 108.09 -169.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.9 m 65.84 6.46 3.99 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.905 1.682 . . . . 0.0 114.078 -176.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -80.68 161.56 24.58 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.468 1.107 . . . . 0.0 108.738 169.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -118.97 143.22 47.17 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.602 -0.686 . . . . 0.0 110.586 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.0 mp -113.84 127.16 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 170.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.29 120.18 5.52 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 108.572 -1.811 . . . . 0.0 108.572 171.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.5 mt -111.05 129.05 56.03 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -79.49 131.01 35.93 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 169.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.7 mt -140.99 155.04 68.94 Favored Pre-proline 0 C--N 1.332 -0.182 0 C-N-CA 125.69 1.596 . . . . 0.0 107.181 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -64.32 -22.81 66.13 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.058 1.839 . . . . 0.0 112.51 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -62.02 -26.48 68.26 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.149 1.38 . . . . 0.0 112.221 170.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 123.75 148.71 7.58 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -169.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.3 m -63.47 131.31 47.74 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 41.9 ttp -149.68 143.32 25.4 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -172.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.03 138.98 34.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 121.702 -0.623 . . . . 0.0 110.48 176.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -110.35 136.15 49.97 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 168.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.4 m -91.85 142.39 27.63 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -177.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.9 t -75.31 121.72 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 172.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -109.54 171.86 15.51 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 107.518 -2.233 . . . . 0.0 107.518 168.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -118.28 118.29 31.41 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 168.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.9 tp -74.45 131.27 40.91 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -58.9 123.36 16.25 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 122.607 0.363 . . . . 0.0 110.89 -170.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.99 8.1 84.65 Favored Glycine 0 CA--C 1.535 1.317 0 CA-C-O 118.672 -1.071 . . . . 0.0 113.994 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.1 t -126.03 -120.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 119.204 1.502 . . . . 0.0 107.914 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.4 m -148.05 -175.7 4.99 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.725 1.61 . . . . 0.0 109.912 -169.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -58.65 145.19 40.73 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.797 0.839 . . . . 0.0 110.542 172.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.12 165.37 35.85 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.572 1.949 . . . . 0.0 107.721 172.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.7 mp -105.33 139.45 39.95 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.7 m -140.28 153.43 46.49 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.891 0.877 . . . . 0.0 110.379 -176.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 41.2 t -143.43 118.04 9.79 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 169.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.8 m -69.72 133.42 47.48 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 174.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.6 mt -106.36 -65.35 1.08 Allowed 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.432 0.693 . . . . 0.0 109.513 -172.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -145.1 161.3 39.79 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.64 1.176 . . . . 0.0 108.982 -177.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.4 m -97.47 109.38 50.01 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 169.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.14 174.28 13.07 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.144 2.562 . . . . 0.0 111.002 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 65.3 tp -59.57 133.83 56.45 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 169.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.8 p -95.79 -28.4 14.77 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -169.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -135.88 156.58 48.55 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 125.222 1.409 . . . . 0.0 109.663 -172.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.5 m 52.68 43.12 31.65 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.726 0.81 . . . . 0.0 110.558 -173.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -130.23 129.6 43.55 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 -171.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 38.8 m -113.32 171.36 7.61 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 122.631 1.205 . . . . 0.0 113.916 -168.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.47 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -63.87 -22.55 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 124.552 1.141 . . . . 0.0 112.262 -172.847 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -69.13 -46.97 66.3 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 119.393 0.997 . . . . 0.0 108.892 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.98 -39.95 83.33 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.63 1.104 . . . . 0.0 109.0 169.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -51.68 -35.18 37.54 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 123.821 0.724 . . . . 0.0 112.973 175.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -95.61 -54.05 3.51 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.876 1.338 . . . . 0.0 110.77 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -67.07 -33.04 74.64 Favored 'General case' 0 C--O 1.227 -0.094 0 C-N-CA 124.594 1.158 . . . . 0.0 112.301 -169.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.2 mt -77.9 -39.41 43.13 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 119.351 0.978 . . . . 0.0 109.073 -177.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.8 m -60.77 -47.18 87.49 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.535 1.134 . . . . 0.0 109.376 176.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.64 -48.53 80.43 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 124.58 1.152 . . . . 0.0 111.393 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -60.41 -40.17 90.01 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 122.614 0.365 . . . . 0.0 110.291 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 73.0 m -66.81 -24.0 66.12 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -73.18 -53.97 9.63 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.381 170.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -59.41 -37.91 79.24 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 121.306 1.866 . . . . 0.0 110.268 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 61.0 ttp -44.66 -35.9 2.85 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.987 172.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 9.0 pt -112.73 1.68 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 124.508 1.123 . . . . 0.0 113.04 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -126.19 66.86 1.21 Allowed 'General case' 0 C--O 1.233 0.199 0 C-N-CA 128.397 2.679 . . . . 0.0 105.278 175.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.5 m -71.29 32.94 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.348 1.459 . . . . 0.0 113.148 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -153.06 156.45 32.69 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 127.972 2.509 . . . . 0.0 109.171 -175.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -59.08 139.93 92.84 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.008 2.472 . . . . 0.0 112.5 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.2 p -74.63 -39.22 46.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.641 0.776 . . . . 0.0 109.901 173.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 8.4 m -73.52 137.06 44.18 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.586 0.754 . . . . 0.0 109.098 -175.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -146.54 118.64 4.89 Favored Pre-proline 0 C--O 1.236 0.378 0 CA-C-O 117.911 -1.042 . . . . 0.0 108.356 173.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -61.07 149.67 87.98 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.644 2.229 . . . . 0.0 112.11 176.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -77.55 118.21 19.75 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 172.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.8 t -145.17 149.68 42.56 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -51.23 -33.54 45.17 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 124.751 3.634 . . . . 0.0 115.152 173.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 64.0 t-80 -143.31 151.36 40.41 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.055 1.342 . . . . 0.0 107.592 175.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.89 139.87 57.86 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 122.779 0.431 . . . . 0.0 110.046 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -74.1 -26.96 67.3 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 119.642 -0.532 . . . . 0.0 112.542 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 78.9 mtp85 50.58 43.04 27.54 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.229 1.412 . . . . 0.0 111.582 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -69.66 153.42 43.43 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -79.46 -4.4 51.02 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.532 0.733 . . . . 0.0 112.62 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -145.42 160.23 41.87 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.892 1.677 . . . . 0.0 109.969 -176.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -88.0 122.38 31.53 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 169.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -106.37 145.84 31.19 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.427 1.091 . . . . 0.0 109.044 175.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -67.24 144.01 43.81 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -175.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 78.4 ttt-85 -63.64 137.95 58.3 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 48.72 38.49 11.75 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.697 1.199 . . . . 0.0 111.072 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 6.6 m 55.15 20.8 3.54 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.121 1.368 . . . . 0.0 114.296 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 68.77 17.8 71.62 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 121.477 -0.764 . . . . 0.0 112.961 -177.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -64.92 139.35 58.75 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 118.629 1.214 . . . . 0.0 109.435 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -69.97 139.24 52.8 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.066 0.546 . . . . 0.0 110.596 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 C-N-CA 125.618 1.567 . . . . 0.0 107.855 174.954 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.3 m -67.92 140.6 56.48 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.954 0.902 . . . . 0.0 109.364 178.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -151.13 156.92 42.01 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.21 1.404 . . . . 0.0 108.585 173.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 35.59 75.74 0.06 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 128.161 2.584 . . . . 0.0 112.218 169.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.7 mt -71.12 129.27 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 126.085 1.754 . . . . 0.0 108.943 -169.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.02 129.79 40.98 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -90.33 143.44 16.91 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 169.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -116.2 173.16 6.74 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.801 1.24 . . . . 0.0 111.897 -169.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -72.39 -11.28 60.62 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.743 1.617 . . . . 0.0 112.173 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 p -148.19 157.55 43.57 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.991 1.717 . . . . 0.0 107.991 170.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 m -62.68 158.29 52.17 Favored Pre-proline 0 CA--C 1.545 0.76 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 169.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.31 55.32 4.07 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.679 3.586 . . . . 0.0 111.328 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -50.08 -49.46 51.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.95 2.1 . . . . 0.0 112.073 -169.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.55 -42.12 83.15 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 122.513 0.325 . . . . 0.0 111.24 -176.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -70.53 -39.31 74.11 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -176.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.4 t -58.91 -46.99 91.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 171.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 -62.31 -50.97 69.55 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-O 118.969 -0.538 . . . . 0.0 110.885 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.34 -38.5 90.32 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.772 0.714 . . . . 0.0 111.073 -175.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.93 -49.38 75.01 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 175.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -66.91 -28.11 68.04 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 118.398 -0.811 . . . . 0.0 112.402 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -66.58 -37.88 85.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.554 1.07 . . . . 0.0 110.074 174.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -73.41 -41.61 63.09 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.626 -0.671 . . . . 0.0 109.35 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.8 mt -60.68 -45.83 96.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.21 -31.84 72.42 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.673 0.789 . . . . 0.0 112.045 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 67.8 ttp85 -65.73 -38.46 89.21 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -86.23 -13.46 46.79 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.169 1.387 . . . . 0.0 112.646 -175.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.1 m -59.73 -42.74 93.8 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.686 1.13 . . . . 0.0 111.629 176.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.5 mmt 45.06 52.7 8.23 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.896 1.278 . . . . 0.0 111.655 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -65.26 -22.99 66.93 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 122.001 -0.437 . . . . 0.0 111.017 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -120.12 138.27 53.67 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 104.433 -2.432 . . . . 0.0 104.433 168.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 45.3 mt -75.55 -0.03 18.94 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -169.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.0 m -123.76 22.31 9.01 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.781 1.632 . . . . 0.0 110.582 171.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -58.82 -43.25 90.59 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.726 0.811 . . . . 0.0 111.257 -178.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.8 mt 51.25 -117.95 1.19 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.508 1.523 . . . . 0.0 111.271 178.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 31.3 t-80 -74.54 140.25 75.22 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 118.998 0.817 . . . . 0.0 110.145 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.83 69.17 2.26 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.341 2.694 . . . . 0.0 112.51 170.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.2 m -70.68 -21.53 62.58 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.578 1.151 . . . . 0.0 111.521 170.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 61.0 tpp -84.56 129.07 58.78 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 171.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -53.11 129.21 32.27 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 N-CA-C 118.625 2.51 . . . . 0.0 118.625 -168.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.668 HG13 HG22 ' A' ' 58' ' ' THR . 45.7 t -106.99 102.2 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 100.257 -3.979 . . . . 0.0 100.257 166.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -132.6 155.74 48.16 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.746 0.818 . . . . 0.0 110.885 -169.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.0 t -134.42 120.07 32.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.081 0.953 . . . . 0.0 108.676 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.9 m -91.65 143.87 26.11 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.429 1.092 . . . . 0.0 108.568 169.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -123.69 146.82 47.96 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.347 1.859 . . . . 0.0 110.128 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.485 ' CE1' ' CB ' ' A' ' 131' ' ' ALA . 81.6 m-85 -149.15 172.77 14.28 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -168.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.4 m -14.99 144.7 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.479 1 C-N-CA 133.851 4.861 . . . . 0.0 116.834 169.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.9 tp -78.85 71.08 5.29 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.159 0.984 . . . . 0.0 109.514 172.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -70.04 119.92 14.98 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.518 1.527 . . . . 0.0 108.686 -177.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 50.72 36.2 13.67 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.944 0.898 . . . . 0.0 111.914 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.87 10.84 80.37 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-O 118.379 -1.234 . . . . 0.0 114.418 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -142.24 141.95 32.56 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 120.11 1.955 . . . . 0.0 109.849 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -67.1 140.14 57.56 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 121.164 -0.96 . . . . 0.0 109.788 -173.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.66 162.21 15.72 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 171.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -171.01 167.34 40.51 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 176.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 3.5 m -141.72 147.26 37.13 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 169.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.7 p -120.41 141.88 38.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 169.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.7 tt -123.04 148.52 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 169.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.668 HG22 HG13 ' A' ' 40' ' ' VAL . 40.6 p -141.61 175.61 2.91 Favored Pre-proline 0 N--CA 1.441 -0.876 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 169.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -65.71 -21.65 58.39 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.184 1.256 . . . . 0.0 111.817 169.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 42.6 p-90 -97.94 -21.87 16.62 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.46 177.78 9.75 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.878 1.672 . . . . 0.0 112.906 -176.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 tt -143.75 127.28 16.95 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 103.102 -2.925 . . . . 0.0 103.102 168.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 56.5 m -137.25 130.62 31.18 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 124.167 0.917 . . . . 0.0 109.215 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.51 147.79 43.69 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 168.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.89 151.85 29.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 72.4 mt -135.83 134.01 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 105.553 -2.018 . . . . 0.0 105.553 177.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -129.62 141.42 41.78 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-O 118.117 -0.944 . . . . 0.0 110.872 -169.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -54.43 142.17 70.7 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.906 2.404 . . . . 0.0 113.76 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.18 173.92 53.64 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.342 0.972 . . . . 0.0 112.825 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -65.83 148.41 86.35 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.266 2.644 . . . . 0.0 112.035 -175.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.5 t70 53.15 44.26 30.52 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.249 1.419 . . . . 0.0 111.857 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -118.67 148.14 43.05 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.838 1.255 . . . . 0.0 108.249 173.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -116.43 84.31 2.11 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 172.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 8.8 t90 -71.45 121.65 84.92 Favored Pre-proline 0 C--O 1.235 0.316 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -170.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -56.17 147.88 63.04 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.171 1.914 . . . . 0.0 112.274 -175.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 40.7 tp -58.5 128.06 35.26 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 169.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -109.95 159.47 17.23 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.145 0.978 . . . . 0.0 109.698 -178.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -86.3 142.69 28.34 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 168.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.8 t -88.96 154.91 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -169.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.2 m 65.87 10.32 6.79 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.242 1.417 . . . . 0.0 113.706 -177.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -80.93 153.74 27.37 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.833 1.253 . . . . 0.0 108.131 169.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -107.76 142.73 37.32 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.383 0.538 . . . . 0.0 110.214 176.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.6 mm -118.46 124.21 72.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 173.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -77.94 120.95 5.6 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 176.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 72.3 mt -106.58 124.75 50.07 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 174.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.86 79.46 9.24 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 55.9 mt -74.92 145.93 81.97 Favored Pre-proline 0 CA--C 1.533 0.292 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 172.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -60.32 -25.61 80.67 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 121.662 1.575 . . . . 0.0 112.763 170.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -55.4 -30.38 60.31 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.527 1.531 . . . . 0.0 111.952 170.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.72 143.21 4.57 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 107.974 -2.05 . . . . 0.0 107.974 -171.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.8 m -61.45 131.25 49.58 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 60.1 ttm -140.22 129.97 24.47 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.28 132.66 35.87 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 118.721 0.691 . . . . 0.0 109.22 173.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -106.24 135.1 48.31 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 169.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.3 m -87.93 137.88 31.94 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 70.1 t -68.96 122.1 19.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 170.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -107.25 157.05 15.7 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 171.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -122.42 95.42 4.63 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 170.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.9 tt -72.77 115.84 12.55 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -175.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.46 131.68 51.51 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 122.633 0.373 . . . . 0.0 111.378 -173.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.66 2.96 71.27 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 118.888 -0.951 . . . . 0.0 113.402 -177.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.3 t -123.72 -103.33 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.5 p -164.01 171.69 14.88 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.719 1.6 . . . . 0.0 111.089 -173.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -73.49 144.7 46.1 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 169.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.54 179.68 8.39 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.826 1.65 . . . . 0.0 108.594 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.2 mt -109.22 137.87 46.44 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.5 m -140.62 158.24 44.28 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.092 0.957 . . . . 0.0 111.275 -173.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 38.7 t -143.44 108.95 5.08 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 169.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.2 m -85.75 143.82 28.12 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.991 0.916 . . . . 0.0 109.942 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.43 -10.7 0.73 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -172.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 10.0 tpp -125.0 147.14 49.08 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 120.592 1.542 . . . . 0.0 111.778 -170.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 14.1 m -92.05 166.83 16.51 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.584 1.154 . . . . 0.0 111.158 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -63.16 156.34 55.9 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.65 2.233 . . . . 0.0 113.77 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 24.4 tp 49.88 69.14 0.64 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 126.713 2.005 . . . . 0.0 111.52 172.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.9 m -58.12 150.49 21.11 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.26 172.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -78.95 146.7 33.3 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.8 m 55.63 27.24 10.23 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.684 1.194 . . . . 0.0 112.736 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.13 140.87 56.19 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 -177.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.6 p -161.48 178.85 8.73 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.119 1.368 . . . . 0.0 108.594 -170.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -62.32 -28.57 44.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 O-C-N 121.472 -0.768 . . . . 0.0 110.624 169.675 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -68.03 -49.0 64.13 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -65.91 -39.37 90.51 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.668 0.667 . . . . 0.0 110.017 177.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.12 -25.31 59.69 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.569 1.08 . . . . 0.0 112.696 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -96.33 -52.37 4.01 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.321 1.06 . . . . 0.0 110.672 173.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 44.1 mtm-85 -65.2 -41.71 94.23 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.648 -0.658 . . . . 0.0 112.199 -170.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -75.72 -35.74 60.18 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 119.406 1.003 . . . . 0.0 110.596 -170.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.64 -45.56 93.62 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.851 0.75 . . . . 0.0 109.067 175.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -66.63 -48.44 69.46 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.012 1.325 . . . . 0.0 111.46 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.61 -38.93 92.71 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.43 -0.794 . . . . 0.0 111.793 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 88.8 m -71.21 -24.16 62.16 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 119.499 -0.286 . . . . 0.0 111.276 -179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.485 ' CB ' ' CE1' ' A' ' 45' ' ' PHE . . . -78.96 -47.17 16.84 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 118.845 0.748 . . . . 0.0 109.037 169.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.1 ttp-105 -55.74 -41.95 74.68 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.731 0.812 . . . . 0.0 112.025 -177.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 16.9 ptt? -55.1 -50.09 70.09 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 118.613 0.642 . . . . 0.0 110.658 175.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 42.8 pt -75.81 -19.8 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 O-C-N 120.957 -1.089 . . . . 0.0 111.376 -177.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.6 tp -65.08 -3.47 3.7 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.857 2.063 . . . . 0.0 110.337 169.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.0 m 63.2 26.97 15.45 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.918 2.087 . . . . 0.0 112.779 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.2 mp -96.82 157.31 35.37 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 124.994 1.318 . . . . 0.0 107.748 169.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.19 155.6 19.06 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 123.222 2.615 . . . . 0.0 111.5 169.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.6 m -69.28 165.1 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 121.637 0.732 . . . . 0.0 109.872 175.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 92.2 m -55.53 133.17 50.06 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.119 1.368 . . . . 0.0 111.923 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -90.58 122.64 66.88 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 105.339 -2.096 . . . . 0.0 105.339 168.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.64 156.88 62.5 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.168 1.912 . . . . 0.0 112.634 -169.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -69.24 130.53 42.88 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 170.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.3 m -138.52 157.35 72.39 Favored Pre-proline 0 C--O 1.239 0.51 0 C-N-CA 125.038 1.335 . . . . 0.0 110.165 -169.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -68.14 149.56 76.57 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.455 2.103 . . . . 0.0 111.955 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 19.1 t60 54.27 24.82 5.3 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.595 1.958 . . . . 0.0 113.914 173.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -159.57 -41.12 0.05 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.489 -0.757 . . . . 0.0 111.967 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -71.11 129.68 18.24 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 -176.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -83.24 127.97 34.1 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 169.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -73.64 141.37 46.51 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -176.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -141.93 25.86 1.92 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.472 1.109 . . . . 0.0 110.773 177.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -81.46 150.88 28.11 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.278 0.631 . . . . 0.0 110.446 -175.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -150.54 148.59 28.87 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 126.188 1.795 . . . . 0.0 107.544 169.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -135.65 167.43 21.14 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.222 1.009 . . . . 0.0 110.711 -169.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 76.84 173.19 37.51 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.099 0.857 . . . . 0.0 113.371 172.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -144.59 162.81 35.68 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.49 2.316 . . . . 0.0 106.207 174.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -62.76 130.96 47.21 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 174.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.9 m -61.53 150.24 36.51 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.701 0.8 . . . . 0.0 111.496 -175.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -160.54 -120.25 0.55 Allowed Glycine 0 CA--C 1.526 0.723 0 N-CA-C 107.926 -2.07 . . . . 0.0 107.926 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -63.35 -39.52 94.78 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 172.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -87.47 133.14 33.8 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 169.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.344 0 C-N-CA 125.153 1.381 . . . . 0.0 107.723 175.739 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.3 p -73.04 151.84 41.55 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.925 0.89 . . . . 0.0 109.819 176.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -84.33 16.44 3.05 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 122.007 0.908 . . . . 0.0 112.46 175.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -144.48 159.49 42.67 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 127.731 2.412 . . . . 0.0 108.226 -175.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.2 mm -123.64 128.61 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 173.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.69 142.44 42.51 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 176.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.6 151.74 50.56 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.487 1.041 . . . . 0.0 112.052 176.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -102.91 154.72 18.93 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.733 1.213 . . . . 0.0 109.996 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 mm-40 -84.73 -21.12 30.2 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.694 -0.629 . . . . 0.0 112.265 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.9 p -158.39 -176.67 6.03 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 129.476 3.11 . . . . 0.0 105.987 170.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.0 m -58.44 145.17 76.68 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 168.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -73.59 59.23 4.03 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.817 3.011 . . . . 0.0 108.943 169.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 32.5 tttm -50.54 -51.62 46.22 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 126.638 1.975 . . . . 0.0 112.481 -168.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.93 -40.89 91.83 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.6 0.36 . . . . 0.0 111.707 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -69.3 -45.32 69.86 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.887 0.875 . . . . 0.0 109.773 -174.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 73.7 t -62.13 -42.97 97.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.372 1.069 . . . . 0.0 108.471 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -59.64 -54.01 51.39 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 118.469 0.577 . . . . 0.0 110.041 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.0 -39.68 93.81 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.194 0.598 . . . . 0.0 111.112 -175.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.03 -46.32 78.3 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -70.86 -27.17 63.64 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-O 117.918 -1.039 . . . . 0.0 112.071 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -61.69 -38.27 87.22 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 120.055 1.298 . . . . 0.0 110.211 171.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -73.8 -41.71 61.97 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 121.702 -0.624 . . . . 0.0 109.389 -177.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.6 mt -61.27 -43.88 97.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.3 -27.28 68.92 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.077 0.853 . . . . 0.0 112.146 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -79.81 -42.32 24.61 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.019 0.928 . . . . 0.0 109.17 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -76.92 -25.48 52.98 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.788 0.835 . . . . 0.0 111.702 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.3 m -72.14 102.3 3.0 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.3 mpt? 64.91 -34.39 0.17 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 128.585 2.754 . . . . 0.0 116.594 169.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -68.25 -57.17 6.4 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 120.012 1.278 . . . . 0.0 109.87 -176.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.2 t0 48.56 38.23 10.76 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.237 1.415 . . . . 0.0 111.704 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.4 tp -151.99 -25.71 0.18 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.414 1.485 . . . . 0.0 111.415 -169.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.87 20.07 0.19 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.57 1.148 . . . . 0.0 113.806 -169.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -78.07 -24.06 47.82 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.912 -1.117 . . . . 0.0 109.322 169.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.4 mt -68.35 -51.98 38.34 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.549 0.739 . . . . 0.0 109.169 174.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -160.76 152.17 16.08 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 127.177 2.191 . . . . 0.0 107.092 175.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -63.68 146.36 92.23 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.05 1.833 . . . . 0.0 110.606 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.4 p -65.99 -46.55 77.6 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.876 0.871 . . . . 0.0 109.237 173.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.1 tpp -146.57 126.85 6.93 Favored Pre-proline 0 C--O 1.234 0.254 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 169.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -54.03 131.54 45.2 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.25 1.966 . . . . 0.0 112.342 178.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.8 t -73.58 139.4 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 169.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -142.65 154.39 44.31 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.968 0.907 . . . . 0.0 108.923 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.2 t -141.09 125.21 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 123.748 0.819 . . . . 0.0 108.895 -173.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.4 m -89.15 144.02 26.42 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.203 1.001 . . . . 0.0 108.745 168.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -119.96 135.82 54.76 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.792 1.637 . . . . 0.0 108.035 169.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -167.57 143.33 4.03 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -176.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.7 m 57.17 166.4 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.525 2.33 . . . . 0.0 115.341 167.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.1 tp -120.99 66.63 0.86 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.806 1.242 . . . . 0.0 108.521 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.2 131.27 42.53 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.646 -0.658 . . . . 0.0 110.117 -175.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 52.38 31.5 9.67 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.477 1.111 . . . . 0.0 111.87 -175.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.65 11.06 85.82 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-O 118.153 -1.359 . . . . 0.0 113.613 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -125.36 143.76 50.82 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.893 1.847 . . . . 0.0 108.062 -174.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -67.97 138.39 55.88 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 119.416 1.007 . . . . 0.0 109.549 -176.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.65 155.39 17.34 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.95 171.43 37.87 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 173.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 45.0 m -140.32 150.62 44.23 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 169.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.4 p -127.66 141.76 45.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 124.853 1.261 . . . . 0.0 107.602 175.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.0 tt -118.52 149.04 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 169.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.6 p -142.83 172.61 5.51 Favored Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 171.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.36 -19.09 65.18 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 CA-C-N 120.149 1.089 . . . . 0.0 111.646 168.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 37.8 p-90 -102.16 -23.36 14.05 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.518 1.054 . . . . 0.0 113.836 -172.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.74 166.06 24.77 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.819 1.247 . . . . 0.0 111.882 -175.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.3 tt -132.94 124.74 28.37 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 104.2 -2.518 . . . . 0.0 104.2 168.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.2 m -137.63 133.15 34.01 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.367 0.604 . . . . 0.0 110.891 -176.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.35 148.28 49.9 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 168.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.4 m -139.97 151.88 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 123.946 0.898 . . . . 0.0 109.038 -178.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 36.6 mt -138.32 145.63 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -133.15 142.49 44.67 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.191 -176.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -44.8 129.42 9.46 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 124.012 3.142 . . . . 0.0 112.447 174.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.97 178.62 15.56 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.085 0.85 . . . . 0.0 114.525 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -67.33 131.16 24.16 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.381 2.721 . . . . 0.0 111.141 -172.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.8 t70 51.15 31.34 6.56 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.538 1.535 . . . . 0.0 113.219 175.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -88.96 155.63 19.39 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -116.8 88.12 2.83 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 170.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -67.24 151.18 97.4 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.164 174.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.38 159.42 49.37 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.256 1.97 . . . . 0.0 109.284 169.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 51.9 tp -64.53 118.75 9.26 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 169.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -88.95 158.98 17.86 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.41 138.26 31.9 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 168.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.7 t -83.13 154.98 3.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 123.834 0.853 . . . . 0.0 108.704 -169.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.1 m 66.23 9.97 6.77 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.295 1.438 . . . . 0.0 113.828 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -83.8 163.0 20.42 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.807 1.243 . . . . 0.0 107.891 168.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -110.93 142.16 43.39 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 118.923 0.783 . . . . 0.0 111.02 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 30.4 mm -113.45 130.96 66.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 176.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -79.08 123.09 6.01 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -109.97 155.31 21.94 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.897 1.279 . . . . 0.0 108.328 170.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.0 tp60 -126.7 131.74 51.31 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 169.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -155.57 166.14 16.89 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 126.067 1.747 . . . . 0.0 107.199 178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -57.72 -22.54 53.29 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.697 2.265 . . . . 0.0 115.0 -174.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -58.29 -33.51 69.53 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.681 0.792 . . . . 0.0 111.715 172.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.24 177.89 15.67 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.677 1.608 . . . . 0.0 110.03 -176.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.2 m -67.01 128.13 35.2 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 169.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 41.0 ttp -147.35 130.74 16.64 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.25 141.71 33.85 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 172.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -113.17 135.92 53.29 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 169.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 15.2 m -80.26 143.81 33.39 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 176.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 62.6 t -76.14 125.72 36.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 170.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -108.97 156.02 15.82 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 108.579 -1.809 . . . . 0.0 108.579 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -133.95 123.32 24.44 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 170.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.6 tp -141.23 144.08 34.52 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.36 0.527 . . . . 0.0 110.171 -172.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -54.27 131.55 41.88 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.32 1.048 . . . . 0.0 110.788 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.8 -1.36 58.77 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 118.717 -1.046 . . . . 0.0 113.591 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 44.8 t -121.57 -28.64 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 119.441 1.62 . . . . 0.0 109.947 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.1 m 60.11 -144.86 0.51 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.804 1.241 . . . . 0.0 108.279 -170.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -83.44 136.6 34.25 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.847 0.749 . . . . 0.0 110.654 -175.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -156.91 175.72 13.7 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.257 1.823 . . . . 0.0 107.869 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.2 mp -116.53 147.09 42.13 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.323 1.049 . . . . 0.0 108.501 -177.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.6 p -143.65 153.04 42.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.754 1.222 . . . . 0.0 110.615 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.8 t -147.28 121.93 9.83 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 170.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.9 m -72.97 137.57 45.56 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.334 0.515 . . . . 0.0 109.99 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -89.17 -66.78 0.89 Allowed 'General case' 0 C--N 1.338 0.102 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 171.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.78 174.64 7.44 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.031 1.332 . . . . 0.0 108.859 -175.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.6 m -85.37 121.29 73.72 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 169.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -88.64 4.71 5.41 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.372 2.715 . . . . 0.0 113.091 -173.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 57.2 tp -67.15 117.72 9.57 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.727 0.694 . . . . 0.0 110.531 -170.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.8 m -144.24 159.52 42.53 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.849 2.06 . . . . 0.0 106.662 171.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -82.97 -29.94 28.63 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.126 0.421 . . . . 0.0 111.29 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.9 m -82.92 60.14 5.25 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.634 1.173 . . . . 0.0 109.032 174.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.22 138.67 35.28 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.276 1.43 . . . . 0.0 108.053 -170.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.3 m -145.16 167.96 21.5 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.726 1.61 . . . . 0.0 108.141 -175.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.49 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -57.1 -27.17 26.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.674 -0.641 . . . . 0.0 111.619 179.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -64.39 -42.26 96.23 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.977 0.511 . . . . 0.0 110.148 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -67.88 -29.28 68.36 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.043 0.937 . . . . 0.0 110.482 171.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.85 -60.87 8.02 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 169.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -65.06 -49.61 69.39 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.864 -0.786 . . . . 0.0 110.279 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -58.08 -45.34 87.3 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 124.439 1.096 . . . . 0.0 110.688 -175.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.5 tp -79.66 -25.76 41.22 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 119.858 1.208 . . . . 0.0 111.668 -173.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.4 m -69.61 -42.88 73.8 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.829 1.195 . . . . 0.0 109.197 173.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -68.51 -41.55 79.83 Favored 'General case' 0 N--CA 1.461 0.095 0 C-N-CA 123.165 0.586 . . . . 0.0 111.358 177.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -66.22 -29.64 69.94 Favored 'General case' 0 C--N 1.332 -0.176 0 O-C-N 121.351 -0.843 . . . . 0.0 110.267 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 20.0 m -69.53 -43.34 73.21 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.991 0.814 . . . . 0.0 110.239 175.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -56.41 -52.92 62.85 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.59 0.756 . . . . 0.0 109.698 171.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -52.61 -53.86 40.99 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.91 1.284 . . . . 0.0 110.559 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 54.0 ttp -49.24 -50.16 39.86 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.607 1.563 . . . . 0.0 110.922 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 6.4 pt -82.12 -19.93 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 119.027 0.83 . . . . 0.0 112.513 -174.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 74.4 mt -72.89 -33.21 65.89 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.387 0.54 . . . . 0.0 109.729 169.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.5 m 55.26 28.51 11.34 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.516 1.926 . . . . 0.0 113.685 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 84.9 mt -85.69 147.09 45.38 Favored Pre-proline 0 C--O 1.236 0.353 0 C-N-CA 124.411 1.084 . . . . 0.0 109.445 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -62.78 155.57 58.8 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 123.637 2.892 . . . . 0.0 111.286 174.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.0 p -60.82 139.13 20.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 123.529 0.731 . . . . 0.0 110.284 -173.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 2.7 m -73.87 147.17 43.5 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.749 0.819 . . . . 0.0 109.261 -177.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -108.23 105.94 57.59 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 169.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -82.14 35.53 0.58 Allowed 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.726 2.95 . . . . 0.0 112.505 -170.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -153.26 140.67 19.69 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.02 1.728 . . . . 0.0 108.665 177.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.6 t -143.85 147.74 39.69 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 175.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -52.59 156.13 9.18 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.758 2.972 . . . . 0.0 111.667 168.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -62.74 138.87 58.62 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 175.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.18 147.71 38.25 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.02 0.528 . . . . 0.0 110.27 -176.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -74.24 160.17 53.05 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 173.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -147.63 141.18 25.46 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.254 1.421 . . . . 0.0 107.33 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -72.55 142.21 48.46 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -130.38 21.66 5.19 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.137 1.375 . . . . 0.0 110.646 173.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.5 pp -80.8 160.3 24.88 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.212 1.005 . . . . 0.0 110.853 -176.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -144.29 157.26 44.37 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.372 1.469 . . . . 0.0 108.515 170.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -72.16 129.74 39.21 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -70.09 138.65 29.84 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 177.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.2 mpt_? -86.34 149.75 24.82 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 171.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -128.86 19.03 6.1 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.262 1.025 . . . . 0.0 112.545 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.6 m 59.35 179.6 0.08 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.322 1.449 . . . . 0.0 112.177 -173.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -174.14 -127.02 0.96 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.68 -30.52 71.54 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.056 0.428 . . . . 0.0 110.214 171.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -93.47 133.48 36.71 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 169.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.28 0 C-N-CA 125.63 1.572 . . . . 0.0 107.753 176.783 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 120.765 0.317 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.1 p -72.69 157.65 37.13 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.192 0.997 . . . . 0.0 110.032 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -138.32 41.35 2.24 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.485 1.114 . . . . 0.0 108.518 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -142.25 158.84 43.27 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.192 1.397 . . . . 0.0 109.317 -172.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.4 mm -120.94 128.93 76.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 171.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.47 131.97 42.39 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.86 151.48 51.2 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.109 0.861 . . . . 0.0 111.096 174.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -93.84 138.45 31.99 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.282 1.033 . . . . 0.0 109.736 -175.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -71.1 -34.03 70.73 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.909 -0.567 . . . . 0.0 109.902 176.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.3 p -156.64 161.78 39.88 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 128.618 2.767 . . . . 0.0 106.812 169.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.0 m -51.82 137.44 34.75 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.226 1.011 . . . . 0.0 112.346 -174.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -76.55 46.71 1.92 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 124.907 3.738 . . . . 0.0 110.555 172.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -62.64 -31.77 72.69 Favored 'General case' 0 C--O 1.221 -0.438 0 O-C-N 120.498 -1.376 . . . . 0.0 113.232 -168.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.76 -42.64 94.97 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-N 118.762 0.71 . . . . 0.0 111.006 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -72.84 -39.3 66.67 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -177.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.2 t -58.46 -46.42 89.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 171.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -60.77 -53.18 60.52 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 123.526 0.73 . . . . 0.0 110.371 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.55 -40.36 95.44 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.694 0.679 . . . . 0.0 110.931 -174.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.21 -41.82 80.73 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 122.013 -0.43 . . . . 0.0 110.506 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -69.52 -27.33 65.08 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-O 118.331 -0.843 . . . . 0.0 112.415 175.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -63.22 -36.74 84.64 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.569 1.077 . . . . 0.0 109.104 172.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -71.48 -46.25 60.33 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.2 mt -61.01 -36.87 75.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 123.491 0.717 . . . . 0.0 109.845 177.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.74 -36.39 78.32 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.196 -0.94 . . . . 0.0 110.614 176.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.7 ttm105 -70.57 -34.8 72.62 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.448 1.099 . . . . 0.0 110.061 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -65.31 -2.44 3.1 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.092 1.357 . . . . 0.0 111.645 169.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.6 m 54.3 72.71 0.44 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.496 1.918 . . . . 0.0 113.234 169.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 4.5 tmm? -62.93 -52.81 61.62 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 169.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -81.01 164.08 22.78 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 168.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -86.96 106.18 17.63 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 15.1 mt -79.19 85.0 5.1 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -174.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.1 m -46.25 160.71 0.06 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.416 1.487 . . . . 0.0 111.974 169.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -63.45 -9.87 14.71 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.451 1.649 . . . . 0.0 115.451 -169.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.0 mt -65.13 166.02 10.3 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.591 0.756 . . . . 0.0 110.888 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -65.64 160.54 59.91 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 170.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -55.31 123.45 13.83 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.304 2.003 . . . . 0.0 111.017 -176.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.6 p -72.95 -28.18 62.27 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 123.572 0.749 . . . . 0.0 112.29 -170.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 76.4 mtm -142.62 134.19 13.04 Favored Pre-proline 0 N--CA 1.45 -0.442 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 170.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -72.64 144.03 38.98 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 N-CA-C 108.562 -1.361 . . . . 0.0 108.562 -172.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.47 HG13 HG22 ' A' ' 58' ' ' THR . 97.1 t -65.62 108.66 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 169.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -149.53 155.73 40.8 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 125.36 1.464 . . . . 0.0 109.256 -168.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.7 t -140.12 120.1 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -178.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.9 m -85.39 148.4 26.03 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.851 0.86 . . . . 0.0 109.792 169.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -125.28 141.86 51.84 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.828 2.051 . . . . 0.0 110.567 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.454 ' CE2' ' CB ' ' A' ' 131' ' ' ALA . 98.4 m-85 -149.61 171.16 17.1 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -169.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.8 m -6.64 135.99 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.357 1 C-N-CA 133.43 4.692 . . . . 0.0 117.285 169.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.0 tt -78.53 103.61 8.59 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 168.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -84.92 -138.65 0.07 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.026 1.73 . . . . 0.0 107.872 -174.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -73.46 74.21 1.41 Allowed 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.823 -1.173 . . . . 0.0 110.129 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 72.79 16.33 78.05 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.542 1.068 . . . . 0.0 113.665 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -153.69 140.43 19.02 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.687 1.243 . . . . 0.0 109.862 -172.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -77.32 148.02 35.88 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.996 1.318 . . . . 0.0 110.063 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.58 158.29 15.86 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.61 0.719 . . . . 0.0 110.374 175.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -167.05 168.88 40.62 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 175.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 15.4 m -143.43 142.82 31.35 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.546 -1.649 . . . . 0.0 106.546 169.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.6 p -114.27 149.96 16.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 124.958 1.303 . . . . 0.0 107.678 172.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.4 tt -136.59 156.67 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 169.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.47 HG22 HG13 ' A' ' 40' ' ' VAL . 44.6 p -146.47 177.35 1.8 Allowed Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 126.353 1.861 . . . . 0.0 106.816 175.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -59.49 -28.88 88.6 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 CA-C-N 120.154 1.091 . . . . 0.0 111.015 168.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 50.0 p-90 -97.19 -19.41 18.64 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -171.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.67 172.81 15.64 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 120.804 1.638 . . . . 0.0 113.717 -176.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 tt -135.68 126.15 26.81 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 103.523 -2.769 . . . . 0.0 103.523 167.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.8 m -135.33 134.25 39.64 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 177.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.21 146.5 47.29 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 169.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.1 m -139.35 147.12 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 C-N-CA 123.639 0.775 . . . . 0.0 109.335 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.9 mm -140.64 142.94 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -171.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -132.81 140.11 36.69 Favored Pre-proline 0 N--CA 1.468 0.43 0 CA-C-O 117.482 -1.247 . . . . 0.0 109.445 -175.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -57.14 142.35 94.39 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.151 1.901 . . . . 0.0 111.29 175.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.99 -179.3 29.16 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.731 1.158 . . . . 0.0 114.24 -171.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.87 145.34 56.21 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 123.35 2.7 . . . . 0.0 111.779 -171.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.6 t0 43.16 57.08 3.89 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.395 1.878 . . . . 0.0 112.395 174.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -142.84 146.59 34.29 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 -172.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -117.12 101.0 8.1 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -76.12 154.72 84.56 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 169.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -69.97 158.9 55.18 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.187 1.924 . . . . 0.0 110.798 172.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 66.0 tp -64.09 136.74 57.53 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 169.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -118.79 160.49 21.79 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 119.109 0.868 . . . . 0.0 109.052 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -86.11 149.56 25.04 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 169.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 36.0 t -90.6 154.73 3.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -169.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.0 m 61.67 28.25 17.44 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.798 0.839 . . . . 0.0 112.344 -175.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -107.46 154.38 21.44 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.819 2.047 . . . . 0.0 107.264 169.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -104.76 147.88 27.22 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.333 0.969 . . . . 0.0 111.463 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.6 mm -122.97 132.12 72.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 176.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -81.75 123.33 6.02 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.5 mp -106.26 134.0 50.08 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 169.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -89.93 116.6 28.12 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 169.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.1 mt -106.12 155.53 38.34 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 169.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.31 -28.03 55.39 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 CA-C-N 120.187 1.102 . . . . 0.0 111.136 169.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -52.46 -38.66 59.82 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.688 1.595 . . . . 0.0 111.517 169.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 153.53 169.88 19.03 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -174.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.3 m -71.74 130.39 41.01 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 173.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 60.4 ttm -138.23 123.43 19.26 Favored 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.35 136.36 37.68 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 121.483 -0.761 . . . . 0.0 109.135 170.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -111.49 140.76 45.82 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 169.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.5 m -90.12 141.45 28.68 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.2 t -70.49 119.1 16.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 169.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -102.53 158.39 18.0 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 108.052 -2.019 . . . . 0.0 108.052 169.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -132.81 122.28 24.23 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 169.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.6 tp -138.26 147.81 44.07 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.794 0.838 . . . . 0.0 109.127 -169.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -58.1 128.91 39.47 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.227 0.611 . . . . 0.0 111.503 -172.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.53 -30.64 1.94 Allowed Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.731 1.634 . . . . 0.0 112.812 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.4 t -79.58 -29.15 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.847 1.659 . . . . 0.0 110.003 178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.0 m 56.75 -139.36 0.92 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 -169.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -84.18 138.36 33.03 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.155 0.889 . . . . 0.0 110.956 -175.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -155.98 169.1 25.23 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.936 2.094 . . . . 0.0 107.115 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.8 mp -112.06 140.68 46.54 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -177.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.2 m -138.3 151.14 47.31 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.29 1.036 . . . . 0.0 110.211 -173.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 44.3 t -138.92 115.67 10.72 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 169.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.5 m -67.44 123.93 21.78 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.28 -47.32 4.98 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.237 0.615 . . . . 0.0 110.47 -170.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 16.2 ptp -159.62 163.9 34.58 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.103 0.961 . . . . 0.0 109.413 175.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.519 ' H ' ' HD2' ' A' ' 113' ' ' PRO . 13.9 m -123.01 -57.63 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 117.643 -1.17 . . . . 0.0 112.217 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.519 ' HD2' ' H ' ' A' ' 112' ' ' SER . 61.3 Cg_endo -68.32 150.76 76.46 Favored 'Trans proline' 0 C--N 1.353 0.804 0 CA-C-N 121.616 1.613 . . . . 0.0 112.074 -174.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 19.5 tp -74.21 129.88 38.66 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 172.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 38.0 m -69.89 138.98 52.93 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 172.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -43.38 -52.25 6.01 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.391 1.476 . . . . 0.0 113.655 -169.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.2 m -99.59 10.78 40.74 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.25 0.62 . . . . 0.0 112.513 -171.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 5.2 ptm -93.56 146.73 23.58 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.495 0.718 . . . . 0.0 110.19 -175.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 43.1 m -136.67 -166.7 1.94 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.982 1.713 . . . . 0.0 108.527 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 14.3 pt -60.52 -25.49 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -174.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -75.72 -47.28 26.75 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 30.0 mp0 -61.47 -35.36 77.41 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.365 1.066 . . . . 0.0 109.623 169.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.84 -54.06 41.13 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 120.197 1.362 . . . . 0.0 110.842 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -64.81 -48.2 75.28 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.528 -0.983 . . . . 0.0 110.275 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 75.5 mtp85 -64.11 -30.85 71.89 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 122.785 0.434 . . . . 0.0 111.387 -177.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 24.2 tp -82.57 -22.68 34.78 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-O 118.003 -0.999 . . . . 0.0 111.311 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.2 m -64.28 -46.24 84.55 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 120.304 1.411 . . . . 0.0 107.762 169.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -64.53 -51.29 63.66 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.006 0.922 . . . . 0.0 111.659 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -61.44 -36.03 79.23 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.628 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 21.8 m -64.01 -39.59 94.44 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.252 0.478 . . . . 0.0 110.211 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.454 ' CB ' ' CE2' ' A' ' 45' ' ' PHE . . . -65.81 -48.81 70.46 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 121.635 -0.666 . . . . 0.0 110.59 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 18.5 ptt85 -67.32 -27.26 67.0 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.444 1.474 . . . . 0.0 112.641 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 12.9 tmm? -56.61 -45.5 81.43 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 118.34 -0.838 . . . . 0.0 110.324 169.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 12.7 pt -81.84 -25.38 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 119.731 1.151 . . . . 0.0 113.118 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 70.8 mt -62.7 -38.08 89.03 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.845 1.202 . . . . 0.0 109.154 169.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.6 m 56.74 20.27 4.99 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.534 1.934 . . . . 0.0 112.837 -169.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 98.3 mt -153.35 156.1 32.22 Favored Pre-proline 0 C--O 1.236 0.389 0 C-N-CA 128.844 2.858 . . . . 0.0 107.65 -170.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.11 164.21 23.19 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.771 2.314 . . . . 0.0 109.75 168.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 10.5 t -65.53 143.71 15.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 20.2 m -127.59 127.05 43.21 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.173 0.989 . . . . 0.0 109.593 -169.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 15.9 t30 -77.78 127.15 82.95 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 168.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -59.76 131.31 39.23 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 121.994 1.796 . . . . 0.0 112.606 -171.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -159.04 147.5 18.14 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.088 1.755 . . . . 0.0 107.91 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.2 p -149.84 148.34 25.08 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 124.145 0.978 . . . . 0.0 108.829 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -55.48 168.13 1.67 Allowed 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 123.975 3.117 . . . . 0.0 112.583 169.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -64.08 113.88 3.8 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -89.35 -12.9 39.16 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.623 0.769 . . . . 0.0 112.556 -172.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 68.09 -163.64 47.83 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -171.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -148.16 143.99 27.46 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.04 1.336 . . . . 0.0 108.004 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 27.4 mmt85 -71.17 153.63 42.34 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.41 119.2 19.17 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 169.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -153.88 165.6 35.57 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.105 1.362 . . . . 0.0 109.662 174.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 62.5 tp -145.32 140.12 27.52 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 173.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -79.01 119.4 22.11 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 172.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 62.61 -157.81 37.25 Favored Glycine 0 CA--C 1.532 1.145 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -172.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -150.86 146.41 26.31 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.22 -1.771 . . . . 0.0 106.22 172.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -65.63 136.6 56.54 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.9 m -74.75 -1.02 20.11 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.446 1.099 . . . . 0.0 113.857 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 82.21 -57.62 4.98 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 125.484 1.516 . . . . 0.0 111.24 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -78.55 -19.82 52.0 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.548 0.739 . . . . 0.0 111.633 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -75.66 137.79 40.93 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.212 0.605 . . . . 0.0 109.455 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 C-N-CA 125.52 1.528 . . . . 0.0 107.794 177.108 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.7 m 65.87 158.92 0.12 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.691 1.596 . . . . 0.0 111.877 -176.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -121.25 133.82 55.16 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 174.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -146.87 169.87 18.23 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.587 1.155 . . . . 0.0 109.905 -169.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.9 mt -119.29 138.77 48.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 171.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.35 160.81 31.6 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.159 0.583 . . . . 0.0 110.865 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.03 160.73 52.89 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.631 -0.587 . . . . 0.0 111.631 171.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -120.53 144.39 48.08 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.81 1.244 . . . . 0.0 111.918 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -104.96 81.25 1.72 Allowed 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.203 -1.776 . . . . 0.0 106.203 169.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.9 p 63.58 176.16 0.16 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 127.249 2.22 . . . . 0.0 111.28 -169.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.1 m -59.9 150.32 69.41 Favored Pre-proline 0 CA--C 1.541 0.625 0 O-C-N 121.713 -0.617 . . . . 0.0 111.17 -171.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.18 54.66 3.29 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 124.639 3.56 . . . . 0.0 109.972 169.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.4 tttm -52.12 -50.0 62.54 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 127.357 2.263 . . . . 0.0 111.962 -169.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.79 -41.49 95.78 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 122.644 0.377 . . . . 0.0 111.463 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -73.49 -38.9 65.23 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -174.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.7 t -61.91 -42.64 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 172.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -62.02 -51.2 68.97 Favored 'General case' 0 C--O 1.225 -0.196 0 CA-C-N 118.305 0.502 . . . . 0.0 110.271 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.67 -40.19 96.2 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.502 0.721 . . . . 0.0 110.907 -176.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.08 -51.27 68.61 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 119.17 -0.443 . . . . 0.0 110.011 176.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -66.6 -31.69 72.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 118.287 -0.863 . . . . 0.0 111.881 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.86 -31.62 72.68 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.586 1.084 . . . . 0.0 110.086 176.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -82.7 -44.49 15.61 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.41 0.684 . . . . 0.0 110.617 175.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.0 mt -65.95 -40.16 86.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 O-C-N 121.027 -1.046 . . . . 0.0 109.016 -175.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.9 -30.14 69.99 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.734 -0.604 . . . . 0.0 111.102 177.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.9 ttp-105 -81.25 -41.78 21.7 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 124.386 1.074 . . . . 0.0 109.917 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 -58.58 -37.37 75.64 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.366 0.666 . . . . 0.0 110.586 173.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.1 m -82.35 -0.77 47.35 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.109 0.964 . . . . 0.0 113.433 174.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 85.7 mtp 54.79 38.46 30.23 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.542 1.937 . . . . 0.0 113.361 176.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 61.2 m-70 -82.6 56.33 3.3 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.849 0.86 . . . . 0.0 110.531 177.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -88.01 -28.38 21.44 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.412 0.685 . . . . 0.0 112.25 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . 0.276 1.0 OUTLIER 40.7 44.3 1.82 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.298 1.839 . . . . 0.0 113.525 -176.078 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.3 m 60.44 18.74 8.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.179 1.791 . . . . 0.0 114.36 177.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -67.42 -33.42 75.14 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.689 1.131 . . . . 0.0 110.578 169.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.0 mt 52.26 19.91 1.22 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.953 2.101 . . . . 0.0 113.062 -173.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -163.38 158.01 17.37 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 127.353 2.261 . . . . 0.0 107.25 -175.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -69.99 40.12 0.3 Allowed 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 124.09 3.193 . . . . 0.0 114.825 174.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.4 m -60.76 -27.84 68.26 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.642 1.177 . . . . 0.0 112.448 -175.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 28.4 ttt -111.24 122.7 37.02 Favored Pre-proline 0 N--CA 1.454 -0.227 0 N-CA-C 103.039 -2.949 . . . . 0.0 103.039 169.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 120' ' ' ILE . 73.7 Cg_endo -77.79 160.43 30.97 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 121.517 1.478 . . . . 0.0 114.687 -168.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.511 HG13 HG22 ' A' ' 58' ' ' THR . 78.8 t -110.84 101.88 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 1 N-CA-C 98.888 -4.486 . . . . 0.0 98.888 166.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -141.99 157.25 45.16 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.64 1.176 . . . . 0.0 110.066 -168.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.0 t -140.39 120.16 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 123.472 0.709 . . . . 0.0 109.192 -172.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.1 m -84.02 142.9 30.13 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 168.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -120.91 137.03 54.79 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 125.682 1.593 . . . . 0.0 108.865 170.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.41 ' CE2' ' HB ' ' A' ' 53' ' ' THR . 44.1 p90 -169.01 146.17 3.64 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -173.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.8 m 57.34 161.35 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 128.1 2.56 . . . . 0.0 115.86 167.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.2 tp -112.68 84.33 1.96 Allowed 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 170.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -76.17 118.63 19.1 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.57 1.148 . . . . 0.0 108.806 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 51.83 35.4 15.39 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.356 1.062 . . . . 0.0 112.336 176.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.37 17.66 73.24 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 118.859 -0.967 . . . . 0.0 113.992 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -133.57 138.64 46.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.809 1.644 . . . . 0.0 107.853 -176.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -71.62 142.49 49.96 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 120.645 -1.284 . . . . 0.0 108.973 -177.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.41 ' HB ' ' CE2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -103.66 157.9 16.74 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.497 1.044 . . . . 0.0 109.56 -179.686 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.89 169.62 38.15 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 171.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 36.1 m -137.04 146.9 45.78 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 169.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 p -123.62 140.86 45.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 175.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.469 HD13 ' HA2' ' A' ' 123' ' ' GLY . 11.6 tt -119.83 152.06 22.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 168.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.511 HG22 HG13 ' A' ' 40' ' ' VAL . 48.6 p -140.53 176.79 2.29 Favored Pre-proline 0 C--N 1.32 -0.701 0 C-N-CA 125.595 1.558 . . . . 0.0 107.237 169.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -59.78 -6.05 4.2 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.501 2.134 . . . . 0.0 114.297 169.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.0 p-90 -130.09 -21.75 2.93 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -169.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.12 166.1 32.69 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 120.089 1.313 . . . . 0.0 112.721 -177.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.81 122.39 18.53 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 105.172 -2.159 . . . . 0.0 105.172 168.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 52.2 m -136.51 135.38 38.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.326 0.584 . . . . 0.0 109.973 -175.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.65 145.11 52.68 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 168.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.5 m -137.61 146.08 28.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 53.9 mt -141.19 146.44 23.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -174.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -134.21 157.09 78.36 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-O 117.438 -1.267 . . . . 0.0 110.376 -172.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -57.2 9.21 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 0.989 1 C-N-CA 126.053 4.502 . . . . 0.0 120.001 -169.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.27 -155.85 44.46 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 117.86 -1.522 . . . . 0.0 111.43 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -65.42 -146.91 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.815 1 C-N-CA 125.324 4.016 . . . . 0.0 113.383 -174.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -74.43 58.1 0.74 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.457 1.503 . . . . 0.0 111.059 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -102.87 135.76 43.95 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 127.178 2.191 . . . . 0.0 106.855 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -108.11 88.19 2.67 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -177.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -69.23 149.79 97.42 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-O 118.847 -0.596 . . . . 0.0 109.407 172.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -67.76 157.21 62.79 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 N-CA-C 107.708 -1.689 . . . . 0.0 107.708 168.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 40.2 tp -62.94 122.99 17.39 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -88.27 159.23 18.2 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -174.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt -86.03 152.65 22.73 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 168.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 83.9 t -99.74 155.08 4.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.342 -1.299 . . . . 0.0 107.862 -169.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.4 m 65.14 7.49 4.15 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.581 1.552 . . . . 0.0 113.489 -173.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -78.27 157.99 29.06 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 125.344 1.457 . . . . 0.0 107.967 169.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -122.86 141.29 52.03 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 123.054 0.542 . . . . 0.0 110.471 -177.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.2 mm -117.2 121.25 67.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -74.28 122.44 7.38 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.655 -1.778 . . . . 0.0 108.655 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.4 tp -120.36 132.35 55.24 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 124.443 1.097 . . . . 0.0 108.637 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -87.48 127.8 35.23 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 173.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mp -135.89 157.91 75.03 Favored Pre-proline 0 C--O 1.235 0.296 0 C-N-CA 125.295 1.438 . . . . 0.0 107.91 173.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -61.66 -20.24 68.15 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.367 2.044 . . . . 0.0 114.243 171.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -58.22 -32.26 68.13 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.504 0.722 . . . . 0.0 111.147 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 133.17 157.31 8.37 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 106.621 -2.592 . . . . 0.0 106.621 -169.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.1 m -66.53 130.02 41.79 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 58.5 mtm -137.46 141.16 41.57 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -176.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.77 129.88 34.77 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 170.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -99.21 124.75 44.51 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 169.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 13.6 m -81.07 140.43 35.11 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 95.3 t -75.38 120.11 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 169.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -109.48 163.54 12.5 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 172.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -125.3 95.04 4.33 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 170.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.7 tp -74.25 125.76 29.14 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -169.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -59.34 128.57 37.73 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.625 0.77 . . . . 0.0 110.108 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.77 3.91 84.53 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.689 -1.062 . . . . 0.0 113.869 -177.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.4 t -126.64 -119.92 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 119.263 1.531 . . . . 0.0 107.596 177.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.2 m -150.73 -179.31 7.15 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.622 1.569 . . . . 0.0 108.791 -169.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -69.85 143.44 52.85 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 169.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.26 172.57 16.79 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.437 1.495 . . . . 0.0 108.559 178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.6 mp -106.52 142.6 35.91 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 172.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.3 p -142.11 152.65 43.46 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.693 0.797 . . . . 0.0 110.411 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 15.7 t -144.43 119.69 10.19 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 171.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.0 m -67.68 129.09 38.82 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 81.4 mt -92.3 -52.57 4.61 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.72 175.32 12.11 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.455 1.502 . . . . 0.0 108.102 171.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.3 m -116.64 62.79 2.71 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.633 1.173 . . . . 0.0 110.69 -175.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -64.33 129.7 24.81 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.297 1.998 . . . . 0.0 109.771 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.2 tt -151.84 110.33 3.78 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 171.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.7 m -148.37 144.1 27.28 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -176.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -82.13 -25.59 34.26 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.332 0.514 . . . . 0.0 109.935 173.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.5 m -80.29 63.95 4.94 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.773 1.229 . . . . 0.0 109.046 170.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.87 161.2 41.78 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.946 1.699 . . . . 0.0 107.745 -175.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 93.5 p -152.37 172.23 16.8 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 121.767 0.794 . . . . 0.0 112.286 -169.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.429 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 1.1 pp -64.64 -20.09 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 124.871 1.268 . . . . 0.0 112.215 169.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -79.63 -55.39 5.06 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -66.1 -30.85 71.43 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 123.591 0.757 . . . . 0.0 110.584 177.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.469 ' HA2' HD13 ' A' ' 57' ' ' ILE . . . -64.15 -52.18 46.57 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-N 119.804 1.184 . . . . 0.0 111.596 175.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -65.75 -46.82 77.4 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.164 0.982 . . . . 0.0 110.082 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -58.55 -43.82 89.47 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 118.423 -0.799 . . . . 0.0 110.566 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 19.0 tp -76.74 -28.34 55.72 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 119.365 0.984 . . . . 0.0 111.619 -173.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -69.08 -39.75 78.87 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 120.083 1.31 . . . . 0.0 109.498 174.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.21 -43.87 66.52 Favored 'General case' 0 N--CA 1.46 0.052 0 C-N-CA 122.985 0.514 . . . . 0.0 111.332 176.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -57.92 -39.14 77.25 Favored 'General case' 0 C--N 1.332 -0.156 0 O-C-N 121.176 -0.952 . . . . 0.0 109.612 173.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 20.0 m -64.33 -34.53 78.36 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 119.424 -0.322 . . . . 0.0 110.758 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.69 -56.79 15.93 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.397 0.679 . . . . 0.0 109.926 174.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -42.16 97.94 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 119.412 1.006 . . . . 0.0 109.556 -177.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 53.1 ttp -49.31 -55.39 12.93 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.956 1.302 . . . . 0.0 110.192 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 6.7 pt -80.3 -21.99 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 119.879 1.218 . . . . 0.0 112.604 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 24.5 mt -67.16 -56.53 9.56 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 118.615 0.643 . . . . 0.0 110.947 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.8 m -143.93 6.7 1.39 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -169.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.9 tp 44.86 54.18 12.5 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.137 1.375 . . . . 0.0 114.255 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -66.33 162.24 37.12 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.777 2.318 . . . . 0.0 111.355 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 43.1 t -123.59 148.46 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.306 1.442 . . . . 0.0 107.256 174.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 7.8 m -57.29 133.1 54.81 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.013 0.925 . . . . 0.0 110.217 -176.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 29.0 t30 -147.85 121.5 4.84 Favored Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 124.925 1.29 . . . . 0.0 107.684 175.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -59.54 150.74 74.05 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.745 2.297 . . . . 0.0 111.915 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -141.0 145.69 36.27 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.315 1.446 . . . . 0.0 109.93 -176.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.27 146.62 20.27 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 125.591 1.557 . . . . 0.0 107.44 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -59.67 -39.79 70.72 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.746 2.298 . . . . 0.0 112.489 178.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -153.07 125.15 7.97 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.877 1.271 . . . . 0.0 108.044 173.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.32 -31.6 48.83 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.403 0.281 . . . . 0.0 111.293 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 71.5 -178.01 35.93 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.106 0.86 . . . . 0.0 111.995 -176.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 89.0 mmt-85 -145.91 157.55 43.89 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 126.034 1.733 . . . . 0.0 107.693 172.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -83.22 64.99 8.02 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 171.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -60.89 -31.43 70.92 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.097 0.559 . . . . 0.0 112.316 -169.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -81.35 -2.71 50.23 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -178.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 37.6 tp -84.08 66.75 9.4 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -70.63 -32.0 69.16 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.474 0.709 . . . . 0.0 111.58 -175.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 66.7 -162.12 45.5 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -172.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 68.76 139.53 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.273 2.229 . . . . 0.0 110.351 -170.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 53.3 29.77 9.1 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.074 0.95 . . . . 0.0 111.549 -169.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.8 m -58.71 139.24 56.43 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.744 0.818 . . . . 0.0 111.077 -169.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 100.13 -48.91 1.18 Allowed Glycine 0 CA--C 1.528 0.89 0 C-N-CA 125.08 1.324 . . . . 0.0 110.032 -175.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -77.7 -45.13 25.75 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 169.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -87.39 127.84 35.2 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.737 1.615 . . . . 0.0 107.006 169.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 C-N-CA 125.583 1.553 . . . . 0.0 107.772 178.04 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 tpt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 120.662 0.267 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.4 p -70.19 -25.52 63.46 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.034 -1.041 . . . . 0.0 112.276 -176.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -84.54 39.35 0.73 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.659 1.184 . . . . 0.0 111.004 -177.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -138.94 162.24 35.36 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.88 1.672 . . . . 0.0 109.374 -177.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 mt -117.91 138.59 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 174.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.07 154.6 39.13 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.744 0.417 . . . . 0.0 110.55 176.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.22 156.65 34.14 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 169.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -125.07 151.48 45.61 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.474 1.11 . . . . 0.0 110.007 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -85.21 -21.16 29.25 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.941 0.896 . . . . 0.0 111.844 -176.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.4 p -159.06 -178.73 7.44 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 128.739 2.815 . . . . 0.0 105.897 173.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.7 m -59.49 139.91 88.87 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 168.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -76.16 54.45 4.19 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 124.553 3.502 . . . . 0.0 107.807 169.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.7 pttm -60.41 -34.89 74.59 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.634 1.174 . . . . 0.0 113.13 -168.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.58 -42.34 87.13 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.207 0.912 . . . . 0.0 110.614 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -70.9 -41.08 71.74 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 81.3 t -59.97 -42.55 89.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 172.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -60.74 -53.55 56.06 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 123.479 0.712 . . . . 0.0 109.71 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -62.57 -40.97 98.55 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.367 0.53 . . . . 0.0 110.857 -176.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.74 -46.81 83.66 Favored 'General case' 0 N--CA 1.456 -0.126 0 O-C-N 122.238 -0.289 . . . . 0.0 110.466 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -70.96 -28.25 64.33 Favored 'General case' 0 C--O 1.23 0.065 0 CA-C-O 118.65 -0.69 . . . . 0.0 112.446 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.8 -37.24 83.64 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 119.114 0.87 . . . . 0.0 109.615 174.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -65.73 -41.49 92.18 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 118.721 -0.657 . . . . 0.0 110.448 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.6 mm -64.76 -41.86 93.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 119.717 1.144 . . . . 0.0 109.559 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.6 -26.54 66.31 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.939 0.495 . . . . 0.0 111.459 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 55.5 ttp85 -71.93 -47.88 49.35 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 172.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.08 -16.34 1.93 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.487 1.515 . . . . 0.0 114.132 175.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.5 m -62.95 -22.73 67.0 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 119.799 1.181 . . . . 0.0 112.084 172.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 21.2 ptt? -110.97 169.59 8.67 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.48 1.512 . . . . 0.0 108.962 169.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -62.44 153.66 30.74 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.021 0.439 . . . . 0.0 110.106 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -63.29 -29.96 71.19 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -169.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -83.49 -8.9 59.27 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.1 m -79.85 147.72 31.64 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 119.028 0.831 . . . . 0.0 109.377 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -136.7 30.84 2.82 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.811 0.844 . . . . 0.0 110.94 -175.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -64.04 147.12 52.89 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.659 -0.65 . . . . 0.0 109.445 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 86.7 t60 -69.64 140.88 89.76 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-O 118.447 -0.787 . . . . 0.0 109.513 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -66.35 -32.39 41.23 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.21 1.94 . . . . 0.0 113.851 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.3 m 65.64 -4.87 0.54 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 127.3 2.24 . . . . 0.0 114.464 -176.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 22.4 mmt -141.61 90.49 8.77 Favored Pre-proline 0 N--CA 1.458 -0.069 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 170.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -51.58 134.72 47.12 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.976 2.451 . . . . 0.0 111.671 -176.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.46 128.68 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 169.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -148.55 150.82 34.02 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.583 1.153 . . . . 0.0 108.634 -170.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.6 t -141.73 121.15 10.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.2 p -96.82 154.93 17.0 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 118.849 0.749 . . . . 0.0 110.939 169.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -119.52 142.87 47.93 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.743 2.017 . . . . 0.0 109.614 -171.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -147.22 167.73 23.47 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -169.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 65.7 m -14.3 139.82 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 1 C-N-CA 133.208 4.603 . . . . 0.0 117.149 169.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.0 tp -78.4 127.95 32.93 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 169.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -147.6 146.07 29.24 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 125.47 1.508 . . . . 0.0 107.311 175.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 53.91 26.63 6.4 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 120.482 1.492 . . . . 0.0 112.876 -175.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.18 25.4 75.47 Favored Glycine 0 CA--C 1.535 1.303 0 O-C-N 121.228 -0.92 . . . . 0.0 113.446 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -148.36 149.06 31.12 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.222 1.409 . . . . 0.0 110.056 -173.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -79.75 140.35 36.96 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 121.212 -0.93 . . . . 0.0 109.122 -177.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.0 160.09 20.11 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 121.805 0.812 . . . . 0.0 108.857 170.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -167.19 162.74 36.53 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 107.581 -2.208 . . . . 0.0 107.581 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 13.0 m -138.92 147.03 41.78 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 169.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 p -122.23 147.65 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 125.108 1.363 . . . . 0.0 107.817 172.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.4 tt -128.31 151.24 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 169.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.0 p -141.98 177.7 1.8 Allowed Pre-proline 0 C--N 1.32 -0.706 0 C-N-CA 125.331 1.452 . . . . 0.0 107.282 171.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -60.23 -30.37 91.06 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 CA-C-N 119.99 1.032 . . . . 0.0 110.552 168.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.8 p-90 -94.29 -25.24 17.1 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -169.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.57 170.36 22.59 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 120.506 1.503 . . . . 0.0 112.965 -174.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 tt -137.72 123.98 20.53 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 168.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 50.7 m -137.36 134.51 36.07 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.438 0.637 . . . . 0.0 110.451 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.32 139.62 44.3 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 168.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.6 m -139.21 140.16 38.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -172.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.6 mm -135.73 138.53 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -169.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -131.02 145.63 58.6 Favored Pre-proline 0 N--CA 1.474 0.729 0 CA-C-O 117.692 -1.147 . . . . 0.0 111.867 -169.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -51.02 137.6 44.26 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.15 2.567 . . . . 0.0 112.698 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.52 179.83 28.92 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 123.427 0.537 . . . . 0.0 113.306 -175.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.43 123.4 11.73 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.992 2.461 . . . . 0.0 110.191 -173.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.1 t70 49.69 35.7 9.37 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.218 1.407 . . . . 0.0 113.15 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -95.87 127.77 42.18 Favored 'General case' 0 C--N 1.344 0.341 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 173.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.49 75.74 0.94 Allowed 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -170.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 48.7 m0 -68.58 149.07 98.1 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.192 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.31 151.84 80.09 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.011 1.807 . . . . 0.0 109.053 169.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.8 tp -56.04 131.91 48.69 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.557 -0.715 . . . . 0.0 109.254 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.41 157.95 16.06 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -90.3 148.86 22.61 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 169.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.2 t -91.6 154.81 3.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -169.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.5 m 60.72 33.7 20.13 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.911 0.884 . . . . 0.0 111.98 -176.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -112.27 155.6 23.79 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 127.019 2.128 . . . . 0.0 106.989 169.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -105.77 142.22 35.87 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.289 0.949 . . . . 0.0 110.546 178.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.7 mm -121.19 131.58 72.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.11 126.36 8.26 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 174.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.8 mt -113.01 124.87 53.62 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 172.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.64 133.36 43.43 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 169.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.4 mt -141.19 158.22 64.79 Favored Pre-proline 0 C--O 1.234 0.254 0 C-N-CA 124.13 0.972 . . . . 0.0 108.465 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -57.77 -29.63 86.48 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.738 2.292 . . . . 0.0 112.81 170.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -64.38 -18.5 64.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.45 1.1 . . . . 0.0 113.023 173.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 110.47 154.54 14.13 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 107.821 -2.112 . . . . 0.0 107.821 -168.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.1 m -65.03 132.35 48.98 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -175.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 64.3 mtm -141.12 145.75 36.16 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.846 1.258 . . . . 0.0 108.345 -178.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.41 136.91 37.09 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 121.597 -0.689 . . . . 0.0 109.33 172.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -115.34 139.7 49.76 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 169.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.7 m -87.12 137.18 32.57 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 52.5 t -68.08 122.56 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 170.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -109.34 163.11 12.57 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 107.565 -2.214 . . . . 0.0 107.565 169.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -133.38 94.25 3.29 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 171.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 51.5 tp -80.28 126.44 31.14 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -170.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -59.81 132.4 53.83 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.219 0.608 . . . . 0.0 110.451 -175.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.94 5.43 75.34 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.659 -1.078 . . . . 0.0 113.482 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.9 t -125.62 -115.27 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.8 p -159.23 178.67 9.74 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 119.742 1.155 . . . . 0.0 110.236 -169.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -73.64 138.05 44.56 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 169.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -153.87 165.15 36.99 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.777 1.631 . . . . 0.0 107.684 -175.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.4 mp -111.47 130.35 55.75 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.5 m -131.23 150.46 52.14 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.519 0.728 . . . . 0.0 110.913 -170.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 40.4 t -143.14 121.47 12.31 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 169.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.1 m -76.2 137.55 40.08 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -90.41 -67.49 0.84 Allowed 'General case' 0 C--N 1.339 0.119 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 175.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.14 173.2 8.1 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.908 1.283 . . . . 0.0 109.054 -175.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.2 m -83.63 124.89 74.8 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 169.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -82.1 41.23 1.09 Allowed 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.61 2.873 . . . . 0.0 112.0 -171.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.2 mt -87.17 42.6 1.04 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.36 1.464 . . . . 0.0 110.242 -173.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.0 m -66.45 155.36 37.75 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.128 0.971 . . . . 0.0 110.418 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -72.17 -56.79 4.97 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 175.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.1 m -84.95 99.44 10.97 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.36 139.58 15.61 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -169.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 62.6 m -148.68 163.9 35.95 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.142 1.777 . . . . 0.0 107.993 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -51.36 -38.42 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.778 1.231 . . . . 0.0 111.394 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -75.74 -35.01 60.34 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.898 0.479 . . . . 0.0 109.751 -174.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -68.15 -28.87 67.67 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 124.6 1.16 . . . . 0.0 110.585 169.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.76 -55.54 30.27 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 120.235 1.379 . . . . 0.0 110.13 171.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -63.56 -51.35 65.75 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.557 -0.966 . . . . 0.0 110.189 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -68.41 -17.61 64.26 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-O 117.979 -1.01 . . . . 0.0 112.908 -175.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 32.8 tp -88.53 -25.86 22.32 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 120.257 1.389 . . . . 0.0 109.56 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.8 m -63.57 -48.74 76.21 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 169.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -61.06 -49.37 77.64 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 124.58 1.152 . . . . 0.0 111.933 175.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -62.47 -33.82 75.6 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.636 0.653 . . . . 0.0 110.469 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 34.8 m -69.99 -28.47 65.55 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.444 0.565 . . . . 0.0 111.216 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.03 -51.07 13.1 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.884 0.765 . . . . 0.0 109.564 170.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -51.84 -49.88 61.98 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.042 0.937 . . . . 0.0 110.147 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -56.79 -39.69 74.55 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.055 -178.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 22.4 pt -82.77 -22.62 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 119.722 1.147 . . . . 0.0 111.928 -178.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 52.2 mt -74.45 -24.93 59.13 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.414 0.686 . . . . 0.0 109.491 169.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.4 m 55.25 18.2 2.37 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 128.15 2.58 . . . . 0.0 114.993 176.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 96.6 mt -151.08 140.66 13.94 Favored Pre-proline 0 C--O 1.234 0.249 0 C-N-CA 127.04 2.136 . . . . 0.0 108.058 -174.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -71.67 124.89 10.62 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.277 1.985 . . . . 0.0 107.985 169.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.2 p -153.46 144.57 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 7.3 m -86.5 144.89 27.03 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.276 1.03 . . . . 0.0 109.185 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -141.13 104.84 6.1 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 169.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -60.32 136.09 65.9 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.561 2.174 . . . . 0.0 111.429 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.51 140.33 38.58 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 170.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.5 t -141.79 146.51 41.37 Favored Pre-proline 0 C--O 1.238 0.467 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.53 147.13 49.61 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.668 2.912 . . . . 0.0 109.928 168.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -69.03 125.09 25.56 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.53 156.94 28.98 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.334 0.654 . . . . 0.0 110.14 -174.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 70.54 18.35 75.45 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.384 -0.676 . . . . 0.0 114.108 170.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 62.5 mtm180 -64.6 147.46 52.88 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.9 1.35 . . . . 0.0 109.455 174.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 94.8 mtm-85 -68.96 153.84 43.1 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.45 -8.02 59.38 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.451 0.701 . . . . 0.0 112.31 175.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -143.35 159.93 41.46 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.336 1.454 . . . . 0.0 110.183 -178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 94.1 mt -107.11 162.72 13.62 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.457 1.103 . . . . 0.0 109.154 172.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -122.33 148.68 44.75 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.955 1.302 . . . . 0.0 109.428 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -97.74 -177.07 33.87 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 173.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -66.08 -32.96 74.74 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.852 -0.793 . . . . 0.0 111.014 176.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -74.73 -19.64 60.16 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.5 m -67.68 153.74 43.03 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.462 0.705 . . . . 0.0 110.772 -178.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -178.23 166.49 36.55 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 177.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -138.6 158.73 43.7 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.637 1.575 . . . . 0.0 108.492 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -74.88 143.71 43.71 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 122.862 0.465 . . . . 0.0 109.975 174.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.2 0 C-N-CA 126.084 1.754 . . . . 0.0 110.599 -178.593 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.495 1.811 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.4 p -80.09 -29.95 39.13 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.943 0.897 . . . . 0.0 111.253 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -66.46 137.95 57.19 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 46.81 80.76 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.738 2.015 . . . . 0.0 112.711 174.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.1 mm -71.24 138.29 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.36 132.27 47.35 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.6 -0.687 . . . . 0.0 109.244 176.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.12 145.76 49.29 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 173.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -91.88 147.08 23.24 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.632 0.773 . . . . 0.0 109.65 -174.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 -74.07 -29.48 61.9 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 118.969 -0.539 . . . . 0.0 110.756 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.1 p -154.88 164.03 39.43 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 127.337 2.255 . . . . 0.0 107.962 171.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.4 m -45.85 135.77 6.36 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 125.644 1.578 . . . . 0.0 111.801 173.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.11 52.41 3.82 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.201 3.267 . . . . 0.0 110.525 172.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -53.54 -49.69 67.07 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.202 1.801 . . . . 0.0 111.675 -169.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.58 -41.34 96.33 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.609 0.363 . . . . 0.0 111.284 -178.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -71.51 -41.57 69.06 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.877 0.471 . . . . 0.0 109.764 -174.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 89.9 t -62.31 -45.95 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 172.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -58.85 -53.12 62.02 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.096 0.862 . . . . 0.0 110.872 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.52 -42.46 95.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.901 0.773 . . . . 0.0 111.034 -174.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.25 -46.26 87.73 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -71.21 -25.34 62.47 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-O 118.147 -0.93 . . . . 0.0 112.014 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -62.91 -34.29 77.11 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.98 1.264 . . . . 0.0 109.579 172.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -79.65 -46.91 16.29 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.718 0.407 . . . . 0.0 110.554 177.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.4 mt -59.93 -39.97 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.447 0.699 . . . . 0.0 109.185 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.79 -36.3 82.68 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.445 -0.784 . . . . 0.0 111.183 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.7 ttp180 -74.36 -40.42 62.14 Favored 'General case' 0 N--CA 1.46 0.06 0 C-N-CA 123.252 0.621 . . . . 0.0 109.955 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -59.57 -40.65 88.02 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.677 0.791 . . . . 0.0 110.831 170.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 64.6 m -77.49 -44.24 29.48 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.259 0.624 . . . . 0.0 112.441 -172.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 47.5 tpp -79.85 146.21 32.34 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 122.975 0.51 . . . . 0.0 110.221 -172.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -116.77 167.0 11.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.893 1.277 . . . . 0.0 110.03 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.3 t70 57.28 35.05 25.63 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 122.924 1.345 . . . . 0.0 109.978 -169.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.9 tp -111.06 41.1 1.89 Allowed 'General case' 0 C--N 1.342 0.263 0 C-N-CA 126.333 1.853 . . . . 0.0 108.878 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.5 m -59.06 -15.5 14.04 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.688 1.195 . . . . 0.0 113.641 -177.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -69.16 -14.58 63.07 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.682 1.193 . . . . 0.0 112.323 170.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 98.7 mt 55.29 27.61 10.09 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.855 2.462 . . . . 0.0 113.943 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 67.7 t60 -142.78 145.91 35.73 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -52.88 142.88 50.92 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.121 2.548 . . . . 0.0 114.349 -178.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 p -79.7 -19.77 48.12 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.784 1.633 . . . . 0.0 112.619 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 68.6 mtm -138.24 159.73 66.91 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 128.147 2.579 . . . . 0.0 104.22 177.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.413 ' HD3' HG22 ' A' ' 120' ' ' ILE . 92.8 Cg_endo -69.62 142.99 50.09 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.221 1.281 . . . . 0.0 112.509 -168.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.457 HG13 HG22 ' A' ' 58' ' ' THR . 97.7 t -104.51 105.89 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 102.058 -3.312 . . . . 0.0 102.058 167.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -142.43 156.33 45.18 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.574 1.15 . . . . 0.0 109.109 -169.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.0 t -137.38 117.24 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -176.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.6 p -78.27 150.06 33.44 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.394 0.997 . . . . 0.0 108.893 168.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.96 131.98 49.25 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.77 1.628 . . . . 0.0 108.64 173.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.769 ' CE1' ' HB1' ' A' ' 131' ' ' ALA . 5.3 p90 -168.78 150.6 4.79 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 123.645 0.778 . . . . 0.0 112.408 -176.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 95.1 m 55.65 157.36 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 128.571 2.748 . . . . 0.0 116.591 167.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.2 tt -111.87 116.15 30.17 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 169.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -139.44 141.82 37.44 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.219 1.408 . . . . 0.0 108.966 -172.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 53.94 26.41 6.27 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.538 1.135 . . . . 0.0 112.297 -172.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.64 5.43 83.2 Favored Glycine 0 CA--C 1.536 1.346 0 O-C-N 120.957 -1.089 . . . . 0.0 113.576 -175.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -118.16 165.92 13.2 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.603 2.361 . . . . 0.0 109.732 -173.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -85.52 148.76 25.8 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.692 1.133 . . . . 0.0 109.866 172.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.19 157.45 19.41 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.494 1.043 . . . . 0.0 110.23 -174.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -171.3 175.76 44.78 Favored Glycine 0 N--CA 1.449 -0.458 0 O-C-N 120.826 -1.171 . . . . 0.0 110.574 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 31.3 m -140.07 154.79 47.17 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 169.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.2 p -124.88 144.37 35.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 173.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.5 tt -124.65 150.79 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 168.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.457 HG22 HG13 ' A' ' 40' ' ' VAL . 26.5 p -142.52 177.16 1.97 Allowed Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 171.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.26 -14.31 44.38 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 CA-C-N 121.179 1.457 . . . . 0.0 111.593 168.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.4 p-90 -108.56 -21.91 12.51 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -172.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 21.9 ptt? -157.59 164.96 36.73 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 120.421 1.464 . . . . 0.0 112.669 -177.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 tt -134.68 123.99 24.59 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 103.185 -2.895 . . . . 0.0 103.185 167.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.7 m -142.17 134.46 27.76 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.029 0.377 . . . . 0.0 110.069 -172.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.76 143.32 57.58 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 168.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.3 m -140.12 145.79 25.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 37.8 mt -139.83 133.05 35.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 -172.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -122.1 154.04 61.39 Favored Pre-proline 0 N--CA 1.467 0.394 0 CA-C-O 117.785 -1.102 . . . . 0.0 111.023 -169.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -47.96 118.91 3.42 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.546 2.831 . . . . 0.0 112.466 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.43 179.09 26.19 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 123.246 0.342 . . . . 0.0 112.478 -177.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.6 160.18 31.68 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.021 2.481 . . . . 0.0 111.571 -174.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.8 t0 42.91 52.09 5.2 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.805 2.042 . . . . 0.0 113.776 169.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -152.31 160.68 43.29 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.525 1.13 . . . . 0.0 108.526 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -103.73 112.19 25.03 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 169.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.0 130.13 91.7 Favored Pre-proline 0 C--O 1.238 0.49 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.76 147.51 81.28 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.883 1.722 . . . . 0.0 109.825 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 34.0 tp -69.29 121.91 17.82 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 173.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.82 159.83 18.61 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.688 1.195 . . . . 0.0 108.924 176.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -80.27 151.23 29.69 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 169.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.4 t -99.34 151.31 4.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -169.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.9 m 59.92 24.66 13.75 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.116 0.967 . . . . 0.0 112.324 -175.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -109.82 157.63 18.99 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 128.652 2.781 . . . . 0.0 105.023 169.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -108.77 147.55 31.87 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.03 0.832 . . . . 0.0 111.606 -176.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.7 mm -122.16 131.98 71.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.35 124.65 7.73 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 173.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.1 mt -111.67 137.26 49.79 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 171.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -90.71 129.43 36.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 174.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -153.86 159.24 32.27 Favored Pre-proline 0 C--O 1.235 0.307 0 C-N-CA 125.06 1.344 . . . . 0.0 108.562 172.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -67.08 -15.7 47.28 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.224 1.949 . . . . 0.0 114.219 -170.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -58.39 -26.01 62.72 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.299 0.64 . . . . 0.0 111.042 169.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.57 148.02 7.59 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 106.41 -2.676 . . . . 0.0 106.41 -169.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.0 m -60.26 130.85 48.69 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 49.9 mtm -134.15 141.92 47.27 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 124.025 0.93 . . . . 0.0 108.649 -175.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -81.96 113.29 19.77 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 172.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -91.9 136.71 32.95 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 171.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 12.1 m -83.48 137.92 33.67 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.5 t -73.39 125.81 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 173.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -106.74 154.83 16.65 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.197 -2.361 . . . . 0.0 107.197 169.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -129.12 103.03 6.75 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 170.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.8 tp -85.26 122.39 29.36 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -176.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -60.38 131.35 50.49 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.265 0.626 . . . . 0.0 110.687 -173.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.01 3.59 69.21 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 118.759 -1.023 . . . . 0.0 113.66 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 15.9 t -120.61 -103.87 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 119.074 1.437 . . . . 0.0 107.24 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.8 p -163.97 173.94 12.01 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 119.952 1.251 . . . . 0.0 110.737 -171.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -78.8 142.01 37.29 Favored 'General case' 0 C--N 1.341 0.201 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 168.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -154.26 177.65 10.89 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.027 1.331 . . . . 0.0 108.029 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.3 mt -124.45 137.79 54.41 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 124.18 0.992 . . . . 0.0 108.922 -173.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.7 m -135.66 147.39 48.56 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.627 1.171 . . . . 0.0 110.028 -173.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 36.6 t -140.52 118.28 11.7 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 172.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.9 m -67.99 135.05 51.73 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.242 0.617 . . . . 0.0 109.438 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.8 mt -109.22 -47.77 3.36 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 123.646 0.778 . . . . 0.0 110.636 -176.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 17.7 ptp -160.42 169.46 23.01 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.918 0.887 . . . . 0.0 110.111 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.2 m -111.68 108.5 56.07 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 169.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -69.12 161.25 46.62 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.569 2.18 . . . . 0.0 111.084 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -143.61 158.23 43.82 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 124.822 1.249 . . . . 0.0 109.563 175.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.5 m -69.01 -17.53 63.93 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -169.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -82.57 140.84 33.03 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 118.775 0.716 . . . . 0.0 109.999 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.9 m 54.19 38.21 28.74 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.323 1.049 . . . . 0.0 111.111 -176.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 8.3 tpt -148.64 144.36 27.13 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.272 1.429 . . . . 0.0 109.12 -169.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 29.8 m -145.02 164.76 30.18 Favored 'General case' 0 C--N 1.334 -0.098 0 C-N-CA 125.977 1.711 . . . . 0.0 107.178 173.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.413 HG22 ' HD3' ' A' ' 39' ' ' PRO . 0.1 OUTLIER -69.33 -21.0 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 O-C-N 121.066 -1.021 . . . . 0.0 112.771 -176.236 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -70.63 -44.72 66.59 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 173.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -60.5 -39.55 88.13 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 118.278 -0.868 . . . . 0.0 109.313 172.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.68 -54.96 33.21 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 119.595 1.088 . . . . 0.0 111.521 177.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -62.36 -49.23 76.38 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.671 -0.9 . . . . 0.0 110.358 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 83.6 mtt-85 -69.97 -19.17 63.37 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.62 -0.675 . . . . 0.0 111.985 -175.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.1 tp -89.06 -18.94 26.28 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 124.138 0.975 . . . . 0.0 109.447 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.5 m -69.64 -44.99 69.48 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 169.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -66.94 -42.53 85.14 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.577 -0.702 . . . . 0.0 112.003 174.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -69.64 -29.76 67.31 Favored 'General case' 0 C--N 1.334 -0.067 0 O-C-N 121.176 -0.953 . . . . 0.0 110.731 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 22.8 m -70.27 -43.02 71.34 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.378 0.535 . . . . 0.0 110.281 174.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.769 ' HB1' ' CE1' ' A' ' 45' ' ' PHE . . . -53.67 -45.79 70.41 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.296 1.039 . . . . 0.0 109.922 173.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 19.5 ttp-105 -69.75 -50.09 46.77 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 121.354 -0.841 . . . . 0.0 111.578 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.88 -26.68 67.59 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.53 1.059 . . . . 0.0 112.764 -171.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 10.7 pt -77.31 -11.52 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 120.2 1.364 . . . . 0.0 113.376 174.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 75.4 mt -73.78 -32.59 63.85 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 169.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.9 m 54.1 24.85 5.1 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.387 1.875 . . . . 0.0 114.89 173.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 92.4 mt -144.45 150.59 48.26 Favored Pre-proline 0 C--O 1.238 0.459 0 C-N-CA 126.197 1.799 . . . . 0.0 108.969 -174.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -70.02 168.9 20.55 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.182 2.588 . . . . 0.0 110.697 170.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 44.6 t -67.23 137.81 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 173.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 3.8 m -65.08 144.62 57.13 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.12 0.968 . . . . 0.0 110.228 -176.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -125.65 84.88 59.78 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 171.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.25 160.57 48.5 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.983 2.455 . . . . 0.0 111.356 -175.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -148.2 132.87 17.84 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.944 1.697 . . . . 0.0 107.823 170.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.5 m -139.94 157.11 70.12 Favored Pre-proline 0 C--O 1.24 0.585 0 C-N-CA 124.898 1.279 . . . . 0.0 110.542 -169.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -67.61 174.22 7.78 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.773 2.315 . . . . 0.0 110.631 169.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -55.79 131.58 47.17 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 123.13 0.572 . . . . 0.0 109.708 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -77.53 -39.47 45.98 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.6 0.36 . . . . 0.0 110.311 176.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -90.35 -149.47 22.38 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.658 1.123 . . . . 0.0 110.715 173.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -61.63 161.86 9.24 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.176 0.59 . . . . 0.0 111.194 173.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -64.33 145.84 55.37 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 169.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -79.77 -9.21 59.62 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 175.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 11.3 mp -63.73 148.88 48.01 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.461 1.104 . . . . 0.0 109.577 177.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -73.56 122.05 21.62 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 169.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -151.56 161.39 42.76 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.332 1.053 . . . . 0.0 109.143 -173.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 73.9 25.3 72.0 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 119.467 -0.63 . . . . 0.0 113.252 174.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -127.91 140.79 51.79 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.339 1.056 . . . . 0.0 108.625 174.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -80.15 -31.83 38.92 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 122.986 0.514 . . . . 0.0 110.633 177.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.3 m -65.33 144.03 57.38 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.882 0.873 . . . . 0.0 111.083 -173.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -81.01 -171.51 44.88 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 169.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -142.79 145.99 33.79 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.986 1.314 . . . . 0.0 107.804 175.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -68.84 137.1 53.65 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 122.922 0.489 . . . . 0.0 110.096 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.303 0 C-N-CA 125.527 1.531 . . . . 0.0 107.89 176.389 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tpt . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 119.604 -0.236 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.2 p -75.19 160.03 30.88 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.045 0.938 . . . . 0.0 110.281 176.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -85.82 55.94 3.75 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.051 0.94 . . . . 0.0 109.201 177.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -143.34 161.68 37.7 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.98 1.712 . . . . 0.0 109.383 -172.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.4 mt -132.15 131.89 61.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 175.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.75 128.22 35.03 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 170.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.67 146.07 48.75 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -93.03 138.79 31.18 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.701 0.8 . . . . 0.0 111.034 -169.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -69.14 -24.32 64.08 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.566 0.747 . . . . 0.0 111.151 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -162.12 172.42 15.87 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.86 1.264 . . . . 0.0 108.984 171.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.2 m -61.08 138.22 94.24 Favored Pre-proline 0 C--N 1.324 -0.502 0 C-N-CA 125.776 1.63 . . . . 0.0 110.432 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -69.77 48.14 0.61 Allowed 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 124.607 3.538 . . . . 0.0 112.706 169.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 42' ' ' VAL . 82.7 tttt -50.97 -57.15 9.32 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.025 1.73 . . . . 0.0 112.771 -169.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.454 ' HB3' ' CD2' ' A' ' 146' ' ' HIS . . . -68.85 -38.18 79.59 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 117.821 0.282 . . . . 0.0 110.273 -177.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -61.01 -45.37 95.07 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.627 0.771 . . . . 0.0 110.842 178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.0 t -64.57 -42.6 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -61.15 -51.54 68.62 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.839 0.745 . . . . 0.0 110.427 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.85 -39.41 93.51 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.006 0.922 . . . . 0.0 110.837 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.84 -46.17 90.62 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 175.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -72.81 -26.09 61.38 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 118.208 -0.901 . . . . 0.0 112.703 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -65.55 -28.87 69.47 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 120.084 1.311 . . . . 0.0 109.636 172.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -81.78 -47.52 12.76 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.244 1.018 . . . . 0.0 109.713 176.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.8 mt -67.9 -38.5 80.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 O-C-N 121.277 -0.889 . . . . 0.0 109.674 -175.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.6 -30.33 71.35 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.413 -0.804 . . . . 0.0 110.676 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 24.9 ttm105 -76.62 -37.5 56.27 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 123.518 0.727 . . . . 0.0 109.713 174.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -54.93 -38.89 68.26 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.915 0.886 . . . . 0.0 110.923 173.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.2 m -67.88 -8.79 39.46 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 174.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 60.9 mtt -122.21 33.97 5.31 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 127.132 2.173 . . . . 0.0 109.088 176.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.26 151.99 11.75 Favored 'General case' 0 C--N 1.34 0.189 0 O-C-N 121.478 -0.764 . . . . 0.0 111.478 -178.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.4 t70 68.41 -33.08 0.23 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 127.726 2.41 . . . . 0.0 112.685 -169.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 mp -89.25 23.92 2.34 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.453 1.501 . . . . 0.0 109.076 169.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.4 m -60.38 -17.22 42.28 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.832 1.653 . . . . 0.0 114.0 -169.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -66.58 -18.1 65.18 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.853 1.261 . . . . 0.0 112.501 174.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.0 mt -66.38 160.21 25.24 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.477 0.711 . . . . 0.0 110.662 177.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 25.8 p-80 -119.26 157.07 52.09 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 125.683 1.593 . . . . 0.0 108.54 169.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -57.44 134.61 64.65 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.538 2.159 . . . . 0.0 112.309 -177.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.2 m -71.42 -15.38 62.35 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.049 0.94 . . . . 0.0 112.638 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 35.2 tpp -144.8 144.41 24.27 Favored Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 174.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -52.77 139.71 58.37 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.014 1.809 . . . . 0.0 114.351 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.9 t -92.58 111.8 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 101.441 -3.541 . . . . 0.0 101.441 167.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -145.4 158.94 43.74 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.075 0.95 . . . . 0.0 110.152 -169.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.408 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 41.1 t -139.27 124.0 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.577 0.751 . . . . 0.0 109.61 -175.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.0 m -90.18 154.51 19.7 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.252 1.021 . . . . 0.0 110.57 168.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -118.83 147.08 44.31 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 127.78 2.432 . . . . 0.0 111.013 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.453 ' CE2' ' HB3' ' A' ' 131' ' ' ALA . 55.0 m-85 -155.65 170.37 22.18 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.919 1.452 . . . . 0.0 114.919 -170.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.1 m -17.17 153.72 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.566 1 C-N-CA 134.413 5.085 . . . . 0.0 118.486 169.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.9 mt -85.97 118.56 25.53 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 169.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -121.89 108.9 13.98 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.813 2.045 . . . . 0.0 106.688 -173.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 52.12 37.93 22.94 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.566 1.146 . . . . 0.0 111.06 -170.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.27 13.77 82.41 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 118.856 -0.969 . . . . 0.0 113.907 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -121.34 134.77 55.14 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.101 1.451 . . . . 0.0 108.608 -177.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -63.28 142.08 58.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 120.354 1.434 . . . . 0.0 109.654 173.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.42 162.93 13.45 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 122.236 1.017 . . . . 0.0 108.748 169.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.84 173.15 40.7 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 107.87 -2.092 . . . . 0.0 107.87 169.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 1.3 m -136.04 145.89 46.51 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 169.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 p -118.4 141.36 38.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 169.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.0 tt -122.75 151.93 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 169.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.1 p -141.19 179.05 1.32 Allowed Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 172.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -68.73 -13.19 36.5 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 CA-C-N 121.602 1.608 . . . . 0.0 111.585 169.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -111.76 -21.09 11.83 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -169.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 17.6 ptt? -157.36 160.57 38.6 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 120.161 1.346 . . . . 0.0 112.172 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.5 tt -130.77 123.21 28.67 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 103.351 -2.833 . . . . 0.0 103.351 167.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.4 m -134.4 131.81 38.64 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 123.875 0.734 . . . . 0.0 109.765 -177.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.01 145.28 50.09 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 168.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.4 m -135.62 147.84 28.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -177.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 58.6 mt -139.7 138.87 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -173.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -130.97 139.05 34.39 Favored Pre-proline 0 N--CA 1.466 0.332 0 CA-C-O 117.595 -1.193 . . . . 0.0 108.98 -177.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.37 130.1 34.47 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.567 2.178 . . . . 0.0 110.827 172.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.64 -166.84 33.47 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 119.602 -0.554 . . . . 0.0 112.426 -174.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -71.6 164.44 35.7 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.892 2.395 . . . . 0.0 112.915 -175.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.4 t0 42.57 55.69 4.09 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 127.397 2.279 . . . . 0.0 113.755 169.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -152.55 148.61 27.57 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.173 0.989 . . . . 0.0 109.35 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.9 mp -110.74 95.0 5.28 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.28 150.7 85.34 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.267 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -66.9 145.78 75.57 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.01 1.807 . . . . 0.0 110.763 171.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.1 tp -66.68 127.03 30.85 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 169.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -98.46 161.79 13.5 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.577 0.626 . . . . 0.0 110.074 -176.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.1 tmtm? -96.05 139.18 32.61 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 169.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.0 t -82.62 154.34 3.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 123.662 0.785 . . . . 0.0 109.332 -169.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 21.4 m 66.09 8.97 5.87 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.91 1.684 . . . . 0.0 113.769 -177.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -79.86 160.69 25.97 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.466 1.106 . . . . 0.0 108.136 168.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -112.9 142.33 45.69 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.708 -0.62 . . . . 0.0 110.41 177.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.6 mm -118.23 121.13 66.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 177.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.44 125.31 8.01 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 108.619 -1.793 . . . . 0.0 108.619 175.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.4 mt -120.51 141.81 49.89 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 124.344 1.057 . . . . 0.0 108.642 174.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -91.18 128.38 36.98 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 174.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 mp -135.07 162.01 60.22 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 124.763 1.225 . . . . 0.0 108.809 177.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -60.23 -21.89 68.28 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.527 2.151 . . . . 0.0 114.004 172.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -72.67 -4.21 29.72 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.599 1.16 . . . . 0.0 112.366 174.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.81 161.88 26.82 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 107.957 -2.057 . . . . 0.0 107.957 -168.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.8 m -68.84 131.99 46.03 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 69.8 mtm -139.9 144.04 36.97 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -177.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.68 132.29 35.18 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 172.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -102.17 132.66 47.94 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 169.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.5 m -83.95 142.19 30.7 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 66.5 t -74.59 124.83 33.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 170.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -112.02 161.4 12.75 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 170.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -132.59 93.78 3.29 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 171.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.9 tp -77.58 135.21 38.14 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -169.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -58.17 123.17 15.06 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.312 0.645 . . . . 0.0 111.691 -169.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.5 -3.4 33.27 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 118.688 -1.062 . . . . 0.0 113.998 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 5.8 t -101.31 -119.75 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 119.68 1.74 . . . . 0.0 106.337 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.3 m -148.17 174.99 11.41 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.629 1.571 . . . . 0.0 108.921 -169.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -72.53 142.31 48.49 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 168.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -153.48 171.8 18.12 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.1 1.36 . . . . 0.0 108.055 -178.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.4 mp -111.41 142.0 44.23 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.1 p -141.82 153.87 44.8 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.627 0.771 . . . . 0.0 110.588 -178.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.3 t -144.0 115.28 7.99 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 173.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.1 m -73.79 135.18 43.5 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 175.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.7 mt -123.95 -35.03 2.9 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.914 -1.041 . . . . 0.0 113.47 -169.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 13.4 ptp -159.64 169.62 23.34 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 120.249 1.386 . . . . 0.0 110.913 176.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.5 m -100.24 120.15 57.29 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.808 1.243 . . . . 0.0 108.425 169.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -70.8 -156.52 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 124.808 3.672 . . . . 0.0 113.313 174.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 62.91 41.09 8.9 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.275 1.43 . . . . 0.0 110.771 -174.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 m -73.18 157.65 36.76 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.926 -0.484 . . . . 0.0 109.854 172.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -63.89 -29.07 70.29 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.535 -0.728 . . . . 0.0 112.346 -170.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.2 m -89.22 -0.03 57.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.014 0.926 . . . . 0.0 112.836 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 42.4 mtp -73.58 156.47 38.04 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.275 0.943 . . . . 0.0 111.96 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.4 ' H ' ' HB2' ' A' ' 122' ' ' GLU . 80.4 p -156.93 176.71 12.4 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.384 2.274 . . . . 0.0 107.426 -175.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.728 ' H ' HD12 ' A' ' 120' ' ' ILE . 2.7 mp -53.82 -39.78 41.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.443 1.097 . . . . 0.0 109.59 171.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.69 -43.61 65.68 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.545 0.738 . . . . 0.0 109.456 -175.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.4 ' HB2' ' H ' ' A' ' 119' ' ' SER . 30.7 mm-40 -66.87 -28.48 68.36 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.079 173.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.61 -57.97 16.77 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 172.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -64.21 -52.73 57.42 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.647 -0.914 . . . . 0.0 110.778 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -66.83 -24.8 66.2 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 117.963 -1.017 . . . . 0.0 112.099 -173.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 26.7 tp -86.38 -29.9 22.57 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 120.748 1.613 . . . . 0.0 109.588 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.9 m -58.96 -48.19 82.42 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 169.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -64.0 -51.37 64.56 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.004 1.322 . . . . 0.0 112.083 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -65.5 -33.5 76.07 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 121.699 -0.626 . . . . 0.0 110.789 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 40.6 t -70.9 -34.03 71.16 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -178.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.453 ' HB3' ' CE2' ' A' ' 45' ' ' PHE . . . -68.13 -52.81 30.61 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 169.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 43.3 tpt85 -53.95 -46.84 71.71 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 123.539 0.736 . . . . 0.0 111.898 -175.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 15.2 ptt? -57.38 -27.25 62.14 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.58 1.082 . . . . 0.0 112.007 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 19.8 pt -102.2 9.9 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 124.421 1.089 . . . . 0.0 111.242 178.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 16.8 tp -151.06 69.97 0.97 Allowed 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.863 1.665 . . . . 0.0 109.108 -168.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.1 m -73.12 32.08 0.07 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.27 126.36 4.75 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 124.12 0.968 . . . . 0.0 109.647 169.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -101.15 146.11 0.3 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.05 2.5 . . . . 0.0 111.249 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.7 p -152.65 157.66 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 124.154 0.981 . . . . 0.0 108.376 169.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 7.4 m -56.25 146.63 23.05 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.527 1.531 . . . . 0.0 111.361 -177.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -131.13 126.15 21.4 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.18 1.392 . . . . 0.0 107.948 170.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -62.43 160.43 31.63 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.274 2.649 . . . . 0.0 113.304 177.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -135.06 143.25 46.6 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.22 1.808 . . . . 0.0 108.953 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 27.9 m -134.05 160.85 66.93 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 126.33 1.852 . . . . 0.0 109.051 -173.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -61.36 117.06 3.83 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 N-CA-C 104.116 -3.071 . . . . 0.0 104.116 167.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . 0.454 ' CD2' ' HB3' ' A' ' 14' ' ' ALA . 3.8 t60 -62.59 137.96 58.38 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -167.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.64 145.52 38.78 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.453 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.79 149.61 46.66 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 175.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -66.36 152.3 45.32 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 117.363 0.582 . . . . 0.0 110.543 175.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 80.8 mtt85 -68.71 141.71 55.22 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.5 134.47 34.84 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 169.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -158.27 167.29 30.17 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.942 1.297 . . . . 0.0 110.02 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -142.5 124.45 15.24 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 169.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -150.69 157.4 42.92 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.463 1.105 . . . . 0.0 108.985 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -169.56 148.79 12.33 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 171.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -87.76 58.03 4.67 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.97 0.908 . . . . 0.0 109.5 -176.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 44.2 mmm-85 -74.31 -25.69 59.72 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.08 -0.387 . . . . 0.0 110.995 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 14.9 m -67.07 132.53 48.05 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 70.43 16.44 73.63 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 119.65 -0.528 . . . . 0.0 113.394 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -67.87 134.07 50.24 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.278 1.039 . . . . 0.0 108.926 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -78.43 138.95 38.74 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.049 0.54 . . . . 0.0 110.013 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.493 0 C-N-CA 125.452 1.501 . . . . 0.0 108.114 175.355 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 119.159 -0.448 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 m 57.93 43.32 21.54 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.285 1.034 . . . . 0.0 111.293 171.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -86.21 45.5 1.23 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.398 1.079 . . . . 0.0 109.343 -178.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -142.98 159.45 42.21 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.535 1.534 . . . . 0.0 110.022 -169.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.4 mm -126.26 125.74 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 170.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.48 150.23 33.0 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.962 0.41 . . . . 0.0 110.092 176.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.18 156.71 47.65 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.589 1.09 . . . . 0.0 112.848 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -112.81 150.5 31.57 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.874 1.27 . . . . 0.0 110.101 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -82.35 -29.15 31.14 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.671 0.788 . . . . 0.0 111.368 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.8 p -158.52 -177.86 6.84 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 129.966 3.306 . . . . 0.0 105.601 172.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.8 m -57.59 144.23 73.22 Favored Pre-proline 0 CA--C 1.541 0.616 0 O-C-N 120.95 -1.094 . . . . 0.0 110.137 169.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.45 58.48 3.77 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 124.811 3.674 . . . . 0.0 109.652 169.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HE2' ' O ' ' A' ' 42' ' ' VAL . 41.1 tttm -50.55 -52.76 35.87 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 127.77 2.428 . . . . 0.0 112.692 -169.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.88 95.59 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.656 0.383 . . . . 0.0 111.144 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -70.11 -39.81 75.26 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -176.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 81.3 t -62.97 -40.79 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 173.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -62.54 -52.43 63.46 Favored 'General case' 0 C--N 1.341 0.201 0 CA-C-N 118.496 0.589 . . . . 0.0 110.195 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.2 -39.29 94.22 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.762 0.825 . . . . 0.0 110.899 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.34 -50.39 73.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -72.43 -29.4 63.67 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 117.84 -1.076 . . . . 0.0 112.493 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -59.95 -35.22 74.49 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 120.293 1.406 . . . . 0.0 109.886 169.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -76.53 -52.59 9.48 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.594 0.634 . . . . 0.0 109.378 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.0 mt -61.28 -39.06 81.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.907 1.283 . . . . 0.0 110.425 -176.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.12 -24.04 67.54 Favored 'General case' 0 CA--C 1.535 0.401 0 O-C-N 121.351 -0.843 . . . . 0.0 112.272 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.4 ttp85 -99.89 -30.34 12.08 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 125.465 1.506 . . . . 0.0 109.494 -175.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -61.21 -43.17 99.31 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 169.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.3 m -63.0 119.72 9.99 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 173.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 11.6 tmm? -65.86 117.47 8.29 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -177.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -140.34 164.23 30.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 127.119 2.168 . . . . 0.0 106.669 175.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -60.24 -35.7 76.08 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.41 -0.806 . . . . 0.0 110.869 173.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.8 pp -65.95 -18.35 65.28 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.533 0.733 . . . . 0.0 112.944 175.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.6 m -70.86 -21.94 62.36 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 120.388 1.449 . . . . 0.0 111.566 -176.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -91.94 -9.98 41.09 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.357 1.063 . . . . 0.0 111.991 177.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.6 mt -129.46 7.57 5.35 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.234 1.414 . . . . 0.0 112.305 -169.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . 0.266 0.1 OUTLIER 64.67 157.76 0.12 Allowed Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 128.37 2.668 . . . . 0.0 112.29 -169.018 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -49.62 135.1 34.05 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 123.484 2.789 . . . . 0.0 113.551 -174.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 p -65.28 -37.89 88.55 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.553 1.141 . . . . 0.0 111.07 -176.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 67.6 mtt -137.43 133.44 18.13 Favored Pre-proline 0 N--CA 1.455 -0.204 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 174.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -47.22 129.4 15.61 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.394 2.729 . . . . 0.0 114.205 178.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.1 t -63.91 136.94 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 168.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -142.49 156.08 45.12 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.028 0.831 . . . . 0.0 110.102 -171.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.41 ' O ' ' HE2' ' A' ' 13' ' ' LYS . 34.5 t -140.03 127.78 24.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -178.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.5 m -100.55 151.62 21.38 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.146 0.979 . . . . 0.0 109.772 169.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -123.95 143.24 50.51 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.136 1.774 . . . . 0.0 110.292 -176.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -145.3 170.2 16.77 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.239 1.415 . . . . 0.0 114.153 -169.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.8 t -54.19 169.29 0.18 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.226 2.611 . . . . 0.0 115.468 -169.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.6 tp -77.31 124.4 27.81 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 114.499 -1.228 . . . . 0.0 107.753 178.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -104.52 -125.12 0.22 Allowed 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.969 2.108 . . . . 0.0 107.172 -175.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -77.29 70.75 3.72 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.701 1.137 . . . . 0.0 109.814 177.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.06 15.58 65.32 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.335 0.969 . . . . 0.0 113.315 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -143.32 143.34 31.64 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 125.637 1.575 . . . . 0.0 108.104 -169.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -72.18 153.88 41.37 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.083 0.856 . . . . 0.0 110.27 174.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.52 158.39 16.11 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 169.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -164.71 168.51 39.02 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 108.056 -2.017 . . . . 0.0 108.056 173.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 48.2 m -140.39 145.14 36.69 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 169.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.07 144.11 25.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 171.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.9 tt -131.17 152.82 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 172.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.4 p -144.5 178.75 1.34 Allowed Pre-proline 0 N--CA 1.446 -0.662 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -63.84 1.0 1.64 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.437 2.092 . . . . 0.0 113.601 168.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.4 p-90 -138.6 -19.54 1.06 Allowed 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 -169.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -153.78 164.44 38.34 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 120.589 1.54 . . . . 0.0 111.703 -176.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 tp -136.49 116.57 13.37 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 169.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.1 m -136.26 122.52 20.49 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -172.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.05 145.87 55.35 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 169.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.6 m -139.5 146.64 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.887 1.275 . . . . 0.0 108.585 -177.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 45.4 mt -142.2 140.94 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 -170.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -137.0 144.37 46.1 Favored Pre-proline 0 N--CA 1.469 0.512 0 CA-C-O 117.638 -1.172 . . . . 0.0 110.065 -170.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -52.49 137.95 57.35 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.312 2.675 . . . . 0.0 112.919 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.41 -178.78 25.58 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 123.815 0.721 . . . . 0.0 112.943 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -64.16 140.7 72.74 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 123.017 2.478 . . . . 0.0 112.8 -171.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.7 t70 52.84 26.86 4.88 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.832 1.653 . . . . 0.0 114.035 170.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -87.02 152.98 21.9 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 171.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.7 83.65 2.03 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 170.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -66.87 152.9 95.16 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.896 172.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -71.56 159.1 52.18 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.901 1.734 . . . . 0.0 109.634 169.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.5 tp -66.78 117.24 8.64 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 169.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -85.78 154.78 21.35 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -177.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -84.19 142.33 30.39 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 168.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.4 t -89.23 154.55 3.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -168.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.3 m 66.12 8.62 5.63 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.702 1.601 . . . . 0.0 113.683 -176.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -78.74 161.55 26.78 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.687 1.195 . . . . 0.0 108.088 169.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -113.46 143.26 44.81 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 121.427 -0.795 . . . . 0.0 110.329 175.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.2 mm -118.33 126.13 74.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 176.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -75.24 123.8 7.42 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 174.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.8 mt -116.24 143.87 44.95 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.604 1.162 . . . . 0.0 108.167 174.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -96.14 128.01 42.67 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 175.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mp -138.54 155.17 73.78 Favored Pre-proline 0 C--O 1.236 0.376 0 C-N-CA 124.809 1.244 . . . . 0.0 107.702 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -63.43 -20.92 70.93 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 121.96 1.774 . . . . 0.0 113.619 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -58.86 -28.98 66.62 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.654 0.781 . . . . 0.0 111.535 169.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 129.03 155.78 8.68 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 106.679 -2.568 . . . . 0.0 106.679 -169.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.1 m -64.29 131.2 46.61 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 176.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 62.9 mtm -141.26 144.13 34.51 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.485 1.114 . . . . 0.0 108.349 -176.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.98 135.14 35.82 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 121.932 -0.48 . . . . 0.0 109.879 172.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -108.61 138.6 44.66 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 168.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.2 m -87.7 140.71 29.24 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.3 t -73.24 126.77 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 169.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -119.27 163.14 13.46 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 108.803 -1.719 . . . . 0.0 108.803 171.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -126.06 93.83 3.93 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 173.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 45.6 tp -75.36 124.89 27.9 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -169.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -59.97 132.79 55.04 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.101 0.56 . . . . 0.0 110.468 -176.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.24 3.7 70.99 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-O 118.752 -1.026 . . . . 0.0 113.581 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.3 t -127.49 -120.13 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.7 m -152.49 -178.6 6.94 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.744 1.618 . . . . 0.0 108.846 -169.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -68.79 143.3 54.66 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 169.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -150.51 169.45 21.46 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.548 1.539 . . . . 0.0 108.679 177.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.5 mp -104.4 141.8 35.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 170.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.8 p -141.13 155.4 46.11 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.705 0.802 . . . . 0.0 110.486 -177.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 48.0 t -144.99 110.83 5.42 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 171.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.7 m -71.22 127.73 33.55 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 24.0 mt -119.76 -40.2 2.78 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 118.677 -0.678 . . . . 0.0 112.33 -169.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 23.8 mtm -141.79 161.5 37.8 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.182 0.993 . . . . 0.0 108.724 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.2 p -123.16 66.19 30.94 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.042 1.337 . . . . 0.0 110.117 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -60.87 153.25 64.56 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.591 2.194 . . . . 0.0 110.699 174.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 95.9 mt -130.57 152.81 49.54 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.633 1.573 . . . . 0.0 106.767 172.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.1 m -73.68 58.45 0.61 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.352 1.461 . . . . 0.0 112.977 -174.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 30.5 t-80 -136.39 -67.28 0.52 Allowed 'General case' 0 C--O 1.231 0.115 0 C-N-CA 124.872 1.269 . . . . 0.0 109.405 172.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.6 m -87.84 51.52 2.23 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.6 tpt -159.3 162.46 36.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 128.047 2.539 . . . . 0.0 106.976 -168.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.5 p -151.2 171.59 17.17 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 174.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.502 ' H ' HD12 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -67.48 -26.55 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 120.986 -1.071 . . . . 0.0 110.33 170.163 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -67.05 -44.19 80.82 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 174.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -65.59 -30.13 70.82 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.204 0.911 . . . . 0.0 110.571 169.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -55.88 -27.63 50.9 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.674 1.13 . . . . 0.0 112.323 171.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -95.5 -55.04 3.16 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.332 1.066 . . . . 0.0 110.828 171.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -71.01 -29.68 65.69 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -169.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 15.5 tp -83.03 -29.72 28.64 Favored 'General case' 0 C--O 1.22 -0.487 0 CA-C-N 120.152 1.342 . . . . 0.0 109.608 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -64.75 -43.23 94.01 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 172.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -64.0 -48.53 76.03 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.167 0.587 . . . . 0.0 111.972 172.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -69.8 -25.71 63.91 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.115 -177.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 35.3 t -64.32 -42.41 96.33 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 174.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -66.68 -47.23 73.09 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 174.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 50.1 ttt-85 -57.0 -46.63 82.15 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.336 0.971 . . . . 0.0 111.315 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 52.6 ttp -47.4 -31.3 3.95 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.565 1.546 . . . . 0.0 112.229 174.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 25.7 pt -104.15 -18.98 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 120.066 1.303 . . . . 0.0 113.009 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . 0.299 3.5 pp -99.99 43.79 1.04 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 120.087 1.312 . . . . 0.0 108.074 168.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.3 p -76.59 52.71 0.82 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.746 2.418 . . . . 0.0 112.325 -169.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -66.76 144.03 98.38 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.067 173.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -81.76 56.55 5.95 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 124.455 3.437 . . . . 0.0 111.841 -174.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.7 t 66.12 153.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 126.708 2.003 . . . . 0.0 111.568 -173.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' THR . . . . . . . . . . . . . 6.8 m -62.07 140.9 58.36 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.105 0.962 . . . . 0.0 109.516 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -140.68 116.48 7.59 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 124.937 1.295 . . . . 0.0 107.835 174.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -80.21 65.19 8.92 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.553 2.835 . . . . 0.0 110.041 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 30.8 t70 63.23 -46.11 0.22 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 129.158 2.983 . . . . 0.0 114.487 -170.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.4 p -149.09 148.03 25.68 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 125.043 1.337 . . . . 0.0 108.843 174.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -54.58 166.02 2.1 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.843 3.028 . . . . 0.0 112.654 169.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -62.91 122.72 16.68 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 169.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -115.04 3.18 14.39 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.364 1.066 . . . . 0.0 112.215 -173.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.35 142.77 41.53 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -71.16 140.37 50.52 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -86.24 162.56 18.23 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 175.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -60.25 -31.01 69.81 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.949 0.5 . . . . 0.0 112.179 -177.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.44 13.07 14.62 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -178.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 37.8 tp -107.69 103.82 13.19 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 171.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -153.6 157.02 39.06 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.539 1.136 . . . . 0.0 109.473 173.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 63.7 -161.67 35.45 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 123.848 0.737 . . . . 0.0 111.509 -175.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 43.6 ttm180 -74.34 -54.48 7.56 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 173.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -145.33 30.77 1.12 Allowed 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.511 1.124 . . . . 0.0 109.675 172.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 9.6 m -71.94 -40.5 68.66 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -85.09 144.32 20.87 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 107.542 -2.223 . . . . 0.0 107.542 169.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.66 23.07 3.21 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -169.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -54.99 -36.62 65.6 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.704 0.802 . . . . 0.0 111.417 172.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 C-N-CA 124.66 1.184 . . . . 0.0 107.897 172.378 . . . . . . . . 0 0 . 1 stop_ save_